data_2mu1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mu1 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mmm . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -52.63 -177.45 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.323 1.849 . . . . 0.0 113.184 164.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -61.2 100.03 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 O-C-N 120.449 -1.407 . . . . 0.0 107.676 168.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.3 m -128.35 148.25 50.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.89 150.01 52.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -127.74 149.75 50.1 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.613 1.565 . . . . 0.0 108.41 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mt -142.82 132.12 21.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -115.67 179.61 3.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.849 1.66 . . . . 0.0 109.999 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -133.92 175.91 9.04 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.517 2.327 . . . . 0.0 106.657 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 C--O 1.236 0.347 0 C-N-CA 124.803 1.241 . . . . 0.0 108.824 -177.056 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -60.33 -21.24 61.81 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -57.66 -69.81 0.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.366 1.466 . . . . 0.0 109.043 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.06 -40.48 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.638 1.175 . . . . 0.0 109.962 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.7 mt -55.52 -50.79 69.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.13 0.877 . . . . 0.0 110.047 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.26 -45.08 89.68 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.286 0.635 . . . . 0.0 111.695 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -57.28 -55.28 36.82 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.227 1.011 . . . . 0.0 109.021 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.26 -40.5 94.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.59 0.756 . . . . 0.0 111.049 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -59.22 -58.64 7.76 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.195 1.398 . . . . 0.0 110.017 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -62.1 -28.49 69.66 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.6 m -71.2 -5.66 33.61 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.468 -0.77 . . . . 0.0 112.672 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.83 9.93 71.32 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 119.639 1.109 . . . . 0.0 113.539 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.3 mt -56.03 149.69 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 119.307 1.553 . . . . 0.0 107.192 160.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.64 105.48 16.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 170.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -78.47 149.43 33.2 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.25 0.932 . . . . 0.0 109.065 172.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -139.81 174.16 10.8 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.203 1.801 . . . . 0.0 108.383 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.0 mt -136.31 150.42 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -134.5 141.44 46.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 152.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.6 t -156.07 165.65 35.8 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -76.42 -12.95 60.13 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.189 -0.944 . . . . 0.0 112.882 174.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -63.98 156.76 26.95 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.149 -0.969 . . . . 0.0 110.063 -174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.49 -169.97 38.96 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.992 0.806 . . . . 0.0 114.252 -170.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -60.22 -12.52 9.0 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.949 1.3 . . . . 0.0 112.264 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -61.54 -12.44 15.35 Favored 'General case' 0 C--O 1.224 -0.238 0 O-C-N 119.781 -1.825 . . . . 0.0 112.384 168.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.44 -47.97 83.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 120.712 1.596 . . . . 0.0 107.804 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -56.46 -45.14 81.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.98 1.712 . . . . 0.0 110.098 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 m -67.46 -44.81 77.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.998 0.919 . . . . 0.0 111.209 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.72 -46.0 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.669 1.188 . . . . 0.0 108.308 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mp -57.36 -45.19 84.66 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.702 0.801 . . . . 0.0 110.504 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -49.9 75.53 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.257 1.023 . . . . 0.0 110.358 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.21 -57.5 7.64 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.755 1.622 . . . . 0.0 109.179 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.94 -12.86 61.78 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.785 1.634 . . . . 0.0 112.727 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 88.77 12.51 64.09 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.562 1.077 . . . . 0.0 113.976 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.4 m -119.87 16.27 6.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 125.105 1.362 . . . . 0.0 111.635 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -59.65 -40.6 88.21 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.267 -0.896 . . . . 0.0 113.37 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.03 -11.04 60.41 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.757 0.661 . . . . 0.0 112.486 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -74.71 4.57 6.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.857 1.208 . . . . 0.0 113.269 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -141.28 123.94 16.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -54.36 -45.96 72.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.284 1.434 . . . . 0.0 110.175 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -153.58 142.82 21.47 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.71 100.96 7.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.1 155.23 34.91 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.9 p -140.91 -174.64 4.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.103 1.361 . . . . 0.0 109.848 -171.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 62.4 p -52.36 -24.51 7.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.534 1.061 . . . . 0.0 112.592 168.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -58.47 -35.22 71.84 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.144 1.378 . . . . 0.0 110.349 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.406 ' HB2' ' CD2' ' A' ' 136' ' ' PHE . 80.5 p -57.36 -35.82 70.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.54 -8.01 50.53 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.671 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.406 ' CD2' ' HB2' ' A' ' 134' ' ' SER . 29.5 m-85 -59.57 156.97 12.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.72 1.26 . . . . 0.0 111.087 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -52.97 159.18 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.054 1.342 . . . . 0.0 113.398 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -67.53 160.64 27.24 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.585 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -61.09 133.01 92.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 117.258 -1.353 . . . . 0.0 108.744 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.66 135.68 41.4 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 121.33 1.511 . . . . 0.0 110.17 -3.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.44 85.45 9.47 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -170.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.21 -16.61 22.27 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 N-CA-C 109.23 -1.104 . . . . 0.0 109.23 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -44.52 -49.96 9.76 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 126.857 2.063 . . . . 0.0 110.717 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.55 65.54 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.491 -171.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.4 -41.16 20.27 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.095 -1.628 . . . . 0.0 109.295 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.8 m -58.87 -30.52 67.79 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.902 0.774 . . . . 0.0 111.082 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.575 ' CZ ' ' HE3' ' A' ' 151' ' ' LYS . 34.4 t80 -60.62 -55.68 30.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.884 0.873 . . . . 0.0 109.389 166.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 4.5 mp -58.09 -28.09 64.27 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.705 1.602 . . . . 0.0 113.095 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.7 mt -71.61 -63.97 1.02 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.467 1.507 . . . . 0.0 107.18 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.36 -20.05 65.97 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.273 0.629 . . . . 0.0 112.55 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.575 ' HE3' ' CZ ' ' A' ' 147' ' ' TYR . 12.5 mmtt -51.78 -41.64 61.82 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 121.345 -0.847 . . . . 0.0 111.897 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -144.46 17.28 1.68 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -172.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.6 mm-40 59.9 62.9 1.57 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.867 1.667 . . . . 0.0 110.983 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.89 173.19 6.42 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.347 1.459 . . . . 0.0 109.973 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -116.51 126.28 53.12 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.522 1.529 . . . . 0.0 108.07 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -44.6 77.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.2 1.0 . . . . 0.0 110.454 174.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.76 -9.32 58.51 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.326 -0.859 . . . . 0.0 112.607 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -117.33 17.44 14.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.819 0.848 . . . . 0.0 108.829 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -106.64 130.31 54.4 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 170.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -122.2 97.78 5.63 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.079 1.752 . . . . 0.0 106.802 -170.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -71.85 158.7 35.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.684 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 47.8 mt -130.03 97.62 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 -171.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -120.81 -179.0 16.12 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 125.562 1.554 . . . . 0.0 112.011 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -128.78 -5.48 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.516 1.126 . . . . 0.0 113.405 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -121.16 165.54 15.23 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 122.347 1.07 . . . . 0.0 112.126 -164.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.8 t -63.25 -39.53 94.85 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.992 1.317 . . . . 0.0 110.187 164.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -32.46 72.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.408 1.083 . . . . 0.0 110.421 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.38 8.45 0.61 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.623 1.969 . . . . 0.0 111.824 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -131.39 -25.06 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 125.296 1.439 . . . . 0.0 110.816 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.53 -56.66 19.02 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.665 -1.272 . . . . 0.0 109.344 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -66.5 -29.52 69.64 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.947 -1.095 . . . . 0.0 110.925 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.54 -51.29 67.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -52.76 -52.84 54.95 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 124.386 1.075 . . . . 0.0 111.027 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -52.63 -47.21 67.16 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.354 0.261 . . . . 0.0 111.496 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.8 m -72.79 -26.85 61.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.763 0.825 . . . . 0.0 112.048 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.96 32.54 39.7 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.561 1.553 . . . . 0.0 111.181 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 22.1 pt -109.83 167.61 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 124.985 1.314 . . . . 0.0 109.36 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -97.63 162.54 13.24 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -175.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 23.5 m -135.33 152.75 51.76 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.327 1.451 . . . . 0.0 109.787 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 42.2 mt -131.84 95.37 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -129.56 149.97 51.1 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.309 1.044 . . . . 0.0 109.117 -165.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -70.7 -12.28 61.46 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.071 -1.018 . . . . 0.0 113.542 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.37 151.64 47.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.658 1.583 . . . . 0.0 109.594 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -78.4 154.95 30.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.4 t -144.11 13.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.387 0.675 . . . . 0.0 110.946 -174.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 71.0 p 57.06 69.66 0.72 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.939 2.096 . . . . 0.0 110.406 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -150.78 135.19 17.07 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.402 1.081 . . . . 0.0 108.405 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -70.12 -7.08 38.61 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -108.19 8.08 35.47 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.297 1.427 . . . . 0.0 112.954 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -108.94 122.06 46.42 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 120.788 2.294 . . . . 0.0 110.437 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -101.21 119.17 38.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.364 1.065 . . . . 0.0 109.427 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -67.61 146.59 53.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.431 0.56 . . . . 0.0 111.273 171.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.2 pt -146.04 175.75 2.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 127.296 2.239 . . . . 0.0 109.594 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -136.38 -12.41 1.84 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.436 1.494 . . . . 0.0 113.142 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.15 160.8 39.14 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.148 1.379 . . . . 0.0 108.075 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.36 -31.8 73.15 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.231 1.412 . . . . 0.0 110.503 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.22 -9.18 51.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -19.02 61.0 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.384 0.993 . . . . 0.0 110.409 172.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 67.8 mt -55.86 -52.85 44.5 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.6 p -60.26 -35.67 76.05 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.113 0.415 . . . . 0.0 111.688 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -62.62 -36.28 82.27 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.876 0.871 . . . . 0.0 112.226 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.3 mt -59.37 -44.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 124.289 1.036 . . . . 0.0 108.8 -172.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -84.86 13.17 6.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.534 1.134 . . . . 0.0 112.55 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 125.295 1.438 . . . . 0.0 110.362 -172.236 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.2 mmm . . . . . 0 N--CA 1.438 -1.033 0 N-CA-C 102.306 -3.22 . . . . 0.0 102.306 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -169.36 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 112.551 -2.113 . . . . 0.0 110.625 158.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -50.22 115.0 1.24 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 156.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.6 m -131.52 157.77 42.68 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 163.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.95 150.71 51.97 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.878 -0.514 . . . . 0.0 109.683 165.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.66 149.28 52.32 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 126.273 1.829 . . . . 0.0 108.156 -173.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.0 mt -142.12 145.65 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -125.22 174.51 8.05 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.086 1.755 . . . . 0.0 109.979 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 -11.2 9.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.561 1.544 . . . . 0.0 111.723 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 N--CA 1.466 0.332 0 C-N-CA 128.437 2.695 . . . . 0.0 112.603 174.132 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.557 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -67.0 -25.31 66.24 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.39 -1.444 . . . . 0.0 114.266 -167.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.04 -53.94 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.108 0.563 . . . . 0.0 110.592 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.8 t -68.63 -34.95 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.713 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.4 mp -44.49 -50.51 9.43 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 121.529 1.968 . . . . 0.0 113.374 164.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.92 -50.47 64.32 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 124.15 0.906 . . . . 0.0 109.782 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -53.36 -50.53 64.88 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 123.836 0.71 . . . . 0.0 110.358 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.04 -39.79 82.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.314 1.046 . . . . 0.0 111.822 -177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -71.96 -41.52 67.64 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 118.455 0.571 . . . . 0.0 110.719 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -64.17 -28.56 69.84 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.508 -0.745 . . . . 0.0 111.547 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.5 m -76.49 -13.0 60.13 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.002 0.921 . . . . 0.0 112.235 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.62 37.38 75.82 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.027 1.299 . . . . 0.0 112.003 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.6 mt -68.12 121.85 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 159.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -68.08 113.6 5.88 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 170.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -94.13 144.13 25.76 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.406 1.482 . . . . 0.0 107.686 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -143.97 177.83 8.28 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.242 1.017 . . . . 0.0 109.298 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.9 mt -135.83 150.52 28.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 124.074 0.95 . . . . 0.0 108.591 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -133.24 113.16 12.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 156.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -133.06 175.52 9.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.315 1.446 . . . . 0.0 109.178 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . 0.274 2.1 p80 -125.99 22.42 7.35 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -72.42 -0.81 13.49 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.16 -177.9 38.42 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.912 1.244 . . . . 0.0 111.793 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -72.27 -2.77 20.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -162.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -70.85 -10.22 59.16 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.741 164.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.96 -52.96 17.62 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.731 1.212 . . . . 0.0 111.335 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -59.47 -44.79 92.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.055 0.542 . . . . 0.0 110.114 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -62.82 -40.82 98.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.938 1.295 . . . . 0.0 111.123 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.7 mt -63.64 -50.75 76.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.33 -38.93 92.78 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.57 -0.706 . . . . 0.0 111.324 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -63.51 -46.02 88.01 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.6 0.76 . . . . 0.0 110.379 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -48.68 -50.42 33.32 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.985 1.374 . . . . 0.0 110.111 172.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.4 mt -69.46 -18.67 63.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.844 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.99 33.32 69.97 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.869 0.759 . . . . 0.0 111.985 174.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.1 m -137.19 22.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 126.361 1.864 . . . . 0.0 108.841 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.81 -42.18 81.93 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.051 -0.405 . . . . 0.0 110.218 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.2 m -58.83 -24.27 61.78 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.935 0.772 . . . . 0.0 112.171 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -68.47 6.35 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.123 1.369 . . . . 0.0 113.986 175.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -140.91 105.94 4.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 47.6 m -55.16 -41.32 71.7 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.521 1.528 . . . . 0.0 111.056 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -150.87 147.26 27.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.74 96.87 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -167.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.97 145.79 48.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.1 p -123.88 -176.26 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.493 1.117 . . . . 0.0 110.323 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.9 t -48.78 -34.88 13.13 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.273 1.429 . . . . 0.0 110.411 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -82.3 -2.58 53.14 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.286 1.434 . . . . 0.0 112.319 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 83.9 p -57.07 -63.13 1.31 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.304 1.411 . . . . 0.0 110.299 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 123.2 -16.0 8.16 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 125.598 1.57 . . . . 0.0 112.643 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -58.63 166.83 1.68 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.049 1.425 . . . . 0.0 112.83 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.3 m -60.57 160.75 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.916 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.4 mtt-85 -84.89 147.71 26.63 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.061 -1.649 . . . . 0.0 109.01 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -48.44 131.79 13.38 Favored Pre-proline 0 C--O 1.243 0.743 0 CA-C-O 117.4 -1.286 . . . . 0.0 109.949 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.27 125.82 7.19 Favored 'Cis proline' 0 C--N 1.351 0.691 0 CA-C-N 121.018 1.399 . . . . 0.0 111.696 -3.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.4 p -141.94 85.43 11.12 Favored Pre-proline 0 N--CA 1.438 -1.026 0 C-N-CA 123.292 0.637 . . . . 0.0 111.893 -173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.69 -18.51 32.57 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.376 . . . . 0.0 112.561 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -45.3 -43.84 11.0 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.285 1.834 . . . . 0.0 112.686 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.63 -7.6 21.67 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.537 0.939 . . . . 0.0 113.537 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.01 -61.05 1.93 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.046 0.938 . . . . 0.0 108.737 163.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.8 m -56.22 -40.29 73.85 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.475 1.91 . . . . 0.0 110.466 -170.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -53.91 -51.25 64.34 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.572 0.749 . . . . 0.0 110.907 174.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.51 -27.98 51.97 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.832 0.853 . . . . 0.0 112.159 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.49 -59.93 4.26 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -67.76 -22.41 65.21 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -61.13 -48.91 79.47 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.788 -1.195 . . . . 0.0 112.438 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -121.63 18.19 11.19 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.078 0.854 . . . . 0.0 112.013 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 54.07 51.96 13.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.335 1.854 . . . . 0.0 111.219 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.33 170.3 15.51 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.371 1.469 . . . . 0.0 110.224 175.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -105.73 130.25 53.78 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.038 1.735 . . . . 0.0 108.288 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 m -58.02 -29.47 65.34 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.261 0.937 . . . . 0.0 110.877 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.52 -27.83 23.75 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.84 -0.94 55.69 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -99.64 138.74 36.3 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.143 0.883 . . . . 0.0 108.654 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -120.15 166.16 13.8 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.871 1.669 . . . . 0.0 107.554 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -139.39 157.25 46.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.455 1.902 . . . . 0.0 107.02 168.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 5.0 mt -135.82 128.73 47.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -161.72 10.01 0.11 Allowed Glycine 0 C--O 1.224 -0.482 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.026 -174.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . 0.293 1.5 p30 60.86 -1.85 0.22 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 129.799 3.24 . . . . 0.0 115.862 163.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -113.36 168.27 9.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.974 0.806 . . . . 0.0 112.858 -168.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.1 t -59.22 -35.39 73.56 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.077 -1.015 . . . . 0.0 111.642 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 -13.44 61.8 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.37 1.468 . . . . 0.0 112.419 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.42 -39.15 88.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.634 0.731 . . . . 0.0 111.595 -167.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.91 -45.86 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 125.022 1.329 . . . . 0.0 108.655 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -59.81 -41.18 90.69 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.021 0.929 . . . . 0.0 110.938 -177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -64.22 -51.81 61.87 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.229 0.922 . . . . 0.0 110.829 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.19 97.51 Favored 'General case' 0 C--O 1.224 -0.287 0 O-C-N 123.577 0.548 . . . . 0.0 111.259 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -62.78 -28.89 70.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.322 0.649 . . . . 0.0 111.81 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -60.04 -46.8 88.34 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.486 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.33 -23.36 32.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.879 1.672 . . . . 0.0 113.318 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 90.0 10.39 64.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.499 2.0 . . . . 0.0 113.847 -175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 23.7 pt -81.79 -173.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.221 1.51 . . . . 0.0 110.163 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -101.17 161.75 13.39 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.287 1.035 . . . . 0.0 110.419 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.05 160.58 40.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.885 1.274 . . . . 0.0 113.419 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.8 mt -142.9 83.34 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.823 1.649 . . . . 0.0 108.845 -172.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -97.66 -171.41 2.18 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.994 -1.066 . . . . 0.0 110.62 173.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -99.74 -5.9 27.95 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.514 -1.366 . . . . 0.0 112.704 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -112.61 137.58 50.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -176.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.96 162.04 29.97 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.958 1.703 . . . . 0.0 109.626 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 34.7 t -155.77 157.87 37.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 10.2 p -85.91 19.64 2.49 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.603 1.161 . . . . 0.0 111.795 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -67.82 -178.62 0.99 Allowed 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.612 -0.68 . . . . 0.0 110.27 168.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.04 5.5 7.93 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -165.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.92 23.39 1.01 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.1 1.81 . . . . 0.0 111.52 167.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -81.92 149.56 28.17 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 120.794 -1.415 . . . . 0.0 108.882 160.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -142.29 99.36 3.49 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.166 0.586 . . . . 0.0 109.612 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -73.93 162.63 28.86 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 118.438 -1.305 . . . . 0.0 112.035 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 6.7 pt -135.31 169.31 21.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.403 1.881 . . . . 0.0 110.099 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -117.57 -2.9 11.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.95 1.3 . . . . 0.0 112.862 168.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.56 167.52 28.34 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.852 1.261 . . . . 0.0 109.079 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.5 tp -76.08 -40.39 53.2 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -173.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.48 -18.86 64.23 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.52 -11.24 60.17 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.811 0.844 . . . . 0.0 111.027 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.39 -55.62 23.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-O 117.835 -1.079 . . . . 0.0 108.484 166.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.2 m -54.27 -38.88 66.33 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.621 1.101 . . . . 0.0 110.158 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -64.14 -25.98 68.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.1 mt -56.44 -48.19 80.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -78.85 -41.07 30.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.436 1.094 . . . . 0.0 109.89 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.235 0.337 0 C-N-CA 126.67 1.988 . . . . 0.0 109.276 -174.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mmm . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 122.846 1.308 . . . . 0.0 107.478 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.35 114.59 28.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 113.985 -1.461 . . . . 0.0 107.588 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.53 83.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.329 1.852 . . . . 0.0 111.368 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 m -124.08 135.11 53.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.8 150.26 31.9 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 170.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -126.49 150.91 48.45 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.291 1.436 . . . . 0.0 108.464 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -138.56 135.47 43.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -125.8 163.05 23.73 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.841 2.057 . . . . 0.0 109.999 -169.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -86.51 -29.92 22.35 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.851 2.06 . . . . 0.0 112.491 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 C-N-CA 125.615 1.566 . . . . 0.0 111.195 -167.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -65.49 -30.08 70.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.676 1.125 . . . . 0.0 112.301 -175.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.46 -55.63 31.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.818 0.847 . . . . 0.0 110.489 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.47 -42.14 94.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.33 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.6 mp -44.55 -52.85 7.65 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 121.645 2.021 . . . . 0.0 112.544 168.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.69 80.68 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.588 1.18 . . . . 0.0 110.957 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -58.63 -46.66 86.61 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.101 0.96 . . . . 0.0 111.421 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.51 -38.0 68.21 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.293 -0.861 . . . . 0.0 112.418 -172.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.52 -40.75 93.33 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.945 0.793 . . . . 0.0 109.752 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -52.03 -54.74 26.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.639 1.176 . . . . 0.0 109.021 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.3 m -74.0 4.77 4.97 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 60.31 24.79 61.76 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.659 1.118 . . . . 0.0 113.151 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.4 mt -71.3 108.22 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 127.032 2.133 . . . . 0.0 107.47 169.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.84 103.18 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.996 0.518 . . . . 0.0 110.165 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -84.8 151.58 24.25 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -145.32 169.64 17.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.943 1.697 . . . . 0.0 109.803 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 22.3 mt -138.79 157.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.774 1.629 . . . . 0.0 110.698 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -137.46 115.77 11.84 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.027 0.931 . . . . 0.0 109.383 163.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -134.42 161.07 36.04 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.454 1.502 . . . . 0.0 108.547 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -88.28 -2.43 58.6 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.283 1.033 . . . . 0.0 110.896 170.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.09 147.87 11.99 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.853 1.661 . . . . 0.0 108.233 172.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.95 -171.59 28.48 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 123.642 0.639 . . . . 0.0 111.616 -170.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -58.7 -22.38 57.18 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.787 -0.831 . . . . 0.0 111.432 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -57.6 -17.37 13.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.727 1.211 . . . . 0.0 114.008 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.79 -49.01 66.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.606 1.548 . . . . 0.0 111.123 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -59.55 -42.2 91.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.17 0.588 . . . . 0.0 110.233 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -62.79 -46.01 89.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.451 1.1 . . . . 0.0 110.906 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 39.6 mt -59.84 -45.61 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 124.421 1.088 . . . . 0.0 108.824 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -57.29 -44.98 84.53 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.463 0.705 . . . . 0.0 111.29 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -48.48 81.61 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.913 0.485 . . . . 0.0 110.267 174.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -51.05 -52.78 39.83 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.747 1.219 . . . . 0.0 110.473 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.47 -3.67 32.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.145 1.778 . . . . 0.0 113.307 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.25 32.98 84.57 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.751 1.167 . . . . 0.0 112.645 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.54 23.59 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.977 0.911 . . . . 0.0 109.706 174.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -48.54 76.85 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.035 -1.04 . . . . 0.0 110.304 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.9 m -70.87 -19.01 62.67 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -66.17 -0.51 2.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 117.132 -1.414 . . . . 0.0 113.638 167.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -139.84 105.06 5.03 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 121.665 2.03 . . . . 0.0 108.97 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.4 m -51.73 -40.79 60.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.933 1.693 . . . . 0.0 112.254 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -157.28 145.55 19.35 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 -172.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.05 131.04 45.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -85.18 151.87 23.77 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 167.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.2 p -137.17 -168.3 2.26 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.608 1.563 . . . . 0.0 110.208 -172.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.4 t -53.78 -26.55 24.26 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.497 -1.377 . . . . 0.0 112.975 167.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -61.03 -33.92 74.05 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.983 0.896 . . . . 0.0 109.168 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.9 m -85.31 69.83 10.77 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 129.07 2.948 . . . . 0.0 104.793 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.51 44.59 1.99 Allowed Glycine 0 CA--C 1.522 0.494 0 CA-C-O 118.693 -1.059 . . . . 0.0 111.324 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -67.22 174.45 3.21 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 124.602 2.144 . . . . 0.0 112.191 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.8 t -76.75 157.64 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 128.261 2.624 . . . . 0.0 110.6 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -72.25 166.34 22.62 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.397 1.479 . . . . 0.0 110.467 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 mmpm? -73.04 149.02 89.5 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 120.36 -1.463 . . . . 0.0 107.967 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.88 -4.99 32.51 Favored 'Cis proline' 0 CA--C 1.533 0.434 0 N-CA-C 115.842 1.439 . . . . 0.0 115.842 11.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.2 t -43.09 91.39 0.05 OUTLIER Pre-proline 0 C--O 1.241 0.655 0 C-N-CA 127.366 2.266 . . . . 0.0 114.576 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.84 6.94 0.05 OUTLIER 'Trans proline' 0 CA--C 1.556 1.616 1 C-N-CA 128.068 5.845 . . . . 0.0 114.64 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -43.74 -71.65 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.333 2.653 . . . . 0.0 112.236 -172.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.8 -16.39 40.18 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -175.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.35 -54.82 6.21 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 119.68 1.127 . . . . 0.0 108.552 171.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 m -53.06 -38.72 62.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.665 1.186 . . . . 0.0 110.605 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -52.04 -50.38 61.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.346 1.058 . . . . 0.0 110.715 174.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.73 -35.85 72.89 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.302 1.041 . . . . 0.0 111.406 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.27 -58.44 8.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -64.47 -29.18 70.23 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.345 1.069 . . . . 0.0 111.758 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -63.77 -27.41 69.17 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.164 -1.585 . . . . 0.0 114.842 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -141.6 8.73 1.97 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.994 0.816 . . . . 0.0 111.862 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 55.43 74.1 0.39 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.709 1.604 . . . . 0.0 109.634 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.14 178.19 4.73 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.846 1.259 . . . . 0.0 109.536 175.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -109.07 130.91 55.49 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -44.84 -53.77 7.13 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 124.579 1.175 . . . . 0.0 108.678 173.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -76.48 -20.88 56.53 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 125.741 1.616 . . . . 0.0 112.732 -159.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -90.53 4.13 52.03 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.679 0.792 . . . . 0.0 109.943 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -92.93 162.06 14.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.791 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -146.65 118.01 7.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.694 0.797 . . . . 0.0 109.133 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -82.83 155.33 24.22 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.084 0.402 . . . . 0.0 110.33 167.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.6 mp -127.61 114.32 35.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.826 1.25 . . . . 0.0 107.94 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.74 158.64 31.61 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 123.469 0.48 . . . . 0.0 112.254 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.44 3.29 34.82 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -163.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -101.69 164.75 11.58 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.05 1.295 . . . . 0.0 111.581 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 6.5 t -72.57 -14.6 61.66 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.665 -0.647 . . . . 0.0 112.295 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -16.24 48.2 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.811 0.732 . . . . 0.0 110.023 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -78.01 11.41 2.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.178 1.791 . . . . 0.0 112.235 -173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.1 p -120.76 -19.82 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.483 1.513 . . . . 0.0 110.922 170.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.9 -38.87 89.87 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 120.729 -1.232 . . . . 0.0 110.221 -171.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -78.87 -28.9 44.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.301 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.84 -51.45 69.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -50.88 -42.15 58.81 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.048 1.339 . . . . 0.0 112.136 171.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -50.29 63.0 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.649 -0.657 . . . . 0.0 111.241 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 8.6 t -69.78 -17.85 63.44 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.709 0.803 . . . . 0.0 110.769 174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.47 33.49 38.85 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.86 2.171 . . . . 0.0 112.525 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.46 171.58 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.591 1.557 . . . . 0.0 111.908 -165.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -92.06 154.57 18.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.715 1.206 . . . . 0.0 111.964 -173.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.7 m -136.46 151.54 49.58 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.198 1.399 . . . . 0.0 110.275 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 46.3 mt -123.6 111.67 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.71 160.26 31.3 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 123.535 0.734 . . . . 0.0 109.027 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -79.63 -16.91 54.94 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.503 -1.373 . . . . 0.0 111.723 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.24 160.93 19.75 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 128.192 2.597 . . . . 0.0 108.655 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -61.22 156.48 18.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.8 m -149.34 22.12 0.94 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.444 1.098 . . . . 0.0 111.184 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 73.7 p 52.29 46.81 25.98 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.966 0.906 . . . . 0.0 111.625 158.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -145.66 176.96 9.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.423 1.489 . . . . 0.0 108.572 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -102.06 -20.64 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.269 1.028 . . . . 0.0 112.447 -177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -106.57 0.0 37.05 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.211 1.386 . . . . 0.0 111.816 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.72 152.29 22.25 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 119.606 1.703 . . . . 0.0 109.411 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -127.69 148.15 50.4 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.511 1.124 . . . . 0.0 108.539 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -85.87 153.51 22.18 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.487 0.585 . . . . 0.0 112.253 166.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.5 169.26 17.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 126.366 1.866 . . . . 0.0 110.244 168.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -123.3 -9.29 8.09 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.547 1.539 . . . . 0.0 112.827 170.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.51 167.85 29.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.259 1.424 . . . . 0.0 108.56 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.3 tp -69.52 -37.93 77.34 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.28 -15.09 59.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -69.64 -21.12 63.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.409 0.55 . . . . 0.0 109.786 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 86.3 mt -58.53 -59.04 4.16 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 125.411 1.485 . . . . 0.0 108.433 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.0 m -55.7 -39.94 71.72 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.709 0.686 . . . . 0.0 110.86 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -59.9 -33.3 71.67 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.888 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.6 mt -55.34 -47.55 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 119.664 1.12 . . . . 0.0 109.433 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.65 -18.21 51.96 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 . . . . . 0 CA--C 1.536 0.426 0 C-N-CA 126.272 1.829 . . . . 0.0 111.923 -174.714 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 C--O 1.235 0.339 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -62.98 -164.8 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.716 1.206 . . . . 0.0 109.864 167.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 69.91 0.07 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.887 1.675 . . . . 0.0 112.178 -176.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.4 m -81.17 153.37 27.26 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.41 147.99 45.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.11 152.94 43.73 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.2 mt -127.99 173.92 12.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 163.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -145.4 164.4 31.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.945 0.898 . . . . 0.0 109.142 167.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -93.01 -24.8 18.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.303 1.441 . . . . 0.0 113.647 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.7 tp . . . . . 0 N--CA 1.475 0.78 0 C-N-CA 129.205 3.002 . . . . 0.0 115.814 -174.814 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.82 -23.19 28.92 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.43 -57.03 6.47 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.661 0.784 . . . . 0.0 110.575 170.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.6 t -53.88 -44.07 59.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 123.604 0.761 . . . . 0.0 109.466 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.1 mt -56.0 -49.33 73.95 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.161 0.891 . . . . 0.0 110.532 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.7 73.97 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.149 0.58 . . . . 0.0 110.95 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -53.31 -46.97 69.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.774 1.23 . . . . 0.0 111.149 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.81 -45.85 66.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.112 1.365 . . . . 0.0 111.323 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -59.97 -48.58 81.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.165 1.386 . . . . 0.0 110.464 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.1 -42.1 80.16 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.569 0.748 . . . . 0.0 110.242 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.6 m -69.76 -6.56 32.9 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.216 1.006 . . . . 0.0 113.67 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.23 -5.57 84.87 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.575 1.56 . . . . 0.0 114.33 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mt -53.36 118.61 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 128.39 2.676 . . . . 0.0 110.268 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -68.15 101.05 1.09 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.368 1.067 . . . . 0.0 108.252 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -84.9 148.81 26.06 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -141.18 179.19 6.9 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.618 1.567 . . . . 0.0 107.525 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.1 mt -131.73 143.74 39.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 167.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -128.52 109.21 11.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 166.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -141.68 150.91 42.49 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -171.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -77.56 -1.95 33.22 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.504 -0.747 . . . . 0.0 112.343 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -63.31 164.22 9.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.043 0.937 . . . . 0.0 110.233 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.47 -176.25 49.61 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -55.58 -25.59 39.07 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.603 0.761 . . . . 0.0 111.74 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -16.81 11.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.752 -1.218 . . . . 0.0 112.576 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.68 -36.59 74.43 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.724 1.147 . . . . 0.0 112.153 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -60.79 -53.88 51.98 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -59.05 -41.49 88.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.519 1.528 . . . . 0.0 111.173 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.94 -50.72 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.748 0.819 . . . . 0.0 109.421 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mp -58.83 -47.87 83.31 Favored 'General case' 0 C--O 1.228 -0.074 0 O-C-N 121.487 -0.758 . . . . 0.0 110.757 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -56.81 -46.48 81.59 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.723 0.809 . . . . 0.0 110.145 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -54.93 -52.22 63.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.184 1.394 . . . . 0.0 109.939 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.42 -7.01 39.87 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.029 1.332 . . . . 0.0 113.592 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.48 28.71 63.03 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.385 0.993 . . . . 0.0 112.469 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.7 m -128.79 28.74 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 124.82 1.248 . . . . 0.0 111.175 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -58.49 -57.61 12.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.533 1.133 . . . . 0.0 112.004 172.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.7 m -73.22 -22.41 60.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.19 0.596 . . . . 0.0 111.615 -165.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.29 -29.57 58.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.86 -0.59 . . . . 0.0 112.564 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -109.17 110.93 22.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 66.5 m -46.77 -47.74 20.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.147 1.379 . . . . 0.0 109.123 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.47 159.25 42.59 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.74 134.92 65.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 171.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.6 mt -99.01 151.08 21.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 42.4 p -145.55 174.3 11.28 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.561 1.544 . . . . 0.0 107.636 -170.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.2 t -57.51 -13.45 3.72 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 121.215 -0.928 . . . . 0.0 113.272 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -59.31 -48.33 82.03 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.387 1.475 . . . . 0.0 109.197 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 95.8 p -54.54 -36.97 64.86 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.204 1.802 . . . . 0.0 113.037 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.03 -4.87 78.96 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.394 -1.226 . . . . 0.0 114.8 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -50.74 158.71 0.62 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.627 1.213 . . . . 0.0 112.438 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.6 m -52.93 154.8 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 122.903 1.335 . . . . 0.0 112.296 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -85.55 160.38 19.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.241 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 136.93 87.25 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.621 -1.181 . . . . 0.0 108.865 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.25 122.35 7.89 Favored 'Cis proline' 0 N--CA 1.454 -0.805 0 CA-C-N 120.755 1.305 . . . . 0.0 110.732 -0.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.0 p -123.32 85.6 51.96 Favored Pre-proline 0 N--CA 1.446 -0.666 0 C-N-CA 125.252 1.421 . . . . 0.0 111.283 -163.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.14 -27.51 8.17 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.709 2.273 . . . . 0.0 113.441 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -53.8 -54.68 34.98 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.364 -0.835 . . . . 0.0 112.191 -166.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.0 -7.75 43.42 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.231 -0.918 . . . . 0.0 113.038 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.97 -48.4 11.5 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 m -55.62 -41.49 73.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.533 1.133 . . . . 0.0 109.946 171.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -58.45 -58.54 8.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.873 0.869 . . . . 0.0 109.996 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -67.12 -19.74 65.66 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.124 0.97 . . . . 0.0 112.855 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -63.14 1.14 Allowed 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 173.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.07 -22.92 65.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.31 -26.46 66.56 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 120.898 -1.126 . . . . 0.0 113.34 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -148.69 23.07 1.0 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.451 1.023 . . . . 0.0 112.232 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 50.14 67.2 0.95 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.584 1.553 . . . . 0.0 111.576 -174.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 mp -100.23 170.7 8.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.791 1.282 . . . . 0.0 111.024 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.81 123.14 42.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.861 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 m -59.92 -39.31 85.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.17 1.388 . . . . 0.0 110.816 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -83.25 -13.2 55.79 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.167 -0.958 . . . . 0.0 112.997 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -109.86 13.41 23.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -92.25 149.42 21.47 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -141.43 113.84 8.19 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -73.15 -40.87 64.51 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.0 mp 56.17 99.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 126.461 1.904 . . . . 0.0 111.73 -169.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -122.96 -171.86 13.78 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.87 148.09 32.49 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 169.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER 58.23 171.12 0.05 Allowed 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 126.595 1.958 . . . . 0.0 114.461 -165.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.49 169.91 1.57 Allowed 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 127.382 2.273 . . . . 0.0 110.119 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 tm? 68.4 -27.1 0.14 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 130.409 3.484 . . . . 0.0 113.339 -164.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -73.63 8.11 2.06 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.726 1.603 . . . . 0.0 114.413 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.54 -13.03 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.0 -1.062 . . . . 0.0 110.823 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -66.52 -40.75 89.31 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.711 -1.243 . . . . 0.0 111.026 -173.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -69.22 -32.74 72.19 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.287 -0.883 . . . . 0.0 111.516 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.28 -45.94 89.09 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.458 0.572 . . . . 0.0 109.52 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -49.89 -53.05 28.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.69 0.796 . . . . 0.0 110.622 168.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -58.25 -47.65 82.9 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.9 m -69.58 -20.79 63.65 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.573 1.079 . . . . 0.0 112.265 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.02 58.59 10.36 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -167.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.8 pt -130.36 169.91 20.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.27 1.428 . . . . 0.0 109.065 173.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -96.27 167.74 11.0 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.838 0.855 . . . . 0.0 110.938 -172.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 11.8 m -147.6 158.72 44.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.568 1.547 . . . . 0.0 111.033 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.8 mt -131.74 124.93 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 168.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -144.6 155.73 43.78 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -69.36 -26.46 64.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.169 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.86 156.96 32.18 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.255 0.934 . . . . 0.0 111.851 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.43 165.25 6.32 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.421 1.105 . . . . 0.0 109.971 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 29.7 t -145.19 172.89 12.47 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 161.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 21.8 p -69.93 24.63 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.202 2.201 . . . . 0.0 113.365 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -133.96 108.02 8.15 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.26 1.424 . . . . 0.0 108.071 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -69.58 -16.67 63.45 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.755 1.222 . . . . 0.0 113.781 -166.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -51.52 -53.31 29.27 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 168.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -53.19 114.56 1.51 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.996 2.119 . . . . 0.0 113.778 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -79.32 118.22 21.03 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.802 0.841 . . . . 0.0 111.052 -176.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -67.14 142.56 57.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.05 0.386 . . . . 0.0 111.514 169.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.6 pt -141.93 168.65 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 126.632 1.973 . . . . 0.0 111.511 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -128.1 -6.09 5.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.476 1.51 . . . . 0.0 111.941 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.13 157.59 40.59 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.777 1.231 . . . . 0.0 108.306 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.73 -34.15 73.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -55.32 -34.95 64.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.355 0.662 . . . . 0.0 112.385 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -64.9 -17.67 64.53 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.327 0.651 . . . . 0.0 111.397 -174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.2 mt -50.44 -61.6 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.362 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 87.8 p -55.38 -34.71 64.57 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.76 0.791 . . . . 0.0 110.698 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -74.45 -25.62 59.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.241 1.416 . . . . 0.0 112.722 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 61.5 mt -53.54 -60.14 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -70.63 8.93 0.73 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.656 1.982 . . . . 0.0 113.792 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 N--CA 1.453 -0.287 0 C-N-CA 125.373 1.469 . . . . 0.0 112.32 177.069 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -60.01 176.76 0.29 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.129 161.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -53.17 82.74 0.0 OUTLIER 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.09 2.156 . . . . 0.0 111.455 172.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.4 m -100.17 153.8 18.96 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.68 150.69 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.139 -0.976 . . . . 0.0 109.314 171.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.97 149.68 51.59 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 126.597 1.959 . . . . 0.0 107.881 -169.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.6 mt -141.92 132.31 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -117.07 167.85 10.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.557 1.543 . . . . 0.0 110.285 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -121.5 -12.8 8.5 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -167.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 127.902 2.481 . . . . 0.0 116.818 174.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -28.3 55.94 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.229 1.012 . . . . 0.0 113.295 -176.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -54.32 -64.83 0.7 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.269 1.428 . . . . 0.0 110.289 173.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.2 t -59.28 -44.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.506 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.1 mt -52.04 -45.76 64.8 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 119.025 0.83 . . . . 0.0 110.307 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.21 -48.21 58.08 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.094 0.558 . . . . 0.0 111.62 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.3 t90 -54.39 -37.77 65.4 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.7 0.8 . . . . 0.0 110.654 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.63 -42.77 27.92 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.456 1.502 . . . . 0.0 112.379 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -58.17 -51.06 71.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.461 1.104 . . . . 0.0 110.372 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -61.82 -23.9 66.54 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.158 1.383 . . . . 0.0 112.587 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 m -92.41 -0.41 57.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.06 0.944 . . . . 0.0 113.223 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.96 25.96 71.07 Favored Glycine 0 CA--C 1.527 0.837 0 O-C-N 121.356 -0.84 . . . . 0.0 112.942 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.9 mt -67.92 125.67 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 164.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -72.33 97.5 2.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 170.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -79.75 151.85 30.16 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -145.01 169.56 17.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.8 mt -130.99 157.42 43.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 169.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -147.34 134.74 20.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.946 1.298 . . . . 0.0 107.993 159.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 t -163.44 -179.02 6.23 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -108.28 -7.5 15.93 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HZ2' ' CD1' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -57.6 -0.87 0.08 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 117.654 2.465 . . . . 0.0 117.654 -172.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.68 -175.69 54.21 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.005 -1.06 . . . . 0.0 111.533 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.91 -12.24 47.03 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -168.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -66.75 -12.96 60.74 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.343 -1.473 . . . . 0.0 111.688 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.16 -55.92 27.17 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.481 1.037 . . . . 0.0 111.44 176.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -54.85 -45.85 74.57 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.996 0.918 . . . . 0.0 109.77 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 m -59.39 -42.43 91.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.925 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.433 ' CD1' ' HZ2' ' A' ' 109' ' ' LYS . 48.2 mt -64.88 -49.46 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 119.199 0.909 . . . . 0.0 109.344 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mp -60.11 -42.88 95.65 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.894 -0.504 . . . . 0.0 111.754 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -57.23 -53.42 58.31 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.486 1.115 . . . . 0.0 109.27 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.1 -54.23 21.93 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.9 1.68 . . . . 0.0 109.264 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.47 -39.08 65.19 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.777 0.831 . . . . 0.0 111.267 -170.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.25 27.89 1.06 Allowed Glycine 0 CA--C 1.535 1.338 0 CA-C-O 121.637 0.576 . . . . 0.0 112.015 163.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.303 2.0 p -133.41 12.66 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 127.191 2.196 . . . . 0.0 110.106 -160.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -67.35 -34.34 77.1 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 121.393 -0.817 . . . . 0.0 110.334 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.4 m -77.83 -22.71 49.55 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 120.037 1.289 . . . . 0.0 113.087 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -60.77 -18.57 55.79 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -116.11 126.68 54.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.0 m -62.32 -30.97 71.54 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.821 0.849 . . . . 0.0 111.652 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.444 ' OE1' ' HE2' ' A' ' 151' ' ' LYS . 7.5 tt0 -154.13 159.93 41.69 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 169.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mp -131.88 111.57 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 mt -80.72 159.34 25.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.844 0.831 . . . . 0.0 109.383 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.9 p -142.17 177.47 8.21 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.337 1.855 . . . . 0.0 108.12 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -61.55 -6.58 2.52 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.4 -0.813 . . . . 0.0 112.868 169.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -57.8 -28.22 63.83 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.669 -1.269 . . . . 0.0 110.703 166.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 58.0 p -58.0 -54.29 48.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.434 0.694 . . . . 0.0 112.394 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.33 -2.88 71.67 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 117.295 -1.836 . . . . 0.0 115.45 -173.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -53.92 164.51 0.58 Allowed 'General case' 0 C--O 1.242 0.694 0 CA-C-N 120.03 1.915 . . . . 0.0 112.235 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.1 176.76 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.407 1.099 . . . . 0.0 113.288 -172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -65.06 147.08 54.12 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.245 -0.909 . . . . 0.0 110.058 174.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -52.1 127.44 37.36 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.984 1.714 . . . . 0.0 107.612 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.01 -40.03 1.31 Allowed 'Cis proline' 0 C--N 1.348 0.531 0 CA-C-N 121.548 1.588 . . . . 0.0 115.25 22.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.267 43.2 p 51.25 72.25 1.28 Allowed Pre-proline 0 N--CA 1.441 -0.897 0 C-N-CA 125.194 1.397 . . . . 0.0 113.077 -172.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -62.14 -18.44 62.02 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.616 2.877 . . . . 0.0 111.907 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -47.71 -43.51 26.9 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.863 1.665 . . . . 0.0 111.273 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.46 -21.66 65.62 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.23 -58.45 3.31 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.188 -0.911 . . . . 0.0 109.392 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.6 m -56.2 -36.16 68.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.552 0.615 . . . . 0.0 110.292 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -50.89 -63.0 1.27 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 124.649 1.18 . . . . 0.0 110.339 170.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 71.2 mt -69.18 -24.46 64.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.26 -67.43 0.44 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -57.46 -41.29 80.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.873 0.469 . . . . 0.0 110.514 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.444 ' HE2' ' OE1' ' A' ' 128' ' ' GLU . 7.0 tmtm? -47.93 -37.32 14.08 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.581 1.552 . . . . 0.0 114.148 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.54 24.81 5.43 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.221 0.919 . . . . 0.0 112.743 173.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 47.71 58.11 5.31 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.46 1.904 . . . . 0.0 112.946 -175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.6 mp -94.68 172.82 7.94 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.75 1.22 . . . . 0.0 111.725 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -102.11 136.08 42.58 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.691 1.196 . . . . 0.0 108.846 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.2 m -62.13 -50.23 72.73 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.93 1.292 . . . . 0.0 108.91 173.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 1.04 53.07 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.99 -1.069 . . . . 0.0 112.645 -167.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -120.39 12.73 11.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.94 1.296 . . . . 0.0 108.999 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 t -107.35 146.63 31.36 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.156 0.889 . . . . 0.0 109.685 168.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -137.22 116.99 13.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.916 1.686 . . . . 0.0 107.633 -167.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -84.84 153.55 22.87 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 170.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.7 mt -128.66 102.4 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.45 124.43 3.33 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.65 37.1 0.4 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.253 1.821 . . . . 0.0 112.139 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.48 158.41 44.31 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.398 1.479 . . . . 0.0 108.304 -176.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.5 t -64.32 -15.27 59.98 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.89 -12.87 60.8 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.597 1.159 . . . . 0.0 112.539 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -48.01 80.11 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.084 0.856 . . . . 0.0 112.202 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.4 -31.59 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.82 -37.48 87.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.131 0.572 . . . . 0.0 109.857 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.74 -53.4 15.67 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.084 -1.01 . . . . 0.0 109.905 172.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.75 -48.11 78.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.319 0.648 . . . . 0.0 111.68 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -56.47 -53.49 56.82 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.362 1.865 . . . . 0.0 111.46 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -73.78 -23.52 59.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 119.383 -0.341 . . . . 0.0 111.778 -172.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.0 p -86.06 -21.28 27.79 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 170.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 76.06 46.94 12.07 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.885 1.231 . . . . 0.0 111.243 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 15.4 pt -131.0 -177.4 2.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 125.985 1.714 . . . . 0.0 109.096 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -92.53 162.21 14.3 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.774 0.83 . . . . 0.0 110.489 -175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.06 139.47 43.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.51 1.524 . . . . 0.0 111.172 -171.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.88 75.13 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 123.07 1.414 . . . . 0.0 109.347 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -93.79 -171.71 2.67 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.801 1.64 . . . . 0.0 111.362 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -106.57 -8.84 16.82 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.66 154.86 32.02 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.728 -1.232 . . . . 0.0 110.275 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.62 140.07 58.48 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 120.832 -1.167 . . . . 0.0 109.277 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 19.5 m -127.52 147.35 50.32 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.881 1.324 . . . . 0.0 112.233 168.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.23 47.94 1.58 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.803 2.841 . . . . 0.0 110.513 -167.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -138.22 159.72 41.32 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.101 1.361 . . . . 0.0 109.663 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -99.06 98.45 9.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 115.89 16.64 6.74 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.667 1.127 . . . . 0.0 112.419 -171.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -89.3 138.32 31.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.847 0.823 . . . . 0.0 109.411 166.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -135.04 90.38 2.63 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.202 1.001 . . . . 0.0 110.564 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . 0.262 0.2 OUTLIER -80.54 152.52 28.61 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.059 -172.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.1 pt -127.01 170.36 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.924 1.689 . . . . 0.0 111.93 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.84 -27.15 12.83 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.716 0.807 . . . . 0.0 112.177 161.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.56 155.84 42.79 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.045 0.938 . . . . 0.0 108.951 -166.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.3 tp -64.63 -35.51 81.23 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.273 1.029 . . . . 0.0 109.035 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -60.18 -30.46 69.36 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -60.91 -20.61 62.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.408 1.004 . . . . 0.0 111.306 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 95.1 mt -53.98 -53.68 25.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 88.1 p -59.68 -39.1 83.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -59.03 -40.88 86.41 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.342 1.057 . . . . 0.0 109.593 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.4 mt -51.81 -49.84 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.761 1.224 . . . . 0.0 110.851 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.76 -5.61 55.63 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.941 0.896 . . . . 0.0 112.514 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 . . . . . 0 N--CA 1.451 -0.42 0 C-N-CA 127.101 2.16 . . . . 0.0 110.104 -174.243 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mmm . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.9 175.98 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.958 2.103 . . . . 0.0 110.649 166.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.1 102.67 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.976 1.71 . . . . 0.0 110.234 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.6 m -133.55 142.41 48.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.54 142.25 51.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.253 1.021 . . . . 0.0 108.294 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.69 153.33 34.53 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.2 mt -141.92 128.01 18.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -115.61 155.97 26.68 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.323 0.649 . . . . 0.0 110.49 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -78.37 -11.13 59.92 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.367 1.067 . . . . 0.0 112.301 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.473 0.693 0 C-N-CA 129.448 3.099 . . . . 0.0 111.466 -164.582 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -59.06 -35.13 72.82 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.751 1.16 . . . . 0.0 113.597 -159.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -59.93 -58.33 9.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 124.096 0.873 . . . . 0.0 110.27 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.6 t -52.62 -41.43 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.085 0.954 . . . . 0.0 110.713 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 85.6 mt -57.61 -48.18 80.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.104 0.866 . . . . 0.0 110.13 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.51 -46.35 83.33 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.607 0.763 . . . . 0.0 111.901 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -57.4 -48.24 79.61 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.57 98.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.63 0.772 . . . . 0.0 111.309 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -54.84 -61.07 2.55 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.68 1.592 . . . . 0.0 110.35 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -60.97 -20.33 62.23 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.3 m -86.75 -4.08 59.13 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.79 1.236 . . . . 0.0 112.815 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.17 22.61 70.94 Favored Glycine 0 CA--C 1.528 0.872 0 O-C-N 120.868 -1.145 . . . . 0.0 112.688 175.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.8 mt -55.54 165.44 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 126.674 1.99 . . . . 0.0 107.433 158.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -118.04 112.72 20.61 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 161.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -80.81 143.34 32.9 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -132.34 168.5 18.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.539 1.536 . . . . 0.0 108.643 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 60.5 mt -140.0 158.86 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.361 1.464 . . . . 0.0 108.309 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -139.88 125.17 18.9 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.882 0.873 . . . . 0.0 108.758 162.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -137.41 164.19 29.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.481 1.112 . . . . 0.0 109.822 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -104.39 -0.03 28.53 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.674 1.19 . . . . 0.0 111.634 172.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -69.04 -0.19 5.42 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.27 -176.61 30.48 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.808 1.194 . . . . 0.0 110.615 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -27.06 61.36 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.653 0.781 . . . . 0.0 111.016 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -60.65 -14.98 23.88 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.1 -49.64 40.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.823 0.738 . . . . 0.0 110.605 168.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -57.43 -44.74 84.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.697 0.68 . . . . 0.0 111.197 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -57.27 -43.96 83.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.731 0.812 . . . . 0.0 110.594 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.83 -53.44 48.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.977 1.311 . . . . 0.0 109.26 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.05 -36.88 84.43 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.005 0.82 . . . . 0.0 110.516 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -61.0 -51.44 69.25 Favored 'General case' 0 C--N 1.337 0.052 0 CA-C-N 118.671 0.669 . . . . 0.0 110.476 175.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -53.46 -51.72 61.79 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 110.168 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.12 -21.01 63.14 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.594 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.95 47.16 5.13 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.913 1.244 . . . . 0.0 111.504 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.0 m -147.51 23.22 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.956 1.702 . . . . 0.0 110.991 -174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.01 -35.27 59.61 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.99 -1.069 . . . . 0.0 110.792 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.9 m -63.64 -27.69 69.4 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.191 0.596 . . . . 0.0 110.79 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.82 7.95 1.01 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -137.78 112.03 8.57 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.0 m -49.44 -39.59 33.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.422 1.089 . . . . 0.0 109.684 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.44 156.36 33.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 118.964 0.802 . . . . 0.0 110.017 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 44.1 mt -139.06 93.41 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 45.2 mt -65.98 146.88 54.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 70.0 p -127.45 -177.81 4.22 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.287 1.035 . . . . 0.0 110.246 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 t -60.28 -18.04 46.46 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.519 -0.738 . . . . 0.0 112.215 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -61.29 -37.13 82.1 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.971 0.805 . . . . 0.0 108.934 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.7 t -56.92 -35.51 69.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.099 0.96 . . . . 0.0 111.704 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.83 -8.48 65.96 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 117.068 -1.962 . . . . 0.0 113.872 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -57.4 164.52 1.84 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 120.047 1.923 . . . . 0.0 111.102 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 t -61.4 162.32 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-N 112.528 -2.124 . . . . 0.0 110.149 166.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -90.69 172.45 8.65 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.51 1.524 . . . . 0.0 109.557 170.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -68.18 150.63 97.66 Favored Pre-proline 0 C--O 1.237 0.441 0 O-C-N 120.774 -1.203 . . . . 0.0 108.942 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.29 -18.12 16.88 Favored 'Cis proline' 0 C--N 1.347 0.492 0 N-CA-C 115.759 1.407 . . . . 0.0 115.759 16.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.67 91.16 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 131.371 3.868 . . . . 0.0 114.604 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -54.13 -7.11 0.61 Allowed 'Trans proline' 0 CA--C 1.544 0.975 1 C-N-CA 126.206 4.604 . . . . 0.0 114.558 -172.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -43.83 -52.05 7.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.819 2.848 . . . . 0.0 113.213 -165.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.96 -3.01 11.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.278 1.031 . . . . 0.0 113.675 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.06 -40.03 7.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.374 1.469 . . . . 0.0 109.869 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 m -51.69 -39.67 58.72 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.337 0.971 . . . . 0.0 109.489 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.96 -53.02 61.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.928 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.7 mt -68.51 -21.2 64.59 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.344 1.457 . . . . 0.0 113.007 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -69.73 0.29 Allowed 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 175.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -54.84 -39.77 68.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -23.38 43.42 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.664 -1.272 . . . . 0.0 113.898 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -138.4 17.04 2.75 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 172.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 49.26 38.73 14.19 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.625 1.97 . . . . 0.0 112.185 -170.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.71 165.4 19.57 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.956 0.902 . . . . 0.0 109.754 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.564 ' ND2' HD22 ' A' ' 158' ' ' ASN . 6.6 m-20 -101.17 -5.89 25.0 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 -160.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 m 76.43 -36.14 0.26 Allowed 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 108.813 -3.812 . . . . 0.0 112.179 -166.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -25.04 56.67 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 120.943 -1.098 . . . . 0.0 112.8 -171.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.564 HD22 ' ND2' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -85.77 -3.16 58.83 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 116.362 -1.78 . . . . 0.0 110.694 -178.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -102.27 123.61 46.39 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.401 1.455 . . . . 0.0 108.712 -170.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -120.81 101.01 7.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.045 2.138 . . . . 0.0 108.903 -170.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -74.68 150.6 39.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.44 129.13 68.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -149.69 172.28 29.66 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.431 0.539 . . . . 0.0 111.883 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.42 3.02 4.22 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.525 1.53 . . . . 0.0 113.564 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -144.09 133.7 23.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 t -47.56 166.71 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.986 2.114 . . . . 0.0 110.858 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 tp 67.74 -5.03 0.86 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 131.404 3.882 . . . . 0.0 112.979 -152.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -58.1 -41.16 82.9 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.355 0.979 . . . . 0.0 110.826 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.2 p -104.13 -18.21 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 126.261 1.824 . . . . 0.0 110.849 -171.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -68.0 -22.72 64.98 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.46 -0.775 . . . . 0.0 111.851 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -88.08 -23.27 23.76 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.292 -0.88 . . . . 0.0 112.331 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.14 90.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.967 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -64.22 -40.68 96.55 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.446 0.566 . . . . 0.0 111.061 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.49 -55.52 34.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.198 0.454 . . . . 0.0 110.356 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 t -75.15 -24.75 57.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.097 -0.477 . . . . 0.0 111.555 -172.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 67.3 61.33 5.2 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -166.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.5 pt -128.88 177.55 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.976 1.711 . . . . 0.0 108.002 172.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -94.99 179.07 5.35 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.184 0.594 . . . . 0.0 109.748 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.51 160.75 34.96 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.633 -1.292 . . . . 0.0 109.436 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.0 mt -142.56 101.91 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.282 1.433 . . . . 0.0 107.158 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -128.24 165.37 20.63 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 123.134 1.445 . . . . 0.0 111.705 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -78.78 -29.84 45.21 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.765 -1.562 . . . . 0.0 111.297 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.79 13.99 27.26 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -157.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . 0.287 12.3 pt-20 50.93 -170.85 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.858 1 C-N-CA 134.999 5.32 . . . . 0.0 114.09 -170.187 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 48.3 t -164.12 167.99 19.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.097 2.159 . . . . 0.0 107.121 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 16.6 p -100.33 66.14 1.26 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.819 1.248 . . . . 0.0 108.185 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -143.46 177.28 8.56 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.792 1.637 . . . . 0.0 108.989 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -106.26 -30.87 8.92 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.597 1.159 . . . . 0.0 112.893 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.09 5.84 82.91 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.235 0.921 . . . . 0.0 111.568 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -72.86 155.19 40.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 118.749 1.274 . . . . 0.0 108.712 168.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -134.75 109.02 8.3 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.31 143.01 58.21 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 122.955 0.502 . . . . 0.0 111.211 177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.2 pt -146.39 173.37 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.684 1.594 . . . . 0.0 112.746 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -127.89 -17.85 4.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.793 1.637 . . . . 0.0 113.417 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.24 165.84 28.02 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.0 1.32 . . . . 0.0 109.802 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.01 -37.56 88.06 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.83 -15.58 54.8 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -75.11 -17.85 60.36 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.168 -0.958 . . . . 0.0 110.796 174.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.25 -53.49 45.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 77.4 p -58.76 -34.3 71.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.928 0.786 . . . . 0.0 111.092 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -62.43 -35.05 78.05 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 116.728 -1.606 . . . . 0.0 111.603 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 77.4 mt -50.75 -52.59 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.726 1.148 . . . . 0.0 108.804 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -81.34 -5.22 57.6 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.935 -0.555 . . . . 0.0 112.422 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 . . . . . 0 CA--C 1.53 0.185 0 C-N-CA 125.77 1.628 . . . . 0.0 112.27 -171.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mmm . . . . . 0 CA--C 1.516 -0.364 0 CA-C-O 124.049 1.88 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.97 177.86 0.11 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 111.608 -2.542 . . . . 0.0 111.389 167.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -54.78 69.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 129.148 2.979 . . . . 0.0 114.556 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.6 m -96.28 141.92 29.04 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.06 147.33 50.16 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.7 144.43 51.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 124.562 1.145 . . . . 0.0 108.108 -170.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.8 mt -133.57 120.44 37.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -105.71 -177.51 3.38 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.674 1.59 . . . . 0.0 108.202 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.2 174.22 9.45 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.301 1.04 . . . . 0.0 109.603 170.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -175.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.6 tpt85 -58.15 -32.7 68.44 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.663 0.665 . . . . 0.0 112.649 -158.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -48.96 -70.3 0.09 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.253 1.421 . . . . 0.0 109.889 168.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.4 t -63.52 -36.02 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 126.836 2.054 . . . . 0.0 110.666 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.3 mt -51.72 -46.31 63.91 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.05 1.295 . . . . 0.0 110.572 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.66 -46.43 85.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.067 0.947 . . . . 0.0 111.657 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -61.65 -42.55 99.06 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.479 0.712 . . . . 0.0 112.227 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.98 -32.79 72.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.157 0.983 . . . . 0.0 111.315 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.41 -43.8 72.66 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.189 1.795 . . . . 0.0 111.857 173.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.3 -13.99 3.95 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.802 1.241 . . . . 0.0 112.004 168.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.3 m -113.96 -5.25 13.17 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.773 1.629 . . . . 0.0 112.241 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.57 19.73 49.3 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.137 1.827 . . . . 0.0 113.862 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mt -51.83 124.74 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 160.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -75.34 111.58 10.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -96.05 153.92 17.52 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 127' ' ' THR . 66.9 m-85 -148.61 165.79 30.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.487 1.515 . . . . 0.0 109.135 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.8 mt -137.72 153.66 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.998 1.719 . . . . 0.0 108.177 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -132.58 143.09 49.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.492 1.517 . . . . 0.0 107.795 160.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 t -169.74 173.11 6.41 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.796 1.638 . . . . 0.0 108.835 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -131.77 66.42 1.55 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.234 1.814 . . . . 0.0 110.106 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.27 6.58 17.44 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.483 1.513 . . . . 0.0 111.646 166.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.77 178.4 43.67 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.695 1.14 . . . . 0.0 111.28 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.47 -18.55 52.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.286 1.034 . . . . 0.0 111.837 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.65 -23.14 49.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.876 0.87 . . . . 0.0 111.652 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.28 -45.45 72.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.474 0.709 . . . . 0.0 111.922 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -62.63 -39.95 95.44 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.984 0.811 . . . . 0.0 109.904 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -62.25 -45.83 91.53 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.78 0.832 . . . . 0.0 110.262 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.21 -43.29 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.534 1.134 . . . . 0.0 109.14 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.84 -40.59 95.85 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.482 -0.761 . . . . 0.0 111.36 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -53.35 58.55 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.702 0.683 . . . . 0.0 110.162 169.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -49.47 -53.44 23.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.047 0.939 . . . . 0.0 111.597 -174.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.57 -11.07 60.11 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.17 1.388 . . . . 0.0 114.051 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 59.97 54.51 36.82 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.67 1.129 . . . . 0.0 110.678 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.7 6.08 2.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 125.085 1.354 . . . . 0.0 111.993 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.03 -53.01 56.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.564 0.697 . . . . 0.0 109.988 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 m -72.46 -11.26 60.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.818 -162.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -62.69 -28.69 70.11 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.172 0.989 . . . . 0.0 112.71 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -107.87 136.12 48.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -174.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.455 ' HB ' ' CE2' ' A' ' 104' ' ' PHE . 78.5 m -61.58 -43.62 98.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.85 157.12 38.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -173.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.0 mp -137.15 143.35 34.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.467 HD22 ' CE1' ' A' ' 147' ' ' TYR . 76.8 mt -99.57 158.87 15.45 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.764 1.225 . . . . 0.0 109.778 174.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 p -137.36 -174.22 3.69 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.136 0.574 . . . . 0.0 111.101 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.9 -30.18 13.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.512 1.125 . . . . 0.0 111.695 166.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -65.71 -19.83 66.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.994 1.318 . . . . 0.0 111.113 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.2 m -89.47 69.53 7.96 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.75 47.75 1.54 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 127.34 2.4 . . . . 0.0 112.116 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -56.66 169.32 0.49 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.367 0.667 . . . . 0.0 110.995 164.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -50.67 166.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 122.634 1.207 . . . . 0.0 112.922 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -61.23 157.44 16.23 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.363 163.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -42.58 147.87 0.58 Allowed Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 124.745 1.218 . . . . 0.0 110.343 166.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.56 -27.3 4.95 Favored 'Cis proline' 0 CA--C 1.533 0.461 0 CA-C-N 119.342 0.801 . . . . 0.0 113.407 -3.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 t 49.39 82.18 0.24 Allowed Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.012 1.325 . . . . 0.0 112.079 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.57 -23.02 70.59 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 121.494 1.462 . . . . 0.0 111.286 165.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -54.03 -50.47 66.6 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.892 1.277 . . . . 0.0 112.713 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.02 -17.11 22.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.88 -47.77 6.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.546 1.138 . . . . 0.0 111.203 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 m -57.27 -39.02 74.8 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.885 0.874 . . . . 0.0 109.585 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.467 ' CE1' HD22 ' A' ' 130' ' ' LEU . 30.6 t80 -57.87 -51.02 71.31 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.544 0.738 . . . . 0.0 110.274 173.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.1 mt -65.95 -36.42 83.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.275 1.03 . . . . 0.0 110.761 -171.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 89.2 mt -60.59 -64.84 0.81 Allowed 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.36 1.864 . . . . 0.0 106.031 175.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.81 -37.26 75.98 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -172.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.32 -23.02 21.37 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 117.299 -1.334 . . . . 0.0 114.325 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -134.52 20.46 3.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.593 1.542 . . . . 0.0 110.612 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 44.14 62.87 1.82 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.679 2.392 . . . . 0.0 110.614 -172.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 67.5 mt -103.08 165.13 11.2 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.499 1.12 . . . . 0.0 110.647 -170.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -100.67 132.25 46.16 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.792 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 m -58.13 -49.37 77.22 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.546 1.138 . . . . 0.0 110.166 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.6 -4.18 41.6 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.133 -1.605 . . . . 0.0 112.818 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -113.6 10.88 18.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 117.876 -1.059 . . . . 0.0 108.838 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -109.9 111.26 22.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.98 0.809 . . . . 0.0 109.406 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -114.87 108.54 16.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.491 1.517 . . . . 0.0 110.152 -168.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -78.39 152.46 32.23 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.415 0.686 . . . . 0.0 109.68 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.5 mp -127.17 127.84 69.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 172.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -167.13 -177.68 38.96 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 121.511 0.506 . . . . 0.0 112.908 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -126.22 9.9 7.39 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.209 1.404 . . . . 0.0 112.452 -165.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -136.32 126.85 26.93 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.038 0.935 . . . . 0.0 110.03 -171.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 6.2 t -46.34 -23.87 0.41 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.133 2.573 . . . . 0.0 115.216 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -12.95 59.79 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.139 1.776 . . . . 0.0 112.312 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -51.64 69.16 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.637 0.775 . . . . 0.0 110.743 174.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.96 -29.68 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 O-C-N 121.811 -0.556 . . . . 0.0 109.611 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.52 -21.26 66.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.475 -0.774 . . . . 0.0 112.238 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -97.32 -39.77 9.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.548 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -57.2 -43.04 82.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 123.698 0.624 . . . . 0.0 111.153 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -59.1 -48.48 81.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.604 1.161 . . . . 0.0 110.934 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -71.1 -33.53 70.25 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 118.234 -0.889 . . . . 0.0 112.298 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 45.9 m -82.66 -21.39 35.0 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.514 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.72 63.67 3.11 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.462 1.506 . . . . 0.0 110.505 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.2 pt -135.73 -166.5 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.863 1.665 . . . . 0.0 108.948 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -120.38 158.64 26.73 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.548 1.067 . . . . 0.0 111.541 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.8 m -139.0 149.82 45.13 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.105 1.762 . . . . 0.0 109.367 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.1 mt -138.7 94.99 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -122.81 158.6 29.91 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.458 1.103 . . . . 0.0 110.938 -170.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -85.87 -26.33 25.7 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.705 -0.622 . . . . 0.0 111.391 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.04 175.55 6.58 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 161.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 192' ' ' ARG . 6.1 pt-20 -108.06 170.53 7.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 164.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.3 t -151.99 -168.97 3.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.9 p -127.78 81.26 2.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.874 1.27 . . . . 0.0 108.054 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -151.26 153.68 35.33 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.62 1.568 . . . . 0.0 108.465 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.87 108.14 16.69 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.775 1.63 . . . . 0.0 110.313 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 117.91 -7.42 15.11 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 123.972 0.796 . . . . 0.0 111.81 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.97 118.91 24.33 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.302 1.441 . . . . 0.0 108.293 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -114.21 136.47 52.92 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.139 1.376 . . . . 0.0 110.674 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.435 ' HD2' ' HB3' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -83.85 146.66 27.98 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.416 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.5 pt -132.82 167.67 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.39 1.476 . . . . 0.0 112.303 165.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -124.75 -12.12 7.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.549 1.539 . . . . 0.0 112.172 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.07 172.09 19.29 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.502 1.521 . . . . 0.0 109.454 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.78 -37.18 79.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.95 1.3 . . . . 0.0 110.352 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.39 -22.43 66.79 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.874 0.845 . . . . 0.0 112.196 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.83 -5.77 45.35 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.825 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 78.5 mt -77.65 -63.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.348 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 168.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.9 p -55.96 -28.03 55.15 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -60.03 -38.69 83.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.145 1.778 . . . . 0.0 112.996 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.91 -50.16 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 C-N-CA 126.632 1.973 . . . . 0.0 106.563 -168.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -71.69 -4.26 26.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.352 1.061 . . . . 0.0 113.338 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 . . . . . 0 N--CA 1.451 -0.415 0 C-N-CA 123.417 0.687 . . . . 0.0 112.389 -179.362 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.0 mmm . . . . . 0 C--O 1.238 0.47 0 CA-C-O 123.267 1.508 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -60.92 -172.31 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.22 1.408 . . . . 0.0 110.214 155.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -66.53 82.99 0.1 Allowed 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.926 1.29 . . . . 0.0 110.141 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.8 m -92.74 158.91 15.66 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 166.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.54 157.33 45.64 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 120.584 -1.323 . . . . 0.0 110.636 164.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -128.42 162.48 27.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.203 2.201 . . . . 0.0 108.587 -172.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.5 mt -138.99 144.5 29.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 126.224 1.81 . . . . 0.0 107.033 166.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -117.13 166.35 12.33 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.983 2.113 . . . . 0.0 110.398 170.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -105.21 171.88 7.09 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 162.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.546 0.792 0 C-N-CA 127.403 2.281 . . . . 0.0 110.736 172.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.371 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -51.65 -36.65 47.0 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.8 0.84 . . . . 0.0 112.219 -175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -56.7 -51.02 70.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.836 1.254 . . . . 0.0 111.047 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.39 -43.88 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.399 1.479 . . . . 0.0 109.815 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.411 ' CD2' ' CD2' ' A' ' 125' ' ' TYR . 8.3 mp -50.39 -50.78 50.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 121.344 1.884 . . . . 0.0 111.205 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.59 -43.97 85.03 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.446 0.466 . . . . 0.0 111.951 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -68.72 -39.66 80.32 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.005 1.322 . . . . 0.0 112.089 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.91 -29.13 60.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.209 1.404 . . . . 0.0 111.597 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -64.38 -59.2 4.64 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 127.401 2.281 . . . . 0.0 110.166 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -55.72 -27.27 49.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.559 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.7 m -90.66 3.5 54.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.93 8.93 44.49 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.127 1.346 . . . . 0.0 114.334 173.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mt -66.37 104.17 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -60.71 111.92 1.81 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.61 150.1 21.85 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 172.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -142.95 166.4 24.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.503 1.121 . . . . 0.0 110.53 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 9.2 mt -127.49 158.25 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 121.041 1.746 . . . . 0.0 109.43 173.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -133.58 112.0 11.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.747 1.219 . . . . 0.0 108.893 167.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -143.11 173.63 11.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -127.68 14.16 6.97 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.759 2.023 . . . . 0.0 110.887 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -3.07 28.98 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.99 173.0 34.4 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.703 1.62 . . . . 0.0 112.557 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.74 -19.99 19.72 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.777 1.631 . . . . 0.0 112.653 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -22.76 20.98 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.419 1.488 . . . . 0.0 111.944 173.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.91 -44.57 78.38 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.027 -1.045 . . . . 0.0 111.576 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -56.79 -46.25 81.66 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.75 0.42 . . . . 0.0 110.506 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -61.3 -47.37 86.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.747 0.819 . . . . 0.0 110.486 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.8 mt -55.59 -50.63 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.83 -32.27 73.45 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.802 -1.186 . . . . 0.0 110.843 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -72.33 -27.2 62.28 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 171.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -63.81 1.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 123.365 1.555 . . . . 0.0 107.08 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.31 -35.59 80.88 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.785 3.234 . . . . 0.0 112.254 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.8 61.93 1.57 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 124.512 1.053 . . . . 0.0 110.495 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.9 m -139.64 5.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.223 1.009 . . . . 0.0 110.856 170.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.11 -30.75 63.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.086 -1.009 . . . . 0.0 111.37 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.3 m -70.36 -26.93 63.96 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 118.801 0.728 . . . . 0.0 111.73 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.411 ' CD2' ' CD2' ' A' ' 93' ' ' LEU . 24.6 m-85 -51.5 -60.33 3.26 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.297 0.639 . . . . 0.0 110.11 164.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -84.9 114.23 21.97 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -152.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.2 m -64.5 -31.85 73.24 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.733 -0.604 . . . . 0.0 111.629 -172.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -158.89 156.72 30.1 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.957 1.253 . . . . 0.0 109.838 167.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.79 105.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 103.871 -2.64 . . . . 0.0 103.871 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.22 158.24 26.7 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.3 p -131.75 179.73 5.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.053 1.341 . . . . 0.0 109.15 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -31.03 42.33 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.155 1.382 . . . . 0.0 112.168 165.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -63.71 -21.55 66.46 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.921 1.288 . . . . 0.0 110.676 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.6 p -57.24 -30.39 64.58 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.0 1.32 . . . . 0.0 114.063 -165.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.75 2.31 44.06 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.538 -1.146 . . . . 0.0 113.954 169.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -63.51 158.47 20.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.318 1.559 . . . . 0.0 111.613 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 t -57.61 157.85 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.564 161.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -136.78 59.8 1.68 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.277 1.431 . . . . 0.0 111.207 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -49.66 -54.84 27.29 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-O 114.834 -2.508 . . . . 0.0 114.344 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.78 114.08 0.19 OUTLIER 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 123.313 2.219 . . . . 0.0 117.016 10.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 m -92.73 154.94 42.2 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 124.873 1.269 . . . . 0.0 112.547 -173.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -81.53 5.25 6.4 Favored 'Trans proline' 0 CA--C 1.549 1.261 1 C-N-CA 125.585 4.19 . . . . 0.0 113.883 170.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -46.77 -63.92 0.9 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.479 1.912 . . . . 0.0 110.942 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.54 -20.96 64.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.461 0.705 . . . . 0.0 111.934 -169.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.18 -60.38 2.32 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.297 1.039 . . . . 0.0 108.766 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.3 m -54.93 -40.57 70.04 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.025 1.33 . . . . 0.0 110.407 -174.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.51 ' CE1' ' HE2' ' A' ' 151' ' ' LYS . 72.0 t80 -52.1 -58.0 7.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.474 1.11 . . . . 0.0 110.633 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 23.3 mt -71.02 -25.19 62.56 Favored 'General case' 0 CA--C 1.521 -0.137 0 O-C-N 121.866 -0.521 . . . . 0.0 112.144 -172.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 87.2 mt -66.48 -61.15 2.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.99 -36.19 72.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.963 0.505 . . . . 0.0 111.699 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.51 ' HE2' ' CE1' ' A' ' 147' ' ' TYR . 7.9 mmtm -57.31 -22.85 44.74 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 114.276 1.214 . . . . 0.0 114.276 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.97 27.43 1.46 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 119.037 0.835 . . . . 0.0 111.822 169.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 67.9 mm-40 44.41 54.56 6.22 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.648 2.379 . . . . 0.0 111.494 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 4.3 mp -75.46 -169.59 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.188 1.395 . . . . 0.0 110.592 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -121.78 129.15 52.44 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.236 1.414 . . . . 0.0 108.751 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.0 m -52.5 -49.1 65.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.985 1.714 . . . . 0.0 110.445 175.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -88.43 9.2 24.4 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 120.791 -1.193 . . . . 0.0 111.881 -169.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.94 8.75 7.45 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.353 1.861 . . . . 0.0 108.733 173.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -107.65 142.42 37.64 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.743 1.156 . . . . 0.0 109.539 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -129.46 156.55 43.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.952 2.101 . . . . 0.0 108.243 -170.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -139.17 128.17 23.7 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.93 116.05 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.152 1.381 . . . . 0.0 107.309 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -142.09 -172.26 13.48 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 174.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -132.51 5.83 4.05 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.404 1.882 . . . . 0.0 113.393 -169.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.83 155.82 47.13 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 120.0 1.273 . . . . 0.0 109.95 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t -72.94 -13.69 61.3 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.584 -1.323 . . . . 0.0 111.059 -169.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.26 -33.18 52.02 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.739 1.616 . . . . 0.0 111.167 167.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -74.06 10.12 1.33 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.376 1.47 . . . . 0.0 113.601 -164.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.22 -13.71 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.288 1.035 . . . . 0.0 110.686 167.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.32 -47.83 77.92 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.803 1.638 . . . . 0.0 110.018 -173.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -76.94 -34.44 57.65 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 121.595 -0.691 . . . . 0.0 111.809 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.48 -58.11 8.29 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.598 0.759 . . . . 0.0 109.867 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -49.84 -45.74 50.57 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.699 2.0 . . . . 0.0 110.841 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -62.49 -26.08 68.35 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.5 p -93.98 -26.01 17.0 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.055 0.843 . . . . 0.0 112.769 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 92.46 9.57 61.48 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.198 1.38 . . . . 0.0 112.556 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.7 pp -88.21 175.66 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.721 1.209 . . . . 0.0 109.39 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -112.37 163.73 14.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.865 0.841 . . . . 0.0 111.694 -165.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 8.8 m -137.39 149.82 47.22 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.665 1.586 . . . . 0.0 110.175 -168.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 47.6 mt -140.4 78.02 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -114.16 165.13 12.97 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.507 1.146 . . . . 0.0 110.693 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -73.4 -13.3 61.06 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.283 -0.885 . . . . 0.0 113.157 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.59 157.12 39.71 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.442 1.019 . . . . 0.0 110.727 -174.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -89.51 159.23 17.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.939 -0.476 . . . . 0.0 111.435 -171.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.25 8.38 1.2 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -169.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 47.7 p 52.81 49.66 19.78 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.101 1.36 . . . . 0.0 113.257 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -131.27 162.65 29.55 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.4 1.88 . . . . 0.0 109.105 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -80.13 -42.87 22.67 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.639 0.776 . . . . 0.0 111.812 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.73 47.4 3.57 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -130.43 125.94 35.72 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.922 1.289 . . . . 0.0 109.52 -164.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -127.2 108.39 10.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.004 0.921 . . . . 0.0 109.156 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -63.94 142.01 58.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 118.149 -1.42 . . . . 0.0 109.699 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 13.7 pt -114.96 159.67 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.3 1.04 . . . . 0.0 110.564 165.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -115.15 -8.17 12.4 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.839 1.256 . . . . 0.0 112.535 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.76 161.62 41.43 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.869 2.468 . . . . 0.0 107.154 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 tp -71.16 -32.94 69.55 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.408 -0.808 . . . . 0.0 110.268 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.77 -18.69 63.06 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.098 -0.953 . . . . 0.0 112.196 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -66.32 -20.02 65.97 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.422 1.01 . . . . 0.0 110.316 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 76.8 mt -62.46 -53.61 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 124.607 1.163 . . . . 0.0 108.96 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 80.7 p -56.27 -39.59 72.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.185 0.902 . . . . 0.0 109.662 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -60.2 -25.71 65.8 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.349 2.26 . . . . 0.0 111.591 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 80.0 mt -61.64 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 120.498 -1.376 . . . . 0.0 109.454 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -89.91 -26.26 20.54 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.492 1.117 . . . . 0.0 110.944 -175.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 . . . . . 0 CA--C 1.535 0.395 0 C-N-CA 125.716 1.606 . . . . 0.0 112.587 -176.216 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mmm . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.16 169.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.901 2.081 . . . . 0.0 109.687 162.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 106.72 0.09 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.476 1.51 . . . . 0.0 108.813 174.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.8 m -134.86 147.18 49.82 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.27 153.96 46.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.402 1.081 . . . . 0.0 108.645 171.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.04 153.31 48.56 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.176 1.79 . . . . 0.0 107.609 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 mt -143.22 138.46 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -128.97 179.96 5.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.43 1.092 . . . . 0.0 110.443 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -130.71 172.35 12.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.172 2.189 . . . . 0.0 109.596 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.0 mt . . . . . 0 CA--C 1.535 0.389 0 C-N-CA 126.501 1.921 . . . . 0.0 111.508 -174.854 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttt-85 -60.75 -28.69 68.89 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.66 0.664 . . . . 0.0 112.208 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -58.77 7.07 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.637 1.575 . . . . 0.0 110.304 170.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.06 -47.47 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.637 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mp -44.68 -54.95 5.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 120.835 1.652 . . . . 0.0 113.237 169.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.57 68.89 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 123.417 0.448 . . . . 0.0 110.563 -176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -54.01 -50.54 66.4 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.989 0.916 . . . . 0.0 110.918 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.4 73.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.089 1.356 . . . . 0.0 112.588 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.82 -54.26 20.46 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 124.556 1.142 . . . . 0.0 110.562 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -67.48 -16.67 64.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.198 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.2 m -84.69 -1.63 56.44 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.783 1.633 . . . . 0.0 113.272 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.47 4.81 87.63 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.845 1.202 . . . . 0.0 114.179 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.2 mt -66.6 138.07 23.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 O-C-N 121.143 -1.21 . . . . 0.0 108.169 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.63 114.83 24.61 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 163.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -86.36 151.69 23.35 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.2 174.99 10.22 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.463 1.905 . . . . 0.0 107.11 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 33.9 mt -133.56 154.9 39.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 170.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -142.47 119.3 11.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 159.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.0 t -145.63 175.63 10.23 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.055 0.542 . . . . 0.0 110.455 170.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -84.39 1.55 44.72 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.125 0.97 . . . . 0.0 113.487 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -64.6 160.8 18.85 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.6 -168.85 43.6 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.367 0.984 . . . . 0.0 111.677 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -62.9 -16.72 60.03 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 122.117 -0.637 . . . . 0.0 112.579 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -55.47 -23.44 25.68 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.951 -1.023 . . . . 0.0 112.389 168.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.97 -49.47 63.15 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.409 1.459 . . . . 0.0 112.791 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -60.67 -48.8 80.18 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.219 1.008 . . . . 0.0 109.493 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.5 m -58.96 -41.1 86.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.426 1.49 . . . . 0.0 111.715 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -64.35 -44.05 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 121.344 -0.847 . . . . 0.0 108.83 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.52 -45.54 93.44 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.925 0.89 . . . . 0.0 111.796 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -58.84 -48.42 81.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.429 1.092 . . . . 0.0 109.226 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -58.25 -49.91 75.45 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.834 1.654 . . . . 0.0 111.857 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.39 -4.54 34.14 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.889 1.276 . . . . 0.0 112.667 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 65.62 39.43 95.43 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.313 0.959 . . . . 0.0 112.296 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.68 15.11 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.81 1.244 . . . . 0.0 110.898 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -61.55 -41.71 97.77 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.877 -0.514 . . . . 0.0 110.738 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 m -57.75 -27.36 62.96 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -63.71 -34.19 77.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 118.988 -0.529 . . . . 0.0 111.897 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -110.37 96.83 6.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -166.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.7 m -51.01 -44.86 61.05 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.581 0.753 . . . . 0.0 110.699 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.45 153.2 44.83 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.501 1.12 . . . . 0.0 108.816 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.59 93.14 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.62 146.72 52.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.3 p -151.24 179.45 8.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.731 -162.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.4 t -47.56 -34.97 8.36 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.247 1.819 . . . . 0.0 112.15 173.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -59.27 -30.0 67.98 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.08 1.352 . . . . 0.0 112.137 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.7 p -58.34 -49.46 77.12 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.597 1.189 . . . . 0.0 110.322 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.93 -1.18 87.29 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-O 116.83 -2.095 . . . . 0.0 113.437 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -56.63 162.61 2.18 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.303 1.552 . . . . 0.0 111.286 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 m -50.64 153.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.73 2.012 . . . . 0.0 112.205 170.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.412 ' HG3' ' H ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -83.88 -77.27 0.26 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.582 1.553 . . . . 0.0 111.702 -168.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.412 ' H ' ' HG3' ' A' ' 138' ' ' ARG . 9.0 mttp -163.59 117.99 1.09 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 128.815 2.846 . . . . 0.0 104.923 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.26 160.42 75.81 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.257 1.127 . . . . 0.0 111.68 -4.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.6 p -156.18 54.94 0.99 Allowed Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -68.11 -14.74 41.61 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 121.37 1.38 . . . . 0.0 113.056 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -55.43 -39.62 70.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.837 1.255 . . . . 0.0 110.761 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.66 -15.19 62.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.921 -0.487 . . . . 0.0 112.024 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.27 -55.91 5.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.0 m -59.26 -37.74 78.34 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.198 0.599 . . . . 0.0 110.777 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -55.48 -56.33 21.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.8 mt -61.17 -38.23 85.76 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.241 -175.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -67.1 0.42 Allowed 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 125.126 1.37 . . . . 0.0 107.385 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.06 -34.31 68.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -47.38 72.96 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 114.957 -2.449 . . . . 0.0 114.198 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -124.55 18.36 8.83 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 121.633 2.015 . . . . 0.0 110.069 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 64.27 56.96 1.26 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 127.013 2.125 . . . . 0.0 108.686 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . 0.26 0.0 OUTLIER -109.58 176.19 5.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 114.7 1.371 . . . . 0.0 114.7 -175.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -108.21 150.02 27.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.426 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.1 p -66.75 -48.33 69.45 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 122.309 1.052 . . . . 0.0 110.765 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.29 -9.47 58.58 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 120.772 -1.205 . . . . 0.0 112.326 -170.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -116.67 21.7 13.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 118.098 -0.953 . . . . 0.0 108.804 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -113.01 136.08 53.08 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.989 0.813 . . . . 0.0 111.397 163.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -120.24 105.0 10.53 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.117 2.167 . . . . 0.0 111.003 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -78.4 148.64 33.57 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.299 1.04 . . . . 0.0 108.83 168.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.98 123.4 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -155.5 -5.53 0.09 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 116.926 1.531 . . . . 0.0 116.926 -172.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.3 5.54 2.6 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.53 1.932 . . . . 0.0 115.953 163.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.412 ' C ' ' H ' ' A' ' 167' ' ' LEU . 10.9 mmm180 -115.94 10.04 15.09 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -156.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t 52.6 5.41 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.805 3.242 . . . . 0.0 115.361 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 165' ' ' ARG . 1.2 tt -112.27 -16.23 13.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.055 2.542 . . . . 0.0 110.099 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.64 -52.29 64.95 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 129.167 2.987 . . . . 0.0 107.852 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.65 -46.07 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 127.081 2.152 . . . . 0.0 112.267 171.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -62.02 -45.17 94.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -169.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -79.78 -32.88 40.91 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.025 -1.047 . . . . 0.0 112.346 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.28 -52.35 53.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.217 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -50.49 -51.59 45.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.272 1.829 . . . . 0.0 110.454 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -65.25 -28.15 69.15 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.29 -22.86 28.38 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.715 -1.241 . . . . 0.0 112.735 170.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.63 55.86 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.538 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 17.3 pt -97.54 167.06 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.132 0.973 . . . . 0.0 109.385 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -87.93 178.97 6.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.985 0.514 . . . . 0.0 109.955 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.17 151.9 19.99 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.69 -1.256 . . . . 0.0 111.645 173.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 35.8 mt -124.96 128.08 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -144.15 139.62 28.91 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 124.192 0.997 . . . . 0.0 108.349 -167.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -68.25 -17.8 64.39 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.499 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.35 166.58 10.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.242 1.417 . . . . 0.0 111.235 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -72.73 169.16 17.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.82 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 45.5 t -156.49 171.85 19.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 157.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.1 p -73.1 4.65 4.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.347 2.259 . . . . 0.0 114.242 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -112.07 153.16 27.33 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.29 1.036 . . . . 0.0 110.569 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.58 -45.58 68.33 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.72 1.208 . . . . 0.0 112.627 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.44 36.62 2.6 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.752 1.167 . . . . 0.0 110.311 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -111.35 93.13 4.32 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 174.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -86.06 108.46 18.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -62.08 149.33 41.5 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.34 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.7 pt -142.22 166.19 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.159 1.384 . . . . 0.0 110.675 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -122.85 -2.68 8.74 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.129 1.772 . . . . 0.0 112.949 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.32 166.23 34.05 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.839 1.656 . . . . 0.0 108.788 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 63.6 mt -69.29 -41.92 76.15 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.34 -0.05 1.67 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.41 1.084 . . . . 0.0 113.892 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -81.78 -18.89 42.55 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.053 -1.654 . . . . 0.0 109.924 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 77.7 mt -58.47 -52.14 62.98 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.3 p -50.67 -43.48 57.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.26 0.482 . . . . 0.0 111.44 177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 63.8 mtt85 -62.86 -21.62 66.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.503 1.521 . . . . 0.0 113.296 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 75.0 mt -60.54 -47.98 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -84.61 -34.89 23.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.729 1.211 . . . . 0.0 111.336 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 . . . . . 0 CA--C 1.536 0.439 0 C-N-CA 124.904 1.282 . . . . 0.0 111.413 -169.902 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.8 mmm . . . . . 0 C--O 1.236 0.348 0 CA-C-O 122.846 1.307 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -45.49 160.3 0.05 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.851 2.06 . . . . 0.0 111.292 166.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -44.24 97.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.347 1.859 . . . . 0.0 111.722 -172.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.2 m -125.82 155.81 40.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.23 150.55 50.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.484 0.714 . . . . 0.0 109.091 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -123.27 155.16 37.74 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.205 1.402 . . . . 0.0 108.333 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.4 mt -140.39 133.82 33.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -131.03 147.16 52.59 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.149 1.38 . . . . 0.0 111.737 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -81.65 -22.3 37.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.655 1.582 . . . . 0.0 111.604 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 127.416 2.286 . . . . 0.0 110.343 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.276 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -39.06 70.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.149 0.886 . . . . 0.0 110.992 -166.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.28 -53.46 58.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.624 0.769 . . . . 0.0 110.699 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -61.33 -40.76 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 118.745 0.702 . . . . 0.0 110.266 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.74 -48.89 78.35 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 118.857 0.753 . . . . 0.0 109.519 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.29 -49.57 75.65 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.977 0.511 . . . . 0.0 111.669 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -57.19 -52.61 64.6 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.741 0.817 . . . . 0.0 110.263 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.43 91.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.059 1.343 . . . . 0.0 111.874 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.13 -46.12 71.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.388 1.875 . . . . 0.0 111.399 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.63 -33.61 76.01 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.744 -0.597 . . . . 0.0 110.865 170.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.3 m -71.9 -2.82 19.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.495 1.118 . . . . 0.0 112.861 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.89 17.06 62.55 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.971 1.272 . . . . 0.0 112.283 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -67.6 116.25 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -67.87 97.02 0.62 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -81.76 137.79 35.28 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.784 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -131.28 172.77 11.76 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.451 1.5 . . . . 0.0 110.366 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.3 mt -138.06 156.31 30.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.438 1.495 . . . . 0.0 108.358 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -138.08 126.61 23.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 167.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.1 t -142.49 169.86 16.79 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.909 0.861 . . . . 0.0 110.242 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -105.07 -5.5 20.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.159 1.784 . . . . 0.0 111.85 169.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -68.33 -5.04 16.58 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 -167.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.52 -179.72 38.95 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.38 -17.85 64.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -172.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.89 -14.14 5.66 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.41 -44.53 68.81 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.391 0.996 . . . . 0.0 111.728 169.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.3 -46.68 87.65 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.198 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -56.04 -46.02 78.99 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.698 0.799 . . . . 0.0 109.95 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.7 mt -60.69 -49.02 86.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.32 -38.9 85.67 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.525 -0.734 . . . . 0.0 111.175 -175.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -62.56 -47.35 84.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.79 -32.35 73.5 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.077 0.951 . . . . 0.0 112.854 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.3 mt -90.17 1.54 56.32 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.379 1.472 . . . . 0.0 112.344 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.51 36.22 92.26 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.279 0.942 . . . . 0.0 112.842 174.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.84 20.57 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 110.648 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -73.53 -36.47 65.69 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 120.6 -1.312 . . . . 0.0 113.188 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -28.79 69.93 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.065 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -67.32 -2.84 6.66 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.026 -0.988 . . . . 0.0 113.292 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -138.23 81.83 1.88 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.719 1.6 . . . . 0.0 108.577 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 m -44.9 -44.89 10.01 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.685 2.394 . . . . 0.0 114.514 -171.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -154.58 91.29 1.38 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-N 120.234 1.379 . . . . 0.0 112.1 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.69 122.78 26.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.021 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.62 154.66 26.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.64 -0.663 . . . . 0.0 110.366 165.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.4 p -138.29 -174.67 3.87 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.296 1.839 . . . . 0.0 108.424 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.9 m -60.77 -13.79 17.36 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.903 -1.123 . . . . 0.0 112.802 164.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.93 -22.34 64.15 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.889 1.677 . . . . 0.0 109.739 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.5 p -53.63 -47.79 69.94 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 123.757 0.66 . . . . 0.0 110.354 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.86 -12.21 68.82 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 117.603 -1.665 . . . . 0.0 111.938 -171.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -52.66 148.54 7.09 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.004 1.402 . . . . 0.0 111.397 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.9 m -66.1 169.16 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-O 122.322 1.058 . . . . 0.0 113.059 -163.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -60.45 143.22 53.88 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 121.308 -0.87 . . . . 0.0 109.697 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -59.09 150.46 61.87 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.588 -1.196 . . . . 0.0 110.604 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -61.18 120.25 1.21 Allowed 'Cis proline' 0 CA--C 1.538 0.701 0 CA-C-N 120.618 1.256 . . . . 0.0 110.685 -17.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.1 p -126.68 81.8 68.13 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.712 1.605 . . . . 0.0 112.546 -172.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -71.28 -10.76 27.73 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.968 2.446 . . . . 0.0 112.415 -170.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -44.91 -50.26 10.55 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.597 2.359 . . . . 0.0 110.918 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.04 -15.61 63.83 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.06 -51.89 6.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.511 0.725 . . . . 0.0 109.521 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 m -50.59 -43.84 56.72 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.315 1.446 . . . . 0.0 109.853 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -57.7 -60.07 4.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.336 0.655 . . . . 0.0 109.604 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.57 -25.38 67.28 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.41 -71.66 0.14 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 172.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -28.34 69.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.609 1.164 . . . . 0.0 113.011 -171.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -31.24 65.67 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.168 1.387 . . . . 0.0 112.142 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -140.8 11.61 2.25 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 44.99 73.55 0.15 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 127.912 2.485 . . . . 0.0 111.565 -163.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.5 mp -103.08 154.92 18.78 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 166.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -93.42 136.96 33.19 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 126.108 1.763 . . . . 0.0 107.969 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -41.89 97.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.095 0.474 . . . . 0.0 111.938 174.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.23 -19.27 60.57 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.997 -1.064 . . . . 0.0 112.396 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -101.87 16.07 27.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -110.1 133.95 52.68 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.272 1.396 . . . . 0.0 108.228 169.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -125.64 117.48 23.62 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.721 1.208 . . . . 0.0 108.327 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -97.84 132.11 43.74 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.011 0.924 . . . . 0.0 109.172 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 7.2 mt -114.91 78.93 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -160.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.49 -177.94 37.01 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.494 1.521 . . . . 0.0 113.549 -170.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -134.82 1.88 3.08 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.665 1.186 . . . . 0.0 113.396 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.05 178.08 6.96 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 122.619 1.199 . . . . 0.0 111.344 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.12 -37.45 61.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.536 -177.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.78 -33.46 64.38 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 125.665 1.586 . . . . 0.0 111.865 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -57.43 -33.29 67.75 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.097 0.959 . . . . 0.0 111.481 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.2 t -92.31 -18.24 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.456 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -61.3 -31.51 71.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.311 0.96 . . . . 0.0 108.502 168.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -64.34 -56.27 15.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.59 -44.73 77.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.836 0.854 . . . . 0.0 111.578 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -55.44 -44.97 76.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.575 1.55 . . . . 0.0 111.503 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -69.25 -52.49 27.09 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.756 -0.59 . . . . 0.0 110.793 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.1 m -66.96 -19.55 65.74 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.147 1.379 . . . . 0.0 112.48 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 67.15 49.77 50.67 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 126.233 1.873 . . . . 0.0 110.799 -173.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.7 pt -117.9 -164.69 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.149 1.379 . . . . 0.0 109.224 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -117.94 163.96 15.79 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.512 0.725 . . . . 0.0 110.265 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 7.1 m -133.29 153.47 51.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.649 1.58 . . . . 0.0 110.005 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 55.1 mt -139.46 90.55 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -119.62 153.93 34.74 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.597 0.713 . . . . 0.0 109.399 -172.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -66.47 -17.13 64.62 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 pp -123.27 157.67 32.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 126.055 1.742 . . . . 0.0 110.339 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.41 139.72 51.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 16.5 m -126.67 -178.39 4.36 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p -72.48 4.97 3.3 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -169.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -142.79 133.01 24.61 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.27 1.428 . . . . 0.0 107.172 -160.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -69.84 -28.96 66.12 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.503 1.521 . . . . 0.0 110.967 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -72.88 10.67 5.23 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.686 1.612 . . . . 0.0 113.865 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -98.12 105.06 17.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.206 1.503 . . . . 0.0 108.364 167.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -79.1 126.67 31.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -69.62 152.65 44.49 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.405 1.002 . . . . 0.0 111.961 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.6 pt -134.42 163.07 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.326 1.451 . . . . 0.0 111.085 168.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -118.45 -14.9 9.69 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.746 1.218 . . . . 0.0 113.105 170.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.72 168.29 21.71 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.43 -42.26 79.14 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.75 -27.24 68.58 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -59.92 -21.12 60.69 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.336 1.854 . . . . 0.0 111.319 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 87.7 mt -57.09 -54.79 25.62 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 C-N-CA 125.557 1.543 . . . . 0.0 108.75 170.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 92.2 p -52.66 -42.24 64.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.481 1.037 . . . . 0.0 110.46 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -17.66 64.35 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.567 1.147 . . . . 0.0 112.995 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.25 -55.59 18.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -78.07 -34.47 50.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.51 1.124 . . . . 0.0 111.685 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 124.648 1.179 . . . . 0.0 112.175 -171.682 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 mmm . . . . . 0 N--CA 1.451 -0.419 0 CA-C-O 122.734 1.255 . . . . 0.0 107.666 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.58 171.51 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.381 159.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -44.43 100.4 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.334 1.854 . . . . 0.0 110.348 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.1 m -127.63 149.82 50.01 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.64 147.26 49.94 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.552 -0.717 . . . . 0.0 109.948 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -126.85 149.93 49.48 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.899 1.28 . . . . 0.0 109.399 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.1 mt -149.54 121.29 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -173.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -112.12 -174.56 2.49 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.014 1.326 . . . . 0.0 110.493 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -130.94 -173.41 3.08 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.96 1.304 . . . . 0.0 108.873 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.6 0 C-N-CA 126.654 1.981 . . . . 0.0 110.101 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.372 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -31.42 29.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.111 1.364 . . . . 0.0 113.733 -174.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.33 -45.81 80.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.502 0.721 . . . . 0.0 110.963 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.0 -41.07 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.405 HD12 HG23 ' A' ' 122' ' ' VAL . 60.4 mt -62.37 -43.56 98.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -174.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.55 -52.45 57.6 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 125.917 1.687 . . . . 0.0 109.649 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -54.43 -45.39 73.01 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.134 0.573 . . . . 0.0 112.155 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.84 64.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.908 0.883 . . . . 0.0 112.124 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -56.97 -48.72 77.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.463 1.905 . . . . 0.0 109.926 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.3 -2.61 13.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.577 2.351 . . . . 0.0 113.407 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.5 m -120.54 7.63 10.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.809 1.644 . . . . 0.0 113.175 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.4 11.09 61.35 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 121.441 -0.787 . . . . 0.0 114.385 171.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.8 mt -60.18 121.27 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -69.58 106.53 3.05 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 167.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -91.17 151.18 21.06 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -145.25 177.43 8.81 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.344 1.458 . . . . 0.0 109.609 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.8 mt -141.55 145.7 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.404 1.082 . . . . 0.0 108.559 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -132.3 141.63 49.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.769 1.228 . . . . 0.0 107.81 163.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.434 HG23 ' H ' ' A' ' 109' ' ' LYS . 5.7 t -167.05 -175.46 3.01 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -104.98 8.13 34.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.376 1.47 . . . . 0.0 112.61 172.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.434 ' H ' HG23 ' A' ' 107' ' ' THR . 6.9 tttm -57.58 153.12 13.68 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.116 -0.99 . . . . 0.0 109.866 171.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.56 175.91 43.02 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.505 1.05 . . . . 0.0 111.341 174.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.69 -17.0 45.29 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.534 -0.98 . . . . 0.0 112.433 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.31 -26.76 8.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.7 1.2 . . . . 0.0 112.284 169.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.36 -53.06 18.93 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.761 1.224 . . . . 0.0 111.24 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -53.42 -42.89 67.51 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.382 1.073 . . . . 0.0 110.027 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.9 m -63.07 -49.34 74.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.189 0.595 . . . . 0.0 110.425 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.5 mt -59.14 -46.58 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.719 0.69 . . . . 0.0 109.769 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 mt -66.96 -35.89 80.98 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.075 -0.391 . . . . 0.0 110.559 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -60.24 -45.18 94.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.232 1.013 . . . . 0.0 109.124 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.7 -61.29 2.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.123 1.769 . . . . 0.0 111.654 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.99 -32.97 63.64 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.212 -165.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 125.89 47.11 0.21 Allowed Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 148.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.405 HG23 HD12 ' A' ' 93' ' ' LEU . 3.6 p -159.4 44.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-O 123.796 1.76 . . . . 0.0 107.425 -169.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.79 -25.02 26.59 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 118.731 -2.481 . . . . 0.0 112.357 173.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.05 -20.29 17.46 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.553 1.158 . . . . 0.0 111.37 -165.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -62.5 1.94 0.32 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 128.578 2.751 . . . . 0.0 114.245 165.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -141.37 109.02 5.62 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 174.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -53.44 -38.92 64.0 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.809 1.644 . . . . 0.0 111.153 -170.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -150.73 148.48 28.6 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.84 126.48 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.9 mt -84.33 160.93 20.59 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 167.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.1 p -138.51 -177.59 4.92 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.428 1.091 . . . . 0.0 109.177 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.58 -30.1 19.71 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.485 -0.759 . . . . 0.0 111.159 161.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -72.23 -9.31 58.29 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.208 -0.933 . . . . 0.0 112.79 -169.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.8 m -56.73 -60.38 3.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.167 1.387 . . . . 0.0 110.758 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.75 -21.43 23.25 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 117.499 -1.723 . . . . 0.0 112.66 -171.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -51.22 154.53 1.62 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.802 1.801 . . . . 0.0 111.336 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.2 m -45.05 156.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.362 1.465 . . . . 0.0 112.257 170.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -70.66 166.99 19.6 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.603 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -43.69 142.36 1.92 Allowed Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 123.138 0.575 . . . . 0.0 110.669 170.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.98 -26.98 8.51 Favored 'Cis proline' 0 CA--C 1.55 1.282 0 CA-C-N 119.619 0.9 . . . . 0.0 114.154 2.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.298 2.7 t 53.77 86.47 0.16 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.227 1.811 . . . . 0.0 115.606 172.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.15 -19.3 29.85 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.397 2.065 . . . . 0.0 111.843 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.98 -43.57 98.56 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.175 0.898 . . . . 0.0 110.155 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.59 -23.79 67.53 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.31 -55.17 5.46 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.224 -0.923 . . . . 0.0 109.464 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 98.7 m -52.47 -39.84 61.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.302 1.041 . . . . 0.0 110.548 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -50.29 -64.89 0.67 Allowed 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 125.312 1.445 . . . . 0.0 109.735 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 52.2 mt -55.76 -39.71 71.58 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.547 0.612 . . . . 0.0 112.495 -173.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 75.5 mt -65.1 -50.82 64.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.329 1.452 . . . . 0.0 108.506 -176.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.6 -41.35 85.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.387 0.613 . . . . 0.0 111.217 172.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -56.91 -46.37 82.0 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.788 -1.195 . . . . 0.0 112.787 -172.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -121.72 21.36 10.81 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.055 0.843 . . . . 0.0 112.479 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 54.96 67.51 1.01 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.571 1.148 . . . . 0.0 108.973 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 14.7 mt -109.84 -179.74 3.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.09 1.356 . . . . 0.0 108.226 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -121.28 140.04 52.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.337 0.655 . . . . 0.0 110.077 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.9 m -51.03 -46.82 61.73 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.508 1.523 . . . . 0.0 111.84 175.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.28 -30.62 62.18 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.082 -1.011 . . . . 0.0 112.068 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.89 13.67 12.16 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -175.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.1 t -108.74 154.6 21.81 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -133.97 143.08 47.95 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 174.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -114.2 159.8 19.71 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.617 1.167 . . . . 0.0 110.825 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.7 mp -132.42 125.86 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 119.946 1.248 . . . . 0.0 109.685 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -146.63 -170.36 15.04 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 170.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.18 15.8 2.61 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -166.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 -165.0 1.74 Allowed 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.357 1.063 . . . . 0.0 109.848 -164.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.7 t -87.74 -25.06 23.62 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.302 0.641 . . . . 0.0 111.418 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -23.45 51.07 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.969 0.508 . . . . 0.0 111.03 -172.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.64 -30.55 61.17 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.249 1.419 . . . . 0.0 113.141 -172.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -111.49 -8.6 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.055 0.942 . . . . 0.0 110.666 -170.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -64.9 -38.63 91.6 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.757 -1.214 . . . . 0.0 110.041 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.94 -32.24 63.41 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.052 -1.03 . . . . 0.0 110.761 174.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.39 65.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.576 0.625 . . . . 0.0 110.418 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -61.3 -54.09 48.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.596 1.159 . . . . 0.0 113.285 174.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -63.21 -48.61 77.58 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.682 1.128 . . . . 0.0 111.628 -167.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 67.6 m -64.48 -38.06 89.71 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.211 0.604 . . . . 0.0 110.955 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.88 71.23 1.26 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 -169.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 41.3 pt -126.78 -172.84 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 127.477 2.311 . . . . 0.0 107.032 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -95.17 -176.21 3.74 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.994 1.318 . . . . 0.0 109.875 173.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.72 162.92 40.46 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.563 -1.336 . . . . 0.0 109.799 168.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 53.1 mt -132.47 129.14 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -149.86 160.06 43.88 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 120.992 -1.067 . . . . 0.0 110.291 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -74.62 -15.81 60.81 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.37 -0.831 . . . . 0.0 112.002 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 5.7 mt -116.04 156.83 25.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.08 1.752 . . . . 0.0 109.86 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -76.01 153.55 36.42 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.56 -167.83 2.51 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.39 1.076 . . . . 0.0 109.383 165.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.8 p -82.35 -10.97 58.87 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -81.43 177.59 8.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.167 0.987 . . . . 0.0 109.596 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -125.74 -36.32 2.42 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -75.22 28.37 1.18 Allowed Glycine 0 C--N 1.338 0.678 0 CA-C-N 119.375 0.989 . . . . 0.0 111.621 172.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.73 140.49 34.94 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 127.962 2.505 . . . . 0.0 106.397 177.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -121.16 109.32 14.85 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -64.52 129.38 39.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 36.0 pt -131.05 176.32 9.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 124.301 1.04 . . . . 0.0 110.167 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -134.72 -16.39 2.02 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.971 1.308 . . . . 0.0 111.888 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.74 -154.59 0.65 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.041 0.837 . . . . 0.0 111.115 173.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -98.9 -27.46 13.89 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.388 0.54 . . . . 0.0 110.409 163.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.02 -25.66 62.77 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 121.156 -0.965 . . . . 0.0 111.997 -167.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -31.6 65.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 129.313 3.045 . . . . 0.0 109.58 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.34 -54.22 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 119.289 0.95 . . . . 0.0 109.388 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.6 m -55.69 -37.68 68.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -60.39 -32.26 71.15 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.177 1.391 . . . . 0.0 112.028 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 93.9 mt -53.56 -43.64 54.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 119.378 0.99 . . . . 0.0 109.556 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -85.09 -41.33 15.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.57 1.548 . . . . 0.0 109.426 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 125.899 1.68 . . . . 0.0 111.027 -171.242 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.8 mmm . . . . . 0 C--O 1.234 0.272 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 173.39 0.57 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.029 1.332 . . . . 0.0 109.689 168.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -45.06 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.483 1.913 . . . . 0.0 112.294 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.4 m -117.49 141.68 48.06 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -176.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.7 144.94 51.05 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.313 0.577 . . . . 0.0 109.942 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -131.39 145.47 51.83 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.872 1.669 . . . . 0.0 108.07 -172.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.2 mt -145.22 89.74 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -171.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -78.36 -171.63 2.51 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 119.769 1.168 . . . . 0.0 110.383 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.471 ' HB2' ' HH ' ' A' ' 161' ' ' TYR . 21.7 t0 -131.28 164.42 25.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.516 1.526 . . . . 0.0 111.788 172.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.416 0 C-N-CA 127.327 2.251 . . . . 0.0 112.824 176.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -59.91 -28.37 67.53 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.835 0.743 . . . . 0.0 112.177 -171.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -58.47 -60.66 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.832 1.653 . . . . 0.0 110.63 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.4 t -60.56 -47.63 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 117.843 -1.075 . . . . 0.0 108.952 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.435 ' HA ' HE22 ' A' ' 103' ' ' GLN . 4.6 mp -44.37 -54.23 6.05 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 120.857 1.662 . . . . 0.0 113.521 171.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.82 -38.43 91.08 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.874 0.469 . . . . 0.0 112.085 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -64.73 -54.23 34.8 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.084 0.954 . . . . 0.0 109.173 174.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.75 94.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.537 1.935 . . . . 0.0 112.957 -172.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.78 -55.01 34.68 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.663 1.585 . . . . 0.0 110.774 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.19 -36.72 80.02 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 111.429 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.6 m -65.65 -2.39 3.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.545 1.138 . . . . 0.0 113.272 168.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.81 19.62 73.55 Favored Glycine 0 CA--C 1.525 0.706 0 O-C-N 119.874 -1.766 . . . . 0.0 112.161 174.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.3 mt -75.08 115.53 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -71.0 133.99 46.78 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.435 HE22 ' HA ' ' A' ' 93' ' ' LEU . 8.1 mt-30 -112.83 151.0 30.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -144.32 175.87 9.78 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 126.763 2.025 . . . . 0.0 106.838 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.3 mt -139.88 148.47 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -132.78 100.5 4.95 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.908 0.777 . . . . 0.0 110.323 168.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -103.44 170.84 7.7 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.428 1.109 . . . . 0.0 108.322 169.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -96.16 -9.24 31.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.042 1.337 . . . . 0.0 111.396 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 178.62 5.85 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.184 1.356 . . . . 0.0 112.152 -172.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.62 176.03 36.33 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.13 1.347 . . . . 0.0 112.579 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.57 -16.57 10.55 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.543 2.337 . . . . 0.0 111.792 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -44.56 -30.56 0.92 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.236 1.814 . . . . 0.0 111.3 164.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -44.96 -62.79 1.1 Allowed 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.106 1.763 . . . . 0.0 110.81 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . 0.418 ' CE1' ' HB ' ' A' ' 129' ' ' ILE . 63.4 m-85 -57.07 -38.35 73.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.529 0.732 . . . . 0.0 111.226 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.7 m -63.43 -39.95 95.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.876 0.87 . . . . 0.0 110.701 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.6 mt -57.83 -57.18 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.493 1.042 . . . . 0.0 109.731 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.61 -37.52 84.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.569 1.077 . . . . 0.0 111.31 -173.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -64.69 -45.81 85.06 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.527 0.731 . . . . 0.0 110.582 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -54.46 -53.64 51.52 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.794 0.838 . . . . 0.0 109.437 174.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.0 -14.81 63.26 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.249 1.02 . . . . 0.0 112.894 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.93 32.84 52.24 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.693 171.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.9 14.5 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.407 1.483 . . . . 0.0 111.672 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -44.61 55.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 m -61.6 -26.28 67.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -60.55 -34.12 73.68 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.004 -0.435 . . . . 0.0 111.112 173.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -99.99 94.51 6.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.524 1.53 . . . . 0.0 107.259 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 39.0 m -52.96 -43.46 66.39 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.819 1.648 . . . . 0.0 111.13 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.28 156.81 44.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.824 1.65 . . . . 0.0 107.262 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.418 ' HB ' ' CE1' ' A' ' 114' ' ' PHE . 5.0 mp -137.93 157.03 32.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.5 mt -131.18 156.02 46.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.259 1.824 . . . . 0.0 108.699 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.3 p -158.89 -174.87 4.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.47 1.508 . . . . 0.0 110.367 -151.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.8 p -59.49 -30.87 68.86 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.975 -1.078 . . . . 0.0 112.255 162.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -63.38 -31.3 72.42 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.254 0.934 . . . . 0.0 111.044 -177.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -63.45 -37.24 86.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.006 1.323 . . . . 0.0 111.289 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.97 5.47 70.38 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.458 170.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -58.26 168.46 1.06 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.214 1.507 . . . . 0.0 111.793 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.3 m -53.27 161.79 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.599 1.16 . . . . 0.0 113.407 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -78.1 160.73 27.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.865 1.266 . . . . 0.0 110.526 169.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -58.53 137.9 85.83 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 117.616 -1.183 . . . . 0.0 109.303 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.9 121.72 5.16 Favored 'Cis proline' 0 CA--C 1.536 0.586 0 CA-C-N 120.405 1.181 . . . . 0.0 110.845 -8.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 p -122.08 68.2 26.24 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 125.604 1.562 . . . . 0.0 110.98 -165.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.74 -24.29 47.49 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 CA-C-N 120.127 1.081 . . . . 0.0 112.198 -163.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.5 -44.11 8.38 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 130.08 3.352 . . . . 0.0 111.117 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.31 -19.94 64.71 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.55 -60.25 2.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 m -56.87 -33.59 67.0 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.332 1.053 . . . . 0.0 111.495 -167.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -54.27 -49.37 69.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.595 0.758 . . . . 0.0 111.197 173.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.44 -31.64 65.64 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 124.914 1.286 . . . . 0.0 111.794 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 81.9 mt -61.49 -59.86 4.58 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -174.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -70.54 -17.24 62.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.19 -177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -54.34 -49.1 70.54 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.353 0.979 . . . . 0.0 109.962 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.92 23.57 5.33 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.487 0.66 . . . . 0.0 112.561 -171.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.0 mp0 45.17 46.69 9.87 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.867 2.067 . . . . 0.0 110.648 -171.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 29.0 mt -77.0 164.68 25.53 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 172.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -104.24 153.53 20.87 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 128.572 2.749 . . . . 0.0 108.533 176.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 48.2 m -62.15 -27.36 68.89 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.645 0.736 . . . . 0.0 109.715 165.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.74 -29.37 25.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.724 -1.235 . . . . 0.0 111.966 -156.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -102.05 20.64 16.21 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.458 -0.776 . . . . 0.0 109.732 174.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.8 m -100.4 122.84 43.8 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -125.15 148.13 48.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.736 1.614 . . . . 0.0 110.077 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.471 ' HH ' ' HB2' ' A' ' 9' ' ' ASP . 60.3 t80 -115.53 -20.22 10.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -168.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.6 mp 44.68 74.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 126.944 2.098 . . . . 0.0 112.797 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.56 173.17 17.54 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -125.19 25.6 7.15 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.521 -0.988 . . . . 0.0 112.573 -153.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -145.96 176.59 9.58 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t -70.97 -29.46 65.47 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.82 1.248 . . . . 0.0 111.038 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.67 11.64 14.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.035 0.934 . . . . 0.0 110.481 -177.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.75 -54.47 6.9 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 76.7 t -71.33 -17.1 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 O-C-N 121.382 -0.824 . . . . 0.0 111.762 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -59.94 -61.16 2.82 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.026 1.73 . . . . 0.0 111.355 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -68.95 -31.76 70.87 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 120.391 -1.443 . . . . 0.0 109.959 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.62 72.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.171 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.5 -52.58 16.85 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.195 1.398 . . . . 0.0 110.618 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.1 -21.41 60.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.766 -171.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.0 m -81.66 -33.47 31.31 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.446 -0.784 . . . . 0.0 111.072 169.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.11 19.81 54.61 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.278 1.418 . . . . 0.0 112.521 -166.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.7 pt -102.14 174.01 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.331 0 CA-C-N 118.982 1.391 . . . . 0.0 111.51 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -87.74 176.45 7.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.766 1.226 . . . . 0.0 110.338 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 5.5 m -153.09 139.48 18.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.86 1.264 . . . . 0.0 109.768 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 61.2 mt -123.0 84.25 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -114.63 149.84 36.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.925 0.869 . . . . 0.0 109.972 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -64.42 -14.79 58.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.608 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.74 166.94 10.62 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.254 1.422 . . . . 0.0 110.183 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -95.07 163.55 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.563 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.0 t -151.14 -175.04 5.0 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.239 1.816 . . . . 0.0 107.352 168.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.6 p -115.57 71.8 0.78 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 170.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -142.28 137.11 30.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.99 91.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.412 1.885 . . . . 0.0 108.695 167.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 133.98 -3.51 4.52 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 117.941 -1.477 . . . . 0.0 113.255 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.46 131.28 34.41 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.525 2.163 . . . . 0.0 106.422 171.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.61 118.76 25.47 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.782 1.233 . . . . 0.0 108.804 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -67.23 147.63 52.79 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.471 0.578 . . . . 0.0 112.039 176.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.5 pt -141.59 164.88 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.876 1.67 . . . . 0.0 111.505 168.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -121.09 -15.37 8.23 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.833 1.653 . . . . 0.0 112.468 171.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.72 164.99 33.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.009 1.724 . . . . 0.0 107.192 171.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.14 -30.69 70.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.114 0.966 . . . . 0.0 109.787 174.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.07 64.92 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -64.77 -22.64 67.03 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.943 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.7 mt -55.27 -57.36 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 83.5 p -50.09 -39.4 42.44 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.444 0.64 . . . . 0.0 112.237 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -67.7 -29.4 68.65 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 125.499 1.52 . . . . 0.0 111.515 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.9 mt -52.37 -48.03 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -86.72 -0.88 57.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.263 1.425 . . . . 0.0 112.226 -173.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 . . . . . 0 CA--C 1.53 0.205 0 C-N-CA 125.276 1.43 . . . . 0.0 111.543 -175.608 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.1 mmm . . . . . 0 C--O 1.234 0.268 0 CA-C-O 123.306 1.527 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -80.77 122.05 26.68 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.3 mtpp 43.08 58.94 3.1 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 161.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.3 m -103.69 149.56 24.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.43 146.14 51.32 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 121.7 -0.625 . . . . 0.0 109.962 173.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.14 149.93 51.63 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 125.29 1.436 . . . . 0.0 108.373 -173.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.7 mt -140.56 131.94 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -120.82 148.49 43.95 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.524 1.53 . . . . 0.0 110.371 -173.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -89.48 -37.73 14.56 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.277 -0.889 . . . . 0.0 112.315 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.51 0 C-N-CA 129.374 3.07 . . . . 0.0 114.157 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 120.531 0.205 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -51.73 -35.44 43.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.325 1.05 . . . . 0.0 111.969 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -45.09 -56.93 4.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.819 2.448 . . . . 0.0 111.079 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.99 -39.83 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.985 1.714 . . . . 0.0 110.052 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.2 mt -51.52 -46.65 63.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.939 1.245 . . . . 0.0 110.078 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.66 -56.03 26.17 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 123.694 0.797 . . . . 0.0 111.257 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.448 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 15.4 t90 -52.57 -46.75 67.0 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.925 1.29 . . . . 0.0 111.198 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.62 82.78 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.159 0.984 . . . . 0.0 111.75 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.94 -42.65 69.57 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.664 0.786 . . . . 0.0 111.017 -177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -60.4 -34.14 73.49 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.54 1.136 . . . . 0.0 110.701 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 m -78.09 -4.52 47.75 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.587 1.155 . . . . 0.0 113.549 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.71 27.26 58.73 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 119.768 1.167 . . . . 0.0 112.969 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.7 mt -60.81 124.67 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 163.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -74.04 103.32 4.47 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -91.29 137.87 32.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.235 0.47 . . . . 0.0 110.21 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -138.44 173.15 11.91 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.036 1.735 . . . . 0.0 110.51 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.6 mt -146.62 150.83 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.229 1.412 . . . . 0.0 108.777 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -158.44 124.94 4.72 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.329 1.452 . . . . 0.0 111.935 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 t -155.8 171.39 20.11 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.642 1.177 . . . . 0.0 111.579 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -65.05 -26.36 68.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.263 1.825 . . . . 0.0 111.917 165.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -61.91 136.38 57.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.43 -161.95 28.29 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 124.146 0.879 . . . . 0.0 112.705 -170.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -47.24 -30.8 3.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.982 2.113 . . . . 0.0 111.999 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -58.45 -24.91 61.52 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.926 -1.109 . . . . 0.0 113.374 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.64 -35.31 77.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.333 0.97 . . . . 0.0 111.636 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -62.06 -40.77 96.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.312 0.96 . . . . 0.0 109.699 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.2 m -63.44 -41.9 98.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.975 1.31 . . . . 0.0 109.533 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 93.0 mt -57.56 -52.39 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.262 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.26 -41.17 96.46 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 120.834 1.652 . . . . 0.0 111.828 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -66.44 -27.81 68.11 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.786 0.721 . . . . 0.0 112.429 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -65.19 -49.1 71.07 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.534 1.159 . . . . 0.0 109.134 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 53.5 mt -73.89 -11.94 60.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.428 1.891 . . . . 0.0 112.123 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.15 19.37 78.59 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 118.878 -0.957 . . . . 0.0 113.253 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.6 18.17 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 119.072 1.436 . . . . 0.0 111.143 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -49.78 67.7 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.866 -0.521 . . . . 0.0 111.021 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.0 t -67.5 -22.44 65.45 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.724 0.64 . . . . 0.0 112.422 -168.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -59.7 -32.35 70.43 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 119.024 0.829 . . . . 0.0 111.644 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.12 122.68 45.19 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -173.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -61.48 -45.12 95.57 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -157.69 145.24 18.54 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -169.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.14 131.54 52.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.406 0.622 . . . . 0.0 109.879 -170.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -89.23 162.92 15.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.034 0.921 . . . . 0.0 110.265 170.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 41.7 p -155.46 -179.06 7.73 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.555 1.542 . . . . 0.0 107.556 -171.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -22.12 1.7 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 168.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -67.39 -58.8 4.12 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.004 0.82 . . . . 0.0 110.357 173.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 61.6 m -99.95 55.36 0.93 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.91 -20.74 75.62 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.12 -171.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 45.0 -167.56 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 126.407 1.883 . . . . 0.0 112.863 -165.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.68 172.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 127.281 2.232 . . . . 0.0 112.252 173.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -59.54 152.71 21.33 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.743 169.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -48.23 138.14 11.0 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 117.666 -1.159 . . . . 0.0 108.968 162.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.87 -43.97 0.42 Allowed 'Cis proline' 0 CA--C 1.533 0.458 0 CA-C-N 120.453 1.198 . . . . 0.0 113.822 6.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 t 55.17 81.45 0.26 Allowed Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.672 1.189 . . . . 0.0 111.679 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.3 -16.62 52.2 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.487 2.125 . . . . 0.0 111.462 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -55.4 -48.53 74.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.261 1.391 . . . . 0.0 110.824 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.99 -18.83 64.68 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.76 -52.9 5.72 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 118.194 -0.907 . . . . 0.0 108.982 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.5 m -54.44 -38.33 66.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.455 0.702 . . . . 0.0 110.157 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -54.52 -58.53 7.1 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.612 1.165 . . . . 0.0 110.403 171.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 22.2 mt -65.59 -27.72 68.62 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.561 1.073 . . . . 0.0 112.093 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 75.8 mt -65.9 -59.75 3.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.52 -30.72 69.92 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.314 1.046 . . . . 0.0 113.131 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.49 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 5.6 mmpt? -57.42 -35.31 69.91 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.09 -1.006 . . . . 0.0 112.092 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.99 24.23 2.18 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 49.94 47.73 22.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.195 1.798 . . . . 0.0 110.235 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 59.3 mt -83.6 165.55 18.94 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.441 1.096 . . . . 0.0 109.395 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -106.34 134.43 49.48 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 124.144 0.977 . . . . 0.0 108.829 -171.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 m -60.47 -42.2 95.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.492 0.663 . . . . 0.0 109.74 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -74.02 -24.82 59.62 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 120.793 -1.192 . . . . 0.0 112.58 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -92.95 5.59 50.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.917 -1.039 . . . . 0.0 109.429 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -107.32 146.97 30.89 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -132.04 167.45 19.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.873 1.669 . . . . 0.0 107.612 -176.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -143.37 151.38 40.37 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.593 0.757 . . . . 0.0 109.968 173.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.6 mt -138.45 118.82 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.49 -6.55 0.03 OUTLIER Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.904 -175.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.5 t0 56.16 67.69 0.97 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.132 2.573 . . . . 0.0 112.356 169.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -153.94 167.96 27.99 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 120.879 -1.138 . . . . 0.0 110.936 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.0 t -61.25 -44.53 97.09 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.293 0.568 . . . . 0.0 109.989 167.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -5.21 14.28 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.755 1.622 . . . . 0.0 112.3 -171.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -54.52 38.5 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.526 1.13 . . . . 0.0 109.786 171.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 25.7 m -70.76 -30.45 42.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 118.248 -1.381 . . . . 0.0 111.688 -170.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -61.5 -48.69 79.94 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.825 0.85 . . . . 0.0 109.827 -172.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -80.02 -39.95 28.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.601 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.0 78.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.622 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -61.2 -53.77 52.71 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.833 0.853 . . . . 0.0 110.833 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -64.81 -34.96 79.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.574 -0.25 . . . . 0.0 110.975 -172.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.4 m -69.96 -34.98 74.1 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.096 0.862 . . . . 0.0 112.826 168.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.07 44.93 6.11 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.865 1.222 . . . . 0.0 111.785 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 10.9 pt -116.09 -179.14 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.565 1.546 . . . . 0.0 108.806 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -103.52 165.75 10.84 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.371 0.605 . . . . 0.0 109.745 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 143.27 38.55 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.987 0.915 . . . . 0.0 108.804 -163.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 62.7 mt -133.92 100.18 3.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -123.78 158.12 32.46 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.634 1.174 . . . . 0.0 109.947 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -86.33 -3.16 58.94 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.229 -1.544 . . . . 0.0 111.218 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.34 155.8 45.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.427 1.891 . . . . 0.0 110.432 -174.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -74.79 142.24 44.27 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.73 177.68 8.53 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.412 1.485 . . . . 0.0 107.996 173.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 32.8 p -93.15 59.65 3.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.126 1.37 . . . . 0.0 110.774 -160.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -142.93 175.06 10.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.972 0.509 . . . . 0.0 112.238 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.84 -3.37 12.2 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 0.0 113.588 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -118.94 9.1 12.43 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.434 1.492 . . . . 0.0 112.417 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.12 138.02 33.24 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 119.15 1.475 . . . . 0.0 107.462 173.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -112.64 107.08 15.64 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -59.69 142.64 52.65 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.438 168.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.6 pt -131.64 165.59 31.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.635 1.574 . . . . 0.0 110.126 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -117.83 -16.3 9.97 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.011 0.924 . . . . 0.0 113.401 169.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.35 165.18 32.78 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.584 1.154 . . . . 0.0 109.021 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 30.6 mt -63.44 -44.55 94.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.232 1.813 . . . . 0.0 107.63 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.42 -15.01 63.4 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.88 -22.89 64.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.337 1.426 . . . . 0.0 110.407 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 19.8 mt -55.83 -53.43 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.049 1.34 . . . . 0.0 109.55 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.448 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 8.6 m -60.06 -32.89 71.36 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.93 1.241 . . . . 0.0 111.898 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -65.02 -26.65 68.37 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 118.3 -0.857 . . . . 0.0 112.227 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.55 -55.97 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.0 10.45 18.95 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.019 1.328 . . . . 0.0 113.62 -169.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 . . . . . 0 C--N 1.333 -0.138 0 C-N-CA 124.552 1.141 . . . . 0.0 112.458 178.03 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 mmm . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.402 ' NE2' ' H ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 55.49 -171.46 0.07 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.938 1.295 . . . . 0.0 113.117 175.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.402 ' H ' ' NE2' ' A' ' 2' ' ' GLN . 2.7 mtpp -78.8 79.4 5.21 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 152.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 m -101.99 146.59 27.67 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.97 149.41 51.71 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 121.501 -0.749 . . . . 0.0 109.242 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -123.13 156.73 34.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.903 1.281 . . . . 0.0 108.03 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.2 mt -140.74 135.84 34.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -120.54 161.66 20.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.011 0.924 . . . . 0.0 111.068 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -102.91 -4.18 25.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.549 1.54 . . . . 0.0 111.941 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.2 tp . . . . . 0 C--O 1.235 0.314 0 C-N-CA 128.837 2.855 . . . . 0.0 111.347 -175.884 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 120.453 0.168 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -32.16 67.45 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.637 -176.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.32 -49.1 77.18 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.425 1.09 . . . . 0.0 111.563 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.9 t -77.55 -43.82 29.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 CA-C-O 117.552 -1.214 . . . . 0.0 109.678 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.402 ' HB3' ' CD1' ' A' ' 125' ' ' TYR . 6.1 mp -44.0 -56.18 4.15 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.649 1.58 . . . . 0.0 111.153 170.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.55 -54.92 41.38 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.74 0.416 . . . . 0.0 110.874 -177.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -56.71 -43.25 80.4 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.106 1.363 . . . . 0.0 112.502 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.5 -38.36 49.14 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.368 1.067 . . . . 0.0 112.049 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.89 -41.47 74.69 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.676 0.79 . . . . 0.0 110.845 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -61.03 -15.53 33.16 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.76 -0.587 . . . . 0.0 111.4 170.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.0 m -108.24 5.96 26.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.182 1.793 . . . . 0.0 113.468 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.06 8.72 55.05 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.671 1.129 . . . . 0.0 113.695 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.4 mt -55.5 120.5 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -71.05 92.68 0.97 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 172.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -71.95 151.56 43.17 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 168.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -141.78 172.59 12.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.008 2.123 . . . . 0.0 107.383 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.9 mt -136.4 155.07 33.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 171.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -136.46 115.38 12.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 164.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.3 t -121.88 157.04 32.02 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.206 1.003 . . . . 0.0 108.971 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -63.57 -30.2 71.35 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.014 165.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -61.58 142.2 57.27 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.198 1.799 . . . . 0.0 109.898 -166.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.5 -170.02 39.09 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.351 -0.843 . . . . 0.0 112.348 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -52.05 -24.94 7.51 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 128.387 2.675 . . . . 0.0 116.015 -163.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -69.91 -11.46 60.89 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.982 0.81 . . . . 0.0 112.154 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.37 80.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.23 1.012 . . . . 0.0 110.953 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -48.4 -46.39 37.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.038 1.335 . . . . 0.0 110.454 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 m -70.88 -37.92 73.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.383 1.073 . . . . 0.0 111.382 -171.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.4 mt -60.77 -45.95 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.13 1.372 . . . . 0.0 108.9 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.33 -35.5 75.98 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.012 -1.055 . . . . 0.0 111.582 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -50.17 73.44 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.289 0.635 . . . . 0.0 109.692 170.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -48.96 -48.13 43.37 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.962 0.905 . . . . 0.0 111.544 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.35 -10.36 59.39 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.097 1.359 . . . . 0.0 113.281 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.01 23.48 78.07 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.78 0.705 . . . . 0.0 114.27 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.3 m -124.23 13.46 4.86 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 C-N-CA 125.027 1.331 . . . . 0.0 110.471 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -43.06 99.51 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.885 1.22 . . . . 0.0 110.617 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.1 m -74.21 3.0 7.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.458 1.503 . . . . 0.0 112.68 -175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.402 ' CD1' ' HB3' ' A' ' 93' ' ' LEU . 10.3 m-85 -80.12 -0.28 35.17 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.605 164.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -144.58 133.02 21.95 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.532 1.515 . . . . 0.0 108.728 -173.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.2 m -60.75 -68.86 0.26 Allowed 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 127.979 2.512 . . . . 0.0 112.072 -174.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -138.81 123.61 18.73 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.155 1.382 . . . . 0.0 107.726 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.1 mp -105.54 98.16 6.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 -172.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.451 HD11 ' CB ' ' A' ' 134' ' ' SER . 4.2 mm? -70.55 147.41 49.32 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.1 p -127.63 -168.78 1.94 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.506 2.322 . . . . 0.0 110.696 -172.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 t -56.96 -23.12 43.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.072 1.349 . . . . 0.0 113.426 166.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -64.98 -22.51 67.01 Favored 'General case' 0 C--O 1.228 -0.079 0 C-N-CA 124.014 0.926 . . . . 0.0 111.073 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.451 ' CB ' HD11 ' A' ' 130' ' ' LEU . 1.0 OUTLIER -110.07 72.52 0.8 Allowed 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 128.719 2.807 . . . . 0.0 105.597 177.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.36 48.68 3.67 Favored Glycine 0 N--CA 1.458 0.13 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -61.49 117.57 5.88 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.823 0.312 . . . . 0.0 110.723 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 138' ' ' ARG . 18.1 t 54.75 -165.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 124.906 1.283 . . . . 0.0 109.982 167.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.517 ' H ' HG12 ' A' ' 137' ' ' VAL . 82.6 mtt180 -128.12 0.4 5.84 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.036 -1.665 . . . . 0.0 114.521 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt 98.23 112.73 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.486 0 C-N-CA 129.003 2.921 . . . . 0.0 107.532 166.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -61.17 154.63 56.4 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 120.729 1.296 . . . . 0.0 111.79 6.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 p -142.17 82.2 13.46 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.726 1.211 . . . . 0.0 111.57 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.42 -20.24 24.22 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.08 2.52 . . . . 0.0 113.965 -177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -69.57 -27.16 64.89 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.209 -0.932 . . . . 0.0 112.034 -170.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.65 94.99 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.79 85.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.34 -0.85 . . . . 0.0 110.144 173.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.9 m -53.85 -40.38 66.44 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.155 1.343 . . . . 0.0 111.158 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -61.76 -48.97 78.27 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.7 mp -62.59 -37.98 88.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.809 1.244 . . . . 0.0 111.496 -172.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 86.7 mt -64.51 -54.13 37.11 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.12 -35.94 76.38 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -56.92 -29.01 62.7 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 120.714 -1.241 . . . . 0.0 112.856 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -138.07 19.52 2.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 48.59 70.19 0.48 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.862 1.665 . . . . 0.0 110.654 -173.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 76.0 mt -109.33 -176.2 2.96 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.184 1.394 . . . . 0.0 109.99 -172.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.08 129.1 52.08 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.465 1.106 . . . . 0.0 109.905 -172.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.37 -17.47 20.42 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 125.165 1.386 . . . . 0.0 112.007 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.49 19.36 13.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.498 -0.751 . . . . 0.0 109.839 -174.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -128.3 8.61 6.05 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.87 1.668 . . . . 0.0 110.917 170.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.8 t -91.23 158.95 16.3 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.897 1.679 . . . . 0.0 109.783 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -147.84 105.47 3.69 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.015 -1.053 . . . . 0.0 109.64 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -85.6 133.07 34.07 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.093 0.957 . . . . 0.0 111.571 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.78 105.53 18.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.681 1.192 . . . . 0.0 109.056 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.37 -164.45 11.76 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.879 1.704 . . . . 0.0 110.859 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -136.91 -9.67 1.8 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.9 158.07 32.78 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.904 1.683 . . . . 0.0 110.912 -170.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.9 t -54.82 -32.3 60.22 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.618 -0.676 . . . . 0.0 112.489 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.6 -28.55 69.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.894 0.878 . . . . 0.0 110.507 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -69.9 -0.99 8.27 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.908 1.683 . . . . 0.0 112.024 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.2 t -120.48 -17.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 125.284 1.434 . . . . 0.0 109.61 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -65.93 -58.5 5.41 Favored 'General case' 0 C--N 1.338 0.101 0 O-C-N 120.916 -1.115 . . . . 0.0 108.734 168.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -63.75 -33.86 76.61 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.202 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.58 97.58 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.913 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -62.54 -43.59 98.43 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.338 0.972 . . . . 0.0 111.08 171.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -64.61 -37.9 89.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 117.705 -1.141 . . . . 0.0 112.464 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.4 p -79.14 -36.8 39.92 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.834 1.652 . . . . 0.0 110.778 168.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.26 65.61 1.26 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -172.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.39 174.61 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 127.295 2.238 . . . . 0.0 108.587 174.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -96.16 170.08 9.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.81 1.644 . . . . 0.0 111.96 -176.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.6 m -143.36 156.92 44.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.842 1.657 . . . . 0.0 111.729 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.2 mt -136.47 104.28 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -126.32 161.65 27.33 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.677 1.591 . . . . 0.0 107.43 -173.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -75.48 -13.19 60.36 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.685 -1.259 . . . . 0.0 112.903 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.3 pp -129.9 166.13 20.64 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.44 1.896 . . . . 0.0 110.16 -175.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -96.29 159.04 15.16 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.123 0.487 . . . . 0.0 111.268 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 38.6 m -151.65 27.91 0.63 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.821 1.649 . . . . 0.0 111.081 -168.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 63.4 p 56.5 10.44 0.68 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.917 2.887 . . . . 0.0 116.037 173.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -106.07 153.26 22.31 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.616 1.567 . . . . 0.0 110.465 -168.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.483 ' HG3' ' H ' ' A' ' 189' ' ' GLY . 0.3 OUTLIER -56.5 -77.48 0.03 OUTLIER 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.756 2.022 . . . . 0.0 112.215 -175.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.483 ' H ' ' HG3' ' A' ' 188' ' ' GLU . . . -75.93 18.33 3.26 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.448 1.975 . . . . 0.0 112.978 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -90.91 112.27 24.05 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.586 1.693 . . . . 0.0 107.28 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -101.84 127.87 48.46 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 25.0 mtm105 -68.57 148.12 50.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.283 0.492 . . . . 0.0 110.384 166.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.3 pt -135.36 170.19 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.325 1.85 . . . . 0.0 110.243 167.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -126.59 -10.75 6.21 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.554 1.142 . . . . 0.0 113.043 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.27 171.54 18.97 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.11 1.764 . . . . 0.0 108.117 172.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.53 -42.42 87.27 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.334 1.054 . . . . 0.0 109.703 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.1 -27.43 69.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.94 -22.78 62.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.238 1.815 . . . . 0.0 111.07 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 94.1 mt -57.4 -56.9 12.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 125.341 1.456 . . . . 0.0 108.863 171.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 80.3 p -53.06 -43.61 66.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.96 0.8 . . . . 0.0 111.483 -172.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -63.1 -21.99 66.56 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.912 1.685 . . . . 0.0 112.973 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.87 -42.96 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.838 0.744 . . . . 0.0 109.581 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -89.66 -32.57 16.99 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.62 0.768 . . . . 0.0 110.897 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 N--CA 1.468 0.463 0 C-N-CA 124.443 1.097 . . . . 0.0 112.878 -173.962 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mmm . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 122.131 0.967 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.5 167.04 0.07 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.419 1.888 . . . . 0.0 110.106 164.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.456 ' C ' ' HZ1' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -54.49 73.78 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.812 2.445 . . . . 0.0 114.365 -171.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.7 m -86.63 160.84 18.77 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 119.46 -2.025 . . . . 0.0 107.875 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.8 151.02 48.7 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.738 -1.226 . . . . 0.0 109.338 165.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -122.74 154.01 38.7 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.214 1.406 . . . . 0.0 108.857 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.46 135.3 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -120.52 143.47 48.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.346 1.858 . . . . 0.0 109.046 -176.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.36 -32.81 66.78 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.446 1.021 . . . . 0.0 111.341 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 N--CA 1.467 0.375 0 C-N-CA 128.81 2.844 . . . . 0.0 112.723 -178.415 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -61.9 -37.86 86.18 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.473 -1.392 . . . . 0.0 112.823 -171.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.28 -54.6 29.26 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.533 1.933 . . . . 0.0 112.203 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.04 -33.54 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.634 1.107 . . . . 0.0 110.732 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.2 mt -57.1 -55.26 36.97 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.97 -13.69 62.35 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.636 1.175 . . . . 0.0 113.542 -174.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -79.74 -55.49 4.96 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 120.486 -1.384 . . . . 0.0 108.426 170.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.99 -37.81 86.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.236 1.414 . . . . 0.0 111.779 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.36 -51.34 66.32 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.789 1.636 . . . . 0.0 111.12 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -65.1 -17.5 64.51 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.163 1.385 . . . . 0.0 110.743 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.7 m -94.61 -1.58 52.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.292 1.437 . . . . 0.0 112.799 176.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.54 5.11 72.2 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.036 1.303 . . . . 0.0 113.571 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.1 mt -56.51 112.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -64.81 101.82 0.52 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 171.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.58 150.18 26.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.325 0.966 . . . . 0.0 108.413 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -146.5 171.84 14.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.413 1.885 . . . . 0.0 108.834 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.6 mt -136.12 156.88 37.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.692 1.197 . . . . 0.0 109.222 171.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -139.76 125.45 19.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.131 0.973 . . . . 0.0 109.112 164.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.7 t -154.09 178.3 10.12 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.552 2.341 . . . . 0.0 108.26 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -137.27 15.53 3.0 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.883 -1.136 . . . . 0.0 113.805 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -11.08 3.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 121.73 167.23 13.09 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 128.043 2.735 . . . . 0.0 110.118 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -52.02 -31.68 30.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.961 1.704 . . . . 0.0 111.367 170.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -53.0 -17.37 1.41 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.436 1.494 . . . . 0.0 114.026 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.19 -47.22 62.27 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.488 1.115 . . . . 0.0 111.028 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -56.78 -48.61 77.49 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.854 1.661 . . . . 0.0 109.93 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.6 m -55.43 -49.78 71.53 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.275 0.489 . . . . 0.0 109.795 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.8 mt -59.33 -47.91 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.79 -37.36 84.41 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.837 -1.165 . . . . 0.0 112.045 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.423 ' HE2' ' OE2' ' A' ' 123' ' ' GLU . 19.5 mtmt -59.71 -48.03 83.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.138 -0.934 . . . . 0.0 109.668 175.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -43.62 95.53 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.532 1.133 . . . . 0.0 111.303 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.87 -4.1 35.93 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.194 0.998 . . . . 0.0 112.531 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.17 -3.22 58.8 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 126.192 1.853 . . . . 0.0 114.993 173.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 m -92.53 3.33 7.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 118.921 1.36 . . . . 0.0 110.064 -170.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.423 ' OE2' ' HE2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -63.51 -27.34 69.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.433 1.015 . . . . 0.0 111.052 171.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.3 m -58.86 -15.26 11.75 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.465 -0.778 . . . . 0.0 112.684 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -96.9 3.05 52.33 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.043 -1.456 . . . . 0.0 114.295 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -133.7 111.71 10.8 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 122.06 2.209 . . . . 0.0 109.471 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.2 m -58.14 -39.91 79.97 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.92 1.688 . . . . 0.0 110.466 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -145.5 158.82 43.78 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.673 1.189 . . . . 0.0 108.007 167.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.99 117.6 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.2 mt -71.63 165.98 22.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.719 0.771 . . . . 0.0 110.218 174.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.8 p -151.06 176.95 10.66 Favored 'General case' 0 C--O 1.231 0.088 0 O-C-N 121.466 -0.771 . . . . 0.0 110.498 -170.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.0 t -48.7 -33.84 10.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.037 0.935 . . . . 0.0 111.978 163.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -71.82 -6.67 43.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.204 1.402 . . . . 0.0 112.21 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.0 m -147.94 49.12 1.06 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 128.121 2.569 . . . . 0.0 105.229 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.05 -29.67 72.27 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.894 -166.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 45.23 -164.65 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.314 1.846 . . . . 0.0 112.595 -163.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.43 162.1 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.631 1.172 . . . . 0.0 112.224 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -65.77 146.02 55.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.13 0.572 . . . . 0.0 110.374 168.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.41 133.52 13.11 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 116.872 -1.537 . . . . 0.0 110.194 166.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.29 126.07 9.55 Favored 'Cis proline' 0 C--N 1.348 0.552 0 CA-C-N 120.487 1.21 . . . . 0.0 111.498 -5.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 p -130.29 78.63 74.11 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 124.779 1.232 . . . . 0.0 112.035 -158.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.89 -30.41 48.93 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 121.916 1.744 . . . . 0.0 113.323 -174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -53.41 -44.81 69.04 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.713 -1.242 . . . . 0.0 113.333 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.74 -18.72 63.05 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.86 -0.59 . . . . 0.0 112.527 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.08 -53.41 7.04 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 119.115 0.87 . . . . 0.0 109.523 172.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 m -56.73 -41.46 77.52 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.371 1.469 . . . . 0.0 110.503 -174.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -56.86 -43.25 81.0 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.422 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.4 mt -78.35 -27.56 47.03 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 78.8 mt -59.37 -61.78 2.37 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 168.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.12 -17.84 64.97 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -64.78 -29.52 70.49 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.43 -1.419 . . . . 0.0 112.789 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -147.07 29.7 0.97 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.092 1.314 . . . . 0.0 112.468 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 54.82 45.12 27.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.608 1.563 . . . . 0.0 111.321 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 68.1 mt -95.34 170.87 9.07 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.422 -0.799 . . . . 0.0 110.0 -170.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -112.07 141.55 45.61 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.244 -0.91 . . . . 0.0 113.111 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 m -57.23 -49.87 74.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.817 0.847 . . . . 0.0 110.252 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.99 -16.83 60.61 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.532 0.682 . . . . 0.0 112.356 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -92.4 -3.09 55.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.701 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 t -101.36 135.61 42.58 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.62 1.1 . . . . 0.0 109.664 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -125.91 112.9 16.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -77.69 159.04 29.39 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.792 0.437 . . . . 0.0 110.525 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 49.4 mt -131.09 92.82 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 127.917 2.487 . . . . 0.0 104.511 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -124.41 169.31 16.46 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.786 1.184 . . . . 0.0 110.388 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -135.21 3.15 3.1 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.915 1.286 . . . . 0.0 113.225 -166.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.28 144.41 25.54 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 119.182 0.901 . . . . 0.0 111.231 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 88.68 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.01 2.124 . . . . 0.0 111.822 -170.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 174.05 -29.62 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 128.691 2.796 . . . . 0.0 107.664 -176.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -52.55 -43.64 65.34 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 126.368 1.867 . . . . 0.0 111.436 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 79.7 t -77.8 -26.19 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 125.184 1.394 . . . . 0.0 111.821 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.32 -38.42 91.08 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.526 -0.734 . . . . 0.0 111.614 -165.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -82.52 -30.77 29.58 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.686 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.34 89.99 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.838 0.855 . . . . 0.0 109.183 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -54.24 -49.67 68.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.655 1.582 . . . . 0.0 111.08 173.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -63.84 -44.24 93.75 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.83 -0.544 . . . . 0.0 110.811 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.0 m -75.0 -21.04 59.38 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.26 44.03 77.06 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.314 0.959 . . . . 0.0 112.171 -169.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.3 pt -110.6 168.73 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 118.094 0.947 . . . . 0.0 108.737 169.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -105.22 171.05 7.53 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.625 0.726 . . . . 0.0 110.626 -170.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.74 135.06 18.2 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 121.672 -0.643 . . . . 0.0 110.224 -157.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 42.9 mt -130.54 105.08 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -136.98 157.59 46.39 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.233 1.413 . . . . 0.0 111.148 -168.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -77.36 -12.43 59.95 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.32 -0.863 . . . . 0.0 112.371 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.14 156.61 38.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.984 0.914 . . . . 0.0 109.99 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -93.03 163.36 13.68 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.313 0.578 . . . . 0.0 110.835 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 44.8 t -145.6 179.8 7.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.13 1.772 . . . . 0.0 108.521 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . 0.303 0.2 OUTLIER -78.06 -22.36 49.19 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.701 -1.249 . . . . 0.0 111.333 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -71.19 121.8 19.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.1 1.36 . . . . 0.0 109.909 -174.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -64.79 -17.51 64.27 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.25 8.5 60.86 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.778 -1.012 . . . . 0.0 113.028 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.51 105.37 15.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 120.11 1.955 . . . . 0.0 110.043 -177.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -94.99 111.75 23.52 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.023 0.929 . . . . 0.0 109.613 -174.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 144.28 56.85 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.526 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.6 pt -137.42 171.36 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 126.922 2.089 . . . . 0.0 112.556 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -122.36 -21.29 5.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.475 1.51 . . . . 0.0 113.227 167.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -151.23 167.49 27.64 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.71 0.686 . . . . 0.0 109.244 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 62.3 mt -74.32 -26.46 60.17 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 119.158 0.89 . . . . 0.0 110.277 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.45 -13.54 62.41 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.234 0.925 . . . . 0.0 112.514 174.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -79.06 -13.53 59.71 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.667 -1.27 . . . . 0.0 108.864 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.76 -57.07 11.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 167.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.6 p -59.96 -36.05 76.29 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.021 0.828 . . . . 0.0 111.499 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -64.78 -34.78 79.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.101 0.864 . . . . 0.0 111.477 -172.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.8 mt -50.07 -57.63 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.144 1.777 . . . . 0.0 108.812 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -72.14 -0.67 12.5 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.821 0.849 . . . . 0.0 113.276 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 125.083 1.353 . . . . 0.0 110.892 -176.232 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mmm . . . . . 0 CA--C 1.516 -0.337 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.53 179.64 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.045 164.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -44.36 106.49 0.07 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.499 1.12 . . . . 0.0 108.797 169.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.3 m -129.83 151.34 50.52 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 170.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.35 156.9 48.18 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.43 0.692 . . . . 0.0 109.44 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -132.36 147.93 52.41 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.396 1.479 . . . . 0.0 109.213 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.44 HD12 ' HG1' ' A' ' 159' ' ' THR . 2.6 mp -132.1 129.46 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -103.49 164.75 11.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.301 1.04 . . . . 0.0 109.009 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.79 176.33 6.67 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.807 0.843 . . . . 0.0 109.891 171.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.6 mt . . . . . 0 CA--C 1.534 0.356 0 C-N-CA 124.771 1.228 . . . . 0.0 111.147 -171.394 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -54.11 -36.37 63.16 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 119.109 0.868 . . . . 0.0 111.725 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.81 -35.97 79.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.724 1.21 . . . . 0.0 112.882 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.3 -48.95 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 118.293 -0.86 . . . . 0.0 108.949 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mp -44.3 -52.39 7.61 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 120.636 1.562 . . . . 0.0 113.287 170.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.82 96.29 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.41 0.684 . . . . 0.0 111.22 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.45 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 20.6 t90 -57.95 -49.44 76.78 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.551 1.141 . . . . 0.0 110.812 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.7 78.78 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.929 1.291 . . . . 0.0 113.24 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.95 -44.42 85.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 122.941 0.496 . . . . 0.0 110.374 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -51.15 -49.8 60.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.194 1.397 . . . . 0.0 110.154 168.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.2 m -68.94 -12.81 61.99 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.03 16.06 77.59 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 120.014 1.279 . . . . 0.0 113.605 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.1 mt -68.44 133.16 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.025 1.33 . . . . 0.0 108.32 170.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -83.14 118.67 23.74 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -99.07 154.24 18.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -147.84 166.33 27.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.909 1.684 . . . . 0.0 108.565 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 42.6 mt -137.43 158.94 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.754 1.622 . . . . 0.0 107.14 166.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -131.77 -85.9 0.48 Allowed 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 124.779 1.231 . . . . 0.0 108.034 166.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.255 15.3 t 65.04 164.98 0.16 Allowed 'General case' 0 C--N 1.315 -0.894 1 C-N-CA 136.816 6.047 . . . . 0.0 113.958 177.772 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -80.41 4.04 19.37 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.395 1.078 . . . . 0.0 111.346 166.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -57.87 156.05 9.57 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.201 -1.562 . . . . 0.0 108.221 167.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.07 171.36 53.58 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-O 122.19 0.884 . . . . 0.0 111.107 173.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -44.87 -28.15 0.61 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 130.025 3.33 . . . . 0.0 114.944 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -63.89 -12.79 39.86 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 120.279 1.399 . . . . 0.0 112.311 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.52 -47.88 38.75 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.88 1.218 . . . . 0.0 111.573 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -56.8 -49.59 74.89 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.606 0.639 . . . . 0.0 110.238 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.7 m -59.39 -42.62 92.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.793 0.837 . . . . 0.0 111.129 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.73 -48.8 87.03 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 119.319 0.963 . . . . 0.0 108.716 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.28 -44.24 95.62 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.878 -0.514 . . . . 0.0 110.457 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -59.26 -51.3 70.54 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.403 1.081 . . . . 0.0 110.836 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -51.13 -56.52 12.3 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.26 1.424 . . . . 0.0 110.583 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.49 -9.73 37.43 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.046 1.338 . . . . 0.0 113.613 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.61 25.81 69.08 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 123.983 0.801 . . . . 0.0 112.525 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.53 57.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.43 -46.94 10.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.901 160.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.9 m -73.62 -14.59 61.2 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -164.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -63.44 -33.83 76.43 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.393 1.451 . . . . 0.0 110.507 170.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -90.82 115.48 27.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.5 m -44.74 -65.95 0.46 Allowed 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 127.016 2.126 . . . . 0.0 108.669 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.07 140.07 43.5 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.5 mt -110.36 148.69 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 171.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 45.9 mt -119.13 -166.89 1.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -173.26 -178.96 1.83 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.607 1.963 . . . . 0.0 107.888 167.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 m -44.53 -45.27 9.25 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.119 0.872 . . . . 0.0 110.458 167.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -70.2 -9.38 55.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.096 1.758 . . . . 0.0 112.96 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.7 m -59.35 -24.04 63.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.839 1.256 . . . . 0.0 110.973 163.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.12 -8.18 77.96 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-O 118.019 -1.434 . . . . 0.0 114.018 170.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -56.56 165.99 1.01 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.783 1.292 . . . . 0.0 111.161 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 m -44.73 155.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.158 1.783 . . . . 0.0 111.786 170.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -69.84 -76.77 0.09 Allowed 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -165.47 159.59 13.84 Favored Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 124.33 1.052 . . . . 0.0 109.804 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -64.16 136.97 26.24 Favored 'Cis proline' 0 N--CA 1.458 -0.601 0 N-CA-C 108.703 -1.307 . . . . 0.0 108.703 -17.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.0 p -124.99 68.78 56.82 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.621 0.768 . . . . 0.0 111.917 -157.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -61.95 -29.45 82.06 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.388 2.059 . . . . 0.0 111.98 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -48.41 -41.08 28.04 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.624 1.97 . . . . 0.0 112.39 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.61 2.47 16.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.518 1.527 . . . . 0.0 112.623 -175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.84 -39.42 2.73 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.868 1.667 . . . . 0.0 108.727 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 m -49.99 -38.78 38.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.086 1.312 . . . . 0.0 110.456 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -52.01 -57.94 7.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.099 1.36 . . . . 0.0 110.76 171.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.0 mp -58.58 -37.96 76.88 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.896 1.678 . . . . 0.0 112.755 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.0 mt -59.83 -57.96 10.65 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -175.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -75.18 -32.98 61.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.754 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -50.76 -53.32 32.63 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.801 -1.187 . . . . 0.0 111.8 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -115.23 8.86 15.62 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 54.26 66.71 1.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 123.064 1.411 . . . . 0.0 109.235 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.17 162.17 13.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.899 1.68 . . . . 0.0 107.784 169.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -106.39 -4.82 19.51 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 125.235 2.445 . . . . 0.0 117.458 -161.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.0 m 76.27 -55.95 0.58 Allowed 'General case' 0 N--CA 1.411 -2.381 0 CA-C-N 110.647 -2.978 . . . . 0.0 109.07 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.84 -2.13 38.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 O-C-N 120.881 -1.137 . . . . 0.0 112.941 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -98.35 -5.34 33.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 116.916 -1.516 . . . . 0.0 111.186 168.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.44 ' HG1' HD12 ' A' ' 7' ' ' ILE . 1.2 t -103.45 137.37 41.64 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.669 1.577 . . . . 0.0 108.099 -174.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -128.42 111.17 13.02 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.963 1.705 . . . . 0.0 109.263 -172.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -85.89 153.38 22.26 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.5 mt -133.01 119.55 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.85 -161.68 9.64 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -139.53 12.88 2.54 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.426 ' HB3' ' H ' ' A' ' 167' ' ' LEU . 3.0 mmt-85 -115.68 162.67 16.92 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 122.839 1.304 . . . . 0.0 111.489 -172.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 t -62.46 -26.95 68.79 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.297 -0.877 . . . . 0.0 109.538 163.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.426 ' H ' ' HB3' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -60.27 -29.82 69.05 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.487 1.515 . . . . 0.0 111.529 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -45.7 -44.93 13.97 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.104 1.762 . . . . 0.0 110.852 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.4 m -90.69 -15.5 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.55 -50.79 49.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.081 -1.012 . . . . 0.0 108.69 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -79.3 -33.4 43.3 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.343 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.92 -42.64 90.17 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.378 172.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -61.16 -49.77 75.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.866 1.212 . . . . 0.0 111.151 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -58.32 -25.37 61.82 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 74.9 m -86.03 -50.86 6.73 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.795 1.18 . . . . 0.0 110.615 165.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 96.09 63.17 0.95 Allowed Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -164.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.9 pt -131.11 173.14 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.577 1.951 . . . . 0.0 106.286 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -99.65 165.83 11.42 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 -171.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 39.4 m -136.26 155.36 50.22 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.637 1.175 . . . . 0.0 110.57 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 34.3 mt -140.66 74.81 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -96.14 169.64 9.81 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.842 0.829 . . . . 0.0 110.157 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -88.25 2.14 52.98 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.532 -1.355 . . . . 0.0 111.951 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.06 132.78 19.96 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 124.72 2.2 . . . . 0.0 115.414 -175.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.24 138.65 58.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.568 -2.105 . . . . 0.0 109.4 -167.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' SER . . . . . 0.594 ' HG ' ' ND2' ' A' ' 190' ' ' ASN . 74.9 p -137.91 163.4 31.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.093 0.557 . . . . 0.0 110.704 -162.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 24.4 p -75.68 45.16 0.31 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.527 1.931 . . . . 0.0 111.55 173.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -131.34 175.67 8.93 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.95 -1.094 . . . . 0.0 109.717 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 189' ' ' GLY . 10.0 pt-20 -98.26 -67.84 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.768 0.827 . . . . 0.0 109.202 177.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . 0.401 ' H ' ' HG3' ' A' ' 188' ' ' GLU . . . -73.15 51.49 1.68 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.984 2.231 . . . . 0.0 113.319 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . 0.594 ' ND2' ' HG ' ' A' ' 185' ' ' SER . 14.4 t30 -121.26 119.6 32.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.376 1.07 . . . . 0.0 108.766 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -106.67 106.56 17.15 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.815 0.846 . . . . 0.0 109.94 -172.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.66 139.85 58.81 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.8 pt -129.98 167.66 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.142 1.377 . . . . 0.0 113.084 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.26 -17.59 8.22 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.972 1.309 . . . . 0.0 113.52 168.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.63 168.69 26.62 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 18.4 mt -70.37 -38.58 74.79 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -171.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.12 -18.07 63.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.82 -0.55 . . . . 0.0 112.329 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.94 -21.34 66.81 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.223 -0.923 . . . . 0.0 110.686 176.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.46 -50.52 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 118.161 -0.924 . . . . 0.0 109.132 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' SER . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 94.4 p -58.04 -41.09 82.54 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.32 0.964 . . . . 0.0 110.364 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.5 mtp-105 -58.98 -39.59 82.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.329 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.6 mt -52.62 -51.96 30.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 118.983 0.81 . . . . 0.0 109.988 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -73.78 -35.76 64.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -174.98 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mmm . . . . . 0 N--CA 1.445 -0.675 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -167.13 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 129.402 3.081 . . . . 0.0 111.272 161.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -57.28 109.94 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 119.543 -1.973 . . . . 0.0 107.72 168.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.5 m -130.37 152.59 49.61 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 166.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.57 150.3 46.19 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.262 -0.899 . . . . 0.0 109.652 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -124.9 160.9 27.77 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.588 1.555 . . . . 0.0 110.211 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 mt -138.19 149.53 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -134.95 168.15 19.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.635 2.374 . . . . 0.0 109.598 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -123.46 24.67 8.55 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.721 2.008 . . . . 0.0 111.666 -171.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 CA--C 1.54 0.558 0 C-N-CA 128.438 2.695 . . . . 0.0 112.791 172.285 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.4 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -24.13 64.99 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 118.974 -2.329 . . . . 0.0 111.97 -176.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -61.01 -45.72 93.67 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.952 0.901 . . . . 0.0 109.745 174.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.75 -44.39 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 123.88 0.872 . . . . 0.0 109.486 -170.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.4 mp -44.3 -44.73 8.28 Favored 'General case' 0 N--CA 1.418 -2.068 0 C-N-CA 126.125 1.77 . . . . 0.0 111.519 169.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.57 -33.57 66.85 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.593 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -65.09 -55.3 19.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.853 1.261 . . . . 0.0 109.827 170.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.28 -36.42 77.8 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.752 1.621 . . . . 0.0 112.527 -174.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.19 -57.96 8.79 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.744 1.218 . . . . 0.0 111.687 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -60.82 -24.39 65.82 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.617 0.723 . . . . 0.0 112.363 175.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.1 m -78.28 -6.02 53.77 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.33 -0.856 . . . . 0.0 112.634 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.39 15.34 81.08 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 124.228 0.918 . . . . 0.0 112.653 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.5 mt -70.5 120.7 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 118.834 1.317 . . . . 0.0 107.726 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -75.13 105.28 6.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 167.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -88.65 150.56 22.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -142.28 169.16 18.11 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.432 1.093 . . . . 0.0 108.94 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.3 mt -131.63 149.67 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -121.7 141.87 50.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 157.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.4 t -163.25 -176.0 4.57 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.196 2.199 . . . . 0.0 105.719 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -134.11 9.22 3.79 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.844 0.858 . . . . 0.0 112.755 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -1.55 8.11 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.47 174.31 34.01 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 125.821 1.677 . . . . 0.0 111.019 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -52.61 -27.5 17.25 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.084 0.954 . . . . 0.0 112.293 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.7 -17.87 3.94 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 177.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.57 -46.99 49.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.8 1.182 . . . . 0.0 112.223 171.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -60.32 -47.38 86.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.435 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.6 m -56.15 -49.83 72.86 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.732 0.696 . . . . 0.0 109.45 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.2 mt -58.89 -48.49 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.01 -38.42 91.13 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 121.326 -0.859 . . . . 0.0 112.235 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -48.85 80.05 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.54 -36.01 82.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.505 0.593 . . . . 0.0 111.354 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.83 -8.22 57.74 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.476 1.11 . . . . 0.0 112.05 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 57.12 33.49 64.69 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 125.44 1.495 . . . . 0.0 113.248 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.79 14.1 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.512 1.156 . . . . 0.0 110.36 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -41.37 97.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.186 0.994 . . . . 0.0 111.176 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 t -65.52 -31.02 71.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.688 -169.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -56.01 -43.91 78.19 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.553 0.615 . . . . 0.0 111.461 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -97.19 95.58 7.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -166.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.4 m -44.66 -49.83 10.18 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.566 1.546 . . . . 0.0 109.682 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.44 147.44 34.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.96 119.31 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.0 163.94 21.79 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.582 0.705 . . . . 0.0 109.63 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.8 p -148.11 -174.2 4.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.239 1.019 . . . . 0.0 112.687 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.6 t -55.25 -15.51 2.47 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 162.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -73.32 -38.8 65.68 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 120.018 1.281 . . . . 0.0 110.499 173.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 136' ' ' PHE . 2.6 p -77.71 77.6 4.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.25 45.76 1.21 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 125.058 1.313 . . . . 0.0 111.224 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 134' ' ' SER . 22.0 m-85 -62.8 166.9 5.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.244 0.545 . . . . 0.0 111.227 168.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.9 m -53.35 161.43 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 127.149 2.18 . . . . 0.0 112.852 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.35 156.07 23.2 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.398 -0.814 . . . . 0.0 110.659 170.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -51.02 139.49 23.09 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.631 1.572 . . . . 0.0 110.442 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.71 123.58 5.74 Favored 'Cis proline' 0 CA--C 1.537 0.644 0 CA-C-N 120.416 1.184 . . . . 0.0 110.099 -9.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.444 ' H ' ' HB3' ' A' ' 171' ' ' PHE . 2.8 p -128.84 81.26 71.16 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 126.398 1.879 . . . . 0.0 110.954 -162.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.62 -9.12 16.0 Favored 'Trans proline' 0 CA--C 1.551 1.334 0 C-N-CA 123.556 2.838 . . . . 0.0 114.635 -173.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.13 -44.73 94.69 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.022 1.283 . . . . 0.0 111.875 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -51.58 -45.47 63.13 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 124.064 0.946 . . . . 0.0 110.669 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.13 -34.77 75.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.769 -0.582 . . . . 0.0 112.139 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.1 m -68.51 -32.21 72.01 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.636 0.774 . . . . 0.0 110.364 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -65.19 -49.73 68.65 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.47 -38.48 80.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.062 0.945 . . . . 0.0 111.332 -176.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -58.05 -68.12 0.28 Allowed 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 173.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -53.43 -46.56 69.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.852 0.72 . . . . 0.0 112.012 -171.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -51.72 -36.0 45.19 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -121.69 12.45 10.66 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.76 0.709 . . . . 0.0 111.539 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 47.16 50.35 14.3 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.84 2.456 . . . . 0.0 110.283 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 66.1 mt -76.85 -172.59 2.34 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.685 1.994 . . . . 0.0 110.105 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -129.34 134.42 47.89 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.79 1.236 . . . . 0.0 107.778 -170.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.8 p -59.35 -40.17 85.55 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 119.522 1.056 . . . . 0.0 111.198 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -75.12 -22.78 57.97 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.529 -0.732 . . . . 0.0 111.943 -172.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -95.82 2.53 53.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.462 -0.773 . . . . 0.0 109.43 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.6 m -96.57 126.56 41.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.702 1.201 . . . . 0.0 108.052 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -112.18 155.75 23.44 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -120.98 163.61 18.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.964 1.706 . . . . 0.0 106.694 161.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.4 mt -126.59 107.63 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 173.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -119.69 177.23 16.34 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.49 166.18 18.45 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 156.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 75.43 156.62 0.18 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 126.689 1.996 . . . . 0.0 111.389 -176.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 t -69.83 -30.1 67.52 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.83 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -25.06 45.29 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.437 1.095 . . . . 0.0 112.631 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -79.68 13.04 2.24 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.479 1.912 . . . . 0.0 111.558 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 1.2 p -109.12 -16.32 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.277 1.031 . . . . 0.0 110.553 163.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -73.9 -52.62 12.36 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.121 1.328 . . . . 0.0 110.805 -168.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.444 ' HB3' ' H ' ' A' ' 141' ' ' SER . 1.4 p90 -63.28 -29.39 70.72 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 120.971 -1.081 . . . . 0.0 111.916 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.47 -52.55 64.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 118.761 -0.637 . . . . 0.0 109.302 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -49.11 -60.88 2.41 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.127 1.371 . . . . 0.0 110.708 170.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -68.33 -14.51 63.05 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -170.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.5 p -95.62 -23.4 17.05 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 120.73 1.604 . . . . 0.0 112.229 165.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.1 22.42 38.36 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.145 1.355 . . . . 0.0 112.515 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.2 pp -99.16 175.2 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.855 1.327 . . . . 0.0 109.982 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.65 162.07 18.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.619 1.168 . . . . 0.0 110.29 -173.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 12.4 m -139.33 143.98 38.06 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.76 1.224 . . . . 0.0 110.348 -165.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 73.6 mt -119.95 92.11 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -111.5 158.98 18.54 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 121.819 0.819 . . . . 0.0 108.956 -172.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -74.18 -6.5 48.15 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.517 -1.365 . . . . 0.0 112.835 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.99 158.81 41.75 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 126.83 2.052 . . . . 0.0 109.159 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.84 160.86 28.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 19.0 t -147.22 174.83 11.25 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.6 169.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.4 p -83.95 63.98 7.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.023 2.529 . . . . 0.0 108.434 -173.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -144.6 178.86 7.67 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.771 2.028 . . . . 0.0 108.355 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -113.38 -35.95 5.13 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.431 1.469 . . . . 0.0 110.459 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -86.19 15.48 49.14 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 127.368 2.413 . . . . 0.0 112.77 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -84.75 152.87 23.39 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 120.621 2.211 . . . . 0.0 107.372 159.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -131.04 148.86 52.8 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 169.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 146.56 25.59 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.273 0.629 . . . . 0.0 110.85 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 18.6 pt -140.03 162.68 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.219 1.008 . . . . 0.0 112.0 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -108.86 -27.02 9.96 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -168.08 145.59 4.25 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -163.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.9 tp -61.74 -30.91 71.09 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 127.186 2.194 . . . . 0.0 111.497 -158.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.92 -11.87 50.43 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 176.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -77.16 -13.14 59.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.816 0.846 . . . . 0.0 109.6 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 39.7 mt -56.34 -59.37 2.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 83.1 p -53.89 -37.9 64.22 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -175.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -61.35 -34.64 75.63 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.77 0.828 . . . . 0.0 112.141 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 76.0 mt -58.22 -34.69 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.985 0.914 . . . . 0.0 110.729 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -91.48 -4.91 55.03 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 120.974 -1.079 . . . . 0.0 112.291 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 CA--C 1.539 0.522 0 C-N-CA 125.828 1.651 . . . . 0.0 111.036 -171.395 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 mmm . . . . . 0 CA--C 1.52 -0.181 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.443 ' NE2' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 52.73 -169.04 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.508 1.523 . . . . 0.0 111.965 171.339 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' H ' ' NE2' ' A' ' 2' ' ' GLN . 12.7 tppt? -80.32 48.64 1.04 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 119.857 -1.777 . . . . 0.0 108.23 165.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.9 m -69.3 143.75 53.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.28 149.47 50.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -125.53 152.91 44.39 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.484 1.114 . . . . 0.0 108.972 -172.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.5 mt -134.49 146.04 31.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 169.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -123.78 171.64 9.47 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.809 2.044 . . . . 0.0 107.82 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.18 164.33 15.75 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 165.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 119.03 0.832 . . . . 0.0 109.185 -168.852 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.304 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.89 -24.08 67.6 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 118.402 -0.809 . . . . 0.0 112.697 -172.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -60.26 -58.46 8.41 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.64 -44.44 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 117.018 -1.468 . . . . 0.0 112.228 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.456 ' CD2' ' CD2' ' A' ' 125' ' ' TYR . 3.7 mp -52.68 -48.35 66.59 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 122.13 2.241 . . . . 0.0 112.368 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.89 -49.08 79.12 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 124.804 1.315 . . . . 0.0 109.552 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -53.57 -48.08 69.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.632 -0.699 . . . . 0.0 111.191 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.64 74.83 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.895 0.77 . . . . 0.0 111.752 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -73.45 -40.89 63.83 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.286 1.834 . . . . 0.0 110.711 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.25 -1.28 4.3 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.227 1.811 . . . . 0.0 111.309 168.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 58.3 m -118.88 -6.6 10.53 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.423 1.489 . . . . 0.0 114.273 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.38 9.14 77.1 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.101 -1.624 . . . . 0.0 115.654 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 93.5 mt -45.63 147.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 149.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -98.65 115.4 28.59 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 167.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.404 HE22 ' HA ' ' A' ' 93' ' ' LEU . 5.3 mt-30 -88.67 150.75 22.85 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -140.0 164.95 28.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 125.12 1.368 . . . . 0.0 107.967 171.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.6 mt -124.51 149.86 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 161.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -129.16 143.84 51.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 152.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.4 t -151.6 163.5 38.93 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.863 1.265 . . . . 0.0 109.585 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -92.64 -0.39 57.31 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.983 -0.448 . . . . 0.0 111.962 165.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -59.19 153.0 19.28 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 119.477 1.035 . . . . 0.0 108.571 166.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -80.93 -175.21 49.6 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.72 -18.18 7.6 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.501 1.521 . . . . 0.0 114.038 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -58.63 -18.1 27.68 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.617 1.099 . . . . 0.0 112.119 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.36 69.69 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.078 0.951 . . . . 0.0 110.366 175.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -57.15 -48.86 77.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -48.03 83.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.829 2.052 . . . . 0.0 111.252 -174.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.13 -50.61 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.481 1.112 . . . . 0.0 108.165 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.89 -37.28 87.11 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 122.16 -0.337 . . . . 0.0 111.162 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -49.1 77.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.517 1.127 . . . . 0.0 109.608 174.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -50.46 73.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 124.016 0.926 . . . . 0.0 110.679 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.54 -40.2 77.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.544 -174.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.41 50.82 0.79 Allowed Glycine 0 C--N 1.339 0.697 0 CA-C-O 121.563 0.535 . . . . 0.0 111.825 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.317 1.3 p -147.61 8.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 129.912 3.285 . . . . 0.0 109.384 -170.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -34.25 77.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 120.768 -1.208 . . . . 0.0 113.028 174.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -15.91 53.71 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.576 0.547 . . . . 0.0 111.774 -168.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.456 ' CD2' ' CD2' ' A' ' 93' ' ' LEU . 13.1 m-85 -66.23 -30.77 71.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -174.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . 0.403 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 5.8 m-85 -110.8 129.4 55.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 -167.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.7 m -55.31 -30.87 61.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.383 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -154.28 151.83 29.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.229 1.012 . . . . 0.0 109.093 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.85 77.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 174.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.4 mt -66.2 147.19 53.7 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 57.8 p -122.96 177.96 5.27 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.061 0.944 . . . . 0.0 110.14 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 t -45.91 -37.61 6.56 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.993 0.917 . . . . 0.0 110.604 165.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -62.32 -18.37 61.2 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.3 p -48.37 -48.89 36.33 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.169 0.895 . . . . 0.0 112.277 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.96 -5.81 56.53 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 117.688 -1.618 . . . . 0.0 112.852 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -60.65 163.12 5.76 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.617 1.708 . . . . 0.0 110.904 172.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.2 m -52.73 156.29 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 126.973 2.109 . . . . 0.0 112.555 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -81.19 154.58 26.6 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.666 0.786 . . . . 0.0 108.924 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -54.66 144.29 45.52 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.282 1.033 . . . . 0.0 113.148 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.58 135.53 35.98 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 N-CA-C 108.261 -1.477 . . . . 0.0 108.261 -8.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 p -128.43 61.28 53.24 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.223 0.609 . . . . 0.0 111.84 -157.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.56 -24.22 77.65 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.164 2.576 . . . . 0.0 113.155 -167.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -51.33 -38.56 53.69 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 120.897 -1.127 . . . . 0.0 112.366 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.3 4.86 5.15 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.236 1.014 . . . . 0.0 112.702 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.71 -40.67 5.67 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.686 163.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.2 m -55.21 -35.45 64.91 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.415 1.007 . . . . 0.0 110.65 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -66.07 -49.37 67.86 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.574 0.75 . . . . 0.0 110.922 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.1 mp -67.43 -14.11 62.63 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.441 1.496 . . . . 0.0 113.171 -177.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.1 mt -84.22 -53.48 5.47 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.877 2.071 . . . . 0.0 107.826 167.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.28 -37.55 85.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -174.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -54.87 -20.0 7.81 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.478 1.911 . . . . 0.0 115.125 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -158.38 22.52 0.24 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.843 2.457 . . . . 0.0 112.71 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 49.25 46.8 22.76 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.004 1.721 . . . . 0.0 113.462 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 30.0 mt -78.45 169.18 18.66 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.251 1.02 . . . . 0.0 109.899 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -108.37 130.94 55.2 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 123.229 0.611 . . . . 0.0 109.958 -174.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.4 m -60.14 -43.96 95.31 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.944 0.898 . . . . 0.0 110.16 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.83 -23.68 59.68 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.633 -1.292 . . . . 0.0 113.449 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -93.2 3.86 54.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.067 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -102.16 126.06 49.03 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -106.46 163.75 12.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -139.67 127.54 22.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 173.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 7.4 mt -98.91 116.92 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.884 1.674 . . . . 0.0 107.003 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.95 -164.97 10.1 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.466 1.508 . . . . 0.0 110.071 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -138.23 -1.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -172.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.09 169.14 13.71 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 122.404 1.097 . . . . 0.0 111.505 -160.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.1 t -59.63 -32.24 70.25 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.571 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.75 -17.25 64.0 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.566 -1.334 . . . . 0.0 111.864 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -83.95 1.7 42.31 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.076 -1.015 . . . . 0.0 111.933 -165.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.8 p -91.87 -28.44 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 O-C-N 121.401 -0.812 . . . . 0.0 112.148 158.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -67.23 -58.26 5.17 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 120.087 1.312 . . . . 0.0 111.399 -161.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -55.9 -45.12 78.75 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.645 1.178 . . . . 0.0 111.915 170.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.91 79.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 122.63 0.372 . . . . 0.0 111.409 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -59.12 -46.11 89.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.396 1.878 . . . . 0.0 109.822 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -59.71 -45.02 93.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.657 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 74.6 m -81.22 -22.14 39.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.87 61.75 2.99 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.474 1.035 . . . . 0.0 110.693 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.0 -173.22 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.749 2.02 . . . . 0.0 109.058 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -111.81 166.01 11.56 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.992 0.917 . . . . 0.0 110.146 -176.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 32.7 m -145.19 151.57 38.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.355 1.062 . . . . 0.0 112.387 -170.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.5 mt -138.0 101.95 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.06 160.88 36.92 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 120.867 -1.145 . . . . 0.0 109.209 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -73.52 0.42 12.54 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.297 -0.877 . . . . 0.0 111.362 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 22.8 mt -114.01 154.7 27.2 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 125.728 1.611 . . . . 0.0 109.54 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -79.94 154.13 28.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 164.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.8 m -136.67 163.85 29.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.876 1.671 . . . . 0.0 107.218 173.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 62.0 p -93.38 64.56 3.71 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -169.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -146.52 162.19 38.87 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.687 1.195 . . . . 0.0 109.8 -170.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.8 -54.86 6.55 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.893 0.877 . . . . 0.0 110.774 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.15 24.48 6.15 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 125.074 1.321 . . . . 0.0 113.774 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -85.45 111.27 19.81 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 125.407 1.483 . . . . 0.0 108.31 171.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -99.23 125.0 44.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 168.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.2 148.47 30.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.737 -0.649 . . . . 0.0 109.394 169.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 13.6 pt -133.96 156.94 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.982 0.913 . . . . 0.0 112.457 172.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 -97.06 -29.63 13.52 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.446 1.098 . . . . 0.0 111.913 164.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.72 162.15 39.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.64 1.576 . . . . 0.0 108.496 -167.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.49 -43.92 88.7 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -60.59 -19.63 58.23 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.79 0.723 . . . . 0.0 112.7 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.42 -21.53 66.67 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.038 0.835 . . . . 0.0 112.031 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 67.1 mt -50.91 -60.2 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.6 m -61.89 -32.27 72.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.164 0.893 . . . . 0.0 112.008 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -62.18 -35.33 78.5 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.204 -0.935 . . . . 0.0 111.231 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 36.1 mt -54.87 -55.08 17.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 124.767 1.227 . . . . 0.0 109.273 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -67.58 -5.65 16.4 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.285 0.634 . . . . 0.0 112.054 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 . . . . . 0 N--CA 1.45 -0.455 0 C-N-CA 127.659 2.383 . . . . 0.0 109.953 -173.657 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 mmm . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 122.814 1.292 . . . . 0.0 107.552 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.01 175.24 0.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.413 162.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.66 101.14 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.72 1.208 . . . . 0.0 109.747 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.9 m -122.88 152.7 40.51 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -175.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.69 152.62 44.05 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.426 0.631 . . . . 0.0 110.154 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -134.74 142.85 46.86 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 125.071 1.349 . . . . 0.0 108.854 -168.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.1 mt -145.98 77.83 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -165.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -69.08 172.19 7.13 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 118.196 0.453 . . . . 0.0 110.505 -173.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -127.08 -167.89 1.8 Allowed 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.578 -1.326 . . . . 0.0 108.559 170.071 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.412 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--O 1.236 0.369 0 C-N-CA 127.921 2.489 . . . . 0.0 106.303 -159.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.29 0 CA-C-O 121.08 0.467 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -63.42 -25.43 68.28 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -164.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -55.68 -66.45 0.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 O-C-N 124.57 1.169 . . . . 0.0 109.211 165.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.36 -46.51 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 116.653 -1.642 . . . . 0.0 113.259 -172.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.441 ' CD2' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -45.44 -53.39 8.82 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 120.365 1.438 . . . . 0.0 112.286 171.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.37 -41.47 76.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.856 0.723 . . . . 0.0 110.611 -170.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -61.88 -50.15 73.36 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.322 1.049 . . . . 0.0 109.812 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.43 74.73 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.809 1.643 . . . . 0.0 111.666 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -59.38 -60.57 3.65 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.631 0.772 . . . . 0.0 109.343 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.55 -13.92 6.84 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.2 -6.66 37.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 175.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.06 16.22 68.36 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.312 0.958 . . . . 0.0 111.927 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.0 mt -66.65 99.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.424 1.49 . . . . 0.0 107.013 171.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.36 108.36 1.09 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -87.34 155.89 19.85 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -150.07 173.76 13.5 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 128.459 2.704 . . . . 0.0 107.325 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 13.7 mt -136.51 156.79 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.669 0.788 . . . . 0.0 109.438 171.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -135.37 140.44 45.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.11 0.964 . . . . 0.0 111.583 165.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.9 t -154.31 167.73 28.96 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.33 -0.856 . . . . 0.0 110.455 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -94.66 -1.39 53.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.199 1.8 . . . . 0.0 111.803 168.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.43 171.02 15.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 121.365 1.893 . . . . 0.0 110.571 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.68 -178.16 20.6 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.738 1.161 . . . . 0.0 112.924 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -53.61 -18.98 3.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.556 1.542 . . . . 0.0 112.539 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.14 -27.34 0.95 Allowed 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 125.6 1.56 . . . . 0.0 113.379 172.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.83 -52.87 29.15 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.197 0.999 . . . . 0.0 111.506 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -56.7 -43.5 80.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.401 0.68 . . . . 0.0 110.311 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -59.89 -48.59 81.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.655 1.182 . . . . 0.0 110.898 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 62.0 mt -56.66 -46.84 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.825 0.85 . . . . 0.0 109.613 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.97 -44.6 92.26 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.78 0.832 . . . . 0.0 110.794 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.96 -60.65 2.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 124.284 0.99 . . . . 0.0 108.943 169.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.61 -58.04 9.08 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.917 0.887 . . . . 0.0 112.185 -174.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.1 -32.17 73.47 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.68 -170.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.82 44.23 0.55 Allowed Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 157.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.441 HG21 ' CD2' ' A' ' 93' ' ' LEU . 2.0 p -166.22 52.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 -166.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -41.04 29.89 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 118.783 -2.448 . . . . 0.0 108.878 153.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.3 t -72.12 -8.29 53.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.349 1.46 . . . . 0.0 113.058 -158.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -80.89 -31.8 35.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.005 0.522 . . . . 0.0 109.857 172.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -105.58 101.97 11.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 120.624 -1.297 . . . . 0.0 108.229 -168.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.8 m -46.19 -51.28 14.51 Favored 'General case' 0 C--O 1.255 1.367 0 C-N-CA 126.117 1.767 . . . . 0.0 111.113 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.42 ' CD ' ' HH ' ' A' ' 147' ' ' TYR . 19.3 tt0 -142.7 144.4 32.69 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.262 0.625 . . . . 0.0 109.553 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.3 mt -132.26 97.81 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 -166.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.41 162.13 29.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.9 p -144.48 -177.38 5.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.358 1.463 . . . . 0.0 108.559 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 96.8 p -51.1 -32.62 23.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.093 0.86 . . . . 0.0 111.856 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -21.87 63.88 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.499 1.92 . . . . 0.0 111.348 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 65.0 p -57.51 -23.37 49.81 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.05 -14.95 59.24 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.225 0.916 . . . . 0.0 111.936 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -66.05 167.74 9.41 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 123.968 1.842 . . . . 0.0 113.23 -173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -58.04 154.14 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 C-N-CA 129.676 3.191 . . . . 0.0 109.91 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.13 43.71 1.05 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.752 0.787 . . . . 0.0 110.808 -172.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 mttt 70.29 147.65 0.12 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 128.394 2.678 . . . . 0.0 110.633 -168.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -62.8 124.34 3.2 Favored 'Cis proline' 0 N--CA 1.45 -1.051 0 N-CA-C 107.619 -1.724 . . . . 0.0 107.619 -22.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -116.32 85.26 15.6 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.49 -22.5 28.67 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.295 1.997 . . . . 0.0 111.405 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -56.31 -38.11 70.82 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.647 1.579 . . . . 0.0 110.397 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.45 -20.55 66.41 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.551 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.66 -41.27 10.82 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 116.338 -1.791 . . . . 0.0 109.553 171.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.5 m -56.58 -36.05 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 120.95 1.705 . . . . 0.0 110.586 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.42 ' HH ' ' CD ' ' A' ' 128' ' ' GLU . 22.8 t80 -56.99 -52.62 64.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.826 0.85 . . . . 0.0 109.756 171.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.34 -39.74 88.22 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.726 1.61 . . . . 0.0 111.343 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.429 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 71.4 mt -57.82 -61.07 2.79 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.83 -31.31 72.45 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.707 0.803 . . . . 0.0 111.56 -171.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.19 -43.08 78.12 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 120.91 -1.119 . . . . 0.0 113.276 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -137.26 26.56 2.9 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 45.93 50.92 11.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.409 2.283 . . . . 0.0 110.441 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 65.8 mt -81.68 167.86 18.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.231 -1.35 . . . . 0.0 109.698 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.07 130.41 51.76 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.92 1.288 . . . . 0.0 108.407 -172.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -52.7 62.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.433 1.111 . . . . 0.0 109.038 176.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.91 -10.74 59.73 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.998 -1.064 . . . . 0.0 112.834 -170.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -112.15 17.54 19.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 109.322 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -104.38 145.69 29.9 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 118.745 0.702 . . . . 0.0 109.501 169.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.409 ' CD1' ' HB2' ' A' ' 178' ' ' GLN . 95.8 m-85 -125.02 159.06 32.19 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.036 1.734 . . . . 0.0 109.856 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -116.03 -39.27 3.47 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.3 mp 57.09 75.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 125.604 1.562 . . . . 0.0 112.44 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -128.1 -175.97 14.28 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.367 0.984 . . . . 0.0 110.867 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.59 26.7 5.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.54 1.536 . . . . 0.0 114.106 -156.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -160.62 159.85 30.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.725 2.01 . . . . 0.0 107.899 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 21.6 p -51.8 -37.56 52.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.761 0.791 . . . . 0.0 111.86 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.1 -13.31 25.38 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -35.15 78.66 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 119.988 1.267 . . . . 0.0 110.546 172.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.5 p -104.36 -24.27 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.3 1.04 . . . . 0.0 110.783 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.73 -38.26 87.27 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 120.474 -1.392 . . . . 0.0 110.949 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -75.27 -38.12 60.59 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 118.36 -0.829 . . . . 0.0 110.287 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.26 69.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.978 1.311 . . . . 0.0 110.271 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.63 -43.09 56.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.946 1.299 . . . . 0.0 111.978 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -72.27 -22.12 61.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 118.419 -0.801 . . . . 0.0 113.057 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 t -96.1 -20.84 18.34 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.669 0.668 . . . . 0.0 110.314 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.9 49.8 6.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.15 178.0 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.038 1.735 . . . . 0.0 109.239 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.409 ' HB2' ' CD1' ' A' ' 160' ' ' TYR . 7.2 mm-40 -109.04 168.61 9.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.661 1.22 . . . . 0.0 111.815 -174.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.56 141.39 25.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.868 2.067 . . . . 0.0 108.785 -174.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 57.3 mt -121.01 86.5 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.43 176.58 6.14 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.835 -167.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -109.64 -6.42 15.35 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 119.654 -1.904 . . . . 0.0 111.469 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.96 146.2 45.18 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.644 1.978 . . . . 0.0 108.574 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.84 144.97 56.49 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 11.7 t -122.23 171.91 8.67 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 112.854 -1.976 . . . . 0.0 107.01 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 9.9 p -114.4 27.7 9.28 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.26 1.824 . . . . 0.0 109.666 -175.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -123.24 140.81 52.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.418 1.487 . . . . 0.0 110.014 -175.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -77.54 96.61 4.8 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.28 1.832 . . . . 0.0 109.415 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 133.76 -1.89 4.38 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.427 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.8 153.51 34.85 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 119.394 1.597 . . . . 0.0 108.407 168.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -138.12 99.95 4.01 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . 0.292 0.2 OUTLIER -75.0 151.44 38.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 115.682 -2.407 . . . . 0.0 109.4 175.403 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.0 pt -126.27 -176.5 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 130.032 3.333 . . . . 0.0 107.982 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -126.83 -14.63 5.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 125.247 1.419 . . . . 0.0 111.75 167.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.93 165.0 36.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.52 0.6 . . . . 0.0 109.455 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.39 -25.89 63.45 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.146 -0.971 . . . . 0.0 110.474 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.34 -32.12 73.32 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.06 -1.025 . . . . 0.0 111.115 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.65 -22.17 63.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.036 2.534 . . . . 0.0 110.728 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.28 -56.7 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 C-N-CA 124.409 1.084 . . . . 0.0 109.009 171.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 96.3 p -52.45 -40.39 62.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.539 0.609 . . . . 0.0 111.384 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 34.0 mtt85 -64.03 -32.8 74.49 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.447 -1.263 . . . . 0.0 112.541 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.23 -45.57 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.088 1.313 . . . . 0.0 109.192 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.69 -5.45 53.12 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 CA--C 1.53 0.207 0 C-N-CA 124.823 1.249 . . . . 0.0 113.205 -177.176 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mmm . . . . . 0 C--O 1.232 0.142 0 CA-C-O 122.478 1.132 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -62.63 173.51 1.25 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.13 -1.396 . . . . 0.0 109.095 173.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -44.17 83.74 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.029 2.132 . . . . 0.0 114.535 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.8 m -110.76 159.83 17.27 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.821 1.248 . . . . 0.0 107.651 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.92 158.5 44.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.411 0.624 . . . . 0.0 110.937 162.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -114.3 174.85 5.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.61 1.164 . . . . 0.0 108.38 169.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mt -139.84 137.2 39.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 163.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -119.07 178.2 4.59 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.485 1.914 . . . . 0.0 109.442 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.24 -179.8 6.47 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.246 1.819 . . . . 0.0 107.641 -170.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.475 0.784 0 O-C-N 120.762 -1.211 . . . . 0.0 114.238 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.28 0 CA-C-O 121.537 0.684 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.74 -9.8 39.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.952 1.701 . . . . 0.0 112.393 176.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -65.82 -38.98 90.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.425 1.09 . . . . 0.0 110.796 165.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.7 -39.72 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.351 -0.843 . . . . 0.0 110.772 -173.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 125' ' ' TYR . 6.9 mp -44.35 -41.0 5.75 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 127.797 2.439 . . . . 0.0 111.549 166.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.17 -50.8 62.66 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.903 1.377 . . . . 0.0 109.581 -177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -56.71 -45.45 81.85 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.766 0.827 . . . . 0.0 110.475 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.31 -38.81 71.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.362 1.065 . . . . 0.0 113.138 -174.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.58 -52.11 59.26 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.613 1.165 . . . . 0.0 109.635 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -60.72 -38.12 84.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.336 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.0 m -71.86 -1.26 13.62 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.5 16.14 60.37 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.46 1.505 . . . . 0.0 113.259 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.9 mt -76.05 101.11 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -57.42 109.95 0.78 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.07 1.348 . . . . 0.0 108.913 -174.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -84.6 147.13 27.14 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 172.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -137.39 168.25 20.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 168.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mt -124.53 149.75 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.529 0.731 . . . . 0.0 109.132 171.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -134.04 128.11 33.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 157.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -145.97 -173.95 4.3 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 162.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -126.04 12.77 7.8 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.36 1.864 . . . . 0.0 112.229 -175.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.454 ' HE2' ' CD1' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -73.28 -10.43 59.75 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -165.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 126.91 174.62 13.85 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 126.399 1.952 . . . . 0.0 109.764 -170.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -29.08 70.37 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 117.491 0.645 . . . . 0.0 110.421 172.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -51.64 -14.81 0.37 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.435 2.294 . . . . 0.0 114.544 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.68 -44.53 69.81 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.528 1.058 . . . . 0.0 111.061 169.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -63.22 -7.82 6.84 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.317 1.847 . . . . 0.0 114.122 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 19.0 m -101.92 -49.3 4.0 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 120.521 -1.362 . . . . 0.0 108.501 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.454 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 52.4 mt -52.64 -48.92 47.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 C-N-CA 123.799 0.84 . . . . 0.0 109.367 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.9 mt -64.01 -35.99 82.52 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.0 -1.062 . . . . 0.0 111.366 -172.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.12 -50.45 73.65 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.064 1.345 . . . . 0.0 109.359 172.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.01 -48.11 79.26 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.56 1.544 . . . . 0.0 111.312 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 99.5 mt -58.81 -50.44 73.95 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.476 1.11 . . . . 0.0 108.391 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.9 36.16 3.04 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.065 1.317 . . . . 0.0 112.271 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.94 22.61 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.855 1.662 . . . . 0.0 110.314 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.25 -54.33 46.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.51 1.524 . . . . 0.0 112.657 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.7 m -76.56 -12.62 60.05 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -164.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.405 ' CD2' ' CD2' ' A' ' 93' ' ' LEU . 26.0 m-85 -54.82 -32.64 60.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.938 0.79 . . . . 0.0 110.943 164.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -98.37 106.18 18.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -172.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.4 m -45.08 -54.11 7.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.559 1.944 . . . . 0.0 110.752 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -142.93 150.24 39.49 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 mt -131.77 88.56 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -168.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.94 145.2 48.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.317 -0.864 . . . . 0.0 109.196 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.7 p -121.77 -173.31 2.62 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.766 0.826 . . . . 0.0 110.553 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 p -56.44 -20.0 17.81 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.001 -1.062 . . . . 0.0 113.31 167.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -77.21 -3.98 42.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.48 1.512 . . . . 0.0 111.918 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.3 p -58.76 -25.64 63.23 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.82 20.19 31.93 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.204 0.906 . . . . 0.0 114.824 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -78.16 -86.89 0.06 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.559 1.679 . . . . 0.0 107.667 168.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.0 t -150.87 168.42 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 126.177 1.791 . . . . 0.0 107.743 -170.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.453 ' H ' ' HD3' ' A' ' 138' ' ' ARG 0.255 0.0 OUTLIER -74.06 -85.16 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 117.817 -1.087 . . . . 0.0 109.583 166.798 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -160.15 139.23 7.94 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 121.32 1.873 . . . . 0.0 109.42 -172.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.86 -28.56 4.55 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 121.035 1.405 . . . . 0.0 115.12 7.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.9 t 59.98 62.3 3.55 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.667 1.187 . . . . 0.0 113.211 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -61.94 -24.42 76.93 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.549 2.166 . . . . 0.0 112.584 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -56.17 -28.77 59.35 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.939 1.296 . . . . 0.0 112.463 -171.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.08 -42.9 77.42 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.056 0.943 . . . . 0.0 110.055 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.26 92.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.693 -0.63 . . . . 0.0 111.288 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 m -55.37 -40.32 71.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.268 0.627 . . . . 0.0 110.514 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -66.64 -51.24 58.47 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.9 mp -56.06 -38.67 70.94 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 111.749 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -60.45 -61.85 2.29 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 126.823 2.049 . . . . 0.0 107.473 177.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -57.35 -36.89 71.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.53 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -48.65 -45.4 38.62 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.378 1.071 . . . . 0.0 112.545 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.75 21.71 10.69 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.411 1.005 . . . . 0.0 112.863 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 50.78 69.5 0.63 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.921 1.689 . . . . 0.0 110.112 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 1.1 mt -122.41 178.87 4.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.544 1.537 . . . . 0.0 108.506 -173.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.0 151.49 38.91 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.689 1.996 . . . . 0.0 111.361 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 53.5 m -55.91 -33.71 64.92 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.355 0.598 . . . . 0.0 110.084 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.93 -35.11 64.55 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 120.559 -1.338 . . . . 0.0 109.866 -176.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -77.83 1.15 21.24 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.977 -1.487 . . . . 0.0 113.639 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.6 t -97.78 140.03 32.77 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.322 1.419 . . . . 0.0 110.43 -176.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -127.7 109.05 11.28 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.423 1.489 . . . . 0.0 110.559 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -91.83 131.31 37.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.838 0.455 . . . . 0.0 111.079 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.18 119.35 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 126.348 1.859 . . . . 0.0 109.011 -174.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -145.52 -21.49 0.14 Allowed Glycine 0 CA--C 1.535 1.299 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.2 t70 59.29 58.13 3.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.538 1.935 . . . . 0.0 112.886 -174.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -163.35 164.28 24.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.498 -1.376 . . . . 0.0 112.128 172.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.3 t -51.72 -53.07 43.35 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.906 1.282 . . . . 0.0 111.366 167.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.76 -20.59 66.45 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.602 1.561 . . . . 0.0 110.882 -165.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.18 -34.78 78.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.677 -0.64 . . . . 0.0 110.267 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.13 -11.98 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.5 0.72 . . . . 0.0 111.353 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.06 -55.89 18.91 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 169.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -54.05 -42.01 68.74 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.261 1.025 . . . . 0.0 111.479 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.77 -26.48 67.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.767 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -90.14 -42.09 11.26 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.921 1.237 . . . . 0.0 109.225 -169.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -29.23 69.22 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.04 -41.23 26.12 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.23 0.923 . . . . 0.0 110.377 169.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 80.4 56.32 3.22 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -170.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 41.7 pt -129.88 165.03 31.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 127.643 2.377 . . . . 0.0 106.146 -174.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -85.27 163.07 18.85 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.168 -0.958 . . . . 0.0 109.96 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.39 162.52 34.83 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.823 0.82 . . . . 0.0 109.834 172.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 36.0 mt -138.57 120.56 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -139.56 164.64 29.36 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -74.69 9.02 2.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.5 151.81 36.99 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.009 1.324 . . . . 0.0 109.18 -166.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -70.55 147.55 49.18 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.15 26.19 2.03 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.522 1.129 . . . . 0.0 111.183 167.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 17.3 p 50.67 45.82 26.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.466 1.507 . . . . 0.0 111.734 164.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -136.28 157.06 47.71 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.983 2.113 . . . . 0.0 106.365 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -75.4 -45.63 37.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.619 0.645 . . . . 0.0 111.665 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -68.86 -9.02 58.69 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.063 -0.854 . . . . 0.0 112.878 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.09 100.92 12.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.041 1.92 . . . . 0.0 109.181 -173.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -79.74 134.07 36.37 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.28 0.632 . . . . 0.0 109.343 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ARG . . . . . 0.413 ' HB3' HH11 ' A' ' 192' ' ' ARG . 0.0 OUTLIER -77.72 151.56 34.1 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 166.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.83 166.68 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.409 1.883 . . . . 0.0 109.955 171.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -129.54 0.73 5.0 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.385 1.474 . . . . 0.0 112.799 168.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.05 165.56 34.32 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.289 1.436 . . . . 0.0 108.307 171.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 69.3 mt -73.62 -33.66 64.67 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 118.578 0.626 . . . . 0.0 110.154 176.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.51 -22.27 66.15 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -62.75 -21.72 66.04 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.367 -0.833 . . . . 0.0 110.799 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.49 -55.97 19.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 125.138 1.375 . . . . 0.0 109.087 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 95.0 p -60.02 -33.19 71.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.055 1.298 . . . . 0.0 110.877 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -63.24 -33.69 76.05 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.044 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.1 mt -50.31 -58.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -67.26 -12.76 60.94 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.584 1.153 . . . . 0.0 112.952 -174.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 CA--C 1.533 0.322 0 C-N-CA 125.184 1.394 . . . . 0.0 112.853 -176.859 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.93 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 55.0 -86.79 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.827 2.851 . . . . 0.0 112.322 -168.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mmm 59.2 102.12 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.825 2.45 . . . . 0.0 113.57 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -52.63 -177.45 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.323 1.849 . . . . 0.0 113.184 164.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -61.2 100.03 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 O-C-N 120.449 -1.407 . . . . 0.0 107.676 168.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.3 m -128.35 148.25 50.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.89 150.01 52.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -127.74 149.75 50.1 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.613 1.565 . . . . 0.0 108.41 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mt -142.82 132.12 21.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -115.67 179.61 3.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.849 1.66 . . . . 0.0 109.999 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -133.92 175.91 9.04 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.517 2.327 . . . . 0.0 106.657 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.9 mt -130.16 52.6 2.0 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.803 1.241 . . . . 0.0 108.824 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -130.11 -11.44 4.19 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.916 1.286 . . . . 0.0 112.638 -172.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.99 -34.72 0.49 Allowed Glycine 0 CA--C 1.526 0.729 0 O-C-N 121.21 -0.931 . . . . 0.0 112.123 171.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.1 m . . . . . 0 C--O 1.256 1.417 0 C-N-CA 127.42 2.288 . . . . 0.0 110.054 174.516 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 tm? . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . 0.276 4.7 tpt 41.82 75.42 0.62 Allowed Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 127.107 2.163 . . . . 0.0 111.897 157.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -57.65 103.15 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.861 3.04 . . . . 0.0 110.184 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.86 -17.41 7.69 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.204 1.383 . . . . 0.0 113.803 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.71 -31.79 22.27 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 120.388 2.094 . . . . 0.0 112.129 -173.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -60.33 -21.24 61.81 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -57.66 -69.81 0.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.366 1.466 . . . . 0.0 109.043 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.06 -40.48 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.638 1.175 . . . . 0.0 109.962 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.7 mt -55.52 -50.79 69.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.13 0.877 . . . . 0.0 110.047 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.26 -45.08 89.68 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.286 0.635 . . . . 0.0 111.695 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -57.28 -55.28 36.82 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.227 1.011 . . . . 0.0 109.021 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.26 -40.5 94.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.59 0.756 . . . . 0.0 111.049 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -59.22 -58.64 7.76 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.195 1.398 . . . . 0.0 110.017 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -62.1 -28.49 69.66 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.6 m -71.2 -5.66 33.61 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.468 -0.77 . . . . 0.0 112.672 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.83 9.93 71.32 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 119.639 1.109 . . . . 0.0 113.539 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.3 mt -56.03 149.69 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 119.307 1.553 . . . . 0.0 107.192 160.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.64 105.48 16.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 170.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -78.47 149.43 33.2 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.25 0.932 . . . . 0.0 109.065 172.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -139.81 174.16 10.8 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.203 1.801 . . . . 0.0 108.383 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.0 mt -136.31 150.42 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -134.5 141.44 46.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 152.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.6 t -156.07 165.65 35.8 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -76.42 -12.95 60.13 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.189 -0.944 . . . . 0.0 112.882 174.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -63.98 156.76 26.95 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.149 -0.969 . . . . 0.0 110.063 -174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.49 -169.97 38.96 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.992 0.806 . . . . 0.0 114.252 -170.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -60.22 -12.52 9.0 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.949 1.3 . . . . 0.0 112.264 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -61.54 -12.44 15.35 Favored 'General case' 0 C--O 1.224 -0.238 0 O-C-N 119.781 -1.825 . . . . 0.0 112.384 168.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.44 -47.97 83.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 120.712 1.596 . . . . 0.0 107.804 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -56.46 -45.14 81.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.98 1.712 . . . . 0.0 110.098 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 m -67.46 -44.81 77.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.998 0.919 . . . . 0.0 111.209 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.72 -46.0 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.669 1.188 . . . . 0.0 108.308 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mp -57.36 -45.19 84.66 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.702 0.801 . . . . 0.0 110.504 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -49.9 75.53 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.257 1.023 . . . . 0.0 110.358 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.21 -57.5 7.64 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.755 1.622 . . . . 0.0 109.179 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.94 -12.86 61.78 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.785 1.634 . . . . 0.0 112.727 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 88.77 12.51 64.09 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.562 1.077 . . . . 0.0 113.976 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.4 m -119.87 16.27 6.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 125.105 1.362 . . . . 0.0 111.635 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -59.65 -40.6 88.21 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.267 -0.896 . . . . 0.0 113.37 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.03 -11.04 60.41 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.757 0.661 . . . . 0.0 112.486 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -74.71 4.57 6.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.857 1.208 . . . . 0.0 113.269 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -141.28 123.94 16.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -54.36 -45.96 72.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.284 1.434 . . . . 0.0 110.175 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -153.58 142.82 21.47 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.71 100.96 7.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.1 155.23 34.91 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.9 p -140.91 -174.64 4.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.103 1.361 . . . . 0.0 109.848 -171.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 62.4 p -52.36 -24.51 7.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.534 1.061 . . . . 0.0 112.592 168.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -58.47 -35.22 71.84 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.144 1.378 . . . . 0.0 110.349 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.406 ' HB2' ' CD2' ' A' ' 136' ' ' PHE . 80.5 p -57.36 -35.82 70.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.54 -8.01 50.53 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.671 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.406 ' CD2' ' HB2' ' A' ' 134' ' ' SER . 29.5 m-85 -59.57 156.97 12.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.72 1.26 . . . . 0.0 111.087 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.3 m -52.97 159.18 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.054 1.342 . . . . 0.0 113.398 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -67.53 160.64 27.24 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.585 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -61.09 133.01 92.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 117.258 -1.353 . . . . 0.0 108.744 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.66 135.68 41.4 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 121.33 1.511 . . . . 0.0 110.17 -3.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.44 85.45 9.47 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -170.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.21 -16.61 22.27 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 N-CA-C 109.23 -1.104 . . . . 0.0 109.23 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -44.52 -49.96 9.76 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 126.857 2.063 . . . . 0.0 110.717 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.55 65.54 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.491 -171.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.4 -41.16 20.27 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.095 -1.628 . . . . 0.0 109.295 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.8 m -58.87 -30.52 67.79 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.902 0.774 . . . . 0.0 111.082 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.575 ' CZ ' ' HE3' ' A' ' 151' ' ' LYS . 34.4 t80 -60.62 -55.68 30.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.884 0.873 . . . . 0.0 109.389 166.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 4.5 mp -58.09 -28.09 64.27 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.705 1.602 . . . . 0.0 113.095 -173.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.7 mt -71.61 -63.97 1.02 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.467 1.507 . . . . 0.0 107.18 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.36 -20.05 65.97 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.273 0.629 . . . . 0.0 112.55 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.575 ' HE3' ' CZ ' ' A' ' 147' ' ' TYR . 12.5 mmtt -51.78 -41.64 61.82 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 121.345 -0.847 . . . . 0.0 111.897 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -144.46 17.28 1.68 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -172.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.6 mm-40 59.9 62.9 1.57 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.867 1.667 . . . . 0.0 110.983 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.89 173.19 6.42 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.347 1.459 . . . . 0.0 109.973 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -116.51 126.28 53.12 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.522 1.529 . . . . 0.0 108.07 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -44.6 77.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.2 1.0 . . . . 0.0 110.454 174.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.76 -9.32 58.51 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.326 -0.859 . . . . 0.0 112.607 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -117.33 17.44 14.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.819 0.848 . . . . 0.0 108.829 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -106.64 130.31 54.4 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 170.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -122.2 97.78 5.63 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.079 1.752 . . . . 0.0 106.802 -170.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -71.85 158.7 35.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.684 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 47.8 mt -130.03 97.62 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 -171.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -120.81 -179.0 16.12 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 125.562 1.554 . . . . 0.0 112.011 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -128.78 -5.48 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.516 1.126 . . . . 0.0 113.405 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -121.16 165.54 15.23 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 122.347 1.07 . . . . 0.0 112.126 -164.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.8 t -63.25 -39.53 94.85 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.992 1.317 . . . . 0.0 110.187 164.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -32.46 72.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.408 1.083 . . . . 0.0 110.421 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.38 8.45 0.61 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.623 1.969 . . . . 0.0 111.824 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -131.39 -25.06 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 125.296 1.439 . . . . 0.0 110.816 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.53 -56.66 19.02 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.665 -1.272 . . . . 0.0 109.344 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -66.5 -29.52 69.64 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.947 -1.095 . . . . 0.0 110.925 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.54 -51.29 67.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -52.76 -52.84 54.95 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 124.386 1.075 . . . . 0.0 111.027 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -52.63 -47.21 67.16 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.354 0.261 . . . . 0.0 111.496 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.8 m -72.79 -26.85 61.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.763 0.825 . . . . 0.0 112.048 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.96 32.54 39.7 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.561 1.553 . . . . 0.0 111.181 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 22.1 pt -109.83 167.61 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 124.985 1.314 . . . . 0.0 109.36 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -97.63 162.54 13.24 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -175.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 23.5 m -135.33 152.75 51.76 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.327 1.451 . . . . 0.0 109.787 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 42.2 mt -131.84 95.37 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -129.56 149.97 51.1 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.309 1.044 . . . . 0.0 109.117 -165.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -70.7 -12.28 61.46 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.071 -1.018 . . . . 0.0 113.542 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.37 151.64 47.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.658 1.583 . . . . 0.0 109.594 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -78.4 154.95 30.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.4 t -144.11 13.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.387 0.675 . . . . 0.0 110.946 -174.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 71.0 p 57.06 69.66 0.72 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.939 2.096 . . . . 0.0 110.406 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -150.78 135.19 17.07 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.402 1.081 . . . . 0.0 108.405 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -70.12 -7.08 38.61 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -108.19 8.08 35.47 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.297 1.427 . . . . 0.0 112.954 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -108.94 122.06 46.42 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 120.788 2.294 . . . . 0.0 110.437 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -101.21 119.17 38.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.364 1.065 . . . . 0.0 109.427 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -67.61 146.59 53.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.431 0.56 . . . . 0.0 111.273 171.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.2 pt -146.04 175.75 2.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 127.296 2.239 . . . . 0.0 109.594 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -136.38 -12.41 1.84 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.436 1.494 . . . . 0.0 113.142 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.15 160.8 39.14 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.148 1.379 . . . . 0.0 108.075 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.36 -31.8 73.15 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.231 1.412 . . . . 0.0 110.503 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.22 -9.18 51.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -19.02 61.0 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.384 0.993 . . . . 0.0 110.409 172.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 67.8 mt -55.86 -52.85 44.5 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.6 p -60.26 -35.67 76.05 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.113 0.415 . . . . 0.0 111.688 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -62.62 -36.28 82.27 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.876 0.871 . . . . 0.0 112.226 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.3 mt -59.37 -44.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 124.289 1.036 . . . . 0.0 108.8 -172.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -84.86 13.17 6.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.534 1.134 . . . . 0.0 112.55 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.73 16.39 4.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.295 1.438 . . . . 0.0 110.362 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.285 5.7 t -154.34 47.62 0.59 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.327 0.967 . . . . 0.0 112.025 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 40.4 pttt . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.719 2.008 . . . . 0.0 111.11 -175.082 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.707 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 25.2 p80 44.3 55.36 5.62 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.926 1.69 . . . . 0.0 112.483 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.2 mmm -117.17 96.7 5.56 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 102.306 -3.22 . . . . 0.0 102.306 168.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -169.36 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 112.551 -2.113 . . . . 0.0 110.625 158.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -50.22 115.0 1.24 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 156.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.6 m -131.52 157.77 42.68 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 163.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.95 150.71 51.97 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.878 -0.514 . . . . 0.0 109.683 165.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.66 149.28 52.32 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 126.273 1.829 . . . . 0.0 108.156 -173.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.0 mt -142.12 145.65 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -125.22 174.51 8.05 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.086 1.755 . . . . 0.0 109.979 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 -11.2 9.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.561 1.544 . . . . 0.0 111.723 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.3 tp 71.91 9.91 6.16 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 128.437 2.695 . . . . 0.0 112.603 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.69 8.79 4.94 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -159.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.99 -79.16 0.05 OUTLIER Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 172.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.251 1.14 0 CA-C-O 117.765 -1.112 . . . . 0.0 108.346 161.199 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . 0.51 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 62.3 tpp 45.27 81.47 0.25 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.909 1.283 . . . . 0.0 111.44 -165.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -61.23 103.39 0.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.46 2.773 . . . . 0.0 109.702 -176.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.25 -35.77 0.19 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 128.424 2.916 . . . . 0.0 107.667 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.33 -15.01 31.98 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -169.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -67.0 -25.31 66.24 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.39 -1.444 . . . . 0.0 114.266 -167.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.04 -53.94 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.108 0.563 . . . . 0.0 110.592 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.8 t -68.63 -34.95 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.713 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.4 mp -44.49 -50.51 9.43 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 121.529 1.968 . . . . 0.0 113.374 164.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.92 -50.47 64.32 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 124.15 0.906 . . . . 0.0 109.782 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -53.36 -50.53 64.88 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 123.836 0.71 . . . . 0.0 110.358 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.04 -39.79 82.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.314 1.046 . . . . 0.0 111.822 -177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -71.96 -41.52 67.64 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 118.455 0.571 . . . . 0.0 110.719 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -64.17 -28.56 69.84 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.508 -0.745 . . . . 0.0 111.547 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.5 m -76.49 -13.0 60.13 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.002 0.921 . . . . 0.0 112.235 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.62 37.38 75.82 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.027 1.299 . . . . 0.0 112.003 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.6 mt -68.12 121.85 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 159.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -68.08 113.6 5.88 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 170.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -94.13 144.13 25.76 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.406 1.482 . . . . 0.0 107.686 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -143.97 177.83 8.28 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.242 1.017 . . . . 0.0 109.298 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.9 mt -135.83 150.52 28.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 124.074 0.95 . . . . 0.0 108.591 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -133.24 113.16 12.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 156.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -133.06 175.52 9.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.315 1.446 . . . . 0.0 109.178 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . 0.274 2.1 p80 -125.99 22.42 7.35 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -72.42 -0.81 13.49 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.16 -177.9 38.42 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.912 1.244 . . . . 0.0 111.793 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -72.27 -2.77 20.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -162.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -70.85 -10.22 59.16 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.741 164.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.96 -52.96 17.62 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.731 1.212 . . . . 0.0 111.335 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -59.47 -44.79 92.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.055 0.542 . . . . 0.0 110.114 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -62.82 -40.82 98.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.938 1.295 . . . . 0.0 111.123 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.7 mt -63.64 -50.75 76.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.33 -38.93 92.78 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.57 -0.706 . . . . 0.0 111.324 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -63.51 -46.02 88.01 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.6 0.76 . . . . 0.0 110.379 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -48.68 -50.42 33.32 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.985 1.374 . . . . 0.0 110.111 172.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.4 mt -69.46 -18.67 63.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.844 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.99 33.32 69.97 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.869 0.759 . . . . 0.0 111.985 174.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.1 m -137.19 22.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 126.361 1.864 . . . . 0.0 108.841 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.81 -42.18 81.93 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.051 -0.405 . . . . 0.0 110.218 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.2 m -58.83 -24.27 61.78 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.935 0.772 . . . . 0.0 112.171 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -68.47 6.35 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.123 1.369 . . . . 0.0 113.986 175.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -140.91 105.94 4.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 47.6 m -55.16 -41.32 71.7 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.521 1.528 . . . . 0.0 111.056 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -150.87 147.26 27.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.74 96.87 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -167.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.97 145.79 48.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.1 p -123.88 -176.26 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.493 1.117 . . . . 0.0 110.323 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.9 t -48.78 -34.88 13.13 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.273 1.429 . . . . 0.0 110.411 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -82.3 -2.58 53.14 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.286 1.434 . . . . 0.0 112.319 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 83.9 p -57.07 -63.13 1.31 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.304 1.411 . . . . 0.0 110.299 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 123.2 -16.0 8.16 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 125.598 1.57 . . . . 0.0 112.643 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -58.63 166.83 1.68 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.049 1.425 . . . . 0.0 112.83 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.3 m -60.57 160.75 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.916 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.4 mtt-85 -84.89 147.71 26.63 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.061 -1.649 . . . . 0.0 109.01 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -48.44 131.79 13.38 Favored Pre-proline 0 C--O 1.243 0.743 0 CA-C-O 117.4 -1.286 . . . . 0.0 109.949 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.27 125.82 7.19 Favored 'Cis proline' 0 C--N 1.351 0.691 0 CA-C-N 121.018 1.399 . . . . 0.0 111.696 -3.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.4 p -141.94 85.43 11.12 Favored Pre-proline 0 N--CA 1.438 -1.026 0 C-N-CA 123.292 0.637 . . . . 0.0 111.893 -173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.69 -18.51 32.57 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.376 . . . . 0.0 112.561 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -45.3 -43.84 11.0 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.285 1.834 . . . . 0.0 112.686 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.63 -7.6 21.67 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.537 0.939 . . . . 0.0 113.537 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.01 -61.05 1.93 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.046 0.938 . . . . 0.0 108.737 163.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.8 m -56.22 -40.29 73.85 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.475 1.91 . . . . 0.0 110.466 -170.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -53.91 -51.25 64.34 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.572 0.749 . . . . 0.0 110.907 174.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.51 -27.98 51.97 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.832 0.853 . . . . 0.0 112.159 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.49 -59.93 4.26 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -67.76 -22.41 65.21 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -61.13 -48.91 79.47 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.788 -1.195 . . . . 0.0 112.438 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -121.63 18.19 11.19 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.078 0.854 . . . . 0.0 112.013 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 54.07 51.96 13.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.335 1.854 . . . . 0.0 111.219 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.33 170.3 15.51 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.371 1.469 . . . . 0.0 110.224 175.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -105.73 130.25 53.78 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.038 1.735 . . . . 0.0 108.288 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 m -58.02 -29.47 65.34 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.261 0.937 . . . . 0.0 110.877 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.52 -27.83 23.75 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.84 -0.94 55.69 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -99.64 138.74 36.3 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.143 0.883 . . . . 0.0 108.654 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -120.15 166.16 13.8 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.871 1.669 . . . . 0.0 107.554 173.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -139.39 157.25 46.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.455 1.902 . . . . 0.0 107.02 168.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 5.0 mt -135.82 128.73 47.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -161.72 10.01 0.11 Allowed Glycine 0 C--O 1.224 -0.482 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.026 -174.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . 0.293 1.5 p30 60.86 -1.85 0.22 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 129.799 3.24 . . . . 0.0 115.862 163.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -113.36 168.27 9.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.974 0.806 . . . . 0.0 112.858 -168.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.1 t -59.22 -35.39 73.56 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.077 -1.015 . . . . 0.0 111.642 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 -13.44 61.8 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.37 1.468 . . . . 0.0 112.419 -178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.42 -39.15 88.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.634 0.731 . . . . 0.0 111.595 -167.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.91 -45.86 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 125.022 1.329 . . . . 0.0 108.655 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -59.81 -41.18 90.69 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.021 0.929 . . . . 0.0 110.938 -177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -64.22 -51.81 61.87 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.229 0.922 . . . . 0.0 110.829 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.19 97.51 Favored 'General case' 0 C--O 1.224 -0.287 0 O-C-N 123.577 0.548 . . . . 0.0 111.259 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -62.78 -28.89 70.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.322 0.649 . . . . 0.0 111.81 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -60.04 -46.8 88.34 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.486 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.33 -23.36 32.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.879 1.672 . . . . 0.0 113.318 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 90.0 10.39 64.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.499 2.0 . . . . 0.0 113.847 -175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 23.7 pt -81.79 -173.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.221 1.51 . . . . 0.0 110.163 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -101.17 161.75 13.39 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.287 1.035 . . . . 0.0 110.419 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.05 160.58 40.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.885 1.274 . . . . 0.0 113.419 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.8 mt -142.9 83.34 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.823 1.649 . . . . 0.0 108.845 -172.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -97.66 -171.41 2.18 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.994 -1.066 . . . . 0.0 110.62 173.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -99.74 -5.9 27.95 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.514 -1.366 . . . . 0.0 112.704 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -112.61 137.58 50.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -176.576 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.96 162.04 29.97 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.958 1.703 . . . . 0.0 109.626 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 34.7 t -155.77 157.87 37.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 10.2 p -85.91 19.64 2.49 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.603 1.161 . . . . 0.0 111.795 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -67.82 -178.62 0.99 Allowed 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.612 -0.68 . . . . 0.0 110.27 168.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.04 5.5 7.93 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -165.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.92 23.39 1.01 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.1 1.81 . . . . 0.0 111.52 167.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -81.92 149.56 28.17 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 120.794 -1.415 . . . . 0.0 108.882 160.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -142.29 99.36 3.49 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.166 0.586 . . . . 0.0 109.612 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -73.93 162.63 28.86 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 118.438 -1.305 . . . . 0.0 112.035 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 6.7 pt -135.31 169.31 21.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.403 1.881 . . . . 0.0 110.099 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -117.57 -2.9 11.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.95 1.3 . . . . 0.0 112.862 168.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.56 167.52 28.34 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.852 1.261 . . . . 0.0 109.079 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 7.5 tp -76.08 -40.39 53.2 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -173.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.48 -18.86 64.23 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.52 -11.24 60.17 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.811 0.844 . . . . 0.0 111.027 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.39 -55.62 23.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-O 117.835 -1.079 . . . . 0.0 108.484 166.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.2 m -54.27 -38.88 66.33 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.621 1.101 . . . . 0.0 110.158 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -64.14 -25.98 68.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.1 mt -56.44 -48.19 80.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -78.85 -41.07 30.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.436 1.094 . . . . 0.0 109.89 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.85 49.2 1.68 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.67 1.988 . . . . 0.0 109.276 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 3.2 m 45.35 68.16 0.61 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.252 2.221 . . . . 0.0 113.428 165.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? . . . . . 0 C--O 1.249 1.067 0 C-N-CA 129.997 3.319 . . . . 0.0 113.822 160.643 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.936 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -117.92 83.06 1.93 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.633 1.173 . . . . 0.0 108.374 -174.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mmm -107.49 73.36 0.91 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 122.846 1.308 . . . . 0.0 107.478 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.35 114.59 28.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 113.985 -1.461 . . . . 0.0 107.588 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.53 83.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.329 1.852 . . . . 0.0 111.368 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 m -124.08 135.11 53.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.8 150.26 31.9 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 170.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -126.49 150.91 48.45 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.291 1.436 . . . . 0.0 108.464 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -138.56 135.47 43.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -125.8 163.05 23.73 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.841 2.057 . . . . 0.0 109.999 -169.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -86.51 -29.92 22.35 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.851 2.06 . . . . 0.0 112.491 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 45.53 58.49 4.2 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.615 1.566 . . . . 0.0 111.195 -167.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.82 -58.2 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 117.855 -1.069 . . . . 0.0 110.503 164.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.44 148.45 18.96 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 120.234 1.379 . . . . 0.0 112.761 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.818 0 C-N-CA 126.979 2.111 . . . . 0.0 109.386 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -105.0 86.85 1.64 Allowed Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.674 1.59 . . . . 0.0 109.433 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -56.63 111.95 0.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.46 2.107 . . . . 0.0 108.118 166.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.37 -15.07 8.71 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 117.938 -1.479 . . . . 0.0 113.251 -170.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.6 -19.47 10.56 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -65.49 -30.08 70.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.676 1.125 . . . . 0.0 112.301 -175.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.46 -55.63 31.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.818 0.847 . . . . 0.0 110.489 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.47 -42.14 94.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.33 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.6 mp -44.55 -52.85 7.65 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 121.645 2.021 . . . . 0.0 112.544 168.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.69 80.68 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.588 1.18 . . . . 0.0 110.957 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -58.63 -46.66 86.61 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.101 0.96 . . . . 0.0 111.421 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.51 -38.0 68.21 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.293 -0.861 . . . . 0.0 112.418 -172.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.52 -40.75 93.33 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.945 0.793 . . . . 0.0 109.752 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -52.03 -54.74 26.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.639 1.176 . . . . 0.0 109.021 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.3 m -74.0 4.77 4.97 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 60.31 24.79 61.76 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.659 1.118 . . . . 0.0 113.151 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.4 mt -71.3 108.22 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 127.032 2.133 . . . . 0.0 107.47 169.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.84 103.18 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.996 0.518 . . . . 0.0 110.165 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -84.8 151.58 24.25 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -145.32 169.64 17.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.943 1.697 . . . . 0.0 109.803 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 22.3 mt -138.79 157.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.774 1.629 . . . . 0.0 110.698 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -137.46 115.77 11.84 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.027 0.931 . . . . 0.0 109.383 163.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -134.42 161.07 36.04 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.454 1.502 . . . . 0.0 108.547 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -88.28 -2.43 58.6 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.283 1.033 . . . . 0.0 110.896 170.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.09 147.87 11.99 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.853 1.661 . . . . 0.0 108.233 172.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.95 -171.59 28.48 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 123.642 0.639 . . . . 0.0 111.616 -170.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -58.7 -22.38 57.18 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.787 -0.831 . . . . 0.0 111.432 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -57.6 -17.37 13.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.727 1.211 . . . . 0.0 114.008 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.79 -49.01 66.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.606 1.548 . . . . 0.0 111.123 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -59.55 -42.2 91.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.17 0.588 . . . . 0.0 110.233 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -62.79 -46.01 89.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.451 1.1 . . . . 0.0 110.906 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 39.6 mt -59.84 -45.61 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 124.421 1.088 . . . . 0.0 108.824 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -57.29 -44.98 84.53 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.463 0.705 . . . . 0.0 111.29 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -48.48 81.61 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.913 0.485 . . . . 0.0 110.267 174.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -51.05 -52.78 39.83 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.747 1.219 . . . . 0.0 110.473 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.47 -3.67 32.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.145 1.778 . . . . 0.0 113.307 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.25 32.98 84.57 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.751 1.167 . . . . 0.0 112.645 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.54 23.59 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.977 0.911 . . . . 0.0 109.706 174.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -48.54 76.85 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.035 -1.04 . . . . 0.0 110.304 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.9 m -70.87 -19.01 62.67 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -66.17 -0.51 2.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 117.132 -1.414 . . . . 0.0 113.638 167.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -139.84 105.06 5.03 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 121.665 2.03 . . . . 0.0 108.97 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.4 m -51.73 -40.79 60.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.933 1.693 . . . . 0.0 112.254 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -157.28 145.55 19.35 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 -172.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.05 131.04 45.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -85.18 151.87 23.77 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 167.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.2 p -137.17 -168.3 2.26 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.608 1.563 . . . . 0.0 110.208 -172.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.4 t -53.78 -26.55 24.26 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.497 -1.377 . . . . 0.0 112.975 167.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -61.03 -33.92 74.05 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.983 0.896 . . . . 0.0 109.168 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.9 m -85.31 69.83 10.77 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 129.07 2.948 . . . . 0.0 104.793 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.51 44.59 1.99 Allowed Glycine 0 CA--C 1.522 0.494 0 CA-C-O 118.693 -1.059 . . . . 0.0 111.324 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -67.22 174.45 3.21 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 124.602 2.144 . . . . 0.0 112.191 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.8 t -76.75 157.64 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 128.261 2.624 . . . . 0.0 110.6 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -72.25 166.34 22.62 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.397 1.479 . . . . 0.0 110.467 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 mmpm? -73.04 149.02 89.5 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 120.36 -1.463 . . . . 0.0 107.967 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.88 -4.99 32.51 Favored 'Cis proline' 0 CA--C 1.533 0.434 0 N-CA-C 115.842 1.439 . . . . 0.0 115.842 11.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.2 t -43.09 91.39 0.05 OUTLIER Pre-proline 0 C--O 1.241 0.655 0 C-N-CA 127.366 2.266 . . . . 0.0 114.576 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.84 6.94 0.05 OUTLIER 'Trans proline' 0 CA--C 1.556 1.616 1 C-N-CA 128.068 5.845 . . . . 0.0 114.64 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -43.74 -71.65 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.333 2.653 . . . . 0.0 112.236 -172.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.8 -16.39 40.18 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -175.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.35 -54.82 6.21 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 119.68 1.127 . . . . 0.0 108.552 171.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 m -53.06 -38.72 62.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.665 1.186 . . . . 0.0 110.605 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -52.04 -50.38 61.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.346 1.058 . . . . 0.0 110.715 174.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.73 -35.85 72.89 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.302 1.041 . . . . 0.0 111.406 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.27 -58.44 8.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -64.47 -29.18 70.23 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.345 1.069 . . . . 0.0 111.758 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -63.77 -27.41 69.17 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.164 -1.585 . . . . 0.0 114.842 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -141.6 8.73 1.97 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.994 0.816 . . . . 0.0 111.862 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 55.43 74.1 0.39 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.709 1.604 . . . . 0.0 109.634 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.1 mp -101.14 178.19 4.73 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.846 1.259 . . . . 0.0 109.536 175.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -109.07 130.91 55.49 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -44.84 -53.77 7.13 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 124.579 1.175 . . . . 0.0 108.678 173.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -76.48 -20.88 56.53 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 125.741 1.616 . . . . 0.0 112.732 -159.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -90.53 4.13 52.03 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.679 0.792 . . . . 0.0 109.943 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -92.93 162.06 14.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.791 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -146.65 118.01 7.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.694 0.797 . . . . 0.0 109.133 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -82.83 155.33 24.22 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.084 0.402 . . . . 0.0 110.33 167.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.6 mp -127.61 114.32 35.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.826 1.25 . . . . 0.0 107.94 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.74 158.64 31.61 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 123.469 0.48 . . . . 0.0 112.254 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.44 3.29 34.82 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -163.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -101.69 164.75 11.58 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.05 1.295 . . . . 0.0 111.581 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 6.5 t -72.57 -14.6 61.66 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.665 -0.647 . . . . 0.0 112.295 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -16.24 48.2 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.811 0.732 . . . . 0.0 110.023 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -78.01 11.41 2.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.178 1.791 . . . . 0.0 112.235 -173.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.1 p -120.76 -19.82 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.483 1.513 . . . . 0.0 110.922 170.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.9 -38.87 89.87 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 120.729 -1.232 . . . . 0.0 110.221 -171.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -78.87 -28.9 44.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.301 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.84 -51.45 69.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -50.88 -42.15 58.81 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.048 1.339 . . . . 0.0 112.136 171.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -50.29 63.0 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.649 -0.657 . . . . 0.0 111.241 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 8.6 t -69.78 -17.85 63.44 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.709 0.803 . . . . 0.0 110.769 174.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.47 33.49 38.85 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.86 2.171 . . . . 0.0 112.525 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.46 171.58 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.591 1.557 . . . . 0.0 111.908 -165.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -92.06 154.57 18.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.715 1.206 . . . . 0.0 111.964 -173.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.7 m -136.46 151.54 49.58 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.198 1.399 . . . . 0.0 110.275 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 46.3 mt -123.6 111.67 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.71 160.26 31.3 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 123.535 0.734 . . . . 0.0 109.027 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -79.63 -16.91 54.94 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.503 -1.373 . . . . 0.0 111.723 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.24 160.93 19.75 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 128.192 2.597 . . . . 0.0 108.655 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -61.22 156.48 18.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.8 m -149.34 22.12 0.94 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.444 1.098 . . . . 0.0 111.184 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 73.7 p 52.29 46.81 25.98 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.966 0.906 . . . . 0.0 111.625 158.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -145.66 176.96 9.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.423 1.489 . . . . 0.0 108.572 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -102.06 -20.64 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.269 1.028 . . . . 0.0 112.447 -177.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -106.57 0.0 37.05 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.211 1.386 . . . . 0.0 111.816 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.72 152.29 22.25 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 119.606 1.703 . . . . 0.0 109.411 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -127.69 148.15 50.4 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.511 1.124 . . . . 0.0 108.539 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -85.87 153.51 22.18 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.487 0.585 . . . . 0.0 112.253 166.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.5 169.26 17.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 126.366 1.866 . . . . 0.0 110.244 168.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -123.3 -9.29 8.09 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.547 1.539 . . . . 0.0 112.827 170.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.51 167.85 29.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.259 1.424 . . . . 0.0 108.56 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.3 tp -69.52 -37.93 77.34 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.28 -15.09 59.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -69.64 -21.12 63.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.409 0.55 . . . . 0.0 109.786 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 86.3 mt -58.53 -59.04 4.16 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 125.411 1.485 . . . . 0.0 108.433 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.0 m -55.7 -39.94 71.72 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.709 0.686 . . . . 0.0 110.86 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -59.9 -33.3 71.67 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.888 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.6 mt -55.34 -47.55 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 119.664 1.12 . . . . 0.0 109.433 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.65 -18.21 51.96 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -108.41 17.3 22.27 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.272 1.829 . . . . 0.0 111.923 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 92.5 m 56.78 81.87 0.13 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.072 2.149 . . . . 0.0 111.931 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? . . . . . 0 C--O 1.245 0.859 0 CA-C-N 112.868 -1.969 . . . . 0.0 111.647 144.77 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.774 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -159.52 77.4 0.69 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.558 1.943 . . . . 0.0 107.212 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm -126.12 84.18 2.24 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -62.98 -164.8 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.716 1.206 . . . . 0.0 109.864 167.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 69.91 0.07 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.887 1.675 . . . . 0.0 112.178 -176.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.4 m -81.17 153.37 27.26 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.41 147.99 45.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.11 152.94 43.73 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.2 mt -127.99 173.92 12.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 163.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -145.4 164.4 31.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.945 0.898 . . . . 0.0 109.142 167.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -93.01 -24.8 18.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.303 1.441 . . . . 0.0 113.647 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.7 tp 60.77 -23.86 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 129.205 3.002 . . . . 0.0 115.814 -174.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.74 -38.03 6.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.98 0.809 . . . . 0.0 111.244 -166.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.55 -89.83 1.06 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 164.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.249 1.063 0 C-N-CA 125.458 1.503 . . . . 0.0 111.345 -178.591 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 8.2 tpt 44.55 75.78 0.61 Allowed Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -165.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -56.53 109.24 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.9 3.066 . . . . 0.0 109.962 -170.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.25 -29.76 2.59 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.877 0.751 . . . . 0.0 111.602 -161.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.56 -37.67 35.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.341 -1.093 . . . . 0.0 110.017 -176.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.82 -23.19 28.92 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.43 -57.03 6.47 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.661 0.784 . . . . 0.0 110.575 170.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.6 t -53.88 -44.07 59.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 123.604 0.761 . . . . 0.0 109.466 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.1 mt -56.0 -49.33 73.95 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.161 0.891 . . . . 0.0 110.532 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.7 73.97 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.149 0.58 . . . . 0.0 110.95 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -53.31 -46.97 69.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.774 1.23 . . . . 0.0 111.149 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.81 -45.85 66.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.112 1.365 . . . . 0.0 111.323 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -59.97 -48.58 81.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.165 1.386 . . . . 0.0 110.464 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.1 -42.1 80.16 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.569 0.748 . . . . 0.0 110.242 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.6 m -69.76 -6.56 32.9 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.216 1.006 . . . . 0.0 113.67 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.23 -5.57 84.87 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.575 1.56 . . . . 0.0 114.33 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mt -53.36 118.61 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 128.39 2.676 . . . . 0.0 110.268 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -68.15 101.05 1.09 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.368 1.067 . . . . 0.0 108.252 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -84.9 148.81 26.06 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -141.18 179.19 6.9 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.618 1.567 . . . . 0.0 107.525 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.1 mt -131.73 143.74 39.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 167.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -128.52 109.21 11.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 166.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -141.68 150.91 42.49 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -171.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -77.56 -1.95 33.22 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.504 -0.747 . . . . 0.0 112.343 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -63.31 164.22 9.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.043 0.937 . . . . 0.0 110.233 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.47 -176.25 49.61 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -55.58 -25.59 39.07 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.603 0.761 . . . . 0.0 111.74 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -16.81 11.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.752 -1.218 . . . . 0.0 112.576 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.68 -36.59 74.43 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.724 1.147 . . . . 0.0 112.153 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -60.79 -53.88 51.98 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -59.05 -41.49 88.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.519 1.528 . . . . 0.0 111.173 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.94 -50.72 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.748 0.819 . . . . 0.0 109.421 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mp -58.83 -47.87 83.31 Favored 'General case' 0 C--O 1.228 -0.074 0 O-C-N 121.487 -0.758 . . . . 0.0 110.757 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -56.81 -46.48 81.59 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.723 0.809 . . . . 0.0 110.145 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -54.93 -52.22 63.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.184 1.394 . . . . 0.0 109.939 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.42 -7.01 39.87 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.029 1.332 . . . . 0.0 113.592 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.48 28.71 63.03 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.385 0.993 . . . . 0.0 112.469 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.7 m -128.79 28.74 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 124.82 1.248 . . . . 0.0 111.175 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -58.49 -57.61 12.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.533 1.133 . . . . 0.0 112.004 172.115 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.7 m -73.22 -22.41 60.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.19 0.596 . . . . 0.0 111.615 -165.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.29 -29.57 58.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.86 -0.59 . . . . 0.0 112.564 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -109.17 110.93 22.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 66.5 m -46.77 -47.74 20.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.147 1.379 . . . . 0.0 109.123 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.47 159.25 42.59 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.74 134.92 65.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 171.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.6 mt -99.01 151.08 21.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 42.4 p -145.55 174.3 11.28 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.561 1.544 . . . . 0.0 107.636 -170.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.2 t -57.51 -13.45 3.72 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 121.215 -0.928 . . . . 0.0 113.272 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -59.31 -48.33 82.03 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.387 1.475 . . . . 0.0 109.197 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 95.8 p -54.54 -36.97 64.86 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.204 1.802 . . . . 0.0 113.037 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.03 -4.87 78.96 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.394 -1.226 . . . . 0.0 114.8 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -50.74 158.71 0.62 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.627 1.213 . . . . 0.0 112.438 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.6 m -52.93 154.8 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 122.903 1.335 . . . . 0.0 112.296 -178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -85.55 160.38 19.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.241 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 136.93 87.25 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.621 -1.181 . . . . 0.0 108.865 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.25 122.35 7.89 Favored 'Cis proline' 0 N--CA 1.454 -0.805 0 CA-C-N 120.755 1.305 . . . . 0.0 110.732 -0.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.0 p -123.32 85.6 51.96 Favored Pre-proline 0 N--CA 1.446 -0.666 0 C-N-CA 125.252 1.421 . . . . 0.0 111.283 -163.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.14 -27.51 8.17 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.709 2.273 . . . . 0.0 113.441 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -53.8 -54.68 34.98 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.364 -0.835 . . . . 0.0 112.191 -166.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.0 -7.75 43.42 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.231 -0.918 . . . . 0.0 113.038 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.97 -48.4 11.5 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 m -55.62 -41.49 73.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.533 1.133 . . . . 0.0 109.946 171.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -58.45 -58.54 8.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.873 0.869 . . . . 0.0 109.996 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -67.12 -19.74 65.66 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.124 0.97 . . . . 0.0 112.855 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -63.14 1.14 Allowed 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 173.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.07 -22.92 65.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.31 -26.46 66.56 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 120.898 -1.126 . . . . 0.0 113.34 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -148.69 23.07 1.0 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.451 1.023 . . . . 0.0 112.232 179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 50.14 67.2 0.95 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.584 1.553 . . . . 0.0 111.576 -174.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.5 mp -100.23 170.7 8.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.791 1.282 . . . . 0.0 111.024 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.81 123.14 42.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.861 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 m -59.92 -39.31 85.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.17 1.388 . . . . 0.0 110.816 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -83.25 -13.2 55.79 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.167 -0.958 . . . . 0.0 112.997 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -109.86 13.41 23.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -92.25 149.42 21.47 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -141.43 113.84 8.19 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -73.15 -40.87 64.51 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.0 mp 56.17 99.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 126.461 1.904 . . . . 0.0 111.73 -169.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -122.96 -171.86 13.78 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.87 148.09 32.49 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 169.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER 58.23 171.12 0.05 Allowed 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 126.595 1.958 . . . . 0.0 114.461 -165.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.49 169.91 1.57 Allowed 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 127.382 2.273 . . . . 0.0 110.119 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 tm? 68.4 -27.1 0.14 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 130.409 3.484 . . . . 0.0 113.339 -164.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -73.63 8.11 2.06 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.726 1.603 . . . . 0.0 114.413 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.54 -13.03 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.0 -1.062 . . . . 0.0 110.823 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -66.52 -40.75 89.31 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.711 -1.243 . . . . 0.0 111.026 -173.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -69.22 -32.74 72.19 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.287 -0.883 . . . . 0.0 111.516 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.28 -45.94 89.09 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.458 0.572 . . . . 0.0 109.52 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -49.89 -53.05 28.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.69 0.796 . . . . 0.0 110.622 168.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -58.25 -47.65 82.9 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.9 m -69.58 -20.79 63.65 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.573 1.079 . . . . 0.0 112.265 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.02 58.59 10.36 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -167.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.8 pt -130.36 169.91 20.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.27 1.428 . . . . 0.0 109.065 173.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -96.27 167.74 11.0 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.838 0.855 . . . . 0.0 110.938 -172.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 11.8 m -147.6 158.72 44.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.568 1.547 . . . . 0.0 111.033 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.8 mt -131.74 124.93 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 168.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -144.6 155.73 43.78 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -69.36 -26.46 64.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.169 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.86 156.96 32.18 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.255 0.934 . . . . 0.0 111.851 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.43 165.25 6.32 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.421 1.105 . . . . 0.0 109.971 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 29.7 t -145.19 172.89 12.47 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 161.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 21.8 p -69.93 24.63 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.202 2.201 . . . . 0.0 113.365 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -133.96 108.02 8.15 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.26 1.424 . . . . 0.0 108.071 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -69.58 -16.67 63.45 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.755 1.222 . . . . 0.0 113.781 -166.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -51.52 -53.31 29.27 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 168.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -53.19 114.56 1.51 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.996 2.119 . . . . 0.0 113.778 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -79.32 118.22 21.03 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.802 0.841 . . . . 0.0 111.052 -176.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -67.14 142.56 57.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.05 0.386 . . . . 0.0 111.514 169.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.6 pt -141.93 168.65 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 126.632 1.973 . . . . 0.0 111.511 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -128.1 -6.09 5.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.476 1.51 . . . . 0.0 111.941 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.13 157.59 40.59 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.777 1.231 . . . . 0.0 108.306 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.73 -34.15 73.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -55.32 -34.95 64.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.355 0.662 . . . . 0.0 112.385 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -64.9 -17.67 64.53 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.327 0.651 . . . . 0.0 111.397 -174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.2 mt -50.44 -61.6 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.362 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 87.8 p -55.38 -34.71 64.57 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.76 0.791 . . . . 0.0 110.698 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -74.45 -25.62 59.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.241 1.416 . . . . 0.0 112.722 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 61.5 mt -53.54 -60.14 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -70.63 8.93 0.73 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.656 1.982 . . . . 0.0 113.792 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -121.19 -2.48 9.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.373 1.469 . . . . 0.0 112.32 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.09 61.66 1.02 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.331 0.652 . . . . 0.0 109.601 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.282 17.2 ptpt . . . . . 0 C--O 1.246 0.903 0 C-N-CA 129.497 3.119 . . . . 0.0 112.496 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.555 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -132.72 99.42 4.61 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.768 1.227 . . . . 0.0 108.004 173.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm -132.61 95.26 3.57 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -60.01 176.76 0.29 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.129 161.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -53.17 82.74 0.0 OUTLIER 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.09 2.156 . . . . 0.0 111.455 172.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.4 m -100.17 153.8 18.96 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.68 150.69 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.139 -0.976 . . . . 0.0 109.314 171.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.97 149.68 51.59 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 126.597 1.959 . . . . 0.0 107.881 -169.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.6 mt -141.92 132.31 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -117.07 167.85 10.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.557 1.543 . . . . 0.0 110.285 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -121.5 -12.8 8.5 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -167.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.02 -5.82 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.902 2.481 . . . . 0.0 116.818 174.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -129.36 32.22 4.71 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.811 1.645 . . . . 0.0 109.945 -167.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.6 -75.76 0.04 OUTLIER Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 C--O 1.246 0.904 0 C-N-CA 124.896 1.278 . . . . 0.0 110.778 168.83 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.454 HD12 ' H ' ' A' ' 86' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.454 ' H ' HD12 ' A' ' 85' ' ' LEU . 33.0 ttm -122.3 85.92 47.56 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 126.621 1.968 . . . . 0.0 107.686 -170.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.16 94.19 0.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.589 2.86 . . . . 0.0 110.198 -172.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 145.73 -9.22 1.6 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-O 117.273 -1.849 . . . . 0.0 113.009 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.34 -40.45 4.66 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.539 2.336 . . . . 0.0 114.573 -168.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -28.3 55.94 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.229 1.012 . . . . 0.0 113.295 -176.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -54.32 -64.83 0.7 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.269 1.428 . . . . 0.0 110.289 173.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.2 t -59.28 -44.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.506 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 77.1 mt -52.04 -45.76 64.8 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 119.025 0.83 . . . . 0.0 110.307 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.21 -48.21 58.08 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.094 0.558 . . . . 0.0 111.62 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.3 t90 -54.39 -37.77 65.4 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.7 0.8 . . . . 0.0 110.654 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.63 -42.77 27.92 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.456 1.502 . . . . 0.0 112.379 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -58.17 -51.06 71.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.461 1.104 . . . . 0.0 110.372 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -61.82 -23.9 66.54 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.158 1.383 . . . . 0.0 112.587 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 m -92.41 -0.41 57.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.06 0.944 . . . . 0.0 113.223 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.96 25.96 71.07 Favored Glycine 0 CA--C 1.527 0.837 0 O-C-N 121.356 -0.84 . . . . 0.0 112.942 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.9 mt -67.92 125.67 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 164.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -72.33 97.5 2.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 170.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -79.75 151.85 30.16 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -145.01 169.56 17.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.8 mt -130.99 157.42 43.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 169.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -147.34 134.74 20.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.946 1.298 . . . . 0.0 107.993 159.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 t -163.44 -179.02 6.23 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -108.28 -7.5 15.93 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.433 ' HZ2' ' CD1' ' A' ' 116' ' ' ILE . 0.9 OUTLIER -57.6 -0.87 0.08 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 117.654 2.465 . . . . 0.0 117.654 -172.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.68 -175.69 54.21 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.005 -1.06 . . . . 0.0 111.533 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -64.91 -12.24 47.03 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -168.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -66.75 -12.96 60.74 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.343 -1.473 . . . . 0.0 111.688 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.16 -55.92 27.17 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.481 1.037 . . . . 0.0 111.44 176.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -54.85 -45.85 74.57 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.996 0.918 . . . . 0.0 109.77 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 m -59.39 -42.43 91.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.925 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.433 ' CD1' ' HZ2' ' A' ' 109' ' ' LYS . 48.2 mt -64.88 -49.46 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 119.199 0.909 . . . . 0.0 109.344 177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mp -60.11 -42.88 95.65 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.894 -0.504 . . . . 0.0 111.754 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -57.23 -53.42 58.31 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.486 1.115 . . . . 0.0 109.27 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.1 -54.23 21.93 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.9 1.68 . . . . 0.0 109.264 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.47 -39.08 65.19 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.777 0.831 . . . . 0.0 111.267 -170.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.25 27.89 1.06 Allowed Glycine 0 CA--C 1.535 1.338 0 CA-C-O 121.637 0.576 . . . . 0.0 112.015 163.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.303 2.0 p -133.41 12.66 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 127.191 2.196 . . . . 0.0 110.106 -160.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -67.35 -34.34 77.1 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 121.393 -0.817 . . . . 0.0 110.334 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.4 m -77.83 -22.71 49.55 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 120.037 1.289 . . . . 0.0 113.087 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -60.77 -18.57 55.79 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -116.11 126.68 54.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.0 m -62.32 -30.97 71.54 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.821 0.849 . . . . 0.0 111.652 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.444 ' OE1' ' HE2' ' A' ' 151' ' ' LYS . 7.5 tt0 -154.13 159.93 41.69 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 169.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mp -131.88 111.57 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 mt -80.72 159.34 25.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.844 0.831 . . . . 0.0 109.383 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.9 p -142.17 177.47 8.21 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.337 1.855 . . . . 0.0 108.12 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -61.55 -6.58 2.52 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.4 -0.813 . . . . 0.0 112.868 169.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -57.8 -28.22 63.83 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.669 -1.269 . . . . 0.0 110.703 166.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 58.0 p -58.0 -54.29 48.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.434 0.694 . . . . 0.0 112.394 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.33 -2.88 71.67 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 117.295 -1.836 . . . . 0.0 115.45 -173.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -53.92 164.51 0.58 Allowed 'General case' 0 C--O 1.242 0.694 0 CA-C-N 120.03 1.915 . . . . 0.0 112.235 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.1 176.76 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.407 1.099 . . . . 0.0 113.288 -172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -65.06 147.08 54.12 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.245 -0.909 . . . . 0.0 110.058 174.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -52.1 127.44 37.36 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.984 1.714 . . . . 0.0 107.612 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.01 -40.03 1.31 Allowed 'Cis proline' 0 C--N 1.348 0.531 0 CA-C-N 121.548 1.588 . . . . 0.0 115.25 22.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.267 43.2 p 51.25 72.25 1.28 Allowed Pre-proline 0 N--CA 1.441 -0.897 0 C-N-CA 125.194 1.397 . . . . 0.0 113.077 -172.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -62.14 -18.44 62.02 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.616 2.877 . . . . 0.0 111.907 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -47.71 -43.51 26.9 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.863 1.665 . . . . 0.0 111.273 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.46 -21.66 65.62 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.23 -58.45 3.31 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.188 -0.911 . . . . 0.0 109.392 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.6 m -56.2 -36.16 68.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.552 0.615 . . . . 0.0 110.292 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -50.89 -63.0 1.27 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 124.649 1.18 . . . . 0.0 110.339 170.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 71.2 mt -69.18 -24.46 64.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -174.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.26 -67.43 0.44 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -57.46 -41.29 80.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.873 0.469 . . . . 0.0 110.514 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.444 ' HE2' ' OE1' ' A' ' 128' ' ' GLU . 7.0 tmtm? -47.93 -37.32 14.08 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.581 1.552 . . . . 0.0 114.148 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.54 24.81 5.43 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.221 0.919 . . . . 0.0 112.743 173.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 47.71 58.11 5.31 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.46 1.904 . . . . 0.0 112.946 -175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.6 mp -94.68 172.82 7.94 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.75 1.22 . . . . 0.0 111.725 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -102.11 136.08 42.58 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.691 1.196 . . . . 0.0 108.846 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.2 m -62.13 -50.23 72.73 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.93 1.292 . . . . 0.0 108.91 173.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 1.04 53.07 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.99 -1.069 . . . . 0.0 112.645 -167.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -120.39 12.73 11.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.94 1.296 . . . . 0.0 108.999 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 t -107.35 146.63 31.36 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.156 0.889 . . . . 0.0 109.685 168.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -137.22 116.99 13.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.916 1.686 . . . . 0.0 107.633 -167.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -84.84 153.55 22.87 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 170.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.7 mt -128.66 102.4 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.45 124.43 3.33 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.65 37.1 0.4 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.253 1.821 . . . . 0.0 112.139 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.48 158.41 44.31 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.398 1.479 . . . . 0.0 108.304 -176.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.5 t -64.32 -15.27 59.98 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.89 -12.87 60.8 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.597 1.159 . . . . 0.0 112.539 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -48.01 80.11 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.084 0.856 . . . . 0.0 112.202 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.4 -31.59 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.82 -37.48 87.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.131 0.572 . . . . 0.0 109.857 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.74 -53.4 15.67 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.084 -1.01 . . . . 0.0 109.905 172.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.75 -48.11 78.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.319 0.648 . . . . 0.0 111.68 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -56.47 -53.49 56.82 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.362 1.865 . . . . 0.0 111.46 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -73.78 -23.52 59.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 119.383 -0.341 . . . . 0.0 111.778 -172.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.0 p -86.06 -21.28 27.79 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 170.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 76.06 46.94 12.07 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.885 1.231 . . . . 0.0 111.243 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 15.4 pt -131.0 -177.4 2.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 125.985 1.714 . . . . 0.0 109.096 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -92.53 162.21 14.3 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.774 0.83 . . . . 0.0 110.489 -175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.06 139.47 43.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.51 1.524 . . . . 0.0 111.172 -171.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.88 75.13 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 123.07 1.414 . . . . 0.0 109.347 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -93.79 -171.71 2.67 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.801 1.64 . . . . 0.0 111.362 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -106.57 -8.84 16.82 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.66 154.86 32.02 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.728 -1.232 . . . . 0.0 110.275 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.62 140.07 58.48 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 120.832 -1.167 . . . . 0.0 109.277 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 19.5 m -127.52 147.35 50.32 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.881 1.324 . . . . 0.0 112.233 168.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.23 47.94 1.58 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.803 2.841 . . . . 0.0 110.513 -167.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -138.22 159.72 41.32 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.101 1.361 . . . . 0.0 109.663 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -99.06 98.45 9.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 115.89 16.64 6.74 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.667 1.127 . . . . 0.0 112.419 -171.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -89.3 138.32 31.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.847 0.823 . . . . 0.0 109.411 166.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -135.04 90.38 2.63 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.202 1.001 . . . . 0.0 110.564 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . 0.262 0.2 OUTLIER -80.54 152.52 28.61 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.059 -172.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.1 pt -127.01 170.36 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.924 1.689 . . . . 0.0 111.93 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.84 -27.15 12.83 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.716 0.807 . . . . 0.0 112.177 161.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.56 155.84 42.79 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.045 0.938 . . . . 0.0 108.951 -166.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.3 tp -64.63 -35.51 81.23 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.273 1.029 . . . . 0.0 109.035 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -60.18 -30.46 69.36 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -60.91 -20.61 62.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.408 1.004 . . . . 0.0 111.306 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 95.1 mt -53.98 -53.68 25.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 88.1 p -59.68 -39.1 83.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -59.03 -40.88 86.41 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.342 1.057 . . . . 0.0 109.593 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.4 mt -51.81 -49.84 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.761 1.224 . . . . 0.0 110.851 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.76 -5.61 55.63 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.941 0.896 . . . . 0.0 112.514 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -111.65 10.97 21.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.101 2.16 . . . . 0.0 110.104 -174.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.0 t -149.76 22.68 0.89 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.919 176.099 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.538 0 N-CA-C 112.042 -0.423 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -67.38 96.52 0.51 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.859 0.829 . . . . 0.0 109.555 -177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mmm -138.05 80.9 1.83 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.918 2.087 . . . . 0.0 106.369 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.9 175.98 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.958 2.103 . . . . 0.0 110.649 166.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.1 102.67 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.976 1.71 . . . . 0.0 110.234 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.6 m -133.55 142.41 48.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.54 142.25 51.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.253 1.021 . . . . 0.0 108.294 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.69 153.33 34.53 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.2 mt -141.92 128.01 18.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -115.61 155.97 26.68 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.323 0.649 . . . . 0.0 110.49 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -78.37 -11.13 59.92 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.367 1.067 . . . . 0.0 112.301 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt 65.77 -48.94 0.4 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 129.448 3.099 . . . . 0.0 111.466 -164.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -139.17 81.71 1.85 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -159.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.429 ' C ' ' HG1' ' A' ' 13' ' ' THR . . . 135.39 73.94 0.07 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -171.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.429 ' HG1' ' C ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.242 0.674 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 167.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . 0.727 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 7.1 tpt 47.0 77.67 0.45 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 127.062 2.145 . . . . 0.0 111.42 -175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -60.77 115.13 2.48 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.765 2.976 . . . . 0.0 109.187 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.45 -44.99 0.81 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -161.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.14 -19.19 61.18 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -169.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -59.06 -35.13 72.82 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.751 1.16 . . . . 0.0 113.597 -159.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -59.93 -58.33 9.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 124.096 0.873 . . . . 0.0 110.27 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.6 t -52.62 -41.43 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.085 0.954 . . . . 0.0 110.713 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 85.6 mt -57.61 -48.18 80.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.104 0.866 . . . . 0.0 110.13 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.51 -46.35 83.33 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.607 0.763 . . . . 0.0 111.901 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -57.4 -48.24 79.61 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.57 98.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.63 0.772 . . . . 0.0 111.309 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -54.84 -61.07 2.55 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.68 1.592 . . . . 0.0 110.35 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -60.97 -20.33 62.23 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.3 m -86.75 -4.08 59.13 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.79 1.236 . . . . 0.0 112.815 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.17 22.61 70.94 Favored Glycine 0 CA--C 1.528 0.872 0 O-C-N 120.868 -1.145 . . . . 0.0 112.688 175.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.8 mt -55.54 165.44 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 126.674 1.99 . . . . 0.0 107.433 158.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -118.04 112.72 20.61 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 161.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -80.81 143.34 32.9 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -132.34 168.5 18.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.539 1.536 . . . . 0.0 108.643 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 60.5 mt -140.0 158.86 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.361 1.464 . . . . 0.0 108.309 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -139.88 125.17 18.9 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.882 0.873 . . . . 0.0 108.758 162.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -137.41 164.19 29.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.481 1.112 . . . . 0.0 109.822 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -104.39 -0.03 28.53 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.674 1.19 . . . . 0.0 111.634 172.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -69.04 -0.19 5.42 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.27 -176.61 30.48 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.808 1.194 . . . . 0.0 110.615 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -27.06 61.36 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.653 0.781 . . . . 0.0 111.016 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -60.65 -14.98 23.88 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.1 -49.64 40.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.823 0.738 . . . . 0.0 110.605 168.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -57.43 -44.74 84.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.697 0.68 . . . . 0.0 111.197 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -57.27 -43.96 83.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.731 0.812 . . . . 0.0 110.594 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.83 -53.44 48.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.977 1.311 . . . . 0.0 109.26 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.05 -36.88 84.43 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.005 0.82 . . . . 0.0 110.516 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -61.0 -51.44 69.25 Favored 'General case' 0 C--N 1.337 0.052 0 CA-C-N 118.671 0.669 . . . . 0.0 110.476 175.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -53.46 -51.72 61.79 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 110.168 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.12 -21.01 63.14 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.594 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.95 47.16 5.13 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.913 1.244 . . . . 0.0 111.504 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.0 m -147.51 23.22 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.956 1.702 . . . . 0.0 110.991 -174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.01 -35.27 59.61 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.99 -1.069 . . . . 0.0 110.792 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.9 m -63.64 -27.69 69.4 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.191 0.596 . . . . 0.0 110.79 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.82 7.95 1.01 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -137.78 112.03 8.57 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.0 m -49.44 -39.59 33.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.422 1.089 . . . . 0.0 109.684 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.44 156.36 33.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 118.964 0.802 . . . . 0.0 110.017 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 44.1 mt -139.06 93.41 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 45.2 mt -65.98 146.88 54.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 70.0 p -127.45 -177.81 4.22 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.287 1.035 . . . . 0.0 110.246 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 t -60.28 -18.04 46.46 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.519 -0.738 . . . . 0.0 112.215 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -61.29 -37.13 82.1 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.971 0.805 . . . . 0.0 108.934 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 12.7 t -56.92 -35.51 69.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.099 0.96 . . . . 0.0 111.704 -178.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.83 -8.48 65.96 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 117.068 -1.962 . . . . 0.0 113.872 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -57.4 164.52 1.84 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 120.047 1.923 . . . . 0.0 111.102 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 t -61.4 162.32 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-N 112.528 -2.124 . . . . 0.0 110.149 166.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -90.69 172.45 8.65 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.51 1.524 . . . . 0.0 109.557 170.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -68.18 150.63 97.66 Favored Pre-proline 0 C--O 1.237 0.441 0 O-C-N 120.774 -1.203 . . . . 0.0 108.942 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.29 -18.12 16.88 Favored 'Cis proline' 0 C--N 1.347 0.492 0 N-CA-C 115.759 1.407 . . . . 0.0 115.759 16.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.67 91.16 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 131.371 3.868 . . . . 0.0 114.604 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -54.13 -7.11 0.61 Allowed 'Trans proline' 0 CA--C 1.544 0.975 1 C-N-CA 126.206 4.604 . . . . 0.0 114.558 -172.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -43.83 -52.05 7.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.819 2.848 . . . . 0.0 113.213 -165.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.96 -3.01 11.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.278 1.031 . . . . 0.0 113.675 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.06 -40.03 7.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.374 1.469 . . . . 0.0 109.869 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 m -51.69 -39.67 58.72 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.337 0.971 . . . . 0.0 109.489 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.96 -53.02 61.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.928 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.7 mt -68.51 -21.2 64.59 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.344 1.457 . . . . 0.0 113.007 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -69.73 0.29 Allowed 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 175.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -54.84 -39.77 68.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -23.38 43.42 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.664 -1.272 . . . . 0.0 113.898 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -138.4 17.04 2.75 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 172.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 49.26 38.73 14.19 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.625 1.97 . . . . 0.0 112.185 -170.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.71 165.4 19.57 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.956 0.902 . . . . 0.0 109.754 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.564 ' ND2' HD22 ' A' ' 158' ' ' ASN . 6.6 m-20 -101.17 -5.89 25.0 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 -160.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 m 76.43 -36.14 0.26 Allowed 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 108.813 -3.812 . . . . 0.0 112.179 -166.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -25.04 56.67 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 120.943 -1.098 . . . . 0.0 112.8 -171.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.564 HD22 ' ND2' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -85.77 -3.16 58.83 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 116.362 -1.78 . . . . 0.0 110.694 -178.121 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -102.27 123.61 46.39 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.401 1.455 . . . . 0.0 108.712 -170.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -120.81 101.01 7.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.045 2.138 . . . . 0.0 108.903 -170.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -74.68 150.6 39.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.44 129.13 68.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -149.69 172.28 29.66 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.431 0.539 . . . . 0.0 111.883 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.42 3.02 4.22 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.525 1.53 . . . . 0.0 113.564 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -144.09 133.7 23.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 t -47.56 166.71 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.986 2.114 . . . . 0.0 110.858 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 tp 67.74 -5.03 0.86 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 131.404 3.882 . . . . 0.0 112.979 -152.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -58.1 -41.16 82.9 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.355 0.979 . . . . 0.0 110.826 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.2 p -104.13 -18.21 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 126.261 1.824 . . . . 0.0 110.849 -171.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -68.0 -22.72 64.98 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.46 -0.775 . . . . 0.0 111.851 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -88.08 -23.27 23.76 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.292 -0.88 . . . . 0.0 112.331 173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.14 90.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.967 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -64.22 -40.68 96.55 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.446 0.566 . . . . 0.0 111.061 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.49 -55.52 34.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.198 0.454 . . . . 0.0 110.356 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 t -75.15 -24.75 57.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.097 -0.477 . . . . 0.0 111.555 -172.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 67.3 61.33 5.2 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -166.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 50.5 pt -128.88 177.55 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.976 1.711 . . . . 0.0 108.002 172.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -94.99 179.07 5.35 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.184 0.594 . . . . 0.0 109.748 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.51 160.75 34.96 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.633 -1.292 . . . . 0.0 109.436 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.0 mt -142.56 101.91 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.282 1.433 . . . . 0.0 107.158 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -128.24 165.37 20.63 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 123.134 1.445 . . . . 0.0 111.705 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -78.78 -29.84 45.21 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.765 -1.562 . . . . 0.0 111.297 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.79 13.99 27.26 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -157.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . 0.287 12.3 pt-20 50.93 -170.85 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.858 1 C-N-CA 134.999 5.32 . . . . 0.0 114.09 -170.187 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 48.3 t -164.12 167.99 19.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.097 2.159 . . . . 0.0 107.121 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 16.6 p -100.33 66.14 1.26 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.819 1.248 . . . . 0.0 108.185 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -143.46 177.28 8.56 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.792 1.637 . . . . 0.0 108.989 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -106.26 -30.87 8.92 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.597 1.159 . . . . 0.0 112.893 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.09 5.84 82.91 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.235 0.921 . . . . 0.0 111.568 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -72.86 155.19 40.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 118.749 1.274 . . . . 0.0 108.712 168.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -134.75 109.02 8.3 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.31 143.01 58.21 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 122.955 0.502 . . . . 0.0 111.211 177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.2 pt -146.39 173.37 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.684 1.594 . . . . 0.0 112.746 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -127.89 -17.85 4.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.793 1.637 . . . . 0.0 113.417 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.24 165.84 28.02 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.0 1.32 . . . . 0.0 109.802 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.01 -37.56 88.06 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.83 -15.58 54.8 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -75.11 -17.85 60.36 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.168 -0.958 . . . . 0.0 110.796 174.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 70.5 mt -58.25 -53.49 45.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 77.4 p -58.76 -34.3 71.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.928 0.786 . . . . 0.0 111.092 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -62.43 -35.05 78.05 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 116.728 -1.606 . . . . 0.0 111.603 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 77.4 mt -50.75 -52.59 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.726 1.148 . . . . 0.0 108.804 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -81.34 -5.22 57.6 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.935 -0.555 . . . . 0.0 112.422 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -109.78 2.44 20.01 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.77 1.628 . . . . 0.0 112.27 -171.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.7 t -129.87 24.09 5.34 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.712 0.767 . . . . 0.0 111.255 -168.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? . . . . . 0 C--O 1.247 0.97 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -176.821 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.69 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -153.01 61.43 0.78 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.427 1.091 . . . . 0.0 108.4 172.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mmm -112.58 78.56 1.14 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 124.049 1.88 . . . . 0.0 108.486 -162.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.97 177.86 0.11 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 111.608 -2.542 . . . . 0.0 111.389 167.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -54.78 69.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 129.148 2.979 . . . . 0.0 114.556 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.6 m -96.28 141.92 29.04 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.06 147.33 50.16 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.7 144.43 51.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 124.562 1.145 . . . . 0.0 108.108 -170.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.8 mt -133.57 120.44 37.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -105.71 -177.51 3.38 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.674 1.59 . . . . 0.0 108.202 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.2 174.22 9.45 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.301 1.04 . . . . 0.0 109.603 170.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.36 117.34 29.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 61.08 60.9 1.7 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.611 1.196 . . . . 0.0 110.099 -175.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.88 -106.73 0.76 Allowed Glycine 0 C--O 1.239 0.421 0 N-CA-C 105.106 -3.197 . . . . 0.0 105.106 164.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 C--O 1.25 1.093 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 169.806 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . 0.542 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.7 ttp -158.43 84.4 2.57 Favored Pre-proline 0 C--O 1.223 -0.307 0 C-N-CA 125.006 1.322 . . . . 0.0 110.067 147.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -94.67 91.71 0.12 Allowed 'Trans proline' 0 N--CA 1.439 -1.734 0 C-N-CA 123.534 2.822 . . . . 0.0 110.948 173.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 44.59 30.02 2.04 Favored Glycine 0 CA--C 1.504 -0.643 0 C-N-CA 126.367 1.937 . . . . 0.0 112.461 172.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -156.58 -46.73 0.07 Allowed 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -169.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.6 tpt85 -58.15 -32.7 68.44 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.663 0.665 . . . . 0.0 112.649 -158.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -48.96 -70.3 0.09 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.253 1.421 . . . . 0.0 109.889 168.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.4 t -63.52 -36.02 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 126.836 2.054 . . . . 0.0 110.666 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.3 mt -51.72 -46.31 63.91 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.05 1.295 . . . . 0.0 110.572 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.66 -46.43 85.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.067 0.947 . . . . 0.0 111.657 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -61.65 -42.55 99.06 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.479 0.712 . . . . 0.0 112.227 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.98 -32.79 72.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.157 0.983 . . . . 0.0 111.315 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.41 -43.8 72.66 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.189 1.795 . . . . 0.0 111.857 173.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.3 -13.99 3.95 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.802 1.241 . . . . 0.0 112.004 168.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.3 m -113.96 -5.25 13.17 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.773 1.629 . . . . 0.0 112.241 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.57 19.73 49.3 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.137 1.827 . . . . 0.0 113.862 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mt -51.83 124.74 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 160.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -75.34 111.58 10.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -96.05 153.92 17.52 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 127' ' ' THR . 66.9 m-85 -148.61 165.79 30.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.487 1.515 . . . . 0.0 109.135 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.8 mt -137.72 153.66 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.998 1.719 . . . . 0.0 108.177 173.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -132.58 143.09 49.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.492 1.517 . . . . 0.0 107.795 160.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 t -169.74 173.11 6.41 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.796 1.638 . . . . 0.0 108.835 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -131.77 66.42 1.55 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.234 1.814 . . . . 0.0 110.106 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.27 6.58 17.44 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.483 1.513 . . . . 0.0 111.646 166.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.77 178.4 43.67 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.695 1.14 . . . . 0.0 111.28 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.47 -18.55 52.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.286 1.034 . . . . 0.0 111.837 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.65 -23.14 49.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.876 0.87 . . . . 0.0 111.652 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.28 -45.45 72.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.474 0.709 . . . . 0.0 111.922 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -62.63 -39.95 95.44 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.984 0.811 . . . . 0.0 109.904 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -62.25 -45.83 91.53 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.78 0.832 . . . . 0.0 110.262 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.21 -43.29 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.534 1.134 . . . . 0.0 109.14 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.84 -40.59 95.85 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.482 -0.761 . . . . 0.0 111.36 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -53.35 58.55 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.702 0.683 . . . . 0.0 110.162 169.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -49.47 -53.44 23.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.047 0.939 . . . . 0.0 111.597 -174.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.57 -11.07 60.11 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.17 1.388 . . . . 0.0 114.051 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 59.97 54.51 36.82 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.67 1.129 . . . . 0.0 110.678 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.7 6.08 2.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 125.085 1.354 . . . . 0.0 111.993 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.03 -53.01 56.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.564 0.697 . . . . 0.0 109.988 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 m -72.46 -11.26 60.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.818 -162.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -62.69 -28.69 70.11 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.172 0.989 . . . . 0.0 112.71 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -107.87 136.12 48.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -174.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.455 ' HB ' ' CE2' ' A' ' 104' ' ' PHE . 78.5 m -61.58 -43.62 98.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.85 157.12 38.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -173.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.0 mp -137.15 143.35 34.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.467 HD22 ' CE1' ' A' ' 147' ' ' TYR . 76.8 mt -99.57 158.87 15.45 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.764 1.225 . . . . 0.0 109.778 174.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 p -137.36 -174.22 3.69 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.136 0.574 . . . . 0.0 111.101 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.9 -30.18 13.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.512 1.125 . . . . 0.0 111.695 166.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -65.71 -19.83 66.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.994 1.318 . . . . 0.0 111.113 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.2 m -89.47 69.53 7.96 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.75 47.75 1.54 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 127.34 2.4 . . . . 0.0 112.116 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -56.66 169.32 0.49 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.367 0.667 . . . . 0.0 110.995 164.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -50.67 166.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 122.634 1.207 . . . . 0.0 112.922 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -61.23 157.44 16.23 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.363 163.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -42.58 147.87 0.58 Allowed Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 124.745 1.218 . . . . 0.0 110.343 166.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.56 -27.3 4.95 Favored 'Cis proline' 0 CA--C 1.533 0.461 0 CA-C-N 119.342 0.801 . . . . 0.0 113.407 -3.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 t 49.39 82.18 0.24 Allowed Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.012 1.325 . . . . 0.0 112.079 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.57 -23.02 70.59 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 121.494 1.462 . . . . 0.0 111.286 165.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -54.03 -50.47 66.6 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.892 1.277 . . . . 0.0 112.713 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.02 -17.11 22.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.88 -47.77 6.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.546 1.138 . . . . 0.0 111.203 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 m -57.27 -39.02 74.8 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.885 0.874 . . . . 0.0 109.585 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.467 ' CE1' HD22 ' A' ' 130' ' ' LEU . 30.6 t80 -57.87 -51.02 71.31 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.544 0.738 . . . . 0.0 110.274 173.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.1 mt -65.95 -36.42 83.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.275 1.03 . . . . 0.0 110.761 -171.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 89.2 mt -60.59 -64.84 0.81 Allowed 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.36 1.864 . . . . 0.0 106.031 175.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.81 -37.26 75.98 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -172.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.32 -23.02 21.37 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 117.299 -1.334 . . . . 0.0 114.325 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -134.52 20.46 3.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.593 1.542 . . . . 0.0 110.612 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 44.14 62.87 1.82 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.679 2.392 . . . . 0.0 110.614 -172.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 67.5 mt -103.08 165.13 11.2 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.499 1.12 . . . . 0.0 110.647 -170.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -100.67 132.25 46.16 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.792 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 m -58.13 -49.37 77.22 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.546 1.138 . . . . 0.0 110.166 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.6 -4.18 41.6 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.133 -1.605 . . . . 0.0 112.818 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -113.6 10.88 18.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 117.876 -1.059 . . . . 0.0 108.838 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -109.9 111.26 22.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.98 0.809 . . . . 0.0 109.406 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -114.87 108.54 16.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.491 1.517 . . . . 0.0 110.152 -168.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -78.39 152.46 32.23 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.415 0.686 . . . . 0.0 109.68 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.5 mp -127.17 127.84 69.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 172.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -167.13 -177.68 38.96 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 121.511 0.506 . . . . 0.0 112.908 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -126.22 9.9 7.39 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.209 1.404 . . . . 0.0 112.452 -165.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -136.32 126.85 26.93 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.038 0.935 . . . . 0.0 110.03 -171.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 6.2 t -46.34 -23.87 0.41 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.133 2.573 . . . . 0.0 115.216 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -12.95 59.79 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.139 1.776 . . . . 0.0 112.312 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -51.64 69.16 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.637 0.775 . . . . 0.0 110.743 174.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.96 -29.68 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 O-C-N 121.811 -0.556 . . . . 0.0 109.611 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.52 -21.26 66.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.475 -0.774 . . . . 0.0 112.238 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -97.32 -39.77 9.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.548 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -57.2 -43.04 82.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 123.698 0.624 . . . . 0.0 111.153 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -59.1 -48.48 81.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.604 1.161 . . . . 0.0 110.934 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -71.1 -33.53 70.25 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 118.234 -0.889 . . . . 0.0 112.298 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 45.9 m -82.66 -21.39 35.0 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.514 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.72 63.67 3.11 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.462 1.506 . . . . 0.0 110.505 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.2 pt -135.73 -166.5 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.863 1.665 . . . . 0.0 108.948 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -120.38 158.64 26.73 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.548 1.067 . . . . 0.0 111.541 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.8 m -139.0 149.82 45.13 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.105 1.762 . . . . 0.0 109.367 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.1 mt -138.7 94.99 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -122.81 158.6 29.91 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.458 1.103 . . . . 0.0 110.938 -170.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -85.87 -26.33 25.7 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.705 -0.622 . . . . 0.0 111.391 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.04 175.55 6.58 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 161.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 192' ' ' ARG . 6.1 pt-20 -108.06 170.53 7.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 164.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.3 t -151.99 -168.97 3.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.9 p -127.78 81.26 2.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.874 1.27 . . . . 0.0 108.054 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -151.26 153.68 35.33 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.62 1.568 . . . . 0.0 108.465 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.87 108.14 16.69 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.775 1.63 . . . . 0.0 110.313 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 117.91 -7.42 15.11 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 123.972 0.796 . . . . 0.0 111.81 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.97 118.91 24.33 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.302 1.441 . . . . 0.0 108.293 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -114.21 136.47 52.92 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.139 1.376 . . . . 0.0 110.674 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.435 ' HD2' ' HB3' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -83.85 146.66 27.98 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.416 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.5 pt -132.82 167.67 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.39 1.476 . . . . 0.0 112.303 165.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -124.75 -12.12 7.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.549 1.539 . . . . 0.0 112.172 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.07 172.09 19.29 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.502 1.521 . . . . 0.0 109.454 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.78 -37.18 79.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.95 1.3 . . . . 0.0 110.352 -176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.39 -22.43 66.79 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.874 0.845 . . . . 0.0 112.196 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.83 -5.77 45.35 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.825 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 78.5 mt -77.65 -63.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.348 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 168.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.9 p -55.96 -28.03 55.15 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -60.03 -38.69 83.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.145 1.778 . . . . 0.0 112.996 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.91 -50.16 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 C-N-CA 126.632 1.973 . . . . 0.0 106.563 -168.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -71.69 -4.26 26.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.352 1.061 . . . . 0.0 113.338 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -123.31 2.87 9.16 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.417 0.687 . . . . 0.0 112.389 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.65 27.97 1.82 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.054 0.542 . . . . 0.0 112.239 -173.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 14.8 mttp . . . . . 0 C--O 1.246 0.869 0 C-N-CA 129.947 3.299 . . . . 0.0 113.103 174.9 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.626 0 N-CA-C 112.26 -0.336 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . 0.337 0.3 OUTLIER 52.22 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 128.582 2.753 . . . . 0.0 115.964 177.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.0 mmm 44.1 89.09 0.01 OUTLIER 'General case' 0 C--O 1.238 0.47 0 C-N-CA 127.287 2.235 . . . . 0.0 112.694 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -60.92 -172.31 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.22 1.408 . . . . 0.0 110.214 155.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -66.53 82.99 0.1 Allowed 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.926 1.29 . . . . 0.0 110.141 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.8 m -92.74 158.91 15.66 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 166.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.54 157.33 45.64 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 120.584 -1.323 . . . . 0.0 110.636 164.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -128.42 162.48 27.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.203 2.201 . . . . 0.0 108.587 -172.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.5 mt -138.99 144.5 29.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 126.224 1.81 . . . . 0.0 107.033 166.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -117.13 166.35 12.33 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.983 2.113 . . . . 0.0 110.398 170.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -105.21 171.88 7.09 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 162.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.33 18.89 10.28 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.403 2.281 . . . . 0.0 110.736 172.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -110.43 -153.91 0.53 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.491 1.916 . . . . 0.0 110.256 -167.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.09 -11.84 83.77 Favored Glycine 0 CA--C 1.528 0.845 0 O-C-N 120.17 -1.581 . . . . 0.0 115.949 -163.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.259 13.3 t . . . . . 0 C--O 1.25 1.094 0 C-N-CA 124.458 1.103 . . . . 0.0 108.955 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -104.09 87.3 1.54 Allowed Pre-proline 0 C--O 1.243 0.719 1 C-N-CA 132.208 4.203 . . . . 0.0 104.467 179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.43 93.05 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 124.652 3.568 . . . . 0.0 111.983 -163.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.38 -34.77 0.76 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-N 113.175 -1.83 . . . . 0.0 109.725 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.39 -26.18 65.43 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 124.146 0.979 . . . . 0.0 110.319 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -51.65 -36.65 47.0 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.8 0.84 . . . . 0.0 112.219 -175.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -56.7 -51.02 70.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.836 1.254 . . . . 0.0 111.047 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.39 -43.88 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.399 1.479 . . . . 0.0 109.815 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.411 ' CD2' ' CD2' ' A' ' 125' ' ' TYR . 8.3 mp -50.39 -50.78 50.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 121.344 1.884 . . . . 0.0 111.205 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.59 -43.97 85.03 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.446 0.466 . . . . 0.0 111.951 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -68.72 -39.66 80.32 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.005 1.322 . . . . 0.0 112.089 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.91 -29.13 60.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.209 1.404 . . . . 0.0 111.597 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -64.38 -59.2 4.64 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 127.401 2.281 . . . . 0.0 110.166 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -55.72 -27.27 49.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.559 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.7 m -90.66 3.5 54.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.93 8.93 44.49 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.127 1.346 . . . . 0.0 114.334 173.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mt -66.37 104.17 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -60.71 111.92 1.81 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.61 150.1 21.85 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 172.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -142.95 166.4 24.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.503 1.121 . . . . 0.0 110.53 175.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 9.2 mt -127.49 158.25 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 121.041 1.746 . . . . 0.0 109.43 173.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -133.58 112.0 11.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.747 1.219 . . . . 0.0 108.893 167.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -143.11 173.63 11.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -127.68 14.16 6.97 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.759 2.023 . . . . 0.0 110.887 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -3.07 28.98 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.99 173.0 34.4 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.703 1.62 . . . . 0.0 112.557 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.74 -19.99 19.72 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.777 1.631 . . . . 0.0 112.653 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -22.76 20.98 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.419 1.488 . . . . 0.0 111.944 173.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.91 -44.57 78.38 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.027 -1.045 . . . . 0.0 111.576 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -56.79 -46.25 81.66 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.75 0.42 . . . . 0.0 110.506 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -61.3 -47.37 86.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.747 0.819 . . . . 0.0 110.486 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.8 mt -55.59 -50.63 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.83 -32.27 73.45 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.802 -1.186 . . . . 0.0 110.843 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -72.33 -27.2 62.28 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 171.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -63.81 1.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 123.365 1.555 . . . . 0.0 107.08 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.31 -35.59 80.88 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.785 3.234 . . . . 0.0 112.254 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.8 61.93 1.57 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 124.512 1.053 . . . . 0.0 110.495 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.9 m -139.64 5.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.223 1.009 . . . . 0.0 110.856 170.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.11 -30.75 63.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.086 -1.009 . . . . 0.0 111.37 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.3 m -70.36 -26.93 63.96 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 118.801 0.728 . . . . 0.0 111.73 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.411 ' CD2' ' CD2' ' A' ' 93' ' ' LEU . 24.6 m-85 -51.5 -60.33 3.26 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.297 0.639 . . . . 0.0 110.11 164.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -84.9 114.23 21.97 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -152.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.2 m -64.5 -31.85 73.24 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.733 -0.604 . . . . 0.0 111.629 -172.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -158.89 156.72 30.1 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.957 1.253 . . . . 0.0 109.838 167.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.79 105.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 103.871 -2.64 . . . . 0.0 103.871 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.22 158.24 26.7 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.3 p -131.75 179.73 5.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.053 1.341 . . . . 0.0 109.15 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -31.03 42.33 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.155 1.382 . . . . 0.0 112.168 165.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -63.71 -21.55 66.46 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.921 1.288 . . . . 0.0 110.676 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.6 p -57.24 -30.39 64.58 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.0 1.32 . . . . 0.0 114.063 -165.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.75 2.31 44.06 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.538 -1.146 . . . . 0.0 113.954 169.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -63.51 158.47 20.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.318 1.559 . . . . 0.0 111.613 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.7 t -57.61 157.85 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.564 161.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -136.78 59.8 1.68 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.277 1.431 . . . . 0.0 111.207 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -49.66 -54.84 27.29 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-O 114.834 -2.508 . . . . 0.0 114.344 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.78 114.08 0.19 OUTLIER 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 123.313 2.219 . . . . 0.0 117.016 10.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 m -92.73 154.94 42.2 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 124.873 1.269 . . . . 0.0 112.547 -173.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -81.53 5.25 6.4 Favored 'Trans proline' 0 CA--C 1.549 1.261 1 C-N-CA 125.585 4.19 . . . . 0.0 113.883 170.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -46.77 -63.92 0.9 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.479 1.912 . . . . 0.0 110.942 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.54 -20.96 64.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.461 0.705 . . . . 0.0 111.934 -169.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.18 -60.38 2.32 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.297 1.039 . . . . 0.0 108.766 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.3 m -54.93 -40.57 70.04 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.025 1.33 . . . . 0.0 110.407 -174.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.51 ' CE1' ' HE2' ' A' ' 151' ' ' LYS . 72.0 t80 -52.1 -58.0 7.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.474 1.11 . . . . 0.0 110.633 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 23.3 mt -71.02 -25.19 62.56 Favored 'General case' 0 CA--C 1.521 -0.137 0 O-C-N 121.866 -0.521 . . . . 0.0 112.144 -172.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 87.2 mt -66.48 -61.15 2.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.99 -36.19 72.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.963 0.505 . . . . 0.0 111.699 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.51 ' HE2' ' CE1' ' A' ' 147' ' ' TYR . 7.9 mmtm -57.31 -22.85 44.74 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 114.276 1.214 . . . . 0.0 114.276 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.97 27.43 1.46 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 119.037 0.835 . . . . 0.0 111.822 169.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 67.9 mm-40 44.41 54.56 6.22 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.648 2.379 . . . . 0.0 111.494 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 4.3 mp -75.46 -169.59 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.188 1.395 . . . . 0.0 110.592 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -121.78 129.15 52.44 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.236 1.414 . . . . 0.0 108.751 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.0 m -52.5 -49.1 65.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.985 1.714 . . . . 0.0 110.445 175.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -88.43 9.2 24.4 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 120.791 -1.193 . . . . 0.0 111.881 -169.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.94 8.75 7.45 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.353 1.861 . . . . 0.0 108.733 173.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -107.65 142.42 37.64 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.743 1.156 . . . . 0.0 109.539 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -129.46 156.55 43.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.952 2.101 . . . . 0.0 108.243 -170.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -139.17 128.17 23.7 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.93 116.05 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.152 1.381 . . . . 0.0 107.309 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -142.09 -172.26 13.48 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 174.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -132.51 5.83 4.05 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.404 1.882 . . . . 0.0 113.393 -169.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.83 155.82 47.13 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 120.0 1.273 . . . . 0.0 109.95 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t -72.94 -13.69 61.3 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.584 -1.323 . . . . 0.0 111.059 -169.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.26 -33.18 52.02 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.739 1.616 . . . . 0.0 111.167 167.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -74.06 10.12 1.33 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.376 1.47 . . . . 0.0 113.601 -164.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.22 -13.71 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.288 1.035 . . . . 0.0 110.686 167.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.32 -47.83 77.92 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.803 1.638 . . . . 0.0 110.018 -173.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -76.94 -34.44 57.65 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 121.595 -0.691 . . . . 0.0 111.809 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.48 -58.11 8.29 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.598 0.759 . . . . 0.0 109.867 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -49.84 -45.74 50.57 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.699 2.0 . . . . 0.0 110.841 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -62.49 -26.08 68.35 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.5 p -93.98 -26.01 17.0 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.055 0.843 . . . . 0.0 112.769 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 92.46 9.57 61.48 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.198 1.38 . . . . 0.0 112.556 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.7 pp -88.21 175.66 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.721 1.209 . . . . 0.0 109.39 178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -112.37 163.73 14.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.865 0.841 . . . . 0.0 111.694 -165.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 8.8 m -137.39 149.82 47.22 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.665 1.586 . . . . 0.0 110.175 -168.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 47.6 mt -140.4 78.02 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -114.16 165.13 12.97 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.507 1.146 . . . . 0.0 110.693 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -73.4 -13.3 61.06 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.283 -0.885 . . . . 0.0 113.157 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.59 157.12 39.71 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.442 1.019 . . . . 0.0 110.727 -174.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -89.51 159.23 17.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.939 -0.476 . . . . 0.0 111.435 -171.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.25 8.38 1.2 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -169.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 47.7 p 52.81 49.66 19.78 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.101 1.36 . . . . 0.0 113.257 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -131.27 162.65 29.55 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.4 1.88 . . . . 0.0 109.105 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -80.13 -42.87 22.67 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.639 0.776 . . . . 0.0 111.812 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.73 47.4 3.57 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -130.43 125.94 35.72 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.922 1.289 . . . . 0.0 109.52 -164.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -127.2 108.39 10.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.004 0.921 . . . . 0.0 109.156 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -63.94 142.01 58.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 118.149 -1.42 . . . . 0.0 109.699 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 13.7 pt -114.96 159.67 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.3 1.04 . . . . 0.0 110.564 165.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -115.15 -8.17 12.4 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.839 1.256 . . . . 0.0 112.535 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.76 161.62 41.43 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.869 2.468 . . . . 0.0 107.154 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 tp -71.16 -32.94 69.55 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.408 -0.808 . . . . 0.0 110.268 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.77 -18.69 63.06 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.098 -0.953 . . . . 0.0 112.196 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -66.32 -20.02 65.97 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.422 1.01 . . . . 0.0 110.316 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 76.8 mt -62.46 -53.61 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 124.607 1.163 . . . . 0.0 108.96 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 80.7 p -56.27 -39.59 72.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.185 0.902 . . . . 0.0 109.662 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -60.2 -25.71 65.8 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.349 2.26 . . . . 0.0 111.591 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 80.0 mt -61.64 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 120.498 -1.376 . . . . 0.0 109.454 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -89.91 -26.26 20.54 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.492 1.117 . . . . 0.0 110.944 -175.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -83.61 4.55 27.88 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.716 1.606 . . . . 0.0 112.587 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.312 87.2 m 59.69 60.67 2.16 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 123.53 1.633 . . . . 0.0 109.93 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.375 9.2 ptmt . . . . . 0 C--O 1.252 1.222 1 C-N-CA 134.42 5.088 . . . . 0.0 116.213 173.136 . . . . . . . . 2 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.751 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -164.15 97.42 0.82 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 117.807 0.803 . . . . 0.0 110.06 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mmm -129.41 87.85 2.61 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.16 169.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.901 2.081 . . . . 0.0 109.687 162.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 106.72 0.09 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.476 1.51 . . . . 0.0 108.813 174.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.8 m -134.86 147.18 49.82 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.27 153.96 46.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.402 1.081 . . . . 0.0 108.645 171.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.04 153.31 48.56 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.176 1.79 . . . . 0.0 107.609 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 mt -143.22 138.46 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -128.97 179.96 5.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.43 1.092 . . . . 0.0 110.443 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -130.71 172.35 12.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.172 2.189 . . . . 0.0 109.596 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 76.0 mt -123.6 25.05 8.33 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.501 1.921 . . . . 0.0 111.508 -174.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -146.39 74.02 1.35 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.108 -0.995 . . . . 0.0 111.794 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.2 -65.83 0.58 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.047 0 C-N-CA 127.241 2.217 . . . . 0.0 111.257 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 8.6 tpt 46.71 85.4 0.17 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 126.938 2.095 . . . . 0.0 111.818 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -49.43 124.74 12.48 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.128 1.886 . . . . 0.0 110.432 174.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.93 -21.54 33.71 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.974 1.749 . . . . 0.0 112.186 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.14 -37.92 66.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.478 1.639 . . . . 0.0 109.117 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttt-85 -60.75 -28.69 68.89 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.66 0.664 . . . . 0.0 112.208 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -58.77 7.07 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.637 1.575 . . . . 0.0 110.304 170.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.06 -47.47 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.637 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mp -44.68 -54.95 5.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 120.835 1.652 . . . . 0.0 113.237 169.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.57 68.89 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 123.417 0.448 . . . . 0.0 110.563 -176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -54.01 -50.54 66.4 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.989 0.916 . . . . 0.0 110.918 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.4 73.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.089 1.356 . . . . 0.0 112.588 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.82 -54.26 20.46 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 124.556 1.142 . . . . 0.0 110.562 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -67.48 -16.67 64.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.198 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.2 m -84.69 -1.63 56.44 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.783 1.633 . . . . 0.0 113.272 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.47 4.81 87.63 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.845 1.202 . . . . 0.0 114.179 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.2 mt -66.6 138.07 23.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 O-C-N 121.143 -1.21 . . . . 0.0 108.169 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.63 114.83 24.61 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 163.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -86.36 151.69 23.35 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 170.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.2 174.99 10.22 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.463 1.905 . . . . 0.0 107.11 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 33.9 mt -133.56 154.9 39.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 170.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -142.47 119.3 11.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 159.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.0 t -145.63 175.63 10.23 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.055 0.542 . . . . 0.0 110.455 170.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -84.39 1.55 44.72 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.125 0.97 . . . . 0.0 113.487 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -64.6 160.8 18.85 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.6 -168.85 43.6 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.367 0.984 . . . . 0.0 111.677 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -62.9 -16.72 60.03 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 122.117 -0.637 . . . . 0.0 112.579 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -55.47 -23.44 25.68 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.951 -1.023 . . . . 0.0 112.389 168.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.97 -49.47 63.15 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.409 1.459 . . . . 0.0 112.791 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -60.67 -48.8 80.18 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.219 1.008 . . . . 0.0 109.493 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.5 m -58.96 -41.1 86.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.426 1.49 . . . . 0.0 111.715 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -64.35 -44.05 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 121.344 -0.847 . . . . 0.0 108.83 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.52 -45.54 93.44 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.925 0.89 . . . . 0.0 111.796 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -58.84 -48.42 81.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.429 1.092 . . . . 0.0 109.226 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -58.25 -49.91 75.45 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.834 1.654 . . . . 0.0 111.857 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.39 -4.54 34.14 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.889 1.276 . . . . 0.0 112.667 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 65.62 39.43 95.43 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.313 0.959 . . . . 0.0 112.296 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.68 15.11 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.81 1.244 . . . . 0.0 110.898 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -61.55 -41.71 97.77 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.877 -0.514 . . . . 0.0 110.738 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 m -57.75 -27.36 62.96 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -63.71 -34.19 77.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 118.988 -0.529 . . . . 0.0 111.897 179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -110.37 96.83 6.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -166.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.7 m -51.01 -44.86 61.05 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.581 0.753 . . . . 0.0 110.699 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.45 153.2 44.83 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.501 1.12 . . . . 0.0 108.816 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.59 93.14 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.62 146.72 52.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.3 p -151.24 179.45 8.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.731 -162.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.4 t -47.56 -34.97 8.36 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.247 1.819 . . . . 0.0 112.15 173.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -59.27 -30.0 67.98 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.08 1.352 . . . . 0.0 112.137 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.7 p -58.34 -49.46 77.12 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.597 1.189 . . . . 0.0 110.322 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.93 -1.18 87.29 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-O 116.83 -2.095 . . . . 0.0 113.437 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -56.63 162.61 2.18 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.303 1.552 . . . . 0.0 111.286 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.1 m -50.64 153.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.73 2.012 . . . . 0.0 112.205 170.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.412 ' HG3' ' H ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -83.88 -77.27 0.26 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.582 1.553 . . . . 0.0 111.702 -168.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.412 ' H ' ' HG3' ' A' ' 138' ' ' ARG . 9.0 mttp -163.59 117.99 1.09 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 128.815 2.846 . . . . 0.0 104.923 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.26 160.42 75.81 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.257 1.127 . . . . 0.0 111.68 -4.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.6 p -156.18 54.94 0.99 Allowed Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -68.11 -14.74 41.61 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 121.37 1.38 . . . . 0.0 113.056 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -55.43 -39.62 70.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.837 1.255 . . . . 0.0 110.761 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.66 -15.19 62.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.921 -0.487 . . . . 0.0 112.024 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.27 -55.91 5.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.0 m -59.26 -37.74 78.34 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.198 0.599 . . . . 0.0 110.777 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -55.48 -56.33 21.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.8 mt -61.17 -38.23 85.76 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.241 -175.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -67.1 0.42 Allowed 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 125.126 1.37 . . . . 0.0 107.385 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.06 -34.31 68.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -47.38 72.96 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 114.957 -2.449 . . . . 0.0 114.198 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -124.55 18.36 8.83 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 121.633 2.015 . . . . 0.0 110.069 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 64.27 56.96 1.26 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 127.013 2.125 . . . . 0.0 108.686 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . 0.26 0.0 OUTLIER -109.58 176.19 5.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 114.7 1.371 . . . . 0.0 114.7 -175.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -108.21 150.02 27.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.426 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.1 p -66.75 -48.33 69.45 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 122.309 1.052 . . . . 0.0 110.765 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.29 -9.47 58.58 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 120.772 -1.205 . . . . 0.0 112.326 -170.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -116.67 21.7 13.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 118.098 -0.953 . . . . 0.0 108.804 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -113.01 136.08 53.08 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.989 0.813 . . . . 0.0 111.397 163.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -120.24 105.0 10.53 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.117 2.167 . . . . 0.0 111.003 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -78.4 148.64 33.57 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.299 1.04 . . . . 0.0 108.83 168.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.98 123.4 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -155.5 -5.53 0.09 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 116.926 1.531 . . . . 0.0 116.926 -172.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.3 5.54 2.6 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.53 1.932 . . . . 0.0 115.953 163.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.412 ' C ' ' H ' ' A' ' 167' ' ' LEU . 10.9 mmm180 -115.94 10.04 15.09 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -156.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t 52.6 5.41 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.805 3.242 . . . . 0.0 115.361 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 165' ' ' ARG . 1.2 tt -112.27 -16.23 13.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.055 2.542 . . . . 0.0 110.099 -176.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.64 -52.29 64.95 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 129.167 2.987 . . . . 0.0 107.852 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.65 -46.07 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 127.081 2.152 . . . . 0.0 112.267 171.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -62.02 -45.17 94.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -169.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -79.78 -32.88 40.91 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.025 -1.047 . . . . 0.0 112.346 175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.28 -52.35 53.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.217 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -50.49 -51.59 45.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.272 1.829 . . . . 0.0 110.454 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -65.25 -28.15 69.15 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.29 -22.86 28.38 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.715 -1.241 . . . . 0.0 112.735 170.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.63 55.86 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.538 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 17.3 pt -97.54 167.06 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.132 0.973 . . . . 0.0 109.385 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -87.93 178.97 6.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.985 0.514 . . . . 0.0 109.955 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.17 151.9 19.99 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.69 -1.256 . . . . 0.0 111.645 173.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 35.8 mt -124.96 128.08 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -144.15 139.62 28.91 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 124.192 0.997 . . . . 0.0 108.349 -167.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -68.25 -17.8 64.39 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.499 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.35 166.58 10.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.242 1.417 . . . . 0.0 111.235 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -72.73 169.16 17.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.82 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 45.5 t -156.49 171.85 19.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 157.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.1 p -73.1 4.65 4.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.347 2.259 . . . . 0.0 114.242 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -112.07 153.16 27.33 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.29 1.036 . . . . 0.0 110.569 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.58 -45.58 68.33 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.72 1.208 . . . . 0.0 112.627 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.44 36.62 2.6 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.752 1.167 . . . . 0.0 110.311 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -111.35 93.13 4.32 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 174.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -86.06 108.46 18.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -62.08 149.33 41.5 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.34 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.7 pt -142.22 166.19 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.159 1.384 . . . . 0.0 110.675 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -122.85 -2.68 8.74 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.129 1.772 . . . . 0.0 112.949 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.32 166.23 34.05 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.839 1.656 . . . . 0.0 108.788 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 63.6 mt -69.29 -41.92 76.15 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.34 -0.05 1.67 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.41 1.084 . . . . 0.0 113.892 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -81.78 -18.89 42.55 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.053 -1.654 . . . . 0.0 109.924 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 77.7 mt -58.47 -52.14 62.98 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.3 p -50.67 -43.48 57.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.26 0.482 . . . . 0.0 111.44 177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 63.8 mtt85 -62.86 -21.62 66.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.503 1.521 . . . . 0.0 113.296 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 75.0 mt -60.54 -47.98 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -84.61 -34.89 23.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.729 1.211 . . . . 0.0 111.336 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -82.97 22.32 0.95 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.904 1.282 . . . . 0.0 111.413 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 25.2 m 56.63 78.44 0.21 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.958 1.703 . . . . 0.0 110.507 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.271 12.7 ptmt . . . . . 0 C--O 1.251 1.169 0 C-N-CA 131.133 3.773 . . . . 0.0 116.41 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.594 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 56.26 14.53 1.58 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.268 2.227 . . . . 0.0 116.195 175.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.8 mmm 48.69 73.2 0.23 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.846 1.307 . . . . 0.0 111.033 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -45.49 160.3 0.05 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.851 2.06 . . . . 0.0 111.292 166.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -44.24 97.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.347 1.859 . . . . 0.0 111.722 -172.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.2 m -125.82 155.81 40.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.23 150.55 50.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.484 0.714 . . . . 0.0 109.091 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -123.27 155.16 37.74 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.205 1.402 . . . . 0.0 108.333 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.4 mt -140.39 133.82 33.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -131.03 147.16 52.59 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.149 1.38 . . . . 0.0 111.737 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -81.65 -22.3 37.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.655 1.582 . . . . 0.0 111.604 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.629 ' CD2' ' H ' ' A' ' 11' ' ' ASP . 0.4 OUTLIER 68.98 -179.71 0.23 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.416 2.286 . . . . 0.0 110.343 -169.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.629 ' H ' ' CD2' ' A' ' 10' ' ' LEU . 3.8 m-20 54.85 -80.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 129.688 3.195 . . . . 0.0 113.274 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.89 101.02 0.93 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -170.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.243 0.721 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 167.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.445 ' CD1' ' H ' ' A' ' 86' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.445 ' H ' ' CD1' ' A' ' 85' ' ' LEU . 52.0 ttm -116.55 85.33 16.36 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -62.33 118.87 5.77 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.456 2.771 . . . . 0.0 107.18 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.7 -29.88 5.92 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.968 1.271 . . . . 0.0 110.865 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.16 -34.23 29.19 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.531 1.165 . . . . 0.0 113.25 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -39.06 70.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.149 0.886 . . . . 0.0 110.992 -166.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.28 -53.46 58.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.624 0.769 . . . . 0.0 110.699 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -61.33 -40.76 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 118.745 0.702 . . . . 0.0 110.266 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.74 -48.89 78.35 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 118.857 0.753 . . . . 0.0 109.519 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.29 -49.57 75.65 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.977 0.511 . . . . 0.0 111.669 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -57.19 -52.61 64.6 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.741 0.817 . . . . 0.0 110.263 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.43 91.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.059 1.343 . . . . 0.0 111.874 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.13 -46.12 71.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.388 1.875 . . . . 0.0 111.399 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.63 -33.61 76.01 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.744 -0.597 . . . . 0.0 110.865 170.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.3 m -71.9 -2.82 19.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.495 1.118 . . . . 0.0 112.861 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.89 17.06 62.55 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.971 1.272 . . . . 0.0 112.283 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -67.6 116.25 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -67.87 97.02 0.62 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -81.76 137.79 35.28 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.784 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -131.28 172.77 11.76 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.451 1.5 . . . . 0.0 110.366 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.3 mt -138.06 156.31 30.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.438 1.495 . . . . 0.0 108.358 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -138.08 126.61 23.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 167.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.1 t -142.49 169.86 16.79 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.909 0.861 . . . . 0.0 110.242 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -105.07 -5.5 20.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.159 1.784 . . . . 0.0 111.85 169.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -68.33 -5.04 16.58 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 -167.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.52 -179.72 38.95 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.38 -17.85 64.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -172.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.89 -14.14 5.66 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.41 -44.53 68.81 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.391 0.996 . . . . 0.0 111.728 169.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.3 -46.68 87.65 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.198 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -56.04 -46.02 78.99 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.698 0.799 . . . . 0.0 109.95 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.7 mt -60.69 -49.02 86.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.32 -38.9 85.67 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.525 -0.734 . . . . 0.0 111.175 -175.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -62.56 -47.35 84.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.79 -32.35 73.5 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.077 0.951 . . . . 0.0 112.854 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.3 mt -90.17 1.54 56.32 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.379 1.472 . . . . 0.0 112.344 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.51 36.22 92.26 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.279 0.942 . . . . 0.0 112.842 174.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.84 20.57 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 110.648 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -73.53 -36.47 65.69 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 120.6 -1.312 . . . . 0.0 113.188 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -28.79 69.93 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.065 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -67.32 -2.84 6.66 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.026 -0.988 . . . . 0.0 113.292 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -138.23 81.83 1.88 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.719 1.6 . . . . 0.0 108.577 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 m -44.9 -44.89 10.01 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.685 2.394 . . . . 0.0 114.514 -171.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -154.58 91.29 1.38 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-N 120.234 1.379 . . . . 0.0 112.1 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.69 122.78 26.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.021 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.62 154.66 26.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.64 -0.663 . . . . 0.0 110.366 165.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.4 p -138.29 -174.67 3.87 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.296 1.839 . . . . 0.0 108.424 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.9 m -60.77 -13.79 17.36 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.903 -1.123 . . . . 0.0 112.802 164.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.93 -22.34 64.15 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.889 1.677 . . . . 0.0 109.739 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.5 p -53.63 -47.79 69.94 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 123.757 0.66 . . . . 0.0 110.354 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.86 -12.21 68.82 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 117.603 -1.665 . . . . 0.0 111.938 -171.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -52.66 148.54 7.09 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.004 1.402 . . . . 0.0 111.397 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.9 m -66.1 169.16 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-O 122.322 1.058 . . . . 0.0 113.059 -163.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -60.45 143.22 53.88 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 121.308 -0.87 . . . . 0.0 109.697 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -59.09 150.46 61.87 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.588 -1.196 . . . . 0.0 110.604 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -61.18 120.25 1.21 Allowed 'Cis proline' 0 CA--C 1.538 0.701 0 CA-C-N 120.618 1.256 . . . . 0.0 110.685 -17.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.1 p -126.68 81.8 68.13 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.712 1.605 . . . . 0.0 112.546 -172.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -71.28 -10.76 27.73 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.968 2.446 . . . . 0.0 112.415 -170.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -44.91 -50.26 10.55 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.597 2.359 . . . . 0.0 110.918 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.04 -15.61 63.83 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.06 -51.89 6.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.511 0.725 . . . . 0.0 109.521 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 m -50.59 -43.84 56.72 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.315 1.446 . . . . 0.0 109.853 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -57.7 -60.07 4.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.336 0.655 . . . . 0.0 109.604 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.57 -25.38 67.28 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.41 -71.66 0.14 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 172.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -28.34 69.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.609 1.164 . . . . 0.0 113.011 -171.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -31.24 65.67 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.168 1.387 . . . . 0.0 112.142 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -140.8 11.61 2.25 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 44.99 73.55 0.15 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 127.912 2.485 . . . . 0.0 111.565 -163.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.5 mp -103.08 154.92 18.78 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 166.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -93.42 136.96 33.19 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 126.108 1.763 . . . . 0.0 107.969 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -41.89 97.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.095 0.474 . . . . 0.0 111.938 174.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.23 -19.27 60.57 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.997 -1.064 . . . . 0.0 112.396 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -101.87 16.07 27.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -110.1 133.95 52.68 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.272 1.396 . . . . 0.0 108.228 169.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -125.64 117.48 23.62 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.721 1.208 . . . . 0.0 108.327 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -97.84 132.11 43.74 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.011 0.924 . . . . 0.0 109.172 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 7.2 mt -114.91 78.93 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -160.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.49 -177.94 37.01 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.494 1.521 . . . . 0.0 113.549 -170.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -134.82 1.88 3.08 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.665 1.186 . . . . 0.0 113.396 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.05 178.08 6.96 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 122.619 1.199 . . . . 0.0 111.344 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.12 -37.45 61.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.536 -177.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.78 -33.46 64.38 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 125.665 1.586 . . . . 0.0 111.865 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -57.43 -33.29 67.75 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.097 0.959 . . . . 0.0 111.481 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 8.2 t -92.31 -18.24 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.456 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -61.3 -31.51 71.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.311 0.96 . . . . 0.0 108.502 168.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -64.34 -56.27 15.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.59 -44.73 77.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.836 0.854 . . . . 0.0 111.578 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -55.44 -44.97 76.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.575 1.55 . . . . 0.0 111.503 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -69.25 -52.49 27.09 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.756 -0.59 . . . . 0.0 110.793 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.1 m -66.96 -19.55 65.74 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.147 1.379 . . . . 0.0 112.48 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 67.15 49.77 50.67 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 126.233 1.873 . . . . 0.0 110.799 -173.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.7 pt -117.9 -164.69 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.149 1.379 . . . . 0.0 109.224 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -117.94 163.96 15.79 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.512 0.725 . . . . 0.0 110.265 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 7.1 m -133.29 153.47 51.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.649 1.58 . . . . 0.0 110.005 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 55.1 mt -139.46 90.55 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -119.62 153.93 34.74 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.597 0.713 . . . . 0.0 109.399 -172.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -66.47 -17.13 64.62 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 pp -123.27 157.67 32.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 126.055 1.742 . . . . 0.0 110.339 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.41 139.72 51.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 16.5 m -126.67 -178.39 4.36 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p -72.48 4.97 3.3 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -169.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -142.79 133.01 24.61 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.27 1.428 . . . . 0.0 107.172 -160.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -69.84 -28.96 66.12 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.503 1.521 . . . . 0.0 110.967 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -72.88 10.67 5.23 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.686 1.612 . . . . 0.0 113.865 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -98.12 105.06 17.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.206 1.503 . . . . 0.0 108.364 167.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -79.1 126.67 31.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -69.62 152.65 44.49 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.405 1.002 . . . . 0.0 111.961 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.6 pt -134.42 163.07 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.326 1.451 . . . . 0.0 111.085 168.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -118.45 -14.9 9.69 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.746 1.218 . . . . 0.0 113.105 170.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.72 168.29 21.71 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.43 -42.26 79.14 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.75 -27.24 68.58 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -59.92 -21.12 60.69 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.336 1.854 . . . . 0.0 111.319 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 87.7 mt -57.09 -54.79 25.62 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 C-N-CA 125.557 1.543 . . . . 0.0 108.75 170.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 92.2 p -52.66 -42.24 64.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.481 1.037 . . . . 0.0 110.46 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -17.66 64.35 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.567 1.147 . . . . 0.0 112.995 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.25 -55.59 18.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -78.07 -34.47 50.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.51 1.124 . . . . 0.0 111.685 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -83.97 2.61 38.03 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.648 1.179 . . . . 0.0 112.175 -171.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.33 4.6 t 47.37 84.95 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 130.437 3.495 . . . . 0.0 107.607 -173.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt . . . . . 0 C--O 1.249 1.055 0 C-N-CA 127.307 2.243 . . . . 0.0 110.464 168.87 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.124 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 60.52 40.26 17.16 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.059 2.143 . . . . 0.0 113.358 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 mmm -98.29 76.14 2.3 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.734 1.255 . . . . 0.0 107.666 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.58 171.51 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.381 159.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -44.43 100.4 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.334 1.854 . . . . 0.0 110.348 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.1 m -127.63 149.82 50.01 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.64 147.26 49.94 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.552 -0.717 . . . . 0.0 109.948 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -126.85 149.93 49.48 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.899 1.28 . . . . 0.0 109.399 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 32.1 mt -149.54 121.29 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -173.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -112.12 -174.56 2.49 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.014 1.326 . . . . 0.0 110.493 -175.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -130.94 -173.41 3.08 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.96 1.304 . . . . 0.0 108.873 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.33 14.11 1.43 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.654 1.981 . . . . 0.0 110.101 175.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . 0.398 0.0 OUTLIER -113.65 4.89 16.26 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 177.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.09 -75.83 0.04 OUTLIER Glycine 0 CA--C 1.527 0.814 0 O-C-N 121.05 -1.031 . . . . 0.0 112.007 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.25 1.103 0 C-N-CA 125.135 1.374 . . . . 0.0 110.065 178.799 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 57.1 tpp 41.78 79.08 0.34 Allowed Pre-proline 0 N--CA 1.468 0.448 0 C-N-CA 124.893 1.277 . . . . 0.0 113.052 141.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.39 98.04 0.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.112 2.541 . . . . 0.0 110.557 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.86 -9.61 3.93 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.788 1.185 . . . . 0.0 114.234 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.53 -45.98 16.55 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 119.557 1.679 . . . . 0.0 109.008 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -31.42 29.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.111 1.364 . . . . 0.0 113.733 -174.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.33 -45.81 80.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.502 0.721 . . . . 0.0 110.963 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.0 -41.07 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -177.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.405 HD12 HG23 ' A' ' 122' ' ' VAL . 60.4 mt -62.37 -43.56 98.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -174.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.55 -52.45 57.6 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 125.917 1.687 . . . . 0.0 109.649 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -54.43 -45.39 73.01 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.134 0.573 . . . . 0.0 112.155 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.84 64.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.908 0.883 . . . . 0.0 112.124 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -56.97 -48.72 77.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.463 1.905 . . . . 0.0 109.926 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.3 -2.61 13.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.577 2.351 . . . . 0.0 113.407 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.5 m -120.54 7.63 10.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.809 1.644 . . . . 0.0 113.175 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.4 11.09 61.35 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 121.441 -0.787 . . . . 0.0 114.385 171.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.8 mt -60.18 121.27 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -69.58 106.53 3.05 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 167.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -91.17 151.18 21.06 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -145.25 177.43 8.81 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.344 1.458 . . . . 0.0 109.609 -177.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.8 mt -141.55 145.7 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.404 1.082 . . . . 0.0 108.559 172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -132.3 141.63 49.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.769 1.228 . . . . 0.0 107.81 163.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.434 HG23 ' H ' ' A' ' 109' ' ' LYS . 5.7 t -167.05 -175.46 3.01 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -104.98 8.13 34.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.376 1.47 . . . . 0.0 112.61 172.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.434 ' H ' HG23 ' A' ' 107' ' ' THR . 6.9 tttm -57.58 153.12 13.68 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.116 -0.99 . . . . 0.0 109.866 171.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.56 175.91 43.02 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.505 1.05 . . . . 0.0 111.341 174.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.69 -17.0 45.29 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.534 -0.98 . . . . 0.0 112.433 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.31 -26.76 8.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.7 1.2 . . . . 0.0 112.284 169.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.36 -53.06 18.93 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.761 1.224 . . . . 0.0 111.24 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -53.42 -42.89 67.51 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.382 1.073 . . . . 0.0 110.027 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.9 m -63.07 -49.34 74.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.189 0.595 . . . . 0.0 110.425 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.5 mt -59.14 -46.58 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.719 0.69 . . . . 0.0 109.769 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 mt -66.96 -35.89 80.98 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.075 -0.391 . . . . 0.0 110.559 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -60.24 -45.18 94.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.232 1.013 . . . . 0.0 109.124 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.7 -61.29 2.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.123 1.769 . . . . 0.0 111.654 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.99 -32.97 63.64 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.212 -165.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 125.89 47.11 0.21 Allowed Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 148.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.405 HG23 HD12 ' A' ' 93' ' ' LEU . 3.6 p -159.4 44.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-O 123.796 1.76 . . . . 0.0 107.425 -169.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.79 -25.02 26.59 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 118.731 -2.481 . . . . 0.0 112.357 173.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.05 -20.29 17.46 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.553 1.158 . . . . 0.0 111.37 -165.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -62.5 1.94 0.32 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 128.578 2.751 . . . . 0.0 114.245 165.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -141.37 109.02 5.62 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 174.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -53.44 -38.92 64.0 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.809 1.644 . . . . 0.0 111.153 -170.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -150.73 148.48 28.6 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.9 mp -126.84 126.48 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.9 mt -84.33 160.93 20.59 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 167.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.1 p -138.51 -177.59 4.92 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.428 1.091 . . . . 0.0 109.177 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.58 -30.1 19.71 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.485 -0.759 . . . . 0.0 111.159 161.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -72.23 -9.31 58.29 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.208 -0.933 . . . . 0.0 112.79 -169.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.8 m -56.73 -60.38 3.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.167 1.387 . . . . 0.0 110.758 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.75 -21.43 23.25 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 117.499 -1.723 . . . . 0.0 112.66 -171.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -51.22 154.53 1.62 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.802 1.801 . . . . 0.0 111.336 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.2 m -45.05 156.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.362 1.465 . . . . 0.0 112.257 170.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -70.66 166.99 19.6 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.603 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -43.69 142.36 1.92 Allowed Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 123.138 0.575 . . . . 0.0 110.669 170.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.98 -26.98 8.51 Favored 'Cis proline' 0 CA--C 1.55 1.282 0 CA-C-N 119.619 0.9 . . . . 0.0 114.154 2.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.298 2.7 t 53.77 86.47 0.16 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.227 1.811 . . . . 0.0 115.606 172.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.15 -19.3 29.85 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.397 2.065 . . . . 0.0 111.843 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.98 -43.57 98.56 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.175 0.898 . . . . 0.0 110.155 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.59 -23.79 67.53 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.31 -55.17 5.46 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.224 -0.923 . . . . 0.0 109.464 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 98.7 m -52.47 -39.84 61.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.302 1.041 . . . . 0.0 110.548 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -50.29 -64.89 0.67 Allowed 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 125.312 1.445 . . . . 0.0 109.735 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 52.2 mt -55.76 -39.71 71.58 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.547 0.612 . . . . 0.0 112.495 -173.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.484 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 75.5 mt -65.1 -50.82 64.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.329 1.452 . . . . 0.0 108.506 -176.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.6 -41.35 85.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.387 0.613 . . . . 0.0 111.217 172.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -56.91 -46.37 82.0 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.788 -1.195 . . . . 0.0 112.787 -172.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -121.72 21.36 10.81 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.055 0.843 . . . . 0.0 112.479 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 54.96 67.51 1.01 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.571 1.148 . . . . 0.0 108.973 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.484 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 14.7 mt -109.84 -179.74 3.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.09 1.356 . . . . 0.0 108.226 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -121.28 140.04 52.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.337 0.655 . . . . 0.0 110.077 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.9 m -51.03 -46.82 61.73 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.508 1.523 . . . . 0.0 111.84 175.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.28 -30.62 62.18 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.082 -1.011 . . . . 0.0 112.068 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.89 13.67 12.16 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -175.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.1 t -108.74 154.6 21.81 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -133.97 143.08 47.95 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 174.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -114.2 159.8 19.71 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.617 1.167 . . . . 0.0 110.825 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.7 mp -132.42 125.86 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 119.946 1.248 . . . . 0.0 109.685 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -146.63 -170.36 15.04 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 170.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.18 15.8 2.61 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -166.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 -165.0 1.74 Allowed 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.357 1.063 . . . . 0.0 109.848 -164.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.7 t -87.74 -25.06 23.62 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.302 0.641 . . . . 0.0 111.418 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -23.45 51.07 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.969 0.508 . . . . 0.0 111.03 -172.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.64 -30.55 61.17 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.249 1.419 . . . . 0.0 113.141 -172.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -111.49 -8.6 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.055 0.942 . . . . 0.0 110.666 -170.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -64.9 -38.63 91.6 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.757 -1.214 . . . . 0.0 110.041 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.94 -32.24 63.41 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.052 -1.03 . . . . 0.0 110.761 174.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.39 65.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.576 0.625 . . . . 0.0 110.418 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -61.3 -54.09 48.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.596 1.159 . . . . 0.0 113.285 174.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -63.21 -48.61 77.58 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.682 1.128 . . . . 0.0 111.628 -167.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 67.6 m -64.48 -38.06 89.71 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.211 0.604 . . . . 0.0 110.955 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.88 71.23 1.26 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 -169.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 41.3 pt -126.78 -172.84 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 127.477 2.311 . . . . 0.0 107.032 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -95.17 -176.21 3.74 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.994 1.318 . . . . 0.0 109.875 173.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.72 162.92 40.46 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.563 -1.336 . . . . 0.0 109.799 168.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 53.1 mt -132.47 129.14 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -149.86 160.06 43.88 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 120.992 -1.067 . . . . 0.0 110.291 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -74.62 -15.81 60.81 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.37 -0.831 . . . . 0.0 112.002 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 5.7 mt -116.04 156.83 25.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.08 1.752 . . . . 0.0 109.86 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -76.01 153.55 36.42 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.56 -167.83 2.51 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.39 1.076 . . . . 0.0 109.383 165.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.8 p -82.35 -10.97 58.87 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -81.43 177.59 8.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.167 0.987 . . . . 0.0 109.596 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -125.74 -36.32 2.42 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -75.22 28.37 1.18 Allowed Glycine 0 C--N 1.338 0.678 0 CA-C-N 119.375 0.989 . . . . 0.0 111.621 172.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.73 140.49 34.94 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 127.962 2.505 . . . . 0.0 106.397 177.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -121.16 109.32 14.85 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -64.52 129.38 39.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 36.0 pt -131.05 176.32 9.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 124.301 1.04 . . . . 0.0 110.167 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -134.72 -16.39 2.02 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.971 1.308 . . . . 0.0 111.888 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.74 -154.59 0.65 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.041 0.837 . . . . 0.0 111.115 173.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -98.9 -27.46 13.89 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.388 0.54 . . . . 0.0 110.409 163.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.02 -25.66 62.77 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 121.156 -0.965 . . . . 0.0 111.997 -167.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -31.6 65.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 129.313 3.045 . . . . 0.0 109.58 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.34 -54.22 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 119.289 0.95 . . . . 0.0 109.388 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.6 m -55.69 -37.68 68.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -60.39 -32.26 71.15 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.177 1.391 . . . . 0.0 112.028 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 93.9 mt -53.56 -43.64 54.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 119.378 0.99 . . . . 0.0 109.556 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -85.09 -41.33 15.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.57 1.548 . . . . 0.0 109.426 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -85.4 36.8 0.65 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.899 1.68 . . . . 0.0 111.027 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 93.3 m 44.85 84.94 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.248 2.219 . . . . 0.0 111.399 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-N 112.97 -1.923 . . . . 0.0 109.832 161.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.756 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -138.63 76.45 1.57 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.295 1.838 . . . . 0.0 107.412 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.8 mmm -126.33 76.79 1.64 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 173.39 0.57 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.029 1.332 . . . . 0.0 109.689 168.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -45.06 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.483 1.913 . . . . 0.0 112.294 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.4 m -117.49 141.68 48.06 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -176.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.7 144.94 51.05 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.313 0.577 . . . . 0.0 109.942 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -131.39 145.47 51.83 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.872 1.669 . . . . 0.0 108.07 -172.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.2 mt -145.22 89.74 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -171.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -78.36 -171.63 2.51 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 119.769 1.168 . . . . 0.0 110.383 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.471 ' HB2' ' HH ' ' A' ' 161' ' ' TYR . 21.7 t0 -131.28 164.42 25.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.516 1.526 . . . . 0.0 111.788 172.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.84 -30.41 45.17 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.327 2.251 . . . . 0.0 112.824 176.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -134.08 13.53 3.92 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.785 1.175 . . . . 0.0 113.905 -173.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.32 135.79 12.89 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 163.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.366 6.5 t . . . . . 0 C--O 1.253 1.242 0 C-N-CA 129.346 3.058 . . . . 0.0 114.948 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 86' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.413 ' H ' ' HG ' ' A' ' 85' ' ' LEU . 2.0 mpp? -103.83 87.13 1.4 Allowed Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 127.824 2.45 . . . . 0.0 105.775 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -56.66 117.82 4.56 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.504 2.803 . . . . 0.0 109.821 -171.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 127.73 -19.51 5.86 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.488 1.518 . . . . 0.0 111.57 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.19 -35.68 17.23 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.772 1.286 . . . . 0.0 112.766 -174.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -59.91 -28.37 67.53 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.835 0.743 . . . . 0.0 112.177 -171.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -58.47 -60.66 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.832 1.653 . . . . 0.0 110.63 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.4 t -60.56 -47.63 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 117.843 -1.075 . . . . 0.0 108.952 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.435 ' HA ' HE22 ' A' ' 103' ' ' GLN . 4.6 mp -44.37 -54.23 6.05 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 120.857 1.662 . . . . 0.0 113.521 171.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.82 -38.43 91.08 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.874 0.469 . . . . 0.0 112.085 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -64.73 -54.23 34.8 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.084 0.954 . . . . 0.0 109.173 174.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.75 94.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.537 1.935 . . . . 0.0 112.957 -172.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.78 -55.01 34.68 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.663 1.585 . . . . 0.0 110.774 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.19 -36.72 80.02 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 111.429 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.6 m -65.65 -2.39 3.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.545 1.138 . . . . 0.0 113.272 168.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.81 19.62 73.55 Favored Glycine 0 CA--C 1.525 0.706 0 O-C-N 119.874 -1.766 . . . . 0.0 112.161 174.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.3 mt -75.08 115.53 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -71.0 133.99 46.78 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.435 HE22 ' HA ' ' A' ' 93' ' ' LEU . 8.1 mt-30 -112.83 151.0 30.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -144.32 175.87 9.78 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 126.763 2.025 . . . . 0.0 106.838 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.3 mt -139.88 148.47 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -132.78 100.5 4.95 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.908 0.777 . . . . 0.0 110.323 168.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -103.44 170.84 7.7 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.428 1.109 . . . . 0.0 108.322 169.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -96.16 -9.24 31.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.042 1.337 . . . . 0.0 111.396 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 178.62 5.85 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.184 1.356 . . . . 0.0 112.152 -172.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.62 176.03 36.33 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.13 1.347 . . . . 0.0 112.579 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.57 -16.57 10.55 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.543 2.337 . . . . 0.0 111.792 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -44.56 -30.56 0.92 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.236 1.814 . . . . 0.0 111.3 164.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -44.96 -62.79 1.1 Allowed 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.106 1.763 . . . . 0.0 110.81 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . 0.418 ' CE1' ' HB ' ' A' ' 129' ' ' ILE . 63.4 m-85 -57.07 -38.35 73.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.529 0.732 . . . . 0.0 111.226 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.7 m -63.43 -39.95 95.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.876 0.87 . . . . 0.0 110.701 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.6 mt -57.83 -57.18 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.493 1.042 . . . . 0.0 109.731 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.61 -37.52 84.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.569 1.077 . . . . 0.0 111.31 -173.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -64.69 -45.81 85.06 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.527 0.731 . . . . 0.0 110.582 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -54.46 -53.64 51.52 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.794 0.838 . . . . 0.0 109.437 174.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.0 -14.81 63.26 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.249 1.02 . . . . 0.0 112.894 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.93 32.84 52.24 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.693 171.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.9 14.5 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.407 1.483 . . . . 0.0 111.672 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -44.61 55.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 m -61.6 -26.28 67.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -60.55 -34.12 73.68 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.004 -0.435 . . . . 0.0 111.112 173.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -99.99 94.51 6.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.524 1.53 . . . . 0.0 107.259 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 39.0 m -52.96 -43.46 66.39 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.819 1.648 . . . . 0.0 111.13 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.28 156.81 44.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.824 1.65 . . . . 0.0 107.262 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.418 ' HB ' ' CE1' ' A' ' 114' ' ' PHE . 5.0 mp -137.93 157.03 32.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.5 mt -131.18 156.02 46.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.259 1.824 . . . . 0.0 108.699 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.3 p -158.89 -174.87 4.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.47 1.508 . . . . 0.0 110.367 -151.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.8 p -59.49 -30.87 68.86 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.975 -1.078 . . . . 0.0 112.255 162.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -63.38 -31.3 72.42 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.254 0.934 . . . . 0.0 111.044 -177.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -63.45 -37.24 86.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.006 1.323 . . . . 0.0 111.289 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.97 5.47 70.38 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.458 170.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -58.26 168.46 1.06 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.214 1.507 . . . . 0.0 111.793 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.3 m -53.27 161.79 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.599 1.16 . . . . 0.0 113.407 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -78.1 160.73 27.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.865 1.266 . . . . 0.0 110.526 169.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -58.53 137.9 85.83 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 117.616 -1.183 . . . . 0.0 109.303 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.9 121.72 5.16 Favored 'Cis proline' 0 CA--C 1.536 0.586 0 CA-C-N 120.405 1.181 . . . . 0.0 110.845 -8.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 p -122.08 68.2 26.24 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 125.604 1.562 . . . . 0.0 110.98 -165.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.74 -24.29 47.49 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 CA-C-N 120.127 1.081 . . . . 0.0 112.198 -163.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.5 -44.11 8.38 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 130.08 3.352 . . . . 0.0 111.117 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.31 -19.94 64.71 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.55 -60.25 2.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 m -56.87 -33.59 67.0 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.332 1.053 . . . . 0.0 111.495 -167.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -54.27 -49.37 69.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.595 0.758 . . . . 0.0 111.197 173.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.44 -31.64 65.64 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 124.914 1.286 . . . . 0.0 111.794 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 81.9 mt -61.49 -59.86 4.58 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -174.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -70.54 -17.24 62.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.19 -177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -54.34 -49.1 70.54 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.353 0.979 . . . . 0.0 109.962 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.92 23.57 5.33 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.487 0.66 . . . . 0.0 112.561 -171.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.0 mp0 45.17 46.69 9.87 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.867 2.067 . . . . 0.0 110.648 -171.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 29.0 mt -77.0 164.68 25.53 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 172.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -104.24 153.53 20.87 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 128.572 2.749 . . . . 0.0 108.533 176.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 48.2 m -62.15 -27.36 68.89 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.645 0.736 . . . . 0.0 109.715 165.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.74 -29.37 25.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.724 -1.235 . . . . 0.0 111.966 -156.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -102.05 20.64 16.21 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.458 -0.776 . . . . 0.0 109.732 174.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.8 m -100.4 122.84 43.8 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -125.15 148.13 48.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.736 1.614 . . . . 0.0 110.077 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.471 ' HH ' ' HB2' ' A' ' 9' ' ' ASP . 60.3 t80 -115.53 -20.22 10.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -168.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.6 mp 44.68 74.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 126.944 2.098 . . . . 0.0 112.797 176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.56 173.17 17.54 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -125.19 25.6 7.15 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.521 -0.988 . . . . 0.0 112.573 -153.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -145.96 176.59 9.58 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t -70.97 -29.46 65.47 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.82 1.248 . . . . 0.0 111.038 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.67 11.64 14.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.035 0.934 . . . . 0.0 110.481 -177.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.75 -54.47 6.9 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 76.7 t -71.33 -17.1 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 O-C-N 121.382 -0.824 . . . . 0.0 111.762 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -59.94 -61.16 2.82 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.026 1.73 . . . . 0.0 111.355 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -68.95 -31.76 70.87 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 120.391 -1.443 . . . . 0.0 109.959 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.62 72.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.171 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.5 -52.58 16.85 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.195 1.398 . . . . 0.0 110.618 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.1 -21.41 60.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.766 -171.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.0 m -81.66 -33.47 31.31 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.446 -0.784 . . . . 0.0 111.072 169.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.11 19.81 54.61 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.278 1.418 . . . . 0.0 112.521 -166.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.7 pt -102.14 174.01 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.331 0 CA-C-N 118.982 1.391 . . . . 0.0 111.51 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -87.74 176.45 7.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.766 1.226 . . . . 0.0 110.338 -176.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 5.5 m -153.09 139.48 18.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.86 1.264 . . . . 0.0 109.768 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 61.2 mt -123.0 84.25 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -114.63 149.84 36.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.925 0.869 . . . . 0.0 109.972 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -64.42 -14.79 58.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.608 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.74 166.94 10.62 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.254 1.422 . . . . 0.0 110.183 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -95.07 163.55 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.563 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.0 t -151.14 -175.04 5.0 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.239 1.816 . . . . 0.0 107.352 168.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.6 p -115.57 71.8 0.78 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 170.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -142.28 137.11 30.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.99 91.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.412 1.885 . . . . 0.0 108.695 167.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 133.98 -3.51 4.52 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 117.941 -1.477 . . . . 0.0 113.255 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.46 131.28 34.41 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.525 2.163 . . . . 0.0 106.422 171.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.61 118.76 25.47 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.782 1.233 . . . . 0.0 108.804 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -67.23 147.63 52.79 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.471 0.578 . . . . 0.0 112.039 176.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.5 pt -141.59 164.88 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.876 1.67 . . . . 0.0 111.505 168.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -121.09 -15.37 8.23 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.833 1.653 . . . . 0.0 112.468 171.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.72 164.99 33.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.009 1.724 . . . . 0.0 107.192 171.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.4 mp -61.14 -30.69 70.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.114 0.966 . . . . 0.0 109.787 174.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.07 64.92 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -64.77 -22.64 67.03 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.943 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.7 mt -55.27 -57.36 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 83.5 p -50.09 -39.4 42.44 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.444 0.64 . . . . 0.0 112.237 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -67.7 -29.4 68.65 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 125.499 1.52 . . . . 0.0 111.515 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.9 mt -52.37 -48.03 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -86.72 -0.88 57.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.263 1.425 . . . . 0.0 112.226 -173.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -119.88 14.04 12.38 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.276 1.43 . . . . 0.0 111.543 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 58.6 m 57.06 87.3 0.06 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.791 1.636 . . . . 0.0 111.143 -167.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 N--CA 1.426 -1.649 0 C-N-CA 127.246 2.219 . . . . 0.0 113.616 147.547 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.693 0 CA-C-O 119.644 -0.531 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 52.18 4.57 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 128.569 2.748 . . . . 0.0 118.294 167.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.1 mmm 55.63 62.23 2.51 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 123.306 1.527 . . . . 0.0 110.039 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -80.77 122.05 26.68 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.3 mtpp 43.08 58.94 3.1 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 161.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.3 m -103.69 149.56 24.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.43 146.14 51.32 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 121.7 -0.625 . . . . 0.0 109.962 173.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.14 149.93 51.63 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 125.29 1.436 . . . . 0.0 108.373 -173.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.7 mt -140.56 131.94 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -120.82 148.49 43.95 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.524 1.53 . . . . 0.0 110.371 -173.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -89.48 -37.73 14.56 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.277 -0.889 . . . . 0.0 112.315 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.16 -20.45 0.08 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 129.374 3.07 . . . . 0.0 114.157 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.78 25.09 1.33 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.701 1.591 . . . . 0.0 110.372 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.07 1.24 0.41 Allowed Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.233 -1.315 . . . . 0.0 115.471 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.37 0 CA-C-O 115.919 -1.991 . . . . 0.0 106.17 161.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.4 HD13 ' H ' ' A' ' 86' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.4 ' H ' HD13 ' A' ' 85' ' ' LEU . 1.8 mmt -118.04 87.27 28.04 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.771 2.028 . . . . 0.0 109.487 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -66.1 94.74 0.3 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 124.555 3.503 . . . . 0.0 109.843 -175.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.08 -27.53 2.65 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 113.801 -1.545 . . . . 0.0 112.162 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.78 -34.81 26.93 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 119.295 1.547 . . . . 0.0 111.173 -170.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -51.73 -35.44 43.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.325 1.05 . . . . 0.0 111.969 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -45.09 -56.93 4.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.819 2.448 . . . . 0.0 111.079 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.99 -39.83 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.985 1.714 . . . . 0.0 110.052 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.2 mt -51.52 -46.65 63.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.939 1.245 . . . . 0.0 110.078 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.66 -56.03 26.17 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 123.694 0.797 . . . . 0.0 111.257 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.448 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 15.4 t90 -52.57 -46.75 67.0 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.925 1.29 . . . . 0.0 111.198 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.62 82.78 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.159 0.984 . . . . 0.0 111.75 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.94 -42.65 69.57 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.664 0.786 . . . . 0.0 111.017 -177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -60.4 -34.14 73.49 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.54 1.136 . . . . 0.0 110.701 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 m -78.09 -4.52 47.75 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.587 1.155 . . . . 0.0 113.549 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.71 27.26 58.73 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 119.768 1.167 . . . . 0.0 112.969 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.7 mt -60.81 124.67 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 163.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -74.04 103.32 4.47 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -91.29 137.87 32.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.235 0.47 . . . . 0.0 110.21 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -138.44 173.15 11.91 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.036 1.735 . . . . 0.0 110.51 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.6 mt -146.62 150.83 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.229 1.412 . . . . 0.0 108.777 -172.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -158.44 124.94 4.72 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.329 1.452 . . . . 0.0 111.935 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 t -155.8 171.39 20.11 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.642 1.177 . . . . 0.0 111.579 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -65.05 -26.36 68.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.263 1.825 . . . . 0.0 111.917 165.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -61.91 136.38 57.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.43 -161.95 28.29 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 124.146 0.879 . . . . 0.0 112.705 -170.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -47.24 -30.8 3.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.982 2.113 . . . . 0.0 111.999 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -58.45 -24.91 61.52 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.926 -1.109 . . . . 0.0 113.374 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.64 -35.31 77.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.333 0.97 . . . . 0.0 111.636 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -62.06 -40.77 96.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.312 0.96 . . . . 0.0 109.699 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.2 m -63.44 -41.9 98.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.975 1.31 . . . . 0.0 109.533 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 93.0 mt -57.56 -52.39 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.262 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.26 -41.17 96.46 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 120.834 1.652 . . . . 0.0 111.828 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -66.44 -27.81 68.11 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.786 0.721 . . . . 0.0 112.429 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -65.19 -49.1 71.07 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.534 1.159 . . . . 0.0 109.134 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 53.5 mt -73.89 -11.94 60.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.428 1.891 . . . . 0.0 112.123 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.15 19.37 78.59 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 118.878 -0.957 . . . . 0.0 113.253 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.6 18.17 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 119.072 1.436 . . . . 0.0 111.143 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -49.78 67.7 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.866 -0.521 . . . . 0.0 111.021 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.0 t -67.5 -22.44 65.45 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.724 0.64 . . . . 0.0 112.422 -168.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -59.7 -32.35 70.43 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 119.024 0.829 . . . . 0.0 111.644 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.12 122.68 45.19 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -173.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -61.48 -45.12 95.57 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -157.69 145.24 18.54 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -169.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.3 mp -135.14 131.54 52.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.406 0.622 . . . . 0.0 109.879 -170.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -89.23 162.92 15.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.034 0.921 . . . . 0.0 110.265 170.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 41.7 p -155.46 -179.06 7.73 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.555 1.542 . . . . 0.0 107.556 -171.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -22.12 1.7 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 168.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -67.39 -58.8 4.12 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.004 0.82 . . . . 0.0 110.357 173.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 61.6 m -99.95 55.36 0.93 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.91 -20.74 75.62 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.12 -171.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 45.0 -167.56 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 126.407 1.883 . . . . 0.0 112.863 -165.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.68 172.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 127.281 2.232 . . . . 0.0 112.252 173.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -59.54 152.71 21.33 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.743 169.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -48.23 138.14 11.0 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 117.666 -1.159 . . . . 0.0 108.968 162.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.87 -43.97 0.42 Allowed 'Cis proline' 0 CA--C 1.533 0.458 0 CA-C-N 120.453 1.198 . . . . 0.0 113.822 6.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 t 55.17 81.45 0.26 Allowed Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.672 1.189 . . . . 0.0 111.679 -176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.3 -16.62 52.2 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.487 2.125 . . . . 0.0 111.462 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -55.4 -48.53 74.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.261 1.391 . . . . 0.0 110.824 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.99 -18.83 64.68 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.76 -52.9 5.72 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 118.194 -0.907 . . . . 0.0 108.982 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.5 m -54.44 -38.33 66.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.455 0.702 . . . . 0.0 110.157 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -54.52 -58.53 7.1 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.612 1.165 . . . . 0.0 110.403 171.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 22.2 mt -65.59 -27.72 68.62 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.561 1.073 . . . . 0.0 112.093 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 75.8 mt -65.9 -59.75 3.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.52 -30.72 69.92 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.314 1.046 . . . . 0.0 113.131 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.49 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 5.6 mmpt? -57.42 -35.31 69.91 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.09 -1.006 . . . . 0.0 112.092 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.99 24.23 2.18 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 49.94 47.73 22.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.195 1.798 . . . . 0.0 110.235 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 59.3 mt -83.6 165.55 18.94 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.441 1.096 . . . . 0.0 109.395 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -106.34 134.43 49.48 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 124.144 0.977 . . . . 0.0 108.829 -171.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 m -60.47 -42.2 95.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.492 0.663 . . . . 0.0 109.74 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -74.02 -24.82 59.62 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 120.793 -1.192 . . . . 0.0 112.58 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -92.95 5.59 50.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.917 -1.039 . . . . 0.0 109.429 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -107.32 146.97 30.89 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -132.04 167.45 19.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.873 1.669 . . . . 0.0 107.612 -176.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -143.37 151.38 40.37 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.593 0.757 . . . . 0.0 109.968 173.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.6 mt -138.45 118.82 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.49 -6.55 0.03 OUTLIER Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.904 -175.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 40.5 t0 56.16 67.69 0.97 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.132 2.573 . . . . 0.0 112.356 169.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -153.94 167.96 27.99 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 120.879 -1.138 . . . . 0.0 110.936 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.0 t -61.25 -44.53 97.09 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.293 0.568 . . . . 0.0 109.989 167.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -5.21 14.28 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.755 1.622 . . . . 0.0 112.3 -171.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -54.52 38.5 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.526 1.13 . . . . 0.0 109.786 171.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 25.7 m -70.76 -30.45 42.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 118.248 -1.381 . . . . 0.0 111.688 -170.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -61.5 -48.69 79.94 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.825 0.85 . . . . 0.0 109.827 -172.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -80.02 -39.95 28.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.601 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.0 78.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.622 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -61.2 -53.77 52.71 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.833 0.853 . . . . 0.0 110.833 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -64.81 -34.96 79.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.574 -0.25 . . . . 0.0 110.975 -172.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.4 m -69.96 -34.98 74.1 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.096 0.862 . . . . 0.0 112.826 168.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.07 44.93 6.11 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.865 1.222 . . . . 0.0 111.785 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 10.9 pt -116.09 -179.14 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.565 1.546 . . . . 0.0 108.806 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -103.52 165.75 10.84 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.371 0.605 . . . . 0.0 109.745 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 143.27 38.55 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.987 0.915 . . . . 0.0 108.804 -163.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 62.7 mt -133.92 100.18 3.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -123.78 158.12 32.46 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.634 1.174 . . . . 0.0 109.947 -176.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -86.33 -3.16 58.94 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.229 -1.544 . . . . 0.0 111.218 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.34 155.8 45.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.427 1.891 . . . . 0.0 110.432 -174.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -74.79 142.24 44.27 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -144.73 177.68 8.53 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.412 1.485 . . . . 0.0 107.996 173.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 32.8 p -93.15 59.65 3.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.126 1.37 . . . . 0.0 110.774 -160.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -142.93 175.06 10.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.972 0.509 . . . . 0.0 112.238 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.84 -3.37 12.2 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 0.0 113.588 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -118.94 9.1 12.43 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.434 1.492 . . . . 0.0 112.417 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.12 138.02 33.24 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 119.15 1.475 . . . . 0.0 107.462 173.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -112.64 107.08 15.64 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -59.69 142.64 52.65 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.438 168.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.6 pt -131.64 165.59 31.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.635 1.574 . . . . 0.0 110.126 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -117.83 -16.3 9.97 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.011 0.924 . . . . 0.0 113.401 169.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.35 165.18 32.78 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.584 1.154 . . . . 0.0 109.021 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 30.6 mt -63.44 -44.55 94.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.232 1.813 . . . . 0.0 107.63 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.42 -15.01 63.4 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.88 -22.89 64.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.337 1.426 . . . . 0.0 110.407 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 19.8 mt -55.83 -53.43 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.049 1.34 . . . . 0.0 109.55 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.448 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 8.6 m -60.06 -32.89 71.36 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.93 1.241 . . . . 0.0 111.898 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -65.02 -26.65 68.37 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 118.3 -0.857 . . . . 0.0 112.227 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.55 -55.97 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.0 10.45 18.95 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.019 1.328 . . . . 0.0 113.62 -169.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -119.99 -1.29 10.44 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.552 1.141 . . . . 0.0 112.458 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.1 m -131.28 24.81 4.86 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.431 0.693 . . . . 0.0 111.878 -172.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 51.6 mttm . . . . . 0 C--O 1.247 0.963 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 170.598 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.243 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -144.55 117.12 8.61 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.664 0.732 . . . . 0.0 110.135 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 mmm -134.9 45.32 2.55 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.07 1.748 . . . . 0.0 110.043 -172.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.402 ' NE2' ' H ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 55.49 -171.46 0.07 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.938 1.295 . . . . 0.0 113.117 175.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' H ' ' NE2' ' A' ' 2' ' ' GLN . 2.7 mtpp -78.8 79.4 5.21 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 152.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 m -101.99 146.59 27.67 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.97 149.41 51.71 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 121.501 -0.749 . . . . 0.0 109.242 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -123.13 156.73 34.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.903 1.281 . . . . 0.0 108.03 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.2 mt -140.74 135.84 34.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -120.54 161.66 20.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.011 0.924 . . . . 0.0 111.068 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -102.91 -4.18 25.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.549 1.54 . . . . 0.0 111.941 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.2 tp 46.95 73.3 0.19 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 128.837 2.855 . . . . 0.0 111.347 -175.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -146.22 -159.37 1.01 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.25 1.36 49.95 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.064 -1.409 . . . . 0.0 114.309 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.2 m . . . . . 0 C--O 1.257 1.465 0 C-N-CA 126.493 1.917 . . . . 0.0 107.426 166.129 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.502 -0.872 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 23.6 tpp -103.37 88.07 1.57 Allowed Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -175.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -53.6 121.12 8.94 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.346 2.031 . . . . 0.0 108.189 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.16 -41.8 1.72 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -168.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.24 -32.39 49.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.644 -0.915 . . . . 0.0 111.038 -169.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -32.16 67.45 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.637 -176.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.32 -49.1 77.18 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.425 1.09 . . . . 0.0 111.563 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.9 t -77.55 -43.82 29.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 CA-C-O 117.552 -1.214 . . . . 0.0 109.678 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.402 ' HB3' ' CD1' ' A' ' 125' ' ' TYR . 6.1 mp -44.0 -56.18 4.15 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.649 1.58 . . . . 0.0 111.153 170.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.55 -54.92 41.38 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.74 0.416 . . . . 0.0 110.874 -177.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -56.71 -43.25 80.4 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.106 1.363 . . . . 0.0 112.502 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.5 -38.36 49.14 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.368 1.067 . . . . 0.0 112.049 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.89 -41.47 74.69 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.676 0.79 . . . . 0.0 110.845 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -61.03 -15.53 33.16 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.76 -0.587 . . . . 0.0 111.4 170.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.0 m -108.24 5.96 26.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.182 1.793 . . . . 0.0 113.468 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.06 8.72 55.05 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.671 1.129 . . . . 0.0 113.695 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.4 mt -55.5 120.5 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -71.05 92.68 0.97 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 172.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -71.95 151.56 43.17 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 168.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -141.78 172.59 12.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.008 2.123 . . . . 0.0 107.383 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 16.9 mt -136.4 155.07 33.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 171.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -136.46 115.38 12.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 164.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.3 t -121.88 157.04 32.02 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.206 1.003 . . . . 0.0 108.971 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -63.57 -30.2 71.35 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.014 165.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -61.58 142.2 57.27 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.198 1.799 . . . . 0.0 109.898 -166.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.5 -170.02 39.09 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.351 -0.843 . . . . 0.0 112.348 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -52.05 -24.94 7.51 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 128.387 2.675 . . . . 0.0 116.015 -163.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -69.91 -11.46 60.89 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.982 0.81 . . . . 0.0 112.154 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.37 80.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.23 1.012 . . . . 0.0 110.953 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -48.4 -46.39 37.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.038 1.335 . . . . 0.0 110.454 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 m -70.88 -37.92 73.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.383 1.073 . . . . 0.0 111.382 -171.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.4 mt -60.77 -45.95 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.13 1.372 . . . . 0.0 108.9 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.33 -35.5 75.98 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.012 -1.055 . . . . 0.0 111.582 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -50.17 73.44 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.289 0.635 . . . . 0.0 109.692 170.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -48.96 -48.13 43.37 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.962 0.905 . . . . 0.0 111.544 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.35 -10.36 59.39 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.097 1.359 . . . . 0.0 113.281 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.01 23.48 78.07 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.78 0.705 . . . . 0.0 114.27 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.3 m -124.23 13.46 4.86 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 C-N-CA 125.027 1.331 . . . . 0.0 110.471 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -43.06 99.51 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.885 1.22 . . . . 0.0 110.617 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.1 m -74.21 3.0 7.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.458 1.503 . . . . 0.0 112.68 -175.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.402 ' CD1' ' HB3' ' A' ' 93' ' ' LEU . 10.3 m-85 -80.12 -0.28 35.17 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.605 164.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -144.58 133.02 21.95 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.532 1.515 . . . . 0.0 108.728 -173.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.2 m -60.75 -68.86 0.26 Allowed 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 127.979 2.512 . . . . 0.0 112.072 -174.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -138.81 123.61 18.73 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.155 1.382 . . . . 0.0 107.726 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.1 mp -105.54 98.16 6.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 -172.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.451 HD11 ' CB ' ' A' ' 134' ' ' SER . 4.2 mm? -70.55 147.41 49.32 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.1 p -127.63 -168.78 1.94 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.506 2.322 . . . . 0.0 110.696 -172.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 t -56.96 -23.12 43.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.072 1.349 . . . . 0.0 113.426 166.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -64.98 -22.51 67.01 Favored 'General case' 0 C--O 1.228 -0.079 0 C-N-CA 124.014 0.926 . . . . 0.0 111.073 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.451 ' CB ' HD11 ' A' ' 130' ' ' LEU . 1.0 OUTLIER -110.07 72.52 0.8 Allowed 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 128.719 2.807 . . . . 0.0 105.597 177.251 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.36 48.68 3.67 Favored Glycine 0 N--CA 1.458 0.13 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -61.49 117.57 5.88 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.823 0.312 . . . . 0.0 110.723 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.517 HG12 ' H ' ' A' ' 138' ' ' ARG . 18.1 t 54.75 -165.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 124.906 1.283 . . . . 0.0 109.982 167.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.517 ' H ' HG12 ' A' ' 137' ' ' VAL . 82.6 mtt180 -128.12 0.4 5.84 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.036 -1.665 . . . . 0.0 114.521 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt 98.23 112.73 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.486 0 C-N-CA 129.003 2.921 . . . . 0.0 107.532 166.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -61.17 154.63 56.4 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 120.729 1.296 . . . . 0.0 111.79 6.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 p -142.17 82.2 13.46 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.726 1.211 . . . . 0.0 111.57 -171.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.42 -20.24 24.22 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.08 2.52 . . . . 0.0 113.965 -177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -69.57 -27.16 64.89 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.209 -0.932 . . . . 0.0 112.034 -170.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.65 94.99 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.79 85.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.34 -0.85 . . . . 0.0 110.144 173.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.9 m -53.85 -40.38 66.44 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.155 1.343 . . . . 0.0 111.158 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -61.76 -48.97 78.27 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.7 mp -62.59 -37.98 88.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.809 1.244 . . . . 0.0 111.496 -172.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.472 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 86.7 mt -64.51 -54.13 37.11 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.12 -35.94 76.38 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -56.92 -29.01 62.7 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 120.714 -1.241 . . . . 0.0 112.856 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -138.07 19.52 2.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 48.59 70.19 0.48 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.862 1.665 . . . . 0.0 110.654 -173.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.472 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 76.0 mt -109.33 -176.2 2.96 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.184 1.394 . . . . 0.0 109.99 -172.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.08 129.1 52.08 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.465 1.106 . . . . 0.0 109.905 -172.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.37 -17.47 20.42 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 125.165 1.386 . . . . 0.0 112.007 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.49 19.36 13.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.498 -0.751 . . . . 0.0 109.839 -174.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -128.3 8.61 6.05 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.87 1.668 . . . . 0.0 110.917 170.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.8 t -91.23 158.95 16.3 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.897 1.679 . . . . 0.0 109.783 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -147.84 105.47 3.69 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.015 -1.053 . . . . 0.0 109.64 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -85.6 133.07 34.07 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.093 0.957 . . . . 0.0 111.571 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.78 105.53 18.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.681 1.192 . . . . 0.0 109.056 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.37 -164.45 11.76 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.879 1.704 . . . . 0.0 110.859 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -136.91 -9.67 1.8 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.9 158.07 32.78 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.904 1.683 . . . . 0.0 110.912 -170.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.9 t -54.82 -32.3 60.22 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.618 -0.676 . . . . 0.0 112.489 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.6 -28.55 69.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.894 0.878 . . . . 0.0 110.507 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -69.9 -0.99 8.27 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.908 1.683 . . . . 0.0 112.024 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.2 t -120.48 -17.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 125.284 1.434 . . . . 0.0 109.61 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -65.93 -58.5 5.41 Favored 'General case' 0 C--N 1.338 0.101 0 O-C-N 120.916 -1.115 . . . . 0.0 108.734 168.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -63.75 -33.86 76.61 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.202 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.58 97.58 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.913 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -62.54 -43.59 98.43 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.338 0.972 . . . . 0.0 111.08 171.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -64.61 -37.9 89.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 117.705 -1.141 . . . . 0.0 112.464 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.4 p -79.14 -36.8 39.92 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.834 1.652 . . . . 0.0 110.778 168.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.26 65.61 1.26 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -172.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.39 174.61 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 127.295 2.238 . . . . 0.0 108.587 174.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -96.16 170.08 9.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.81 1.644 . . . . 0.0 111.96 -176.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.6 m -143.36 156.92 44.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.842 1.657 . . . . 0.0 111.729 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.2 mt -136.47 104.28 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -126.32 161.65 27.33 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.677 1.591 . . . . 0.0 107.43 -173.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -75.48 -13.19 60.36 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.685 -1.259 . . . . 0.0 112.903 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.3 pp -129.9 166.13 20.64 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.44 1.896 . . . . 0.0 110.16 -175.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -96.29 159.04 15.16 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.123 0.487 . . . . 0.0 111.268 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 38.6 m -151.65 27.91 0.63 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.821 1.649 . . . . 0.0 111.081 -168.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 63.4 p 56.5 10.44 0.68 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.917 2.887 . . . . 0.0 116.037 173.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -106.07 153.26 22.31 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.616 1.567 . . . . 0.0 110.465 -168.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.483 ' HG3' ' H ' ' A' ' 189' ' ' GLY . 0.3 OUTLIER -56.5 -77.48 0.03 OUTLIER 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.756 2.022 . . . . 0.0 112.215 -175.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.483 ' H ' ' HG3' ' A' ' 188' ' ' GLU . . . -75.93 18.33 3.26 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.448 1.975 . . . . 0.0 112.978 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -90.91 112.27 24.05 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.586 1.693 . . . . 0.0 107.28 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -101.84 127.87 48.46 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 25.0 mtm105 -68.57 148.12 50.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.283 0.492 . . . . 0.0 110.384 166.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.3 pt -135.36 170.19 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.325 1.85 . . . . 0.0 110.243 167.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -126.59 -10.75 6.21 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.554 1.142 . . . . 0.0 113.043 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.27 171.54 18.97 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.11 1.764 . . . . 0.0 108.117 172.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.53 -42.42 87.27 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.334 1.054 . . . . 0.0 109.703 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.1 -27.43 69.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.94 -22.78 62.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.238 1.815 . . . . 0.0 111.07 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 94.1 mt -57.4 -56.9 12.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 125.341 1.456 . . . . 0.0 108.863 171.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 80.3 p -53.06 -43.61 66.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.96 0.8 . . . . 0.0 111.483 -172.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -63.1 -21.99 66.56 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.912 1.685 . . . . 0.0 112.973 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.87 -42.96 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.838 0.744 . . . . 0.0 109.581 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -89.66 -32.57 16.99 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.62 0.768 . . . . 0.0 110.897 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -75.77 1.36 15.0 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.443 1.097 . . . . 0.0 112.878 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.328 13.4 t 46.57 53.88 9.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.998 2.119 . . . . 0.0 111.468 -168.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.257 1.469 0 C-N-CA 126.242 1.817 . . . . 0.0 112.034 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.924 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -77.52 -13.46 59.91 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -175.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mmm 51.12 78.93 0.1 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.837 1.655 . . . . 0.0 111.635 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.5 167.04 0.07 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.419 1.888 . . . . 0.0 110.106 164.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.456 ' C ' ' HZ1' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -54.49 73.78 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.812 2.445 . . . . 0.0 114.365 -171.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.7 m -86.63 160.84 18.77 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 119.46 -2.025 . . . . 0.0 107.875 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.8 151.02 48.7 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.738 -1.226 . . . . 0.0 109.338 165.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -122.74 154.01 38.7 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.214 1.406 . . . . 0.0 108.857 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.46 135.3 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -120.52 143.47 48.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.346 1.858 . . . . 0.0 109.046 -176.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.36 -32.81 66.78 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.446 1.021 . . . . 0.0 111.341 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tm? 60.94 120.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 128.81 2.844 . . . . 0.0 112.723 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.9 t0 62.77 34.82 14.29 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.738 1.215 . . . . 0.0 108.845 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.92 36.35 0.09 OUTLIER Glycine 0 CA--C 1.528 0.865 0 C-N-CA 129.222 3.296 . . . . 0.0 109.066 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.244 0.779 0 N-CA-C 101.604 -3.48 . . . . 0.0 101.604 174.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.535 ' HG ' ' H ' ' A' ' 86' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.535 ' H ' ' HG ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -104.32 87.56 1.72 Allowed Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 129.91 3.284 . . . . 0.0 106.271 177.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -59.66 107.16 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.633 2.889 . . . . 0.0 109.048 -176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.68 -9.58 3.14 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-O 116.725 -2.153 . . . . 0.0 112.933 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.63 -16.78 13.17 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 120.411 2.106 . . . . 0.0 114.845 -170.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -61.9 -37.86 86.18 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.473 -1.392 . . . . 0.0 112.823 -171.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.28 -54.6 29.26 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.533 1.933 . . . . 0.0 112.203 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.04 -33.54 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.634 1.107 . . . . 0.0 110.732 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.2 mt -57.1 -55.26 36.97 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.97 -13.69 62.35 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.636 1.175 . . . . 0.0 113.542 -174.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -79.74 -55.49 4.96 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 120.486 -1.384 . . . . 0.0 108.426 170.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.99 -37.81 86.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.236 1.414 . . . . 0.0 111.779 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.36 -51.34 66.32 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.789 1.636 . . . . 0.0 111.12 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -65.1 -17.5 64.51 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.163 1.385 . . . . 0.0 110.743 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.7 m -94.61 -1.58 52.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.292 1.437 . . . . 0.0 112.799 176.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.54 5.11 72.2 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.036 1.303 . . . . 0.0 113.571 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.1 mt -56.51 112.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -64.81 101.82 0.52 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 171.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.58 150.18 26.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.325 0.966 . . . . 0.0 108.413 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -146.5 171.84 14.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.413 1.885 . . . . 0.0 108.834 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.6 mt -136.12 156.88 37.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.692 1.197 . . . . 0.0 109.222 171.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -139.76 125.45 19.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.131 0.973 . . . . 0.0 109.112 164.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.7 t -154.09 178.3 10.12 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.552 2.341 . . . . 0.0 108.26 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -137.27 15.53 3.0 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.883 -1.136 . . . . 0.0 113.805 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -11.08 3.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 121.73 167.23 13.09 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 128.043 2.735 . . . . 0.0 110.118 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -52.02 -31.68 30.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.961 1.704 . . . . 0.0 111.367 170.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -53.0 -17.37 1.41 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.436 1.494 . . . . 0.0 114.026 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.19 -47.22 62.27 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.488 1.115 . . . . 0.0 111.028 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -56.78 -48.61 77.49 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.854 1.661 . . . . 0.0 109.93 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.6 m -55.43 -49.78 71.53 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.275 0.489 . . . . 0.0 109.795 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.8 mt -59.33 -47.91 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.79 -37.36 84.41 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.837 -1.165 . . . . 0.0 112.045 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.423 ' HE2' ' OE2' ' A' ' 123' ' ' GLU . 19.5 mtmt -59.71 -48.03 83.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.138 -0.934 . . . . 0.0 109.668 175.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -43.62 95.53 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.532 1.133 . . . . 0.0 111.303 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.87 -4.1 35.93 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.194 0.998 . . . . 0.0 112.531 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.17 -3.22 58.8 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 126.192 1.853 . . . . 0.0 114.993 173.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 m -92.53 3.33 7.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 118.921 1.36 . . . . 0.0 110.064 -170.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.423 ' OE2' ' HE2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -63.51 -27.34 69.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.433 1.015 . . . . 0.0 111.052 171.794 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.3 m -58.86 -15.26 11.75 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.465 -0.778 . . . . 0.0 112.684 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -96.9 3.05 52.33 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.043 -1.456 . . . . 0.0 114.295 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -133.7 111.71 10.8 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 122.06 2.209 . . . . 0.0 109.471 -176.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.2 m -58.14 -39.91 79.97 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.92 1.688 . . . . 0.0 110.466 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -145.5 158.82 43.78 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.673 1.189 . . . . 0.0 108.007 167.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.99 117.6 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.2 mt -71.63 165.98 22.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.719 0.771 . . . . 0.0 110.218 174.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.8 p -151.06 176.95 10.66 Favored 'General case' 0 C--O 1.231 0.088 0 O-C-N 121.466 -0.771 . . . . 0.0 110.498 -170.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.0 t -48.7 -33.84 10.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.037 0.935 . . . . 0.0 111.978 163.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -71.82 -6.67 43.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.204 1.402 . . . . 0.0 112.21 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.0 m -147.94 49.12 1.06 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 128.121 2.569 . . . . 0.0 105.229 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.05 -29.67 72.27 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.894 -166.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 45.23 -164.65 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.314 1.846 . . . . 0.0 112.595 -163.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.43 162.1 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.631 1.172 . . . . 0.0 112.224 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -65.77 146.02 55.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.13 0.572 . . . . 0.0 110.374 168.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.41 133.52 13.11 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 116.872 -1.537 . . . . 0.0 110.194 166.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.29 126.07 9.55 Favored 'Cis proline' 0 C--N 1.348 0.552 0 CA-C-N 120.487 1.21 . . . . 0.0 111.498 -5.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 p -130.29 78.63 74.11 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 124.779 1.232 . . . . 0.0 112.035 -158.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.89 -30.41 48.93 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 121.916 1.744 . . . . 0.0 113.323 -174.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -53.41 -44.81 69.04 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.713 -1.242 . . . . 0.0 113.333 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.74 -18.72 63.05 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.86 -0.59 . . . . 0.0 112.527 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.08 -53.41 7.04 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 119.115 0.87 . . . . 0.0 109.523 172.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 m -56.73 -41.46 77.52 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.371 1.469 . . . . 0.0 110.503 -174.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -56.86 -43.25 81.0 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.422 175.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.4 mt -78.35 -27.56 47.03 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.415 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 78.8 mt -59.37 -61.78 2.37 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 168.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.12 -17.84 64.97 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -64.78 -29.52 70.49 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.43 -1.419 . . . . 0.0 112.789 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -147.07 29.7 0.97 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.092 1.314 . . . . 0.0 112.468 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 54.82 45.12 27.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.608 1.563 . . . . 0.0 111.321 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 68.1 mt -95.34 170.87 9.07 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.422 -0.799 . . . . 0.0 110.0 -170.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -112.07 141.55 45.61 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.244 -0.91 . . . . 0.0 113.111 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 m -57.23 -49.87 74.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.817 0.847 . . . . 0.0 110.252 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.99 -16.83 60.61 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.532 0.682 . . . . 0.0 112.356 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -92.4 -3.09 55.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.701 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 t -101.36 135.61 42.58 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.62 1.1 . . . . 0.0 109.664 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -125.91 112.9 16.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -77.69 159.04 29.39 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.792 0.437 . . . . 0.0 110.525 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 49.4 mt -131.09 92.82 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 127.917 2.487 . . . . 0.0 104.511 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -124.41 169.31 16.46 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.786 1.184 . . . . 0.0 110.388 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -135.21 3.15 3.1 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.915 1.286 . . . . 0.0 113.225 -166.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.28 144.41 25.54 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 119.182 0.901 . . . . 0.0 111.231 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 88.68 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.01 2.124 . . . . 0.0 111.822 -170.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 174.05 -29.62 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 128.691 2.796 . . . . 0.0 107.664 -176.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -52.55 -43.64 65.34 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 126.368 1.867 . . . . 0.0 111.436 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 79.7 t -77.8 -26.19 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 125.184 1.394 . . . . 0.0 111.821 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.32 -38.42 91.08 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.526 -0.734 . . . . 0.0 111.614 -165.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -82.52 -30.77 29.58 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.686 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.34 89.99 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.838 0.855 . . . . 0.0 109.183 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -54.24 -49.67 68.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.655 1.582 . . . . 0.0 111.08 173.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -63.84 -44.24 93.75 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.83 -0.544 . . . . 0.0 110.811 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.0 m -75.0 -21.04 59.38 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.26 44.03 77.06 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.314 0.959 . . . . 0.0 112.171 -169.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.3 pt -110.6 168.73 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 118.094 0.947 . . . . 0.0 108.737 169.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -105.22 171.05 7.53 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.625 0.726 . . . . 0.0 110.626 -170.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.74 135.06 18.2 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 121.672 -0.643 . . . . 0.0 110.224 -157.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 42.9 mt -130.54 105.08 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 176.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -136.98 157.59 46.39 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.233 1.413 . . . . 0.0 111.148 -168.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -77.36 -12.43 59.95 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.32 -0.863 . . . . 0.0 112.371 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.14 156.61 38.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.984 0.914 . . . . 0.0 109.99 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -93.03 163.36 13.68 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.313 0.578 . . . . 0.0 110.835 -176.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 44.8 t -145.6 179.8 7.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.13 1.772 . . . . 0.0 108.521 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . 0.303 0.2 OUTLIER -78.06 -22.36 49.19 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.701 -1.249 . . . . 0.0 111.333 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -71.19 121.8 19.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.1 1.36 . . . . 0.0 109.909 -174.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -64.79 -17.51 64.27 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.25 8.5 60.86 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.778 -1.012 . . . . 0.0 113.028 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.51 105.37 15.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 120.11 1.955 . . . . 0.0 110.043 -177.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -94.99 111.75 23.52 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.023 0.929 . . . . 0.0 109.613 -174.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 144.28 56.85 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.526 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.6 pt -137.42 171.36 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 126.922 2.089 . . . . 0.0 112.556 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -122.36 -21.29 5.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.475 1.51 . . . . 0.0 113.227 167.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -151.23 167.49 27.64 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.71 0.686 . . . . 0.0 109.244 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 62.3 mt -74.32 -26.46 60.17 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 119.158 0.89 . . . . 0.0 110.277 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.45 -13.54 62.41 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.234 0.925 . . . . 0.0 112.514 174.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -79.06 -13.53 59.71 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.667 -1.27 . . . . 0.0 108.864 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.76 -57.07 11.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 167.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.6 p -59.96 -36.05 76.29 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.021 0.828 . . . . 0.0 111.499 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -64.78 -34.78 79.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.101 0.864 . . . . 0.0 111.477 -172.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.8 mt -50.07 -57.63 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.144 1.777 . . . . 0.0 108.812 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -72.14 -0.67 12.5 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.821 0.849 . . . . 0.0 113.276 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -121.09 4.43 10.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.083 1.353 . . . . 0.0 110.892 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 m -132.35 47.0 2.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.918 1.287 . . . . 0.0 110.561 -177.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt . . . . . 0 C--O 1.251 1.151 0 C-N-CA 128.486 2.714 . . . . 0.0 114.557 171.389 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 CA-C-O 118.808 -0.996 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . 0.273 6.8 p80 43.53 78.54 0.05 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.694 1.997 . . . . 0.0 115.898 162.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mmm -135.17 89.56 2.53 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.413 1.885 . . . . 0.0 105.949 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.53 179.64 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.045 164.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -44.36 106.49 0.07 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.499 1.12 . . . . 0.0 108.797 169.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.3 m -129.83 151.34 50.52 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 170.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.35 156.9 48.18 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.43 0.692 . . . . 0.0 109.44 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -132.36 147.93 52.41 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.396 1.479 . . . . 0.0 109.213 -173.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.44 HD12 ' HG1' ' A' ' 159' ' ' THR . 2.6 mp -132.1 129.46 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -103.49 164.75 11.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.301 1.04 . . . . 0.0 109.009 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.79 176.33 6.67 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.807 0.843 . . . . 0.0 109.891 171.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.6 mt -138.54 1.73 2.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.771 1.228 . . . . 0.0 111.147 -171.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -86.8 41.73 0.98 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.039 1.335 . . . . 0.0 111.086 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.6 -106.04 1.06 Allowed Glycine 0 C--N 1.331 0.277 0 N-CA-C 107.355 -2.298 . . . . 0.0 107.355 -173.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.02 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -161.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.448 ' HG ' ' H ' ' A' ' 86' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.448 ' H ' ' HG ' ' A' ' 85' ' ' LEU . 1.6 mpp? -104.82 86.27 1.43 Allowed Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.623 1.969 . . . . 0.0 107.583 166.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.99 99.84 0.49 Allowed 'Trans proline' 0 C--N 1.349 0.564 1 C-N-CA 125.599 4.199 . . . . 0.0 112.736 -164.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.62 -29.91 1.29 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 125.482 1.515 . . . . 0.0 109.742 -168.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.32 -34.09 23.77 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.186 0.993 . . . . 0.0 110.915 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -54.11 -36.37 63.16 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 119.109 0.868 . . . . 0.0 111.725 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.81 -35.97 79.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.724 1.21 . . . . 0.0 112.882 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.3 -48.95 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 118.293 -0.86 . . . . 0.0 108.949 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mp -44.3 -52.39 7.61 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 120.636 1.562 . . . . 0.0 113.287 170.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.82 96.29 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.41 0.684 . . . . 0.0 111.22 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.45 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 20.6 t90 -57.95 -49.44 76.78 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.551 1.141 . . . . 0.0 110.812 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.7 78.78 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.929 1.291 . . . . 0.0 113.24 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.95 -44.42 85.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 122.941 0.496 . . . . 0.0 110.374 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -51.15 -49.8 60.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.194 1.397 . . . . 0.0 110.154 168.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.2 m -68.94 -12.81 61.99 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.03 16.06 77.59 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 120.014 1.279 . . . . 0.0 113.605 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.1 mt -68.44 133.16 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.025 1.33 . . . . 0.0 108.32 170.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -83.14 118.67 23.74 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -99.07 154.24 18.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -147.84 166.33 27.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.909 1.684 . . . . 0.0 108.565 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 42.6 mt -137.43 158.94 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.754 1.622 . . . . 0.0 107.14 166.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -131.77 -85.9 0.48 Allowed 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 124.779 1.231 . . . . 0.0 108.034 166.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . 0.255 15.3 t 65.04 164.98 0.16 Allowed 'General case' 0 C--N 1.315 -0.894 1 C-N-CA 136.816 6.047 . . . . 0.0 113.958 177.772 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -80.41 4.04 19.37 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.395 1.078 . . . . 0.0 111.346 166.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -57.87 156.05 9.57 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.201 -1.562 . . . . 0.0 108.221 167.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.07 171.36 53.58 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-O 122.19 0.884 . . . . 0.0 111.107 173.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -44.87 -28.15 0.61 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 130.025 3.33 . . . . 0.0 114.944 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -63.89 -12.79 39.86 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 120.279 1.399 . . . . 0.0 112.311 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.52 -47.88 38.75 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.88 1.218 . . . . 0.0 111.573 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -56.8 -49.59 74.89 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.606 0.639 . . . . 0.0 110.238 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.7 m -59.39 -42.62 92.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.793 0.837 . . . . 0.0 111.129 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.73 -48.8 87.03 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 119.319 0.963 . . . . 0.0 108.716 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.28 -44.24 95.62 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.878 -0.514 . . . . 0.0 110.457 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -59.26 -51.3 70.54 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.403 1.081 . . . . 0.0 110.836 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -51.13 -56.52 12.3 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.26 1.424 . . . . 0.0 110.583 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.49 -9.73 37.43 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.046 1.338 . . . . 0.0 113.613 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.61 25.81 69.08 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 123.983 0.801 . . . . 0.0 112.525 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.53 57.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.43 -46.94 10.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.901 160.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.9 m -73.62 -14.59 61.2 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -164.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -63.44 -33.83 76.43 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.393 1.451 . . . . 0.0 110.507 170.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -90.82 115.48 27.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.5 m -44.74 -65.95 0.46 Allowed 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 127.016 2.126 . . . . 0.0 108.669 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.07 140.07 43.5 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.5 mt -110.36 148.69 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 171.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 45.9 mt -119.13 -166.89 1.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -173.26 -178.96 1.83 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.607 1.963 . . . . 0.0 107.888 167.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 m -44.53 -45.27 9.25 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.119 0.872 . . . . 0.0 110.458 167.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -70.2 -9.38 55.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.096 1.758 . . . . 0.0 112.96 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.7 m -59.35 -24.04 63.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.839 1.256 . . . . 0.0 110.973 163.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.12 -8.18 77.96 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-O 118.019 -1.434 . . . . 0.0 114.018 170.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -56.56 165.99 1.01 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.783 1.292 . . . . 0.0 111.161 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 m -44.73 155.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.158 1.783 . . . . 0.0 111.786 170.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -69.84 -76.77 0.09 Allowed 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -165.47 159.59 13.84 Favored Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 124.33 1.052 . . . . 0.0 109.804 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -64.16 136.97 26.24 Favored 'Cis proline' 0 N--CA 1.458 -0.601 0 N-CA-C 108.703 -1.307 . . . . 0.0 108.703 -17.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.0 p -124.99 68.78 56.82 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.621 0.768 . . . . 0.0 111.917 -157.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -61.95 -29.45 82.06 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.388 2.059 . . . . 0.0 111.98 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -48.41 -41.08 28.04 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.624 1.97 . . . . 0.0 112.39 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.61 2.47 16.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.518 1.527 . . . . 0.0 112.623 -175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.84 -39.42 2.73 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.868 1.667 . . . . 0.0 108.727 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 m -49.99 -38.78 38.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.086 1.312 . . . . 0.0 110.456 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -52.01 -57.94 7.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.099 1.36 . . . . 0.0 110.76 171.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.0 mp -58.58 -37.96 76.88 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.896 1.678 . . . . 0.0 112.755 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.0 mt -59.83 -57.96 10.65 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -175.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -75.18 -32.98 61.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.754 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -50.76 -53.32 32.63 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.801 -1.187 . . . . 0.0 111.8 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -115.23 8.86 15.62 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 54.26 66.71 1.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 123.064 1.411 . . . . 0.0 109.235 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.17 162.17 13.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.899 1.68 . . . . 0.0 107.784 169.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -106.39 -4.82 19.51 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 125.235 2.445 . . . . 0.0 117.458 -161.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.0 m 76.27 -55.95 0.58 Allowed 'General case' 0 N--CA 1.411 -2.381 0 CA-C-N 110.647 -2.978 . . . . 0.0 109.07 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.84 -2.13 38.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 O-C-N 120.881 -1.137 . . . . 0.0 112.941 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -98.35 -5.34 33.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 116.916 -1.516 . . . . 0.0 111.186 168.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.44 ' HG1' HD12 ' A' ' 7' ' ' ILE . 1.2 t -103.45 137.37 41.64 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.669 1.577 . . . . 0.0 108.099 -174.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -128.42 111.17 13.02 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.963 1.705 . . . . 0.0 109.263 -172.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -85.89 153.38 22.26 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.5 mt -133.01 119.55 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.85 -161.68 9.64 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -139.53 12.88 2.54 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.426 ' HB3' ' H ' ' A' ' 167' ' ' LEU . 3.0 mmt-85 -115.68 162.67 16.92 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 122.839 1.304 . . . . 0.0 111.489 -172.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 t -62.46 -26.95 68.79 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.297 -0.877 . . . . 0.0 109.538 163.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.426 ' H ' ' HB3' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -60.27 -29.82 69.05 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.487 1.515 . . . . 0.0 111.529 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -45.7 -44.93 13.97 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.104 1.762 . . . . 0.0 110.852 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 28.4 m -90.69 -15.5 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.55 -50.79 49.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.081 -1.012 . . . . 0.0 108.69 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -79.3 -33.4 43.3 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.343 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.92 -42.64 90.17 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.378 172.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -61.16 -49.77 75.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.866 1.212 . . . . 0.0 111.151 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -58.32 -25.37 61.82 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 74.9 m -86.03 -50.86 6.73 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.795 1.18 . . . . 0.0 110.615 165.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 96.09 63.17 0.95 Allowed Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -164.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.9 pt -131.11 173.14 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.577 1.951 . . . . 0.0 106.286 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -99.65 165.83 11.42 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 -171.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 39.4 m -136.26 155.36 50.22 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.637 1.175 . . . . 0.0 110.57 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 34.3 mt -140.66 74.81 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -96.14 169.64 9.81 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.842 0.829 . . . . 0.0 110.157 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -88.25 2.14 52.98 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.532 -1.355 . . . . 0.0 111.951 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.06 132.78 19.96 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 124.72 2.2 . . . . 0.0 115.414 -175.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.24 138.65 58.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.568 -2.105 . . . . 0.0 109.4 -167.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.594 ' HG ' ' ND2' ' A' ' 190' ' ' ASN . 74.9 p -137.91 163.4 31.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.093 0.557 . . . . 0.0 110.704 -162.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 24.4 p -75.68 45.16 0.31 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.527 1.931 . . . . 0.0 111.55 173.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -131.34 175.67 8.93 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.95 -1.094 . . . . 0.0 109.717 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 189' ' ' GLY . 10.0 pt-20 -98.26 -67.84 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.768 0.827 . . . . 0.0 109.202 177.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.401 ' H ' ' HG3' ' A' ' 188' ' ' GLU . . . -73.15 51.49 1.68 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.984 2.231 . . . . 0.0 113.319 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.594 ' ND2' ' HG ' ' A' ' 185' ' ' SER . 14.4 t30 -121.26 119.6 32.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.376 1.07 . . . . 0.0 108.766 175.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -106.67 106.56 17.15 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.815 0.846 . . . . 0.0 109.94 -172.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.66 139.85 58.81 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.8 pt -129.98 167.66 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.142 1.377 . . . . 0.0 113.084 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.26 -17.59 8.22 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.972 1.309 . . . . 0.0 113.52 168.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.63 168.69 26.62 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 18.4 mt -70.37 -38.58 74.79 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -171.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.12 -18.07 63.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.82 -0.55 . . . . 0.0 112.329 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.94 -21.34 66.81 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.223 -0.923 . . . . 0.0 110.686 176.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 72.7 mt -61.46 -50.52 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 118.161 -0.924 . . . . 0.0 109.132 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' SER . . . . . 0.45 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 94.4 p -58.04 -41.09 82.54 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.32 0.964 . . . . 0.0 110.364 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.5 mtp-105 -58.98 -39.59 82.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.329 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.6 mt -52.62 -51.96 30.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 118.983 0.81 . . . . 0.0 109.988 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -73.78 -35.76 64.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -74.9 -5.35 43.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.3 t -130.98 23.88 4.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.88 0.848 . . . . 0.0 110.328 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp . . . . . 0 C--O 1.256 1.396 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 158.335 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -115.94 23.91 11.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.156 0.982 . . . . 0.0 112.11 -168.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mmm -98.63 82.92 2.9 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -167.13 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 129.402 3.081 . . . . 0.0 111.272 161.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -57.28 109.94 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 119.543 -1.973 . . . . 0.0 107.72 168.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.5 m -130.37 152.59 49.61 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 166.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.57 150.3 46.19 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.262 -0.899 . . . . 0.0 109.652 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -124.9 160.9 27.77 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.588 1.555 . . . . 0.0 110.211 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 mt -138.19 149.53 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -134.95 168.15 19.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.635 2.374 . . . . 0.0 109.598 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -123.46 24.67 8.55 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.721 2.008 . . . . 0.0 111.666 -171.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt 60.4 96.42 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.438 2.695 . . . . 0.0 112.791 172.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t70 71.24 20.06 5.19 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.977 1.711 . . . . 0.0 112.979 169.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.73 12.31 15.35 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 117.377 1.711 . . . . 0.0 117.377 -164.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 55.3 p . . . . . 0 C--O 1.255 1.348 0 CA-C-N 120.131 1.965 . . . . 0.0 110.208 -168.702 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.415 HD11 ' H ' ' A' ' 86' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.415 ' H ' HD11 ' A' ' 85' ' ' LEU . 2.1 mmm -118.4 86.98 29.3 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 128.087 2.555 . . . . 0.0 110.121 178.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -64.85 94.34 0.22 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 1 C-N-CA 125.438 4.092 . . . . 0.0 110.37 -173.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.71 -37.38 0.96 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 126.608 2.052 . . . . 0.0 110.503 -176.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.25 -25.88 22.61 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -171.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -24.13 64.99 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 118.974 -2.329 . . . . 0.0 111.97 -176.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -61.01 -45.72 93.67 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.952 0.901 . . . . 0.0 109.745 174.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.75 -44.39 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 123.88 0.872 . . . . 0.0 109.486 -170.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.4 mp -44.3 -44.73 8.28 Favored 'General case' 0 N--CA 1.418 -2.068 0 C-N-CA 126.125 1.77 . . . . 0.0 111.519 169.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.57 -33.57 66.85 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.593 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -65.09 -55.3 19.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.853 1.261 . . . . 0.0 109.827 170.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.28 -36.42 77.8 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.752 1.621 . . . . 0.0 112.527 -174.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.19 -57.96 8.79 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.744 1.218 . . . . 0.0 111.687 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -60.82 -24.39 65.82 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.617 0.723 . . . . 0.0 112.363 175.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.1 m -78.28 -6.02 53.77 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.33 -0.856 . . . . 0.0 112.634 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.39 15.34 81.08 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 124.228 0.918 . . . . 0.0 112.653 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.5 mt -70.5 120.7 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 118.834 1.317 . . . . 0.0 107.726 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -75.13 105.28 6.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 167.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -88.65 150.56 22.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -142.28 169.16 18.11 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.432 1.093 . . . . 0.0 108.94 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.3 mt -131.63 149.67 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -121.7 141.87 50.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 157.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.4 t -163.25 -176.0 4.57 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.196 2.199 . . . . 0.0 105.719 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -134.11 9.22 3.79 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.844 0.858 . . . . 0.0 112.755 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -1.55 8.11 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.47 174.31 34.01 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 125.821 1.677 . . . . 0.0 111.019 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -52.61 -27.5 17.25 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.084 0.954 . . . . 0.0 112.293 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.7 -17.87 3.94 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 177.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.57 -46.99 49.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.8 1.182 . . . . 0.0 112.223 171.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -60.32 -47.38 86.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.435 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.6 m -56.15 -49.83 72.86 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.732 0.696 . . . . 0.0 109.45 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.2 mt -58.89 -48.49 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.01 -38.42 91.13 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 121.326 -0.859 . . . . 0.0 112.235 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -48.85 80.05 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.54 -36.01 82.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.505 0.593 . . . . 0.0 111.354 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.83 -8.22 57.74 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.476 1.11 . . . . 0.0 112.05 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 57.12 33.49 64.69 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 125.44 1.495 . . . . 0.0 113.248 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.79 14.1 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.512 1.156 . . . . 0.0 110.36 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -41.37 97.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.186 0.994 . . . . 0.0 111.176 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 t -65.52 -31.02 71.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.688 -169.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -56.01 -43.91 78.19 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.553 0.615 . . . . 0.0 111.461 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -97.19 95.58 7.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -166.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.4 m -44.66 -49.83 10.18 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.566 1.546 . . . . 0.0 109.682 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.44 147.44 34.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.96 119.31 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -82.0 163.94 21.79 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.582 0.705 . . . . 0.0 109.63 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.8 p -148.11 -174.2 4.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.239 1.019 . . . . 0.0 112.687 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.6 t -55.25 -15.51 2.47 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 162.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -73.32 -38.8 65.68 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 120.018 1.281 . . . . 0.0 110.499 173.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 136' ' ' PHE . 2.6 p -77.71 77.6 4.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.25 45.76 1.21 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 125.058 1.313 . . . . 0.0 111.224 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.452 ' H ' ' C ' ' A' ' 134' ' ' SER . 22.0 m-85 -62.8 166.9 5.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.244 0.545 . . . . 0.0 111.227 168.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.9 m -53.35 161.43 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 127.149 2.18 . . . . 0.0 112.852 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.35 156.07 23.2 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.398 -0.814 . . . . 0.0 110.659 170.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -51.02 139.49 23.09 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.631 1.572 . . . . 0.0 110.442 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.71 123.58 5.74 Favored 'Cis proline' 0 CA--C 1.537 0.644 0 CA-C-N 120.416 1.184 . . . . 0.0 110.099 -9.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.444 ' H ' ' HB3' ' A' ' 171' ' ' PHE . 2.8 p -128.84 81.26 71.16 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 126.398 1.879 . . . . 0.0 110.954 -162.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.62 -9.12 16.0 Favored 'Trans proline' 0 CA--C 1.551 1.334 0 C-N-CA 123.556 2.838 . . . . 0.0 114.635 -173.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.13 -44.73 94.69 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.022 1.283 . . . . 0.0 111.875 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -51.58 -45.47 63.13 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 124.064 0.946 . . . . 0.0 110.669 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.13 -34.77 75.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.769 -0.582 . . . . 0.0 112.139 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.1 m -68.51 -32.21 72.01 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.636 0.774 . . . . 0.0 110.364 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -65.19 -49.73 68.65 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.47 -38.48 80.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.062 0.945 . . . . 0.0 111.332 -176.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -58.05 -68.12 0.28 Allowed 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 173.787 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -53.43 -46.56 69.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.852 0.72 . . . . 0.0 112.012 -171.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -51.72 -36.0 45.19 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -121.69 12.45 10.66 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.76 0.709 . . . . 0.0 111.539 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 47.16 50.35 14.3 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.84 2.456 . . . . 0.0 110.283 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 66.1 mt -76.85 -172.59 2.34 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.685 1.994 . . . . 0.0 110.105 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -129.34 134.42 47.89 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.79 1.236 . . . . 0.0 107.778 -170.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.8 p -59.35 -40.17 85.55 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 119.522 1.056 . . . . 0.0 111.198 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -75.12 -22.78 57.97 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.529 -0.732 . . . . 0.0 111.943 -172.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -95.82 2.53 53.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.462 -0.773 . . . . 0.0 109.43 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.6 m -96.57 126.56 41.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.702 1.201 . . . . 0.0 108.052 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -112.18 155.75 23.44 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -120.98 163.61 18.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.964 1.706 . . . . 0.0 106.694 161.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.4 mt -126.59 107.63 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 173.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -119.69 177.23 16.34 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.49 166.18 18.45 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 156.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 75.43 156.62 0.18 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 126.689 1.996 . . . . 0.0 111.389 -176.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 t -69.83 -30.1 67.52 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.83 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -25.06 45.29 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.437 1.095 . . . . 0.0 112.631 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -79.68 13.04 2.24 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.479 1.912 . . . . 0.0 111.558 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 1.2 p -109.12 -16.32 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.277 1.031 . . . . 0.0 110.553 163.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -73.9 -52.62 12.36 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.121 1.328 . . . . 0.0 110.805 -168.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.444 ' HB3' ' H ' ' A' ' 141' ' ' SER . 1.4 p90 -63.28 -29.39 70.72 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 120.971 -1.081 . . . . 0.0 111.916 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.47 -52.55 64.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 118.761 -0.637 . . . . 0.0 109.302 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -49.11 -60.88 2.41 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.127 1.371 . . . . 0.0 110.708 170.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -68.33 -14.51 63.05 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -170.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.5 p -95.62 -23.4 17.05 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 120.73 1.604 . . . . 0.0 112.229 165.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.1 22.42 38.36 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.145 1.355 . . . . 0.0 112.515 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.2 pp -99.16 175.2 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.855 1.327 . . . . 0.0 109.982 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.65 162.07 18.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.619 1.168 . . . . 0.0 110.29 -173.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 12.4 m -139.33 143.98 38.06 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.76 1.224 . . . . 0.0 110.348 -165.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 73.6 mt -119.95 92.11 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -111.5 158.98 18.54 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 121.819 0.819 . . . . 0.0 108.956 -172.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -74.18 -6.5 48.15 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.517 -1.365 . . . . 0.0 112.835 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.99 158.81 41.75 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 126.83 2.052 . . . . 0.0 109.159 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.84 160.86 28.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 19.0 t -147.22 174.83 11.25 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.6 169.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.4 p -83.95 63.98 7.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.023 2.529 . . . . 0.0 108.434 -173.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -144.6 178.86 7.67 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.771 2.028 . . . . 0.0 108.355 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -113.38 -35.95 5.13 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.431 1.469 . . . . 0.0 110.459 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -86.19 15.48 49.14 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 127.368 2.413 . . . . 0.0 112.77 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -84.75 152.87 23.39 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 120.621 2.211 . . . . 0.0 107.372 159.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -131.04 148.86 52.8 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 169.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 146.56 25.59 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.273 0.629 . . . . 0.0 110.85 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 18.6 pt -140.03 162.68 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.219 1.008 . . . . 0.0 112.0 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -108.86 -27.02 9.96 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -168.08 145.59 4.25 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -163.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 2.9 tp -61.74 -30.91 71.09 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 127.186 2.194 . . . . 0.0 111.497 -158.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.92 -11.87 50.43 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 176.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -77.16 -13.14 59.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.816 0.846 . . . . 0.0 109.6 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 39.7 mt -56.34 -59.37 2.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 83.1 p -53.89 -37.9 64.22 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -175.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -61.35 -34.64 75.63 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.77 0.828 . . . . 0.0 112.141 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 76.0 mt -58.22 -34.69 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.985 0.914 . . . . 0.0 110.729 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -91.48 -4.91 55.03 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 120.974 -1.079 . . . . 0.0 112.291 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -120.55 4.54 10.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.828 1.651 . . . . 0.0 111.036 -171.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.13 33.93 2.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.844 1.258 . . . . 0.0 112.819 -173.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.284 27.1 pttt . . . . . 0 C--O 1.249 1.027 0 C-N-CA 126.969 2.107 . . . . 0.0 113.1 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.826 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -158.98 73.3 0.6 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.469 1.108 . . . . 0.0 111.169 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 mmm -119.1 34.24 5.31 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.278 -0.889 . . . . 0.0 112.549 -166.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.443 ' NE2' ' H ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER 52.73 -169.04 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.508 1.523 . . . . 0.0 111.965 171.339 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' H ' ' NE2' ' A' ' 2' ' ' GLN . 12.7 tppt? -80.32 48.64 1.04 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 119.857 -1.777 . . . . 0.0 108.23 165.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.9 m -69.3 143.75 53.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.28 149.47 50.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -125.53 152.91 44.39 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.484 1.114 . . . . 0.0 108.972 -172.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.5 mt -134.49 146.04 31.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 169.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -123.78 171.64 9.47 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.809 2.044 . . . . 0.0 107.82 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.18 164.33 15.75 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 165.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -121.56 141.85 50.67 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.03 0.832 . . . . 0.0 109.185 -168.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 61.58 4.47 1.03 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.008 1.723 . . . . 0.0 112.687 -168.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -103.43 -88.67 2.07 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.296 2.9 t . . . . . 0 C--O 1.252 1.212 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 172.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 119.858 -0.115 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . 0.263 3.7 tpt 40.52 76.48 0.5 Allowed Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 124.688 1.195 . . . . 0.0 114.127 135.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -64.6 103.76 0.49 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 123.032 2.488 . . . . 0.0 108.246 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 124.68 -13.12 7.75 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.055 1.312 . . . . 0.0 113.71 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.18 70.85 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 121.009 2.404 . . . . 0.0 107.928 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.89 -24.08 67.6 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 118.402 -0.809 . . . . 0.0 112.697 -172.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -60.26 -58.46 8.41 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.64 -44.44 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 117.018 -1.468 . . . . 0.0 112.228 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.456 ' CD2' ' CD2' ' A' ' 125' ' ' TYR . 3.7 mp -52.68 -48.35 66.59 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 122.13 2.241 . . . . 0.0 112.368 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.89 -49.08 79.12 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 124.804 1.315 . . . . 0.0 109.552 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -53.57 -48.08 69.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.632 -0.699 . . . . 0.0 111.191 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.64 74.83 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.895 0.77 . . . . 0.0 111.752 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -73.45 -40.89 63.83 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.286 1.834 . . . . 0.0 110.711 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.25 -1.28 4.3 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.227 1.811 . . . . 0.0 111.309 168.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 58.3 m -118.88 -6.6 10.53 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.423 1.489 . . . . 0.0 114.273 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.38 9.14 77.1 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.101 -1.624 . . . . 0.0 115.654 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 93.5 mt -45.63 147.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 149.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -98.65 115.4 28.59 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 167.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.404 HE22 ' HA ' ' A' ' 93' ' ' LEU . 5.3 mt-30 -88.67 150.75 22.85 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -140.0 164.95 28.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 125.12 1.368 . . . . 0.0 107.967 171.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.6 mt -124.51 149.86 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 161.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -129.16 143.84 51.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 152.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.4 t -151.6 163.5 38.93 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.863 1.265 . . . . 0.0 109.585 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -92.64 -0.39 57.31 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.983 -0.448 . . . . 0.0 111.962 165.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -59.19 153.0 19.28 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 119.477 1.035 . . . . 0.0 108.571 166.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -80.93 -175.21 49.6 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.72 -18.18 7.6 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.501 1.521 . . . . 0.0 114.038 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -58.63 -18.1 27.68 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.617 1.099 . . . . 0.0 112.119 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.36 69.69 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.078 0.951 . . . . 0.0 110.366 175.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -57.15 -48.86 77.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -48.03 83.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.829 2.052 . . . . 0.0 111.252 -174.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.13 -50.61 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.481 1.112 . . . . 0.0 108.165 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.89 -37.28 87.11 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 122.16 -0.337 . . . . 0.0 111.162 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -49.1 77.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.517 1.127 . . . . 0.0 109.608 174.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -50.46 73.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 124.016 0.926 . . . . 0.0 110.679 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.54 -40.2 77.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.544 -174.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.41 50.82 0.79 Allowed Glycine 0 C--N 1.339 0.697 0 CA-C-O 121.563 0.535 . . . . 0.0 111.825 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.317 1.3 p -147.61 8.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 129.912 3.285 . . . . 0.0 109.384 -170.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -34.25 77.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 120.768 -1.208 . . . . 0.0 113.028 174.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -15.91 53.71 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.576 0.547 . . . . 0.0 111.774 -168.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.456 ' CD2' ' CD2' ' A' ' 93' ' ' LEU . 13.1 m-85 -66.23 -30.77 71.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -174.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.403 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 5.8 m-85 -110.8 129.4 55.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 -167.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.7 m -55.31 -30.87 61.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.383 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -154.28 151.83 29.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.229 1.012 . . . . 0.0 109.093 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.85 77.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 174.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.4 mt -66.2 147.19 53.7 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 57.8 p -122.96 177.96 5.27 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.061 0.944 . . . . 0.0 110.14 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 t -45.91 -37.61 6.56 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.993 0.917 . . . . 0.0 110.604 165.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -62.32 -18.37 61.2 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.3 p -48.37 -48.89 36.33 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.169 0.895 . . . . 0.0 112.277 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.96 -5.81 56.53 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 117.688 -1.618 . . . . 0.0 112.852 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -60.65 163.12 5.76 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.617 1.708 . . . . 0.0 110.904 172.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.2 m -52.73 156.29 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 126.973 2.109 . . . . 0.0 112.555 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -81.19 154.58 26.6 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.666 0.786 . . . . 0.0 108.924 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -54.66 144.29 45.52 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.282 1.033 . . . . 0.0 113.148 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.58 135.53 35.98 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 N-CA-C 108.261 -1.477 . . . . 0.0 108.261 -8.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 p -128.43 61.28 53.24 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.223 0.609 . . . . 0.0 111.84 -157.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.56 -24.22 77.65 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.164 2.576 . . . . 0.0 113.155 -167.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -51.33 -38.56 53.69 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 120.897 -1.127 . . . . 0.0 112.366 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.3 4.86 5.15 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.236 1.014 . . . . 0.0 112.702 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.71 -40.67 5.67 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.686 163.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.2 m -55.21 -35.45 64.91 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.415 1.007 . . . . 0.0 110.65 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -66.07 -49.37 67.86 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.574 0.75 . . . . 0.0 110.922 171.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.1 mp -67.43 -14.11 62.63 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.441 1.496 . . . . 0.0 113.171 -177.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.1 mt -84.22 -53.48 5.47 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.877 2.071 . . . . 0.0 107.826 167.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.28 -37.55 85.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -174.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -54.87 -20.0 7.81 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.478 1.911 . . . . 0.0 115.125 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -158.38 22.52 0.24 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.843 2.457 . . . . 0.0 112.71 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 49.25 46.8 22.76 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.004 1.721 . . . . 0.0 113.462 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 30.0 mt -78.45 169.18 18.66 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.251 1.02 . . . . 0.0 109.899 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -108.37 130.94 55.2 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 123.229 0.611 . . . . 0.0 109.958 -174.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.4 m -60.14 -43.96 95.31 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.944 0.898 . . . . 0.0 110.16 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.83 -23.68 59.68 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.633 -1.292 . . . . 0.0 113.449 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -93.2 3.86 54.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.067 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -102.16 126.06 49.03 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -106.46 163.75 12.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -139.67 127.54 22.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 173.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 7.4 mt -98.91 116.92 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.884 1.674 . . . . 0.0 107.003 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.95 -164.97 10.1 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.466 1.508 . . . . 0.0 110.071 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -138.23 -1.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -172.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.09 169.14 13.71 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 122.404 1.097 . . . . 0.0 111.505 -160.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.1 t -59.63 -32.24 70.25 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.571 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.75 -17.25 64.0 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.566 -1.334 . . . . 0.0 111.864 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -83.95 1.7 42.31 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.076 -1.015 . . . . 0.0 111.933 -165.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.8 p -91.87 -28.44 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 O-C-N 121.401 -0.812 . . . . 0.0 112.148 158.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -67.23 -58.26 5.17 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 120.087 1.312 . . . . 0.0 111.399 -161.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -55.9 -45.12 78.75 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.645 1.178 . . . . 0.0 111.915 170.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.91 79.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 122.63 0.372 . . . . 0.0 111.409 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -59.12 -46.11 89.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.396 1.878 . . . . 0.0 109.822 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -59.71 -45.02 93.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.657 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 74.6 m -81.22 -22.14 39.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.87 61.75 2.99 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.474 1.035 . . . . 0.0 110.693 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.0 -173.22 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.749 2.02 . . . . 0.0 109.058 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -111.81 166.01 11.56 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.992 0.917 . . . . 0.0 110.146 -176.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 32.7 m -145.19 151.57 38.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.355 1.062 . . . . 0.0 112.387 -170.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.5 mt -138.0 101.95 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.06 160.88 36.92 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 120.867 -1.145 . . . . 0.0 109.209 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -73.52 0.42 12.54 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.297 -0.877 . . . . 0.0 111.362 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 22.8 mt -114.01 154.7 27.2 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 125.728 1.611 . . . . 0.0 109.54 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -79.94 154.13 28.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 164.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.8 m -136.67 163.85 29.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.876 1.671 . . . . 0.0 107.218 173.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 62.0 p -93.38 64.56 3.71 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -169.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -146.52 162.19 38.87 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.687 1.195 . . . . 0.0 109.8 -170.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.8 -54.86 6.55 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.893 0.877 . . . . 0.0 110.774 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.15 24.48 6.15 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 125.074 1.321 . . . . 0.0 113.774 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -85.45 111.27 19.81 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 125.407 1.483 . . . . 0.0 108.31 171.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -99.23 125.0 44.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 168.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.2 148.47 30.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.737 -0.649 . . . . 0.0 109.394 169.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 13.6 pt -133.96 156.94 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.982 0.913 . . . . 0.0 112.457 172.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 -97.06 -29.63 13.52 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.446 1.098 . . . . 0.0 111.913 164.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.72 162.15 39.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.64 1.576 . . . . 0.0 108.496 -167.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.49 -43.92 88.7 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -60.59 -19.63 58.23 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.79 0.723 . . . . 0.0 112.7 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.42 -21.53 66.67 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.038 0.835 . . . . 0.0 112.031 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 67.1 mt -50.91 -60.2 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.6 m -61.89 -32.27 72.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.164 0.893 . . . . 0.0 112.008 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -62.18 -35.33 78.5 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.204 -0.935 . . . . 0.0 111.231 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 36.1 mt -54.87 -55.08 17.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 124.767 1.227 . . . . 0.0 109.273 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -67.58 -5.65 16.4 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.285 0.634 . . . . 0.0 112.054 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -121.14 8.5 10.36 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.659 2.383 . . . . 0.0 109.953 -173.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.3 m -151.33 62.0 0.89 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.067 2.147 . . . . 0.0 106.347 170.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? . . . . . 0 C--O 1.25 1.1 0 C-N-CA 129.317 3.047 . . . . 0.0 112.399 176.375 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.855 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 44.81 62.82 1.93 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.235 1.814 . . . . 0.0 113.572 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 mmm -123.75 85.02 2.35 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 122.814 1.292 . . . . 0.0 107.552 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.01 175.24 0.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.413 162.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.66 101.14 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.72 1.208 . . . . 0.0 109.747 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.9 m -122.88 152.7 40.51 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -175.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.69 152.62 44.05 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.426 0.631 . . . . 0.0 110.154 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -134.74 142.85 46.86 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 125.071 1.349 . . . . 0.0 108.854 -168.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.1 mt -145.98 77.83 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -165.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -69.08 172.19 7.13 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 118.196 0.453 . . . . 0.0 110.505 -173.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -127.08 -167.89 1.8 Allowed 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.578 -1.326 . . . . 0.0 108.559 170.071 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.412 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -142.66 66.56 1.32 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 127.921 2.489 . . . . 0.0 106.303 -159.491 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -162.65 -64.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 123.18 0.592 . . . . 0.0 109.547 -170.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -121.62 -1.54 10.84 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.859 1.218 . . . . 0.0 113.841 -173.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 C--O 1.26 1.628 0 C-N-CA 124.616 1.167 . . . . 0.0 108.859 168.055 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.6 ttm -103.53 87.35 1.38 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 127.267 2.227 . . . . 0.0 108.793 -166.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -61.9 113.23 1.76 Allowed 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 124.341 3.361 . . . . 0.0 109.595 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.53 -50.25 0.9 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -166.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.9 88.54 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.988 0.915 . . . . 0.0 109.946 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -63.42 -25.43 68.28 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -164.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -55.68 -66.45 0.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 O-C-N 124.57 1.169 . . . . 0.0 109.211 165.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.36 -46.51 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 116.653 -1.642 . . . . 0.0 113.259 -172.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.441 ' CD2' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -45.44 -53.39 8.82 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 120.365 1.438 . . . . 0.0 112.286 171.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.37 -41.47 76.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.856 0.723 . . . . 0.0 110.611 -170.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -61.88 -50.15 73.36 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.322 1.049 . . . . 0.0 109.812 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.43 74.73 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.809 1.643 . . . . 0.0 111.666 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -59.38 -60.57 3.65 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.631 0.772 . . . . 0.0 109.343 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.55 -13.92 6.84 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.2 -6.66 37.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 175.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.06 16.22 68.36 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.312 0.958 . . . . 0.0 111.927 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.0 mt -66.65 99.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.424 1.49 . . . . 0.0 107.013 171.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.36 108.36 1.09 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -87.34 155.89 19.85 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -150.07 173.76 13.5 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 128.459 2.704 . . . . 0.0 107.325 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 13.7 mt -136.51 156.79 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.669 0.788 . . . . 0.0 109.438 171.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -135.37 140.44 45.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.11 0.964 . . . . 0.0 111.583 165.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.9 t -154.31 167.73 28.96 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.33 -0.856 . . . . 0.0 110.455 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -94.66 -1.39 53.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.199 1.8 . . . . 0.0 111.803 168.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.43 171.02 15.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 121.365 1.893 . . . . 0.0 110.571 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.68 -178.16 20.6 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.738 1.161 . . . . 0.0 112.924 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -53.61 -18.98 3.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.556 1.542 . . . . 0.0 112.539 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.14 -27.34 0.95 Allowed 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 125.6 1.56 . . . . 0.0 113.379 172.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.83 -52.87 29.15 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.197 0.999 . . . . 0.0 111.506 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -56.7 -43.5 80.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.401 0.68 . . . . 0.0 110.311 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -59.89 -48.59 81.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.655 1.182 . . . . 0.0 110.898 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 62.0 mt -56.66 -46.84 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.825 0.85 . . . . 0.0 109.613 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.97 -44.6 92.26 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.78 0.832 . . . . 0.0 110.794 -174.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.96 -60.65 2.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 124.284 0.99 . . . . 0.0 108.943 169.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.61 -58.04 9.08 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.917 0.887 . . . . 0.0 112.185 -174.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.1 -32.17 73.47 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.68 -170.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.82 44.23 0.55 Allowed Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 157.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.441 HG21 ' CD2' ' A' ' 93' ' ' LEU . 2.0 p -166.22 52.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 -166.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -41.04 29.89 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 118.783 -2.448 . . . . 0.0 108.878 153.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.3 t -72.12 -8.29 53.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.349 1.46 . . . . 0.0 113.058 -158.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -80.89 -31.8 35.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.005 0.522 . . . . 0.0 109.857 172.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -105.58 101.97 11.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 120.624 -1.297 . . . . 0.0 108.229 -168.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.8 m -46.19 -51.28 14.51 Favored 'General case' 0 C--O 1.255 1.367 0 C-N-CA 126.117 1.767 . . . . 0.0 111.113 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.42 ' CD ' ' HH ' ' A' ' 147' ' ' TYR . 19.3 tt0 -142.7 144.4 32.69 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.262 0.625 . . . . 0.0 109.553 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.3 mt -132.26 97.81 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 -166.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.41 162.13 29.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.9 p -144.48 -177.38 5.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.358 1.463 . . . . 0.0 108.559 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 96.8 p -51.1 -32.62 23.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.093 0.86 . . . . 0.0 111.856 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -21.87 63.88 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.499 1.92 . . . . 0.0 111.348 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 65.0 p -57.51 -23.37 49.81 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.05 -14.95 59.24 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.225 0.916 . . . . 0.0 111.936 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -66.05 167.74 9.41 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 123.968 1.842 . . . . 0.0 113.23 -173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -58.04 154.14 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 C-N-CA 129.676 3.191 . . . . 0.0 109.91 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.13 43.71 1.05 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.752 0.787 . . . . 0.0 110.808 -172.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 mttt 70.29 147.65 0.12 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 128.394 2.678 . . . . 0.0 110.633 -168.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -62.8 124.34 3.2 Favored 'Cis proline' 0 N--CA 1.45 -1.051 0 N-CA-C 107.619 -1.724 . . . . 0.0 107.619 -22.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -116.32 85.26 15.6 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.49 -22.5 28.67 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.295 1.997 . . . . 0.0 111.405 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -56.31 -38.11 70.82 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.647 1.579 . . . . 0.0 110.397 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.45 -20.55 66.41 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.551 -169.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.66 -41.27 10.82 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 116.338 -1.791 . . . . 0.0 109.553 171.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 23.5 m -56.58 -36.05 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 120.95 1.705 . . . . 0.0 110.586 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.42 ' HH ' ' CD ' ' A' ' 128' ' ' GLU . 22.8 t80 -56.99 -52.62 64.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.826 0.85 . . . . 0.0 109.756 171.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.34 -39.74 88.22 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.726 1.61 . . . . 0.0 111.343 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.429 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 71.4 mt -57.82 -61.07 2.79 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.83 -31.31 72.45 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.707 0.803 . . . . 0.0 111.56 -171.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.19 -43.08 78.12 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 120.91 -1.119 . . . . 0.0 113.276 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -137.26 26.56 2.9 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 45.93 50.92 11.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.409 2.283 . . . . 0.0 110.441 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 65.8 mt -81.68 167.86 18.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.231 -1.35 . . . . 0.0 109.698 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.07 130.41 51.76 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.92 1.288 . . . . 0.0 108.407 -172.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -52.7 62.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.433 1.111 . . . . 0.0 109.038 176.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.91 -10.74 59.73 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.998 -1.064 . . . . 0.0 112.834 -170.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -112.15 17.54 19.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 109.322 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -104.38 145.69 29.9 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 118.745 0.702 . . . . 0.0 109.501 169.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.409 ' CD1' ' HB2' ' A' ' 178' ' ' GLN . 95.8 m-85 -125.02 159.06 32.19 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.036 1.734 . . . . 0.0 109.856 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -116.03 -39.27 3.47 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 1.3 mp 57.09 75.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 125.604 1.562 . . . . 0.0 112.44 177.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -128.1 -175.97 14.28 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.367 0.984 . . . . 0.0 110.867 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.59 26.7 5.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.54 1.536 . . . . 0.0 114.106 -156.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 1.9 ptp85 -160.62 159.85 30.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.725 2.01 . . . . 0.0 107.899 -178.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 21.6 p -51.8 -37.56 52.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.761 0.791 . . . . 0.0 111.86 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.1 -13.31 25.38 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -35.15 78.66 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 119.988 1.267 . . . . 0.0 110.546 172.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.5 p -104.36 -24.27 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.3 1.04 . . . . 0.0 110.783 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.73 -38.26 87.27 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 120.474 -1.392 . . . . 0.0 110.949 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -75.27 -38.12 60.59 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 118.36 -0.829 . . . . 0.0 110.287 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.26 69.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.978 1.311 . . . . 0.0 110.271 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.63 -43.09 56.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.946 1.299 . . . . 0.0 111.978 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -72.27 -22.12 61.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 118.419 -0.801 . . . . 0.0 113.057 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 t -96.1 -20.84 18.34 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.669 0.668 . . . . 0.0 110.314 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.9 49.8 6.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.15 178.0 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.038 1.735 . . . . 0.0 109.239 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.409 ' HB2' ' CD1' ' A' ' 160' ' ' TYR . 7.2 mm-40 -109.04 168.61 9.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.661 1.22 . . . . 0.0 111.815 -174.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.56 141.39 25.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.868 2.067 . . . . 0.0 108.785 -174.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 57.3 mt -121.01 86.5 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.43 176.58 6.14 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.835 -167.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -109.64 -6.42 15.35 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 119.654 -1.904 . . . . 0.0 111.469 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.96 146.2 45.18 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.644 1.978 . . . . 0.0 108.574 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.84 144.97 56.49 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 11.7 t -122.23 171.91 8.67 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 112.854 -1.976 . . . . 0.0 107.01 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 9.9 p -114.4 27.7 9.28 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.26 1.824 . . . . 0.0 109.666 -175.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -123.24 140.81 52.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.418 1.487 . . . . 0.0 110.014 -175.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -77.54 96.61 4.8 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.28 1.832 . . . . 0.0 109.415 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 133.76 -1.89 4.38 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.427 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.8 153.51 34.85 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 119.394 1.597 . . . . 0.0 108.407 168.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -138.12 99.95 4.01 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . 0.292 0.2 OUTLIER -75.0 151.44 38.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 115.682 -2.407 . . . . 0.0 109.4 175.403 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.0 pt -126.27 -176.5 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 130.032 3.333 . . . . 0.0 107.982 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -126.83 -14.63 5.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 125.247 1.419 . . . . 0.0 111.75 167.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.93 165.0 36.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.52 0.6 . . . . 0.0 109.455 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.39 -25.89 63.45 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.146 -0.971 . . . . 0.0 110.474 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.34 -32.12 73.32 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.06 -1.025 . . . . 0.0 111.115 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.65 -22.17 63.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.036 2.534 . . . . 0.0 110.728 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.28 -56.7 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 C-N-CA 124.409 1.084 . . . . 0.0 109.009 171.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 96.3 p -52.45 -40.39 62.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.539 0.609 . . . . 0.0 111.384 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 34.0 mtt85 -64.03 -32.8 74.49 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.447 -1.263 . . . . 0.0 112.541 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.23 -45.57 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.088 1.313 . . . . 0.0 109.192 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.69 -5.45 53.12 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.477 ' C ' ' HG1' ' A' ' 205' ' ' THR . 46.5 mt-10 -117.1 5.94 12.83 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.823 1.249 . . . . 0.0 113.205 -177.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.477 ' HG1' ' C ' ' A' ' 204' ' ' GLU 0.271 86.0 m -143.64 28.43 1.45 Allowed 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.893 -1.129 . . . . 0.0 110.816 -169.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.314 29.8 pttt . . . . . 0 N--CA 1.476 0.853 1 C-N-CA 132.07 4.148 . . . . 0.0 114.811 175.908 . . . . . . . . 2 1 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -123.49 15.39 9.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.049 0.925 . . . . 0.0 112.35 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mmm 50.19 74.11 0.23 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.735 1.214 . . . . 0.0 110.181 -172.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -62.63 173.51 1.25 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.13 -1.396 . . . . 0.0 109.095 173.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -44.17 83.74 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.029 2.132 . . . . 0.0 114.535 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.8 m -110.76 159.83 17.27 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.821 1.248 . . . . 0.0 107.651 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.92 158.5 44.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.411 0.624 . . . . 0.0 110.937 162.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -114.3 174.85 5.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.61 1.164 . . . . 0.0 108.38 169.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mt -139.84 137.2 39.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 163.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -119.07 178.2 4.59 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.485 1.914 . . . . 0.0 109.442 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.24 -179.8 6.47 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.246 1.819 . . . . 0.0 107.641 -170.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.57 -1.36 10.1 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.762 -1.211 . . . . 0.0 114.238 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.05 -42.05 27.37 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 120.743 -1.223 . . . . 0.0 111.6 -172.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.49 -155.89 7.37 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -170.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.41 1.3 t . . . . . 0 C--O 1.255 1.378 0 C-N-CA 127.828 2.451 . . . . 0.0 111.139 170.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 41.3 tpp -115.34 86.3 14.41 Favored Pre-proline 0 N--CA 1.448 -0.574 0 C-N-CA 125.849 1.659 . . . . 0.0 108.322 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -64.94 100.92 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.474 3.45 . . . . 0.0 110.255 -172.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 132.83 -40.46 1.61 Allowed Glycine 0 C--O 1.227 -0.31 0 C-N-CA 124.66 1.124 . . . . 0.0 110.571 -175.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.86 -20.11 60.53 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.126 -1.22 . . . . 0.0 109.319 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.74 -9.8 39.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.952 1.701 . . . . 0.0 112.393 176.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -65.82 -38.98 90.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.425 1.09 . . . . 0.0 110.796 165.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.7 -39.72 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.351 -0.843 . . . . 0.0 110.772 -173.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 125' ' ' TYR . 6.9 mp -44.35 -41.0 5.75 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 127.797 2.439 . . . . 0.0 111.549 166.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.17 -50.8 62.66 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.903 1.377 . . . . 0.0 109.581 -177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -56.71 -45.45 81.85 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.766 0.827 . . . . 0.0 110.475 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.31 -38.81 71.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.362 1.065 . . . . 0.0 113.138 -174.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.58 -52.11 59.26 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.613 1.165 . . . . 0.0 109.635 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -60.72 -38.12 84.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.336 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.0 m -71.86 -1.26 13.62 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.5 16.14 60.37 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.46 1.505 . . . . 0.0 113.259 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.9 mt -76.05 101.11 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -57.42 109.95 0.78 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.07 1.348 . . . . 0.0 108.913 -174.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -84.6 147.13 27.14 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 172.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -137.39 168.25 20.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 168.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mt -124.53 149.75 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.529 0.731 . . . . 0.0 109.132 171.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -134.04 128.11 33.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 157.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -145.97 -173.95 4.3 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 162.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -126.04 12.77 7.8 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.36 1.864 . . . . 0.0 112.229 -175.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.454 ' HE2' ' CD1' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -73.28 -10.43 59.75 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -165.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 126.91 174.62 13.85 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 126.399 1.952 . . . . 0.0 109.764 -170.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -29.08 70.37 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 117.491 0.645 . . . . 0.0 110.421 172.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -51.64 -14.81 0.37 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.435 2.294 . . . . 0.0 114.544 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.68 -44.53 69.81 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.528 1.058 . . . . 0.0 111.061 169.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -63.22 -7.82 6.84 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.317 1.847 . . . . 0.0 114.122 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 19.0 m -101.92 -49.3 4.0 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 120.521 -1.362 . . . . 0.0 108.501 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.454 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 52.4 mt -52.64 -48.92 47.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 C-N-CA 123.799 0.84 . . . . 0.0 109.367 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.9 mt -64.01 -35.99 82.52 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.0 -1.062 . . . . 0.0 111.366 -172.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.12 -50.45 73.65 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.064 1.345 . . . . 0.0 109.359 172.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.01 -48.11 79.26 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.56 1.544 . . . . 0.0 111.312 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 99.5 mt -58.81 -50.44 73.95 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.476 1.11 . . . . 0.0 108.391 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.9 36.16 3.04 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.065 1.317 . . . . 0.0 112.271 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.94 22.61 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.855 1.662 . . . . 0.0 110.314 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.25 -54.33 46.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.51 1.524 . . . . 0.0 112.657 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.7 m -76.56 -12.62 60.05 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -164.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.405 ' CD2' ' CD2' ' A' ' 93' ' ' LEU . 26.0 m-85 -54.82 -32.64 60.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.938 0.79 . . . . 0.0 110.943 164.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -98.37 106.18 18.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -172.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.4 m -45.08 -54.11 7.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.559 1.944 . . . . 0.0 110.752 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -142.93 150.24 39.49 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 mt -131.77 88.56 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -168.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.94 145.2 48.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.317 -0.864 . . . . 0.0 109.196 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.7 p -121.77 -173.31 2.62 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.766 0.826 . . . . 0.0 110.553 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 p -56.44 -20.0 17.81 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.001 -1.062 . . . . 0.0 113.31 167.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -77.21 -3.98 42.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.48 1.512 . . . . 0.0 111.918 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.3 p -58.76 -25.64 63.23 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.82 20.19 31.93 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.204 0.906 . . . . 0.0 114.824 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -78.16 -86.89 0.06 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.559 1.679 . . . . 0.0 107.667 168.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.0 t -150.87 168.42 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 126.177 1.791 . . . . 0.0 107.743 -170.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.453 ' H ' ' HD3' ' A' ' 138' ' ' ARG 0.255 0.0 OUTLIER -74.06 -85.16 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 117.817 -1.087 . . . . 0.0 109.583 166.798 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -160.15 139.23 7.94 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 121.32 1.873 . . . . 0.0 109.42 -172.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.86 -28.56 4.55 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 121.035 1.405 . . . . 0.0 115.12 7.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.9 t 59.98 62.3 3.55 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.667 1.187 . . . . 0.0 113.211 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -61.94 -24.42 76.93 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.549 2.166 . . . . 0.0 112.584 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -56.17 -28.77 59.35 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.939 1.296 . . . . 0.0 112.463 -171.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.08 -42.9 77.42 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.056 0.943 . . . . 0.0 110.055 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.26 92.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.693 -0.63 . . . . 0.0 111.288 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 m -55.37 -40.32 71.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.268 0.627 . . . . 0.0 110.514 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -66.64 -51.24 58.47 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.9 mp -56.06 -38.67 70.94 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 111.749 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -60.45 -61.85 2.29 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 126.823 2.049 . . . . 0.0 107.473 177.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -57.35 -36.89 71.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.53 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -48.65 -45.4 38.62 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.378 1.071 . . . . 0.0 112.545 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.75 21.71 10.69 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.411 1.005 . . . . 0.0 112.863 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 50.78 69.5 0.63 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.921 1.689 . . . . 0.0 110.112 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 1.1 mt -122.41 178.87 4.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.544 1.537 . . . . 0.0 108.506 -173.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.0 151.49 38.91 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.689 1.996 . . . . 0.0 111.361 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 53.5 m -55.91 -33.71 64.92 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.355 0.598 . . . . 0.0 110.084 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.93 -35.11 64.55 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 120.559 -1.338 . . . . 0.0 109.866 -176.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -77.83 1.15 21.24 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.977 -1.487 . . . . 0.0 113.639 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.6 t -97.78 140.03 32.77 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.322 1.419 . . . . 0.0 110.43 -176.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -127.7 109.05 11.28 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.423 1.489 . . . . 0.0 110.559 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -91.83 131.31 37.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.838 0.455 . . . . 0.0 111.079 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.18 119.35 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 126.348 1.859 . . . . 0.0 109.011 -174.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -145.52 -21.49 0.14 Allowed Glycine 0 CA--C 1.535 1.299 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 19.2 t70 59.29 58.13 3.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.538 1.935 . . . . 0.0 112.886 -174.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -163.35 164.28 24.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.498 -1.376 . . . . 0.0 112.128 172.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.3 t -51.72 -53.07 43.35 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.906 1.282 . . . . 0.0 111.366 167.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.76 -20.59 66.45 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.602 1.561 . . . . 0.0 110.882 -165.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.18 -34.78 78.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.677 -0.64 . . . . 0.0 110.267 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.13 -11.98 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.5 0.72 . . . . 0.0 111.353 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.06 -55.89 18.91 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 169.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -54.05 -42.01 68.74 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.261 1.025 . . . . 0.0 111.479 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.77 -26.48 67.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.767 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -90.14 -42.09 11.26 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.921 1.237 . . . . 0.0 109.225 -169.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -29.23 69.22 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.04 -41.23 26.12 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.23 0.923 . . . . 0.0 110.377 169.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 80.4 56.32 3.22 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -170.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 41.7 pt -129.88 165.03 31.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 127.643 2.377 . . . . 0.0 106.146 -174.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -85.27 163.07 18.85 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.168 -0.958 . . . . 0.0 109.96 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.39 162.52 34.83 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.823 0.82 . . . . 0.0 109.834 172.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 36.0 mt -138.57 120.56 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -139.56 164.64 29.36 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -74.69 9.02 2.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.5 151.81 36.99 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.009 1.324 . . . . 0.0 109.18 -166.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -70.55 147.55 49.18 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.15 26.19 2.03 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.522 1.129 . . . . 0.0 111.183 167.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 17.3 p 50.67 45.82 26.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.466 1.507 . . . . 0.0 111.734 164.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -136.28 157.06 47.71 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.983 2.113 . . . . 0.0 106.365 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -75.4 -45.63 37.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.619 0.645 . . . . 0.0 111.665 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -68.86 -9.02 58.69 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.063 -0.854 . . . . 0.0 112.878 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.09 100.92 12.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.041 1.92 . . . . 0.0 109.181 -173.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -79.74 134.07 36.37 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.28 0.632 . . . . 0.0 109.343 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . 0.413 ' HB3' HH11 ' A' ' 192' ' ' ARG . 0.0 OUTLIER -77.72 151.56 34.1 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 166.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.83 166.68 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.409 1.883 . . . . 0.0 109.955 171.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -129.54 0.73 5.0 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.385 1.474 . . . . 0.0 112.799 168.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.05 165.56 34.32 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.289 1.436 . . . . 0.0 108.307 171.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 69.3 mt -73.62 -33.66 64.67 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 118.578 0.626 . . . . 0.0 110.154 176.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.51 -22.27 66.15 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -62.75 -21.72 66.04 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.367 -0.833 . . . . 0.0 110.799 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.49 -55.97 19.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 125.138 1.375 . . . . 0.0 109.087 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 95.0 p -60.02 -33.19 71.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.055 1.298 . . . . 0.0 110.877 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -63.24 -33.69 76.05 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.044 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.1 mt -50.31 -58.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -67.26 -12.76 60.94 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.584 1.153 . . . . 0.0 112.952 -174.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -106.23 5.73 30.11 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.184 1.394 . . . . 0.0 112.853 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.4 m -128.87 25.17 5.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.28 1.032 . . . . 0.0 112.236 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.271 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 C-N-CA 128.923 2.889 . . . . 0.0 111.19 -168.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mmm . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -52.63 -177.45 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.323 1.849 . . . . 0.0 113.184 164.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -61.2 100.03 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 O-C-N 120.449 -1.407 . . . . 0.0 107.676 168.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.3 m -128.35 148.25 50.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.89 150.01 52.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -127.74 149.75 50.1 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.613 1.565 . . . . 0.0 108.41 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mt -142.82 132.12 21.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -115.67 179.61 3.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.849 1.66 . . . . 0.0 109.999 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -133.92 175.91 9.04 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.517 2.327 . . . . 0.0 106.657 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 C--O 1.236 0.347 0 C-N-CA 124.803 1.241 . . . . 0.0 108.824 -177.056 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -60.33 -21.24 61.81 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -57.66 -69.81 0.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.366 1.466 . . . . 0.0 109.043 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.06 -40.48 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.638 1.175 . . . . 0.0 109.962 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.7 mt -55.52 -50.79 69.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.13 0.877 . . . . 0.0 110.047 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.26 -45.08 89.68 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.286 0.635 . . . . 0.0 111.695 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -57.28 -55.28 36.82 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.227 1.011 . . . . 0.0 109.021 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.26 -40.5 94.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.59 0.756 . . . . 0.0 111.049 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -59.22 -58.64 7.76 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.195 1.398 . . . . 0.0 110.017 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -62.1 -28.49 69.66 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.6 m -71.2 -5.66 33.61 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.468 -0.77 . . . . 0.0 112.672 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.83 9.93 71.32 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 119.639 1.109 . . . . 0.0 113.539 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.3 mt -56.03 149.69 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 119.307 1.553 . . . . 0.0 107.192 160.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.64 105.48 16.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 170.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -78.47 149.43 33.2 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.25 0.932 . . . . 0.0 109.065 172.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -139.81 174.16 10.8 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.203 1.801 . . . . 0.0 108.383 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.0 mt -136.31 150.42 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 4.8 t80 -134.5 141.44 46.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 152.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 109' ' ' LYS . 2.6 t -156.07 165.65 35.8 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -76.42 -12.95 60.13 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.189 -0.944 . . . . 0.0 112.882 174.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.45 ' H ' HG23 ' A' ' 107' ' ' THR . 1.5 ttmm -63.98 156.76 26.95 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.149 -0.969 . . . . 0.0 110.063 -174.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.49 -169.97 38.96 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.992 0.806 . . . . 0.0 114.252 -170.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.22 -12.52 9.0 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.949 1.3 . . . . 0.0 112.264 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -61.54 -12.44 15.35 Favored 'General case' 0 C--O 1.224 -0.238 0 O-C-N 119.781 -1.825 . . . . 0.0 112.384 168.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.44 -47.97 83.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 120.712 1.596 . . . . 0.0 107.804 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -56.46 -45.14 81.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.98 1.712 . . . . 0.0 110.098 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 m -67.46 -44.81 77.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.998 0.919 . . . . 0.0 111.209 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.72 -46.0 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.669 1.188 . . . . 0.0 108.308 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mp -57.36 -45.19 84.66 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.702 0.801 . . . . 0.0 110.504 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -49.9 75.53 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.257 1.023 . . . . 0.0 110.358 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.21 -57.5 7.64 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.755 1.622 . . . . 0.0 109.179 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.94 -12.86 61.78 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.785 1.634 . . . . 0.0 112.727 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 88.77 12.51 64.09 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.562 1.077 . . . . 0.0 113.976 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.4 m -119.87 16.27 6.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 125.105 1.362 . . . . 0.0 111.635 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -59.65 -40.6 88.21 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.267 -0.896 . . . . 0.0 113.37 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.03 -11.04 60.41 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.757 0.661 . . . . 0.0 112.486 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -74.71 4.57 6.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.857 1.208 . . . . 0.0 113.269 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -141.28 123.94 16.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -54.36 -45.96 72.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.284 1.434 . . . . 0.0 110.175 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -153.58 142.82 21.47 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.71 100.96 7.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 106' ' ' TYR . 3.5 mm? -76.1 155.23 34.91 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.9 p -140.91 -174.64 4.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.103 1.361 . . . . 0.0 109.848 -171.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 62.4 p -52.36 -24.51 7.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.534 1.061 . . . . 0.0 112.592 168.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -58.47 -35.22 71.84 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.144 1.378 . . . . 0.0 110.349 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.421 ' HB2' ' CD2' ' A' ' 136' ' ' PHE . 80.5 p -57.36 -35.82 70.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.54 -8.01 50.53 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.671 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.421 ' CD2' ' HB2' ' A' ' 134' ' ' SER . 29.5 m-85 -59.57 156.97 12.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.72 1.26 . . . . 0.0 111.087 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.74 HG23 ' HB2' ' A' ' 141' ' ' SER . 2.3 m -52.97 159.18 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.054 1.342 . . . . 0.0 113.398 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -67.53 160.64 27.24 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.585 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -61.09 133.01 92.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 117.258 -1.353 . . . . 0.0 108.744 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.66 135.68 41.4 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 121.33 1.511 . . . . 0.0 110.17 -3.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.74 ' HB2' HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -143.44 85.45 9.47 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -170.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.21 -16.61 22.27 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 N-CA-C 109.23 -1.104 . . . . 0.0 109.23 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -44.52 -49.96 9.76 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 126.857 2.063 . . . . 0.0 110.717 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.55 65.54 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.491 -171.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.4 -41.16 20.27 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.095 -1.628 . . . . 0.0 109.295 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.8 m -58.87 -30.52 67.79 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.902 0.774 . . . . 0.0 111.082 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.578 ' CZ ' ' HE3' ' A' ' 151' ' ' LYS . 34.4 t80 -60.62 -55.68 30.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.884 0.873 . . . . 0.0 109.389 166.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.437 HD12 ' HD1' ' A' ' 147' ' ' TYR . 4.5 mp -58.09 -28.09 64.27 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.705 1.602 . . . . 0.0 113.095 -173.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.7 mt -71.61 -63.97 1.02 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.467 1.507 . . . . 0.0 107.18 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.36 -20.05 65.97 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.273 0.629 . . . . 0.0 112.55 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.578 ' HE3' ' CZ ' ' A' ' 147' ' ' TYR . 12.5 mmtt -51.78 -41.64 61.82 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 121.345 -0.847 . . . . 0.0 111.897 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -144.46 17.28 1.68 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -172.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.6 mm-40 59.9 62.9 1.57 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.867 1.667 . . . . 0.0 110.983 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.89 173.19 6.42 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.347 1.459 . . . . 0.0 109.973 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -116.51 126.28 53.12 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.522 1.529 . . . . 0.0 108.07 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -44.6 77.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.2 1.0 . . . . 0.0 110.454 174.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.76 -9.32 58.51 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.326 -0.859 . . . . 0.0 112.607 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -117.33 17.44 14.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.819 0.848 . . . . 0.0 108.829 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -106.64 130.31 54.4 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 170.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -122.2 97.78 5.63 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.079 1.752 . . . . 0.0 106.802 -170.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -71.85 158.7 35.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.684 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 47.8 mt -130.03 97.62 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 -171.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -120.81 -179.0 16.12 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 125.562 1.554 . . . . 0.0 112.011 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -128.78 -5.48 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.516 1.126 . . . . 0.0 113.405 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -121.16 165.54 15.23 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 122.347 1.07 . . . . 0.0 112.126 -164.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.8 t -63.25 -39.53 94.85 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.992 1.317 . . . . 0.0 110.187 164.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -32.46 72.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.408 1.083 . . . . 0.0 110.421 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.38 8.45 0.61 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.623 1.969 . . . . 0.0 111.824 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -131.39 -25.06 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 125.296 1.439 . . . . 0.0 110.816 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.53 -56.66 19.02 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.665 -1.272 . . . . 0.0 109.344 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -66.5 -29.52 69.64 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.947 -1.095 . . . . 0.0 110.925 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.54 -51.29 67.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -52.76 -52.84 54.95 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 124.386 1.075 . . . . 0.0 111.027 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -52.63 -47.21 67.16 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.354 0.261 . . . . 0.0 111.496 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.8 m -72.79 -26.85 61.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.763 0.825 . . . . 0.0 112.048 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.96 32.54 39.7 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.561 1.553 . . . . 0.0 111.181 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 22.1 pt -109.83 167.61 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 124.985 1.314 . . . . 0.0 109.36 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -97.63 162.54 13.24 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -175.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 23.5 m -135.33 152.75 51.76 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.327 1.451 . . . . 0.0 109.787 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 42.2 mt -131.84 95.37 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -129.56 149.97 51.1 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.309 1.044 . . . . 0.0 109.117 -165.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -70.7 -12.28 61.46 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.071 -1.018 . . . . 0.0 113.542 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.37 151.64 47.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.658 1.583 . . . . 0.0 109.594 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -78.4 154.95 30.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.4 t -144.11 13.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.387 0.675 . . . . 0.0 110.946 -174.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 71.0 p 57.06 69.66 0.72 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.939 2.096 . . . . 0.0 110.406 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -150.78 135.19 17.07 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.402 1.081 . . . . 0.0 108.405 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -70.12 -7.08 38.61 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -108.19 8.08 35.47 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.297 1.427 . . . . 0.0 112.954 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -108.94 122.06 46.42 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 120.788 2.294 . . . . 0.0 110.437 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -101.21 119.17 38.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.364 1.065 . . . . 0.0 109.427 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -67.61 146.59 53.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.431 0.56 . . . . 0.0 111.273 171.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.2 pt -146.04 175.75 2.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 127.296 2.239 . . . . 0.0 109.594 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -136.38 -12.41 1.84 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.436 1.494 . . . . 0.0 113.142 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.15 160.8 39.14 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.148 1.379 . . . . 0.0 108.075 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.36 -31.8 73.15 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.231 1.412 . . . . 0.0 110.503 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.22 -9.18 51.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -19.02 61.0 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.384 0.993 . . . . 0.0 110.409 172.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 67.8 mt -55.86 -52.85 44.5 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.6 p -60.26 -35.67 76.05 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.113 0.415 . . . . 0.0 111.688 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -62.62 -36.28 82.27 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.876 0.871 . . . . 0.0 112.226 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.3 mt -59.37 -44.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 124.289 1.036 . . . . 0.0 108.8 -172.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -84.86 13.17 6.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.534 1.134 . . . . 0.0 112.55 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 125.295 1.438 . . . . 0.0 110.362 -172.236 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.2 mmm . . . . . 0 N--CA 1.438 -1.033 0 N-CA-C 102.306 -3.22 . . . . 0.0 102.306 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -169.36 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 112.551 -2.113 . . . . 0.0 110.625 158.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -50.22 115.0 1.24 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 156.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.6 m -131.52 157.77 42.68 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 163.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.95 150.71 51.97 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.878 -0.514 . . . . 0.0 109.683 165.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.66 149.28 52.32 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 126.273 1.829 . . . . 0.0 108.156 -173.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.0 mt -142.12 145.65 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -125.22 174.51 8.05 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.086 1.755 . . . . 0.0 109.979 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 -11.2 9.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.561 1.544 . . . . 0.0 111.723 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 N--CA 1.466 0.332 0 C-N-CA 128.437 2.695 . . . . 0.0 112.603 174.132 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.557 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -67.0 -25.31 66.24 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.39 -1.444 . . . . 0.0 114.266 -167.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.04 -53.94 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.108 0.563 . . . . 0.0 110.592 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.8 t -68.63 -34.95 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.713 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.832 HD23 ' CD2' ' A' ' 125' ' ' TYR . 7.4 mp -44.49 -50.51 9.43 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 121.529 1.968 . . . . 0.0 113.374 164.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.92 -50.47 64.32 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 124.15 0.906 . . . . 0.0 109.782 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -53.36 -50.53 64.88 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 123.836 0.71 . . . . 0.0 110.358 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.04 -39.79 82.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.314 1.046 . . . . 0.0 111.822 -177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -71.96 -41.52 67.64 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 118.455 0.571 . . . . 0.0 110.719 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -64.17 -28.56 69.84 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.508 -0.745 . . . . 0.0 111.547 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.5 m -76.49 -13.0 60.13 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.002 0.921 . . . . 0.0 112.235 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.62 37.38 75.82 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.027 1.299 . . . . 0.0 112.003 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.6 mt -68.12 121.85 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 159.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -68.08 113.6 5.88 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 170.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -94.13 144.13 25.76 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.406 1.482 . . . . 0.0 107.686 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -143.97 177.83 8.28 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.242 1.017 . . . . 0.0 109.298 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.9 mt -135.83 150.52 28.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 124.074 0.95 . . . . 0.0 108.591 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -133.24 113.16 12.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 156.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -133.06 175.52 9.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.315 1.446 . . . . 0.0 109.178 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . 0.274 2.1 p80 -125.99 22.42 7.35 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -72.42 -0.81 13.49 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.16 -177.9 38.42 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.912 1.244 . . . . 0.0 111.793 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -72.27 -2.77 20.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -162.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -70.85 -10.22 59.16 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.741 164.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.96 -52.96 17.62 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.731 1.212 . . . . 0.0 111.335 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -59.47 -44.79 92.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.055 0.542 . . . . 0.0 110.114 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -62.82 -40.82 98.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.938 1.295 . . . . 0.0 111.123 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.7 mt -63.64 -50.75 76.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.33 -38.93 92.78 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.57 -0.706 . . . . 0.0 111.324 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -63.51 -46.02 88.01 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.6 0.76 . . . . 0.0 110.379 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -48.68 -50.42 33.32 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.985 1.374 . . . . 0.0 110.111 172.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.4 mt -69.46 -18.67 63.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.844 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.99 33.32 69.97 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.869 0.759 . . . . 0.0 111.985 174.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.1 m -137.19 22.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 126.361 1.864 . . . . 0.0 108.841 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.81 -42.18 81.93 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.051 -0.405 . . . . 0.0 110.218 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.2 m -58.83 -24.27 61.78 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.935 0.772 . . . . 0.0 112.171 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.832 ' CD2' HD23 ' A' ' 93' ' ' LEU . 26.0 m-85 -68.47 6.35 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.123 1.369 . . . . 0.0 113.986 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -140.91 105.94 4.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 47.6 m -55.16 -41.32 71.7 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.521 1.528 . . . . 0.0 111.056 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -150.87 147.26 27.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.74 96.87 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -167.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.97 145.79 48.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.1 p -123.88 -176.26 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.493 1.117 . . . . 0.0 110.323 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.9 t -48.78 -34.88 13.13 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.273 1.429 . . . . 0.0 110.411 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -82.3 -2.58 53.14 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.286 1.434 . . . . 0.0 112.319 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 83.9 p -57.07 -63.13 1.31 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.304 1.411 . . . . 0.0 110.299 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 123.2 -16.0 8.16 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 125.598 1.57 . . . . 0.0 112.643 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -58.63 166.83 1.68 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.049 1.425 . . . . 0.0 112.83 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.484 HG23 ' CB ' ' A' ' 141' ' ' SER . 16.3 m -60.57 160.75 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.916 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.4 mtt-85 -84.89 147.71 26.63 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.061 -1.649 . . . . 0.0 109.01 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -48.44 131.79 13.38 Favored Pre-proline 0 C--O 1.243 0.743 0 CA-C-O 117.4 -1.286 . . . . 0.0 109.949 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.27 125.82 7.19 Favored 'Cis proline' 0 C--N 1.351 0.691 0 CA-C-N 121.018 1.399 . . . . 0.0 111.696 -3.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.484 ' CB ' HG23 ' A' ' 137' ' ' VAL . 10.4 p -141.94 85.43 11.12 Favored Pre-proline 0 N--CA 1.438 -1.026 0 C-N-CA 123.292 0.637 . . . . 0.0 111.893 -173.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.69 -18.51 32.57 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.376 . . . . 0.0 112.561 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -45.3 -43.84 11.0 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.285 1.834 . . . . 0.0 112.686 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.63 -7.6 21.67 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.537 0.939 . . . . 0.0 113.537 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.01 -61.05 1.93 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.046 0.938 . . . . 0.0 108.737 163.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.8 m -56.22 -40.29 73.85 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.475 1.91 . . . . 0.0 110.466 -170.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -53.91 -51.25 64.34 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.572 0.749 . . . . 0.0 110.907 174.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.51 -27.98 51.97 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.832 0.853 . . . . 0.0 112.159 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.49 -59.93 4.26 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -67.76 -22.41 65.21 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -61.13 -48.91 79.47 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.788 -1.195 . . . . 0.0 112.438 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -121.63 18.19 11.19 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.078 0.854 . . . . 0.0 112.013 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 54.07 51.96 13.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.335 1.854 . . . . 0.0 111.219 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.33 170.3 15.51 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.371 1.469 . . . . 0.0 110.224 175.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -105.73 130.25 53.78 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.038 1.735 . . . . 0.0 108.288 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 m -58.02 -29.47 65.34 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.261 0.937 . . . . 0.0 110.877 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.52 -27.83 23.75 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -84.84 -0.94 55.69 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -99.64 138.74 36.3 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.143 0.883 . . . . 0.0 108.654 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.444 ' CD1' ' HB2' ' A' ' 178' ' ' GLN . 92.6 m-85 -120.15 166.16 13.8 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.871 1.669 . . . . 0.0 107.554 173.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -139.39 157.25 46.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.455 1.902 . . . . 0.0 107.02 168.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 5.0 mt -135.82 128.73 47.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -161.72 10.01 0.11 Allowed Glycine 0 C--O 1.224 -0.482 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.026 -174.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . 0.293 1.5 p30 60.86 -1.85 0.22 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 129.799 3.24 . . . . 0.0 115.862 163.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -113.36 168.27 9.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.974 0.806 . . . . 0.0 112.858 -168.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.1 t -59.22 -35.39 73.56 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.077 -1.015 . . . . 0.0 111.642 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.727 HD12 ' CE1' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -66.94 -13.44 61.8 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.37 1.468 . . . . 0.0 112.419 -178.026 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.42 -39.15 88.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.634 0.731 . . . . 0.0 111.595 -167.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.91 -45.86 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 125.022 1.329 . . . . 0.0 108.655 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.526 ' HB2' HD13 ' A' ' 167' ' ' LEU . 59.8 mm-40 -59.81 -41.18 90.69 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.021 0.929 . . . . 0.0 110.938 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.727 ' CE1' HD12 ' A' ' 167' ' ' LEU . 19.5 m-85 -64.22 -51.81 61.87 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.229 0.922 . . . . 0.0 110.829 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.19 97.51 Favored 'General case' 0 C--O 1.224 -0.287 0 O-C-N 123.577 0.548 . . . . 0.0 111.259 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.78 -28.89 70.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.322 0.649 . . . . 0.0 111.81 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -60.04 -46.8 88.34 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.486 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.33 -23.36 32.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.879 1.672 . . . . 0.0 113.318 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 90.0 10.39 64.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.499 2.0 . . . . 0.0 113.847 -175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 23.7 pt -81.79 -173.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.221 1.51 . . . . 0.0 110.163 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.444 ' HB2' ' CD1' ' A' ' 160' ' ' TYR . 23.9 mm-40 -101.17 161.75 13.39 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.287 1.035 . . . . 0.0 110.419 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.05 160.58 40.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.885 1.274 . . . . 0.0 113.419 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.8 mt -142.9 83.34 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.823 1.649 . . . . 0.0 108.845 -172.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -97.66 -171.41 2.18 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.994 -1.066 . . . . 0.0 110.62 173.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -99.74 -5.9 27.95 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.514 -1.366 . . . . 0.0 112.704 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.677 HD22 ' H ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -112.61 137.58 50.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -176.576 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.96 162.04 29.97 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.958 1.703 . . . . 0.0 109.626 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 34.7 t -155.77 157.87 37.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 10.2 p -85.91 19.64 2.49 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.603 1.161 . . . . 0.0 111.795 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -67.82 -178.62 0.99 Allowed 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.612 -0.68 . . . . 0.0 110.27 168.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.04 5.5 7.93 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -165.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.92 23.39 1.01 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.1 1.81 . . . . 0.0 111.52 167.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -81.92 149.56 28.17 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 120.794 -1.415 . . . . 0.0 108.882 160.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -142.29 99.36 3.49 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.166 0.586 . . . . 0.0 109.612 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -73.93 162.63 28.86 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 118.438 -1.305 . . . . 0.0 112.035 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 6.7 pt -135.31 169.31 21.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.403 1.881 . . . . 0.0 110.099 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.57 -2.9 11.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.95 1.3 . . . . 0.0 112.862 168.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.56 167.52 28.34 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.852 1.261 . . . . 0.0 109.079 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 196' ' ' LEU . 7.5 tp -76.08 -40.39 53.2 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -173.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.48 -18.86 64.23 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.52 -11.24 60.17 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.811 0.844 . . . . 0.0 111.027 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.39 -55.62 23.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-O 117.835 -1.079 . . . . 0.0 108.484 166.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.2 m -54.27 -38.88 66.33 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.621 1.101 . . . . 0.0 110.158 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -64.14 -25.98 68.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.1 mt -56.44 -48.19 80.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -78.85 -41.07 30.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.436 1.094 . . . . 0.0 109.89 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.235 0.337 0 C-N-CA 126.67 1.988 . . . . 0.0 109.276 -174.928 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mmm . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 122.846 1.308 . . . . 0.0 107.478 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.35 114.59 28.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 113.985 -1.461 . . . . 0.0 107.588 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.53 83.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.329 1.852 . . . . 0.0 111.368 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 m -124.08 135.11 53.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.8 150.26 31.9 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 170.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -126.49 150.91 48.45 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.291 1.436 . . . . 0.0 108.464 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -138.56 135.47 43.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -125.8 163.05 23.73 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.841 2.057 . . . . 0.0 109.999 -169.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -86.51 -29.92 22.35 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.851 2.06 . . . . 0.0 112.491 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 C-N-CA 125.615 1.566 . . . . 0.0 111.195 -167.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -65.49 -30.08 70.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.676 1.125 . . . . 0.0 112.301 -175.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.46 -55.63 31.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.818 0.847 . . . . 0.0 110.489 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.47 -42.14 94.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.33 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.619 HD23 ' CD2' ' A' ' 125' ' ' TYR . 6.6 mp -44.55 -52.85 7.65 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 121.645 2.021 . . . . 0.0 112.544 168.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.69 80.68 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.588 1.18 . . . . 0.0 110.957 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -58.63 -46.66 86.61 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.101 0.96 . . . . 0.0 111.421 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.51 -38.0 68.21 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.293 -0.861 . . . . 0.0 112.418 -172.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.52 -40.75 93.33 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.945 0.793 . . . . 0.0 109.752 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -52.03 -54.74 26.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.639 1.176 . . . . 0.0 109.021 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.3 m -74.0 4.77 4.97 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 60.31 24.79 61.76 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.659 1.118 . . . . 0.0 113.151 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.4 mt -71.3 108.22 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 127.032 2.133 . . . . 0.0 107.47 169.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 2.8 pt20 -65.84 103.18 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.996 0.518 . . . . 0.0 110.165 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -84.8 151.58 24.25 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -145.32 169.64 17.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.943 1.697 . . . . 0.0 109.803 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 22.3 mt -138.79 157.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.774 1.629 . . . . 0.0 110.698 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -137.46 115.77 11.84 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.027 0.931 . . . . 0.0 109.383 163.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -134.42 161.07 36.04 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.454 1.502 . . . . 0.0 108.547 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -88.28 -2.43 58.6 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.283 1.033 . . . . 0.0 110.896 170.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.09 147.87 11.99 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.853 1.661 . . . . 0.0 108.233 172.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.95 -171.59 28.48 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 123.642 0.639 . . . . 0.0 111.616 -170.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -58.7 -22.38 57.18 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.787 -0.831 . . . . 0.0 111.432 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -57.6 -17.37 13.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.727 1.211 . . . . 0.0 114.008 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.79 -49.01 66.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.606 1.548 . . . . 0.0 111.123 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -59.55 -42.2 91.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.17 0.588 . . . . 0.0 110.233 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -62.79 -46.01 89.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.451 1.1 . . . . 0.0 110.906 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 39.6 mt -59.84 -45.61 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 124.421 1.088 . . . . 0.0 108.824 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -57.29 -44.98 84.53 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.463 0.705 . . . . 0.0 111.29 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -48.48 81.61 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.913 0.485 . . . . 0.0 110.267 174.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -51.05 -52.78 39.83 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.747 1.219 . . . . 0.0 110.473 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.47 -3.67 32.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.145 1.778 . . . . 0.0 113.307 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.25 32.98 84.57 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.751 1.167 . . . . 0.0 112.645 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.54 23.59 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.977 0.911 . . . . 0.0 109.706 174.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -48.54 76.85 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.035 -1.04 . . . . 0.0 110.304 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.9 m -70.87 -19.01 62.67 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.619 ' CD2' HD23 ' A' ' 93' ' ' LEU . 21.0 m-85 -66.17 -0.51 2.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 117.132 -1.414 . . . . 0.0 113.638 167.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -139.84 105.06 5.03 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 121.665 2.03 . . . . 0.0 108.97 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.4 m -51.73 -40.79 60.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.933 1.693 . . . . 0.0 112.254 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -157.28 145.55 19.35 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 -172.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.05 131.04 45.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -85.18 151.87 23.77 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 167.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.2 p -137.17 -168.3 2.26 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.608 1.563 . . . . 0.0 110.208 -172.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.4 t -53.78 -26.55 24.26 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.497 -1.377 . . . . 0.0 112.975 167.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -61.03 -33.92 74.05 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.983 0.896 . . . . 0.0 109.168 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.9 m -85.31 69.83 10.77 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 129.07 2.948 . . . . 0.0 104.793 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.51 44.59 1.99 Allowed Glycine 0 CA--C 1.522 0.494 0 CA-C-O 118.693 -1.059 . . . . 0.0 111.324 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -67.22 174.45 3.21 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 124.602 2.144 . . . . 0.0 112.191 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.8 t -76.75 157.64 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 128.261 2.624 . . . . 0.0 110.6 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -72.25 166.34 22.62 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.397 1.479 . . . . 0.0 110.467 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 mmpm? -73.04 149.02 89.5 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 120.36 -1.463 . . . . 0.0 107.967 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.88 -4.99 32.51 Favored 'Cis proline' 0 CA--C 1.533 0.434 0 N-CA-C 115.842 1.439 . . . . 0.0 115.842 11.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.2 t -43.09 91.39 0.05 OUTLIER Pre-proline 0 C--O 1.241 0.655 0 C-N-CA 127.366 2.266 . . . . 0.0 114.576 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.84 6.94 0.05 OUTLIER 'Trans proline' 0 CA--C 1.556 1.616 1 C-N-CA 128.068 5.845 . . . . 0.0 114.64 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -43.74 -71.65 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.333 2.653 . . . . 0.0 112.236 -172.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.8 -16.39 40.18 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -175.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.35 -54.82 6.21 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 119.68 1.127 . . . . 0.0 108.552 171.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 m -53.06 -38.72 62.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.665 1.186 . . . . 0.0 110.605 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -52.04 -50.38 61.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.346 1.058 . . . . 0.0 110.715 174.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.73 -35.85 72.89 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.302 1.041 . . . . 0.0 111.406 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.27 -58.44 8.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -64.47 -29.18 70.23 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.345 1.069 . . . . 0.0 111.758 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -63.77 -27.41 69.17 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.164 -1.585 . . . . 0.0 114.842 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.42 ' HB3' HD13 ' A' ' 154' ' ' LEU . 2.7 t80 -141.6 8.73 1.97 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.994 0.816 . . . . 0.0 111.862 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 55.43 74.1 0.39 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.709 1.604 . . . . 0.0 109.634 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.42 HD13 ' HB3' ' A' ' 152' ' ' TYR . 5.1 mp -101.14 178.19 4.73 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.846 1.259 . . . . 0.0 109.536 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -109.07 130.91 55.49 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 159' ' ' THR . 0.7 OUTLIER -44.84 -53.77 7.13 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 124.579 1.175 . . . . 0.0 108.678 173.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -76.48 -20.88 56.53 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 125.741 1.616 . . . . 0.0 112.732 -159.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -90.53 4.13 52.03 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.679 0.792 . . . . 0.0 109.943 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 156' ' ' SER . 1.2 t -92.93 162.06 14.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.791 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -146.65 118.01 7.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.694 0.797 . . . . 0.0 109.133 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -82.83 155.33 24.22 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.084 0.402 . . . . 0.0 110.33 167.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.6 mp -127.61 114.32 35.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.826 1.25 . . . . 0.0 107.94 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.74 158.64 31.61 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 123.469 0.48 . . . . 0.0 112.254 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.44 3.29 34.82 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -163.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -101.69 164.75 11.58 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.05 1.295 . . . . 0.0 111.581 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 6.5 t -72.57 -14.6 61.66 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.665 -0.647 . . . . 0.0 112.295 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -16.24 48.2 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.811 0.732 . . . . 0.0 110.023 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -78.01 11.41 2.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.178 1.791 . . . . 0.0 112.235 -173.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.1 p -120.76 -19.82 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.483 1.513 . . . . 0.0 110.922 170.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.9 -38.87 89.87 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 120.729 -1.232 . . . . 0.0 110.221 -171.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -78.87 -28.9 44.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.301 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.84 -51.45 69.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -50.88 -42.15 58.81 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.048 1.339 . . . . 0.0 112.136 171.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -50.29 63.0 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.649 -0.657 . . . . 0.0 111.241 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 8.6 t -69.78 -17.85 63.44 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.709 0.803 . . . . 0.0 110.769 174.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.47 33.49 38.85 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.86 2.171 . . . . 0.0 112.525 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.46 171.58 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.591 1.557 . . . . 0.0 111.908 -165.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -92.06 154.57 18.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.715 1.206 . . . . 0.0 111.964 -173.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.7 m -136.46 151.54 49.58 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.198 1.399 . . . . 0.0 110.275 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 46.3 mt -123.6 111.67 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.71 160.26 31.3 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 123.535 0.734 . . . . 0.0 109.027 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -79.63 -16.91 54.94 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.503 -1.373 . . . . 0.0 111.723 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.24 160.93 19.75 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 128.192 2.597 . . . . 0.0 108.655 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -61.22 156.48 18.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.8 m -149.34 22.12 0.94 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.444 1.098 . . . . 0.0 111.184 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 73.7 p 52.29 46.81 25.98 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.966 0.906 . . . . 0.0 111.625 158.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -145.66 176.96 9.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.423 1.489 . . . . 0.0 108.572 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -102.06 -20.64 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.269 1.028 . . . . 0.0 112.447 -177.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -106.57 0.0 37.05 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.211 1.386 . . . . 0.0 111.816 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.72 152.29 22.25 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 119.606 1.703 . . . . 0.0 109.411 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -127.69 148.15 50.4 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.511 1.124 . . . . 0.0 108.539 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -85.87 153.51 22.18 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.487 0.585 . . . . 0.0 112.253 166.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.5 169.26 17.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 126.366 1.866 . . . . 0.0 110.244 168.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.3 -9.29 8.09 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.547 1.539 . . . . 0.0 112.827 170.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.51 167.85 29.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.259 1.424 . . . . 0.0 108.56 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.3 tp -69.52 -37.93 77.34 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.28 -15.09 59.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -69.64 -21.12 63.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.409 0.55 . . . . 0.0 109.786 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 86.3 mt -58.53 -59.04 4.16 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 125.411 1.485 . . . . 0.0 108.433 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.0 m -55.7 -39.94 71.72 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.709 0.686 . . . . 0.0 110.86 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -59.9 -33.3 71.67 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.888 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.6 mt -55.34 -47.55 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 119.664 1.12 . . . . 0.0 109.433 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.65 -18.21 51.96 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 . . . . . 0 CA--C 1.536 0.426 0 C-N-CA 126.272 1.829 . . . . 0.0 111.923 -174.714 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 C--O 1.235 0.339 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -62.98 -164.8 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.716 1.206 . . . . 0.0 109.864 167.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 69.91 0.07 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.887 1.675 . . . . 0.0 112.178 -176.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.4 m -81.17 153.37 27.26 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.41 147.99 45.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.11 152.94 43.73 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.2 mt -127.99 173.92 12.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 163.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -145.4 164.4 31.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.945 0.898 . . . . 0.0 109.142 167.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -93.01 -24.8 18.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.303 1.441 . . . . 0.0 113.647 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.7 tp . . . . . 0 N--CA 1.475 0.78 0 C-N-CA 129.205 3.002 . . . . 0.0 115.814 -174.814 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.82 -23.19 28.92 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.43 -57.03 6.47 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.661 0.784 . . . . 0.0 110.575 170.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.6 t -53.88 -44.07 59.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 123.604 0.761 . . . . 0.0 109.466 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.1 mt -56.0 -49.33 73.95 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.161 0.891 . . . . 0.0 110.532 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.7 73.97 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.149 0.58 . . . . 0.0 110.95 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -53.31 -46.97 69.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.774 1.23 . . . . 0.0 111.149 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.81 -45.85 66.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.112 1.365 . . . . 0.0 111.323 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -59.97 -48.58 81.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.165 1.386 . . . . 0.0 110.464 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.1 -42.1 80.16 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.569 0.748 . . . . 0.0 110.242 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.6 m -69.76 -6.56 32.9 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.216 1.006 . . . . 0.0 113.67 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.23 -5.57 84.87 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.575 1.56 . . . . 0.0 114.33 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mt -53.36 118.61 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 128.39 2.676 . . . . 0.0 110.268 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -68.15 101.05 1.09 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.368 1.067 . . . . 0.0 108.252 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -84.9 148.81 26.06 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -141.18 179.19 6.9 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.618 1.567 . . . . 0.0 107.525 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.1 mt -131.73 143.74 39.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 167.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -128.52 109.21 11.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 166.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -141.68 150.91 42.49 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -171.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -77.56 -1.95 33.22 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.504 -0.747 . . . . 0.0 112.343 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -63.31 164.22 9.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.043 0.937 . . . . 0.0 110.233 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.47 -176.25 49.61 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.58 -25.59 39.07 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.603 0.761 . . . . 0.0 111.74 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -16.81 11.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.752 -1.218 . . . . 0.0 112.576 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.68 -36.59 74.43 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.724 1.147 . . . . 0.0 112.153 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -60.79 -53.88 51.98 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -59.05 -41.49 88.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.519 1.528 . . . . 0.0 111.173 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.94 -50.72 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.748 0.819 . . . . 0.0 109.421 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mp -58.83 -47.87 83.31 Favored 'General case' 0 C--O 1.228 -0.074 0 O-C-N 121.487 -0.758 . . . . 0.0 110.757 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -56.81 -46.48 81.59 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.723 0.809 . . . . 0.0 110.145 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -54.93 -52.22 63.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.184 1.394 . . . . 0.0 109.939 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.42 -7.01 39.87 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.029 1.332 . . . . 0.0 113.592 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.48 28.71 63.03 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.385 0.993 . . . . 0.0 112.469 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.7 m -128.79 28.74 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 124.82 1.248 . . . . 0.0 111.175 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.49 -57.61 12.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.533 1.133 . . . . 0.0 112.004 172.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.7 m -73.22 -22.41 60.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.19 0.596 . . . . 0.0 111.615 -165.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.29 -29.57 58.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.86 -0.59 . . . . 0.0 112.564 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -109.17 110.93 22.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 66.5 m -46.77 -47.74 20.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.147 1.379 . . . . 0.0 109.123 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.47 159.25 42.59 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.74 134.92 65.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 171.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.6 mt -99.01 151.08 21.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 42.4 p -145.55 174.3 11.28 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.561 1.544 . . . . 0.0 107.636 -170.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.2 t -57.51 -13.45 3.72 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 121.215 -0.928 . . . . 0.0 113.272 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -59.31 -48.33 82.03 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.387 1.475 . . . . 0.0 109.197 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 95.8 p -54.54 -36.97 64.86 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.204 1.802 . . . . 0.0 113.037 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.03 -4.87 78.96 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.394 -1.226 . . . . 0.0 114.8 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -50.74 158.71 0.62 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.627 1.213 . . . . 0.0 112.438 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 141' ' ' SER . 18.6 m -52.93 154.8 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 122.903 1.335 . . . . 0.0 112.296 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -85.55 160.38 19.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.241 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 136.93 87.25 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.621 -1.181 . . . . 0.0 108.865 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.25 122.35 7.89 Favored 'Cis proline' 0 N--CA 1.454 -0.805 0 CA-C-N 120.755 1.305 . . . . 0.0 110.732 -0.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.402 ' HA ' HG23 ' A' ' 137' ' ' VAL . 12.0 p -123.32 85.6 51.96 Favored Pre-proline 0 N--CA 1.446 -0.666 0 C-N-CA 125.252 1.421 . . . . 0.0 111.283 -163.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.14 -27.51 8.17 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.709 2.273 . . . . 0.0 113.441 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -53.8 -54.68 34.98 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.364 -0.835 . . . . 0.0 112.191 -166.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.0 -7.75 43.42 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.231 -0.918 . . . . 0.0 113.038 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.97 -48.4 11.5 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 m -55.62 -41.49 73.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.533 1.133 . . . . 0.0 109.946 171.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -58.45 -58.54 8.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.873 0.869 . . . . 0.0 109.996 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -67.12 -19.74 65.66 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.124 0.97 . . . . 0.0 112.855 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -63.14 1.14 Allowed 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 173.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.07 -22.92 65.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.31 -26.46 66.56 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 120.898 -1.126 . . . . 0.0 113.34 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.417 ' HB3' HD13 ' A' ' 154' ' ' LEU . 13.0 t80 -148.69 23.07 1.0 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.451 1.023 . . . . 0.0 112.232 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 50.14 67.2 0.95 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.584 1.553 . . . . 0.0 111.576 -174.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 152' ' ' TYR . 4.5 mp -100.23 170.7 8.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.791 1.282 . . . . 0.0 111.024 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.81 123.14 42.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.861 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 m -59.92 -39.31 85.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.17 1.388 . . . . 0.0 110.816 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -83.25 -13.2 55.79 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.167 -0.958 . . . . 0.0 112.997 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -109.86 13.41 23.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -92.25 149.42 21.47 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -141.43 113.84 8.19 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -73.15 -40.87 64.51 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.0 mp 56.17 99.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 126.461 1.904 . . . . 0.0 111.73 -169.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -122.96 -171.86 13.78 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.87 148.09 32.49 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 169.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER 58.23 171.12 0.05 Allowed 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 126.595 1.958 . . . . 0.0 114.461 -165.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.49 169.91 1.57 Allowed 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 127.382 2.273 . . . . 0.0 110.119 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 tm? 68.4 -27.1 0.14 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 130.409 3.484 . . . . 0.0 113.339 -164.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -73.63 8.11 2.06 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.726 1.603 . . . . 0.0 114.413 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.54 -13.03 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.0 -1.062 . . . . 0.0 110.823 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -66.52 -40.75 89.31 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.711 -1.243 . . . . 0.0 111.026 -173.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -69.22 -32.74 72.19 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.287 -0.883 . . . . 0.0 111.516 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.28 -45.94 89.09 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.458 0.572 . . . . 0.0 109.52 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -49.89 -53.05 28.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.69 0.796 . . . . 0.0 110.622 168.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -58.25 -47.65 82.9 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.9 m -69.58 -20.79 63.65 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.573 1.079 . . . . 0.0 112.265 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.02 58.59 10.36 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -167.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.8 pt -130.36 169.91 20.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.27 1.428 . . . . 0.0 109.065 173.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -96.27 167.74 11.0 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.838 0.855 . . . . 0.0 110.938 -172.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 11.8 m -147.6 158.72 44.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.568 1.547 . . . . 0.0 111.033 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.8 mt -131.74 124.93 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 168.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -144.6 155.73 43.78 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -69.36 -26.46 64.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.169 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.86 156.96 32.18 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.255 0.934 . . . . 0.0 111.851 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.43 165.25 6.32 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.421 1.105 . . . . 0.0 109.971 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 29.7 t -145.19 172.89 12.47 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 161.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 21.8 p -69.93 24.63 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.202 2.201 . . . . 0.0 113.365 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -133.96 108.02 8.15 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.26 1.424 . . . . 0.0 108.071 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -69.58 -16.67 63.45 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.755 1.222 . . . . 0.0 113.781 -166.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -51.52 -53.31 29.27 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 168.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -53.19 114.56 1.51 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.996 2.119 . . . . 0.0 113.778 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -79.32 118.22 21.03 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.802 0.841 . . . . 0.0 111.052 -176.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -67.14 142.56 57.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.05 0.386 . . . . 0.0 111.514 169.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.6 pt -141.93 168.65 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 126.632 1.973 . . . . 0.0 111.511 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -128.1 -6.09 5.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.476 1.51 . . . . 0.0 111.941 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.13 157.59 40.59 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.777 1.231 . . . . 0.0 108.306 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.73 -34.15 73.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -55.32 -34.95 64.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.355 0.662 . . . . 0.0 112.385 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -64.9 -17.67 64.53 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.327 0.651 . . . . 0.0 111.397 -174.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.2 mt -50.44 -61.6 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.362 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 87.8 p -55.38 -34.71 64.57 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.76 0.791 . . . . 0.0 110.698 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -74.45 -25.62 59.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.241 1.416 . . . . 0.0 112.722 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 61.5 mt -53.54 -60.14 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -70.63 8.93 0.73 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.656 1.982 . . . . 0.0 113.792 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 N--CA 1.453 -0.287 0 C-N-CA 125.373 1.469 . . . . 0.0 112.32 177.069 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -60.01 176.76 0.29 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.129 161.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -53.17 82.74 0.0 OUTLIER 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.09 2.156 . . . . 0.0 111.455 172.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.4 m -100.17 153.8 18.96 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.68 150.69 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.139 -0.976 . . . . 0.0 109.314 171.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.97 149.68 51.59 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 126.597 1.959 . . . . 0.0 107.881 -169.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.6 mt -141.92 132.31 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -117.07 167.85 10.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.557 1.543 . . . . 0.0 110.285 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -121.5 -12.8 8.5 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -167.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 127.902 2.481 . . . . 0.0 116.818 174.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.664 ' HA ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -55.88 -28.3 55.94 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.229 1.012 . . . . 0.0 113.295 -176.348 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -54.32 -64.83 0.7 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.269 1.428 . . . . 0.0 110.289 173.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.2 t -59.28 -44.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.506 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 90' ' ' ARG . 77.1 mt -52.04 -45.76 64.8 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 119.025 0.83 . . . . 0.0 110.307 -176.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.21 -48.21 58.08 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.094 0.558 . . . . 0.0 111.62 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.3 t90 -54.39 -37.77 65.4 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.7 0.8 . . . . 0.0 110.654 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.63 -42.77 27.92 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.456 1.502 . . . . 0.0 112.379 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -58.17 -51.06 71.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.461 1.104 . . . . 0.0 110.372 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -61.82 -23.9 66.54 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.158 1.383 . . . . 0.0 112.587 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 m -92.41 -0.41 57.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.06 0.944 . . . . 0.0 113.223 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.96 25.96 71.07 Favored Glycine 0 CA--C 1.527 0.837 0 O-C-N 121.356 -0.84 . . . . 0.0 112.942 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.9 mt -67.92 125.67 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 164.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -72.33 97.5 2.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 170.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -79.75 151.85 30.16 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.416 ' CG ' HD13 ' A' ' 148' ' ' LEU . 86.9 m-85 -145.01 169.56 17.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.8 mt -130.99 157.42 43.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 169.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -147.34 134.74 20.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.946 1.298 . . . . 0.0 107.993 159.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 t -163.44 -179.02 6.23 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -108.28 -7.5 15.93 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -0.87 0.08 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 117.654 2.465 . . . . 0.0 117.654 -172.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.68 -175.69 54.21 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.005 -1.06 . . . . 0.0 111.533 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -12.24 47.03 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -168.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -66.75 -12.96 60.74 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.343 -1.473 . . . . 0.0 111.688 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.16 -55.92 27.17 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.481 1.037 . . . . 0.0 111.44 176.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -54.85 -45.85 74.57 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.996 0.918 . . . . 0.0 109.77 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 m -59.39 -42.43 91.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.925 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.2 mt -64.88 -49.46 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 119.199 0.909 . . . . 0.0 109.344 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mp -60.11 -42.88 95.65 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.894 -0.504 . . . . 0.0 111.754 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -57.23 -53.42 58.31 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.486 1.115 . . . . 0.0 109.27 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.1 -54.23 21.93 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.9 1.68 . . . . 0.0 109.264 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.47 -39.08 65.19 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.777 0.831 . . . . 0.0 111.267 -170.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.25 27.89 1.06 Allowed Glycine 0 CA--C 1.535 1.338 0 CA-C-O 121.637 0.576 . . . . 0.0 112.015 163.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.648 HG23 ' CD2' ' A' ' 125' ' ' TYR 0.303 2.0 p -133.41 12.66 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 127.191 2.196 . . . . 0.0 110.106 -160.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -67.35 -34.34 77.1 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 121.393 -0.817 . . . . 0.0 110.334 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.4 m -77.83 -22.71 49.55 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 120.037 1.289 . . . . 0.0 113.087 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.648 ' CD2' HG23 ' A' ' 122' ' ' VAL . 19.1 m-85 -60.77 -18.57 55.79 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -116.11 126.68 54.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.0 m -62.32 -30.97 71.54 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.821 0.849 . . . . 0.0 111.652 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.476 ' OE1' ' HE2' ' A' ' 151' ' ' LYS . 7.5 tt0 -154.13 159.93 41.69 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 169.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mp -131.88 111.57 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 mt -80.72 159.34 25.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.844 0.831 . . . . 0.0 109.383 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.9 p -142.17 177.47 8.21 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.337 1.855 . . . . 0.0 108.12 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -61.55 -6.58 2.52 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.4 -0.813 . . . . 0.0 112.868 169.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -57.8 -28.22 63.83 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.669 -1.269 . . . . 0.0 110.703 166.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 58.0 p -58.0 -54.29 48.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.434 0.694 . . . . 0.0 112.394 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.33 -2.88 71.67 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 117.295 -1.836 . . . . 0.0 115.45 -173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -53.92 164.51 0.58 Allowed 'General case' 0 C--O 1.242 0.694 0 CA-C-N 120.03 1.915 . . . . 0.0 112.235 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.1 176.76 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.407 1.099 . . . . 0.0 113.288 -172.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -65.06 147.08 54.12 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.245 -0.909 . . . . 0.0 110.058 174.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -52.1 127.44 37.36 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.984 1.714 . . . . 0.0 107.612 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.01 -40.03 1.31 Allowed 'Cis proline' 0 C--N 1.348 0.531 0 CA-C-N 121.548 1.588 . . . . 0.0 115.25 22.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.267 43.2 p 51.25 72.25 1.28 Allowed Pre-proline 0 N--CA 1.441 -0.897 0 C-N-CA 125.194 1.397 . . . . 0.0 113.077 -172.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -62.14 -18.44 62.02 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.616 2.877 . . . . 0.0 111.907 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -47.71 -43.51 26.9 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.863 1.665 . . . . 0.0 111.273 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.46 -21.66 65.62 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.23 -58.45 3.31 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.188 -0.911 . . . . 0.0 109.392 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.6 m -56.2 -36.16 68.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.552 0.615 . . . . 0.0 110.292 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -50.89 -63.0 1.27 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 124.649 1.18 . . . . 0.0 110.339 170.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.416 HD13 ' CG ' ' A' ' 104' ' ' PHE . 71.2 mt -69.18 -24.46 64.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -174.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.26 -67.43 0.44 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -57.46 -41.29 80.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.873 0.469 . . . . 0.0 110.514 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.476 ' HE2' ' OE1' ' A' ' 128' ' ' GLU . 7.0 tmtm? -47.93 -37.32 14.08 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.581 1.552 . . . . 0.0 114.148 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.54 24.81 5.43 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.221 0.919 . . . . 0.0 112.743 173.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 47.71 58.11 5.31 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.46 1.904 . . . . 0.0 112.946 -175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.6 mp -94.68 172.82 7.94 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.75 1.22 . . . . 0.0 111.725 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -102.11 136.08 42.58 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.691 1.196 . . . . 0.0 108.846 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.2 m -62.13 -50.23 72.73 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.93 1.292 . . . . 0.0 108.91 173.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 1.04 53.07 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.99 -1.069 . . . . 0.0 112.645 -167.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -120.39 12.73 11.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.94 1.296 . . . . 0.0 108.999 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 t -107.35 146.63 31.36 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.156 0.889 . . . . 0.0 109.685 168.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.419 ' CD2' ' HB2' ' A' ' 178' ' ' GLN . 88.9 m-85 -137.22 116.99 13.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.916 1.686 . . . . 0.0 107.633 -167.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -84.84 153.55 22.87 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 170.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.7 mt -128.66 102.4 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.45 124.43 3.33 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.65 37.1 0.4 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.253 1.821 . . . . 0.0 112.139 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.48 158.41 44.31 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.398 1.479 . . . . 0.0 108.304 -176.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.5 t -64.32 -15.27 59.98 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.89 -12.87 60.8 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.597 1.159 . . . . 0.0 112.539 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -48.01 80.11 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.084 0.856 . . . . 0.0 112.202 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.4 -31.59 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.82 -37.48 87.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.131 0.572 . . . . 0.0 109.857 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.74 -53.4 15.67 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.084 -1.01 . . . . 0.0 109.905 172.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.75 -48.11 78.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.319 0.648 . . . . 0.0 111.68 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -56.47 -53.49 56.82 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.362 1.865 . . . . 0.0 111.46 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -73.78 -23.52 59.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 119.383 -0.341 . . . . 0.0 111.778 -172.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.0 p -86.06 -21.28 27.79 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 170.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 76.06 46.94 12.07 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.885 1.231 . . . . 0.0 111.243 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 15.4 pt -131.0 -177.4 2.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 125.985 1.714 . . . . 0.0 109.096 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.419 ' HB2' ' CD2' ' A' ' 160' ' ' TYR . 18.6 mm-40 -92.53 162.21 14.3 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.774 0.83 . . . . 0.0 110.489 -175.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.06 139.47 43.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.51 1.524 . . . . 0.0 111.172 -171.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.88 75.13 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 123.07 1.414 . . . . 0.0 109.347 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -93.79 -171.71 2.67 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.801 1.64 . . . . 0.0 111.362 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -106.57 -8.84 16.82 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.485 ' H ' HD12 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -118.66 154.86 32.02 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.728 -1.232 . . . . 0.0 110.275 177.708 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.62 140.07 58.48 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 120.832 -1.167 . . . . 0.0 109.277 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.406 ' H ' ' ND2' ' A' ' 190' ' ' ASN . 19.5 m -127.52 147.35 50.32 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.881 1.324 . . . . 0.0 112.233 168.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.23 47.94 1.58 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.803 2.841 . . . . 0.0 110.513 -167.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -138.22 159.72 41.32 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.101 1.361 . . . . 0.0 109.663 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -99.06 98.45 9.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 115.89 16.64 6.74 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.667 1.127 . . . . 0.0 112.419 -171.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.406 ' ND2' ' H ' ' A' ' 185' ' ' SER . 12.0 t30 -89.3 138.32 31.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.847 0.823 . . . . 0.0 109.411 166.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -135.04 90.38 2.63 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.202 1.001 . . . . 0.0 110.564 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . 0.262 0.2 OUTLIER -80.54 152.52 28.61 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.059 -172.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.1 pt -127.01 170.36 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.924 1.689 . . . . 0.0 111.93 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.84 -27.15 12.83 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.716 0.807 . . . . 0.0 112.177 161.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.56 155.84 42.79 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.045 0.938 . . . . 0.0 108.951 -166.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 196' ' ' LEU . 3.3 tp -64.63 -35.51 81.23 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.273 1.029 . . . . 0.0 109.035 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -60.18 -30.46 69.36 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -60.91 -20.61 62.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.408 1.004 . . . . 0.0 111.306 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 95.1 mt -53.98 -53.68 25.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 88.1 p -59.68 -39.1 83.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -59.03 -40.88 86.41 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.342 1.057 . . . . 0.0 109.593 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.4 mt -51.81 -49.84 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.761 1.224 . . . . 0.0 110.851 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.76 -5.61 55.63 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.941 0.896 . . . . 0.0 112.514 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 . . . . . 0 N--CA 1.451 -0.42 0 C-N-CA 127.101 2.16 . . . . 0.0 110.104 -174.243 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mmm . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.9 175.98 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.958 2.103 . . . . 0.0 110.649 166.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.1 102.67 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.976 1.71 . . . . 0.0 110.234 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.6 m -133.55 142.41 48.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.54 142.25 51.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.253 1.021 . . . . 0.0 108.294 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.69 153.33 34.53 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.2 mt -141.92 128.01 18.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -115.61 155.97 26.68 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.323 0.649 . . . . 0.0 110.49 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -78.37 -11.13 59.92 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.367 1.067 . . . . 0.0 112.301 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.473 0.693 0 C-N-CA 129.448 3.099 . . . . 0.0 111.466 -164.582 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -59.06 -35.13 72.82 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.751 1.16 . . . . 0.0 113.597 -159.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -59.93 -58.33 9.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 124.096 0.873 . . . . 0.0 110.27 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.6 t -52.62 -41.43 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.085 0.954 . . . . 0.0 110.713 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 85.6 mt -57.61 -48.18 80.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.104 0.866 . . . . 0.0 110.13 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.51 -46.35 83.33 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.607 0.763 . . . . 0.0 111.901 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -57.4 -48.24 79.61 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.57 98.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.63 0.772 . . . . 0.0 111.309 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -54.84 -61.07 2.55 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.68 1.592 . . . . 0.0 110.35 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -60.97 -20.33 62.23 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.3 m -86.75 -4.08 59.13 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.79 1.236 . . . . 0.0 112.815 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.17 22.61 70.94 Favored Glycine 0 CA--C 1.528 0.872 0 O-C-N 120.868 -1.145 . . . . 0.0 112.688 175.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.8 mt -55.54 165.44 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 126.674 1.99 . . . . 0.0 107.433 158.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -118.04 112.72 20.61 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 161.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -80.81 143.34 32.9 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -132.34 168.5 18.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.539 1.536 . . . . 0.0 108.643 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 60.5 mt -140.0 158.86 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.361 1.464 . . . . 0.0 108.309 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -139.88 125.17 18.9 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.882 0.873 . . . . 0.0 108.758 162.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -137.41 164.19 29.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.481 1.112 . . . . 0.0 109.822 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -104.39 -0.03 28.53 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.674 1.19 . . . . 0.0 111.634 172.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -69.04 -0.19 5.42 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.27 -176.61 30.48 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.808 1.194 . . . . 0.0 110.615 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -27.06 61.36 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.653 0.781 . . . . 0.0 111.016 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -60.65 -14.98 23.88 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.1 -49.64 40.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.823 0.738 . . . . 0.0 110.605 168.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -57.43 -44.74 84.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.697 0.68 . . . . 0.0 111.197 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -57.27 -43.96 83.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.731 0.812 . . . . 0.0 110.594 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.83 -53.44 48.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.977 1.311 . . . . 0.0 109.26 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.05 -36.88 84.43 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.005 0.82 . . . . 0.0 110.516 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -61.0 -51.44 69.25 Favored 'General case' 0 C--N 1.337 0.052 0 CA-C-N 118.671 0.669 . . . . 0.0 110.476 175.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -53.46 -51.72 61.79 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 110.168 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.12 -21.01 63.14 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.594 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.95 47.16 5.13 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.913 1.244 . . . . 0.0 111.504 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.0 m -147.51 23.22 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.956 1.702 . . . . 0.0 110.991 -174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.01 -35.27 59.61 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.99 -1.069 . . . . 0.0 110.792 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.9 m -63.64 -27.69 69.4 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.191 0.596 . . . . 0.0 110.79 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.82 7.95 1.01 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -137.78 112.03 8.57 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.0 m -49.44 -39.59 33.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.422 1.089 . . . . 0.0 109.684 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.44 156.36 33.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 118.964 0.802 . . . . 0.0 110.017 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 44.1 mt -139.06 93.41 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.438 HD22 ' OG ' ' A' ' 134' ' ' SER . 45.2 mt -65.98 146.88 54.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 70.0 p -127.45 -177.81 4.22 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.287 1.035 . . . . 0.0 110.246 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 t -60.28 -18.04 46.46 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.519 -0.738 . . . . 0.0 112.215 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -61.29 -37.13 82.1 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.971 0.805 . . . . 0.0 108.934 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.438 ' OG ' HD22 ' A' ' 130' ' ' LEU . 12.7 t -56.92 -35.51 69.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.099 0.96 . . . . 0.0 111.704 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.83 -8.48 65.96 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 117.068 -1.962 . . . . 0.0 113.872 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -57.4 164.52 1.84 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 120.047 1.923 . . . . 0.0 111.102 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 t -61.4 162.32 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-N 112.528 -2.124 . . . . 0.0 110.149 166.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -90.69 172.45 8.65 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.51 1.524 . . . . 0.0 109.557 170.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -68.18 150.63 97.66 Favored Pre-proline 0 C--O 1.237 0.441 0 O-C-N 120.774 -1.203 . . . . 0.0 108.942 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.29 -18.12 16.88 Favored 'Cis proline' 0 C--N 1.347 0.492 0 N-CA-C 115.759 1.407 . . . . 0.0 115.759 16.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.67 91.16 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 131.371 3.868 . . . . 0.0 114.604 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -54.13 -7.11 0.61 Allowed 'Trans proline' 0 CA--C 1.544 0.975 1 C-N-CA 126.206 4.604 . . . . 0.0 114.558 -172.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -43.83 -52.05 7.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.819 2.848 . . . . 0.0 113.213 -165.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.96 -3.01 11.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.278 1.031 . . . . 0.0 113.675 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.06 -40.03 7.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.374 1.469 . . . . 0.0 109.869 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 m -51.69 -39.67 58.72 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.337 0.971 . . . . 0.0 109.489 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.96 -53.02 61.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.928 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.7 mt -68.51 -21.2 64.59 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.344 1.457 . . . . 0.0 113.007 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.407 HD11 ' HA ' ' A' ' 156' ' ' SER . 0.0 OUTLIER -67.08 -69.73 0.29 Allowed 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 175.163 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -54.84 -39.77 68.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -23.38 43.42 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.664 -1.272 . . . . 0.0 113.898 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TYR . . . . . 0.475 ' HB3' HD13 ' A' ' 154' ' ' LEU . 6.3 t80 -138.4 17.04 2.75 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 172.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 49.26 38.73 14.19 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.625 1.97 . . . . 0.0 112.185 -170.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -68.71 165.4 19.57 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.956 0.902 . . . . 0.0 109.754 176.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -101.17 -5.89 25.0 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 -160.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.407 ' HA ' HD11 ' A' ' 149' ' ' LEU . 1.4 m 76.43 -36.14 0.26 Allowed 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 108.813 -3.812 . . . . 0.0 112.179 -166.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -25.04 56.67 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 120.943 -1.098 . . . . 0.0 112.8 -171.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.77 -3.16 58.83 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 116.362 -1.78 . . . . 0.0 110.694 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -102.27 123.61 46.39 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.401 1.455 . . . . 0.0 108.712 -170.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -120.81 101.01 7.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.045 2.138 . . . . 0.0 108.903 -170.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -74.68 150.6 39.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.44 129.13 68.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -149.69 172.28 29.66 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.431 0.539 . . . . 0.0 111.883 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.42 3.02 4.22 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.525 1.53 . . . . 0.0 113.564 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -144.09 133.7 23.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 t -47.56 166.71 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.986 2.114 . . . . 0.0 110.858 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 tp 67.74 -5.03 0.86 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 131.404 3.882 . . . . 0.0 112.979 -152.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -58.1 -41.16 82.9 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.355 0.979 . . . . 0.0 110.826 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 185' ' ' SER . 13.2 p -104.13 -18.21 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 126.261 1.824 . . . . 0.0 110.849 -171.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -68.0 -22.72 64.98 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.46 -0.775 . . . . 0.0 111.851 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.427 ' CE1' HD11 ' A' ' 177' ' ' ILE . 7.2 p90 -88.08 -23.27 23.76 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.292 -0.88 . . . . 0.0 112.331 173.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.14 90.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.967 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -64.22 -40.68 96.55 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.446 0.566 . . . . 0.0 111.061 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.49 -55.52 34.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.198 0.454 . . . . 0.0 110.356 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 t -75.15 -24.75 57.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.097 -0.477 . . . . 0.0 111.555 -172.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 67.3 61.33 5.2 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -166.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.427 HD11 ' CE1' ' A' ' 171' ' ' PHE . 50.5 pt -128.88 177.55 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.976 1.711 . . . . 0.0 108.002 172.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -94.99 179.07 5.35 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.184 0.594 . . . . 0.0 109.748 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.51 160.75 34.96 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.633 -1.292 . . . . 0.0 109.436 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.0 mt -142.56 101.91 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.282 1.433 . . . . 0.0 107.158 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -128.24 165.37 20.63 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 123.134 1.445 . . . . 0.0 111.705 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -78.78 -29.84 45.21 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.765 -1.562 . . . . 0.0 111.297 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.79 13.99 27.26 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -157.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . 0.287 12.3 pt-20 50.93 -170.85 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.858 1 C-N-CA 134.999 5.32 . . . . 0.0 114.09 -170.187 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.448 ' HB2' HG11 ' A' ' 169' ' ' VAL . 48.3 t -164.12 167.99 19.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.097 2.159 . . . . 0.0 107.121 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 16.6 p -100.33 66.14 1.26 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.819 1.248 . . . . 0.0 108.185 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -143.46 177.28 8.56 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.792 1.637 . . . . 0.0 108.989 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -106.26 -30.87 8.92 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.597 1.159 . . . . 0.0 112.893 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.09 5.84 82.91 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.235 0.921 . . . . 0.0 111.568 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -72.86 155.19 40.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 118.749 1.274 . . . . 0.0 108.712 168.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -134.75 109.02 8.3 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.31 143.01 58.21 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 122.955 0.502 . . . . 0.0 111.211 177.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.2 pt -146.39 173.37 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.684 1.594 . . . . 0.0 112.746 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -127.89 -17.85 4.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.793 1.637 . . . . 0.0 113.417 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.24 165.84 28.02 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.0 1.32 . . . . 0.0 109.802 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.01 -37.56 88.06 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.83 -15.58 54.8 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -75.11 -17.85 60.36 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.168 -0.958 . . . . 0.0 110.796 174.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.408 ' HA ' HD12 ' A' ' 202' ' ' ILE . 70.5 mt -58.25 -53.49 45.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 77.4 p -58.76 -34.3 71.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.928 0.786 . . . . 0.0 111.092 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -62.43 -35.05 78.05 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 116.728 -1.606 . . . . 0.0 111.603 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 199' ' ' ILE . 77.4 mt -50.75 -52.59 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.726 1.148 . . . . 0.0 108.804 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -81.34 -5.22 57.6 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.935 -0.555 . . . . 0.0 112.422 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 . . . . . 0 CA--C 1.53 0.185 0 C-N-CA 125.77 1.628 . . . . 0.0 112.27 -171.978 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mmm . . . . . 0 CA--C 1.516 -0.364 0 CA-C-O 124.049 1.88 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.97 177.86 0.11 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 111.608 -2.542 . . . . 0.0 111.389 167.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -54.78 69.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 129.148 2.979 . . . . 0.0 114.556 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.6 m -96.28 141.92 29.04 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.06 147.33 50.16 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.438 ' CD2' HD11 ' A' ' 162' ' ' ILE . 0.8 OUTLIER -130.7 144.43 51.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 124.562 1.145 . . . . 0.0 108.108 -170.285 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.8 mt -133.57 120.44 37.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -105.71 -177.51 3.38 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.674 1.59 . . . . 0.0 108.202 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.2 174.22 9.45 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.301 1.04 . . . . 0.0 109.603 170.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -175.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.505 ' N ' HD11 ' A' ' 196' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.6 tpt85 -58.15 -32.7 68.44 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.663 0.665 . . . . 0.0 112.649 -158.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -48.96 -70.3 0.09 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.253 1.421 . . . . 0.0 109.889 168.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.4 t -63.52 -36.02 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 126.836 2.054 . . . . 0.0 110.666 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.3 mt -51.72 -46.31 63.91 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.05 1.295 . . . . 0.0 110.572 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.66 -46.43 85.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.067 0.947 . . . . 0.0 111.657 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -61.65 -42.55 99.06 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.479 0.712 . . . . 0.0 112.227 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.98 -32.79 72.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.157 0.983 . . . . 0.0 111.315 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.41 -43.8 72.66 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.189 1.795 . . . . 0.0 111.857 173.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.3 -13.99 3.95 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.802 1.241 . . . . 0.0 112.004 168.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.3 m -113.96 -5.25 13.17 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.773 1.629 . . . . 0.0 112.241 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.57 19.73 49.3 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.137 1.827 . . . . 0.0 113.862 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mt -51.83 124.74 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 160.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -75.34 111.58 10.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -96.05 153.92 17.52 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 127' ' ' THR . 66.9 m-85 -148.61 165.79 30.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.487 1.515 . . . . 0.0 109.135 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.457 ' HB ' HG23 ' A' ' 129' ' ' ILE . 36.8 mt -137.72 153.66 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.998 1.719 . . . . 0.0 108.177 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -132.58 143.09 49.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.492 1.517 . . . . 0.0 107.795 160.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 t -169.74 173.11 6.41 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.796 1.638 . . . . 0.0 108.835 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -131.77 66.42 1.55 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.234 1.814 . . . . 0.0 110.106 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.27 6.58 17.44 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.483 1.513 . . . . 0.0 111.646 166.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.77 178.4 43.67 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.695 1.14 . . . . 0.0 111.28 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.47 -18.55 52.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.286 1.034 . . . . 0.0 111.837 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.65 -23.14 49.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.876 0.87 . . . . 0.0 111.652 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.28 -45.45 72.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.474 0.709 . . . . 0.0 111.922 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -62.63 -39.95 95.44 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.984 0.811 . . . . 0.0 109.904 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -62.25 -45.83 91.53 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.78 0.832 . . . . 0.0 110.262 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.21 -43.29 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.534 1.134 . . . . 0.0 109.14 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.84 -40.59 95.85 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.482 -0.761 . . . . 0.0 111.36 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -53.35 58.55 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.702 0.683 . . . . 0.0 110.162 169.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -49.47 -53.44 23.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.047 0.939 . . . . 0.0 111.597 -174.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.57 -11.07 60.11 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.17 1.388 . . . . 0.0 114.051 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 59.97 54.51 36.82 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.67 1.129 . . . . 0.0 110.678 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.7 6.08 2.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 125.085 1.354 . . . . 0.0 111.993 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.03 -53.01 56.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.564 0.697 . . . . 0.0 109.988 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 m -72.46 -11.26 60.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.818 -162.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -62.69 -28.69 70.11 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.172 0.989 . . . . 0.0 112.71 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -107.87 136.12 48.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -174.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.455 ' HB ' ' CE2' ' A' ' 104' ' ' PHE . 78.5 m -61.58 -43.62 98.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.85 157.12 38.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -173.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.457 HG23 ' HB ' ' A' ' 105' ' ' ILE . 5.0 mp -137.15 143.35 34.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.5 HD21 ' CE1' ' A' ' 147' ' ' TYR . 76.8 mt -99.57 158.87 15.45 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.764 1.225 . . . . 0.0 109.778 174.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 p -137.36 -174.22 3.69 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.136 0.574 . . . . 0.0 111.101 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.9 -30.18 13.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.512 1.125 . . . . 0.0 111.695 166.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -65.71 -19.83 66.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.994 1.318 . . . . 0.0 111.113 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.2 m -89.47 69.53 7.96 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.75 47.75 1.54 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 127.34 2.4 . . . . 0.0 112.116 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -56.66 169.32 0.49 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.367 0.667 . . . . 0.0 110.995 164.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' CB ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -50.67 166.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 122.634 1.207 . . . . 0.0 112.922 177.537 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -61.23 157.44 16.23 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.363 163.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -42.58 147.87 0.58 Allowed Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 124.745 1.218 . . . . 0.0 110.343 166.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.56 -27.3 4.95 Favored 'Cis proline' 0 CA--C 1.533 0.461 0 CA-C-N 119.342 0.801 . . . . 0.0 113.407 -3.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.503 ' CB ' HG23 ' A' ' 137' ' ' VAL . 3.3 t 49.39 82.18 0.24 Allowed Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.012 1.325 . . . . 0.0 112.079 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.57 -23.02 70.59 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 121.494 1.462 . . . . 0.0 111.286 165.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -54.03 -50.47 66.6 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.892 1.277 . . . . 0.0 112.713 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.02 -17.11 22.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.88 -47.77 6.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.546 1.138 . . . . 0.0 111.203 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 m -57.27 -39.02 74.8 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.885 0.874 . . . . 0.0 109.585 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.5 ' CE1' HD21 ' A' ' 130' ' ' LEU . 30.6 t80 -57.87 -51.02 71.31 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.544 0.738 . . . . 0.0 110.274 173.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.1 mt -65.95 -36.42 83.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.275 1.03 . . . . 0.0 110.761 -171.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 89.2 mt -60.59 -64.84 0.81 Allowed 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.36 1.864 . . . . 0.0 106.031 175.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.81 -37.26 75.98 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -172.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.32 -23.02 21.37 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 117.299 -1.334 . . . . 0.0 114.325 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -134.52 20.46 3.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.593 1.542 . . . . 0.0 110.612 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 44.14 62.87 1.82 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.679 2.392 . . . . 0.0 110.614 -172.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 67.5 mt -103.08 165.13 11.2 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.499 1.12 . . . . 0.0 110.647 -170.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -100.67 132.25 46.16 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.792 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 m -58.13 -49.37 77.22 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.546 1.138 . . . . 0.0 110.166 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.6 -4.18 41.6 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.133 -1.605 . . . . 0.0 112.818 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -113.6 10.88 18.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 117.876 -1.059 . . . . 0.0 108.838 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -109.9 111.26 22.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.98 0.809 . . . . 0.0 109.406 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -114.87 108.54 16.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.491 1.517 . . . . 0.0 110.152 -168.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -78.39 152.46 32.23 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.415 0.686 . . . . 0.0 109.68 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.438 HD11 ' CD2' ' A' ' 6' ' ' PHE . 2.5 mp -127.17 127.84 69.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 172.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -167.13 -177.68 38.96 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 121.511 0.506 . . . . 0.0 112.908 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -126.22 9.9 7.39 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.209 1.404 . . . . 0.0 112.452 -165.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -136.32 126.85 26.93 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.038 0.935 . . . . 0.0 110.03 -171.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 6.2 t -46.34 -23.87 0.41 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.133 2.573 . . . . 0.0 115.216 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -12.95 59.79 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.139 1.776 . . . . 0.0 112.312 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -51.64 69.16 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.637 0.775 . . . . 0.0 110.743 174.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.96 -29.68 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 O-C-N 121.811 -0.556 . . . . 0.0 109.611 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.52 -21.26 66.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.475 -0.774 . . . . 0.0 112.238 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -97.32 -39.77 9.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.548 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -57.2 -43.04 82.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 123.698 0.624 . . . . 0.0 111.153 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -59.1 -48.48 81.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.604 1.161 . . . . 0.0 110.934 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -71.1 -33.53 70.25 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 118.234 -0.889 . . . . 0.0 112.298 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 45.9 m -82.66 -21.39 35.0 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.514 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.72 63.67 3.11 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.462 1.506 . . . . 0.0 110.505 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.2 pt -135.73 -166.5 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.863 1.665 . . . . 0.0 108.948 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -120.38 158.64 26.73 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.548 1.067 . . . . 0.0 111.541 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.8 m -139.0 149.82 45.13 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.105 1.762 . . . . 0.0 109.367 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.1 mt -138.7 94.99 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -122.81 158.6 29.91 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.458 1.103 . . . . 0.0 110.938 -170.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -85.87 -26.33 25.7 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.705 -0.622 . . . . 0.0 111.391 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.412 ' H ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -73.04 175.55 6.58 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 161.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 192' ' ' ARG . 6.1 pt-20 -108.06 170.53 7.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 164.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.3 t -151.99 -168.97 3.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.9 p -127.78 81.26 2.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.874 1.27 . . . . 0.0 108.054 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -151.26 153.68 35.33 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.62 1.568 . . . . 0.0 108.465 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.87 108.14 16.69 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.775 1.63 . . . . 0.0 110.313 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 117.91 -7.42 15.11 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 123.972 0.796 . . . . 0.0 111.81 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.97 118.91 24.33 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.302 1.441 . . . . 0.0 108.293 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -114.21 136.47 52.92 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.139 1.376 . . . . 0.0 110.674 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.509 ' HD2' ' HB3' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -83.85 146.66 27.98 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.416 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.446 HG22 ' HB3' ' A' ' 198' ' ' ASP . 22.5 pt -132.82 167.67 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.39 1.476 . . . . 0.0 112.303 165.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -124.75 -12.12 7.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.549 1.539 . . . . 0.0 112.172 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.07 172.09 19.29 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.502 1.521 . . . . 0.0 109.454 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.505 HD11 ' N ' ' A' ' 89' ' ' ALA . 10.2 mt -68.78 -37.18 79.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.95 1.3 . . . . 0.0 110.352 -176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.39 -22.43 66.79 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.874 0.845 . . . . 0.0 112.196 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.446 ' HB3' HG22 ' A' ' 193' ' ' ILE . 0.5 OUTLIER -74.83 -5.77 45.35 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.825 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 78.5 mt -77.65 -63.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.348 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 168.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.9 p -55.96 -28.03 55.15 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -60.03 -38.69 83.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.145 1.778 . . . . 0.0 112.996 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.91 -50.16 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 C-N-CA 126.632 1.973 . . . . 0.0 106.563 -168.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -71.69 -4.26 26.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.352 1.061 . . . . 0.0 113.338 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 . . . . . 0 N--CA 1.451 -0.415 0 C-N-CA 123.417 0.687 . . . . 0.0 112.389 -179.362 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.0 mmm . . . . . 0 C--O 1.238 0.47 0 CA-C-O 123.267 1.508 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -60.92 -172.31 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.22 1.408 . . . . 0.0 110.214 155.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -66.53 82.99 0.1 Allowed 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.926 1.29 . . . . 0.0 110.141 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.8 m -92.74 158.91 15.66 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 166.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.54 157.33 45.64 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 120.584 -1.323 . . . . 0.0 110.636 164.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -128.42 162.48 27.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.203 2.201 . . . . 0.0 108.587 -172.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.5 mt -138.99 144.5 29.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 126.224 1.81 . . . . 0.0 107.033 166.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -117.13 166.35 12.33 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.983 2.113 . . . . 0.0 110.398 170.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -105.21 171.88 7.09 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 162.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.546 0.792 0 C-N-CA 127.403 2.281 . . . . 0.0 110.736 172.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.371 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -51.65 -36.65 47.0 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.8 0.84 . . . . 0.0 112.219 -175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -56.7 -51.02 70.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.836 1.254 . . . . 0.0 111.047 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.39 -43.88 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.399 1.479 . . . . 0.0 109.815 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.726 HD23 ' CD2' ' A' ' 125' ' ' TYR . 8.3 mp -50.39 -50.78 50.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 121.344 1.884 . . . . 0.0 111.205 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.59 -43.97 85.03 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.446 0.466 . . . . 0.0 111.951 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -68.72 -39.66 80.32 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.005 1.322 . . . . 0.0 112.089 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.91 -29.13 60.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.209 1.404 . . . . 0.0 111.597 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -64.38 -59.2 4.64 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 127.401 2.281 . . . . 0.0 110.166 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -55.72 -27.27 49.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.559 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.7 m -90.66 3.5 54.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.93 8.93 44.49 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.127 1.346 . . . . 0.0 114.334 173.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mt -66.37 104.17 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -60.71 111.92 1.81 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.61 150.1 21.85 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 172.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.519 ' CD2' HD22 ' A' ' 148' ' ' LEU . 79.5 m-85 -142.95 166.4 24.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.503 1.121 . . . . 0.0 110.53 175.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 9.2 mt -127.49 158.25 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 121.041 1.746 . . . . 0.0 109.43 173.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -133.58 112.0 11.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.747 1.219 . . . . 0.0 108.893 167.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -143.11 173.63 11.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -127.68 14.16 6.97 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.759 2.023 . . . . 0.0 110.887 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -3.07 28.98 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.99 173.0 34.4 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.703 1.62 . . . . 0.0 112.557 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.74 -19.99 19.72 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.777 1.631 . . . . 0.0 112.653 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -22.76 20.98 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.419 1.488 . . . . 0.0 111.944 173.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.91 -44.57 78.38 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.027 -1.045 . . . . 0.0 111.576 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -56.79 -46.25 81.66 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.75 0.42 . . . . 0.0 110.506 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -61.3 -47.37 86.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.747 0.819 . . . . 0.0 110.486 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.8 mt -55.59 -50.63 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.83 -32.27 73.45 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.802 -1.186 . . . . 0.0 110.843 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -72.33 -27.2 62.28 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 171.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -63.81 1.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 123.365 1.555 . . . . 0.0 107.08 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.31 -35.59 80.88 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.785 3.234 . . . . 0.0 112.254 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.8 61.93 1.57 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 124.512 1.053 . . . . 0.0 110.495 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.9 m -139.64 5.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.223 1.009 . . . . 0.0 110.856 170.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.11 -30.75 63.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.086 -1.009 . . . . 0.0 111.37 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.3 m -70.36 -26.93 63.96 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 118.801 0.728 . . . . 0.0 111.73 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.726 ' CD2' HD23 ' A' ' 93' ' ' LEU . 24.6 m-85 -51.5 -60.33 3.26 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.297 0.639 . . . . 0.0 110.11 164.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.53 ' CE1' HD21 ' A' ' 93' ' ' LEU . 28.9 m-85 -84.9 114.23 21.97 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -152.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.2 m -64.5 -31.85 73.24 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.733 -0.604 . . . . 0.0 111.629 -172.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -158.89 156.72 30.1 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.957 1.253 . . . . 0.0 109.838 167.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.79 105.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 103.871 -2.64 . . . . 0.0 103.871 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.22 158.24 26.7 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.3 p -131.75 179.73 5.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.053 1.341 . . . . 0.0 109.15 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -31.03 42.33 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.155 1.382 . . . . 0.0 112.168 165.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -63.71 -21.55 66.46 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.921 1.288 . . . . 0.0 110.676 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.6 p -57.24 -30.39 64.58 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.0 1.32 . . . . 0.0 114.063 -165.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.75 2.31 44.06 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.538 -1.146 . . . . 0.0 113.954 169.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -63.51 158.47 20.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.318 1.559 . . . . 0.0 111.613 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 137' ' ' VAL . 8.7 t -57.61 157.85 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.564 161.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -136.78 59.8 1.68 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.277 1.431 . . . . 0.0 111.207 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -49.66 -54.84 27.29 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-O 114.834 -2.508 . . . . 0.0 114.344 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.78 114.08 0.19 OUTLIER 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 123.313 2.219 . . . . 0.0 117.016 10.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 m -92.73 154.94 42.2 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 124.873 1.269 . . . . 0.0 112.547 -173.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -81.53 5.25 6.4 Favored 'Trans proline' 0 CA--C 1.549 1.261 1 C-N-CA 125.585 4.19 . . . . 0.0 113.883 170.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -46.77 -63.92 0.9 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.479 1.912 . . . . 0.0 110.942 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.54 -20.96 64.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.461 0.705 . . . . 0.0 111.934 -169.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.18 -60.38 2.32 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.297 1.039 . . . . 0.0 108.766 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.3 m -54.93 -40.57 70.04 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.025 1.33 . . . . 0.0 110.407 -174.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.512 ' CE1' ' HE2' ' A' ' 151' ' ' LYS . 72.0 t80 -52.1 -58.0 7.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.474 1.11 . . . . 0.0 110.633 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.519 HD22 ' CD2' ' A' ' 104' ' ' PHE . 23.3 mt -71.02 -25.19 62.56 Favored 'General case' 0 CA--C 1.521 -0.137 0 O-C-N 121.866 -0.521 . . . . 0.0 112.144 -172.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 87.2 mt -66.48 -61.15 2.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.99 -36.19 72.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.963 0.505 . . . . 0.0 111.699 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.512 ' HE2' ' CE1' ' A' ' 147' ' ' TYR . 7.9 mmtm -57.31 -22.85 44.74 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 114.276 1.214 . . . . 0.0 114.276 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.97 27.43 1.46 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 119.037 0.835 . . . . 0.0 111.822 169.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 67.9 mm-40 44.41 54.56 6.22 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.648 2.379 . . . . 0.0 111.494 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 4.3 mp -75.46 -169.59 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.188 1.395 . . . . 0.0 110.592 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -121.78 129.15 52.44 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.236 1.414 . . . . 0.0 108.751 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.0 m -52.5 -49.1 65.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.985 1.714 . . . . 0.0 110.445 175.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -88.43 9.2 24.4 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 120.791 -1.193 . . . . 0.0 111.881 -169.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -125.94 8.75 7.45 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.353 1.861 . . . . 0.0 108.733 173.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -107.65 142.42 37.64 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.743 1.156 . . . . 0.0 109.539 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -129.46 156.55 43.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.952 2.101 . . . . 0.0 108.243 -170.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -139.17 128.17 23.7 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.93 116.05 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.152 1.381 . . . . 0.0 107.309 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -142.09 -172.26 13.48 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 174.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -132.51 5.83 4.05 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.404 1.882 . . . . 0.0 113.393 -169.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.405 ' HG2' HH11 ' A' ' 165' ' ' ARG . 0.6 OUTLIER -131.83 155.82 47.13 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 120.0 1.273 . . . . 0.0 109.95 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t -72.94 -13.69 61.3 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.584 -1.323 . . . . 0.0 111.059 -169.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.26 -33.18 52.02 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.739 1.616 . . . . 0.0 111.167 167.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -74.06 10.12 1.33 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.376 1.47 . . . . 0.0 113.601 -164.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.22 -13.71 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.288 1.035 . . . . 0.0 110.686 167.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.32 -47.83 77.92 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.803 1.638 . . . . 0.0 110.018 -173.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -76.94 -34.44 57.65 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 121.595 -0.691 . . . . 0.0 111.809 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.48 -58.11 8.29 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.598 0.759 . . . . 0.0 109.867 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -49.84 -45.74 50.57 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.699 2.0 . . . . 0.0 110.841 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -62.49 -26.08 68.35 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.5 p -93.98 -26.01 17.0 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.055 0.843 . . . . 0.0 112.769 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 92.46 9.57 61.48 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.198 1.38 . . . . 0.0 112.556 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 178' ' ' GLN . 1.7 pp -88.21 175.66 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.721 1.209 . . . . 0.0 109.39 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.411 ' N ' HD12 ' A' ' 177' ' ' ILE . 32.5 mt-30 -112.37 163.73 14.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.865 0.841 . . . . 0.0 111.694 -165.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 8.8 m -137.39 149.82 47.22 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.665 1.586 . . . . 0.0 110.175 -168.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 47.6 mt -140.4 78.02 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -114.16 165.13 12.97 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.507 1.146 . . . . 0.0 110.693 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -73.4 -13.3 61.06 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.283 -0.885 . . . . 0.0 113.157 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.59 157.12 39.71 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.442 1.019 . . . . 0.0 110.727 -174.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -89.51 159.23 17.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.939 -0.476 . . . . 0.0 111.435 -171.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.25 8.38 1.2 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -169.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 47.7 p 52.81 49.66 19.78 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.101 1.36 . . . . 0.0 113.257 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -131.27 162.65 29.55 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.4 1.88 . . . . 0.0 109.105 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -80.13 -42.87 22.67 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.639 0.776 . . . . 0.0 111.812 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.73 47.4 3.57 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -130.43 125.94 35.72 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.922 1.289 . . . . 0.0 109.52 -164.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -127.2 108.39 10.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.004 0.921 . . . . 0.0 109.156 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -63.94 142.01 58.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 118.149 -1.42 . . . . 0.0 109.699 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 13.7 pt -114.96 159.67 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.3 1.04 . . . . 0.0 110.564 165.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.15 -8.17 12.4 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.839 1.256 . . . . 0.0 112.535 172.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.76 161.62 41.43 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.869 2.468 . . . . 0.0 107.154 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 tp -71.16 -32.94 69.55 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.408 -0.808 . . . . 0.0 110.268 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.77 -18.69 63.06 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.098 -0.953 . . . . 0.0 112.196 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -66.32 -20.02 65.97 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.422 1.01 . . . . 0.0 110.316 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 76.8 mt -62.46 -53.61 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 124.607 1.163 . . . . 0.0 108.96 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 80.7 p -56.27 -39.59 72.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.185 0.902 . . . . 0.0 109.662 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -60.2 -25.71 65.8 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.349 2.26 . . . . 0.0 111.591 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 80.0 mt -61.64 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 120.498 -1.376 . . . . 0.0 109.454 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -89.91 -26.26 20.54 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.492 1.117 . . . . 0.0 110.944 -175.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 . . . . . 0 CA--C 1.535 0.395 0 C-N-CA 125.716 1.606 . . . . 0.0 112.587 -176.216 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mmm . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.16 169.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.901 2.081 . . . . 0.0 109.687 162.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 106.72 0.09 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.476 1.51 . . . . 0.0 108.813 174.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.8 m -134.86 147.18 49.82 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.27 153.96 46.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.402 1.081 . . . . 0.0 108.645 171.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.04 153.31 48.56 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.176 1.79 . . . . 0.0 107.609 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 mt -143.22 138.46 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -128.97 179.96 5.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.43 1.092 . . . . 0.0 110.443 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -130.71 172.35 12.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.172 2.189 . . . . 0.0 109.596 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.411 HD12 HG21 ' A' ' 107' ' ' THR . 76.0 mt . . . . . 0 CA--C 1.535 0.389 0 C-N-CA 126.501 1.921 . . . . 0.0 111.508 -174.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttt-85 -60.75 -28.69 68.89 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.66 0.664 . . . . 0.0 112.208 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -58.77 7.07 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.637 1.575 . . . . 0.0 110.304 170.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.06 -47.47 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.637 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.522 ' HA ' HE22 ' A' ' 103' ' ' GLN . 3.9 mp -44.68 -54.95 5.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 120.835 1.652 . . . . 0.0 113.237 169.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.57 68.89 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 123.417 0.448 . . . . 0.0 110.563 -176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -54.01 -50.54 66.4 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.989 0.916 . . . . 0.0 110.918 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.4 73.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.089 1.356 . . . . 0.0 112.588 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.82 -54.26 20.46 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 124.556 1.142 . . . . 0.0 110.562 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -67.48 -16.67 64.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.198 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.2 m -84.69 -1.63 56.44 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.783 1.633 . . . . 0.0 113.272 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.47 4.81 87.63 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.845 1.202 . . . . 0.0 114.179 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.2 mt -66.6 138.07 23.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 O-C-N 121.143 -1.21 . . . . 0.0 108.169 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.63 114.83 24.61 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 163.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.522 HE22 ' HA ' ' A' ' 93' ' ' LEU . 11.8 mt-30 -86.36 151.69 23.35 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 170.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.2 174.99 10.22 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.463 1.905 . . . . 0.0 107.11 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 33.9 mt -133.56 154.9 39.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 170.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.413 ' CD1' ' HB3' ' A' ' 130' ' ' LEU . 9.8 t80 -142.47 119.3 11.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 159.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.696 HG23 ' H ' ' A' ' 109' ' ' LYS . 6.0 t -145.63 175.63 10.23 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.055 0.542 . . . . 0.0 110.455 170.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -84.39 1.55 44.72 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.125 0.97 . . . . 0.0 113.487 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.696 ' H ' HG23 ' A' ' 107' ' ' THR . 11.9 ttmm -64.6 160.8 18.85 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.6 -168.85 43.6 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.367 0.984 . . . . 0.0 111.677 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.9 -16.72 60.03 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 122.117 -0.637 . . . . 0.0 112.579 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -55.47 -23.44 25.68 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.951 -1.023 . . . . 0.0 112.389 168.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.97 -49.47 63.15 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.409 1.459 . . . . 0.0 112.791 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -60.67 -48.8 80.18 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.219 1.008 . . . . 0.0 109.493 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.5 m -58.96 -41.1 86.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.426 1.49 . . . . 0.0 111.715 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -64.35 -44.05 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 121.344 -0.847 . . . . 0.0 108.83 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -60.52 -45.54 93.44 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.925 0.89 . . . . 0.0 111.796 177.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -58.84 -48.42 81.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.429 1.092 . . . . 0.0 109.226 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -58.25 -49.91 75.45 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.834 1.654 . . . . 0.0 111.857 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.39 -4.54 34.14 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.889 1.276 . . . . 0.0 112.667 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 65.62 39.43 95.43 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.313 0.959 . . . . 0.0 112.296 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.68 15.11 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.81 1.244 . . . . 0.0 110.898 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -61.55 -41.71 97.77 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.877 -0.514 . . . . 0.0 110.738 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 m -57.75 -27.36 62.96 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.437 ' CD2' HD23 ' A' ' 93' ' ' LEU . 32.4 m-85 -63.71 -34.19 77.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 118.988 -0.529 . . . . 0.0 111.897 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -110.37 96.83 6.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -166.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.7 m -51.01 -44.86 61.05 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.581 0.753 . . . . 0.0 110.699 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.45 153.2 44.83 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.501 1.12 . . . . 0.0 108.816 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.59 93.14 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 106' ' ' TYR . 16.6 mt -68.62 146.72 52.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.3 p -151.24 179.45 8.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.731 -162.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.4 t -47.56 -34.97 8.36 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.247 1.819 . . . . 0.0 112.15 173.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -59.27 -30.0 67.98 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.08 1.352 . . . . 0.0 112.137 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.7 p -58.34 -49.46 77.12 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.597 1.189 . . . . 0.0 110.322 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.93 -1.18 87.29 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-O 116.83 -2.095 . . . . 0.0 113.437 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -56.63 162.61 2.18 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.303 1.552 . . . . 0.0 111.286 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.46 HG23 ' HA ' ' A' ' 141' ' ' SER . 6.1 m -50.64 153.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.73 2.012 . . . . 0.0 112.205 170.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.425 ' HG3' ' H ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -83.88 -77.27 0.26 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.582 1.553 . . . . 0.0 111.702 -168.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.425 ' H ' ' HG3' ' A' ' 138' ' ' ARG . 9.0 mttp -163.59 117.99 1.09 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 128.815 2.846 . . . . 0.0 104.923 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.26 160.42 75.81 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.257 1.127 . . . . 0.0 111.68 -4.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.464 ' H ' ' HB2' ' A' ' 171' ' ' PHE . 2.6 p -156.18 54.94 0.99 Allowed Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -68.11 -14.74 41.61 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 121.37 1.38 . . . . 0.0 113.056 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -55.43 -39.62 70.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.837 1.255 . . . . 0.0 110.761 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.66 -15.19 62.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.921 -0.487 . . . . 0.0 112.024 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.27 -55.91 5.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.0 m -59.26 -37.74 78.34 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.198 0.599 . . . . 0.0 110.777 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -55.48 -56.33 21.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.8 mt -61.17 -38.23 85.76 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.241 -175.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -67.1 0.42 Allowed 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 125.126 1.37 . . . . 0.0 107.385 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.06 -34.31 68.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -47.38 72.96 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 114.957 -2.449 . . . . 0.0 114.198 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -124.55 18.36 8.83 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 121.633 2.015 . . . . 0.0 110.069 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 64.27 56.96 1.26 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 127.013 2.125 . . . . 0.0 108.686 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . 0.26 0.0 OUTLIER -109.58 176.19 5.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 114.7 1.371 . . . . 0.0 114.7 -175.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -108.21 150.02 27.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.426 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.1 p -66.75 -48.33 69.45 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 122.309 1.052 . . . . 0.0 110.765 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.29 -9.47 58.58 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 120.772 -1.205 . . . . 0.0 112.326 -170.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -116.67 21.7 13.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 118.098 -0.953 . . . . 0.0 108.804 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -113.01 136.08 53.08 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.989 0.813 . . . . 0.0 111.397 163.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -120.24 105.0 10.53 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.117 2.167 . . . . 0.0 111.003 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -78.4 148.64 33.57 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.299 1.04 . . . . 0.0 108.83 168.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.98 123.4 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -155.5 -5.53 0.09 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 116.926 1.531 . . . . 0.0 116.926 -172.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.3 5.54 2.6 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.53 1.932 . . . . 0.0 115.953 163.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -115.94 10.04 15.09 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -156.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t 52.6 5.41 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.805 3.242 . . . . 0.0 115.361 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.2 tt -112.27 -16.23 13.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.055 2.542 . . . . 0.0 110.099 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.64 -52.29 64.95 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 129.167 2.987 . . . . 0.0 107.852 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.4 HG11 ' CB ' ' A' ' 185' ' ' SER . 7.7 p -52.65 -46.07 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 127.081 2.152 . . . . 0.0 112.267 171.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -62.02 -45.17 94.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -169.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.464 ' HB2' ' H ' ' A' ' 141' ' ' SER . 3.3 p90 -79.78 -32.88 40.91 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.025 -1.047 . . . . 0.0 112.346 175.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.28 -52.35 53.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.217 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -50.49 -51.59 45.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.272 1.829 . . . . 0.0 110.454 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -65.25 -28.15 69.15 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.29 -22.86 28.38 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.715 -1.241 . . . . 0.0 112.735 170.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.63 55.86 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.538 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 17.3 pt -97.54 167.06 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.132 0.973 . . . . 0.0 109.385 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -87.93 178.97 6.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.985 0.514 . . . . 0.0 109.955 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.17 151.9 19.99 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.69 -1.256 . . . . 0.0 111.645 173.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 35.8 mt -124.96 128.08 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -144.15 139.62 28.91 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 124.192 0.997 . . . . 0.0 108.349 -167.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -68.25 -17.8 64.39 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.499 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.35 166.58 10.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.242 1.417 . . . . 0.0 111.235 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -72.73 169.16 17.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.82 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.4 ' CB ' HG11 ' A' ' 169' ' ' VAL . 45.5 t -156.49 171.85 19.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 157.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.1 p -73.1 4.65 4.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.347 2.259 . . . . 0.0 114.242 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -112.07 153.16 27.33 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.29 1.036 . . . . 0.0 110.569 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.58 -45.58 68.33 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.72 1.208 . . . . 0.0 112.627 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.44 36.62 2.6 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.752 1.167 . . . . 0.0 110.311 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -111.35 93.13 4.32 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 174.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -86.06 108.46 18.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -62.08 149.33 41.5 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.34 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.7 pt -142.22 166.19 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.159 1.384 . . . . 0.0 110.675 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.85 -2.68 8.74 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.129 1.772 . . . . 0.0 112.949 170.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.32 166.23 34.05 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.839 1.656 . . . . 0.0 108.788 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 63.6 mt -69.29 -41.92 76.15 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.34 -0.05 1.67 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.41 1.084 . . . . 0.0 113.892 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -81.78 -18.89 42.55 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.053 -1.654 . . . . 0.0 109.924 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 77.7 mt -58.47 -52.14 62.98 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.3 p -50.67 -43.48 57.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.26 0.482 . . . . 0.0 111.44 177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 63.8 mtt85 -62.86 -21.62 66.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.503 1.521 . . . . 0.0 113.296 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 75.0 mt -60.54 -47.98 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -84.61 -34.89 23.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.729 1.211 . . . . 0.0 111.336 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 . . . . . 0 CA--C 1.536 0.439 0 C-N-CA 124.904 1.282 . . . . 0.0 111.413 -169.902 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.8 mmm . . . . . 0 C--O 1.236 0.348 0 CA-C-O 122.846 1.307 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -45.49 160.3 0.05 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.851 2.06 . . . . 0.0 111.292 166.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -44.24 97.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.347 1.859 . . . . 0.0 111.722 -172.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.2 m -125.82 155.81 40.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.23 150.55 50.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.484 0.714 . . . . 0.0 109.091 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -123.27 155.16 37.74 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.205 1.402 . . . . 0.0 108.333 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.4 mt -140.39 133.82 33.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -131.03 147.16 52.59 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.149 1.38 . . . . 0.0 111.737 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -81.65 -22.3 37.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.655 1.582 . . . . 0.0 111.604 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 127.416 2.286 . . . . 0.0 110.343 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.276 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -39.06 70.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.149 0.886 . . . . 0.0 110.992 -166.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.28 -53.46 58.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.624 0.769 . . . . 0.0 110.699 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -61.33 -40.76 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 118.745 0.702 . . . . 0.0 110.266 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.74 -48.89 78.35 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 118.857 0.753 . . . . 0.0 109.519 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.29 -49.57 75.65 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.977 0.511 . . . . 0.0 111.669 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -57.19 -52.61 64.6 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.741 0.817 . . . . 0.0 110.263 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.43 91.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.059 1.343 . . . . 0.0 111.874 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.13 -46.12 71.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.388 1.875 . . . . 0.0 111.399 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.63 -33.61 76.01 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.744 -0.597 . . . . 0.0 110.865 170.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.3 m -71.9 -2.82 19.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.495 1.118 . . . . 0.0 112.861 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.89 17.06 62.55 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.971 1.272 . . . . 0.0 112.283 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -67.6 116.25 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -67.87 97.02 0.62 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -81.76 137.79 35.28 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.784 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -131.28 172.77 11.76 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.451 1.5 . . . . 0.0 110.366 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.3 mt -138.06 156.31 30.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.438 1.495 . . . . 0.0 108.358 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -138.08 126.61 23.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 167.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.1 t -142.49 169.86 16.79 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.909 0.861 . . . . 0.0 110.242 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -105.07 -5.5 20.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.159 1.784 . . . . 0.0 111.85 169.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -68.33 -5.04 16.58 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 -167.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.52 -179.72 38.95 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.38 -17.85 64.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -172.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.89 -14.14 5.66 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.41 -44.53 68.81 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.391 0.996 . . . . 0.0 111.728 169.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.3 -46.68 87.65 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.198 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -56.04 -46.02 78.99 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.698 0.799 . . . . 0.0 109.95 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.7 mt -60.69 -49.02 86.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.32 -38.9 85.67 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.525 -0.734 . . . . 0.0 111.175 -175.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -62.56 -47.35 84.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.79 -32.35 73.5 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.077 0.951 . . . . 0.0 112.854 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.3 mt -90.17 1.54 56.32 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.379 1.472 . . . . 0.0 112.344 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.51 36.22 92.26 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.279 0.942 . . . . 0.0 112.842 174.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.84 20.57 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 110.648 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -73.53 -36.47 65.69 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 120.6 -1.312 . . . . 0.0 113.188 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -28.79 69.93 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.065 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -67.32 -2.84 6.66 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.026 -0.988 . . . . 0.0 113.292 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -138.23 81.83 1.88 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.719 1.6 . . . . 0.0 108.577 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 m -44.9 -44.89 10.01 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.685 2.394 . . . . 0.0 114.514 -171.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -154.58 91.29 1.38 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-N 120.234 1.379 . . . . 0.0 112.1 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.69 122.78 26.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.021 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.62 154.66 26.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.64 -0.663 . . . . 0.0 110.366 165.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.4 p -138.29 -174.67 3.87 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.296 1.839 . . . . 0.0 108.424 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.9 m -60.77 -13.79 17.36 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.903 -1.123 . . . . 0.0 112.802 164.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.93 -22.34 64.15 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.889 1.677 . . . . 0.0 109.739 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.5 p -53.63 -47.79 69.94 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 123.757 0.66 . . . . 0.0 110.354 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.86 -12.21 68.82 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 117.603 -1.665 . . . . 0.0 111.938 -171.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -52.66 148.54 7.09 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.004 1.402 . . . . 0.0 111.397 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' A' ' 141' ' ' SER . 22.9 m -66.1 169.16 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-O 122.322 1.058 . . . . 0.0 113.059 -163.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -60.45 143.22 53.88 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 121.308 -0.87 . . . . 0.0 109.697 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -59.09 150.46 61.87 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.588 -1.196 . . . . 0.0 110.604 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -61.18 120.25 1.21 Allowed 'Cis proline' 0 CA--C 1.538 0.701 0 CA-C-N 120.618 1.256 . . . . 0.0 110.685 -17.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 137' ' ' VAL . 6.1 p -126.68 81.8 68.13 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.712 1.605 . . . . 0.0 112.546 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -71.28 -10.76 27.73 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.968 2.446 . . . . 0.0 112.415 -170.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -44.91 -50.26 10.55 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.597 2.359 . . . . 0.0 110.918 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.04 -15.61 63.83 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.06 -51.89 6.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.511 0.725 . . . . 0.0 109.521 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 m -50.59 -43.84 56.72 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.315 1.446 . . . . 0.0 109.853 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -57.7 -60.07 4.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.336 0.655 . . . . 0.0 109.604 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.57 -25.38 67.28 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.41 -71.66 0.14 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 172.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -28.34 69.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.609 1.164 . . . . 0.0 113.011 -171.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -31.24 65.67 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.168 1.387 . . . . 0.0 112.142 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -140.8 11.61 2.25 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 44.99 73.55 0.15 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 127.912 2.485 . . . . 0.0 111.565 -163.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.5 mp -103.08 154.92 18.78 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 166.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -93.42 136.96 33.19 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 126.108 1.763 . . . . 0.0 107.969 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -41.89 97.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.095 0.474 . . . . 0.0 111.938 174.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.23 -19.27 60.57 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.997 -1.064 . . . . 0.0 112.396 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -101.87 16.07 27.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -110.1 133.95 52.68 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.272 1.396 . . . . 0.0 108.228 169.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -125.64 117.48 23.62 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.721 1.208 . . . . 0.0 108.327 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -97.84 132.11 43.74 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.011 0.924 . . . . 0.0 109.172 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 7.2 mt -114.91 78.93 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -160.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.49 -177.94 37.01 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.494 1.521 . . . . 0.0 113.549 -170.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -134.82 1.88 3.08 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.665 1.186 . . . . 0.0 113.396 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.05 178.08 6.96 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 122.619 1.199 . . . . 0.0 111.344 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.12 -37.45 61.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.536 -177.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.78 -33.46 64.38 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 125.665 1.586 . . . . 0.0 111.865 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -57.43 -33.29 67.75 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.097 0.959 . . . . 0.0 111.481 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.401 HG21 ' CB ' ' A' ' 185' ' ' SER . 8.2 t -92.31 -18.24 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.456 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -61.3 -31.51 71.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.311 0.96 . . . . 0.0 108.502 168.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -64.34 -56.27 15.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.59 -44.73 77.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.836 0.854 . . . . 0.0 111.578 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -55.44 -44.97 76.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.575 1.55 . . . . 0.0 111.503 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -69.25 -52.49 27.09 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.756 -0.59 . . . . 0.0 110.793 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.1 m -66.96 -19.55 65.74 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.147 1.379 . . . . 0.0 112.48 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 67.15 49.77 50.67 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 126.233 1.873 . . . . 0.0 110.799 -173.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.7 pt -117.9 -164.69 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.149 1.379 . . . . 0.0 109.224 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -117.94 163.96 15.79 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.512 0.725 . . . . 0.0 110.265 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 7.1 m -133.29 153.47 51.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.649 1.58 . . . . 0.0 110.005 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 55.1 mt -139.46 90.55 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -119.62 153.93 34.74 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.597 0.713 . . . . 0.0 109.399 -172.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -66.47 -17.13 64.62 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 pp -123.27 157.67 32.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 126.055 1.742 . . . . 0.0 110.339 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.41 139.72 51.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.401 ' CB ' HG21 ' A' ' 169' ' ' VAL . 16.5 m -126.67 -178.39 4.36 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p -72.48 4.97 3.3 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -169.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -142.79 133.01 24.61 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.27 1.428 . . . . 0.0 107.172 -160.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -69.84 -28.96 66.12 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.503 1.521 . . . . 0.0 110.967 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -72.88 10.67 5.23 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.686 1.612 . . . . 0.0 113.865 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -98.12 105.06 17.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.206 1.503 . . . . 0.0 108.364 167.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -79.1 126.67 31.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -69.62 152.65 44.49 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.405 1.002 . . . . 0.0 111.961 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.6 pt -134.42 163.07 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.326 1.451 . . . . 0.0 111.085 168.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -118.45 -14.9 9.69 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.746 1.218 . . . . 0.0 113.105 170.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.72 168.29 21.71 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.43 -42.26 79.14 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.75 -27.24 68.58 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -59.92 -21.12 60.69 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.336 1.854 . . . . 0.0 111.319 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 87.7 mt -57.09 -54.79 25.62 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 C-N-CA 125.557 1.543 . . . . 0.0 108.75 170.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 92.2 p -52.66 -42.24 64.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.481 1.037 . . . . 0.0 110.46 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -17.66 64.35 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.567 1.147 . . . . 0.0 112.995 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.25 -55.59 18.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -78.07 -34.47 50.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.51 1.124 . . . . 0.0 111.685 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 124.648 1.179 . . . . 0.0 112.175 -171.682 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 mmm . . . . . 0 N--CA 1.451 -0.419 0 CA-C-O 122.734 1.255 . . . . 0.0 107.666 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.58 171.51 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.381 159.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -44.43 100.4 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.334 1.854 . . . . 0.0 110.348 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.1 m -127.63 149.82 50.01 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.64 147.26 49.94 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.552 -0.717 . . . . 0.0 109.948 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -126.85 149.93 49.48 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.899 1.28 . . . . 0.0 109.399 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.484 ' O ' HD12 ' A' ' 162' ' ' ILE . 32.1 mt -149.54 121.29 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -173.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TRP . . . . . 0.588 ' CD2' HD13 ' A' ' 162' ' ' ILE . 76.1 m95 -112.12 -174.56 2.49 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.014 1.326 . . . . 0.0 110.493 -175.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -130.94 -173.41 3.08 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.96 1.304 . . . . 0.0 108.873 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.6 0 C-N-CA 126.654 1.981 . . . . 0.0 110.101 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.372 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.711 ' HA ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -52.01 -31.42 29.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.111 1.364 . . . . 0.0 113.733 -174.018 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.33 -45.81 80.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.502 0.721 . . . . 0.0 110.963 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.421 HG11 ' CH2' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -71.0 -41.07 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -177.607 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' A' ' 90' ' ' ARG . 60.4 mt -62.37 -43.56 98.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -174.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.55 -52.45 57.6 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 125.917 1.687 . . . . 0.0 109.649 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -54.43 -45.39 73.01 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.134 0.573 . . . . 0.0 112.155 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.84 64.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.908 0.883 . . . . 0.0 112.124 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -56.97 -48.72 77.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.463 1.905 . . . . 0.0 109.926 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.3 -2.61 13.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.577 2.351 . . . . 0.0 113.407 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.5 m -120.54 7.63 10.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.809 1.644 . . . . 0.0 113.175 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.4 11.09 61.35 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 121.441 -0.787 . . . . 0.0 114.385 171.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.8 mt -60.18 121.27 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -69.58 106.53 3.05 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 167.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -91.17 151.18 21.06 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.414 ' CD1' HD22 ' A' ' 148' ' ' LEU . 80.6 m-85 -145.25 177.43 8.81 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.344 1.458 . . . . 0.0 109.609 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.586 ' HB ' HG23 ' A' ' 129' ' ' ILE . 18.8 mt -141.55 145.7 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.404 1.082 . . . . 0.0 108.559 172.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -132.3 141.63 49.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.769 1.228 . . . . 0.0 107.81 163.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 109' ' ' LYS . 5.7 t -167.05 -175.46 3.01 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -104.98 8.13 34.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.376 1.47 . . . . 0.0 112.61 172.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.628 ' H ' HG23 ' A' ' 107' ' ' THR . 6.9 tttm -57.58 153.12 13.68 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.116 -0.99 . . . . 0.0 109.866 171.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.56 175.91 43.02 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.505 1.05 . . . . 0.0 111.341 174.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -60.69 -17.0 45.29 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.534 -0.98 . . . . 0.0 112.433 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.31 -26.76 8.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.7 1.2 . . . . 0.0 112.284 169.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.36 -53.06 18.93 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.761 1.224 . . . . 0.0 111.24 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -53.42 -42.89 67.51 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.382 1.073 . . . . 0.0 110.027 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.9 m -63.07 -49.34 74.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.189 0.595 . . . . 0.0 110.425 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.5 mt -59.14 -46.58 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.719 0.69 . . . . 0.0 109.769 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 mt -66.96 -35.89 80.98 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.075 -0.391 . . . . 0.0 110.559 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -60.24 -45.18 94.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.232 1.013 . . . . 0.0 109.124 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.7 -61.29 2.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.123 1.769 . . . . 0.0 111.654 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.99 -32.97 63.64 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.212 -165.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 125.89 47.11 0.21 Allowed Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 148.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.772 HG23 ' CD2' ' A' ' 125' ' ' TYR . 3.6 p -159.4 44.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-O 123.796 1.76 . . . . 0.0 107.425 -169.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.79 -25.02 26.59 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 118.731 -2.481 . . . . 0.0 112.357 173.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.05 -20.29 17.46 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.553 1.158 . . . . 0.0 111.37 -165.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.772 ' CD2' HG23 ' A' ' 122' ' ' VAL . 35.6 m-85 -62.5 1.94 0.32 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 128.578 2.751 . . . . 0.0 114.245 165.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.518 ' CE2' HG22 ' A' ' 122' ' ' VAL . 8.3 m-85 -141.37 109.02 5.62 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 174.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -53.44 -38.92 64.0 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.809 1.644 . . . . 0.0 111.153 -170.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -150.73 148.48 28.6 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.586 HG23 ' HB ' ' A' ' 105' ' ' ILE . 4.9 mp -126.84 126.48 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.9 mt -84.33 160.93 20.59 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 167.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.1 p -138.51 -177.59 4.92 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.428 1.091 . . . . 0.0 109.177 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.58 -30.1 19.71 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.485 -0.759 . . . . 0.0 111.159 161.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -72.23 -9.31 58.29 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.208 -0.933 . . . . 0.0 112.79 -169.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.8 m -56.73 -60.38 3.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.167 1.387 . . . . 0.0 110.758 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.75 -21.43 23.25 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 117.499 -1.723 . . . . 0.0 112.66 -171.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -51.22 154.53 1.62 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.802 1.801 . . . . 0.0 111.336 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 141' ' ' SER . 1.2 m -45.05 156.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.362 1.465 . . . . 0.0 112.257 170.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -70.66 166.99 19.6 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.603 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -43.69 142.36 1.92 Allowed Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 123.138 0.575 . . . . 0.0 110.669 170.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.98 -26.98 8.51 Favored 'Cis proline' 0 CA--C 1.55 1.282 0 CA-C-N 119.619 0.9 . . . . 0.0 114.154 2.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.495 ' HB2' HG23 ' A' ' 137' ' ' VAL 0.298 2.7 t 53.77 86.47 0.16 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.227 1.811 . . . . 0.0 115.606 172.107 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.15 -19.3 29.85 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.397 2.065 . . . . 0.0 111.843 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.98 -43.57 98.56 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.175 0.898 . . . . 0.0 110.155 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.59 -23.79 67.53 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.31 -55.17 5.46 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.224 -0.923 . . . . 0.0 109.464 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 98.7 m -52.47 -39.84 61.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.302 1.041 . . . . 0.0 110.548 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -50.29 -64.89 0.67 Allowed 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 125.312 1.445 . . . . 0.0 109.735 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.414 HD22 ' CD1' ' A' ' 104' ' ' PHE . 52.2 mt -55.76 -39.71 71.58 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.547 0.612 . . . . 0.0 112.495 -173.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 75.5 mt -65.1 -50.82 64.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.329 1.452 . . . . 0.0 108.506 -176.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.6 -41.35 85.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.387 0.613 . . . . 0.0 111.217 172.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -56.91 -46.37 82.0 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.788 -1.195 . . . . 0.0 112.787 -172.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -121.72 21.36 10.81 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.055 0.843 . . . . 0.0 112.479 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 54.96 67.51 1.01 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.571 1.148 . . . . 0.0 108.973 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 14.7 mt -109.84 -179.74 3.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.09 1.356 . . . . 0.0 108.226 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -121.28 140.04 52.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.337 0.655 . . . . 0.0 110.077 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.9 m -51.03 -46.82 61.73 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.508 1.523 . . . . 0.0 111.84 175.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.28 -30.62 62.18 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.082 -1.011 . . . . 0.0 112.068 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -88.89 13.67 12.16 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -175.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.1 t -108.74 154.6 21.81 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -133.97 143.08 47.95 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 174.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -114.2 159.8 19.71 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.617 1.167 . . . . 0.0 110.825 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.588 HD13 ' CD2' ' A' ' 8' ' ' TRP . 2.7 mp -132.42 125.86 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 119.946 1.248 . . . . 0.0 109.685 177.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -146.63 -170.36 15.04 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 170.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.18 15.8 2.61 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -166.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 -165.0 1.74 Allowed 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.357 1.063 . . . . 0.0 109.848 -164.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.7 t -87.74 -25.06 23.62 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.302 0.641 . . . . 0.0 111.418 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -23.45 51.07 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.969 0.508 . . . . 0.0 111.03 -172.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.64 -30.55 61.17 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.249 1.419 . . . . 0.0 113.141 -172.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -111.49 -8.6 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.055 0.942 . . . . 0.0 110.666 -170.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -64.9 -38.63 91.6 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.757 -1.214 . . . . 0.0 110.041 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.94 -32.24 63.41 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.052 -1.03 . . . . 0.0 110.761 174.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.39 65.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.576 0.625 . . . . 0.0 110.418 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -61.3 -54.09 48.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.596 1.159 . . . . 0.0 113.285 174.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -63.21 -48.61 77.58 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.682 1.128 . . . . 0.0 111.628 -167.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 67.6 m -64.48 -38.06 89.71 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.211 0.604 . . . . 0.0 110.955 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.88 71.23 1.26 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 -169.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 41.3 pt -126.78 -172.84 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 127.477 2.311 . . . . 0.0 107.032 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -95.17 -176.21 3.74 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.994 1.318 . . . . 0.0 109.875 173.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.72 162.92 40.46 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.563 -1.336 . . . . 0.0 109.799 168.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 53.1 mt -132.47 129.14 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -149.86 160.06 43.88 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 120.992 -1.067 . . . . 0.0 110.291 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -74.62 -15.81 60.81 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.37 -0.831 . . . . 0.0 112.002 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 5.7 mt -116.04 156.83 25.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.08 1.752 . . . . 0.0 109.86 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -76.01 153.55 36.42 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.56 -167.83 2.51 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.39 1.076 . . . . 0.0 109.383 165.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.8 p -82.35 -10.97 58.87 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -81.43 177.59 8.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.167 0.987 . . . . 0.0 109.596 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 190' ' ' ASN . 14.3 pt-20 -125.74 -36.32 2.42 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -172.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -75.22 28.37 1.18 Allowed Glycine 0 C--N 1.338 0.678 0 CA-C-N 119.375 0.989 . . . . 0.0 111.621 172.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -100.73 140.49 34.94 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 127.962 2.505 . . . . 0.0 106.397 177.186 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -121.16 109.32 14.85 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -64.52 129.38 39.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 195' ' ' ALA . 36.0 pt -131.05 176.32 9.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 124.301 1.04 . . . . 0.0 110.167 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -134.72 -16.39 2.02 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.971 1.308 . . . . 0.0 111.888 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 193' ' ' ILE . . . -128.74 -154.59 0.65 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.041 0.837 . . . . 0.0 111.115 173.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -98.9 -27.46 13.89 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.388 0.54 . . . . 0.0 110.409 163.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.02 -25.66 62.77 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 121.156 -0.965 . . . . 0.0 111.997 -167.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -31.6 65.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 129.313 3.045 . . . . 0.0 109.58 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.34 -54.22 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 119.289 0.95 . . . . 0.0 109.388 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.6 m -55.69 -37.68 68.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -60.39 -32.26 71.15 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.177 1.391 . . . . 0.0 112.028 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 93.9 mt -53.56 -43.64 54.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 119.378 0.99 . . . . 0.0 109.556 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -85.09 -41.33 15.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.57 1.548 . . . . 0.0 109.426 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 125.899 1.68 . . . . 0.0 111.027 -171.242 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.8 mmm . . . . . 0 C--O 1.234 0.272 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 173.39 0.57 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.029 1.332 . . . . 0.0 109.689 168.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -45.06 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.483 1.913 . . . . 0.0 112.294 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.4 m -117.49 141.68 48.06 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -176.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.7 144.94 51.05 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.313 0.577 . . . . 0.0 109.942 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.59 ' CD2' HD11 ' A' ' 162' ' ' ILE . 2.0 m-85 -131.39 145.47 51.83 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.872 1.669 . . . . 0.0 108.07 -172.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.2 mt -145.22 89.74 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -171.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -78.36 -171.63 2.51 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 119.769 1.168 . . . . 0.0 110.383 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -131.28 164.42 25.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.516 1.526 . . . . 0.0 111.788 172.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.416 0 C-N-CA 127.327 2.251 . . . . 0.0 112.824 176.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.413 ' HA ' HD23 ' A' ' 196' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -59.91 -28.37 67.53 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.835 0.743 . . . . 0.0 112.177 -171.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -58.47 -60.66 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.832 1.653 . . . . 0.0 110.63 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.4 t -60.56 -47.63 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 117.843 -1.075 . . . . 0.0 108.952 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.54 ' HA ' HE22 ' A' ' 103' ' ' GLN . 4.6 mp -44.37 -54.23 6.05 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 120.857 1.662 . . . . 0.0 113.521 171.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.82 -38.43 91.08 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.874 0.469 . . . . 0.0 112.085 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -64.73 -54.23 34.8 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.084 0.954 . . . . 0.0 109.173 174.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.75 94.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.537 1.935 . . . . 0.0 112.957 -172.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.78 -55.01 34.68 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.663 1.585 . . . . 0.0 110.774 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.19 -36.72 80.02 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 111.429 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.6 m -65.65 -2.39 3.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.545 1.138 . . . . 0.0 113.272 168.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.81 19.62 73.55 Favored Glycine 0 CA--C 1.525 0.706 0 O-C-N 119.874 -1.766 . . . . 0.0 112.161 174.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.3 mt -75.08 115.53 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -71.0 133.99 46.78 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.54 HE22 ' HA ' ' A' ' 93' ' ' LEU . 8.1 mt-30 -112.83 151.0 30.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -144.32 175.87 9.78 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 126.763 2.025 . . . . 0.0 106.838 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.3 mt -139.88 148.47 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -132.78 100.5 4.95 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.908 0.777 . . . . 0.0 110.323 168.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -103.44 170.84 7.7 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.428 1.109 . . . . 0.0 108.322 169.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -96.16 -9.24 31.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.042 1.337 . . . . 0.0 111.396 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 178.62 5.85 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.184 1.356 . . . . 0.0 112.152 -172.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.62 176.03 36.33 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.13 1.347 . . . . 0.0 112.579 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.57 -16.57 10.55 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.543 2.337 . . . . 0.0 111.792 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -44.56 -30.56 0.92 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.236 1.814 . . . . 0.0 111.3 164.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -44.96 -62.79 1.1 Allowed 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.106 1.763 . . . . 0.0 110.81 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.444 ' CE1' ' HB ' ' A' ' 129' ' ' ILE . 63.4 m-85 -57.07 -38.35 73.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.529 0.732 . . . . 0.0 111.226 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.7 m -63.43 -39.95 95.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.876 0.87 . . . . 0.0 110.701 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.6 mt -57.83 -57.18 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.493 1.042 . . . . 0.0 109.731 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.61 -37.52 84.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.569 1.077 . . . . 0.0 111.31 -173.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -64.69 -45.81 85.06 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.527 0.731 . . . . 0.0 110.582 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -54.46 -53.64 51.52 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.794 0.838 . . . . 0.0 109.437 174.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.0 -14.81 63.26 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.249 1.02 . . . . 0.0 112.894 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.93 32.84 52.24 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.693 171.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.9 14.5 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.407 1.483 . . . . 0.0 111.672 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -44.61 55.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 m -61.6 -26.28 67.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CD2' HD23 ' A' ' 93' ' ' LEU . 49.3 m-85 -60.55 -34.12 73.68 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.004 -0.435 . . . . 0.0 111.112 173.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -99.99 94.51 6.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.524 1.53 . . . . 0.0 107.259 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 39.0 m -52.96 -43.46 66.39 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.819 1.648 . . . . 0.0 111.13 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.28 156.81 44.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.824 1.65 . . . . 0.0 107.262 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.444 ' HB ' ' CE1' ' A' ' 114' ' ' PHE . 5.0 mp -137.93 157.03 32.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.5 mt -131.18 156.02 46.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.259 1.824 . . . . 0.0 108.699 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.3 p -158.89 -174.87 4.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.47 1.508 . . . . 0.0 110.367 -151.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.8 p -59.49 -30.87 68.86 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.975 -1.078 . . . . 0.0 112.255 162.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -63.38 -31.3 72.42 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.254 0.934 . . . . 0.0 111.044 -177.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -63.45 -37.24 86.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.006 1.323 . . . . 0.0 111.289 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.97 5.47 70.38 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.458 170.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -58.26 168.46 1.06 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.214 1.507 . . . . 0.0 111.793 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.3 m -53.27 161.79 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.599 1.16 . . . . 0.0 113.407 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -78.1 160.73 27.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.865 1.266 . . . . 0.0 110.526 169.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -58.53 137.9 85.83 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 117.616 -1.183 . . . . 0.0 109.303 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.9 121.72 5.16 Favored 'Cis proline' 0 CA--C 1.536 0.586 0 CA-C-N 120.405 1.181 . . . . 0.0 110.845 -8.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 p -122.08 68.2 26.24 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 125.604 1.562 . . . . 0.0 110.98 -165.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.74 -24.29 47.49 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 CA-C-N 120.127 1.081 . . . . 0.0 112.198 -163.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.5 -44.11 8.38 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 130.08 3.352 . . . . 0.0 111.117 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.31 -19.94 64.71 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.55 -60.25 2.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 m -56.87 -33.59 67.0 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.332 1.053 . . . . 0.0 111.495 -167.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -54.27 -49.37 69.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.595 0.758 . . . . 0.0 111.197 173.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.44 -31.64 65.64 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 124.914 1.286 . . . . 0.0 111.794 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 81.9 mt -61.49 -59.86 4.58 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -174.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -70.54 -17.24 62.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.19 -177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -54.34 -49.1 70.54 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.353 0.979 . . . . 0.0 109.962 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.92 23.57 5.33 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.487 0.66 . . . . 0.0 112.561 -171.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.0 mp0 45.17 46.69 9.87 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.867 2.067 . . . . 0.0 110.648 -171.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 29.0 mt -77.0 164.68 25.53 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 172.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.438 ' CG ' ' H ' ' A' ' 158' ' ' ASN . 26.1 p-10 -104.24 153.53 20.87 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 128.572 2.749 . . . . 0.0 108.533 176.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 48.2 m -62.15 -27.36 68.89 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.645 0.736 . . . . 0.0 109.715 165.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.74 -29.37 25.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.724 -1.235 . . . . 0.0 111.966 -156.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.438 ' H ' ' CG ' ' A' ' 155' ' ' ASN . 3.3 m-80 -102.05 20.64 16.21 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.458 -0.776 . . . . 0.0 109.732 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.8 m -100.4 122.84 43.8 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 178' ' ' GLN . 97.7 m-85 -125.15 148.13 48.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.736 1.614 . . . . 0.0 110.077 -174.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -115.53 -20.22 10.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -168.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.59 HD11 ' CD2' ' A' ' 6' ' ' PHE . 1.6 mp 44.68 74.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 126.944 2.098 . . . . 0.0 112.797 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.56 173.17 17.54 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -125.19 25.6 7.15 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.521 -0.988 . . . . 0.0 112.573 -153.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -145.96 176.59 9.58 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t -70.97 -29.46 65.47 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.82 1.248 . . . . 0.0 111.038 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.67 11.64 14.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.035 0.934 . . . . 0.0 110.481 -177.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.75 -54.47 6.9 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 76.7 t -71.33 -17.1 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 O-C-N 121.382 -0.824 . . . . 0.0 111.762 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -59.94 -61.16 2.82 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.026 1.73 . . . . 0.0 111.355 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -68.95 -31.76 70.87 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 120.391 -1.443 . . . . 0.0 109.959 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.62 72.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.171 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.5 -52.58 16.85 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.195 1.398 . . . . 0.0 110.618 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.1 -21.41 60.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.766 -171.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.0 m -81.66 -33.47 31.31 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.446 -0.784 . . . . 0.0 111.072 169.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.11 19.81 54.61 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.278 1.418 . . . . 0.0 112.521 -166.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.7 pt -102.14 174.01 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.331 0 CA-C-N 118.982 1.391 . . . . 0.0 111.51 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 160' ' ' TYR . 23.8 mm-40 -87.74 176.45 7.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.766 1.226 . . . . 0.0 110.338 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 5.5 m -153.09 139.48 18.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.86 1.264 . . . . 0.0 109.768 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.437 HG21 HG12 ' A' ' 199' ' ' ILE . 61.2 mt -123.0 84.25 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -114.63 149.84 36.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.925 0.869 . . . . 0.0 109.972 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -64.42 -14.79 58.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.608 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.74 166.94 10.62 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.254 1.422 . . . . 0.0 110.183 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -95.07 163.55 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.563 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.0 t -151.14 -175.04 5.0 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.239 1.816 . . . . 0.0 107.352 168.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.6 p -115.57 71.8 0.78 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 170.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -142.28 137.11 30.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.99 91.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.412 1.885 . . . . 0.0 108.695 167.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 133.98 -3.51 4.52 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 117.941 -1.477 . . . . 0.0 113.255 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.46 131.28 34.41 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.525 2.163 . . . . 0.0 106.422 171.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.61 118.76 25.47 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.782 1.233 . . . . 0.0 108.804 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -67.23 147.63 52.79 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.471 0.578 . . . . 0.0 112.039 176.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.5 pt -141.59 164.88 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.876 1.67 . . . . 0.0 111.505 168.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -121.09 -15.37 8.23 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.833 1.653 . . . . 0.0 112.468 171.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.72 164.99 33.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.009 1.724 . . . . 0.0 107.192 171.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 89' ' ' ALA . 1.4 mp -61.14 -30.69 70.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.114 0.966 . . . . 0.0 109.787 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.07 64.92 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -64.77 -22.64 67.03 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.943 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.437 HG12 HG21 ' A' ' 180' ' ' ILE . 96.7 mt -55.27 -57.36 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 83.5 p -50.09 -39.4 42.44 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.444 0.64 . . . . 0.0 112.237 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -67.7 -29.4 68.65 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 125.499 1.52 . . . . 0.0 111.515 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.9 mt -52.37 -48.03 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -86.72 -0.88 57.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.263 1.425 . . . . 0.0 112.226 -173.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 . . . . . 0 CA--C 1.53 0.205 0 C-N-CA 125.276 1.43 . . . . 0.0 111.543 -175.608 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.1 mmm . . . . . 0 C--O 1.234 0.268 0 CA-C-O 123.306 1.527 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -80.77 122.05 26.68 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.3 mtpp 43.08 58.94 3.1 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 161.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.3 m -103.69 149.56 24.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.43 146.14 51.32 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 121.7 -0.625 . . . . 0.0 109.962 173.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.14 149.93 51.63 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 125.29 1.436 . . . . 0.0 108.373 -173.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.7 mt -140.56 131.94 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -120.82 148.49 43.95 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.524 1.53 . . . . 0.0 110.371 -173.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -89.48 -37.73 14.56 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.277 -0.889 . . . . 0.0 112.315 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.51 0 C-N-CA 129.374 3.07 . . . . 0.0 114.157 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 120.531 0.205 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -51.73 -35.44 43.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.325 1.05 . . . . 0.0 111.969 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -45.09 -56.93 4.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.819 2.448 . . . . 0.0 111.079 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.99 -39.83 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.985 1.714 . . . . 0.0 110.052 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.2 mt -51.52 -46.65 63.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.939 1.245 . . . . 0.0 110.078 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.66 -56.03 26.17 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 123.694 0.797 . . . . 0.0 111.257 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.46 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 15.4 t90 -52.57 -46.75 67.0 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.925 1.29 . . . . 0.0 111.198 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.62 82.78 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.159 0.984 . . . . 0.0 111.75 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.94 -42.65 69.57 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.664 0.786 . . . . 0.0 111.017 -177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -60.4 -34.14 73.49 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.54 1.136 . . . . 0.0 110.701 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 m -78.09 -4.52 47.75 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.587 1.155 . . . . 0.0 113.549 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.71 27.26 58.73 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 119.768 1.167 . . . . 0.0 112.969 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.7 mt -60.81 124.67 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 163.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -74.04 103.32 4.47 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -91.29 137.87 32.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.235 0.47 . . . . 0.0 110.21 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -138.44 173.15 11.91 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.036 1.735 . . . . 0.0 110.51 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.417 ' HB ' HG23 ' A' ' 129' ' ' ILE . 17.6 mt -146.62 150.83 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.229 1.412 . . . . 0.0 108.777 -172.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -158.44 124.94 4.72 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.329 1.452 . . . . 0.0 111.935 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 t -155.8 171.39 20.11 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.642 1.177 . . . . 0.0 111.579 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -65.05 -26.36 68.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.263 1.825 . . . . 0.0 111.917 165.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -61.91 136.38 57.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.43 -161.95 28.29 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 124.146 0.879 . . . . 0.0 112.705 -170.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.406 ' ND2' ' HG3' ' A' ' 133' ' ' GLN . 32.0 m120 -47.24 -30.8 3.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.982 2.113 . . . . 0.0 111.999 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -58.45 -24.91 61.52 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.926 -1.109 . . . . 0.0 113.374 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.64 -35.31 77.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.333 0.97 . . . . 0.0 111.636 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -62.06 -40.77 96.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.312 0.96 . . . . 0.0 109.699 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.2 m -63.44 -41.9 98.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.975 1.31 . . . . 0.0 109.533 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 93.0 mt -57.56 -52.39 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.262 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.26 -41.17 96.46 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 120.834 1.652 . . . . 0.0 111.828 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -66.44 -27.81 68.11 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.786 0.721 . . . . 0.0 112.429 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -65.19 -49.1 71.07 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.534 1.159 . . . . 0.0 109.134 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 53.5 mt -73.89 -11.94 60.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.428 1.891 . . . . 0.0 112.123 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.15 19.37 78.59 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 118.878 -0.957 . . . . 0.0 113.253 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.6 18.17 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 119.072 1.436 . . . . 0.0 111.143 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -49.78 67.7 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.866 -0.521 . . . . 0.0 111.021 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.0 t -67.5 -22.44 65.45 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.724 0.64 . . . . 0.0 112.422 -168.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -59.7 -32.35 70.43 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 119.024 0.829 . . . . 0.0 111.644 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.12 122.68 45.19 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -173.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -61.48 -45.12 95.57 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -157.69 145.24 18.54 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -169.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.417 HG23 ' HB ' ' A' ' 105' ' ' ILE . 4.3 mp -135.14 131.54 52.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.406 0.622 . . . . 0.0 109.879 -170.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -89.23 162.92 15.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.034 0.921 . . . . 0.0 110.265 170.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 41.7 p -155.46 -179.06 7.73 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.555 1.542 . . . . 0.0 107.556 -171.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -22.12 1.7 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 168.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.406 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 91.5 mm-40 -67.39 -58.8 4.12 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.004 0.82 . . . . 0.0 110.357 173.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 61.6 m -99.95 55.36 0.93 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.91 -20.74 75.62 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.12 -171.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 45.0 -167.56 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 126.407 1.883 . . . . 0.0 112.863 -165.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.488 HG23 ' CB ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -54.68 172.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 127.281 2.232 . . . . 0.0 112.252 173.825 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -59.54 152.71 21.33 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.743 169.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -48.23 138.14 11.0 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 117.666 -1.159 . . . . 0.0 108.968 162.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.87 -43.97 0.42 Allowed 'Cis proline' 0 CA--C 1.533 0.458 0 CA-C-N 120.453 1.198 . . . . 0.0 113.822 6.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.488 ' CB ' HG23 ' A' ' 137' ' ' VAL . 3.6 t 55.17 81.45 0.26 Allowed Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.672 1.189 . . . . 0.0 111.679 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.3 -16.62 52.2 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.487 2.125 . . . . 0.0 111.462 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -55.4 -48.53 74.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.261 1.391 . . . . 0.0 110.824 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.99 -18.83 64.68 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.76 -52.9 5.72 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 118.194 -0.907 . . . . 0.0 108.982 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.5 m -54.44 -38.33 66.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.455 0.702 . . . . 0.0 110.157 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -54.52 -58.53 7.1 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.612 1.165 . . . . 0.0 110.403 171.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 22.2 mt -65.59 -27.72 68.62 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.561 1.073 . . . . 0.0 112.093 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 75.8 mt -65.9 -59.75 3.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.52 -30.72 69.92 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.314 1.046 . . . . 0.0 113.131 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.544 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 5.6 mmpt? -57.42 -35.31 69.91 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.09 -1.006 . . . . 0.0 112.092 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.99 24.23 2.18 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 49.94 47.73 22.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.195 1.798 . . . . 0.0 110.235 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 59.3 mt -83.6 165.55 18.94 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.441 1.096 . . . . 0.0 109.395 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -106.34 134.43 49.48 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 124.144 0.977 . . . . 0.0 108.829 -171.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 m -60.47 -42.2 95.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.492 0.663 . . . . 0.0 109.74 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -74.02 -24.82 59.62 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 120.793 -1.192 . . . . 0.0 112.58 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -92.95 5.59 50.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.917 -1.039 . . . . 0.0 109.429 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -107.32 146.97 30.89 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -132.04 167.45 19.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.873 1.669 . . . . 0.0 107.612 -176.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -143.37 151.38 40.37 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.593 0.757 . . . . 0.0 109.968 173.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.6 mt -138.45 118.82 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.49 -6.55 0.03 OUTLIER Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.904 -175.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.456 ' HB2' ' CD1' ' A' ' 182' ' ' PHE . 40.5 t0 56.16 67.69 0.97 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.132 2.573 . . . . 0.0 112.356 169.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -153.94 167.96 27.99 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 120.879 -1.138 . . . . 0.0 110.936 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.0 t -61.25 -44.53 97.09 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.293 0.568 . . . . 0.0 109.989 167.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -5.21 14.28 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.755 1.622 . . . . 0.0 112.3 -171.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -54.52 38.5 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.526 1.13 . . . . 0.0 109.786 171.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 185' ' ' SER . 25.7 m -70.76 -30.45 42.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 118.248 -1.381 . . . . 0.0 111.688 -170.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -61.5 -48.69 79.94 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.825 0.85 . . . . 0.0 109.827 -172.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -80.02 -39.95 28.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.601 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.0 78.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.622 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -61.2 -53.77 52.71 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.833 0.853 . . . . 0.0 110.833 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -64.81 -34.96 79.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.574 -0.25 . . . . 0.0 110.975 -172.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.4 m -69.96 -34.98 74.1 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.096 0.862 . . . . 0.0 112.826 168.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.07 44.93 6.11 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.865 1.222 . . . . 0.0 111.785 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 10.9 pt -116.09 -179.14 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.565 1.546 . . . . 0.0 108.806 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -103.52 165.75 10.84 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.371 0.605 . . . . 0.0 109.745 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 143.27 38.55 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.987 0.915 . . . . 0.0 108.804 -163.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 62.7 mt -133.92 100.18 3.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.454 ' HB2' HD12 ' A' ' 183' ' ' LEU . 18.6 p30 -123.78 158.12 32.46 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.634 1.174 . . . . 0.0 109.947 -176.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 164' ' ' ASP . 64.3 m-85 -86.33 -3.16 58.94 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.229 -1.544 . . . . 0.0 111.218 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 181' ' ' ASN . 0.3 OUTLIER -129.34 155.8 45.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.427 1.891 . . . . 0.0 110.432 -174.324 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -74.79 142.24 44.27 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.451 ' HB3' HG21 ' A' ' 169' ' ' VAL . 0.6 OUTLIER -144.73 177.68 8.53 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.412 1.485 . . . . 0.0 107.996 173.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 32.8 p -93.15 59.65 3.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.126 1.37 . . . . 0.0 110.774 -160.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -142.93 175.06 10.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.972 0.509 . . . . 0.0 112.238 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.84 -3.37 12.2 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 0.0 113.588 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -118.94 9.1 12.43 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.434 1.492 . . . . 0.0 112.417 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.12 138.02 33.24 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 119.15 1.475 . . . . 0.0 107.462 173.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -112.64 107.08 15.64 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -59.69 142.64 52.65 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.438 168.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.6 pt -131.64 165.59 31.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.635 1.574 . . . . 0.0 110.126 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -117.83 -16.3 9.97 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.011 0.924 . . . . 0.0 113.401 169.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.35 165.18 32.78 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.584 1.154 . . . . 0.0 109.021 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 30.6 mt -63.44 -44.55 94.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.232 1.813 . . . . 0.0 107.63 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.42 -15.01 63.4 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.88 -22.89 64.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.337 1.426 . . . . 0.0 110.407 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 19.8 mt -55.83 -53.43 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.049 1.34 . . . . 0.0 109.55 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.46 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 8.6 m -60.06 -32.89 71.36 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.93 1.241 . . . . 0.0 111.898 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -65.02 -26.65 68.37 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 118.3 -0.857 . . . . 0.0 112.227 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.55 -55.97 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.0 10.45 18.95 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.019 1.328 . . . . 0.0 113.62 -169.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 . . . . . 0 C--N 1.333 -0.138 0 C-N-CA 124.552 1.141 . . . . 0.0 112.458 178.03 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 mmm . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 55.49 -171.46 0.07 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.938 1.295 . . . . 0.0 113.117 175.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -78.8 79.4 5.21 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 152.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 m -101.99 146.59 27.67 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.97 149.41 51.71 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 121.501 -0.749 . . . . 0.0 109.242 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -123.13 156.73 34.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.903 1.281 . . . . 0.0 108.03 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.2 mt -140.74 135.84 34.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -120.54 161.66 20.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.011 0.924 . . . . 0.0 111.068 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -102.91 -4.18 25.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.549 1.54 . . . . 0.0 111.941 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.2 tp . . . . . 0 C--O 1.235 0.314 0 C-N-CA 128.837 2.855 . . . . 0.0 111.347 -175.884 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 120.453 0.168 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -32.16 67.45 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.637 -176.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.32 -49.1 77.18 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.425 1.09 . . . . 0.0 111.563 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.9 t -77.55 -43.82 29.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 CA-C-O 117.552 -1.214 . . . . 0.0 109.678 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 mp -44.0 -56.18 4.15 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.649 1.58 . . . . 0.0 111.153 170.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.55 -54.92 41.38 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.74 0.416 . . . . 0.0 110.874 -177.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -56.71 -43.25 80.4 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.106 1.363 . . . . 0.0 112.502 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.5 -38.36 49.14 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.368 1.067 . . . . 0.0 112.049 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.89 -41.47 74.69 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.676 0.79 . . . . 0.0 110.845 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -61.03 -15.53 33.16 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.76 -0.587 . . . . 0.0 111.4 170.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.0 m -108.24 5.96 26.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.182 1.793 . . . . 0.0 113.468 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.06 8.72 55.05 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.671 1.129 . . . . 0.0 113.695 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.4 mt -55.5 120.5 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -71.05 92.68 0.97 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 172.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -71.95 151.56 43.17 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 168.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -141.78 172.59 12.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.008 2.123 . . . . 0.0 107.383 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.535 ' HB ' HG23 ' A' ' 129' ' ' ILE . 16.9 mt -136.4 155.07 33.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 171.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -136.46 115.38 12.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 164.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.3 t -121.88 157.04 32.02 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.206 1.003 . . . . 0.0 108.971 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -63.57 -30.2 71.35 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.014 165.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -61.58 142.2 57.27 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.198 1.799 . . . . 0.0 109.898 -166.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.5 -170.02 39.09 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.351 -0.843 . . . . 0.0 112.348 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -52.05 -24.94 7.51 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 128.387 2.675 . . . . 0.0 116.015 -163.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -69.91 -11.46 60.89 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.982 0.81 . . . . 0.0 112.154 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.37 80.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.23 1.012 . . . . 0.0 110.953 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -48.4 -46.39 37.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.038 1.335 . . . . 0.0 110.454 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 m -70.88 -37.92 73.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.383 1.073 . . . . 0.0 111.382 -171.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.4 mt -60.77 -45.95 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.13 1.372 . . . . 0.0 108.9 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.33 -35.5 75.98 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.012 -1.055 . . . . 0.0 111.582 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -50.17 73.44 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.289 0.635 . . . . 0.0 109.692 170.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -48.96 -48.13 43.37 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.962 0.905 . . . . 0.0 111.544 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.35 -10.36 59.39 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.097 1.359 . . . . 0.0 113.281 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.01 23.48 78.07 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.78 0.705 . . . . 0.0 114.27 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.3 m -124.23 13.46 4.86 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 C-N-CA 125.027 1.331 . . . . 0.0 110.471 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -43.06 99.51 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.885 1.22 . . . . 0.0 110.617 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.1 m -74.21 3.0 7.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.458 1.503 . . . . 0.0 112.68 -175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -80.12 -0.28 35.17 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.605 164.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -144.58 133.02 21.95 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.532 1.515 . . . . 0.0 108.728 -173.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.2 m -60.75 -68.86 0.26 Allowed 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 127.979 2.512 . . . . 0.0 112.072 -174.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -138.81 123.61 18.73 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.155 1.382 . . . . 0.0 107.726 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.535 HG23 ' HB ' ' A' ' 105' ' ' ILE . 5.1 mp -105.54 98.16 6.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 -172.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.73 HD12 ' CB ' ' A' ' 134' ' ' SER . 4.2 mm? -70.55 147.41 49.32 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.1 p -127.63 -168.78 1.94 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.506 2.322 . . . . 0.0 110.696 -172.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 t -56.96 -23.12 43.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.072 1.349 . . . . 0.0 113.426 166.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -64.98 -22.51 67.01 Favored 'General case' 0 C--O 1.228 -0.079 0 C-N-CA 124.014 0.926 . . . . 0.0 111.073 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.73 ' CB ' HD12 ' A' ' 130' ' ' LEU . 1.0 OUTLIER -110.07 72.52 0.8 Allowed 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 128.719 2.807 . . . . 0.0 105.597 177.251 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.36 48.68 3.67 Favored Glycine 0 N--CA 1.458 0.13 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -61.49 117.57 5.88 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.823 0.312 . . . . 0.0 110.723 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 138' ' ' ARG . 18.1 t 54.75 -165.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 124.906 1.283 . . . . 0.0 109.982 167.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.695 ' H ' HG12 ' A' ' 137' ' ' VAL . 82.6 mtt180 -128.12 0.4 5.84 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.036 -1.665 . . . . 0.0 114.521 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt 98.23 112.73 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.486 0 C-N-CA 129.003 2.921 . . . . 0.0 107.532 166.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -61.17 154.63 56.4 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 120.729 1.296 . . . . 0.0 111.79 6.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.406 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 3.0 p -142.17 82.2 13.46 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.726 1.211 . . . . 0.0 111.57 -171.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.42 -20.24 24.22 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.08 2.52 . . . . 0.0 113.965 -177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -69.57 -27.16 64.89 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.209 -0.932 . . . . 0.0 112.034 -170.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.65 94.99 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.79 85.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.34 -0.85 . . . . 0.0 110.144 173.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.9 m -53.85 -40.38 66.44 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.155 1.343 . . . . 0.0 111.158 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -61.76 -48.97 78.27 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.7 mp -62.59 -37.98 88.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.809 1.244 . . . . 0.0 111.496 -172.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 86.7 mt -64.51 -54.13 37.11 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.12 -35.94 76.38 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -56.92 -29.01 62.7 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 120.714 -1.241 . . . . 0.0 112.856 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -138.07 19.52 2.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 48.59 70.19 0.48 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.862 1.665 . . . . 0.0 110.654 -173.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 76.0 mt -109.33 -176.2 2.96 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.184 1.394 . . . . 0.0 109.99 -172.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.08 129.1 52.08 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.465 1.106 . . . . 0.0 109.905 -172.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.37 -17.47 20.42 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 125.165 1.386 . . . . 0.0 112.007 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.413 ' HA ' HE22 ' A' ' 178' ' ' GLN . 0.3 OUTLIER -118.49 19.36 13.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.498 -0.751 . . . . 0.0 109.839 -174.024 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -128.3 8.61 6.05 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.87 1.668 . . . . 0.0 110.917 170.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 159' ' ' THR . 1.8 t -91.23 158.95 16.3 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.897 1.679 . . . . 0.0 109.783 176.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -147.84 105.47 3.69 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.015 -1.053 . . . . 0.0 109.64 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -85.6 133.07 34.07 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.093 0.957 . . . . 0.0 111.571 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.78 105.53 18.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.681 1.192 . . . . 0.0 109.056 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.37 -164.45 11.76 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.879 1.704 . . . . 0.0 110.859 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -136.91 -9.67 1.8 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.9 158.07 32.78 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.904 1.683 . . . . 0.0 110.912 -170.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.9 t -54.82 -32.3 60.22 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.618 -0.676 . . . . 0.0 112.489 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.6 -28.55 69.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.894 0.878 . . . . 0.0 110.507 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -69.9 -0.99 8.27 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.908 1.683 . . . . 0.0 112.024 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.2 t -120.48 -17.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 125.284 1.434 . . . . 0.0 109.61 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -65.93 -58.5 5.41 Favored 'General case' 0 C--N 1.338 0.101 0 O-C-N 120.916 -1.115 . . . . 0.0 108.734 168.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -63.75 -33.86 76.61 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.202 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.58 97.58 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.913 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -62.54 -43.59 98.43 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.338 0.972 . . . . 0.0 111.08 171.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -64.61 -37.9 89.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 117.705 -1.141 . . . . 0.0 112.464 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.4 p -79.14 -36.8 39.92 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.834 1.652 . . . . 0.0 110.778 168.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.26 65.61 1.26 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -172.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.39 174.61 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 127.295 2.238 . . . . 0.0 108.587 174.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.413 HE22 ' HA ' ' A' ' 157' ' ' ASP . 14.0 mp0 -96.16 170.08 9.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.81 1.644 . . . . 0.0 111.96 -176.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.6 m -143.36 156.92 44.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.842 1.657 . . . . 0.0 111.729 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.2 mt -136.47 104.28 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -126.32 161.65 27.33 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.677 1.591 . . . . 0.0 107.43 -173.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -75.48 -13.19 60.36 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.685 -1.259 . . . . 0.0 112.903 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.3 pp -129.9 166.13 20.64 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.44 1.896 . . . . 0.0 110.16 -175.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -96.29 159.04 15.16 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.123 0.487 . . . . 0.0 111.268 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 38.6 m -151.65 27.91 0.63 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.821 1.649 . . . . 0.0 111.081 -168.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 63.4 p 56.5 10.44 0.68 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.917 2.887 . . . . 0.0 116.037 173.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -106.07 153.26 22.31 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.616 1.567 . . . . 0.0 110.465 -168.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.502 ' HG3' ' H ' ' A' ' 189' ' ' GLY . 0.3 OUTLIER -56.5 -77.48 0.03 OUTLIER 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.756 2.022 . . . . 0.0 112.215 -175.349 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLY . . . . . 0.502 ' H ' ' HG3' ' A' ' 188' ' ' GLU . . . -75.93 18.33 3.26 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.448 1.975 . . . . 0.0 112.978 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -90.91 112.27 24.05 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.586 1.693 . . . . 0.0 107.28 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -101.84 127.87 48.46 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 25.0 mtm105 -68.57 148.12 50.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.283 0.492 . . . . 0.0 110.384 166.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.3 pt -135.36 170.19 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.325 1.85 . . . . 0.0 110.243 167.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -126.59 -10.75 6.21 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.554 1.142 . . . . 0.0 113.043 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.27 171.54 18.97 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.11 1.764 . . . . 0.0 108.117 172.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.53 -42.42 87.27 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.334 1.054 . . . . 0.0 109.703 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.1 -27.43 69.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.94 -22.78 62.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.238 1.815 . . . . 0.0 111.07 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 94.1 mt -57.4 -56.9 12.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 125.341 1.456 . . . . 0.0 108.863 171.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 80.3 p -53.06 -43.61 66.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.96 0.8 . . . . 0.0 111.483 -172.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -63.1 -21.99 66.56 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.912 1.685 . . . . 0.0 112.973 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.87 -42.96 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.838 0.744 . . . . 0.0 109.581 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -89.66 -32.57 16.99 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.62 0.768 . . . . 0.0 110.897 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 N--CA 1.468 0.463 0 C-N-CA 124.443 1.097 . . . . 0.0 112.878 -173.962 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mmm . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 122.131 0.967 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.5 167.04 0.07 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.419 1.888 . . . . 0.0 110.106 164.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 73.78 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.812 2.445 . . . . 0.0 114.365 -171.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.7 m -86.63 160.84 18.77 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 119.46 -2.025 . . . . 0.0 107.875 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.8 151.02 48.7 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.738 -1.226 . . . . 0.0 109.338 165.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -122.74 154.01 38.7 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.214 1.406 . . . . 0.0 108.857 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.46 135.3 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -120.52 143.47 48.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.346 1.858 . . . . 0.0 109.046 -176.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.36 -32.81 66.78 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.446 1.021 . . . . 0.0 111.341 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 N--CA 1.467 0.375 0 C-N-CA 128.81 2.844 . . . . 0.0 112.723 -178.415 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -61.9 -37.86 86.18 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.473 -1.392 . . . . 0.0 112.823 -171.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.28 -54.6 29.26 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.533 1.933 . . . . 0.0 112.203 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.04 -33.54 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.634 1.107 . . . . 0.0 110.732 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.2 mt -57.1 -55.26 36.97 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.97 -13.69 62.35 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.636 1.175 . . . . 0.0 113.542 -174.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -79.74 -55.49 4.96 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 120.486 -1.384 . . . . 0.0 108.426 170.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.99 -37.81 86.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.236 1.414 . . . . 0.0 111.779 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.36 -51.34 66.32 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.789 1.636 . . . . 0.0 111.12 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -65.1 -17.5 64.51 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.163 1.385 . . . . 0.0 110.743 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.7 m -94.61 -1.58 52.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.292 1.437 . . . . 0.0 112.799 176.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.54 5.11 72.2 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.036 1.303 . . . . 0.0 113.571 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.1 mt -56.51 112.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -64.81 101.82 0.52 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 171.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.58 150.18 26.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.325 0.966 . . . . 0.0 108.413 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -146.5 171.84 14.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.413 1.885 . . . . 0.0 108.834 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 129' ' ' ILE . 18.6 mt -136.12 156.88 37.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.692 1.197 . . . . 0.0 109.222 171.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -139.76 125.45 19.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.131 0.973 . . . . 0.0 109.112 164.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.7 t -154.09 178.3 10.12 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.552 2.341 . . . . 0.0 108.26 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -137.27 15.53 3.0 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.883 -1.136 . . . . 0.0 113.805 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -11.08 3.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 121.73 167.23 13.09 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 128.043 2.735 . . . . 0.0 110.118 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -52.02 -31.68 30.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.961 1.704 . . . . 0.0 111.367 170.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -53.0 -17.37 1.41 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.436 1.494 . . . . 0.0 114.026 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.19 -47.22 62.27 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.488 1.115 . . . . 0.0 111.028 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -56.78 -48.61 77.49 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.854 1.661 . . . . 0.0 109.93 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.6 m -55.43 -49.78 71.53 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.275 0.489 . . . . 0.0 109.795 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.8 mt -59.33 -47.91 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.79 -37.36 84.41 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.837 -1.165 . . . . 0.0 112.045 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.424 ' HE2' ' OE2' ' A' ' 123' ' ' GLU . 19.5 mtmt -59.71 -48.03 83.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.138 -0.934 . . . . 0.0 109.668 175.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -43.62 95.53 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.532 1.133 . . . . 0.0 111.303 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.87 -4.1 35.93 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.194 0.998 . . . . 0.0 112.531 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.17 -3.22 58.8 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 126.192 1.853 . . . . 0.0 114.993 173.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 m -92.53 3.33 7.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 118.921 1.36 . . . . 0.0 110.064 -170.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.424 ' OE2' ' HE2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -63.51 -27.34 69.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.433 1.015 . . . . 0.0 111.052 171.794 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.3 m -58.86 -15.26 11.75 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.465 -0.778 . . . . 0.0 112.684 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -96.9 3.05 52.33 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.043 -1.456 . . . . 0.0 114.295 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.449 ' HB2' HD11 ' A' ' 129' ' ' ILE . 52.3 m-85 -133.7 111.71 10.8 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 122.06 2.209 . . . . 0.0 109.471 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.2 m -58.14 -39.91 79.97 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.92 1.688 . . . . 0.0 110.466 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -145.5 158.82 43.78 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.673 1.189 . . . . 0.0 108.007 167.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.536 HG23 ' HB ' ' A' ' 105' ' ' ILE . 5.3 mp -130.99 117.6 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.439 HD21 ' CE1' ' A' ' 147' ' ' TYR . 12.2 mt -71.63 165.98 22.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.719 0.771 . . . . 0.0 110.218 174.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.8 p -151.06 176.95 10.66 Favored 'General case' 0 C--O 1.231 0.088 0 O-C-N 121.466 -0.771 . . . . 0.0 110.498 -170.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.0 t -48.7 -33.84 10.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.037 0.935 . . . . 0.0 111.978 163.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -71.82 -6.67 43.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.204 1.402 . . . . 0.0 112.21 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.0 m -147.94 49.12 1.06 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 128.121 2.569 . . . . 0.0 105.229 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.05 -29.67 72.27 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.894 -166.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 45.23 -164.65 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.314 1.846 . . . . 0.0 112.595 -163.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.43 162.1 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.631 1.172 . . . . 0.0 112.224 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -65.77 146.02 55.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.13 0.572 . . . . 0.0 110.374 168.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.41 133.52 13.11 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 116.872 -1.537 . . . . 0.0 110.194 166.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.29 126.07 9.55 Favored 'Cis proline' 0 C--N 1.348 0.552 0 CA-C-N 120.487 1.21 . . . . 0.0 111.498 -5.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 p -130.29 78.63 74.11 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 124.779 1.232 . . . . 0.0 112.035 -158.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.89 -30.41 48.93 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 121.916 1.744 . . . . 0.0 113.323 -174.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -53.41 -44.81 69.04 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.713 -1.242 . . . . 0.0 113.333 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.74 -18.72 63.05 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.86 -0.59 . . . . 0.0 112.527 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.08 -53.41 7.04 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 119.115 0.87 . . . . 0.0 109.523 172.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 m -56.73 -41.46 77.52 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.371 1.469 . . . . 0.0 110.503 -174.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.439 ' CE1' HD21 ' A' ' 130' ' ' LEU . 4.0 t80 -56.86 -43.25 81.0 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.422 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.4 mt -78.35 -27.56 47.03 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 78.8 mt -59.37 -61.78 2.37 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 168.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.12 -17.84 64.97 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -64.78 -29.52 70.49 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.43 -1.419 . . . . 0.0 112.789 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -147.07 29.7 0.97 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.092 1.314 . . . . 0.0 112.468 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 54.82 45.12 27.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.608 1.563 . . . . 0.0 111.321 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 68.1 mt -95.34 170.87 9.07 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.422 -0.799 . . . . 0.0 110.0 -170.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -112.07 141.55 45.61 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.244 -0.91 . . . . 0.0 113.111 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 m -57.23 -49.87 74.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.817 0.847 . . . . 0.0 110.252 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.99 -16.83 60.61 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.532 0.682 . . . . 0.0 112.356 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -92.4 -3.09 55.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.701 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 t -101.36 135.61 42.58 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.62 1.1 . . . . 0.0 109.664 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -125.91 112.9 16.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -77.69 159.04 29.39 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.792 0.437 . . . . 0.0 110.525 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 49.4 mt -131.09 92.82 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 127.917 2.487 . . . . 0.0 104.511 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -124.41 169.31 16.46 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.786 1.184 . . . . 0.0 110.388 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -135.21 3.15 3.1 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.915 1.286 . . . . 0.0 113.225 -166.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.28 144.41 25.54 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 119.182 0.901 . . . . 0.0 111.231 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 88.68 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.01 2.124 . . . . 0.0 111.822 -170.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 174.05 -29.62 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 128.691 2.796 . . . . 0.0 107.664 -176.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -52.55 -43.64 65.34 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 126.368 1.867 . . . . 0.0 111.436 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 79.7 t -77.8 -26.19 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 125.184 1.394 . . . . 0.0 111.821 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.32 -38.42 91.08 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.526 -0.734 . . . . 0.0 111.614 -165.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -82.52 -30.77 29.58 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.686 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.34 89.99 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.838 0.855 . . . . 0.0 109.183 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -54.24 -49.67 68.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.655 1.582 . . . . 0.0 111.08 173.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -63.84 -44.24 93.75 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.83 -0.544 . . . . 0.0 110.811 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.0 m -75.0 -21.04 59.38 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.26 44.03 77.06 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.314 0.959 . . . . 0.0 112.171 -169.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.3 pt -110.6 168.73 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 118.094 0.947 . . . . 0.0 108.737 169.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -105.22 171.05 7.53 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.625 0.726 . . . . 0.0 110.626 -170.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.74 135.06 18.2 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 121.672 -0.643 . . . . 0.0 110.224 -157.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 42.9 mt -130.54 105.08 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -136.98 157.59 46.39 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.233 1.413 . . . . 0.0 111.148 -168.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -77.36 -12.43 59.95 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.32 -0.863 . . . . 0.0 112.371 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.14 156.61 38.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.984 0.914 . . . . 0.0 109.99 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.644 ' HA ' HD21 ' A' ' 190' ' ' ASN . 8.7 pt-20 -93.03 163.36 13.68 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.313 0.578 . . . . 0.0 110.835 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 44.8 t -145.6 179.8 7.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.13 1.772 . . . . 0.0 108.521 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . 0.303 0.2 OUTLIER -78.06 -22.36 49.19 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.701 -1.249 . . . . 0.0 111.333 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -71.19 121.8 19.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.1 1.36 . . . . 0.0 109.909 -174.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -64.79 -17.51 64.27 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.25 8.5 60.86 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.778 -1.012 . . . . 0.0 113.028 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ASN . . . . . 0.644 HD21 ' HA ' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -104.51 105.37 15.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 120.11 1.955 . . . . 0.0 110.043 -177.279 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -94.99 111.75 23.52 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.023 0.929 . . . . 0.0 109.613 -174.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 144.28 56.85 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.526 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.6 pt -137.42 171.36 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 126.922 2.089 . . . . 0.0 112.556 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -122.36 -21.29 5.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.475 1.51 . . . . 0.0 113.227 167.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -151.23 167.49 27.64 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.71 0.686 . . . . 0.0 109.244 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 62.3 mt -74.32 -26.46 60.17 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 119.158 0.89 . . . . 0.0 110.277 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.45 -13.54 62.41 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.234 0.925 . . . . 0.0 112.514 174.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 201' ' ' ARG . 31.5 t0 -79.06 -13.53 59.71 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.667 -1.27 . . . . 0.0 108.864 174.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.76 -57.07 11.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 167.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.6 p -59.96 -36.05 76.29 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.021 0.828 . . . . 0.0 111.499 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ARG . . . . . 0.413 ' HG2' ' HA ' ' A' ' 198' ' ' ASP . 18.0 ptt180 -64.78 -34.78 79.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.101 0.864 . . . . 0.0 111.477 -172.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.8 mt -50.07 -57.63 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.144 1.777 . . . . 0.0 108.812 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -72.14 -0.67 12.5 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.821 0.849 . . . . 0.0 113.276 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 125.083 1.353 . . . . 0.0 110.892 -176.232 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mmm . . . . . 0 CA--C 1.516 -0.337 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.53 179.64 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.045 164.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -44.36 106.49 0.07 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.499 1.12 . . . . 0.0 108.797 169.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.3 m -129.83 151.34 50.52 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 170.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.35 156.9 48.18 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.43 0.692 . . . . 0.0 109.44 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 199' ' ' ILE . 1.4 m-85 -132.36 147.93 52.41 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.396 1.479 . . . . 0.0 109.213 -173.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp -132.1 129.46 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -103.49 164.75 11.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.301 1.04 . . . . 0.0 109.009 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.79 176.33 6.67 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.807 0.843 . . . . 0.0 109.891 171.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.6 mt . . . . . 0 CA--C 1.534 0.356 0 C-N-CA 124.771 1.228 . . . . 0.0 111.147 -171.394 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -54.11 -36.37 63.16 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 119.109 0.868 . . . . 0.0 111.725 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.81 -35.97 79.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.724 1.21 . . . . 0.0 112.882 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.3 -48.95 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 118.293 -0.86 . . . . 0.0 108.949 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.448 ' HA ' HE22 ' A' ' 103' ' ' GLN . 2.4 mp -44.3 -52.39 7.61 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 120.636 1.562 . . . . 0.0 113.287 170.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.82 96.29 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.41 0.684 . . . . 0.0 111.22 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 20.6 t90 -57.95 -49.44 76.78 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.551 1.141 . . . . 0.0 110.812 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.7 78.78 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.929 1.291 . . . . 0.0 113.24 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.95 -44.42 85.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 122.941 0.496 . . . . 0.0 110.374 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -51.15 -49.8 60.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.194 1.397 . . . . 0.0 110.154 168.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.2 m -68.94 -12.81 61.99 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.03 16.06 77.59 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 120.014 1.279 . . . . 0.0 113.605 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.1 mt -68.44 133.16 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.025 1.33 . . . . 0.0 108.32 170.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -83.14 118.67 23.74 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.448 HE22 ' HA ' ' A' ' 93' ' ' LEU . 12.4 mt-30 -99.07 154.24 18.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -147.84 166.33 27.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.909 1.684 . . . . 0.0 108.565 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 42.6 mt -137.43 158.94 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.754 1.622 . . . . 0.0 107.14 166.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.522 ' O ' HG22 ' A' ' 107' ' ' THR . 4.3 t80 -131.77 -85.9 0.48 Allowed 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 124.779 1.231 . . . . 0.0 108.034 166.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 106' ' ' TYR 0.255 15.3 t 65.04 164.98 0.16 Allowed 'General case' 0 C--N 1.315 -0.894 1 C-N-CA 136.816 6.047 . . . . 0.0 113.958 177.772 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -80.41 4.04 19.37 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.395 1.078 . . . . 0.0 111.346 166.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -57.87 156.05 9.57 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.201 -1.562 . . . . 0.0 108.221 167.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.07 171.36 53.58 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-O 122.19 0.884 . . . . 0.0 111.107 173.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -44.87 -28.15 0.61 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 130.025 3.33 . . . . 0.0 114.944 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -63.89 -12.79 39.86 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 120.279 1.399 . . . . 0.0 112.311 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.52 -47.88 38.75 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.88 1.218 . . . . 0.0 111.573 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -56.8 -49.59 74.89 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.606 0.639 . . . . 0.0 110.238 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.7 m -59.39 -42.62 92.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.793 0.837 . . . . 0.0 111.129 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.73 -48.8 87.03 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 119.319 0.963 . . . . 0.0 108.716 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.28 -44.24 95.62 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.878 -0.514 . . . . 0.0 110.457 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -59.26 -51.3 70.54 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.403 1.081 . . . . 0.0 110.836 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -51.13 -56.52 12.3 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.26 1.424 . . . . 0.0 110.583 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.49 -9.73 37.43 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.046 1.338 . . . . 0.0 113.613 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.61 25.81 69.08 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 123.983 0.801 . . . . 0.0 112.525 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.53 57.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.43 -46.94 10.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.901 160.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.9 m -73.62 -14.59 61.2 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -164.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -63.44 -33.83 76.43 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.393 1.451 . . . . 0.0 110.507 170.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -90.82 115.48 27.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.5 m -44.74 -65.95 0.46 Allowed 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 127.016 2.126 . . . . 0.0 108.669 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.07 140.07 43.5 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.5 mt -110.36 148.69 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 171.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 45.9 mt -119.13 -166.89 1.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -173.26 -178.96 1.83 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.607 1.963 . . . . 0.0 107.888 167.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 m -44.53 -45.27 9.25 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.119 0.872 . . . . 0.0 110.458 167.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -70.2 -9.38 55.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.096 1.758 . . . . 0.0 112.96 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.7 m -59.35 -24.04 63.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.839 1.256 . . . . 0.0 110.973 163.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.12 -8.18 77.96 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-O 118.019 -1.434 . . . . 0.0 114.018 170.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -56.56 165.99 1.01 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.783 1.292 . . . . 0.0 111.161 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 m -44.73 155.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.158 1.783 . . . . 0.0 111.786 170.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -69.84 -76.77 0.09 Allowed 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -165.47 159.59 13.84 Favored Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 124.33 1.052 . . . . 0.0 109.804 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -64.16 136.97 26.24 Favored 'Cis proline' 0 N--CA 1.458 -0.601 0 N-CA-C 108.703 -1.307 . . . . 0.0 108.703 -17.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.0 p -124.99 68.78 56.82 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.621 0.768 . . . . 0.0 111.917 -157.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -61.95 -29.45 82.06 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.388 2.059 . . . . 0.0 111.98 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -48.41 -41.08 28.04 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.624 1.97 . . . . 0.0 112.39 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.61 2.47 16.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.518 1.527 . . . . 0.0 112.623 -175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.84 -39.42 2.73 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.868 1.667 . . . . 0.0 108.727 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 m -49.99 -38.78 38.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.086 1.312 . . . . 0.0 110.456 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.653 ' HD1' HD12 ' A' ' 148' ' ' LEU . 53.7 t80 -52.01 -57.94 7.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.099 1.36 . . . . 0.0 110.76 171.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.653 HD12 ' HD1' ' A' ' 147' ' ' TYR . 9.0 mp -58.58 -37.96 76.88 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.896 1.678 . . . . 0.0 112.755 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.0 mt -59.83 -57.96 10.65 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -175.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -75.18 -32.98 61.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.754 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 4.0 mmpt? -50.76 -53.32 32.63 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.801 -1.187 . . . . 0.0 111.8 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -115.23 8.86 15.62 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 54.26 66.71 1.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 123.064 1.411 . . . . 0.0 109.235 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.17 162.17 13.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.899 1.68 . . . . 0.0 107.784 169.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -106.39 -4.82 19.51 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 125.235 2.445 . . . . 0.0 117.458 -161.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.0 m 76.27 -55.95 0.58 Allowed 'General case' 0 N--CA 1.411 -2.381 0 CA-C-N 110.647 -2.978 . . . . 0.0 109.07 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.84 -2.13 38.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 O-C-N 120.881 -1.137 . . . . 0.0 112.941 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -98.35 -5.34 33.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 116.916 -1.516 . . . . 0.0 111.186 168.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -103.45 137.37 41.64 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.669 1.577 . . . . 0.0 108.099 -174.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -128.42 111.17 13.02 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.963 1.705 . . . . 0.0 109.263 -172.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -85.89 153.38 22.26 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.406 HD11 ' CD2' ' A' ' 6' ' ' PHE . 3.5 mt -133.01 119.55 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.85 -161.68 9.64 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -139.53 12.88 2.54 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.456 ' HB3' ' H ' ' A' ' 167' ' ' LEU . 3.0 mmt-85 -115.68 162.67 16.92 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 122.839 1.304 . . . . 0.0 111.489 -172.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 t -62.46 -26.95 68.79 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.297 -0.877 . . . . 0.0 109.538 163.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.456 ' H ' ' HB3' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -60.27 -29.82 69.05 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.487 1.515 . . . . 0.0 111.529 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -45.7 -44.93 13.97 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.104 1.762 . . . . 0.0 110.852 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.628 HG21 ' HB2' ' A' ' 185' ' ' SER . 28.4 m -90.69 -15.5 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.55 -50.79 49.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.081 -1.012 . . . . 0.0 108.69 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -79.3 -33.4 43.3 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.343 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.92 -42.64 90.17 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.378 172.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -61.16 -49.77 75.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.866 1.212 . . . . 0.0 111.151 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -58.32 -25.37 61.82 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 74.9 m -86.03 -50.86 6.73 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.795 1.18 . . . . 0.0 110.615 165.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 96.09 63.17 0.95 Allowed Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -164.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.9 pt -131.11 173.14 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.577 1.951 . . . . 0.0 106.286 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -99.65 165.83 11.42 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 -171.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 39.4 m -136.26 155.36 50.22 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.637 1.175 . . . . 0.0 110.57 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 34.3 mt -140.66 74.81 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -96.14 169.64 9.81 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.842 0.829 . . . . 0.0 110.157 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -88.25 2.14 52.98 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.532 -1.355 . . . . 0.0 111.951 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.06 132.78 19.96 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 124.72 2.2 . . . . 0.0 115.414 -175.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.24 138.65 58.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.568 -2.105 . . . . 0.0 109.4 -167.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' SER . . . . . 0.628 ' HB2' HG21 ' A' ' 169' ' ' VAL . 74.9 p -137.91 163.4 31.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.093 0.557 . . . . 0.0 110.704 -162.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 24.4 p -75.68 45.16 0.31 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.527 1.931 . . . . 0.0 111.55 173.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -131.34 175.67 8.93 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.95 -1.094 . . . . 0.0 109.717 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -98.26 -67.84 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.768 0.827 . . . . 0.0 109.202 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -73.15 51.49 1.68 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.984 2.231 . . . . 0.0 113.319 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -121.26 119.6 32.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.376 1.07 . . . . 0.0 108.766 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -106.67 106.56 17.15 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.815 0.846 . . . . 0.0 109.94 -172.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.66 139.85 58.81 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.8 pt -129.98 167.66 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.142 1.377 . . . . 0.0 113.084 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.26 -17.59 8.22 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.972 1.309 . . . . 0.0 113.52 168.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.63 168.69 26.62 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 18.4 mt -70.37 -38.58 74.79 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -171.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.12 -18.07 63.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.82 -0.55 . . . . 0.0 112.329 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.94 -21.34 66.81 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.223 -0.923 . . . . 0.0 110.686 176.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.436 HG21 ' CE2' ' A' ' 6' ' ' PHE . 72.7 mt -61.46 -50.52 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 118.161 -0.924 . . . . 0.0 109.132 176.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' SER . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 94.4 p -58.04 -41.09 82.54 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.32 0.964 . . . . 0.0 110.364 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.5 mtp-105 -58.98 -39.59 82.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.329 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.6 mt -52.62 -51.96 30.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 118.983 0.81 . . . . 0.0 109.988 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -73.78 -35.76 64.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -174.98 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mmm . . . . . 0 N--CA 1.445 -0.675 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -167.13 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 129.402 3.081 . . . . 0.0 111.272 161.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -57.28 109.94 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 119.543 -1.973 . . . . 0.0 107.72 168.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.5 m -130.37 152.59 49.61 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 166.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.57 150.3 46.19 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.262 -0.899 . . . . 0.0 109.652 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -124.9 160.9 27.77 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.588 1.555 . . . . 0.0 110.211 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 mt -138.19 149.53 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -134.95 168.15 19.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.635 2.374 . . . . 0.0 109.598 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -123.46 24.67 8.55 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.721 2.008 . . . . 0.0 111.666 -171.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 CA--C 1.54 0.558 0 C-N-CA 128.438 2.695 . . . . 0.0 112.791 172.285 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.4 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.464 ' HA ' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -68.11 -24.13 64.99 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 118.974 -2.329 . . . . 0.0 111.97 -176.018 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -61.01 -45.72 93.67 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.952 0.901 . . . . 0.0 109.745 174.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.75 -44.39 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 123.88 0.872 . . . . 0.0 109.486 -170.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.61 HD23 ' CD2' ' A' ' 125' ' ' TYR . 4.4 mp -44.3 -44.73 8.28 Favored 'General case' 0 N--CA 1.418 -2.068 0 C-N-CA 126.125 1.77 . . . . 0.0 111.519 169.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.57 -33.57 66.85 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.593 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -65.09 -55.3 19.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.853 1.261 . . . . 0.0 109.827 170.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.28 -36.42 77.8 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.752 1.621 . . . . 0.0 112.527 -174.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.19 -57.96 8.79 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.744 1.218 . . . . 0.0 111.687 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -60.82 -24.39 65.82 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.617 0.723 . . . . 0.0 112.363 175.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.1 m -78.28 -6.02 53.77 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.33 -0.856 . . . . 0.0 112.634 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.39 15.34 81.08 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 124.228 0.918 . . . . 0.0 112.653 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.5 mt -70.5 120.7 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 118.834 1.317 . . . . 0.0 107.726 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -75.13 105.28 6.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 167.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.452 HE22 ' HA ' ' A' ' 93' ' ' LEU . 19.4 mt-30 -88.65 150.56 22.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -142.28 169.16 18.11 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.432 1.093 . . . . 0.0 108.94 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.3 mt -131.63 149.67 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -121.7 141.87 50.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 157.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.4 t -163.25 -176.0 4.57 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.196 2.199 . . . . 0.0 105.719 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -134.11 9.22 3.79 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.844 0.858 . . . . 0.0 112.755 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -1.55 8.11 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.47 174.31 34.01 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 125.821 1.677 . . . . 0.0 111.019 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -52.61 -27.5 17.25 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.084 0.954 . . . . 0.0 112.293 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -54.7 -17.87 3.94 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.57 -46.99 49.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.8 1.182 . . . . 0.0 112.223 171.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -60.32 -47.38 86.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.435 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.6 m -56.15 -49.83 72.86 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.732 0.696 . . . . 0.0 109.45 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.2 mt -58.89 -48.49 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.01 -38.42 91.13 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 121.326 -0.859 . . . . 0.0 112.235 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -48.85 80.05 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.54 -36.01 82.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.505 0.593 . . . . 0.0 111.354 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.83 -8.22 57.74 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.476 1.11 . . . . 0.0 112.05 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 57.12 33.49 64.69 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 125.44 1.495 . . . . 0.0 113.248 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.79 14.1 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.512 1.156 . . . . 0.0 110.36 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -41.37 97.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.186 0.994 . . . . 0.0 111.176 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 t -65.52 -31.02 71.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.688 -169.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.61 ' CD2' HD23 ' A' ' 93' ' ' LEU . 37.8 m-85 -56.01 -43.91 78.19 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.553 0.615 . . . . 0.0 111.461 174.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -97.19 95.58 7.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -166.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.4 m -44.66 -49.83 10.18 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.566 1.546 . . . . 0.0 109.682 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.44 147.44 34.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.96 119.31 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 134' ' ' SER . 4.3 mm? -82.0 163.94 21.79 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.582 0.705 . . . . 0.0 109.63 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.8 p -148.11 -174.2 4.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.239 1.019 . . . . 0.0 112.687 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.6 t -55.25 -15.51 2.47 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 162.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -73.32 -38.8 65.68 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 120.018 1.281 . . . . 0.0 110.499 173.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.713 ' HB3' HD12 ' A' ' 130' ' ' LEU . 2.6 p -77.71 77.6 4.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.25 45.76 1.21 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 125.058 1.313 . . . . 0.0 111.224 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -62.8 166.9 5.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.244 0.545 . . . . 0.0 111.227 168.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.9 m -53.35 161.43 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 127.149 2.18 . . . . 0.0 112.852 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.418 ' NE ' ' H ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -83.35 156.07 23.2 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.398 -0.814 . . . . 0.0 110.659 170.349 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -51.02 139.49 23.09 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.631 1.572 . . . . 0.0 110.442 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.71 123.58 5.74 Favored 'Cis proline' 0 CA--C 1.537 0.644 0 CA-C-N 120.416 1.184 . . . . 0.0 110.099 -9.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.72 ' H ' ' HB3' ' A' ' 171' ' ' PHE . 2.8 p -128.84 81.26 71.16 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 126.398 1.879 . . . . 0.0 110.954 -162.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.62 -9.12 16.0 Favored 'Trans proline' 0 CA--C 1.551 1.334 0 C-N-CA 123.556 2.838 . . . . 0.0 114.635 -173.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.13 -44.73 94.69 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.022 1.283 . . . . 0.0 111.875 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -51.58 -45.47 63.13 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 124.064 0.946 . . . . 0.0 110.669 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.13 -34.77 75.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.769 -0.582 . . . . 0.0 112.139 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.1 m -68.51 -32.21 72.01 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.636 0.774 . . . . 0.0 110.364 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -65.19 -49.73 68.65 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.47 -38.48 80.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.062 0.945 . . . . 0.0 111.332 -176.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -58.05 -68.12 0.28 Allowed 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 173.787 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -53.43 -46.56 69.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.852 0.72 . . . . 0.0 112.012 -171.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -51.72 -36.0 45.19 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -121.69 12.45 10.66 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.76 0.709 . . . . 0.0 111.539 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 47.16 50.35 14.3 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.84 2.456 . . . . 0.0 110.283 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 66.1 mt -76.85 -172.59 2.34 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.685 1.994 . . . . 0.0 110.105 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -129.34 134.42 47.89 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.79 1.236 . . . . 0.0 107.778 -170.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.8 p -59.35 -40.17 85.55 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 119.522 1.056 . . . . 0.0 111.198 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -75.12 -22.78 57.97 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.529 -0.732 . . . . 0.0 111.943 -172.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -95.82 2.53 53.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.462 -0.773 . . . . 0.0 109.43 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.6 m -96.57 126.56 41.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.702 1.201 . . . . 0.0 108.052 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -112.18 155.75 23.44 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -120.98 163.61 18.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.964 1.706 . . . . 0.0 106.694 161.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.4 mt -126.59 107.63 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 173.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -119.69 177.23 16.34 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.49 166.18 18.45 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 156.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 75.43 156.62 0.18 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 126.689 1.996 . . . . 0.0 111.389 -176.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 t -69.83 -30.1 67.52 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.83 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -25.06 45.29 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.437 1.095 . . . . 0.0 112.631 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -79.68 13.04 2.24 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.479 1.912 . . . . 0.0 111.558 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 1.2 p -109.12 -16.32 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.277 1.031 . . . . 0.0 110.553 163.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -73.9 -52.62 12.36 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.121 1.328 . . . . 0.0 110.805 -168.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.72 ' HB3' ' H ' ' A' ' 141' ' ' SER . 1.4 p90 -63.28 -29.39 70.72 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 120.971 -1.081 . . . . 0.0 111.916 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.47 -52.55 64.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 118.761 -0.637 . . . . 0.0 109.302 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -49.11 -60.88 2.41 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.127 1.371 . . . . 0.0 110.708 170.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -68.33 -14.51 63.05 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -170.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.5 p -95.62 -23.4 17.05 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 120.73 1.604 . . . . 0.0 112.229 165.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.1 22.42 38.36 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.145 1.355 . . . . 0.0 112.515 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.2 pp -99.16 175.2 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.855 1.327 . . . . 0.0 109.982 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -117.65 162.07 18.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.619 1.168 . . . . 0.0 110.29 -173.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 12.4 m -139.33 143.98 38.06 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.76 1.224 . . . . 0.0 110.348 -165.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 73.6 mt -119.95 92.11 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -111.5 158.98 18.54 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 121.819 0.819 . . . . 0.0 108.956 -172.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -74.18 -6.5 48.15 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.517 -1.365 . . . . 0.0 112.835 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.99 158.81 41.75 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 126.83 2.052 . . . . 0.0 109.159 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.84 160.86 28.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 19.0 t -147.22 174.83 11.25 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.6 169.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.4 p -83.95 63.98 7.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.023 2.529 . . . . 0.0 108.434 -173.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -144.6 178.86 7.67 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.771 2.028 . . . . 0.0 108.355 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -113.38 -35.95 5.13 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.431 1.469 . . . . 0.0 110.459 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -86.19 15.48 49.14 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 127.368 2.413 . . . . 0.0 112.77 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -84.75 152.87 23.39 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 120.621 2.211 . . . . 0.0 107.372 159.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -131.04 148.86 52.8 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 169.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 146.56 25.59 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.273 0.629 . . . . 0.0 110.85 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 18.6 pt -140.03 162.68 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.219 1.008 . . . . 0.0 112.0 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -108.86 -27.02 9.96 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -168.08 145.59 4.25 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -163.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 196' ' ' LEU . 2.9 tp -61.74 -30.91 71.09 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 127.186 2.194 . . . . 0.0 111.497 -158.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.92 -11.87 50.43 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -77.16 -13.14 59.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.816 0.846 . . . . 0.0 109.6 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 39.7 mt -56.34 -59.37 2.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 83.1 p -53.89 -37.9 64.22 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -175.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -61.35 -34.64 75.63 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.77 0.828 . . . . 0.0 112.141 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 76.0 mt -58.22 -34.69 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.985 0.914 . . . . 0.0 110.729 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -91.48 -4.91 55.03 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 120.974 -1.079 . . . . 0.0 112.291 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 CA--C 1.539 0.522 0 C-N-CA 125.828 1.651 . . . . 0.0 111.036 -171.395 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 mmm . . . . . 0 CA--C 1.52 -0.181 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.73 -169.04 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.508 1.523 . . . . 0.0 111.965 171.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -80.32 48.64 1.04 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 119.857 -1.777 . . . . 0.0 108.23 165.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.9 m -69.3 143.75 53.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.28 149.47 50.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -125.53 152.91 44.39 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.484 1.114 . . . . 0.0 108.972 -172.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.5 mt -134.49 146.04 31.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 169.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -123.78 171.64 9.47 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.809 2.044 . . . . 0.0 107.82 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.18 164.33 15.75 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 165.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 119.03 0.832 . . . . 0.0 109.185 -168.852 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.304 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.89 -24.08 67.6 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 118.402 -0.809 . . . . 0.0 112.697 -172.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -60.26 -58.46 8.41 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.64 -44.44 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 117.018 -1.468 . . . . 0.0 112.228 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.614 HD23 ' CG ' ' A' ' 125' ' ' TYR . 3.7 mp -52.68 -48.35 66.59 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 122.13 2.241 . . . . 0.0 112.368 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.89 -49.08 79.12 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 124.804 1.315 . . . . 0.0 109.552 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -53.57 -48.08 69.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.632 -0.699 . . . . 0.0 111.191 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.64 74.83 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.895 0.77 . . . . 0.0 111.752 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -73.45 -40.89 63.83 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.286 1.834 . . . . 0.0 110.711 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.25 -1.28 4.3 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.227 1.811 . . . . 0.0 111.309 168.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 58.3 m -118.88 -6.6 10.53 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.423 1.489 . . . . 0.0 114.273 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.38 9.14 77.1 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.101 -1.624 . . . . 0.0 115.654 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 93.5 mt -45.63 147.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 149.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -98.65 115.4 28.59 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 167.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.471 HE22 ' HA ' ' A' ' 93' ' ' LEU . 5.3 mt-30 -88.67 150.75 22.85 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -140.0 164.95 28.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 125.12 1.368 . . . . 0.0 107.967 171.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.6 mt -124.51 149.86 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 161.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -129.16 143.84 51.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 152.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.4 t -151.6 163.5 38.93 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.863 1.265 . . . . 0.0 109.585 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -92.64 -0.39 57.31 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.983 -0.448 . . . . 0.0 111.962 165.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -59.19 153.0 19.28 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 119.477 1.035 . . . . 0.0 108.571 166.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -80.93 -175.21 49.6 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.72 -18.18 7.6 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.501 1.521 . . . . 0.0 114.038 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -58.63 -18.1 27.68 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.617 1.099 . . . . 0.0 112.119 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.36 69.69 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.078 0.951 . . . . 0.0 110.366 175.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -57.15 -48.86 77.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -48.03 83.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.829 2.052 . . . . 0.0 111.252 -174.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.13 -50.61 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.481 1.112 . . . . 0.0 108.165 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.89 -37.28 87.11 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 122.16 -0.337 . . . . 0.0 111.162 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -49.1 77.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.517 1.127 . . . . 0.0 109.608 174.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -50.46 73.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 124.016 0.926 . . . . 0.0 110.679 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.54 -40.2 77.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.544 -174.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.41 50.82 0.79 Allowed Glycine 0 C--N 1.339 0.697 0 CA-C-O 121.563 0.535 . . . . 0.0 111.825 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.317 1.3 p -147.61 8.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 129.912 3.285 . . . . 0.0 109.384 -170.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -34.25 77.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 120.768 -1.208 . . . . 0.0 113.028 174.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -15.91 53.71 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.576 0.547 . . . . 0.0 111.774 -168.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.614 ' CG ' HD23 ' A' ' 93' ' ' LEU . 13.1 m-85 -66.23 -30.77 71.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -174.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 5.8 m-85 -110.8 129.4 55.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 -167.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.7 m -55.31 -30.87 61.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.383 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -154.28 151.83 29.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.229 1.012 . . . . 0.0 109.093 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.85 77.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 174.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.4 mt -66.2 147.19 53.7 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 57.8 p -122.96 177.96 5.27 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.061 0.944 . . . . 0.0 110.14 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 t -45.91 -37.61 6.56 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.993 0.917 . . . . 0.0 110.604 165.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -62.32 -18.37 61.2 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.3 p -48.37 -48.89 36.33 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.169 0.895 . . . . 0.0 112.277 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.96 -5.81 56.53 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 117.688 -1.618 . . . . 0.0 112.852 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -60.65 163.12 5.76 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.617 1.708 . . . . 0.0 110.904 172.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.2 m -52.73 156.29 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 126.973 2.109 . . . . 0.0 112.555 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -81.19 154.58 26.6 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.666 0.786 . . . . 0.0 108.924 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -54.66 144.29 45.52 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.282 1.033 . . . . 0.0 113.148 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.58 135.53 35.98 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 N-CA-C 108.261 -1.477 . . . . 0.0 108.261 -8.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 p -128.43 61.28 53.24 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.223 0.609 . . . . 0.0 111.84 -157.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.56 -24.22 77.65 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.164 2.576 . . . . 0.0 113.155 -167.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -51.33 -38.56 53.69 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 120.897 -1.127 . . . . 0.0 112.366 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.671 ' O ' HD13 ' A' ' 148' ' ' LEU . . . -74.3 4.86 5.15 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.236 1.014 . . . . 0.0 112.702 -178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.71 -40.67 5.67 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.686 163.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.2 m -55.21 -35.45 64.91 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.415 1.007 . . . . 0.0 110.65 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.694 ' HD1' HD12 ' A' ' 148' ' ' LEU . 47.8 t80 -66.07 -49.37 67.86 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.574 0.75 . . . . 0.0 110.922 171.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.694 HD12 ' HD1' ' A' ' 147' ' ' TYR . 8.1 mp -67.43 -14.11 62.63 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.441 1.496 . . . . 0.0 113.171 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 92.1 mt -84.22 -53.48 5.47 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.877 2.071 . . . . 0.0 107.826 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.28 -37.55 85.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -174.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -54.87 -20.0 7.81 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.478 1.911 . . . . 0.0 115.125 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -158.38 22.52 0.24 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.843 2.457 . . . . 0.0 112.71 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 49.25 46.8 22.76 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.004 1.721 . . . . 0.0 113.462 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 30.0 mt -78.45 169.18 18.66 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.251 1.02 . . . . 0.0 109.899 -177.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -108.37 130.94 55.2 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 123.229 0.611 . . . . 0.0 109.958 -174.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.4 m -60.14 -43.96 95.31 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.944 0.898 . . . . 0.0 110.16 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.83 -23.68 59.68 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.633 -1.292 . . . . 0.0 113.449 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -93.2 3.86 54.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.067 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -102.16 126.06 49.03 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -106.46 163.75 12.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -139.67 127.54 22.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 173.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 7.4 mt -98.91 116.92 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.884 1.674 . . . . 0.0 107.003 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.95 -164.97 10.1 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.466 1.508 . . . . 0.0 110.071 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -138.23 -1.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -172.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.09 169.14 13.71 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 122.404 1.097 . . . . 0.0 111.505 -160.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.1 t -59.63 -32.24 70.25 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.571 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.75 -17.25 64.0 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.566 -1.334 . . . . 0.0 111.864 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -83.95 1.7 42.31 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.076 -1.015 . . . . 0.0 111.933 -165.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.8 p -91.87 -28.44 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 O-C-N 121.401 -0.812 . . . . 0.0 112.148 158.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -67.23 -58.26 5.17 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 120.087 1.312 . . . . 0.0 111.399 -161.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -55.9 -45.12 78.75 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.645 1.178 . . . . 0.0 111.915 170.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.91 79.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 122.63 0.372 . . . . 0.0 111.409 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -59.12 -46.11 89.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.396 1.878 . . . . 0.0 109.822 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -59.71 -45.02 93.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.657 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 74.6 m -81.22 -22.14 39.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.87 61.75 2.99 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.474 1.035 . . . . 0.0 110.693 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.0 -173.22 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.749 2.02 . . . . 0.0 109.058 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -111.81 166.01 11.56 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.992 0.917 . . . . 0.0 110.146 -176.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 32.7 m -145.19 151.57 38.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.355 1.062 . . . . 0.0 112.387 -170.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.5 mt -138.0 101.95 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.06 160.88 36.92 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 120.867 -1.145 . . . . 0.0 109.209 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -73.52 0.42 12.54 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.297 -0.877 . . . . 0.0 111.362 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 22.8 mt -114.01 154.7 27.2 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 125.728 1.611 . . . . 0.0 109.54 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -79.94 154.13 28.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 164.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.8 m -136.67 163.85 29.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.876 1.671 . . . . 0.0 107.218 173.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 62.0 p -93.38 64.56 3.71 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -169.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -146.52 162.19 38.87 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.687 1.195 . . . . 0.0 109.8 -170.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.8 -54.86 6.55 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.893 0.877 . . . . 0.0 110.774 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.15 24.48 6.15 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 125.074 1.321 . . . . 0.0 113.774 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -85.45 111.27 19.81 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 125.407 1.483 . . . . 0.0 108.31 171.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -99.23 125.0 44.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 168.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.2 148.47 30.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.737 -0.649 . . . . 0.0 109.394 169.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 13.6 pt -133.96 156.94 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.982 0.913 . . . . 0.0 112.457 172.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 -97.06 -29.63 13.52 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.446 1.098 . . . . 0.0 111.913 164.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.72 162.15 39.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.64 1.576 . . . . 0.0 108.496 -167.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.49 -43.92 88.7 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -60.59 -19.63 58.23 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.79 0.723 . . . . 0.0 112.7 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.42 -21.53 66.67 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.038 0.835 . . . . 0.0 112.031 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 67.1 mt -50.91 -60.2 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.6 m -61.89 -32.27 72.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.164 0.893 . . . . 0.0 112.008 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -62.18 -35.33 78.5 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.204 -0.935 . . . . 0.0 111.231 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 36.1 mt -54.87 -55.08 17.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 124.767 1.227 . . . . 0.0 109.273 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -67.58 -5.65 16.4 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.285 0.634 . . . . 0.0 112.054 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 . . . . . 0 N--CA 1.45 -0.455 0 C-N-CA 127.659 2.383 . . . . 0.0 109.953 -173.657 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.413 ' CE ' HD11 ' A' ' 101' ' ' ILE . 61.2 mmm . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 122.814 1.292 . . . . 0.0 107.552 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.01 175.24 0.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.413 162.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.66 101.14 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.72 1.208 . . . . 0.0 109.747 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.9 m -122.88 152.7 40.51 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -175.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.69 152.62 44.05 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.426 0.631 . . . . 0.0 110.154 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.428 ' CD2' HD11 ' A' ' 162' ' ' ILE . 1.6 m-85 -134.74 142.85 46.86 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 125.071 1.349 . . . . 0.0 108.854 -168.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.1 mt -145.98 77.83 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -165.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -69.08 172.19 7.13 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 118.196 0.453 . . . . 0.0 110.505 -173.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -127.08 -167.89 1.8 Allowed 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.578 -1.326 . . . . 0.0 108.559 170.071 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.426 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--O 1.236 0.369 0 C-N-CA 127.921 2.489 . . . . 0.0 106.303 -159.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.29 0 CA-C-O 121.08 0.467 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.51 ' HA ' HD22 ' A' ' 93' ' ' LEU . 15.9 ttt180 -63.42 -25.43 68.28 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -164.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -55.68 -66.45 0.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 O-C-N 124.57 1.169 . . . . 0.0 109.211 165.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.36 -46.51 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 116.653 -1.642 . . . . 0.0 113.259 -172.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.51 HD22 ' HA ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -45.44 -53.39 8.82 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 120.365 1.438 . . . . 0.0 112.286 171.686 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.37 -41.47 76.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.856 0.723 . . . . 0.0 110.611 -170.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -61.88 -50.15 73.36 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.322 1.049 . . . . 0.0 109.812 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.43 74.73 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.809 1.643 . . . . 0.0 111.666 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -59.38 -60.57 3.65 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.631 0.772 . . . . 0.0 109.343 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.55 -13.92 6.84 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.2 -6.66 37.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 175.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.06 16.22 68.36 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.312 0.958 . . . . 0.0 111.927 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.413 HD11 ' CE ' ' A' ' 1' ' ' MET . 54.0 mt -66.65 99.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.424 1.49 . . . . 0.0 107.013 171.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.36 108.36 1.09 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -87.34 155.89 19.85 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -150.07 173.76 13.5 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 128.459 2.704 . . . . 0.0 107.325 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.473 HD12 HD11 ' A' ' 117' ' ' LEU . 13.7 mt -136.51 156.79 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.669 0.788 . . . . 0.0 109.438 171.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -135.37 140.44 45.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.11 0.964 . . . . 0.0 111.583 165.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.9 t -154.31 167.73 28.96 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.33 -0.856 . . . . 0.0 110.455 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -94.66 -1.39 53.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.199 1.8 . . . . 0.0 111.803 168.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HE2' ' CD1' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -78.43 171.02 15.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 121.365 1.893 . . . . 0.0 110.571 178.391 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.68 -178.16 20.6 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.738 1.161 . . . . 0.0 112.924 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -53.61 -18.98 3.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.556 1.542 . . . . 0.0 112.539 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.14 -27.34 0.95 Allowed 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 125.6 1.56 . . . . 0.0 113.379 172.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.83 -52.87 29.15 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.197 0.999 . . . . 0.0 111.506 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -56.7 -43.5 80.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.401 0.68 . . . . 0.0 110.311 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -59.89 -48.59 81.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.655 1.182 . . . . 0.0 110.898 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.401 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 62.0 mt -56.66 -46.84 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.825 0.85 . . . . 0.0 109.613 -177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 105' ' ' ILE . 94.1 mt -63.97 -44.6 92.26 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.78 0.832 . . . . 0.0 110.794 -174.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.96 -60.65 2.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 124.284 0.99 . . . . 0.0 108.943 169.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.61 -58.04 9.08 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.917 0.887 . . . . 0.0 112.185 -174.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.1 -32.17 73.47 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.68 -170.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.82 44.23 0.55 Allowed Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 157.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.722 HG23 ' HD2' ' A' ' 125' ' ' TYR . 2.0 p -166.22 52.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 -166.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -41.04 29.89 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 118.783 -2.448 . . . . 0.0 108.878 153.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.3 t -72.12 -8.29 53.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.349 1.46 . . . . 0.0 113.058 -158.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.722 ' HD2' HG23 ' A' ' 122' ' ' VAL . 75.7 m-85 -80.89 -31.8 35.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.005 0.522 . . . . 0.0 109.857 172.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PHE . . . . . 0.557 ' CE2' HG22 ' A' ' 122' ' ' VAL . 14.9 m-85 -105.58 101.97 11.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 120.624 -1.297 . . . . 0.0 108.229 -168.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.8 m -46.19 -51.28 14.51 Favored 'General case' 0 C--O 1.255 1.367 0 C-N-CA 126.117 1.767 . . . . 0.0 111.113 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -142.7 144.4 32.69 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.262 0.625 . . . . 0.0 109.553 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.3 mt -132.26 97.81 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 -166.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.41 162.13 29.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.9 p -144.48 -177.38 5.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.358 1.463 . . . . 0.0 108.559 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 96.8 p -51.1 -32.62 23.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.093 0.86 . . . . 0.0 111.856 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -21.87 63.88 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.499 1.92 . . . . 0.0 111.348 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 65.0 p -57.51 -23.37 49.81 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.05 -14.95 59.24 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.225 0.916 . . . . 0.0 111.936 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -66.05 167.74 9.41 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 123.968 1.842 . . . . 0.0 113.23 -173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -58.04 154.14 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 C-N-CA 129.676 3.191 . . . . 0.0 109.91 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.13 43.71 1.05 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.752 0.787 . . . . 0.0 110.808 -172.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 mttt 70.29 147.65 0.12 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 128.394 2.678 . . . . 0.0 110.633 -168.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -62.8 124.34 3.2 Favored 'Cis proline' 0 N--CA 1.45 -1.051 0 N-CA-C 107.619 -1.724 . . . . 0.0 107.619 -22.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -116.32 85.26 15.6 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.49 -22.5 28.67 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.295 1.997 . . . . 0.0 111.405 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -56.31 -38.11 70.82 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.647 1.579 . . . . 0.0 110.397 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.596 ' O ' HD13 ' A' ' 148' ' ' LEU . . . -65.45 -20.55 66.41 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.551 -169.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.66 -41.27 10.82 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 116.338 -1.791 . . . . 0.0 109.553 171.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.453 ' HA ' HD12 ' A' ' 149' ' ' LEU . 23.5 m -56.58 -36.05 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 120.95 1.705 . . . . 0.0 110.586 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.721 ' HD1' HD12 ' A' ' 148' ' ' LEU . 22.8 t80 -56.99 -52.62 64.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.826 0.85 . . . . 0.0 109.756 171.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.721 HD12 ' HD1' ' A' ' 147' ' ' TYR . 8.8 mp -60.34 -39.74 88.22 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.726 1.61 . . . . 0.0 111.343 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.509 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 71.4 mt -57.82 -61.07 2.79 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.83 -31.31 72.45 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.707 0.803 . . . . 0.0 111.56 -171.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.19 -43.08 78.12 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 120.91 -1.119 . . . . 0.0 113.276 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -137.26 26.56 2.9 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 45.93 50.92 11.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.409 2.283 . . . . 0.0 110.441 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 65.8 mt -81.68 167.86 18.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.231 -1.35 . . . . 0.0 109.698 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.07 130.41 51.76 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.92 1.288 . . . . 0.0 108.407 -172.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -52.7 62.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.433 1.111 . . . . 0.0 109.038 176.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.91 -10.74 59.73 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.998 -1.064 . . . . 0.0 112.834 -170.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -112.15 17.54 19.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 109.322 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -104.38 145.69 29.9 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 118.745 0.702 . . . . 0.0 109.501 169.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.474 ' CD1' ' HB2' ' A' ' 178' ' ' GLN . 95.8 m-85 -125.02 159.06 32.19 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.036 1.734 . . . . 0.0 109.856 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -116.03 -39.27 3.47 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.428 HD11 ' CD2' ' A' ' 6' ' ' PHE . 1.3 mp 57.09 75.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 125.604 1.562 . . . . 0.0 112.44 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -128.1 -175.97 14.28 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.367 0.984 . . . . 0.0 110.867 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.59 26.7 5.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.54 1.536 . . . . 0.0 114.106 -156.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.442 ' HD3' ' HB2' ' A' ' 167' ' ' LEU . 1.9 ptp85 -160.62 159.85 30.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.725 2.01 . . . . 0.0 107.899 -178.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 21.6 p -51.8 -37.56 52.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.761 0.791 . . . . 0.0 111.86 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.442 ' HB2' ' HD3' ' A' ' 165' ' ' ARG . 0.2 OUTLIER -62.1 -13.31 25.38 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -35.15 78.66 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 119.988 1.267 . . . . 0.0 110.546 172.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.5 p -104.36 -24.27 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.3 1.04 . . . . 0.0 110.783 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.73 -38.26 87.27 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 120.474 -1.392 . . . . 0.0 110.949 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -75.27 -38.12 60.59 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 118.36 -0.829 . . . . 0.0 110.287 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.26 69.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.978 1.311 . . . . 0.0 110.271 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.63 -43.09 56.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.946 1.299 . . . . 0.0 111.978 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -72.27 -22.12 61.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 118.419 -0.801 . . . . 0.0 113.057 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 t -96.1 -20.84 18.34 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.669 0.668 . . . . 0.0 110.314 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.9 49.8 6.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.15 178.0 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.038 1.735 . . . . 0.0 109.239 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.474 ' HB2' ' CD1' ' A' ' 160' ' ' TYR . 7.2 mm-40 -109.04 168.61 9.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.661 1.22 . . . . 0.0 111.815 -174.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.56 141.39 25.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.868 2.067 . . . . 0.0 108.785 -174.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 57.3 mt -121.01 86.5 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -95.43 176.58 6.14 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.835 -167.054 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -109.64 -6.42 15.35 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 119.654 -1.904 . . . . 0.0 111.469 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.494 ' H ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -118.96 146.2 45.18 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.644 1.978 . . . . 0.0 108.574 176.471 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.84 144.97 56.49 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 11.7 t -122.23 171.91 8.67 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 112.854 -1.976 . . . . 0.0 107.01 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 9.9 p -114.4 27.7 9.28 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.26 1.824 . . . . 0.0 109.666 -175.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -123.24 140.81 52.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.418 1.487 . . . . 0.0 110.014 -175.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -77.54 96.61 4.8 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.28 1.832 . . . . 0.0 109.415 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 133.76 -1.89 4.38 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.427 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.8 153.51 34.85 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 119.394 1.597 . . . . 0.0 108.407 168.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -138.12 99.95 4.01 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 181' ' ' ASN 0.292 0.2 OUTLIER -75.0 151.44 38.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 115.682 -2.407 . . . . 0.0 109.4 175.403 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.0 pt -126.27 -176.5 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 130.032 3.333 . . . . 0.0 107.982 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.83 -14.63 5.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 125.247 1.419 . . . . 0.0 111.75 167.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.93 165.0 36.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.52 0.6 . . . . 0.0 109.455 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.39 -25.89 63.45 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.146 -0.971 . . . . 0.0 110.474 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.34 -32.12 73.32 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.06 -1.025 . . . . 0.0 111.115 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.65 -22.17 63.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.036 2.534 . . . . 0.0 110.728 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.28 -56.7 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 C-N-CA 124.409 1.084 . . . . 0.0 109.009 171.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 96.3 p -52.45 -40.39 62.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.539 0.609 . . . . 0.0 111.384 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 34.0 mtt85 -64.03 -32.8 74.49 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.447 -1.263 . . . . 0.0 112.541 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.23 -45.57 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.088 1.313 . . . . 0.0 109.192 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.69 -5.45 53.12 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 CA--C 1.53 0.207 0 C-N-CA 124.823 1.249 . . . . 0.0 113.205 -177.176 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mmm . . . . . 0 C--O 1.232 0.142 0 CA-C-O 122.478 1.132 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -62.63 173.51 1.25 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.13 -1.396 . . . . 0.0 109.095 173.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -44.17 83.74 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.029 2.132 . . . . 0.0 114.535 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.8 m -110.76 159.83 17.27 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.821 1.248 . . . . 0.0 107.651 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.514 ' HB2' HD22 ' A' ' 154' ' ' LEU . . . -136.92 158.5 44.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.411 0.624 . . . . 0.0 110.937 162.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -114.3 174.85 5.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.61 1.164 . . . . 0.0 108.38 169.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mt -139.84 137.2 39.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 163.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -119.07 178.2 4.59 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.485 1.914 . . . . 0.0 109.442 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.24 -179.8 6.47 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.246 1.819 . . . . 0.0 107.641 -170.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.475 0.784 0 O-C-N 120.762 -1.211 . . . . 0.0 114.238 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.28 0 CA-C-O 121.537 0.684 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.552 ' HG3' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.74 -9.8 39.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.952 1.701 . . . . 0.0 112.393 176.703 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -65.82 -38.98 90.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.425 1.09 . . . . 0.0 110.796 165.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.7 -39.72 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.351 -0.843 . . . . 0.0 110.772 -173.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.922 HD23 ' CD2' ' A' ' 125' ' ' TYR . 6.9 mp -44.35 -41.0 5.75 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 127.797 2.439 . . . . 0.0 111.549 166.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.17 -50.8 62.66 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.903 1.377 . . . . 0.0 109.581 -177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -56.71 -45.45 81.85 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.766 0.827 . . . . 0.0 110.475 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.31 -38.81 71.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.362 1.065 . . . . 0.0 113.138 -174.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.58 -52.11 59.26 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.613 1.165 . . . . 0.0 109.635 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -60.72 -38.12 84.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.336 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.0 m -71.86 -1.26 13.62 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.5 16.14 60.37 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.46 1.505 . . . . 0.0 113.259 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.9 mt -76.05 101.11 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -57.42 109.95 0.78 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.07 1.348 . . . . 0.0 108.913 -174.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -84.6 147.13 27.14 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 172.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -137.39 168.25 20.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 168.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mt -124.53 149.75 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.529 0.731 . . . . 0.0 109.132 171.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -134.04 128.11 33.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 157.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -145.97 -173.95 4.3 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 162.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.04 12.77 7.8 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.36 1.864 . . . . 0.0 112.229 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.491 ' HE2' ' CD1' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -73.28 -10.43 59.75 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -165.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 126.91 174.62 13.85 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 126.399 1.952 . . . . 0.0 109.764 -170.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -63.63 -29.08 70.37 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 117.491 0.645 . . . . 0.0 110.421 172.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -51.64 -14.81 0.37 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.435 2.294 . . . . 0.0 114.544 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.68 -44.53 69.81 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.528 1.058 . . . . 0.0 111.061 169.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -63.22 -7.82 6.84 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.317 1.847 . . . . 0.0 114.122 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 19.0 m -101.92 -49.3 4.0 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 120.521 -1.362 . . . . 0.0 108.501 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.491 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 52.4 mt -52.64 -48.92 47.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 C-N-CA 123.799 0.84 . . . . 0.0 109.367 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.9 mt -64.01 -35.99 82.52 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.0 -1.062 . . . . 0.0 111.366 -172.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.12 -50.45 73.65 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.064 1.345 . . . . 0.0 109.359 172.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.01 -48.11 79.26 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.56 1.544 . . . . 0.0 111.312 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 99.5 mt -58.81 -50.44 73.95 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.476 1.11 . . . . 0.0 108.391 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.9 36.16 3.04 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.065 1.317 . . . . 0.0 112.271 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.94 22.61 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.855 1.662 . . . . 0.0 110.314 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.25 -54.33 46.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.51 1.524 . . . . 0.0 112.657 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.7 m -76.56 -12.62 60.05 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -164.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.922 ' CD2' HD23 ' A' ' 93' ' ' LEU . 26.0 m-85 -54.82 -32.64 60.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.938 0.79 . . . . 0.0 110.943 164.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -98.37 106.18 18.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -172.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.4 m -45.08 -54.11 7.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.559 1.944 . . . . 0.0 110.752 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -142.93 150.24 39.49 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 mt -131.77 88.56 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -168.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.94 145.2 48.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.317 -0.864 . . . . 0.0 109.196 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.7 p -121.77 -173.31 2.62 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.766 0.826 . . . . 0.0 110.553 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 p -56.44 -20.0 17.81 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.001 -1.062 . . . . 0.0 113.31 167.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -77.21 -3.98 42.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.48 1.512 . . . . 0.0 111.918 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.3 p -58.76 -25.64 63.23 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.82 20.19 31.93 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.204 0.906 . . . . 0.0 114.824 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -78.16 -86.89 0.06 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.559 1.679 . . . . 0.0 107.667 168.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.0 t -150.87 168.42 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 126.177 1.791 . . . . 0.0 107.743 -170.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.604 ' H ' ' HD3' ' A' ' 138' ' ' ARG 0.255 0.0 OUTLIER -74.06 -85.16 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 117.817 -1.087 . . . . 0.0 109.583 166.798 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -160.15 139.23 7.94 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 121.32 1.873 . . . . 0.0 109.42 -172.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.86 -28.56 4.55 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 121.035 1.405 . . . . 0.0 115.12 7.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.9 t 59.98 62.3 3.55 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.667 1.187 . . . . 0.0 113.211 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -61.94 -24.42 76.93 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.549 2.166 . . . . 0.0 112.584 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -56.17 -28.77 59.35 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.939 1.296 . . . . 0.0 112.463 -171.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.08 -42.9 77.42 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.056 0.943 . . . . 0.0 110.055 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.26 92.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.693 -0.63 . . . . 0.0 111.288 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 m -55.37 -40.32 71.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.268 0.627 . . . . 0.0 110.514 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -66.64 -51.24 58.47 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.9 mp -56.06 -38.67 70.94 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 111.749 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -60.45 -61.85 2.29 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 126.823 2.049 . . . . 0.0 107.473 177.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -57.35 -36.89 71.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.53 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -48.65 -45.4 38.62 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.378 1.071 . . . . 0.0 112.545 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.75 21.71 10.69 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.411 1.005 . . . . 0.0 112.863 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 50.78 69.5 0.63 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.921 1.689 . . . . 0.0 110.112 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 5' ' ' ALA . 1.1 mt -122.41 178.87 4.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.544 1.537 . . . . 0.0 108.506 -173.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.0 151.49 38.91 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.689 1.996 . . . . 0.0 111.361 -176.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 53.5 m -55.91 -33.71 64.92 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.355 0.598 . . . . 0.0 110.084 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.93 -35.11 64.55 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 120.559 -1.338 . . . . 0.0 109.866 -176.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -77.83 1.15 21.24 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.977 -1.487 . . . . 0.0 113.639 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.709 HG23 ' HB ' ' A' ' 177' ' ' ILE . 4.6 t -97.78 140.03 32.77 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.322 1.419 . . . . 0.0 110.43 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -127.7 109.05 11.28 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.423 1.489 . . . . 0.0 110.559 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -91.83 131.31 37.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.838 0.455 . . . . 0.0 111.079 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.18 119.35 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 126.348 1.859 . . . . 0.0 109.011 -174.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -145.52 -21.49 0.14 Allowed Glycine 0 CA--C 1.535 1.299 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.404 ' HB2' ' CD1' ' A' ' 182' ' ' PHE . 19.2 t70 59.29 58.13 3.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.538 1.935 . . . . 0.0 112.886 -174.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -163.35 164.28 24.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.498 -1.376 . . . . 0.0 112.128 172.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.3 t -51.72 -53.07 43.35 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.906 1.282 . . . . 0.0 111.366 167.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.76 -20.59 66.45 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.602 1.561 . . . . 0.0 110.882 -165.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.18 -34.78 78.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.677 -0.64 . . . . 0.0 110.267 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.402 ' HA ' ' HB3' ' A' ' 172' ' ' ALA . 2.7 t -82.13 -11.98 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.5 0.72 . . . . 0.0 111.353 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.06 -55.89 18.91 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 169.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -54.05 -42.01 68.74 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.261 1.025 . . . . 0.0 111.479 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . . . -60.77 -26.48 67.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.767 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -90.14 -42.09 11.26 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.921 1.237 . . . . 0.0 109.225 -169.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -29.23 69.22 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.419 ' HB3' HG23 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -80.04 -41.23 26.12 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.23 0.923 . . . . 0.0 110.377 169.028 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 80.4 56.32 3.22 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -170.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.709 ' HB ' HG23 ' A' ' 159' ' ' THR . 41.7 pt -129.88 165.03 31.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 127.643 2.377 . . . . 0.0 106.146 -174.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -85.27 163.07 18.85 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.168 -0.958 . . . . 0.0 109.96 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.39 162.52 34.83 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.823 0.82 . . . . 0.0 109.834 172.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 36.0 mt -138.57 120.56 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -139.56 164.64 29.36 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' PHE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 164' ' ' ASP . 86.2 m-85 -74.69 9.02 2.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.5 151.81 36.99 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.009 1.324 . . . . 0.0 109.18 -166.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -70.55 147.55 49.18 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.15 26.19 2.03 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.522 1.129 . . . . 0.0 111.183 167.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 17.3 p 50.67 45.82 26.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.466 1.507 . . . . 0.0 111.734 164.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -136.28 157.06 47.71 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.983 2.113 . . . . 0.0 106.365 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -75.4 -45.63 37.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.619 0.645 . . . . 0.0 111.665 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -68.86 -9.02 58.69 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.063 -0.854 . . . . 0.0 112.878 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.09 100.92 12.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.041 1.92 . . . . 0.0 109.181 -173.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -79.74 134.07 36.37 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.28 0.632 . . . . 0.0 109.343 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ARG . . . . . 0.41 ' HB3' HH11 ' A' ' 192' ' ' ARG . 0.0 OUTLIER -77.72 151.56 34.1 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 166.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.83 166.68 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.409 1.883 . . . . 0.0 109.955 171.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -129.54 0.73 5.0 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.385 1.474 . . . . 0.0 112.799 168.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.05 165.56 34.32 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.289 1.436 . . . . 0.0 108.307 171.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 69.3 mt -73.62 -33.66 64.67 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 118.578 0.626 . . . . 0.0 110.154 176.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.51 -22.27 66.15 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -62.75 -21.72 66.04 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.367 -0.833 . . . . 0.0 110.799 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.49 -55.97 19.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 125.138 1.375 . . . . 0.0 109.087 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 95.0 p -60.02 -33.19 71.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.055 1.298 . . . . 0.0 110.877 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -63.24 -33.69 76.05 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.044 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.1 mt -50.31 -58.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -67.26 -12.76 60.94 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.584 1.153 . . . . 0.0 112.952 -174.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 CA--C 1.533 0.322 0 C-N-CA 125.184 1.394 . . . . 0.0 112.853 -176.859 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.93 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 55.0 -86.79 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.827 2.851 . . . . 0.0 112.322 -168.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mmm 59.2 102.12 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.825 2.45 . . . . 0.0 113.57 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -52.63 -177.45 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.323 1.849 . . . . 0.0 113.184 164.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -61.2 100.03 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 O-C-N 120.449 -1.407 . . . . 0.0 107.676 168.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.3 m -128.35 148.25 50.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.89 150.01 52.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -127.74 149.75 50.1 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.613 1.565 . . . . 0.0 108.41 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mt -142.82 132.12 21.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -115.67 179.61 3.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.849 1.66 . . . . 0.0 109.999 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -133.92 175.91 9.04 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.517 2.327 . . . . 0.0 106.657 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.9 mt -130.16 52.6 2.0 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.803 1.241 . . . . 0.0 108.824 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -130.11 -11.44 4.19 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.916 1.286 . . . . 0.0 112.638 -172.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.99 -34.72 0.49 Allowed Glycine 0 CA--C 1.526 0.729 0 O-C-N 121.21 -0.931 . . . . 0.0 112.123 171.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.1 m . . . . . 0 C--O 1.256 1.417 0 C-N-CA 127.42 2.288 . . . . 0.0 110.054 174.516 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 tm? . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . 0.276 4.7 tpt 41.82 75.42 0.62 Allowed Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 127.107 2.163 . . . . 0.0 111.897 157.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -57.65 103.15 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.861 3.04 . . . . 0.0 110.184 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.86 -17.41 7.69 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.204 1.383 . . . . 0.0 113.803 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.71 -31.79 22.27 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 120.388 2.094 . . . . 0.0 112.129 -173.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -60.33 -21.24 61.81 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -57.66 -69.81 0.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.366 1.466 . . . . 0.0 109.043 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.06 -40.48 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.638 1.175 . . . . 0.0 109.962 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.7 mt -55.52 -50.79 69.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.13 0.877 . . . . 0.0 110.047 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.26 -45.08 89.68 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.286 0.635 . . . . 0.0 111.695 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -57.28 -55.28 36.82 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.227 1.011 . . . . 0.0 109.021 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.26 -40.5 94.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.59 0.756 . . . . 0.0 111.049 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -59.22 -58.64 7.76 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.195 1.398 . . . . 0.0 110.017 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -62.1 -28.49 69.66 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.6 m -71.2 -5.66 33.61 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.468 -0.77 . . . . 0.0 112.672 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.83 9.93 71.32 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 119.639 1.109 . . . . 0.0 113.539 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.3 mt -56.03 149.69 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 119.307 1.553 . . . . 0.0 107.192 160.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.64 105.48 16.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 170.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -78.47 149.43 33.2 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.25 0.932 . . . . 0.0 109.065 172.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -139.81 174.16 10.8 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.203 1.801 . . . . 0.0 108.383 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.0 mt -136.31 150.42 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 4.8 t80 -134.5 141.44 46.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 152.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 109' ' ' LYS . 2.6 t -156.07 165.65 35.8 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -76.42 -12.95 60.13 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.189 -0.944 . . . . 0.0 112.882 174.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.45 ' H ' HG23 ' A' ' 107' ' ' THR . 1.5 ttmm -63.98 156.76 26.95 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.149 -0.969 . . . . 0.0 110.063 -174.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.49 -169.97 38.96 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.992 0.806 . . . . 0.0 114.252 -170.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.22 -12.52 9.0 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.949 1.3 . . . . 0.0 112.264 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -61.54 -12.44 15.35 Favored 'General case' 0 C--O 1.224 -0.238 0 O-C-N 119.781 -1.825 . . . . 0.0 112.384 168.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.44 -47.97 83.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 120.712 1.596 . . . . 0.0 107.804 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -56.46 -45.14 81.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.98 1.712 . . . . 0.0 110.098 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 m -67.46 -44.81 77.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.998 0.919 . . . . 0.0 111.209 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.72 -46.0 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.669 1.188 . . . . 0.0 108.308 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mp -57.36 -45.19 84.66 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.702 0.801 . . . . 0.0 110.504 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -49.9 75.53 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.257 1.023 . . . . 0.0 110.358 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.21 -57.5 7.64 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.755 1.622 . . . . 0.0 109.179 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.94 -12.86 61.78 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.785 1.634 . . . . 0.0 112.727 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 88.77 12.51 64.09 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.562 1.077 . . . . 0.0 113.976 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.4 m -119.87 16.27 6.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 125.105 1.362 . . . . 0.0 111.635 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -59.65 -40.6 88.21 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.267 -0.896 . . . . 0.0 113.37 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.03 -11.04 60.41 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.757 0.661 . . . . 0.0 112.486 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -74.71 4.57 6.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.857 1.208 . . . . 0.0 113.269 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -141.28 123.94 16.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -54.36 -45.96 72.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.284 1.434 . . . . 0.0 110.175 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -153.58 142.82 21.47 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.71 100.96 7.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 106' ' ' TYR . 3.5 mm? -76.1 155.23 34.91 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.9 p -140.91 -174.64 4.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.103 1.361 . . . . 0.0 109.848 -171.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 62.4 p -52.36 -24.51 7.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.534 1.061 . . . . 0.0 112.592 168.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -58.47 -35.22 71.84 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.144 1.378 . . . . 0.0 110.349 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.421 ' HB2' ' CD2' ' A' ' 136' ' ' PHE . 80.5 p -57.36 -35.82 70.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.54 -8.01 50.53 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.671 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.421 ' CD2' ' HB2' ' A' ' 134' ' ' SER . 29.5 m-85 -59.57 156.97 12.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.72 1.26 . . . . 0.0 111.087 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.74 HG23 ' HB2' ' A' ' 141' ' ' SER . 2.3 m -52.97 159.18 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.054 1.342 . . . . 0.0 113.398 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -67.53 160.64 27.24 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.585 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -61.09 133.01 92.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 117.258 -1.353 . . . . 0.0 108.744 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.66 135.68 41.4 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 121.33 1.511 . . . . 0.0 110.17 -3.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.74 ' HB2' HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -143.44 85.45 9.47 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -170.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.21 -16.61 22.27 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 N-CA-C 109.23 -1.104 . . . . 0.0 109.23 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -44.52 -49.96 9.76 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 126.857 2.063 . . . . 0.0 110.717 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.55 65.54 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.491 -171.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.4 -41.16 20.27 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.095 -1.628 . . . . 0.0 109.295 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.8 m -58.87 -30.52 67.79 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.902 0.774 . . . . 0.0 111.082 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.578 ' CZ ' ' HE3' ' A' ' 151' ' ' LYS . 34.4 t80 -60.62 -55.68 30.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.884 0.873 . . . . 0.0 109.389 166.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.437 HD12 ' HD1' ' A' ' 147' ' ' TYR . 4.5 mp -58.09 -28.09 64.27 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.705 1.602 . . . . 0.0 113.095 -173.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.7 mt -71.61 -63.97 1.02 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.467 1.507 . . . . 0.0 107.18 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.36 -20.05 65.97 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.273 0.629 . . . . 0.0 112.55 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.578 ' HE3' ' CZ ' ' A' ' 147' ' ' TYR . 12.5 mmtt -51.78 -41.64 61.82 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 121.345 -0.847 . . . . 0.0 111.897 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -144.46 17.28 1.68 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -172.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.6 mm-40 59.9 62.9 1.57 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.867 1.667 . . . . 0.0 110.983 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.89 173.19 6.42 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.347 1.459 . . . . 0.0 109.973 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -116.51 126.28 53.12 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.522 1.529 . . . . 0.0 108.07 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -44.6 77.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.2 1.0 . . . . 0.0 110.454 174.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.76 -9.32 58.51 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.326 -0.859 . . . . 0.0 112.607 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -117.33 17.44 14.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.819 0.848 . . . . 0.0 108.829 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -106.64 130.31 54.4 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 170.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -122.2 97.78 5.63 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.079 1.752 . . . . 0.0 106.802 -170.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -71.85 158.7 35.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.684 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 47.8 mt -130.03 97.62 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 -171.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -120.81 -179.0 16.12 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 125.562 1.554 . . . . 0.0 112.011 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -128.78 -5.48 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.516 1.126 . . . . 0.0 113.405 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -121.16 165.54 15.23 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 122.347 1.07 . . . . 0.0 112.126 -164.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.8 t -63.25 -39.53 94.85 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.992 1.317 . . . . 0.0 110.187 164.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -32.46 72.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.408 1.083 . . . . 0.0 110.421 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.38 8.45 0.61 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.623 1.969 . . . . 0.0 111.824 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -131.39 -25.06 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 125.296 1.439 . . . . 0.0 110.816 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.53 -56.66 19.02 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.665 -1.272 . . . . 0.0 109.344 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -66.5 -29.52 69.64 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.947 -1.095 . . . . 0.0 110.925 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.54 -51.29 67.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -52.76 -52.84 54.95 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 124.386 1.075 . . . . 0.0 111.027 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -52.63 -47.21 67.16 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.354 0.261 . . . . 0.0 111.496 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.8 m -72.79 -26.85 61.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.763 0.825 . . . . 0.0 112.048 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.96 32.54 39.7 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.561 1.553 . . . . 0.0 111.181 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 22.1 pt -109.83 167.61 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 124.985 1.314 . . . . 0.0 109.36 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -97.63 162.54 13.24 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -175.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 23.5 m -135.33 152.75 51.76 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.327 1.451 . . . . 0.0 109.787 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 42.2 mt -131.84 95.37 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -129.56 149.97 51.1 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.309 1.044 . . . . 0.0 109.117 -165.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -70.7 -12.28 61.46 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.071 -1.018 . . . . 0.0 113.542 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.37 151.64 47.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.658 1.583 . . . . 0.0 109.594 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -78.4 154.95 30.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.4 t -144.11 13.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.387 0.675 . . . . 0.0 110.946 -174.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 71.0 p 57.06 69.66 0.72 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.939 2.096 . . . . 0.0 110.406 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -150.78 135.19 17.07 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.402 1.081 . . . . 0.0 108.405 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -70.12 -7.08 38.61 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -108.19 8.08 35.47 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.297 1.427 . . . . 0.0 112.954 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -108.94 122.06 46.42 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 120.788 2.294 . . . . 0.0 110.437 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -101.21 119.17 38.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.364 1.065 . . . . 0.0 109.427 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -67.61 146.59 53.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.431 0.56 . . . . 0.0 111.273 171.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.2 pt -146.04 175.75 2.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 127.296 2.239 . . . . 0.0 109.594 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -136.38 -12.41 1.84 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.436 1.494 . . . . 0.0 113.142 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.15 160.8 39.14 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.148 1.379 . . . . 0.0 108.075 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.36 -31.8 73.15 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.231 1.412 . . . . 0.0 110.503 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.22 -9.18 51.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -19.02 61.0 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.384 0.993 . . . . 0.0 110.409 172.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 67.8 mt -55.86 -52.85 44.5 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.6 p -60.26 -35.67 76.05 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.113 0.415 . . . . 0.0 111.688 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -62.62 -36.28 82.27 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.876 0.871 . . . . 0.0 112.226 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.3 mt -59.37 -44.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 124.289 1.036 . . . . 0.0 108.8 -172.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -84.86 13.17 6.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.534 1.134 . . . . 0.0 112.55 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.73 16.39 4.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.295 1.438 . . . . 0.0 110.362 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.285 5.7 t -154.34 47.62 0.59 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.327 0.967 . . . . 0.0 112.025 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 40.4 pttt . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.719 2.008 . . . . 0.0 111.11 -175.082 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.707 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 25.2 p80 44.3 55.36 5.62 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.926 1.69 . . . . 0.0 112.483 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.2 mmm -117.17 96.7 5.56 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 102.306 -3.22 . . . . 0.0 102.306 168.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -169.36 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 112.551 -2.113 . . . . 0.0 110.625 158.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -50.22 115.0 1.24 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 156.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.6 m -131.52 157.77 42.68 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 163.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.95 150.71 51.97 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.878 -0.514 . . . . 0.0 109.683 165.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.66 149.28 52.32 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 126.273 1.829 . . . . 0.0 108.156 -173.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.0 mt -142.12 145.65 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -125.22 174.51 8.05 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.086 1.755 . . . . 0.0 109.979 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 -11.2 9.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.561 1.544 . . . . 0.0 111.723 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.3 tp 71.91 9.91 6.16 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 128.437 2.695 . . . . 0.0 112.603 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.69 8.79 4.94 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -159.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.99 -79.16 0.05 OUTLIER Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 172.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.251 1.14 0 CA-C-O 117.765 -1.112 . . . . 0.0 108.346 161.199 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.424 ' N ' HD13 ' A' ' 85' ' ' LEU 0.51 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 62.3 tpp 45.27 81.47 0.25 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.909 1.283 . . . . 0.0 111.44 -165.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -61.23 103.39 0.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.46 2.773 . . . . 0.0 109.702 -176.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.25 -35.77 0.19 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 128.424 2.916 . . . . 0.0 107.667 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.33 -15.01 31.98 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -169.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -67.0 -25.31 66.24 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.39 -1.444 . . . . 0.0 114.266 -167.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.04 -53.94 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.108 0.563 . . . . 0.0 110.592 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.8 t -68.63 -34.95 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.713 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.832 HD23 ' CD2' ' A' ' 125' ' ' TYR . 7.4 mp -44.49 -50.51 9.43 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 121.529 1.968 . . . . 0.0 113.374 164.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.92 -50.47 64.32 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 124.15 0.906 . . . . 0.0 109.782 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -53.36 -50.53 64.88 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 123.836 0.71 . . . . 0.0 110.358 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.04 -39.79 82.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.314 1.046 . . . . 0.0 111.822 -177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -71.96 -41.52 67.64 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 118.455 0.571 . . . . 0.0 110.719 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -64.17 -28.56 69.84 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.508 -0.745 . . . . 0.0 111.547 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.5 m -76.49 -13.0 60.13 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.002 0.921 . . . . 0.0 112.235 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.62 37.38 75.82 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.027 1.299 . . . . 0.0 112.003 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.6 mt -68.12 121.85 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 159.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -68.08 113.6 5.88 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 170.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -94.13 144.13 25.76 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.406 1.482 . . . . 0.0 107.686 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -143.97 177.83 8.28 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.242 1.017 . . . . 0.0 109.298 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.9 mt -135.83 150.52 28.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 124.074 0.95 . . . . 0.0 108.591 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -133.24 113.16 12.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 156.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -133.06 175.52 9.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.315 1.446 . . . . 0.0 109.178 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . 0.274 2.1 p80 -125.99 22.42 7.35 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -72.42 -0.81 13.49 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.16 -177.9 38.42 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.912 1.244 . . . . 0.0 111.793 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -72.27 -2.77 20.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -162.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -70.85 -10.22 59.16 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.741 164.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.96 -52.96 17.62 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.731 1.212 . . . . 0.0 111.335 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -59.47 -44.79 92.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.055 0.542 . . . . 0.0 110.114 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -62.82 -40.82 98.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.938 1.295 . . . . 0.0 111.123 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.7 mt -63.64 -50.75 76.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.33 -38.93 92.78 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.57 -0.706 . . . . 0.0 111.324 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -63.51 -46.02 88.01 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.6 0.76 . . . . 0.0 110.379 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -48.68 -50.42 33.32 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.985 1.374 . . . . 0.0 110.111 172.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.4 mt -69.46 -18.67 63.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.844 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.99 33.32 69.97 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.869 0.759 . . . . 0.0 111.985 174.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.1 m -137.19 22.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 126.361 1.864 . . . . 0.0 108.841 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.81 -42.18 81.93 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.051 -0.405 . . . . 0.0 110.218 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.2 m -58.83 -24.27 61.78 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.935 0.772 . . . . 0.0 112.171 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.832 ' CD2' HD23 ' A' ' 93' ' ' LEU . 26.0 m-85 -68.47 6.35 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.123 1.369 . . . . 0.0 113.986 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -140.91 105.94 4.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 47.6 m -55.16 -41.32 71.7 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.521 1.528 . . . . 0.0 111.056 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -150.87 147.26 27.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.74 96.87 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -167.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.97 145.79 48.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.1 p -123.88 -176.26 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.493 1.117 . . . . 0.0 110.323 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.9 t -48.78 -34.88 13.13 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.273 1.429 . . . . 0.0 110.411 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -82.3 -2.58 53.14 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.286 1.434 . . . . 0.0 112.319 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 83.9 p -57.07 -63.13 1.31 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.304 1.411 . . . . 0.0 110.299 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 123.2 -16.0 8.16 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 125.598 1.57 . . . . 0.0 112.643 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -58.63 166.83 1.68 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.049 1.425 . . . . 0.0 112.83 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.484 HG23 ' CB ' ' A' ' 141' ' ' SER . 16.3 m -60.57 160.75 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.916 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.4 mtt-85 -84.89 147.71 26.63 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.061 -1.649 . . . . 0.0 109.01 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -48.44 131.79 13.38 Favored Pre-proline 0 C--O 1.243 0.743 0 CA-C-O 117.4 -1.286 . . . . 0.0 109.949 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.27 125.82 7.19 Favored 'Cis proline' 0 C--N 1.351 0.691 0 CA-C-N 121.018 1.399 . . . . 0.0 111.696 -3.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.484 ' CB ' HG23 ' A' ' 137' ' ' VAL . 10.4 p -141.94 85.43 11.12 Favored Pre-proline 0 N--CA 1.438 -1.026 0 C-N-CA 123.292 0.637 . . . . 0.0 111.893 -173.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.69 -18.51 32.57 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.376 . . . . 0.0 112.561 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -45.3 -43.84 11.0 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.285 1.834 . . . . 0.0 112.686 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.63 -7.6 21.67 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.537 0.939 . . . . 0.0 113.537 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.01 -61.05 1.93 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.046 0.938 . . . . 0.0 108.737 163.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.8 m -56.22 -40.29 73.85 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.475 1.91 . . . . 0.0 110.466 -170.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -53.91 -51.25 64.34 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.572 0.749 . . . . 0.0 110.907 174.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.51 -27.98 51.97 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.832 0.853 . . . . 0.0 112.159 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.49 -59.93 4.26 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -67.76 -22.41 65.21 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -61.13 -48.91 79.47 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.788 -1.195 . . . . 0.0 112.438 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -121.63 18.19 11.19 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.078 0.854 . . . . 0.0 112.013 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 54.07 51.96 13.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.335 1.854 . . . . 0.0 111.219 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.33 170.3 15.51 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.371 1.469 . . . . 0.0 110.224 175.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -105.73 130.25 53.78 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.038 1.735 . . . . 0.0 108.288 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 m -58.02 -29.47 65.34 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.261 0.937 . . . . 0.0 110.877 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.52 -27.83 23.75 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -84.84 -0.94 55.69 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -99.64 138.74 36.3 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.143 0.883 . . . . 0.0 108.654 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.444 ' CD1' ' HB2' ' A' ' 178' ' ' GLN . 92.6 m-85 -120.15 166.16 13.8 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.871 1.669 . . . . 0.0 107.554 173.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -139.39 157.25 46.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.455 1.902 . . . . 0.0 107.02 168.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 5.0 mt -135.82 128.73 47.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -161.72 10.01 0.11 Allowed Glycine 0 C--O 1.224 -0.482 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.026 -174.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . 0.293 1.5 p30 60.86 -1.85 0.22 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 129.799 3.24 . . . . 0.0 115.862 163.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -113.36 168.27 9.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.974 0.806 . . . . 0.0 112.858 -168.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.1 t -59.22 -35.39 73.56 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.077 -1.015 . . . . 0.0 111.642 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.727 HD12 ' CE1' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -66.94 -13.44 61.8 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.37 1.468 . . . . 0.0 112.419 -178.026 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.42 -39.15 88.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.634 0.731 . . . . 0.0 111.595 -167.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.91 -45.86 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 125.022 1.329 . . . . 0.0 108.655 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.526 ' HB2' HD13 ' A' ' 167' ' ' LEU . 59.8 mm-40 -59.81 -41.18 90.69 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.021 0.929 . . . . 0.0 110.938 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.727 ' CE1' HD12 ' A' ' 167' ' ' LEU . 19.5 m-85 -64.22 -51.81 61.87 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.229 0.922 . . . . 0.0 110.829 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.19 97.51 Favored 'General case' 0 C--O 1.224 -0.287 0 O-C-N 123.577 0.548 . . . . 0.0 111.259 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -62.78 -28.89 70.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.322 0.649 . . . . 0.0 111.81 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -60.04 -46.8 88.34 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.486 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.33 -23.36 32.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.879 1.672 . . . . 0.0 113.318 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 90.0 10.39 64.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.499 2.0 . . . . 0.0 113.847 -175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 23.7 pt -81.79 -173.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.221 1.51 . . . . 0.0 110.163 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.444 ' HB2' ' CD1' ' A' ' 160' ' ' TYR . 23.9 mm-40 -101.17 161.75 13.39 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.287 1.035 . . . . 0.0 110.419 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.05 160.58 40.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.885 1.274 . . . . 0.0 113.419 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.8 mt -142.9 83.34 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.823 1.649 . . . . 0.0 108.845 -172.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -97.66 -171.41 2.18 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.994 -1.066 . . . . 0.0 110.62 173.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -99.74 -5.9 27.95 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.514 -1.366 . . . . 0.0 112.704 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.677 HD22 ' H ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -112.61 137.58 50.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -176.576 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.96 162.04 29.97 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.958 1.703 . . . . 0.0 109.626 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 34.7 t -155.77 157.87 37.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 10.2 p -85.91 19.64 2.49 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.603 1.161 . . . . 0.0 111.795 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -67.82 -178.62 0.99 Allowed 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.612 -0.68 . . . . 0.0 110.27 168.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.04 5.5 7.93 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -165.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.92 23.39 1.01 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.1 1.81 . . . . 0.0 111.52 167.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -81.92 149.56 28.17 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 120.794 -1.415 . . . . 0.0 108.882 160.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -142.29 99.36 3.49 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.166 0.586 . . . . 0.0 109.612 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -73.93 162.63 28.86 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 118.438 -1.305 . . . . 0.0 112.035 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 6.7 pt -135.31 169.31 21.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.403 1.881 . . . . 0.0 110.099 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.57 -2.9 11.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.95 1.3 . . . . 0.0 112.862 168.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.56 167.52 28.34 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.852 1.261 . . . . 0.0 109.079 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 196' ' ' LEU . 7.5 tp -76.08 -40.39 53.2 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -173.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.48 -18.86 64.23 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.52 -11.24 60.17 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.811 0.844 . . . . 0.0 111.027 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.39 -55.62 23.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-O 117.835 -1.079 . . . . 0.0 108.484 166.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.2 m -54.27 -38.88 66.33 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.621 1.101 . . . . 0.0 110.158 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -64.14 -25.98 68.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.1 mt -56.44 -48.19 80.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -78.85 -41.07 30.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.436 1.094 . . . . 0.0 109.89 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.85 49.2 1.68 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.67 1.988 . . . . 0.0 109.276 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 3.2 m 45.35 68.16 0.61 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.252 2.221 . . . . 0.0 113.428 165.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? . . . . . 0 C--O 1.249 1.067 0 C-N-CA 129.997 3.319 . . . . 0.0 113.822 160.643 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.936 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -117.92 83.06 1.93 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.633 1.173 . . . . 0.0 108.374 -174.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mmm -107.49 73.36 0.91 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 122.846 1.308 . . . . 0.0 107.478 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.35 114.59 28.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 113.985 -1.461 . . . . 0.0 107.588 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.53 83.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.329 1.852 . . . . 0.0 111.368 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 m -124.08 135.11 53.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.8 150.26 31.9 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 170.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -126.49 150.91 48.45 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.291 1.436 . . . . 0.0 108.464 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -138.56 135.47 43.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -125.8 163.05 23.73 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.841 2.057 . . . . 0.0 109.999 -169.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -86.51 -29.92 22.35 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.851 2.06 . . . . 0.0 112.491 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 45.53 58.49 4.2 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.615 1.566 . . . . 0.0 111.195 -167.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.82 -58.2 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 117.855 -1.069 . . . . 0.0 110.503 164.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.44 148.45 18.96 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 120.234 1.379 . . . . 0.0 112.761 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.818 0 C-N-CA 126.979 2.111 . . . . 0.0 109.386 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.457 HD21 HG21 ' A' ' 122' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -105.0 86.85 1.64 Allowed Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.674 1.59 . . . . 0.0 109.433 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -56.63 111.95 0.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.46 2.107 . . . . 0.0 108.118 166.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.37 -15.07 8.71 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 117.938 -1.479 . . . . 0.0 113.251 -170.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.6 -19.47 10.56 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -65.49 -30.08 70.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.676 1.125 . . . . 0.0 112.301 -175.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.46 -55.63 31.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.818 0.847 . . . . 0.0 110.489 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.47 -42.14 94.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.33 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.619 HD23 ' CD2' ' A' ' 125' ' ' TYR . 6.6 mp -44.55 -52.85 7.65 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 121.645 2.021 . . . . 0.0 112.544 168.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.69 80.68 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.588 1.18 . . . . 0.0 110.957 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -58.63 -46.66 86.61 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.101 0.96 . . . . 0.0 111.421 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.51 -38.0 68.21 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.293 -0.861 . . . . 0.0 112.418 -172.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.52 -40.75 93.33 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.945 0.793 . . . . 0.0 109.752 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -52.03 -54.74 26.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.639 1.176 . . . . 0.0 109.021 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.3 m -74.0 4.77 4.97 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 60.31 24.79 61.76 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.659 1.118 . . . . 0.0 113.151 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.4 mt -71.3 108.22 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 127.032 2.133 . . . . 0.0 107.47 169.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 2.8 pt20 -65.84 103.18 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.996 0.518 . . . . 0.0 110.165 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -84.8 151.58 24.25 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -145.32 169.64 17.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.943 1.697 . . . . 0.0 109.803 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 22.3 mt -138.79 157.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.774 1.629 . . . . 0.0 110.698 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -137.46 115.77 11.84 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.027 0.931 . . . . 0.0 109.383 163.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -134.42 161.07 36.04 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.454 1.502 . . . . 0.0 108.547 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -88.28 -2.43 58.6 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.283 1.033 . . . . 0.0 110.896 170.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.09 147.87 11.99 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.853 1.661 . . . . 0.0 108.233 172.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.95 -171.59 28.48 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 123.642 0.639 . . . . 0.0 111.616 -170.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -58.7 -22.38 57.18 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.787 -0.831 . . . . 0.0 111.432 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -57.6 -17.37 13.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.727 1.211 . . . . 0.0 114.008 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.79 -49.01 66.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.606 1.548 . . . . 0.0 111.123 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -59.55 -42.2 91.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.17 0.588 . . . . 0.0 110.233 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -62.79 -46.01 89.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.451 1.1 . . . . 0.0 110.906 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 39.6 mt -59.84 -45.61 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 124.421 1.088 . . . . 0.0 108.824 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -57.29 -44.98 84.53 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.463 0.705 . . . . 0.0 111.29 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -48.48 81.61 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.913 0.485 . . . . 0.0 110.267 174.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -51.05 -52.78 39.83 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.747 1.219 . . . . 0.0 110.473 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.47 -3.67 32.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.145 1.778 . . . . 0.0 113.307 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.25 32.98 84.57 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.751 1.167 . . . . 0.0 112.645 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.457 HG21 HD21 ' A' ' 85' ' ' LEU . 35.7 m -124.54 23.59 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.977 0.911 . . . . 0.0 109.706 174.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -48.54 76.85 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.035 -1.04 . . . . 0.0 110.304 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.9 m -70.87 -19.01 62.67 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.619 ' CD2' HD23 ' A' ' 93' ' ' LEU . 21.0 m-85 -66.17 -0.51 2.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 117.132 -1.414 . . . . 0.0 113.638 167.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -139.84 105.06 5.03 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 121.665 2.03 . . . . 0.0 108.97 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.4 m -51.73 -40.79 60.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.933 1.693 . . . . 0.0 112.254 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -157.28 145.55 19.35 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 -172.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.05 131.04 45.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -85.18 151.87 23.77 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 167.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.2 p -137.17 -168.3 2.26 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.608 1.563 . . . . 0.0 110.208 -172.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.4 t -53.78 -26.55 24.26 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.497 -1.377 . . . . 0.0 112.975 167.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -61.03 -33.92 74.05 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.983 0.896 . . . . 0.0 109.168 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.9 m -85.31 69.83 10.77 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 129.07 2.948 . . . . 0.0 104.793 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.51 44.59 1.99 Allowed Glycine 0 CA--C 1.522 0.494 0 CA-C-O 118.693 -1.059 . . . . 0.0 111.324 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -67.22 174.45 3.21 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 124.602 2.144 . . . . 0.0 112.191 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.8 t -76.75 157.64 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 128.261 2.624 . . . . 0.0 110.6 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -72.25 166.34 22.62 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.397 1.479 . . . . 0.0 110.467 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 mmpm? -73.04 149.02 89.5 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 120.36 -1.463 . . . . 0.0 107.967 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.88 -4.99 32.51 Favored 'Cis proline' 0 CA--C 1.533 0.434 0 N-CA-C 115.842 1.439 . . . . 0.0 115.842 11.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.2 t -43.09 91.39 0.05 OUTLIER Pre-proline 0 C--O 1.241 0.655 0 C-N-CA 127.366 2.266 . . . . 0.0 114.576 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.84 6.94 0.05 OUTLIER 'Trans proline' 0 CA--C 1.556 1.616 1 C-N-CA 128.068 5.845 . . . . 0.0 114.64 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -43.74 -71.65 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.333 2.653 . . . . 0.0 112.236 -172.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.8 -16.39 40.18 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -175.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.35 -54.82 6.21 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 119.68 1.127 . . . . 0.0 108.552 171.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 m -53.06 -38.72 62.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.665 1.186 . . . . 0.0 110.605 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -52.04 -50.38 61.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.346 1.058 . . . . 0.0 110.715 174.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.73 -35.85 72.89 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.302 1.041 . . . . 0.0 111.406 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.27 -58.44 8.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -64.47 -29.18 70.23 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.345 1.069 . . . . 0.0 111.758 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -63.77 -27.41 69.17 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.164 -1.585 . . . . 0.0 114.842 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.42 ' HB3' HD13 ' A' ' 154' ' ' LEU . 2.7 t80 -141.6 8.73 1.97 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.994 0.816 . . . . 0.0 111.862 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 55.43 74.1 0.39 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.709 1.604 . . . . 0.0 109.634 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.42 HD13 ' HB3' ' A' ' 152' ' ' TYR . 5.1 mp -101.14 178.19 4.73 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.846 1.259 . . . . 0.0 109.536 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -109.07 130.91 55.49 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 159' ' ' THR . 0.7 OUTLIER -44.84 -53.77 7.13 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 124.579 1.175 . . . . 0.0 108.678 173.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -76.48 -20.88 56.53 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 125.741 1.616 . . . . 0.0 112.732 -159.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -90.53 4.13 52.03 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.679 0.792 . . . . 0.0 109.943 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 156' ' ' SER . 1.2 t -92.93 162.06 14.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.791 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -146.65 118.01 7.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.694 0.797 . . . . 0.0 109.133 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -82.83 155.33 24.22 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.084 0.402 . . . . 0.0 110.33 167.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.6 mp -127.61 114.32 35.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.826 1.25 . . . . 0.0 107.94 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.74 158.64 31.61 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 123.469 0.48 . . . . 0.0 112.254 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.44 3.29 34.82 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -163.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -101.69 164.75 11.58 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.05 1.295 . . . . 0.0 111.581 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 6.5 t -72.57 -14.6 61.66 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.665 -0.647 . . . . 0.0 112.295 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -16.24 48.2 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.811 0.732 . . . . 0.0 110.023 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -78.01 11.41 2.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.178 1.791 . . . . 0.0 112.235 -173.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.1 p -120.76 -19.82 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.483 1.513 . . . . 0.0 110.922 170.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.9 -38.87 89.87 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 120.729 -1.232 . . . . 0.0 110.221 -171.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -78.87 -28.9 44.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.301 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.84 -51.45 69.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -50.88 -42.15 58.81 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.048 1.339 . . . . 0.0 112.136 171.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -50.29 63.0 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.649 -0.657 . . . . 0.0 111.241 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 8.6 t -69.78 -17.85 63.44 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.709 0.803 . . . . 0.0 110.769 174.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.47 33.49 38.85 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.86 2.171 . . . . 0.0 112.525 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.46 171.58 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.591 1.557 . . . . 0.0 111.908 -165.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -92.06 154.57 18.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.715 1.206 . . . . 0.0 111.964 -173.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.7 m -136.46 151.54 49.58 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.198 1.399 . . . . 0.0 110.275 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 46.3 mt -123.6 111.67 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.71 160.26 31.3 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 123.535 0.734 . . . . 0.0 109.027 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -79.63 -16.91 54.94 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.503 -1.373 . . . . 0.0 111.723 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.24 160.93 19.75 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 128.192 2.597 . . . . 0.0 108.655 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -61.22 156.48 18.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.8 m -149.34 22.12 0.94 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.444 1.098 . . . . 0.0 111.184 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 73.7 p 52.29 46.81 25.98 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.966 0.906 . . . . 0.0 111.625 158.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -145.66 176.96 9.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.423 1.489 . . . . 0.0 108.572 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -102.06 -20.64 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.269 1.028 . . . . 0.0 112.447 -177.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -106.57 0.0 37.05 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.211 1.386 . . . . 0.0 111.816 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.72 152.29 22.25 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 119.606 1.703 . . . . 0.0 109.411 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -127.69 148.15 50.4 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.511 1.124 . . . . 0.0 108.539 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -85.87 153.51 22.18 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.487 0.585 . . . . 0.0 112.253 166.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.5 169.26 17.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 126.366 1.866 . . . . 0.0 110.244 168.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.3 -9.29 8.09 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.547 1.539 . . . . 0.0 112.827 170.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.51 167.85 29.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.259 1.424 . . . . 0.0 108.56 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.3 tp -69.52 -37.93 77.34 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.28 -15.09 59.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -69.64 -21.12 63.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.409 0.55 . . . . 0.0 109.786 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 86.3 mt -58.53 -59.04 4.16 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 125.411 1.485 . . . . 0.0 108.433 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.0 m -55.7 -39.94 71.72 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.709 0.686 . . . . 0.0 110.86 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -59.9 -33.3 71.67 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.888 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.6 mt -55.34 -47.55 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 119.664 1.12 . . . . 0.0 109.433 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.65 -18.21 51.96 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -108.41 17.3 22.27 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.272 1.829 . . . . 0.0 111.923 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 92.5 m 56.78 81.87 0.13 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.072 2.149 . . . . 0.0 111.931 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? . . . . . 0 C--O 1.245 0.859 0 CA-C-N 112.868 -1.969 . . . . 0.0 111.647 144.77 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.774 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -159.52 77.4 0.69 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.558 1.943 . . . . 0.0 107.212 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm -126.12 84.18 2.24 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -62.98 -164.8 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.716 1.206 . . . . 0.0 109.864 167.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 69.91 0.07 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.887 1.675 . . . . 0.0 112.178 -176.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.4 m -81.17 153.37 27.26 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.41 147.99 45.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.11 152.94 43.73 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.2 mt -127.99 173.92 12.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 163.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -145.4 164.4 31.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.945 0.898 . . . . 0.0 109.142 167.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -93.01 -24.8 18.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.303 1.441 . . . . 0.0 113.647 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.7 tp 60.77 -23.86 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 129.205 3.002 . . . . 0.0 115.814 -174.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.74 -38.03 6.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.98 0.809 . . . . 0.0 111.244 -166.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.55 -89.83 1.06 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 164.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.249 1.063 0 C-N-CA 125.458 1.503 . . . . 0.0 111.345 -178.591 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.695 ' O ' HD13 ' A' ' 85' ' ' LEU . 1.9 tm? . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 8.2 tpt 44.55 75.78 0.61 Allowed Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -165.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -56.53 109.24 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.9 3.066 . . . . 0.0 109.962 -170.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.25 -29.76 2.59 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.877 0.751 . . . . 0.0 111.602 -161.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.56 -37.67 35.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.341 -1.093 . . . . 0.0 110.017 -176.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.478 ' CG ' HD11 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -55.82 -23.19 28.92 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -174.03 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.43 -57.03 6.47 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.661 0.784 . . . . 0.0 110.575 170.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.6 t -53.88 -44.07 59.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 123.604 0.761 . . . . 0.0 109.466 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.1 mt -56.0 -49.33 73.95 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.161 0.891 . . . . 0.0 110.532 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.7 73.97 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.149 0.58 . . . . 0.0 110.95 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -53.31 -46.97 69.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.774 1.23 . . . . 0.0 111.149 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.81 -45.85 66.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.112 1.365 . . . . 0.0 111.323 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -59.97 -48.58 81.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.165 1.386 . . . . 0.0 110.464 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.1 -42.1 80.16 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.569 0.748 . . . . 0.0 110.242 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.6 m -69.76 -6.56 32.9 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.216 1.006 . . . . 0.0 113.67 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.23 -5.57 84.87 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.575 1.56 . . . . 0.0 114.33 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mt -53.36 118.61 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 128.39 2.676 . . . . 0.0 110.268 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -68.15 101.05 1.09 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.368 1.067 . . . . 0.0 108.252 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -84.9 148.81 26.06 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -141.18 179.19 6.9 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.618 1.567 . . . . 0.0 107.525 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.1 mt -131.73 143.74 39.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 167.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -128.52 109.21 11.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 166.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -141.68 150.91 42.49 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -171.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -77.56 -1.95 33.22 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.504 -0.747 . . . . 0.0 112.343 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -63.31 164.22 9.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.043 0.937 . . . . 0.0 110.233 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.47 -176.25 49.61 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -55.58 -25.59 39.07 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.603 0.761 . . . . 0.0 111.74 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -16.81 11.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.752 -1.218 . . . . 0.0 112.576 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.68 -36.59 74.43 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.724 1.147 . . . . 0.0 112.153 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -60.79 -53.88 51.98 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -59.05 -41.49 88.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.519 1.528 . . . . 0.0 111.173 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.94 -50.72 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.748 0.819 . . . . 0.0 109.421 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mp -58.83 -47.87 83.31 Favored 'General case' 0 C--O 1.228 -0.074 0 O-C-N 121.487 -0.758 . . . . 0.0 110.757 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -56.81 -46.48 81.59 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.723 0.809 . . . . 0.0 110.145 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -54.93 -52.22 63.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.184 1.394 . . . . 0.0 109.939 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.42 -7.01 39.87 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.029 1.332 . . . . 0.0 113.592 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.48 28.71 63.03 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.385 0.993 . . . . 0.0 112.469 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.7 m -128.79 28.74 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 124.82 1.248 . . . . 0.0 111.175 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.49 -57.61 12.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.533 1.133 . . . . 0.0 112.004 172.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.7 m -73.22 -22.41 60.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.19 0.596 . . . . 0.0 111.615 -165.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.29 -29.57 58.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.86 -0.59 . . . . 0.0 112.564 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -109.17 110.93 22.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 66.5 m -46.77 -47.74 20.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.147 1.379 . . . . 0.0 109.123 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.47 159.25 42.59 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.74 134.92 65.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 171.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.6 mt -99.01 151.08 21.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 42.4 p -145.55 174.3 11.28 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.561 1.544 . . . . 0.0 107.636 -170.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.2 t -57.51 -13.45 3.72 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 121.215 -0.928 . . . . 0.0 113.272 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -59.31 -48.33 82.03 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.387 1.475 . . . . 0.0 109.197 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 95.8 p -54.54 -36.97 64.86 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.204 1.802 . . . . 0.0 113.037 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.03 -4.87 78.96 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.394 -1.226 . . . . 0.0 114.8 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -50.74 158.71 0.62 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.627 1.213 . . . . 0.0 112.438 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 141' ' ' SER . 18.6 m -52.93 154.8 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 122.903 1.335 . . . . 0.0 112.296 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -85.55 160.38 19.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.241 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 136.93 87.25 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.621 -1.181 . . . . 0.0 108.865 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.25 122.35 7.89 Favored 'Cis proline' 0 N--CA 1.454 -0.805 0 CA-C-N 120.755 1.305 . . . . 0.0 110.732 -0.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.402 ' HA ' HG23 ' A' ' 137' ' ' VAL . 12.0 p -123.32 85.6 51.96 Favored Pre-proline 0 N--CA 1.446 -0.666 0 C-N-CA 125.252 1.421 . . . . 0.0 111.283 -163.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.14 -27.51 8.17 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.709 2.273 . . . . 0.0 113.441 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -53.8 -54.68 34.98 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.364 -0.835 . . . . 0.0 112.191 -166.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.0 -7.75 43.42 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.231 -0.918 . . . . 0.0 113.038 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.97 -48.4 11.5 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 m -55.62 -41.49 73.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.533 1.133 . . . . 0.0 109.946 171.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -58.45 -58.54 8.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.873 0.869 . . . . 0.0 109.996 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -67.12 -19.74 65.66 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.124 0.97 . . . . 0.0 112.855 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -63.14 1.14 Allowed 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 173.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.07 -22.92 65.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.31 -26.46 66.56 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 120.898 -1.126 . . . . 0.0 113.34 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.417 ' HB3' HD13 ' A' ' 154' ' ' LEU . 13.0 t80 -148.69 23.07 1.0 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.451 1.023 . . . . 0.0 112.232 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 50.14 67.2 0.95 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.584 1.553 . . . . 0.0 111.576 -174.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 152' ' ' TYR . 4.5 mp -100.23 170.7 8.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.791 1.282 . . . . 0.0 111.024 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.81 123.14 42.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.861 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 m -59.92 -39.31 85.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.17 1.388 . . . . 0.0 110.816 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -83.25 -13.2 55.79 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.167 -0.958 . . . . 0.0 112.997 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -109.86 13.41 23.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -92.25 149.42 21.47 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -141.43 113.84 8.19 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -73.15 -40.87 64.51 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.0 mp 56.17 99.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 126.461 1.904 . . . . 0.0 111.73 -169.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -122.96 -171.86 13.78 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.87 148.09 32.49 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 169.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER 58.23 171.12 0.05 Allowed 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 126.595 1.958 . . . . 0.0 114.461 -165.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.49 169.91 1.57 Allowed 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 127.382 2.273 . . . . 0.0 110.119 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 tm? 68.4 -27.1 0.14 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 130.409 3.484 . . . . 0.0 113.339 -164.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -73.63 8.11 2.06 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.726 1.603 . . . . 0.0 114.413 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.54 -13.03 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.0 -1.062 . . . . 0.0 110.823 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -66.52 -40.75 89.31 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.711 -1.243 . . . . 0.0 111.026 -173.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -69.22 -32.74 72.19 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.287 -0.883 . . . . 0.0 111.516 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.28 -45.94 89.09 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.458 0.572 . . . . 0.0 109.52 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -49.89 -53.05 28.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.69 0.796 . . . . 0.0 110.622 168.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -58.25 -47.65 82.9 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.9 m -69.58 -20.79 63.65 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.573 1.079 . . . . 0.0 112.265 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.02 58.59 10.36 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -167.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.8 pt -130.36 169.91 20.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.27 1.428 . . . . 0.0 109.065 173.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -96.27 167.74 11.0 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.838 0.855 . . . . 0.0 110.938 -172.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 11.8 m -147.6 158.72 44.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.568 1.547 . . . . 0.0 111.033 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.8 mt -131.74 124.93 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 168.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -144.6 155.73 43.78 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -69.36 -26.46 64.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.169 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.86 156.96 32.18 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.255 0.934 . . . . 0.0 111.851 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.43 165.25 6.32 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.421 1.105 . . . . 0.0 109.971 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 29.7 t -145.19 172.89 12.47 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 161.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 21.8 p -69.93 24.63 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.202 2.201 . . . . 0.0 113.365 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -133.96 108.02 8.15 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.26 1.424 . . . . 0.0 108.071 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -69.58 -16.67 63.45 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.755 1.222 . . . . 0.0 113.781 -166.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -51.52 -53.31 29.27 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 168.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -53.19 114.56 1.51 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.996 2.119 . . . . 0.0 113.778 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -79.32 118.22 21.03 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.802 0.841 . . . . 0.0 111.052 -176.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -67.14 142.56 57.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.05 0.386 . . . . 0.0 111.514 169.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.6 pt -141.93 168.65 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 126.632 1.973 . . . . 0.0 111.511 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -128.1 -6.09 5.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.476 1.51 . . . . 0.0 111.941 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.13 157.59 40.59 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.777 1.231 . . . . 0.0 108.306 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.73 -34.15 73.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -55.32 -34.95 64.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.355 0.662 . . . . 0.0 112.385 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -64.9 -17.67 64.53 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.327 0.651 . . . . 0.0 111.397 -174.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.2 mt -50.44 -61.6 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.362 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 87.8 p -55.38 -34.71 64.57 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.76 0.791 . . . . 0.0 110.698 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -74.45 -25.62 59.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.241 1.416 . . . . 0.0 112.722 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 61.5 mt -53.54 -60.14 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -70.63 8.93 0.73 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.656 1.982 . . . . 0.0 113.792 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -121.19 -2.48 9.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.373 1.469 . . . . 0.0 112.32 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.09 61.66 1.02 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.331 0.652 . . . . 0.0 109.601 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.282 17.2 ptpt . . . . . 0 C--O 1.246 0.903 0 C-N-CA 129.497 3.119 . . . . 0.0 112.496 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.555 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -132.72 99.42 4.61 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.768 1.227 . . . . 0.0 108.004 173.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm -132.61 95.26 3.57 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -60.01 176.76 0.29 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.129 161.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -53.17 82.74 0.0 OUTLIER 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.09 2.156 . . . . 0.0 111.455 172.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.4 m -100.17 153.8 18.96 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.68 150.69 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.139 -0.976 . . . . 0.0 109.314 171.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.97 149.68 51.59 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 126.597 1.959 . . . . 0.0 107.881 -169.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.6 mt -141.92 132.31 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -117.07 167.85 10.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.557 1.543 . . . . 0.0 110.285 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -121.5 -12.8 8.5 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -167.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.02 -5.82 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.902 2.481 . . . . 0.0 116.818 174.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -129.36 32.22 4.71 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.811 1.645 . . . . 0.0 109.945 -167.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.6 -75.76 0.04 OUTLIER Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 C--O 1.246 0.904 0 C-N-CA 124.896 1.278 . . . . 0.0 110.778 168.83 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 86' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.562 ' H ' HD13 ' A' ' 85' ' ' LEU . 33.0 ttm -122.3 85.92 47.56 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 126.621 1.968 . . . . 0.0 107.686 -170.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.16 94.19 0.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.589 2.86 . . . . 0.0 110.198 -172.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 145.73 -9.22 1.6 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-O 117.273 -1.849 . . . . 0.0 113.009 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.34 -40.45 4.66 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.539 2.336 . . . . 0.0 114.573 -168.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.664 ' HA ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -55.88 -28.3 55.94 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.229 1.012 . . . . 0.0 113.295 -176.348 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -54.32 -64.83 0.7 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.269 1.428 . . . . 0.0 110.289 173.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.2 t -59.28 -44.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.506 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 90' ' ' ARG . 77.1 mt -52.04 -45.76 64.8 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 119.025 0.83 . . . . 0.0 110.307 -176.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.21 -48.21 58.08 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.094 0.558 . . . . 0.0 111.62 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.3 t90 -54.39 -37.77 65.4 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.7 0.8 . . . . 0.0 110.654 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.63 -42.77 27.92 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.456 1.502 . . . . 0.0 112.379 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -58.17 -51.06 71.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.461 1.104 . . . . 0.0 110.372 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -61.82 -23.9 66.54 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.158 1.383 . . . . 0.0 112.587 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 m -92.41 -0.41 57.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.06 0.944 . . . . 0.0 113.223 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.96 25.96 71.07 Favored Glycine 0 CA--C 1.527 0.837 0 O-C-N 121.356 -0.84 . . . . 0.0 112.942 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.9 mt -67.92 125.67 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 164.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.5 mm-40 -72.33 97.5 2.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 170.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -79.75 151.85 30.16 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.416 ' CG ' HD13 ' A' ' 148' ' ' LEU . 86.9 m-85 -145.01 169.56 17.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.8 mt -130.99 157.42 43.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 169.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -147.34 134.74 20.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.946 1.298 . . . . 0.0 107.993 159.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 t -163.44 -179.02 6.23 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -108.28 -7.5 15.93 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -0.87 0.08 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 117.654 2.465 . . . . 0.0 117.654 -172.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.68 -175.69 54.21 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.005 -1.06 . . . . 0.0 111.533 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -12.24 47.03 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -168.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -66.75 -12.96 60.74 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.343 -1.473 . . . . 0.0 111.688 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.16 -55.92 27.17 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.481 1.037 . . . . 0.0 111.44 176.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -54.85 -45.85 74.57 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.996 0.918 . . . . 0.0 109.77 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 m -59.39 -42.43 91.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.925 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.2 mt -64.88 -49.46 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 119.199 0.909 . . . . 0.0 109.344 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mp -60.11 -42.88 95.65 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.894 -0.504 . . . . 0.0 111.754 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -57.23 -53.42 58.31 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.486 1.115 . . . . 0.0 109.27 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.1 -54.23 21.93 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.9 1.68 . . . . 0.0 109.264 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.47 -39.08 65.19 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.777 0.831 . . . . 0.0 111.267 -170.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.25 27.89 1.06 Allowed Glycine 0 CA--C 1.535 1.338 0 CA-C-O 121.637 0.576 . . . . 0.0 112.015 163.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.648 HG23 ' CD2' ' A' ' 125' ' ' TYR 0.303 2.0 p -133.41 12.66 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 127.191 2.196 . . . . 0.0 110.106 -160.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -67.35 -34.34 77.1 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 121.393 -0.817 . . . . 0.0 110.334 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.4 m -77.83 -22.71 49.55 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 120.037 1.289 . . . . 0.0 113.087 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.648 ' CD2' HG23 ' A' ' 122' ' ' VAL . 19.1 m-85 -60.77 -18.57 55.79 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -116.11 126.68 54.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.0 m -62.32 -30.97 71.54 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.821 0.849 . . . . 0.0 111.652 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.476 ' OE1' ' HE2' ' A' ' 151' ' ' LYS . 7.5 tt0 -154.13 159.93 41.69 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 169.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mp -131.88 111.57 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 mt -80.72 159.34 25.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.844 0.831 . . . . 0.0 109.383 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.9 p -142.17 177.47 8.21 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.337 1.855 . . . . 0.0 108.12 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -61.55 -6.58 2.52 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.4 -0.813 . . . . 0.0 112.868 169.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -57.8 -28.22 63.83 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.669 -1.269 . . . . 0.0 110.703 166.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 58.0 p -58.0 -54.29 48.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.434 0.694 . . . . 0.0 112.394 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.33 -2.88 71.67 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 117.295 -1.836 . . . . 0.0 115.45 -173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -53.92 164.51 0.58 Allowed 'General case' 0 C--O 1.242 0.694 0 CA-C-N 120.03 1.915 . . . . 0.0 112.235 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.1 176.76 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.407 1.099 . . . . 0.0 113.288 -172.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -65.06 147.08 54.12 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.245 -0.909 . . . . 0.0 110.058 174.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -52.1 127.44 37.36 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.984 1.714 . . . . 0.0 107.612 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.01 -40.03 1.31 Allowed 'Cis proline' 0 C--N 1.348 0.531 0 CA-C-N 121.548 1.588 . . . . 0.0 115.25 22.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.267 43.2 p 51.25 72.25 1.28 Allowed Pre-proline 0 N--CA 1.441 -0.897 0 C-N-CA 125.194 1.397 . . . . 0.0 113.077 -172.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -62.14 -18.44 62.02 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.616 2.877 . . . . 0.0 111.907 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -47.71 -43.51 26.9 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.863 1.665 . . . . 0.0 111.273 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.46 -21.66 65.62 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.23 -58.45 3.31 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.188 -0.911 . . . . 0.0 109.392 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.6 m -56.2 -36.16 68.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.552 0.615 . . . . 0.0 110.292 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -50.89 -63.0 1.27 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 124.649 1.18 . . . . 0.0 110.339 170.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.416 HD13 ' CG ' ' A' ' 104' ' ' PHE . 71.2 mt -69.18 -24.46 64.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -174.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.26 -67.43 0.44 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -57.46 -41.29 80.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.873 0.469 . . . . 0.0 110.514 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.476 ' HE2' ' OE1' ' A' ' 128' ' ' GLU . 7.0 tmtm? -47.93 -37.32 14.08 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.581 1.552 . . . . 0.0 114.148 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.54 24.81 5.43 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.221 0.919 . . . . 0.0 112.743 173.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 47.71 58.11 5.31 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.46 1.904 . . . . 0.0 112.946 -175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.6 mp -94.68 172.82 7.94 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.75 1.22 . . . . 0.0 111.725 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -102.11 136.08 42.58 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.691 1.196 . . . . 0.0 108.846 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.2 m -62.13 -50.23 72.73 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.93 1.292 . . . . 0.0 108.91 173.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 1.04 53.07 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.99 -1.069 . . . . 0.0 112.645 -167.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -120.39 12.73 11.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.94 1.296 . . . . 0.0 108.999 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 t -107.35 146.63 31.36 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.156 0.889 . . . . 0.0 109.685 168.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.419 ' CD2' ' HB2' ' A' ' 178' ' ' GLN . 88.9 m-85 -137.22 116.99 13.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.916 1.686 . . . . 0.0 107.633 -167.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -84.84 153.55 22.87 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 170.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.7 mt -128.66 102.4 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.45 124.43 3.33 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.65 37.1 0.4 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.253 1.821 . . . . 0.0 112.139 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.48 158.41 44.31 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.398 1.479 . . . . 0.0 108.304 -176.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.5 t -64.32 -15.27 59.98 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.89 -12.87 60.8 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.597 1.159 . . . . 0.0 112.539 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -48.01 80.11 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.084 0.856 . . . . 0.0 112.202 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.4 -31.59 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.82 -37.48 87.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.131 0.572 . . . . 0.0 109.857 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.74 -53.4 15.67 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.084 -1.01 . . . . 0.0 109.905 172.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.75 -48.11 78.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.319 0.648 . . . . 0.0 111.68 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -56.47 -53.49 56.82 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.362 1.865 . . . . 0.0 111.46 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -73.78 -23.52 59.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 119.383 -0.341 . . . . 0.0 111.778 -172.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.0 p -86.06 -21.28 27.79 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 170.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 76.06 46.94 12.07 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.885 1.231 . . . . 0.0 111.243 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 15.4 pt -131.0 -177.4 2.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 125.985 1.714 . . . . 0.0 109.096 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.419 ' HB2' ' CD2' ' A' ' 160' ' ' TYR . 18.6 mm-40 -92.53 162.21 14.3 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.774 0.83 . . . . 0.0 110.489 -175.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.06 139.47 43.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.51 1.524 . . . . 0.0 111.172 -171.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.88 75.13 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 123.07 1.414 . . . . 0.0 109.347 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -93.79 -171.71 2.67 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.801 1.64 . . . . 0.0 111.362 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -106.57 -8.84 16.82 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.485 ' H ' HD12 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -118.66 154.86 32.02 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.728 -1.232 . . . . 0.0 110.275 177.708 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.62 140.07 58.48 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 120.832 -1.167 . . . . 0.0 109.277 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.406 ' H ' ' ND2' ' A' ' 190' ' ' ASN . 19.5 m -127.52 147.35 50.32 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.881 1.324 . . . . 0.0 112.233 168.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.23 47.94 1.58 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.803 2.841 . . . . 0.0 110.513 -167.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -138.22 159.72 41.32 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.101 1.361 . . . . 0.0 109.663 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -99.06 98.45 9.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 115.89 16.64 6.74 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.667 1.127 . . . . 0.0 112.419 -171.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.406 ' ND2' ' H ' ' A' ' 185' ' ' SER . 12.0 t30 -89.3 138.32 31.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.847 0.823 . . . . 0.0 109.411 166.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -135.04 90.38 2.63 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.202 1.001 . . . . 0.0 110.564 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . 0.262 0.2 OUTLIER -80.54 152.52 28.61 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.059 -172.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.1 pt -127.01 170.36 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.924 1.689 . . . . 0.0 111.93 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.84 -27.15 12.83 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.716 0.807 . . . . 0.0 112.177 161.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.56 155.84 42.79 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.045 0.938 . . . . 0.0 108.951 -166.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 196' ' ' LEU . 3.3 tp -64.63 -35.51 81.23 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.273 1.029 . . . . 0.0 109.035 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -60.18 -30.46 69.36 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -60.91 -20.61 62.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.408 1.004 . . . . 0.0 111.306 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 95.1 mt -53.98 -53.68 25.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 88.1 p -59.68 -39.1 83.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -59.03 -40.88 86.41 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.342 1.057 . . . . 0.0 109.593 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.4 mt -51.81 -49.84 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.761 1.224 . . . . 0.0 110.851 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.76 -5.61 55.63 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.941 0.896 . . . . 0.0 112.514 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -111.65 10.97 21.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.101 2.16 . . . . 0.0 110.104 -174.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.0 t -149.76 22.68 0.89 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.919 176.099 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.538 0 N-CA-C 112.042 -0.423 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -67.38 96.52 0.51 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.859 0.829 . . . . 0.0 109.555 -177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mmm -138.05 80.9 1.83 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.918 2.087 . . . . 0.0 106.369 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.9 175.98 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.958 2.103 . . . . 0.0 110.649 166.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.1 102.67 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.976 1.71 . . . . 0.0 110.234 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.6 m -133.55 142.41 48.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.54 142.25 51.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.253 1.021 . . . . 0.0 108.294 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.69 153.33 34.53 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.2 mt -141.92 128.01 18.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -115.61 155.97 26.68 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.323 0.649 . . . . 0.0 110.49 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -78.37 -11.13 59.92 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.367 1.067 . . . . 0.0 112.301 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt 65.77 -48.94 0.4 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 129.448 3.099 . . . . 0.0 111.466 -164.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -139.17 81.71 1.85 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -159.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.39 73.94 0.07 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -171.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.242 0.674 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 167.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.463 ' C ' HD13 ' A' ' 85' ' ' LEU 0.727 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 7.1 tpt 47.0 77.67 0.45 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 127.062 2.145 . . . . 0.0 111.42 -175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -60.77 115.13 2.48 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.765 2.976 . . . . 0.0 109.187 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.45 -44.99 0.81 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -161.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.14 -19.19 61.18 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -169.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -59.06 -35.13 72.82 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.751 1.16 . . . . 0.0 113.597 -159.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -59.93 -58.33 9.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 124.096 0.873 . . . . 0.0 110.27 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.6 t -52.62 -41.43 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.085 0.954 . . . . 0.0 110.713 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 85.6 mt -57.61 -48.18 80.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.104 0.866 . . . . 0.0 110.13 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.51 -46.35 83.33 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.607 0.763 . . . . 0.0 111.901 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -57.4 -48.24 79.61 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.57 98.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.63 0.772 . . . . 0.0 111.309 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -54.84 -61.07 2.55 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.68 1.592 . . . . 0.0 110.35 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -60.97 -20.33 62.23 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.3 m -86.75 -4.08 59.13 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.79 1.236 . . . . 0.0 112.815 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.17 22.61 70.94 Favored Glycine 0 CA--C 1.528 0.872 0 O-C-N 120.868 -1.145 . . . . 0.0 112.688 175.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.8 mt -55.54 165.44 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 126.674 1.99 . . . . 0.0 107.433 158.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -118.04 112.72 20.61 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 161.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -80.81 143.34 32.9 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -132.34 168.5 18.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.539 1.536 . . . . 0.0 108.643 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 60.5 mt -140.0 158.86 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.361 1.464 . . . . 0.0 108.309 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -139.88 125.17 18.9 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.882 0.873 . . . . 0.0 108.758 162.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -137.41 164.19 29.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.481 1.112 . . . . 0.0 109.822 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -104.39 -0.03 28.53 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.674 1.19 . . . . 0.0 111.634 172.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -69.04 -0.19 5.42 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.27 -176.61 30.48 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.808 1.194 . . . . 0.0 110.615 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -27.06 61.36 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.653 0.781 . . . . 0.0 111.016 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -60.65 -14.98 23.88 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.1 -49.64 40.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.823 0.738 . . . . 0.0 110.605 168.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -57.43 -44.74 84.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.697 0.68 . . . . 0.0 111.197 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -57.27 -43.96 83.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.731 0.812 . . . . 0.0 110.594 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.83 -53.44 48.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.977 1.311 . . . . 0.0 109.26 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.05 -36.88 84.43 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.005 0.82 . . . . 0.0 110.516 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -61.0 -51.44 69.25 Favored 'General case' 0 C--N 1.337 0.052 0 CA-C-N 118.671 0.669 . . . . 0.0 110.476 175.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -53.46 -51.72 61.79 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 110.168 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.12 -21.01 63.14 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.594 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.95 47.16 5.13 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.913 1.244 . . . . 0.0 111.504 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.0 m -147.51 23.22 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.956 1.702 . . . . 0.0 110.991 -174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.01 -35.27 59.61 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.99 -1.069 . . . . 0.0 110.792 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.9 m -63.64 -27.69 69.4 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.191 0.596 . . . . 0.0 110.79 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.82 7.95 1.01 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -137.78 112.03 8.57 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.0 m -49.44 -39.59 33.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.422 1.089 . . . . 0.0 109.684 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.44 156.36 33.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 118.964 0.802 . . . . 0.0 110.017 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 44.1 mt -139.06 93.41 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.438 HD22 ' OG ' ' A' ' 134' ' ' SER . 45.2 mt -65.98 146.88 54.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 70.0 p -127.45 -177.81 4.22 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.287 1.035 . . . . 0.0 110.246 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 t -60.28 -18.04 46.46 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.519 -0.738 . . . . 0.0 112.215 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -61.29 -37.13 82.1 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.971 0.805 . . . . 0.0 108.934 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.438 ' OG ' HD22 ' A' ' 130' ' ' LEU . 12.7 t -56.92 -35.51 69.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.099 0.96 . . . . 0.0 111.704 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.83 -8.48 65.96 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 117.068 -1.962 . . . . 0.0 113.872 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -57.4 164.52 1.84 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 120.047 1.923 . . . . 0.0 111.102 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 t -61.4 162.32 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-N 112.528 -2.124 . . . . 0.0 110.149 166.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -90.69 172.45 8.65 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.51 1.524 . . . . 0.0 109.557 170.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -68.18 150.63 97.66 Favored Pre-proline 0 C--O 1.237 0.441 0 O-C-N 120.774 -1.203 . . . . 0.0 108.942 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.29 -18.12 16.88 Favored 'Cis proline' 0 C--N 1.347 0.492 0 N-CA-C 115.759 1.407 . . . . 0.0 115.759 16.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.67 91.16 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 131.371 3.868 . . . . 0.0 114.604 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -54.13 -7.11 0.61 Allowed 'Trans proline' 0 CA--C 1.544 0.975 1 C-N-CA 126.206 4.604 . . . . 0.0 114.558 -172.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -43.83 -52.05 7.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.819 2.848 . . . . 0.0 113.213 -165.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.96 -3.01 11.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.278 1.031 . . . . 0.0 113.675 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.06 -40.03 7.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.374 1.469 . . . . 0.0 109.869 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 m -51.69 -39.67 58.72 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.337 0.971 . . . . 0.0 109.489 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.96 -53.02 61.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.928 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.7 mt -68.51 -21.2 64.59 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.344 1.457 . . . . 0.0 113.007 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.407 HD11 ' HA ' ' A' ' 156' ' ' SER . 0.0 OUTLIER -67.08 -69.73 0.29 Allowed 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 175.163 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -54.84 -39.77 68.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -23.38 43.42 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.664 -1.272 . . . . 0.0 113.898 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TYR . . . . . 0.475 ' HB3' HD13 ' A' ' 154' ' ' LEU . 6.3 t80 -138.4 17.04 2.75 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 172.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 49.26 38.73 14.19 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.625 1.97 . . . . 0.0 112.185 -170.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -68.71 165.4 19.57 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.956 0.902 . . . . 0.0 109.754 176.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -101.17 -5.89 25.0 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 -160.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.407 ' HA ' HD11 ' A' ' 149' ' ' LEU . 1.4 m 76.43 -36.14 0.26 Allowed 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 108.813 -3.812 . . . . 0.0 112.179 -166.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -25.04 56.67 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 120.943 -1.098 . . . . 0.0 112.8 -171.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.77 -3.16 58.83 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 116.362 -1.78 . . . . 0.0 110.694 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -102.27 123.61 46.39 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.401 1.455 . . . . 0.0 108.712 -170.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -120.81 101.01 7.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.045 2.138 . . . . 0.0 108.903 -170.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -74.68 150.6 39.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.44 129.13 68.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -149.69 172.28 29.66 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.431 0.539 . . . . 0.0 111.883 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.42 3.02 4.22 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.525 1.53 . . . . 0.0 113.564 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -144.09 133.7 23.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 t -47.56 166.71 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.986 2.114 . . . . 0.0 110.858 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 tp 67.74 -5.03 0.86 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 131.404 3.882 . . . . 0.0 112.979 -152.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -58.1 -41.16 82.9 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.355 0.979 . . . . 0.0 110.826 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 185' ' ' SER . 13.2 p -104.13 -18.21 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 126.261 1.824 . . . . 0.0 110.849 -171.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -68.0 -22.72 64.98 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.46 -0.775 . . . . 0.0 111.851 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.427 ' CE1' HD11 ' A' ' 177' ' ' ILE . 7.2 p90 -88.08 -23.27 23.76 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.292 -0.88 . . . . 0.0 112.331 173.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.14 90.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.967 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -64.22 -40.68 96.55 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.446 0.566 . . . . 0.0 111.061 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.49 -55.52 34.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.198 0.454 . . . . 0.0 110.356 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 t -75.15 -24.75 57.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.097 -0.477 . . . . 0.0 111.555 -172.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 67.3 61.33 5.2 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -166.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.427 HD11 ' CE1' ' A' ' 171' ' ' PHE . 50.5 pt -128.88 177.55 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.976 1.711 . . . . 0.0 108.002 172.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -94.99 179.07 5.35 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.184 0.594 . . . . 0.0 109.748 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.51 160.75 34.96 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.633 -1.292 . . . . 0.0 109.436 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.0 mt -142.56 101.91 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.282 1.433 . . . . 0.0 107.158 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -128.24 165.37 20.63 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 123.134 1.445 . . . . 0.0 111.705 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -78.78 -29.84 45.21 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.765 -1.562 . . . . 0.0 111.297 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.79 13.99 27.26 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -157.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . 0.287 12.3 pt-20 50.93 -170.85 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.858 1 C-N-CA 134.999 5.32 . . . . 0.0 114.09 -170.187 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.448 ' HB2' HG11 ' A' ' 169' ' ' VAL . 48.3 t -164.12 167.99 19.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.097 2.159 . . . . 0.0 107.121 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 16.6 p -100.33 66.14 1.26 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.819 1.248 . . . . 0.0 108.185 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -143.46 177.28 8.56 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.792 1.637 . . . . 0.0 108.989 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -106.26 -30.87 8.92 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.597 1.159 . . . . 0.0 112.893 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.09 5.84 82.91 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.235 0.921 . . . . 0.0 111.568 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -72.86 155.19 40.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 118.749 1.274 . . . . 0.0 108.712 168.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -134.75 109.02 8.3 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.31 143.01 58.21 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 122.955 0.502 . . . . 0.0 111.211 177.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.2 pt -146.39 173.37 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.684 1.594 . . . . 0.0 112.746 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -127.89 -17.85 4.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.793 1.637 . . . . 0.0 113.417 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.24 165.84 28.02 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.0 1.32 . . . . 0.0 109.802 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.01 -37.56 88.06 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.83 -15.58 54.8 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -75.11 -17.85 60.36 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.168 -0.958 . . . . 0.0 110.796 174.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.408 ' HA ' HD12 ' A' ' 202' ' ' ILE . 70.5 mt -58.25 -53.49 45.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 77.4 p -58.76 -34.3 71.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.928 0.786 . . . . 0.0 111.092 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -62.43 -35.05 78.05 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 116.728 -1.606 . . . . 0.0 111.603 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 199' ' ' ILE . 77.4 mt -50.75 -52.59 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.726 1.148 . . . . 0.0 108.804 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -81.34 -5.22 57.6 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.935 -0.555 . . . . 0.0 112.422 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -109.78 2.44 20.01 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.77 1.628 . . . . 0.0 112.27 -171.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.7 t -129.87 24.09 5.34 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.712 0.767 . . . . 0.0 111.255 -168.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? . . . . . 0 C--O 1.247 0.97 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -176.821 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.69 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -153.01 61.43 0.78 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.427 1.091 . . . . 0.0 108.4 172.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mmm -112.58 78.56 1.14 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 124.049 1.88 . . . . 0.0 108.486 -162.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.97 177.86 0.11 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 111.608 -2.542 . . . . 0.0 111.389 167.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -54.78 69.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 129.148 2.979 . . . . 0.0 114.556 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.6 m -96.28 141.92 29.04 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.06 147.33 50.16 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.438 ' CD2' HD11 ' A' ' 162' ' ' ILE . 0.8 OUTLIER -130.7 144.43 51.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 124.562 1.145 . . . . 0.0 108.108 -170.285 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.8 mt -133.57 120.44 37.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -105.71 -177.51 3.38 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.674 1.59 . . . . 0.0 108.202 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.2 174.22 9.45 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.301 1.04 . . . . 0.0 109.603 170.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.36 117.34 29.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 61.08 60.9 1.7 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.611 1.196 . . . . 0.0 110.099 -175.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.88 -106.73 0.76 Allowed Glycine 0 C--O 1.239 0.421 0 N-CA-C 105.106 -3.197 . . . . 0.0 105.106 164.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 C--O 1.25 1.093 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 169.806 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.748 HD22 ' CD ' ' A' ' 87' ' ' PRO 0.542 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.7 ttp -158.43 84.4 2.57 Favored Pre-proline 0 C--O 1.223 -0.307 0 C-N-CA 125.006 1.322 . . . . 0.0 110.067 147.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.748 ' CD ' HD22 ' A' ' 85' ' ' LEU . 62.9 Cg_endo -94.67 91.71 0.12 Allowed 'Trans proline' 0 N--CA 1.439 -1.734 0 C-N-CA 123.534 2.822 . . . . 0.0 110.948 173.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.679 ' C ' HD11 ' A' ' 196' ' ' LEU . . . 44.59 30.02 2.04 Favored Glycine 0 CA--C 1.504 -0.643 0 C-N-CA 126.367 1.937 . . . . 0.0 112.461 172.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.505 ' N ' HD11 ' A' ' 196' ' ' LEU . . . -156.58 -46.73 0.07 Allowed 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -169.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.6 tpt85 -58.15 -32.7 68.44 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.663 0.665 . . . . 0.0 112.649 -158.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -48.96 -70.3 0.09 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.253 1.421 . . . . 0.0 109.889 168.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.4 t -63.52 -36.02 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 126.836 2.054 . . . . 0.0 110.666 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.3 mt -51.72 -46.31 63.91 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.05 1.295 . . . . 0.0 110.572 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.66 -46.43 85.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.067 0.947 . . . . 0.0 111.657 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -61.65 -42.55 99.06 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.479 0.712 . . . . 0.0 112.227 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.98 -32.79 72.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.157 0.983 . . . . 0.0 111.315 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.41 -43.8 72.66 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.189 1.795 . . . . 0.0 111.857 173.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.3 -13.99 3.95 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.802 1.241 . . . . 0.0 112.004 168.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.3 m -113.96 -5.25 13.17 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.773 1.629 . . . . 0.0 112.241 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.57 19.73 49.3 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.137 1.827 . . . . 0.0 113.862 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mt -51.83 124.74 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 160.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -75.34 111.58 10.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -96.05 153.92 17.52 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 127' ' ' THR . 66.9 m-85 -148.61 165.79 30.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.487 1.515 . . . . 0.0 109.135 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.457 ' HB ' HG23 ' A' ' 129' ' ' ILE . 36.8 mt -137.72 153.66 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.998 1.719 . . . . 0.0 108.177 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -132.58 143.09 49.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.492 1.517 . . . . 0.0 107.795 160.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 t -169.74 173.11 6.41 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.796 1.638 . . . . 0.0 108.835 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -131.77 66.42 1.55 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.234 1.814 . . . . 0.0 110.106 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.27 6.58 17.44 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.483 1.513 . . . . 0.0 111.646 166.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.77 178.4 43.67 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.695 1.14 . . . . 0.0 111.28 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.47 -18.55 52.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.286 1.034 . . . . 0.0 111.837 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.65 -23.14 49.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.876 0.87 . . . . 0.0 111.652 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.28 -45.45 72.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.474 0.709 . . . . 0.0 111.922 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -62.63 -39.95 95.44 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.984 0.811 . . . . 0.0 109.904 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -62.25 -45.83 91.53 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.78 0.832 . . . . 0.0 110.262 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.21 -43.29 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.534 1.134 . . . . 0.0 109.14 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.84 -40.59 95.85 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.482 -0.761 . . . . 0.0 111.36 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -53.35 58.55 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.702 0.683 . . . . 0.0 110.162 169.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -49.47 -53.44 23.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.047 0.939 . . . . 0.0 111.597 -174.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.57 -11.07 60.11 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.17 1.388 . . . . 0.0 114.051 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 59.97 54.51 36.82 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.67 1.129 . . . . 0.0 110.678 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.7 6.08 2.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 125.085 1.354 . . . . 0.0 111.993 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.03 -53.01 56.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.564 0.697 . . . . 0.0 109.988 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 m -72.46 -11.26 60.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.818 -162.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -62.69 -28.69 70.11 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.172 0.989 . . . . 0.0 112.71 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -107.87 136.12 48.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -174.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.455 ' HB ' ' CE2' ' A' ' 104' ' ' PHE . 78.5 m -61.58 -43.62 98.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.85 157.12 38.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -173.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.457 HG23 ' HB ' ' A' ' 105' ' ' ILE . 5.0 mp -137.15 143.35 34.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.5 HD21 ' CE1' ' A' ' 147' ' ' TYR . 76.8 mt -99.57 158.87 15.45 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.764 1.225 . . . . 0.0 109.778 174.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 p -137.36 -174.22 3.69 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.136 0.574 . . . . 0.0 111.101 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.9 -30.18 13.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.512 1.125 . . . . 0.0 111.695 166.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -65.71 -19.83 66.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.994 1.318 . . . . 0.0 111.113 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.2 m -89.47 69.53 7.96 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.75 47.75 1.54 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 127.34 2.4 . . . . 0.0 112.116 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -56.66 169.32 0.49 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.367 0.667 . . . . 0.0 110.995 164.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' CB ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -50.67 166.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 122.634 1.207 . . . . 0.0 112.922 177.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -61.23 157.44 16.23 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.363 163.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -42.58 147.87 0.58 Allowed Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 124.745 1.218 . . . . 0.0 110.343 166.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.56 -27.3 4.95 Favored 'Cis proline' 0 CA--C 1.533 0.461 0 CA-C-N 119.342 0.801 . . . . 0.0 113.407 -3.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.503 ' CB ' HG23 ' A' ' 137' ' ' VAL . 3.3 t 49.39 82.18 0.24 Allowed Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.012 1.325 . . . . 0.0 112.079 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.57 -23.02 70.59 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 121.494 1.462 . . . . 0.0 111.286 165.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -54.03 -50.47 66.6 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.892 1.277 . . . . 0.0 112.713 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.02 -17.11 22.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.88 -47.77 6.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.546 1.138 . . . . 0.0 111.203 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 m -57.27 -39.02 74.8 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.885 0.874 . . . . 0.0 109.585 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.5 ' CE1' HD21 ' A' ' 130' ' ' LEU . 30.6 t80 -57.87 -51.02 71.31 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.544 0.738 . . . . 0.0 110.274 173.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.1 mt -65.95 -36.42 83.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.275 1.03 . . . . 0.0 110.761 -171.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 89.2 mt -60.59 -64.84 0.81 Allowed 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.36 1.864 . . . . 0.0 106.031 175.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.81 -37.26 75.98 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -172.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.32 -23.02 21.37 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 117.299 -1.334 . . . . 0.0 114.325 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -134.52 20.46 3.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.593 1.542 . . . . 0.0 110.612 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 44.14 62.87 1.82 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.679 2.392 . . . . 0.0 110.614 -172.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 67.5 mt -103.08 165.13 11.2 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.499 1.12 . . . . 0.0 110.647 -170.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -100.67 132.25 46.16 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.792 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 m -58.13 -49.37 77.22 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.546 1.138 . . . . 0.0 110.166 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.6 -4.18 41.6 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.133 -1.605 . . . . 0.0 112.818 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -113.6 10.88 18.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 117.876 -1.059 . . . . 0.0 108.838 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -109.9 111.26 22.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.98 0.809 . . . . 0.0 109.406 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -114.87 108.54 16.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.491 1.517 . . . . 0.0 110.152 -168.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -78.39 152.46 32.23 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.415 0.686 . . . . 0.0 109.68 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.438 HD11 ' CD2' ' A' ' 6' ' ' PHE . 2.5 mp -127.17 127.84 69.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 172.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -167.13 -177.68 38.96 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 121.511 0.506 . . . . 0.0 112.908 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -126.22 9.9 7.39 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.209 1.404 . . . . 0.0 112.452 -165.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -136.32 126.85 26.93 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.038 0.935 . . . . 0.0 110.03 -171.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 6.2 t -46.34 -23.87 0.41 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.133 2.573 . . . . 0.0 115.216 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -12.95 59.79 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.139 1.776 . . . . 0.0 112.312 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -51.64 69.16 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.637 0.775 . . . . 0.0 110.743 174.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.96 -29.68 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 O-C-N 121.811 -0.556 . . . . 0.0 109.611 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.52 -21.26 66.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.475 -0.774 . . . . 0.0 112.238 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -97.32 -39.77 9.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.548 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -57.2 -43.04 82.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 123.698 0.624 . . . . 0.0 111.153 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -59.1 -48.48 81.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.604 1.161 . . . . 0.0 110.934 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -71.1 -33.53 70.25 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 118.234 -0.889 . . . . 0.0 112.298 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 45.9 m -82.66 -21.39 35.0 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.514 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.72 63.67 3.11 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.462 1.506 . . . . 0.0 110.505 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.2 pt -135.73 -166.5 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.863 1.665 . . . . 0.0 108.948 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -120.38 158.64 26.73 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.548 1.067 . . . . 0.0 111.541 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.8 m -139.0 149.82 45.13 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.105 1.762 . . . . 0.0 109.367 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.1 mt -138.7 94.99 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -122.81 158.6 29.91 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.458 1.103 . . . . 0.0 110.938 -170.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -85.87 -26.33 25.7 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.705 -0.622 . . . . 0.0 111.391 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.412 ' H ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -73.04 175.55 6.58 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 161.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 192' ' ' ARG . 6.1 pt-20 -108.06 170.53 7.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 164.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.3 t -151.99 -168.97 3.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.9 p -127.78 81.26 2.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.874 1.27 . . . . 0.0 108.054 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -151.26 153.68 35.33 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.62 1.568 . . . . 0.0 108.465 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.87 108.14 16.69 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.775 1.63 . . . . 0.0 110.313 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 117.91 -7.42 15.11 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 123.972 0.796 . . . . 0.0 111.81 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.97 118.91 24.33 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.302 1.441 . . . . 0.0 108.293 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -114.21 136.47 52.92 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.139 1.376 . . . . 0.0 110.674 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.509 ' HD2' ' HB3' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -83.85 146.66 27.98 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.416 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.446 HG22 ' HB3' ' A' ' 198' ' ' ASP . 22.5 pt -132.82 167.67 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.39 1.476 . . . . 0.0 112.303 165.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -124.75 -12.12 7.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.549 1.539 . . . . 0.0 112.172 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.07 172.09 19.29 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.502 1.521 . . . . 0.0 109.454 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.679 HD11 ' C ' ' A' ' 88' ' ' GLY . 10.2 mt -68.78 -37.18 79.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.95 1.3 . . . . 0.0 110.352 -176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.39 -22.43 66.79 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.874 0.845 . . . . 0.0 112.196 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.446 ' HB3' HG22 ' A' ' 193' ' ' ILE . 0.5 OUTLIER -74.83 -5.77 45.35 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.825 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 78.5 mt -77.65 -63.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.348 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 168.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.9 p -55.96 -28.03 55.15 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -60.03 -38.69 83.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.145 1.778 . . . . 0.0 112.996 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.91 -50.16 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 C-N-CA 126.632 1.973 . . . . 0.0 106.563 -168.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -71.69 -4.26 26.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.352 1.061 . . . . 0.0 113.338 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -123.31 2.87 9.16 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.417 0.687 . . . . 0.0 112.389 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.65 27.97 1.82 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.054 0.542 . . . . 0.0 112.239 -173.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 14.8 mttp . . . . . 0 C--O 1.246 0.869 0 C-N-CA 129.947 3.299 . . . . 0.0 113.103 174.9 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.626 0 N-CA-C 112.26 -0.336 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . 0.337 0.3 OUTLIER 52.22 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 128.582 2.753 . . . . 0.0 115.964 177.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.0 mmm 44.1 89.09 0.01 OUTLIER 'General case' 0 C--O 1.238 0.47 0 C-N-CA 127.287 2.235 . . . . 0.0 112.694 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -60.92 -172.31 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.22 1.408 . . . . 0.0 110.214 155.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -66.53 82.99 0.1 Allowed 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.926 1.29 . . . . 0.0 110.141 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.8 m -92.74 158.91 15.66 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 166.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.54 157.33 45.64 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 120.584 -1.323 . . . . 0.0 110.636 164.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -128.42 162.48 27.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.203 2.201 . . . . 0.0 108.587 -172.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.5 mt -138.99 144.5 29.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 126.224 1.81 . . . . 0.0 107.033 166.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -117.13 166.35 12.33 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.983 2.113 . . . . 0.0 110.398 170.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -105.21 171.88 7.09 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 162.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.33 18.89 10.28 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.403 2.281 . . . . 0.0 110.736 172.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -110.43 -153.91 0.53 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.491 1.916 . . . . 0.0 110.256 -167.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.09 -11.84 83.77 Favored Glycine 0 CA--C 1.528 0.845 0 O-C-N 120.17 -1.581 . . . . 0.0 115.949 -163.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.259 13.3 t . . . . . 0 C--O 1.25 1.094 0 C-N-CA 124.458 1.103 . . . . 0.0 108.955 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.644 HD23 HG21 ' A' ' 122' ' ' VAL . 1.7 tm? . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.414 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -104.09 87.3 1.54 Allowed Pre-proline 0 C--O 1.243 0.719 1 C-N-CA 132.208 4.203 . . . . 0.0 104.467 179.846 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.43 93.05 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 124.652 3.568 . . . . 0.0 111.983 -163.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.38 -34.77 0.76 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-N 113.175 -1.83 . . . . 0.0 109.725 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.39 -26.18 65.43 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 124.146 0.979 . . . . 0.0 110.319 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -51.65 -36.65 47.0 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.8 0.84 . . . . 0.0 112.219 -175.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -56.7 -51.02 70.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.836 1.254 . . . . 0.0 111.047 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.39 -43.88 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.399 1.479 . . . . 0.0 109.815 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.726 HD23 ' CD2' ' A' ' 125' ' ' TYR . 8.3 mp -50.39 -50.78 50.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 121.344 1.884 . . . . 0.0 111.205 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.59 -43.97 85.03 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.446 0.466 . . . . 0.0 111.951 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -68.72 -39.66 80.32 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.005 1.322 . . . . 0.0 112.089 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.91 -29.13 60.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.209 1.404 . . . . 0.0 111.597 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -64.38 -59.2 4.64 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 127.401 2.281 . . . . 0.0 110.166 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -55.72 -27.27 49.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.559 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.7 m -90.66 3.5 54.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.93 8.93 44.49 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.127 1.346 . . . . 0.0 114.334 173.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mt -66.37 104.17 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -60.71 111.92 1.81 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.61 150.1 21.85 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 172.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.519 ' CD2' HD22 ' A' ' 148' ' ' LEU . 79.5 m-85 -142.95 166.4 24.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.503 1.121 . . . . 0.0 110.53 175.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 9.2 mt -127.49 158.25 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 121.041 1.746 . . . . 0.0 109.43 173.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -133.58 112.0 11.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.747 1.219 . . . . 0.0 108.893 167.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -143.11 173.63 11.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -127.68 14.16 6.97 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.759 2.023 . . . . 0.0 110.887 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -3.07 28.98 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.99 173.0 34.4 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.703 1.62 . . . . 0.0 112.557 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.74 -19.99 19.72 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.777 1.631 . . . . 0.0 112.653 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -22.76 20.98 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.419 1.488 . . . . 0.0 111.944 173.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.91 -44.57 78.38 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.027 -1.045 . . . . 0.0 111.576 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -56.79 -46.25 81.66 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.75 0.42 . . . . 0.0 110.506 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -61.3 -47.37 86.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.747 0.819 . . . . 0.0 110.486 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.8 mt -55.59 -50.63 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.83 -32.27 73.45 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.802 -1.186 . . . . 0.0 110.843 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -72.33 -27.2 62.28 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 171.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -63.81 1.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 123.365 1.555 . . . . 0.0 107.08 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.31 -35.59 80.88 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.785 3.234 . . . . 0.0 112.254 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.8 61.93 1.57 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 124.512 1.053 . . . . 0.0 110.495 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.644 HG21 HD23 ' A' ' 85' ' ' LEU . 5.9 m -139.64 5.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.223 1.009 . . . . 0.0 110.856 170.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.11 -30.75 63.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.086 -1.009 . . . . 0.0 111.37 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.3 m -70.36 -26.93 63.96 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 118.801 0.728 . . . . 0.0 111.73 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.726 ' CD2' HD23 ' A' ' 93' ' ' LEU . 24.6 m-85 -51.5 -60.33 3.26 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.297 0.639 . . . . 0.0 110.11 164.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.53 ' CE1' HD21 ' A' ' 93' ' ' LEU . 28.9 m-85 -84.9 114.23 21.97 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -152.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.2 m -64.5 -31.85 73.24 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.733 -0.604 . . . . 0.0 111.629 -172.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -158.89 156.72 30.1 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.957 1.253 . . . . 0.0 109.838 167.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.79 105.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 103.871 -2.64 . . . . 0.0 103.871 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.22 158.24 26.7 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.3 p -131.75 179.73 5.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.053 1.341 . . . . 0.0 109.15 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -31.03 42.33 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.155 1.382 . . . . 0.0 112.168 165.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -63.71 -21.55 66.46 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.921 1.288 . . . . 0.0 110.676 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.6 p -57.24 -30.39 64.58 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.0 1.32 . . . . 0.0 114.063 -165.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.75 2.31 44.06 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.538 -1.146 . . . . 0.0 113.954 169.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -63.51 158.47 20.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.318 1.559 . . . . 0.0 111.613 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 137' ' ' VAL . 8.7 t -57.61 157.85 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.564 161.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -136.78 59.8 1.68 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.277 1.431 . . . . 0.0 111.207 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -49.66 -54.84 27.29 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-O 114.834 -2.508 . . . . 0.0 114.344 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.78 114.08 0.19 OUTLIER 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 123.313 2.219 . . . . 0.0 117.016 10.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 m -92.73 154.94 42.2 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 124.873 1.269 . . . . 0.0 112.547 -173.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -81.53 5.25 6.4 Favored 'Trans proline' 0 CA--C 1.549 1.261 1 C-N-CA 125.585 4.19 . . . . 0.0 113.883 170.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -46.77 -63.92 0.9 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.479 1.912 . . . . 0.0 110.942 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.54 -20.96 64.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.461 0.705 . . . . 0.0 111.934 -169.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.18 -60.38 2.32 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.297 1.039 . . . . 0.0 108.766 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.3 m -54.93 -40.57 70.04 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.025 1.33 . . . . 0.0 110.407 -174.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.512 ' CE1' ' HE2' ' A' ' 151' ' ' LYS . 72.0 t80 -52.1 -58.0 7.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.474 1.11 . . . . 0.0 110.633 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.519 HD22 ' CD2' ' A' ' 104' ' ' PHE . 23.3 mt -71.02 -25.19 62.56 Favored 'General case' 0 CA--C 1.521 -0.137 0 O-C-N 121.866 -0.521 . . . . 0.0 112.144 -172.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 87.2 mt -66.48 -61.15 2.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.99 -36.19 72.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.963 0.505 . . . . 0.0 111.699 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.512 ' HE2' ' CE1' ' A' ' 147' ' ' TYR . 7.9 mmtm -57.31 -22.85 44.74 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 114.276 1.214 . . . . 0.0 114.276 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.97 27.43 1.46 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 119.037 0.835 . . . . 0.0 111.822 169.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 67.9 mm-40 44.41 54.56 6.22 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.648 2.379 . . . . 0.0 111.494 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 4.3 mp -75.46 -169.59 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.188 1.395 . . . . 0.0 110.592 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -121.78 129.15 52.44 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.236 1.414 . . . . 0.0 108.751 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.0 m -52.5 -49.1 65.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.985 1.714 . . . . 0.0 110.445 175.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -88.43 9.2 24.4 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 120.791 -1.193 . . . . 0.0 111.881 -169.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -125.94 8.75 7.45 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.353 1.861 . . . . 0.0 108.733 173.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -107.65 142.42 37.64 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.743 1.156 . . . . 0.0 109.539 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -129.46 156.55 43.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.952 2.101 . . . . 0.0 108.243 -170.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -139.17 128.17 23.7 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.93 116.05 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.152 1.381 . . . . 0.0 107.309 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -142.09 -172.26 13.48 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 174.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -132.51 5.83 4.05 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.404 1.882 . . . . 0.0 113.393 -169.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.405 ' HG2' HH11 ' A' ' 165' ' ' ARG . 0.6 OUTLIER -131.83 155.82 47.13 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 120.0 1.273 . . . . 0.0 109.95 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t -72.94 -13.69 61.3 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.584 -1.323 . . . . 0.0 111.059 -169.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.26 -33.18 52.02 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.739 1.616 . . . . 0.0 111.167 167.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -74.06 10.12 1.33 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.376 1.47 . . . . 0.0 113.601 -164.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.22 -13.71 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.288 1.035 . . . . 0.0 110.686 167.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.32 -47.83 77.92 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.803 1.638 . . . . 0.0 110.018 -173.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -76.94 -34.44 57.65 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 121.595 -0.691 . . . . 0.0 111.809 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.48 -58.11 8.29 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.598 0.759 . . . . 0.0 109.867 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -49.84 -45.74 50.57 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.699 2.0 . . . . 0.0 110.841 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -62.49 -26.08 68.35 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.5 p -93.98 -26.01 17.0 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.055 0.843 . . . . 0.0 112.769 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 92.46 9.57 61.48 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.198 1.38 . . . . 0.0 112.556 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 178' ' ' GLN . 1.7 pp -88.21 175.66 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.721 1.209 . . . . 0.0 109.39 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.411 ' N ' HD12 ' A' ' 177' ' ' ILE . 32.5 mt-30 -112.37 163.73 14.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.865 0.841 . . . . 0.0 111.694 -165.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 8.8 m -137.39 149.82 47.22 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.665 1.586 . . . . 0.0 110.175 -168.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 47.6 mt -140.4 78.02 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -114.16 165.13 12.97 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.507 1.146 . . . . 0.0 110.693 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -73.4 -13.3 61.06 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.283 -0.885 . . . . 0.0 113.157 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.59 157.12 39.71 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.442 1.019 . . . . 0.0 110.727 -174.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -89.51 159.23 17.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.939 -0.476 . . . . 0.0 111.435 -171.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.25 8.38 1.2 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -169.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 47.7 p 52.81 49.66 19.78 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.101 1.36 . . . . 0.0 113.257 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -131.27 162.65 29.55 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.4 1.88 . . . . 0.0 109.105 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -80.13 -42.87 22.67 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.639 0.776 . . . . 0.0 111.812 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.73 47.4 3.57 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -130.43 125.94 35.72 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.922 1.289 . . . . 0.0 109.52 -164.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -127.2 108.39 10.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.004 0.921 . . . . 0.0 109.156 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -63.94 142.01 58.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 118.149 -1.42 . . . . 0.0 109.699 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 13.7 pt -114.96 159.67 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.3 1.04 . . . . 0.0 110.564 165.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.15 -8.17 12.4 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.839 1.256 . . . . 0.0 112.535 172.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.76 161.62 41.43 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.869 2.468 . . . . 0.0 107.154 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 tp -71.16 -32.94 69.55 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.408 -0.808 . . . . 0.0 110.268 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.77 -18.69 63.06 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.098 -0.953 . . . . 0.0 112.196 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -66.32 -20.02 65.97 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.422 1.01 . . . . 0.0 110.316 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 76.8 mt -62.46 -53.61 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 124.607 1.163 . . . . 0.0 108.96 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 80.7 p -56.27 -39.59 72.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.185 0.902 . . . . 0.0 109.662 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -60.2 -25.71 65.8 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.349 2.26 . . . . 0.0 111.591 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 80.0 mt -61.64 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 120.498 -1.376 . . . . 0.0 109.454 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -89.91 -26.26 20.54 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.492 1.117 . . . . 0.0 110.944 -175.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -83.61 4.55 27.88 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.716 1.606 . . . . 0.0 112.587 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.312 87.2 m 59.69 60.67 2.16 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 123.53 1.633 . . . . 0.0 109.93 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.375 9.2 ptmt . . . . . 0 C--O 1.252 1.222 1 C-N-CA 134.42 5.088 . . . . 0.0 116.213 173.136 . . . . . . . . 2 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.751 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -164.15 97.42 0.82 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 117.807 0.803 . . . . 0.0 110.06 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mmm -129.41 87.85 2.61 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.16 169.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.901 2.081 . . . . 0.0 109.687 162.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 106.72 0.09 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.476 1.51 . . . . 0.0 108.813 174.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.8 m -134.86 147.18 49.82 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.27 153.96 46.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.402 1.081 . . . . 0.0 108.645 171.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.04 153.31 48.56 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.176 1.79 . . . . 0.0 107.609 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 mt -143.22 138.46 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -128.97 179.96 5.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.43 1.092 . . . . 0.0 110.443 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -130.71 172.35 12.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.172 2.189 . . . . 0.0 109.596 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.411 HD12 HG21 ' A' ' 107' ' ' THR . 76.0 mt -123.6 25.05 8.33 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.501 1.921 . . . . 0.0 111.508 -174.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -146.39 74.02 1.35 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.108 -0.995 . . . . 0.0 111.794 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.2 -65.83 0.58 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.047 0 C-N-CA 127.241 2.217 . . . . 0.0 111.257 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.415 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 8.6 tpt 46.71 85.4 0.17 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 126.938 2.095 . . . . 0.0 111.818 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 86' ' ' MET . 19.8 Cg_endo -49.43 124.74 12.48 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.128 1.886 . . . . 0.0 110.432 174.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.93 -21.54 33.71 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.974 1.749 . . . . 0.0 112.186 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.14 -37.92 66.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.478 1.639 . . . . 0.0 109.117 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttt-85 -60.75 -28.69 68.89 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.66 0.664 . . . . 0.0 112.208 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -58.77 7.07 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.637 1.575 . . . . 0.0 110.304 170.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.06 -47.47 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.637 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.522 ' HA ' HE22 ' A' ' 103' ' ' GLN . 3.9 mp -44.68 -54.95 5.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 120.835 1.652 . . . . 0.0 113.237 169.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.57 68.89 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 123.417 0.448 . . . . 0.0 110.563 -176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -54.01 -50.54 66.4 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.989 0.916 . . . . 0.0 110.918 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.4 73.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.089 1.356 . . . . 0.0 112.588 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.82 -54.26 20.46 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 124.556 1.142 . . . . 0.0 110.562 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -67.48 -16.67 64.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.198 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.2 m -84.69 -1.63 56.44 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.783 1.633 . . . . 0.0 113.272 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.47 4.81 87.63 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.845 1.202 . . . . 0.0 114.179 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.2 mt -66.6 138.07 23.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 O-C-N 121.143 -1.21 . . . . 0.0 108.169 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.63 114.83 24.61 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 163.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.522 HE22 ' HA ' ' A' ' 93' ' ' LEU . 11.8 mt-30 -86.36 151.69 23.35 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 170.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.2 174.99 10.22 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.463 1.905 . . . . 0.0 107.11 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 33.9 mt -133.56 154.9 39.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 170.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.413 ' CD1' ' HB3' ' A' ' 130' ' ' LEU . 9.8 t80 -142.47 119.3 11.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 159.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.696 HG23 ' H ' ' A' ' 109' ' ' LYS . 6.0 t -145.63 175.63 10.23 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.055 0.542 . . . . 0.0 110.455 170.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -84.39 1.55 44.72 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.125 0.97 . . . . 0.0 113.487 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.696 ' H ' HG23 ' A' ' 107' ' ' THR . 11.9 ttmm -64.6 160.8 18.85 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.6 -168.85 43.6 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.367 0.984 . . . . 0.0 111.677 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -62.9 -16.72 60.03 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 122.117 -0.637 . . . . 0.0 112.579 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -55.47 -23.44 25.68 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.951 -1.023 . . . . 0.0 112.389 168.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.97 -49.47 63.15 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.409 1.459 . . . . 0.0 112.791 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -60.67 -48.8 80.18 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.219 1.008 . . . . 0.0 109.493 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.5 m -58.96 -41.1 86.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.426 1.49 . . . . 0.0 111.715 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -64.35 -44.05 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 121.344 -0.847 . . . . 0.0 108.83 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -60.52 -45.54 93.44 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.925 0.89 . . . . 0.0 111.796 177.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -58.84 -48.42 81.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.429 1.092 . . . . 0.0 109.226 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -58.25 -49.91 75.45 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.834 1.654 . . . . 0.0 111.857 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.39 -4.54 34.14 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.889 1.276 . . . . 0.0 112.667 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 65.62 39.43 95.43 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.313 0.959 . . . . 0.0 112.296 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.68 15.11 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.81 1.244 . . . . 0.0 110.898 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -61.55 -41.71 97.77 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.877 -0.514 . . . . 0.0 110.738 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 m -57.75 -27.36 62.96 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.437 ' CD2' HD23 ' A' ' 93' ' ' LEU . 32.4 m-85 -63.71 -34.19 77.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 118.988 -0.529 . . . . 0.0 111.897 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -110.37 96.83 6.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -166.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.7 m -51.01 -44.86 61.05 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.581 0.753 . . . . 0.0 110.699 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.45 153.2 44.83 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.501 1.12 . . . . 0.0 108.816 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.59 93.14 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 106' ' ' TYR . 16.6 mt -68.62 146.72 52.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.3 p -151.24 179.45 8.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.731 -162.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.4 t -47.56 -34.97 8.36 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.247 1.819 . . . . 0.0 112.15 173.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -59.27 -30.0 67.98 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.08 1.352 . . . . 0.0 112.137 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.7 p -58.34 -49.46 77.12 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.597 1.189 . . . . 0.0 110.322 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.93 -1.18 87.29 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-O 116.83 -2.095 . . . . 0.0 113.437 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -56.63 162.61 2.18 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.303 1.552 . . . . 0.0 111.286 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.46 HG23 ' HA ' ' A' ' 141' ' ' SER . 6.1 m -50.64 153.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.73 2.012 . . . . 0.0 112.205 170.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.425 ' HG3' ' H ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -83.88 -77.27 0.26 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.582 1.553 . . . . 0.0 111.702 -168.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.425 ' H ' ' HG3' ' A' ' 138' ' ' ARG . 9.0 mttp -163.59 117.99 1.09 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 128.815 2.846 . . . . 0.0 104.923 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.26 160.42 75.81 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.257 1.127 . . . . 0.0 111.68 -4.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.464 ' H ' ' HB2' ' A' ' 171' ' ' PHE . 2.6 p -156.18 54.94 0.99 Allowed Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -68.11 -14.74 41.61 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 121.37 1.38 . . . . 0.0 113.056 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -55.43 -39.62 70.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.837 1.255 . . . . 0.0 110.761 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.66 -15.19 62.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.921 -0.487 . . . . 0.0 112.024 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.27 -55.91 5.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.0 m -59.26 -37.74 78.34 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.198 0.599 . . . . 0.0 110.777 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -55.48 -56.33 21.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.8 mt -61.17 -38.23 85.76 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.241 -175.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -67.1 0.42 Allowed 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 125.126 1.37 . . . . 0.0 107.385 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.06 -34.31 68.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -47.38 72.96 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 114.957 -2.449 . . . . 0.0 114.198 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -124.55 18.36 8.83 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 121.633 2.015 . . . . 0.0 110.069 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 64.27 56.96 1.26 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 127.013 2.125 . . . . 0.0 108.686 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . 0.26 0.0 OUTLIER -109.58 176.19 5.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 114.7 1.371 . . . . 0.0 114.7 -175.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -108.21 150.02 27.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.426 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.1 p -66.75 -48.33 69.45 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 122.309 1.052 . . . . 0.0 110.765 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.29 -9.47 58.58 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 120.772 -1.205 . . . . 0.0 112.326 -170.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -116.67 21.7 13.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 118.098 -0.953 . . . . 0.0 108.804 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -113.01 136.08 53.08 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.989 0.813 . . . . 0.0 111.397 163.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -120.24 105.0 10.53 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.117 2.167 . . . . 0.0 111.003 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -78.4 148.64 33.57 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.299 1.04 . . . . 0.0 108.83 168.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.98 123.4 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -155.5 -5.53 0.09 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 116.926 1.531 . . . . 0.0 116.926 -172.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.3 5.54 2.6 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.53 1.932 . . . . 0.0 115.953 163.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -115.94 10.04 15.09 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -156.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t 52.6 5.41 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.805 3.242 . . . . 0.0 115.361 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.2 tt -112.27 -16.23 13.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.055 2.542 . . . . 0.0 110.099 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.64 -52.29 64.95 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 129.167 2.987 . . . . 0.0 107.852 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.4 HG11 ' CB ' ' A' ' 185' ' ' SER . 7.7 p -52.65 -46.07 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 127.081 2.152 . . . . 0.0 112.267 171.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -62.02 -45.17 94.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -169.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.464 ' HB2' ' H ' ' A' ' 141' ' ' SER . 3.3 p90 -79.78 -32.88 40.91 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.025 -1.047 . . . . 0.0 112.346 175.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.28 -52.35 53.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.217 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -50.49 -51.59 45.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.272 1.829 . . . . 0.0 110.454 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -65.25 -28.15 69.15 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.29 -22.86 28.38 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.715 -1.241 . . . . 0.0 112.735 170.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.63 55.86 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.538 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 17.3 pt -97.54 167.06 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.132 0.973 . . . . 0.0 109.385 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -87.93 178.97 6.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.985 0.514 . . . . 0.0 109.955 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.17 151.9 19.99 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.69 -1.256 . . . . 0.0 111.645 173.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 35.8 mt -124.96 128.08 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -144.15 139.62 28.91 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 124.192 0.997 . . . . 0.0 108.349 -167.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -68.25 -17.8 64.39 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.499 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.35 166.58 10.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.242 1.417 . . . . 0.0 111.235 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -72.73 169.16 17.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.82 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.4 ' CB ' HG11 ' A' ' 169' ' ' VAL . 45.5 t -156.49 171.85 19.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 157.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.1 p -73.1 4.65 4.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.347 2.259 . . . . 0.0 114.242 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -112.07 153.16 27.33 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.29 1.036 . . . . 0.0 110.569 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.58 -45.58 68.33 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.72 1.208 . . . . 0.0 112.627 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.44 36.62 2.6 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.752 1.167 . . . . 0.0 110.311 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -111.35 93.13 4.32 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 174.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -86.06 108.46 18.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -62.08 149.33 41.5 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.34 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.7 pt -142.22 166.19 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.159 1.384 . . . . 0.0 110.675 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.85 -2.68 8.74 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.129 1.772 . . . . 0.0 112.949 170.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.32 166.23 34.05 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.839 1.656 . . . . 0.0 108.788 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 63.6 mt -69.29 -41.92 76.15 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.34 -0.05 1.67 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.41 1.084 . . . . 0.0 113.892 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -81.78 -18.89 42.55 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.053 -1.654 . . . . 0.0 109.924 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 77.7 mt -58.47 -52.14 62.98 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.3 p -50.67 -43.48 57.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.26 0.482 . . . . 0.0 111.44 177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 63.8 mtt85 -62.86 -21.62 66.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.503 1.521 . . . . 0.0 113.296 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 75.0 mt -60.54 -47.98 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -84.61 -34.89 23.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.729 1.211 . . . . 0.0 111.336 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -82.97 22.32 0.95 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.904 1.282 . . . . 0.0 111.413 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 25.2 m 56.63 78.44 0.21 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.958 1.703 . . . . 0.0 110.507 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.271 12.7 ptmt . . . . . 0 C--O 1.251 1.169 0 C-N-CA 131.133 3.773 . . . . 0.0 116.41 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.594 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 56.26 14.53 1.58 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.268 2.227 . . . . 0.0 116.195 175.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.8 mmm 48.69 73.2 0.23 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.846 1.307 . . . . 0.0 111.033 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -45.49 160.3 0.05 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.851 2.06 . . . . 0.0 111.292 166.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -44.24 97.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.347 1.859 . . . . 0.0 111.722 -172.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.2 m -125.82 155.81 40.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.23 150.55 50.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.484 0.714 . . . . 0.0 109.091 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -123.27 155.16 37.74 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.205 1.402 . . . . 0.0 108.333 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.4 mt -140.39 133.82 33.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -131.03 147.16 52.59 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.149 1.38 . . . . 0.0 111.737 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -81.65 -22.3 37.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.655 1.582 . . . . 0.0 111.604 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.613 ' CD2' ' H ' ' A' ' 11' ' ' ASP . 0.4 OUTLIER 68.98 -179.71 0.23 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.416 2.286 . . . . 0.0 110.343 -169.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.613 ' H ' ' CD2' ' A' ' 10' ' ' LEU . 3.8 m-20 54.85 -80.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 129.688 3.195 . . . . 0.0 113.274 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.89 101.02 0.93 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -170.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.243 0.721 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 167.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.732 HD13 ' H ' ' A' ' 86' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.732 ' H ' HD13 ' A' ' 85' ' ' LEU . 52.0 ttm -116.55 85.33 16.36 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -62.33 118.87 5.77 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.456 2.771 . . . . 0.0 107.18 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.7 -29.88 5.92 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.968 1.271 . . . . 0.0 110.865 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.16 -34.23 29.19 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.531 1.165 . . . . 0.0 113.25 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -39.06 70.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.149 0.886 . . . . 0.0 110.992 -166.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.28 -53.46 58.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.624 0.769 . . . . 0.0 110.699 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -61.33 -40.76 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 118.745 0.702 . . . . 0.0 110.266 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.74 -48.89 78.35 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 118.857 0.753 . . . . 0.0 109.519 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.29 -49.57 75.65 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.977 0.511 . . . . 0.0 111.669 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -57.19 -52.61 64.6 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.741 0.817 . . . . 0.0 110.263 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.43 91.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.059 1.343 . . . . 0.0 111.874 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.13 -46.12 71.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.388 1.875 . . . . 0.0 111.399 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.63 -33.61 76.01 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.744 -0.597 . . . . 0.0 110.865 170.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.3 m -71.9 -2.82 19.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.495 1.118 . . . . 0.0 112.861 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.89 17.06 62.55 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.971 1.272 . . . . 0.0 112.283 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -67.6 116.25 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -67.87 97.02 0.62 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -81.76 137.79 35.28 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.784 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -131.28 172.77 11.76 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.451 1.5 . . . . 0.0 110.366 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.3 mt -138.06 156.31 30.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.438 1.495 . . . . 0.0 108.358 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -138.08 126.61 23.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 167.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.1 t -142.49 169.86 16.79 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.909 0.861 . . . . 0.0 110.242 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -105.07 -5.5 20.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.159 1.784 . . . . 0.0 111.85 169.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -68.33 -5.04 16.58 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 -167.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.52 -179.72 38.95 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.38 -17.85 64.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -172.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.89 -14.14 5.66 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.41 -44.53 68.81 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.391 0.996 . . . . 0.0 111.728 169.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.3 -46.68 87.65 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.198 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -56.04 -46.02 78.99 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.698 0.799 . . . . 0.0 109.95 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.7 mt -60.69 -49.02 86.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.32 -38.9 85.67 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.525 -0.734 . . . . 0.0 111.175 -175.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -62.56 -47.35 84.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.79 -32.35 73.5 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.077 0.951 . . . . 0.0 112.854 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.3 mt -90.17 1.54 56.32 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.379 1.472 . . . . 0.0 112.344 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.51 36.22 92.26 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.279 0.942 . . . . 0.0 112.842 174.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.84 20.57 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 110.648 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -73.53 -36.47 65.69 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 120.6 -1.312 . . . . 0.0 113.188 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -28.79 69.93 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.065 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -67.32 -2.84 6.66 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.026 -0.988 . . . . 0.0 113.292 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -138.23 81.83 1.88 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.719 1.6 . . . . 0.0 108.577 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 m -44.9 -44.89 10.01 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.685 2.394 . . . . 0.0 114.514 -171.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -154.58 91.29 1.38 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-N 120.234 1.379 . . . . 0.0 112.1 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.69 122.78 26.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.021 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.62 154.66 26.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.64 -0.663 . . . . 0.0 110.366 165.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.4 p -138.29 -174.67 3.87 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.296 1.839 . . . . 0.0 108.424 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.9 m -60.77 -13.79 17.36 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.903 -1.123 . . . . 0.0 112.802 164.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.93 -22.34 64.15 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.889 1.677 . . . . 0.0 109.739 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.5 p -53.63 -47.79 69.94 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 123.757 0.66 . . . . 0.0 110.354 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.86 -12.21 68.82 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 117.603 -1.665 . . . . 0.0 111.938 -171.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -52.66 148.54 7.09 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.004 1.402 . . . . 0.0 111.397 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' A' ' 141' ' ' SER . 22.9 m -66.1 169.16 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-O 122.322 1.058 . . . . 0.0 113.059 -163.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -60.45 143.22 53.88 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 121.308 -0.87 . . . . 0.0 109.697 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -59.09 150.46 61.87 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.588 -1.196 . . . . 0.0 110.604 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -61.18 120.25 1.21 Allowed 'Cis proline' 0 CA--C 1.538 0.701 0 CA-C-N 120.618 1.256 . . . . 0.0 110.685 -17.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 137' ' ' VAL . 6.1 p -126.68 81.8 68.13 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.712 1.605 . . . . 0.0 112.546 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -71.28 -10.76 27.73 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.968 2.446 . . . . 0.0 112.415 -170.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -44.91 -50.26 10.55 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.597 2.359 . . . . 0.0 110.918 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.04 -15.61 63.83 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.06 -51.89 6.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.511 0.725 . . . . 0.0 109.521 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 m -50.59 -43.84 56.72 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.315 1.446 . . . . 0.0 109.853 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -57.7 -60.07 4.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.336 0.655 . . . . 0.0 109.604 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.57 -25.38 67.28 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.41 -71.66 0.14 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 172.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -28.34 69.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.609 1.164 . . . . 0.0 113.011 -171.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -31.24 65.67 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.168 1.387 . . . . 0.0 112.142 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -140.8 11.61 2.25 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 44.99 73.55 0.15 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 127.912 2.485 . . . . 0.0 111.565 -163.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.5 mp -103.08 154.92 18.78 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 166.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -93.42 136.96 33.19 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 126.108 1.763 . . . . 0.0 107.969 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -41.89 97.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.095 0.474 . . . . 0.0 111.938 174.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.23 -19.27 60.57 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.997 -1.064 . . . . 0.0 112.396 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -101.87 16.07 27.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -110.1 133.95 52.68 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.272 1.396 . . . . 0.0 108.228 169.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -125.64 117.48 23.62 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.721 1.208 . . . . 0.0 108.327 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -97.84 132.11 43.74 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.011 0.924 . . . . 0.0 109.172 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 7.2 mt -114.91 78.93 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -160.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.49 -177.94 37.01 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.494 1.521 . . . . 0.0 113.549 -170.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -134.82 1.88 3.08 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.665 1.186 . . . . 0.0 113.396 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.05 178.08 6.96 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 122.619 1.199 . . . . 0.0 111.344 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.12 -37.45 61.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.536 -177.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.78 -33.46 64.38 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 125.665 1.586 . . . . 0.0 111.865 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -57.43 -33.29 67.75 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.097 0.959 . . . . 0.0 111.481 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.401 HG21 ' CB ' ' A' ' 185' ' ' SER . 8.2 t -92.31 -18.24 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.456 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -61.3 -31.51 71.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.311 0.96 . . . . 0.0 108.502 168.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -64.34 -56.27 15.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.59 -44.73 77.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.836 0.854 . . . . 0.0 111.578 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -55.44 -44.97 76.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.575 1.55 . . . . 0.0 111.503 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -69.25 -52.49 27.09 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.756 -0.59 . . . . 0.0 110.793 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.1 m -66.96 -19.55 65.74 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.147 1.379 . . . . 0.0 112.48 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 67.15 49.77 50.67 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 126.233 1.873 . . . . 0.0 110.799 -173.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.7 pt -117.9 -164.69 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.149 1.379 . . . . 0.0 109.224 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -117.94 163.96 15.79 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.512 0.725 . . . . 0.0 110.265 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 7.1 m -133.29 153.47 51.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.649 1.58 . . . . 0.0 110.005 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 55.1 mt -139.46 90.55 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -119.62 153.93 34.74 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.597 0.713 . . . . 0.0 109.399 -172.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -66.47 -17.13 64.62 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 pp -123.27 157.67 32.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 126.055 1.742 . . . . 0.0 110.339 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.41 139.72 51.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.401 ' CB ' HG21 ' A' ' 169' ' ' VAL . 16.5 m -126.67 -178.39 4.36 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p -72.48 4.97 3.3 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -169.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -142.79 133.01 24.61 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.27 1.428 . . . . 0.0 107.172 -160.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -69.84 -28.96 66.12 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.503 1.521 . . . . 0.0 110.967 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -72.88 10.67 5.23 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.686 1.612 . . . . 0.0 113.865 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -98.12 105.06 17.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.206 1.503 . . . . 0.0 108.364 167.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -79.1 126.67 31.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -69.62 152.65 44.49 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.405 1.002 . . . . 0.0 111.961 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.6 pt -134.42 163.07 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.326 1.451 . . . . 0.0 111.085 168.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -118.45 -14.9 9.69 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.746 1.218 . . . . 0.0 113.105 170.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.72 168.29 21.71 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.43 -42.26 79.14 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.75 -27.24 68.58 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -59.92 -21.12 60.69 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.336 1.854 . . . . 0.0 111.319 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 87.7 mt -57.09 -54.79 25.62 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 C-N-CA 125.557 1.543 . . . . 0.0 108.75 170.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 92.2 p -52.66 -42.24 64.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.481 1.037 . . . . 0.0 110.46 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -17.66 64.35 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.567 1.147 . . . . 0.0 112.995 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.25 -55.59 18.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -78.07 -34.47 50.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.51 1.124 . . . . 0.0 111.685 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -83.97 2.61 38.03 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.648 1.179 . . . . 0.0 112.175 -171.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.33 4.6 t 47.37 84.95 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 130.437 3.495 . . . . 0.0 107.607 -173.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt . . . . . 0 C--O 1.249 1.055 0 C-N-CA 127.307 2.243 . . . . 0.0 110.464 168.87 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.124 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 60.52 40.26 17.16 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.059 2.143 . . . . 0.0 113.358 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 mmm -98.29 76.14 2.3 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.734 1.255 . . . . 0.0 107.666 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.58 171.51 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.381 159.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -44.43 100.4 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.334 1.854 . . . . 0.0 110.348 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.1 m -127.63 149.82 50.01 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.64 147.26 49.94 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.552 -0.717 . . . . 0.0 109.948 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -126.85 149.93 49.48 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.899 1.28 . . . . 0.0 109.399 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' O ' HD12 ' A' ' 162' ' ' ILE . 32.1 mt -149.54 121.29 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -173.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TRP . . . . . 0.588 ' CD2' HD13 ' A' ' 162' ' ' ILE . 76.1 m95 -112.12 -174.56 2.49 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.014 1.326 . . . . 0.0 110.493 -175.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -130.94 -173.41 3.08 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.96 1.304 . . . . 0.0 108.873 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.33 14.11 1.43 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.654 1.981 . . . . 0.0 110.101 175.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . 0.398 0.0 OUTLIER -113.65 4.89 16.26 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 177.306 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.09 -75.83 0.04 OUTLIER Glycine 0 CA--C 1.527 0.814 0 O-C-N 121.05 -1.031 . . . . 0.0 112.007 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.25 1.103 0 C-N-CA 125.135 1.374 . . . . 0.0 110.065 178.799 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 57.1 tpp 41.78 79.08 0.34 Allowed Pre-proline 0 N--CA 1.468 0.448 0 C-N-CA 124.893 1.277 . . . . 0.0 113.052 141.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.39 98.04 0.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.112 2.541 . . . . 0.0 110.557 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.86 -9.61 3.93 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.788 1.185 . . . . 0.0 114.234 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.53 -45.98 16.55 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 119.557 1.679 . . . . 0.0 109.008 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.711 ' HA ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -52.01 -31.42 29.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.111 1.364 . . . . 0.0 113.733 -174.018 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.33 -45.81 80.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.502 0.721 . . . . 0.0 110.963 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.421 HG11 ' CH2' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -71.0 -41.07 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -177.607 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' A' ' 90' ' ' ARG . 60.4 mt -62.37 -43.56 98.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -174.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.55 -52.45 57.6 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 125.917 1.687 . . . . 0.0 109.649 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -54.43 -45.39 73.01 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.134 0.573 . . . . 0.0 112.155 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.84 64.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.908 0.883 . . . . 0.0 112.124 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -56.97 -48.72 77.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.463 1.905 . . . . 0.0 109.926 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.3 -2.61 13.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.577 2.351 . . . . 0.0 113.407 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.5 m -120.54 7.63 10.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.809 1.644 . . . . 0.0 113.175 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.4 11.09 61.35 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 121.441 -0.787 . . . . 0.0 114.385 171.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.8 mt -60.18 121.27 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -69.58 106.53 3.05 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 167.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -91.17 151.18 21.06 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.414 ' CD1' HD22 ' A' ' 148' ' ' LEU . 80.6 m-85 -145.25 177.43 8.81 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.344 1.458 . . . . 0.0 109.609 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.586 ' HB ' HG23 ' A' ' 129' ' ' ILE . 18.8 mt -141.55 145.7 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.404 1.082 . . . . 0.0 108.559 172.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -132.3 141.63 49.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.769 1.228 . . . . 0.0 107.81 163.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 109' ' ' LYS . 5.7 t -167.05 -175.46 3.01 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -104.98 8.13 34.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.376 1.47 . . . . 0.0 112.61 172.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.628 ' H ' HG23 ' A' ' 107' ' ' THR . 6.9 tttm -57.58 153.12 13.68 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.116 -0.99 . . . . 0.0 109.866 171.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.56 175.91 43.02 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.505 1.05 . . . . 0.0 111.341 174.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -60.69 -17.0 45.29 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.534 -0.98 . . . . 0.0 112.433 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.31 -26.76 8.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.7 1.2 . . . . 0.0 112.284 169.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.36 -53.06 18.93 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.761 1.224 . . . . 0.0 111.24 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -53.42 -42.89 67.51 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.382 1.073 . . . . 0.0 110.027 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.9 m -63.07 -49.34 74.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.189 0.595 . . . . 0.0 110.425 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.5 mt -59.14 -46.58 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.719 0.69 . . . . 0.0 109.769 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 mt -66.96 -35.89 80.98 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.075 -0.391 . . . . 0.0 110.559 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -60.24 -45.18 94.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.232 1.013 . . . . 0.0 109.124 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.7 -61.29 2.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.123 1.769 . . . . 0.0 111.654 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.99 -32.97 63.64 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.212 -165.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 125.89 47.11 0.21 Allowed Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 148.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.772 HG23 ' CD2' ' A' ' 125' ' ' TYR . 3.6 p -159.4 44.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-O 123.796 1.76 . . . . 0.0 107.425 -169.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.79 -25.02 26.59 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 118.731 -2.481 . . . . 0.0 112.357 173.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.05 -20.29 17.46 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.553 1.158 . . . . 0.0 111.37 -165.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.772 ' CD2' HG23 ' A' ' 122' ' ' VAL . 35.6 m-85 -62.5 1.94 0.32 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 128.578 2.751 . . . . 0.0 114.245 165.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.518 ' CE2' HG22 ' A' ' 122' ' ' VAL . 8.3 m-85 -141.37 109.02 5.62 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 174.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -53.44 -38.92 64.0 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.809 1.644 . . . . 0.0 111.153 -170.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -150.73 148.48 28.6 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.586 HG23 ' HB ' ' A' ' 105' ' ' ILE . 4.9 mp -126.84 126.48 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.9 mt -84.33 160.93 20.59 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 167.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.1 p -138.51 -177.59 4.92 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.428 1.091 . . . . 0.0 109.177 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.58 -30.1 19.71 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.485 -0.759 . . . . 0.0 111.159 161.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -72.23 -9.31 58.29 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.208 -0.933 . . . . 0.0 112.79 -169.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.8 m -56.73 -60.38 3.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.167 1.387 . . . . 0.0 110.758 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.75 -21.43 23.25 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 117.499 -1.723 . . . . 0.0 112.66 -171.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -51.22 154.53 1.62 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.802 1.801 . . . . 0.0 111.336 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 141' ' ' SER . 1.2 m -45.05 156.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.362 1.465 . . . . 0.0 112.257 170.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -70.66 166.99 19.6 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.603 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -43.69 142.36 1.92 Allowed Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 123.138 0.575 . . . . 0.0 110.669 170.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.98 -26.98 8.51 Favored 'Cis proline' 0 CA--C 1.55 1.282 0 CA-C-N 119.619 0.9 . . . . 0.0 114.154 2.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.495 ' HB2' HG23 ' A' ' 137' ' ' VAL 0.298 2.7 t 53.77 86.47 0.16 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.227 1.811 . . . . 0.0 115.606 172.107 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.15 -19.3 29.85 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.397 2.065 . . . . 0.0 111.843 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.98 -43.57 98.56 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.175 0.898 . . . . 0.0 110.155 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.59 -23.79 67.53 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.31 -55.17 5.46 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.224 -0.923 . . . . 0.0 109.464 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 98.7 m -52.47 -39.84 61.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.302 1.041 . . . . 0.0 110.548 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -50.29 -64.89 0.67 Allowed 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 125.312 1.445 . . . . 0.0 109.735 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.414 HD22 ' CD1' ' A' ' 104' ' ' PHE . 52.2 mt -55.76 -39.71 71.58 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.547 0.612 . . . . 0.0 112.495 -173.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 75.5 mt -65.1 -50.82 64.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.329 1.452 . . . . 0.0 108.506 -176.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.6 -41.35 85.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.387 0.613 . . . . 0.0 111.217 172.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -56.91 -46.37 82.0 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.788 -1.195 . . . . 0.0 112.787 -172.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -121.72 21.36 10.81 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.055 0.843 . . . . 0.0 112.479 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 54.96 67.51 1.01 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.571 1.148 . . . . 0.0 108.973 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 14.7 mt -109.84 -179.74 3.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.09 1.356 . . . . 0.0 108.226 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -121.28 140.04 52.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.337 0.655 . . . . 0.0 110.077 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.9 m -51.03 -46.82 61.73 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.508 1.523 . . . . 0.0 111.84 175.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.28 -30.62 62.18 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.082 -1.011 . . . . 0.0 112.068 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -88.89 13.67 12.16 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -175.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.1 t -108.74 154.6 21.81 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -133.97 143.08 47.95 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 174.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -114.2 159.8 19.71 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.617 1.167 . . . . 0.0 110.825 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.588 HD13 ' CD2' ' A' ' 8' ' ' TRP . 2.7 mp -132.42 125.86 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 119.946 1.248 . . . . 0.0 109.685 177.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -146.63 -170.36 15.04 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 170.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.18 15.8 2.61 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -166.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 -165.0 1.74 Allowed 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.357 1.063 . . . . 0.0 109.848 -164.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.7 t -87.74 -25.06 23.62 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.302 0.641 . . . . 0.0 111.418 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -23.45 51.07 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.969 0.508 . . . . 0.0 111.03 -172.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.64 -30.55 61.17 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.249 1.419 . . . . 0.0 113.141 -172.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -111.49 -8.6 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.055 0.942 . . . . 0.0 110.666 -170.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -64.9 -38.63 91.6 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.757 -1.214 . . . . 0.0 110.041 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.94 -32.24 63.41 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.052 -1.03 . . . . 0.0 110.761 174.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.39 65.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.576 0.625 . . . . 0.0 110.418 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -61.3 -54.09 48.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.596 1.159 . . . . 0.0 113.285 174.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -63.21 -48.61 77.58 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.682 1.128 . . . . 0.0 111.628 -167.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 67.6 m -64.48 -38.06 89.71 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.211 0.604 . . . . 0.0 110.955 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.88 71.23 1.26 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 -169.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 41.3 pt -126.78 -172.84 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 127.477 2.311 . . . . 0.0 107.032 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -95.17 -176.21 3.74 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.994 1.318 . . . . 0.0 109.875 173.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.72 162.92 40.46 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.563 -1.336 . . . . 0.0 109.799 168.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 53.1 mt -132.47 129.14 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -149.86 160.06 43.88 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 120.992 -1.067 . . . . 0.0 110.291 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -74.62 -15.81 60.81 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.37 -0.831 . . . . 0.0 112.002 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 5.7 mt -116.04 156.83 25.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.08 1.752 . . . . 0.0 109.86 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -76.01 153.55 36.42 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.56 -167.83 2.51 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.39 1.076 . . . . 0.0 109.383 165.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.8 p -82.35 -10.97 58.87 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -81.43 177.59 8.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.167 0.987 . . . . 0.0 109.596 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 190' ' ' ASN . 14.3 pt-20 -125.74 -36.32 2.42 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -172.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -75.22 28.37 1.18 Allowed Glycine 0 C--N 1.338 0.678 0 CA-C-N 119.375 0.989 . . . . 0.0 111.621 172.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -100.73 140.49 34.94 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 127.962 2.505 . . . . 0.0 106.397 177.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -121.16 109.32 14.85 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -64.52 129.38 39.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 195' ' ' ALA . 36.0 pt -131.05 176.32 9.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 124.301 1.04 . . . . 0.0 110.167 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -134.72 -16.39 2.02 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.971 1.308 . . . . 0.0 111.888 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 193' ' ' ILE . . . -128.74 -154.59 0.65 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.041 0.837 . . . . 0.0 111.115 173.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -98.9 -27.46 13.89 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.388 0.54 . . . . 0.0 110.409 163.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.02 -25.66 62.77 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 121.156 -0.965 . . . . 0.0 111.997 -167.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -31.6 65.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 129.313 3.045 . . . . 0.0 109.58 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.34 -54.22 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 119.289 0.95 . . . . 0.0 109.388 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.6 m -55.69 -37.68 68.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -60.39 -32.26 71.15 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.177 1.391 . . . . 0.0 112.028 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 93.9 mt -53.56 -43.64 54.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 119.378 0.99 . . . . 0.0 109.556 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -85.09 -41.33 15.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.57 1.548 . . . . 0.0 109.426 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -85.4 36.8 0.65 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.899 1.68 . . . . 0.0 111.027 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 93.3 m 44.85 84.94 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.248 2.219 . . . . 0.0 111.399 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-N 112.97 -1.923 . . . . 0.0 109.832 161.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.756 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -138.63 76.45 1.57 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.295 1.838 . . . . 0.0 107.412 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.8 mmm -126.33 76.79 1.64 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 173.39 0.57 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.029 1.332 . . . . 0.0 109.689 168.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -45.06 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.483 1.913 . . . . 0.0 112.294 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.4 m -117.49 141.68 48.06 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -176.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.7 144.94 51.05 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.313 0.577 . . . . 0.0 109.942 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.59 ' CD2' HD11 ' A' ' 162' ' ' ILE . 2.0 m-85 -131.39 145.47 51.83 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.872 1.669 . . . . 0.0 108.07 -172.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.2 mt -145.22 89.74 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -171.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -78.36 -171.63 2.51 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 119.769 1.168 . . . . 0.0 110.383 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -131.28 164.42 25.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.516 1.526 . . . . 0.0 111.788 172.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.84 -30.41 45.17 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.327 2.251 . . . . 0.0 112.824 176.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -134.08 13.53 3.92 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.785 1.175 . . . . 0.0 113.905 -173.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.32 135.79 12.89 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 163.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.366 6.5 t . . . . . 0 C--O 1.253 1.242 0 C-N-CA 129.346 3.058 . . . . 0.0 114.948 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.458 ' HG ' ' H ' ' A' ' 86' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.458 ' H ' ' HG ' ' A' ' 85' ' ' LEU . 2.0 mpp? -103.83 87.13 1.4 Allowed Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 127.824 2.45 . . . . 0.0 105.775 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -56.66 117.82 4.56 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.504 2.803 . . . . 0.0 109.821 -171.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 127.73 -19.51 5.86 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.488 1.518 . . . . 0.0 111.57 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.413 ' HA ' HD23 ' A' ' 196' ' ' LEU . . . -88.19 -35.68 17.23 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.772 1.286 . . . . 0.0 112.766 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -59.91 -28.37 67.53 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.835 0.743 . . . . 0.0 112.177 -171.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -58.47 -60.66 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.832 1.653 . . . . 0.0 110.63 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.4 t -60.56 -47.63 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 117.843 -1.075 . . . . 0.0 108.952 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.54 ' HA ' HE22 ' A' ' 103' ' ' GLN . 4.6 mp -44.37 -54.23 6.05 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 120.857 1.662 . . . . 0.0 113.521 171.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.82 -38.43 91.08 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.874 0.469 . . . . 0.0 112.085 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -64.73 -54.23 34.8 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.084 0.954 . . . . 0.0 109.173 174.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.75 94.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.537 1.935 . . . . 0.0 112.957 -172.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.78 -55.01 34.68 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.663 1.585 . . . . 0.0 110.774 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.19 -36.72 80.02 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 111.429 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.6 m -65.65 -2.39 3.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.545 1.138 . . . . 0.0 113.272 168.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.81 19.62 73.55 Favored Glycine 0 CA--C 1.525 0.706 0 O-C-N 119.874 -1.766 . . . . 0.0 112.161 174.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.3 mt -75.08 115.53 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -71.0 133.99 46.78 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.54 HE22 ' HA ' ' A' ' 93' ' ' LEU . 8.1 mt-30 -112.83 151.0 30.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -144.32 175.87 9.78 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 126.763 2.025 . . . . 0.0 106.838 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.3 mt -139.88 148.47 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -132.78 100.5 4.95 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.908 0.777 . . . . 0.0 110.323 168.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -103.44 170.84 7.7 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.428 1.109 . . . . 0.0 108.322 169.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -96.16 -9.24 31.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.042 1.337 . . . . 0.0 111.396 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 178.62 5.85 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.184 1.356 . . . . 0.0 112.152 -172.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.62 176.03 36.33 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.13 1.347 . . . . 0.0 112.579 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.57 -16.57 10.55 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.543 2.337 . . . . 0.0 111.792 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -44.56 -30.56 0.92 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.236 1.814 . . . . 0.0 111.3 164.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -44.96 -62.79 1.1 Allowed 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.106 1.763 . . . . 0.0 110.81 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.444 ' CE1' ' HB ' ' A' ' 129' ' ' ILE . 63.4 m-85 -57.07 -38.35 73.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.529 0.732 . . . . 0.0 111.226 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.7 m -63.43 -39.95 95.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.876 0.87 . . . . 0.0 110.701 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.6 mt -57.83 -57.18 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.493 1.042 . . . . 0.0 109.731 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.61 -37.52 84.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.569 1.077 . . . . 0.0 111.31 -173.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -64.69 -45.81 85.06 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.527 0.731 . . . . 0.0 110.582 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -54.46 -53.64 51.52 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.794 0.838 . . . . 0.0 109.437 174.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.0 -14.81 63.26 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.249 1.02 . . . . 0.0 112.894 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.93 32.84 52.24 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.693 171.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.413 HG11 HD11 ' A' ' 85' ' ' LEU . 3.4 m -132.9 14.5 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.407 1.483 . . . . 0.0 111.672 177.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -44.61 55.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 m -61.6 -26.28 67.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CD2' HD23 ' A' ' 93' ' ' LEU . 49.3 m-85 -60.55 -34.12 73.68 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.004 -0.435 . . . . 0.0 111.112 173.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -99.99 94.51 6.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.524 1.53 . . . . 0.0 107.259 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 39.0 m -52.96 -43.46 66.39 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.819 1.648 . . . . 0.0 111.13 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.28 156.81 44.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.824 1.65 . . . . 0.0 107.262 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.444 ' HB ' ' CE1' ' A' ' 114' ' ' PHE . 5.0 mp -137.93 157.03 32.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.5 mt -131.18 156.02 46.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.259 1.824 . . . . 0.0 108.699 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.3 p -158.89 -174.87 4.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.47 1.508 . . . . 0.0 110.367 -151.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.8 p -59.49 -30.87 68.86 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.975 -1.078 . . . . 0.0 112.255 162.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -63.38 -31.3 72.42 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.254 0.934 . . . . 0.0 111.044 -177.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -63.45 -37.24 86.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.006 1.323 . . . . 0.0 111.289 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.97 5.47 70.38 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.458 170.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -58.26 168.46 1.06 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.214 1.507 . . . . 0.0 111.793 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.3 m -53.27 161.79 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.599 1.16 . . . . 0.0 113.407 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -78.1 160.73 27.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.865 1.266 . . . . 0.0 110.526 169.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -58.53 137.9 85.83 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 117.616 -1.183 . . . . 0.0 109.303 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.9 121.72 5.16 Favored 'Cis proline' 0 CA--C 1.536 0.586 0 CA-C-N 120.405 1.181 . . . . 0.0 110.845 -8.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 p -122.08 68.2 26.24 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 125.604 1.562 . . . . 0.0 110.98 -165.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.74 -24.29 47.49 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 CA-C-N 120.127 1.081 . . . . 0.0 112.198 -163.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.5 -44.11 8.38 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 130.08 3.352 . . . . 0.0 111.117 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.31 -19.94 64.71 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.55 -60.25 2.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 m -56.87 -33.59 67.0 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.332 1.053 . . . . 0.0 111.495 -167.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -54.27 -49.37 69.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.595 0.758 . . . . 0.0 111.197 173.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.44 -31.64 65.64 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 124.914 1.286 . . . . 0.0 111.794 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 81.9 mt -61.49 -59.86 4.58 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -174.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -70.54 -17.24 62.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.19 -177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -54.34 -49.1 70.54 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.353 0.979 . . . . 0.0 109.962 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.92 23.57 5.33 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.487 0.66 . . . . 0.0 112.561 -171.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.0 mp0 45.17 46.69 9.87 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.867 2.067 . . . . 0.0 110.648 -171.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 29.0 mt -77.0 164.68 25.53 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 172.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.438 ' CG ' ' H ' ' A' ' 158' ' ' ASN . 26.1 p-10 -104.24 153.53 20.87 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 128.572 2.749 . . . . 0.0 108.533 176.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 48.2 m -62.15 -27.36 68.89 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.645 0.736 . . . . 0.0 109.715 165.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.74 -29.37 25.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.724 -1.235 . . . . 0.0 111.966 -156.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.438 ' H ' ' CG ' ' A' ' 155' ' ' ASN . 3.3 m-80 -102.05 20.64 16.21 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.458 -0.776 . . . . 0.0 109.732 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.8 m -100.4 122.84 43.8 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 178' ' ' GLN . 97.7 m-85 -125.15 148.13 48.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.736 1.614 . . . . 0.0 110.077 -174.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -115.53 -20.22 10.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -168.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.59 HD11 ' CD2' ' A' ' 6' ' ' PHE . 1.6 mp 44.68 74.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 126.944 2.098 . . . . 0.0 112.797 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.56 173.17 17.54 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -125.19 25.6 7.15 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.521 -0.988 . . . . 0.0 112.573 -153.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -145.96 176.59 9.58 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t -70.97 -29.46 65.47 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.82 1.248 . . . . 0.0 111.038 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.67 11.64 14.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.035 0.934 . . . . 0.0 110.481 -177.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.75 -54.47 6.9 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 76.7 t -71.33 -17.1 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 O-C-N 121.382 -0.824 . . . . 0.0 111.762 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -59.94 -61.16 2.82 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.026 1.73 . . . . 0.0 111.355 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -68.95 -31.76 70.87 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 120.391 -1.443 . . . . 0.0 109.959 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.62 72.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.171 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -47.5 -52.58 16.85 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.195 1.398 . . . . 0.0 110.618 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.1 -21.41 60.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.766 -171.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.0 m -81.66 -33.47 31.31 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.446 -0.784 . . . . 0.0 111.072 169.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.11 19.81 54.61 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.278 1.418 . . . . 0.0 112.521 -166.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.7 pt -102.14 174.01 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.331 0 CA-C-N 118.982 1.391 . . . . 0.0 111.51 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 160' ' ' TYR . 23.8 mm-40 -87.74 176.45 7.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.766 1.226 . . . . 0.0 110.338 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 5.5 m -153.09 139.48 18.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.86 1.264 . . . . 0.0 109.768 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.437 HG21 HG12 ' A' ' 199' ' ' ILE . 61.2 mt -123.0 84.25 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -114.63 149.84 36.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.925 0.869 . . . . 0.0 109.972 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -64.42 -14.79 58.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.608 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.74 166.94 10.62 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.254 1.422 . . . . 0.0 110.183 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -95.07 163.55 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.563 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.0 t -151.14 -175.04 5.0 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.239 1.816 . . . . 0.0 107.352 168.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.6 p -115.57 71.8 0.78 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 170.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -142.28 137.11 30.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.99 91.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.412 1.885 . . . . 0.0 108.695 167.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 133.98 -3.51 4.52 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 117.941 -1.477 . . . . 0.0 113.255 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.46 131.28 34.41 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.525 2.163 . . . . 0.0 106.422 171.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.61 118.76 25.47 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.782 1.233 . . . . 0.0 108.804 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -67.23 147.63 52.79 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.471 0.578 . . . . 0.0 112.039 176.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.5 pt -141.59 164.88 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.876 1.67 . . . . 0.0 111.505 168.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -121.09 -15.37 8.23 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.833 1.653 . . . . 0.0 112.468 171.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.72 164.99 33.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.009 1.724 . . . . 0.0 107.192 171.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 89' ' ' ALA . 1.4 mp -61.14 -30.69 70.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.114 0.966 . . . . 0.0 109.787 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.07 64.92 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -64.77 -22.64 67.03 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.943 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.437 HG12 HG21 ' A' ' 180' ' ' ILE . 96.7 mt -55.27 -57.36 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 83.5 p -50.09 -39.4 42.44 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.444 0.64 . . . . 0.0 112.237 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -67.7 -29.4 68.65 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 125.499 1.52 . . . . 0.0 111.515 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.9 mt -52.37 -48.03 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -86.72 -0.88 57.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.263 1.425 . . . . 0.0 112.226 -173.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -119.88 14.04 12.38 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.276 1.43 . . . . 0.0 111.543 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 58.6 m 57.06 87.3 0.06 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.791 1.636 . . . . 0.0 111.143 -167.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 N--CA 1.426 -1.649 0 C-N-CA 127.246 2.219 . . . . 0.0 113.616 147.547 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.693 0 CA-C-O 119.644 -0.531 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 52.18 4.57 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 128.569 2.748 . . . . 0.0 118.294 167.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.1 mmm 55.63 62.23 2.51 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 123.306 1.527 . . . . 0.0 110.039 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -80.77 122.05 26.68 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.3 mtpp 43.08 58.94 3.1 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 161.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.3 m -103.69 149.56 24.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.43 146.14 51.32 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 121.7 -0.625 . . . . 0.0 109.962 173.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.14 149.93 51.63 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 125.29 1.436 . . . . 0.0 108.373 -173.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.7 mt -140.56 131.94 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -120.82 148.49 43.95 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.524 1.53 . . . . 0.0 110.371 -173.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -89.48 -37.73 14.56 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.277 -0.889 . . . . 0.0 112.315 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.16 -20.45 0.08 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 129.374 3.07 . . . . 0.0 114.157 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.78 25.09 1.33 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.701 1.591 . . . . 0.0 110.372 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.07 1.24 0.41 Allowed Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.233 -1.315 . . . . 0.0 115.471 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.37 0 CA-C-O 115.919 -1.991 . . . . 0.0 106.17 161.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.509 HD13 ' H ' ' A' ' 86' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.509 ' H ' HD13 ' A' ' 85' ' ' LEU . 1.8 mmt -118.04 87.27 28.04 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.771 2.028 . . . . 0.0 109.487 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -66.1 94.74 0.3 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 124.555 3.503 . . . . 0.0 109.843 -175.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.08 -27.53 2.65 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 113.801 -1.545 . . . . 0.0 112.162 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.78 -34.81 26.93 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 119.295 1.547 . . . . 0.0 111.173 -170.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -51.73 -35.44 43.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.325 1.05 . . . . 0.0 111.969 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -45.09 -56.93 4.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.819 2.448 . . . . 0.0 111.079 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.99 -39.83 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.985 1.714 . . . . 0.0 110.052 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.2 mt -51.52 -46.65 63.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.939 1.245 . . . . 0.0 110.078 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.66 -56.03 26.17 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 123.694 0.797 . . . . 0.0 111.257 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.46 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 15.4 t90 -52.57 -46.75 67.0 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.925 1.29 . . . . 0.0 111.198 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.62 82.78 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.159 0.984 . . . . 0.0 111.75 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.94 -42.65 69.57 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.664 0.786 . . . . 0.0 111.017 -177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -60.4 -34.14 73.49 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.54 1.136 . . . . 0.0 110.701 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 m -78.09 -4.52 47.75 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.587 1.155 . . . . 0.0 113.549 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.71 27.26 58.73 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 119.768 1.167 . . . . 0.0 112.969 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.7 mt -60.81 124.67 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 163.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -74.04 103.32 4.47 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -91.29 137.87 32.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.235 0.47 . . . . 0.0 110.21 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -138.44 173.15 11.91 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.036 1.735 . . . . 0.0 110.51 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.417 ' HB ' HG23 ' A' ' 129' ' ' ILE . 17.6 mt -146.62 150.83 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.229 1.412 . . . . 0.0 108.777 -172.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -158.44 124.94 4.72 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.329 1.452 . . . . 0.0 111.935 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 t -155.8 171.39 20.11 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.642 1.177 . . . . 0.0 111.579 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -65.05 -26.36 68.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.263 1.825 . . . . 0.0 111.917 165.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -61.91 136.38 57.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.43 -161.95 28.29 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 124.146 0.879 . . . . 0.0 112.705 -170.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.406 ' ND2' ' HG3' ' A' ' 133' ' ' GLN . 32.0 m120 -47.24 -30.8 3.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.982 2.113 . . . . 0.0 111.999 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -58.45 -24.91 61.52 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.926 -1.109 . . . . 0.0 113.374 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.64 -35.31 77.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.333 0.97 . . . . 0.0 111.636 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -62.06 -40.77 96.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.312 0.96 . . . . 0.0 109.699 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.2 m -63.44 -41.9 98.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.975 1.31 . . . . 0.0 109.533 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 93.0 mt -57.56 -52.39 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.262 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.26 -41.17 96.46 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 120.834 1.652 . . . . 0.0 111.828 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -66.44 -27.81 68.11 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.786 0.721 . . . . 0.0 112.429 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -65.19 -49.1 71.07 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.534 1.159 . . . . 0.0 109.134 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 53.5 mt -73.89 -11.94 60.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.428 1.891 . . . . 0.0 112.123 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.15 19.37 78.59 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 118.878 -0.957 . . . . 0.0 113.253 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.6 18.17 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 119.072 1.436 . . . . 0.0 111.143 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -49.78 67.7 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.866 -0.521 . . . . 0.0 111.021 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.0 t -67.5 -22.44 65.45 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.724 0.64 . . . . 0.0 112.422 -168.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -59.7 -32.35 70.43 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 119.024 0.829 . . . . 0.0 111.644 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.12 122.68 45.19 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -173.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -61.48 -45.12 95.57 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -157.69 145.24 18.54 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -169.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.417 HG23 ' HB ' ' A' ' 105' ' ' ILE . 4.3 mp -135.14 131.54 52.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.406 0.622 . . . . 0.0 109.879 -170.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -89.23 162.92 15.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.034 0.921 . . . . 0.0 110.265 170.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 41.7 p -155.46 -179.06 7.73 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.555 1.542 . . . . 0.0 107.556 -171.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -22.12 1.7 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 168.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.406 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 91.5 mm-40 -67.39 -58.8 4.12 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.004 0.82 . . . . 0.0 110.357 173.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 61.6 m -99.95 55.36 0.93 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.91 -20.74 75.62 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.12 -171.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 45.0 -167.56 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 126.407 1.883 . . . . 0.0 112.863 -165.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.488 HG23 ' CB ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -54.68 172.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 127.281 2.232 . . . . 0.0 112.252 173.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -59.54 152.71 21.33 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.743 169.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -48.23 138.14 11.0 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 117.666 -1.159 . . . . 0.0 108.968 162.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.87 -43.97 0.42 Allowed 'Cis proline' 0 CA--C 1.533 0.458 0 CA-C-N 120.453 1.198 . . . . 0.0 113.822 6.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.488 ' CB ' HG23 ' A' ' 137' ' ' VAL . 3.6 t 55.17 81.45 0.26 Allowed Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.672 1.189 . . . . 0.0 111.679 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.3 -16.62 52.2 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.487 2.125 . . . . 0.0 111.462 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -55.4 -48.53 74.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.261 1.391 . . . . 0.0 110.824 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.99 -18.83 64.68 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.76 -52.9 5.72 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 118.194 -0.907 . . . . 0.0 108.982 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.5 m -54.44 -38.33 66.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.455 0.702 . . . . 0.0 110.157 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -54.52 -58.53 7.1 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.612 1.165 . . . . 0.0 110.403 171.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 22.2 mt -65.59 -27.72 68.62 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.561 1.073 . . . . 0.0 112.093 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 75.8 mt -65.9 -59.75 3.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.52 -30.72 69.92 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.314 1.046 . . . . 0.0 113.131 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.544 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 5.6 mmpt? -57.42 -35.31 69.91 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.09 -1.006 . . . . 0.0 112.092 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.99 24.23 2.18 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 49.94 47.73 22.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.195 1.798 . . . . 0.0 110.235 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 59.3 mt -83.6 165.55 18.94 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.441 1.096 . . . . 0.0 109.395 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -106.34 134.43 49.48 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 124.144 0.977 . . . . 0.0 108.829 -171.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 m -60.47 -42.2 95.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.492 0.663 . . . . 0.0 109.74 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -74.02 -24.82 59.62 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 120.793 -1.192 . . . . 0.0 112.58 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -92.95 5.59 50.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.917 -1.039 . . . . 0.0 109.429 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -107.32 146.97 30.89 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -132.04 167.45 19.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.873 1.669 . . . . 0.0 107.612 -176.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -143.37 151.38 40.37 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.593 0.757 . . . . 0.0 109.968 173.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.6 mt -138.45 118.82 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.49 -6.55 0.03 OUTLIER Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.904 -175.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.456 ' HB2' ' CD1' ' A' ' 182' ' ' PHE . 40.5 t0 56.16 67.69 0.97 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.132 2.573 . . . . 0.0 112.356 169.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -153.94 167.96 27.99 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 120.879 -1.138 . . . . 0.0 110.936 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.0 t -61.25 -44.53 97.09 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.293 0.568 . . . . 0.0 109.989 167.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -5.21 14.28 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.755 1.622 . . . . 0.0 112.3 -171.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -54.52 38.5 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.526 1.13 . . . . 0.0 109.786 171.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 185' ' ' SER . 25.7 m -70.76 -30.45 42.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 118.248 -1.381 . . . . 0.0 111.688 -170.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -61.5 -48.69 79.94 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.825 0.85 . . . . 0.0 109.827 -172.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -80.02 -39.95 28.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.601 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.0 78.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.622 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -61.2 -53.77 52.71 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.833 0.853 . . . . 0.0 110.833 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -64.81 -34.96 79.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.574 -0.25 . . . . 0.0 110.975 -172.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.4 m -69.96 -34.98 74.1 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.096 0.862 . . . . 0.0 112.826 168.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.07 44.93 6.11 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.865 1.222 . . . . 0.0 111.785 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 10.9 pt -116.09 -179.14 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.565 1.546 . . . . 0.0 108.806 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -103.52 165.75 10.84 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.371 0.605 . . . . 0.0 109.745 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 143.27 38.55 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.987 0.915 . . . . 0.0 108.804 -163.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 62.7 mt -133.92 100.18 3.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.454 ' HB2' HD12 ' A' ' 183' ' ' LEU . 18.6 p30 -123.78 158.12 32.46 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.634 1.174 . . . . 0.0 109.947 -176.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 164' ' ' ASP . 64.3 m-85 -86.33 -3.16 58.94 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.229 -1.544 . . . . 0.0 111.218 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 181' ' ' ASN . 0.3 OUTLIER -129.34 155.8 45.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.427 1.891 . . . . 0.0 110.432 -174.324 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -74.79 142.24 44.27 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.451 ' HB3' HG21 ' A' ' 169' ' ' VAL . 0.6 OUTLIER -144.73 177.68 8.53 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.412 1.485 . . . . 0.0 107.996 173.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 32.8 p -93.15 59.65 3.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.126 1.37 . . . . 0.0 110.774 -160.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -142.93 175.06 10.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.972 0.509 . . . . 0.0 112.238 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.84 -3.37 12.2 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 0.0 113.588 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -118.94 9.1 12.43 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.434 1.492 . . . . 0.0 112.417 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.12 138.02 33.24 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 119.15 1.475 . . . . 0.0 107.462 173.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -112.64 107.08 15.64 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -59.69 142.64 52.65 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.438 168.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.6 pt -131.64 165.59 31.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.635 1.574 . . . . 0.0 110.126 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -117.83 -16.3 9.97 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.011 0.924 . . . . 0.0 113.401 169.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.35 165.18 32.78 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.584 1.154 . . . . 0.0 109.021 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 30.6 mt -63.44 -44.55 94.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.232 1.813 . . . . 0.0 107.63 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.42 -15.01 63.4 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.88 -22.89 64.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.337 1.426 . . . . 0.0 110.407 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 19.8 mt -55.83 -53.43 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.049 1.34 . . . . 0.0 109.55 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.46 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 8.6 m -60.06 -32.89 71.36 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.93 1.241 . . . . 0.0 111.898 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -65.02 -26.65 68.37 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 118.3 -0.857 . . . . 0.0 112.227 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.55 -55.97 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.0 10.45 18.95 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.019 1.328 . . . . 0.0 113.62 -169.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -119.99 -1.29 10.44 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.552 1.141 . . . . 0.0 112.458 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.1 m -131.28 24.81 4.86 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.431 0.693 . . . . 0.0 111.878 -172.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 51.6 mttm . . . . . 0 C--O 1.247 0.963 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 170.598 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.243 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -144.55 117.12 8.61 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.664 0.732 . . . . 0.0 110.135 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 mmm -134.9 45.32 2.55 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.07 1.748 . . . . 0.0 110.043 -172.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 55.49 -171.46 0.07 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.938 1.295 . . . . 0.0 113.117 175.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -78.8 79.4 5.21 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 152.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 m -101.99 146.59 27.67 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.97 149.41 51.71 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 121.501 -0.749 . . . . 0.0 109.242 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -123.13 156.73 34.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.903 1.281 . . . . 0.0 108.03 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.2 mt -140.74 135.84 34.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -120.54 161.66 20.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.011 0.924 . . . . 0.0 111.068 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -102.91 -4.18 25.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.549 1.54 . . . . 0.0 111.941 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.2 tp 46.95 73.3 0.19 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 128.837 2.855 . . . . 0.0 111.347 -175.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -146.22 -159.37 1.01 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.25 1.36 49.95 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.064 -1.409 . . . . 0.0 114.309 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.2 m . . . . . 0 C--O 1.257 1.465 0 C-N-CA 126.493 1.917 . . . . 0.0 107.426 166.129 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.456 HD21 HG11 ' A' ' 122' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.502 -0.872 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 23.6 tpp -103.37 88.07 1.57 Allowed Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -175.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -53.6 121.12 8.94 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.346 2.031 . . . . 0.0 108.189 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.16 -41.8 1.72 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -168.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.24 -32.39 49.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.644 -0.915 . . . . 0.0 111.038 -169.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -32.16 67.45 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.637 -176.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.32 -49.1 77.18 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.425 1.09 . . . . 0.0 111.563 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.9 t -77.55 -43.82 29.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 CA-C-O 117.552 -1.214 . . . . 0.0 109.678 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 mp -44.0 -56.18 4.15 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.649 1.58 . . . . 0.0 111.153 170.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.55 -54.92 41.38 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.74 0.416 . . . . 0.0 110.874 -177.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -56.71 -43.25 80.4 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.106 1.363 . . . . 0.0 112.502 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.5 -38.36 49.14 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.368 1.067 . . . . 0.0 112.049 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.89 -41.47 74.69 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.676 0.79 . . . . 0.0 110.845 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -61.03 -15.53 33.16 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.76 -0.587 . . . . 0.0 111.4 170.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.0 m -108.24 5.96 26.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.182 1.793 . . . . 0.0 113.468 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.06 8.72 55.05 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.671 1.129 . . . . 0.0 113.695 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.4 mt -55.5 120.5 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -71.05 92.68 0.97 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 172.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -71.95 151.56 43.17 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 168.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -141.78 172.59 12.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.008 2.123 . . . . 0.0 107.383 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.535 ' HB ' HG23 ' A' ' 129' ' ' ILE . 16.9 mt -136.4 155.07 33.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 171.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -136.46 115.38 12.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 164.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.3 t -121.88 157.04 32.02 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.206 1.003 . . . . 0.0 108.971 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -63.57 -30.2 71.35 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.014 165.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -61.58 142.2 57.27 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.198 1.799 . . . . 0.0 109.898 -166.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.5 -170.02 39.09 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.351 -0.843 . . . . 0.0 112.348 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -52.05 -24.94 7.51 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 128.387 2.675 . . . . 0.0 116.015 -163.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -69.91 -11.46 60.89 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.982 0.81 . . . . 0.0 112.154 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.37 80.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.23 1.012 . . . . 0.0 110.953 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -48.4 -46.39 37.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.038 1.335 . . . . 0.0 110.454 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 m -70.88 -37.92 73.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.383 1.073 . . . . 0.0 111.382 -171.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.4 mt -60.77 -45.95 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.13 1.372 . . . . 0.0 108.9 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.33 -35.5 75.98 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.012 -1.055 . . . . 0.0 111.582 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -50.17 73.44 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.289 0.635 . . . . 0.0 109.692 170.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -48.96 -48.13 43.37 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.962 0.905 . . . . 0.0 111.544 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.35 -10.36 59.39 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.097 1.359 . . . . 0.0 113.281 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.01 23.48 78.07 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.78 0.705 . . . . 0.0 114.27 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.456 HG11 HD21 ' A' ' 85' ' ' LEU . 13.3 m -124.23 13.46 4.86 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 C-N-CA 125.027 1.331 . . . . 0.0 110.471 176.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -43.06 99.51 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.885 1.22 . . . . 0.0 110.617 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.1 m -74.21 3.0 7.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.458 1.503 . . . . 0.0 112.68 -175.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -80.12 -0.28 35.17 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.605 164.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -144.58 133.02 21.95 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.532 1.515 . . . . 0.0 108.728 -173.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.2 m -60.75 -68.86 0.26 Allowed 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 127.979 2.512 . . . . 0.0 112.072 -174.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -138.81 123.61 18.73 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.155 1.382 . . . . 0.0 107.726 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.535 HG23 ' HB ' ' A' ' 105' ' ' ILE . 5.1 mp -105.54 98.16 6.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 -172.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.73 HD12 ' CB ' ' A' ' 134' ' ' SER . 4.2 mm? -70.55 147.41 49.32 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.1 p -127.63 -168.78 1.94 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.506 2.322 . . . . 0.0 110.696 -172.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 t -56.96 -23.12 43.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.072 1.349 . . . . 0.0 113.426 166.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -64.98 -22.51 67.01 Favored 'General case' 0 C--O 1.228 -0.079 0 C-N-CA 124.014 0.926 . . . . 0.0 111.073 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.73 ' CB ' HD12 ' A' ' 130' ' ' LEU . 1.0 OUTLIER -110.07 72.52 0.8 Allowed 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 128.719 2.807 . . . . 0.0 105.597 177.251 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.36 48.68 3.67 Favored Glycine 0 N--CA 1.458 0.13 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -61.49 117.57 5.88 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.823 0.312 . . . . 0.0 110.723 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 138' ' ' ARG . 18.1 t 54.75 -165.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 124.906 1.283 . . . . 0.0 109.982 167.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.695 ' H ' HG12 ' A' ' 137' ' ' VAL . 82.6 mtt180 -128.12 0.4 5.84 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.036 -1.665 . . . . 0.0 114.521 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt 98.23 112.73 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.486 0 C-N-CA 129.003 2.921 . . . . 0.0 107.532 166.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -61.17 154.63 56.4 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 120.729 1.296 . . . . 0.0 111.79 6.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.406 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 3.0 p -142.17 82.2 13.46 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.726 1.211 . . . . 0.0 111.57 -171.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.42 -20.24 24.22 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.08 2.52 . . . . 0.0 113.965 -177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -69.57 -27.16 64.89 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.209 -0.932 . . . . 0.0 112.034 -170.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.65 94.99 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.79 85.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.34 -0.85 . . . . 0.0 110.144 173.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.9 m -53.85 -40.38 66.44 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.155 1.343 . . . . 0.0 111.158 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -61.76 -48.97 78.27 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.7 mp -62.59 -37.98 88.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.809 1.244 . . . . 0.0 111.496 -172.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 86.7 mt -64.51 -54.13 37.11 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.12 -35.94 76.38 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -56.92 -29.01 62.7 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 120.714 -1.241 . . . . 0.0 112.856 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -138.07 19.52 2.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 48.59 70.19 0.48 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.862 1.665 . . . . 0.0 110.654 -173.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 76.0 mt -109.33 -176.2 2.96 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.184 1.394 . . . . 0.0 109.99 -172.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.08 129.1 52.08 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.465 1.106 . . . . 0.0 109.905 -172.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.37 -17.47 20.42 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 125.165 1.386 . . . . 0.0 112.007 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.413 ' HA ' HE22 ' A' ' 178' ' ' GLN . 0.3 OUTLIER -118.49 19.36 13.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.498 -0.751 . . . . 0.0 109.839 -174.024 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -128.3 8.61 6.05 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.87 1.668 . . . . 0.0 110.917 170.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 159' ' ' THR . 1.8 t -91.23 158.95 16.3 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.897 1.679 . . . . 0.0 109.783 176.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -147.84 105.47 3.69 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.015 -1.053 . . . . 0.0 109.64 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -85.6 133.07 34.07 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.093 0.957 . . . . 0.0 111.571 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.78 105.53 18.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.681 1.192 . . . . 0.0 109.056 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.37 -164.45 11.76 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.879 1.704 . . . . 0.0 110.859 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -136.91 -9.67 1.8 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.9 158.07 32.78 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.904 1.683 . . . . 0.0 110.912 -170.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.9 t -54.82 -32.3 60.22 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.618 -0.676 . . . . 0.0 112.489 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.6 -28.55 69.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.894 0.878 . . . . 0.0 110.507 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -69.9 -0.99 8.27 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.908 1.683 . . . . 0.0 112.024 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.2 t -120.48 -17.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 125.284 1.434 . . . . 0.0 109.61 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -65.93 -58.5 5.41 Favored 'General case' 0 C--N 1.338 0.101 0 O-C-N 120.916 -1.115 . . . . 0.0 108.734 168.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -63.75 -33.86 76.61 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.202 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.58 97.58 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.913 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -62.54 -43.59 98.43 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.338 0.972 . . . . 0.0 111.08 171.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -64.61 -37.9 89.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 117.705 -1.141 . . . . 0.0 112.464 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.4 p -79.14 -36.8 39.92 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.834 1.652 . . . . 0.0 110.778 168.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.26 65.61 1.26 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -172.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.39 174.61 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 127.295 2.238 . . . . 0.0 108.587 174.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.413 HE22 ' HA ' ' A' ' 157' ' ' ASP . 14.0 mp0 -96.16 170.08 9.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.81 1.644 . . . . 0.0 111.96 -176.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.6 m -143.36 156.92 44.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.842 1.657 . . . . 0.0 111.729 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.2 mt -136.47 104.28 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -126.32 161.65 27.33 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.677 1.591 . . . . 0.0 107.43 -173.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -75.48 -13.19 60.36 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.685 -1.259 . . . . 0.0 112.903 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.3 pp -129.9 166.13 20.64 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.44 1.896 . . . . 0.0 110.16 -175.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -96.29 159.04 15.16 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.123 0.487 . . . . 0.0 111.268 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 38.6 m -151.65 27.91 0.63 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.821 1.649 . . . . 0.0 111.081 -168.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 63.4 p 56.5 10.44 0.68 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.917 2.887 . . . . 0.0 116.037 173.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -106.07 153.26 22.31 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.616 1.567 . . . . 0.0 110.465 -168.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.502 ' HG3' ' H ' ' A' ' 189' ' ' GLY . 0.3 OUTLIER -56.5 -77.48 0.03 OUTLIER 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.756 2.022 . . . . 0.0 112.215 -175.349 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.502 ' H ' ' HG3' ' A' ' 188' ' ' GLU . . . -75.93 18.33 3.26 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.448 1.975 . . . . 0.0 112.978 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -90.91 112.27 24.05 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.586 1.693 . . . . 0.0 107.28 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -101.84 127.87 48.46 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 25.0 mtm105 -68.57 148.12 50.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.283 0.492 . . . . 0.0 110.384 166.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.3 pt -135.36 170.19 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.325 1.85 . . . . 0.0 110.243 167.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -126.59 -10.75 6.21 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.554 1.142 . . . . 0.0 113.043 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.27 171.54 18.97 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.11 1.764 . . . . 0.0 108.117 172.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.53 -42.42 87.27 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.334 1.054 . . . . 0.0 109.703 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.1 -27.43 69.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.94 -22.78 62.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.238 1.815 . . . . 0.0 111.07 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 94.1 mt -57.4 -56.9 12.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 125.341 1.456 . . . . 0.0 108.863 171.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 80.3 p -53.06 -43.61 66.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.96 0.8 . . . . 0.0 111.483 -172.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -63.1 -21.99 66.56 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.912 1.685 . . . . 0.0 112.973 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.87 -42.96 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.838 0.744 . . . . 0.0 109.581 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -89.66 -32.57 16.99 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.62 0.768 . . . . 0.0 110.897 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -75.77 1.36 15.0 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.443 1.097 . . . . 0.0 112.878 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.328 13.4 t 46.57 53.88 9.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.998 2.119 . . . . 0.0 111.468 -168.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.257 1.469 0 C-N-CA 126.242 1.817 . . . . 0.0 112.034 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.924 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -77.52 -13.46 59.91 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -175.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mmm 51.12 78.93 0.1 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.837 1.655 . . . . 0.0 111.635 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.5 167.04 0.07 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.419 1.888 . . . . 0.0 110.106 164.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 73.78 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.812 2.445 . . . . 0.0 114.365 -171.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.7 m -86.63 160.84 18.77 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 119.46 -2.025 . . . . 0.0 107.875 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.8 151.02 48.7 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.738 -1.226 . . . . 0.0 109.338 165.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -122.74 154.01 38.7 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.214 1.406 . . . . 0.0 108.857 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.46 135.3 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -120.52 143.47 48.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.346 1.858 . . . . 0.0 109.046 -176.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.36 -32.81 66.78 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.446 1.021 . . . . 0.0 111.341 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tm? 60.94 120.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 128.81 2.844 . . . . 0.0 112.723 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.9 t0 62.77 34.82 14.29 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.738 1.215 . . . . 0.0 108.845 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.92 36.35 0.09 OUTLIER Glycine 0 CA--C 1.528 0.865 0 C-N-CA 129.222 3.296 . . . . 0.0 109.066 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.244 0.779 0 N-CA-C 101.604 -3.48 . . . . 0.0 101.604 174.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.65 ' HG ' ' H ' ' A' ' 86' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.65 ' H ' ' HG ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -104.32 87.56 1.72 Allowed Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 129.91 3.284 . . . . 0.0 106.271 177.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -59.66 107.16 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.633 2.889 . . . . 0.0 109.048 -176.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.68 -9.58 3.14 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-O 116.725 -2.153 . . . . 0.0 112.933 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.63 -16.78 13.17 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 120.411 2.106 . . . . 0.0 114.845 -170.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -61.9 -37.86 86.18 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.473 -1.392 . . . . 0.0 112.823 -171.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.28 -54.6 29.26 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.533 1.933 . . . . 0.0 112.203 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.04 -33.54 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.634 1.107 . . . . 0.0 110.732 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.2 mt -57.1 -55.26 36.97 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.97 -13.69 62.35 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.636 1.175 . . . . 0.0 113.542 -174.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -79.74 -55.49 4.96 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 120.486 -1.384 . . . . 0.0 108.426 170.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.99 -37.81 86.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.236 1.414 . . . . 0.0 111.779 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.36 -51.34 66.32 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.789 1.636 . . . . 0.0 111.12 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -65.1 -17.5 64.51 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.163 1.385 . . . . 0.0 110.743 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.7 m -94.61 -1.58 52.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.292 1.437 . . . . 0.0 112.799 176.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.54 5.11 72.2 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.036 1.303 . . . . 0.0 113.571 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.1 mt -56.51 112.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -64.81 101.82 0.52 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 171.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.58 150.18 26.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.325 0.966 . . . . 0.0 108.413 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -146.5 171.84 14.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.413 1.885 . . . . 0.0 108.834 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 129' ' ' ILE . 18.6 mt -136.12 156.88 37.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.692 1.197 . . . . 0.0 109.222 171.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -139.76 125.45 19.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.131 0.973 . . . . 0.0 109.112 164.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.7 t -154.09 178.3 10.12 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.552 2.341 . . . . 0.0 108.26 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -137.27 15.53 3.0 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.883 -1.136 . . . . 0.0 113.805 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -11.08 3.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 121.73 167.23 13.09 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 128.043 2.735 . . . . 0.0 110.118 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -52.02 -31.68 30.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.961 1.704 . . . . 0.0 111.367 170.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -53.0 -17.37 1.41 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.436 1.494 . . . . 0.0 114.026 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.19 -47.22 62.27 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.488 1.115 . . . . 0.0 111.028 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -56.78 -48.61 77.49 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.854 1.661 . . . . 0.0 109.93 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.6 m -55.43 -49.78 71.53 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.275 0.489 . . . . 0.0 109.795 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.8 mt -59.33 -47.91 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.79 -37.36 84.41 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.837 -1.165 . . . . 0.0 112.045 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.424 ' HE2' ' OE2' ' A' ' 123' ' ' GLU . 19.5 mtmt -59.71 -48.03 83.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.138 -0.934 . . . . 0.0 109.668 175.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -43.62 95.53 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.532 1.133 . . . . 0.0 111.303 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.87 -4.1 35.93 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.194 0.998 . . . . 0.0 112.531 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.17 -3.22 58.8 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 126.192 1.853 . . . . 0.0 114.993 173.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 85' ' ' LEU . 10.5 m -92.53 3.33 7.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 118.921 1.36 . . . . 0.0 110.064 -170.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.424 ' OE2' ' HE2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -63.51 -27.34 69.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.433 1.015 . . . . 0.0 111.052 171.794 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.3 m -58.86 -15.26 11.75 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.465 -0.778 . . . . 0.0 112.684 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -96.9 3.05 52.33 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.043 -1.456 . . . . 0.0 114.295 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.449 ' HB2' HD11 ' A' ' 129' ' ' ILE . 52.3 m-85 -133.7 111.71 10.8 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 122.06 2.209 . . . . 0.0 109.471 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.2 m -58.14 -39.91 79.97 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.92 1.688 . . . . 0.0 110.466 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -145.5 158.82 43.78 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.673 1.189 . . . . 0.0 108.007 167.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.536 HG23 ' HB ' ' A' ' 105' ' ' ILE . 5.3 mp -130.99 117.6 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.439 HD21 ' CE1' ' A' ' 147' ' ' TYR . 12.2 mt -71.63 165.98 22.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.719 0.771 . . . . 0.0 110.218 174.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.8 p -151.06 176.95 10.66 Favored 'General case' 0 C--O 1.231 0.088 0 O-C-N 121.466 -0.771 . . . . 0.0 110.498 -170.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.0 t -48.7 -33.84 10.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.037 0.935 . . . . 0.0 111.978 163.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -71.82 -6.67 43.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.204 1.402 . . . . 0.0 112.21 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.0 m -147.94 49.12 1.06 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 128.121 2.569 . . . . 0.0 105.229 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.05 -29.67 72.27 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.894 -166.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 45.23 -164.65 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.314 1.846 . . . . 0.0 112.595 -163.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.43 162.1 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.631 1.172 . . . . 0.0 112.224 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -65.77 146.02 55.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.13 0.572 . . . . 0.0 110.374 168.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.41 133.52 13.11 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 116.872 -1.537 . . . . 0.0 110.194 166.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.29 126.07 9.55 Favored 'Cis proline' 0 C--N 1.348 0.552 0 CA-C-N 120.487 1.21 . . . . 0.0 111.498 -5.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 p -130.29 78.63 74.11 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 124.779 1.232 . . . . 0.0 112.035 -158.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.89 -30.41 48.93 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 121.916 1.744 . . . . 0.0 113.323 -174.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -53.41 -44.81 69.04 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.713 -1.242 . . . . 0.0 113.333 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.74 -18.72 63.05 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.86 -0.59 . . . . 0.0 112.527 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.08 -53.41 7.04 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 119.115 0.87 . . . . 0.0 109.523 172.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 m -56.73 -41.46 77.52 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.371 1.469 . . . . 0.0 110.503 -174.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.439 ' CE1' HD21 ' A' ' 130' ' ' LEU . 4.0 t80 -56.86 -43.25 81.0 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.422 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.4 mt -78.35 -27.56 47.03 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 78.8 mt -59.37 -61.78 2.37 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 168.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.12 -17.84 64.97 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -64.78 -29.52 70.49 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.43 -1.419 . . . . 0.0 112.789 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -147.07 29.7 0.97 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.092 1.314 . . . . 0.0 112.468 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 54.82 45.12 27.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.608 1.563 . . . . 0.0 111.321 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 68.1 mt -95.34 170.87 9.07 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.422 -0.799 . . . . 0.0 110.0 -170.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -112.07 141.55 45.61 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.244 -0.91 . . . . 0.0 113.111 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 m -57.23 -49.87 74.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.817 0.847 . . . . 0.0 110.252 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.99 -16.83 60.61 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.532 0.682 . . . . 0.0 112.356 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -92.4 -3.09 55.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.701 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 t -101.36 135.61 42.58 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.62 1.1 . . . . 0.0 109.664 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -125.91 112.9 16.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -77.69 159.04 29.39 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.792 0.437 . . . . 0.0 110.525 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 49.4 mt -131.09 92.82 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 127.917 2.487 . . . . 0.0 104.511 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -124.41 169.31 16.46 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.786 1.184 . . . . 0.0 110.388 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -135.21 3.15 3.1 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.915 1.286 . . . . 0.0 113.225 -166.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.28 144.41 25.54 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 119.182 0.901 . . . . 0.0 111.231 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 88.68 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.01 2.124 . . . . 0.0 111.822 -170.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 174.05 -29.62 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 128.691 2.796 . . . . 0.0 107.664 -176.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -52.55 -43.64 65.34 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 126.368 1.867 . . . . 0.0 111.436 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 79.7 t -77.8 -26.19 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 125.184 1.394 . . . . 0.0 111.821 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.32 -38.42 91.08 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.526 -0.734 . . . . 0.0 111.614 -165.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -82.52 -30.77 29.58 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.686 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.34 89.99 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.838 0.855 . . . . 0.0 109.183 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -54.24 -49.67 68.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.655 1.582 . . . . 0.0 111.08 173.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -63.84 -44.24 93.75 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.83 -0.544 . . . . 0.0 110.811 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.0 m -75.0 -21.04 59.38 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.26 44.03 77.06 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.314 0.959 . . . . 0.0 112.171 -169.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.3 pt -110.6 168.73 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 118.094 0.947 . . . . 0.0 108.737 169.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -105.22 171.05 7.53 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.625 0.726 . . . . 0.0 110.626 -170.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.74 135.06 18.2 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 121.672 -0.643 . . . . 0.0 110.224 -157.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 42.9 mt -130.54 105.08 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 176.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -136.98 157.59 46.39 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.233 1.413 . . . . 0.0 111.148 -168.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -77.36 -12.43 59.95 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.32 -0.863 . . . . 0.0 112.371 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.14 156.61 38.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.984 0.914 . . . . 0.0 109.99 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.644 ' HA ' HD21 ' A' ' 190' ' ' ASN . 8.7 pt-20 -93.03 163.36 13.68 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.313 0.578 . . . . 0.0 110.835 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 44.8 t -145.6 179.8 7.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.13 1.772 . . . . 0.0 108.521 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . 0.303 0.2 OUTLIER -78.06 -22.36 49.19 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.701 -1.249 . . . . 0.0 111.333 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -71.19 121.8 19.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.1 1.36 . . . . 0.0 109.909 -174.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -64.79 -17.51 64.27 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.25 8.5 60.86 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.778 -1.012 . . . . 0.0 113.028 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.644 HD21 ' HA ' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -104.51 105.37 15.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 120.11 1.955 . . . . 0.0 110.043 -177.279 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -94.99 111.75 23.52 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.023 0.929 . . . . 0.0 109.613 -174.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 144.28 56.85 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.526 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.6 pt -137.42 171.36 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 126.922 2.089 . . . . 0.0 112.556 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -122.36 -21.29 5.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.475 1.51 . . . . 0.0 113.227 167.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -151.23 167.49 27.64 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.71 0.686 . . . . 0.0 109.244 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 62.3 mt -74.32 -26.46 60.17 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 119.158 0.89 . . . . 0.0 110.277 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.45 -13.54 62.41 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.234 0.925 . . . . 0.0 112.514 174.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 201' ' ' ARG . 31.5 t0 -79.06 -13.53 59.71 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.667 -1.27 . . . . 0.0 108.864 174.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.76 -57.07 11.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 167.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.6 p -59.96 -36.05 76.29 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.021 0.828 . . . . 0.0 111.499 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ARG . . . . . 0.413 ' HG2' ' HA ' ' A' ' 198' ' ' ASP . 18.0 ptt180 -64.78 -34.78 79.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.101 0.864 . . . . 0.0 111.477 -172.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.8 mt -50.07 -57.63 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.144 1.777 . . . . 0.0 108.812 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -72.14 -0.67 12.5 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.821 0.849 . . . . 0.0 113.276 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -121.09 4.43 10.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.083 1.353 . . . . 0.0 110.892 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 m -132.35 47.0 2.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.918 1.287 . . . . 0.0 110.561 -177.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt . . . . . 0 C--O 1.251 1.151 0 C-N-CA 128.486 2.714 . . . . 0.0 114.557 171.389 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 CA-C-O 118.808 -0.996 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . 0.273 6.8 p80 43.53 78.54 0.05 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.694 1.997 . . . . 0.0 115.898 162.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mmm -135.17 89.56 2.53 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.413 1.885 . . . . 0.0 105.949 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.53 179.64 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.045 164.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -44.36 106.49 0.07 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.499 1.12 . . . . 0.0 108.797 169.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.3 m -129.83 151.34 50.52 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 170.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.35 156.9 48.18 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.43 0.692 . . . . 0.0 109.44 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 199' ' ' ILE . 1.4 m-85 -132.36 147.93 52.41 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.396 1.479 . . . . 0.0 109.213 -173.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp -132.1 129.46 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -103.49 164.75 11.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.301 1.04 . . . . 0.0 109.009 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.79 176.33 6.67 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.807 0.843 . . . . 0.0 109.891 171.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.6 mt -138.54 1.73 2.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.771 1.228 . . . . 0.0 111.147 -171.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -86.8 41.73 0.98 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.039 1.335 . . . . 0.0 111.086 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.6 -106.04 1.06 Allowed Glycine 0 C--N 1.331 0.277 0 N-CA-C 107.355 -2.298 . . . . 0.0 107.355 -173.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.02 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -161.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.469 ' HG ' ' H ' ' A' ' 86' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.469 ' H ' ' HG ' ' A' ' 85' ' ' LEU . 1.6 mpp? -104.82 86.27 1.43 Allowed Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.623 1.969 . . . . 0.0 107.583 166.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.99 99.84 0.49 Allowed 'Trans proline' 0 C--N 1.349 0.564 1 C-N-CA 125.599 4.199 . . . . 0.0 112.736 -164.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.62 -29.91 1.29 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 125.482 1.515 . . . . 0.0 109.742 -168.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.32 -34.09 23.77 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.186 0.993 . . . . 0.0 110.915 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -54.11 -36.37 63.16 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 119.109 0.868 . . . . 0.0 111.725 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.81 -35.97 79.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.724 1.21 . . . . 0.0 112.882 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.3 -48.95 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 118.293 -0.86 . . . . 0.0 108.949 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.448 ' HA ' HE22 ' A' ' 103' ' ' GLN . 2.4 mp -44.3 -52.39 7.61 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 120.636 1.562 . . . . 0.0 113.287 170.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.82 96.29 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.41 0.684 . . . . 0.0 111.22 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 20.6 t90 -57.95 -49.44 76.78 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.551 1.141 . . . . 0.0 110.812 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.7 78.78 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.929 1.291 . . . . 0.0 113.24 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.95 -44.42 85.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 122.941 0.496 . . . . 0.0 110.374 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -51.15 -49.8 60.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.194 1.397 . . . . 0.0 110.154 168.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.2 m -68.94 -12.81 61.99 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.03 16.06 77.59 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 120.014 1.279 . . . . 0.0 113.605 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.1 mt -68.44 133.16 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.025 1.33 . . . . 0.0 108.32 170.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -83.14 118.67 23.74 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.448 HE22 ' HA ' ' A' ' 93' ' ' LEU . 12.4 mt-30 -99.07 154.24 18.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -147.84 166.33 27.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.909 1.684 . . . . 0.0 108.565 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 42.6 mt -137.43 158.94 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.754 1.622 . . . . 0.0 107.14 166.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.522 ' O ' HG22 ' A' ' 107' ' ' THR . 4.3 t80 -131.77 -85.9 0.48 Allowed 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 124.779 1.231 . . . . 0.0 108.034 166.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 106' ' ' TYR 0.255 15.3 t 65.04 164.98 0.16 Allowed 'General case' 0 C--N 1.315 -0.894 1 C-N-CA 136.816 6.047 . . . . 0.0 113.958 177.772 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -80.41 4.04 19.37 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.395 1.078 . . . . 0.0 111.346 166.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -57.87 156.05 9.57 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.201 -1.562 . . . . 0.0 108.221 167.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.07 171.36 53.58 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-O 122.19 0.884 . . . . 0.0 111.107 173.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -44.87 -28.15 0.61 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 130.025 3.33 . . . . 0.0 114.944 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -63.89 -12.79 39.86 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 120.279 1.399 . . . . 0.0 112.311 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.52 -47.88 38.75 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.88 1.218 . . . . 0.0 111.573 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -56.8 -49.59 74.89 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.606 0.639 . . . . 0.0 110.238 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.7 m -59.39 -42.62 92.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.793 0.837 . . . . 0.0 111.129 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.73 -48.8 87.03 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 119.319 0.963 . . . . 0.0 108.716 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.28 -44.24 95.62 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.878 -0.514 . . . . 0.0 110.457 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -59.26 -51.3 70.54 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.403 1.081 . . . . 0.0 110.836 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -51.13 -56.52 12.3 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.26 1.424 . . . . 0.0 110.583 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.49 -9.73 37.43 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.046 1.338 . . . . 0.0 113.613 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.61 25.81 69.08 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 123.983 0.801 . . . . 0.0 112.525 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 85' ' ' LEU . 11.3 m -135.53 57.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.43 -46.94 10.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.901 160.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.9 m -73.62 -14.59 61.2 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -164.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -63.44 -33.83 76.43 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.393 1.451 . . . . 0.0 110.507 170.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -90.82 115.48 27.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.5 m -44.74 -65.95 0.46 Allowed 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 127.016 2.126 . . . . 0.0 108.669 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.07 140.07 43.5 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.5 mt -110.36 148.69 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 171.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 45.9 mt -119.13 -166.89 1.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -173.26 -178.96 1.83 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.607 1.963 . . . . 0.0 107.888 167.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 m -44.53 -45.27 9.25 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.119 0.872 . . . . 0.0 110.458 167.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -70.2 -9.38 55.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.096 1.758 . . . . 0.0 112.96 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.7 m -59.35 -24.04 63.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.839 1.256 . . . . 0.0 110.973 163.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.12 -8.18 77.96 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-O 118.019 -1.434 . . . . 0.0 114.018 170.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -56.56 165.99 1.01 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.783 1.292 . . . . 0.0 111.161 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 m -44.73 155.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.158 1.783 . . . . 0.0 111.786 170.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -69.84 -76.77 0.09 Allowed 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -165.47 159.59 13.84 Favored Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 124.33 1.052 . . . . 0.0 109.804 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -64.16 136.97 26.24 Favored 'Cis proline' 0 N--CA 1.458 -0.601 0 N-CA-C 108.703 -1.307 . . . . 0.0 108.703 -17.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.0 p -124.99 68.78 56.82 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.621 0.768 . . . . 0.0 111.917 -157.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -61.95 -29.45 82.06 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.388 2.059 . . . . 0.0 111.98 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -48.41 -41.08 28.04 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.624 1.97 . . . . 0.0 112.39 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.61 2.47 16.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.518 1.527 . . . . 0.0 112.623 -175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.84 -39.42 2.73 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.868 1.667 . . . . 0.0 108.727 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 m -49.99 -38.78 38.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.086 1.312 . . . . 0.0 110.456 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.653 ' HD1' HD12 ' A' ' 148' ' ' LEU . 53.7 t80 -52.01 -57.94 7.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.099 1.36 . . . . 0.0 110.76 171.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.653 HD12 ' HD1' ' A' ' 147' ' ' TYR . 9.0 mp -58.58 -37.96 76.88 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.896 1.678 . . . . 0.0 112.755 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.0 mt -59.83 -57.96 10.65 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -175.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -75.18 -32.98 61.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.754 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 4.0 mmpt? -50.76 -53.32 32.63 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.801 -1.187 . . . . 0.0 111.8 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -115.23 8.86 15.62 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 54.26 66.71 1.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 123.064 1.411 . . . . 0.0 109.235 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.17 162.17 13.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.899 1.68 . . . . 0.0 107.784 169.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -106.39 -4.82 19.51 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 125.235 2.445 . . . . 0.0 117.458 -161.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.0 m 76.27 -55.95 0.58 Allowed 'General case' 0 N--CA 1.411 -2.381 0 CA-C-N 110.647 -2.978 . . . . 0.0 109.07 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.84 -2.13 38.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 O-C-N 120.881 -1.137 . . . . 0.0 112.941 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -98.35 -5.34 33.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 116.916 -1.516 . . . . 0.0 111.186 168.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -103.45 137.37 41.64 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.669 1.577 . . . . 0.0 108.099 -174.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -128.42 111.17 13.02 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.963 1.705 . . . . 0.0 109.263 -172.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -85.89 153.38 22.26 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.406 HD11 ' CD2' ' A' ' 6' ' ' PHE . 3.5 mt -133.01 119.55 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.85 -161.68 9.64 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -139.53 12.88 2.54 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.456 ' HB3' ' H ' ' A' ' 167' ' ' LEU . 3.0 mmt-85 -115.68 162.67 16.92 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 122.839 1.304 . . . . 0.0 111.489 -172.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 t -62.46 -26.95 68.79 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.297 -0.877 . . . . 0.0 109.538 163.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.456 ' H ' ' HB3' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -60.27 -29.82 69.05 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.487 1.515 . . . . 0.0 111.529 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -45.7 -44.93 13.97 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.104 1.762 . . . . 0.0 110.852 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.628 HG21 ' HB2' ' A' ' 185' ' ' SER . 28.4 m -90.69 -15.5 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.55 -50.79 49.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.081 -1.012 . . . . 0.0 108.69 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -79.3 -33.4 43.3 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.343 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.92 -42.64 90.17 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.378 172.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -61.16 -49.77 75.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.866 1.212 . . . . 0.0 111.151 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -58.32 -25.37 61.82 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 74.9 m -86.03 -50.86 6.73 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.795 1.18 . . . . 0.0 110.615 165.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 96.09 63.17 0.95 Allowed Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -164.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.9 pt -131.11 173.14 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.577 1.951 . . . . 0.0 106.286 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -99.65 165.83 11.42 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 -171.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 39.4 m -136.26 155.36 50.22 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.637 1.175 . . . . 0.0 110.57 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 34.3 mt -140.66 74.81 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -96.14 169.64 9.81 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.842 0.829 . . . . 0.0 110.157 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -88.25 2.14 52.98 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.532 -1.355 . . . . 0.0 111.951 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.06 132.78 19.96 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 124.72 2.2 . . . . 0.0 115.414 -175.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.24 138.65 58.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.568 -2.105 . . . . 0.0 109.4 -167.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.628 ' HB2' HG21 ' A' ' 169' ' ' VAL . 74.9 p -137.91 163.4 31.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.093 0.557 . . . . 0.0 110.704 -162.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 24.4 p -75.68 45.16 0.31 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.527 1.931 . . . . 0.0 111.55 173.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -131.34 175.67 8.93 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.95 -1.094 . . . . 0.0 109.717 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -98.26 -67.84 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.768 0.827 . . . . 0.0 109.202 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -73.15 51.49 1.68 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.984 2.231 . . . . 0.0 113.319 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -121.26 119.6 32.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.376 1.07 . . . . 0.0 108.766 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -106.67 106.56 17.15 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.815 0.846 . . . . 0.0 109.94 -172.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.66 139.85 58.81 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.8 pt -129.98 167.66 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.142 1.377 . . . . 0.0 113.084 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.26 -17.59 8.22 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.972 1.309 . . . . 0.0 113.52 168.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.63 168.69 26.62 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 18.4 mt -70.37 -38.58 74.79 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -171.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.12 -18.07 63.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.82 -0.55 . . . . 0.0 112.329 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.94 -21.34 66.81 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.223 -0.923 . . . . 0.0 110.686 176.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.436 HG21 ' CE2' ' A' ' 6' ' ' PHE . 72.7 mt -61.46 -50.52 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 118.161 -0.924 . . . . 0.0 109.132 176.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' SER . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 94.4 p -58.04 -41.09 82.54 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.32 0.964 . . . . 0.0 110.364 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ARG . . . . . 0.542 ' O ' HG22 ' A' ' 205' ' ' THR . 8.5 mtp-105 -58.98 -39.59 82.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.329 -176.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.6 mt -52.62 -51.96 30.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 118.983 0.81 . . . . 0.0 109.988 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -73.78 -35.76 64.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -74.9 -5.35 43.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 201' ' ' ARG . 5.3 t -130.98 23.88 4.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.88 0.848 . . . . 0.0 110.328 -176.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp . . . . . 0 C--O 1.256 1.396 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 158.335 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -115.94 23.91 11.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.156 0.982 . . . . 0.0 112.11 -168.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mmm -98.63 82.92 2.9 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -167.13 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 129.402 3.081 . . . . 0.0 111.272 161.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -57.28 109.94 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 119.543 -1.973 . . . . 0.0 107.72 168.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.5 m -130.37 152.59 49.61 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 166.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.57 150.3 46.19 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.262 -0.899 . . . . 0.0 109.652 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -124.9 160.9 27.77 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.588 1.555 . . . . 0.0 110.211 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 mt -138.19 149.53 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -134.95 168.15 19.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.635 2.374 . . . . 0.0 109.598 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -123.46 24.67 8.55 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.721 2.008 . . . . 0.0 111.666 -171.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt 60.4 96.42 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.438 2.695 . . . . 0.0 112.791 172.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t70 71.24 20.06 5.19 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.977 1.711 . . . . 0.0 112.979 169.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.73 12.31 15.35 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 117.377 1.711 . . . . 0.0 117.377 -164.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 55.3 p . . . . . 0 C--O 1.255 1.348 0 CA-C-N 120.131 1.965 . . . . 0.0 110.208 -168.702 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.506 HD13 ' H ' ' A' ' 86' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.506 ' H ' HD13 ' A' ' 85' ' ' LEU . 2.1 mmm -118.4 86.98 29.3 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 128.087 2.555 . . . . 0.0 110.121 178.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -64.85 94.34 0.22 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 1 C-N-CA 125.438 4.092 . . . . 0.0 110.37 -173.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.71 -37.38 0.96 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 126.608 2.052 . . . . 0.0 110.503 -176.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.25 -25.88 22.61 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -171.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.464 ' HA ' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -68.11 -24.13 64.99 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 118.974 -2.329 . . . . 0.0 111.97 -176.018 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -61.01 -45.72 93.67 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.952 0.901 . . . . 0.0 109.745 174.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.75 -44.39 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 123.88 0.872 . . . . 0.0 109.486 -170.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.61 HD23 ' CD2' ' A' ' 125' ' ' TYR . 4.4 mp -44.3 -44.73 8.28 Favored 'General case' 0 N--CA 1.418 -2.068 0 C-N-CA 126.125 1.77 . . . . 0.0 111.519 169.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.57 -33.57 66.85 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.593 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -65.09 -55.3 19.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.853 1.261 . . . . 0.0 109.827 170.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.28 -36.42 77.8 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.752 1.621 . . . . 0.0 112.527 -174.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.19 -57.96 8.79 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.744 1.218 . . . . 0.0 111.687 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -60.82 -24.39 65.82 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.617 0.723 . . . . 0.0 112.363 175.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.1 m -78.28 -6.02 53.77 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.33 -0.856 . . . . 0.0 112.634 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.39 15.34 81.08 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 124.228 0.918 . . . . 0.0 112.653 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.5 mt -70.5 120.7 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 118.834 1.317 . . . . 0.0 107.726 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -75.13 105.28 6.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 167.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.452 HE22 ' HA ' ' A' ' 93' ' ' LEU . 19.4 mt-30 -88.65 150.56 22.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -142.28 169.16 18.11 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.432 1.093 . . . . 0.0 108.94 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.3 mt -131.63 149.67 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -121.7 141.87 50.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 157.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.4 t -163.25 -176.0 4.57 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.196 2.199 . . . . 0.0 105.719 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -134.11 9.22 3.79 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.844 0.858 . . . . 0.0 112.755 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -1.55 8.11 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.47 174.31 34.01 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 125.821 1.677 . . . . 0.0 111.019 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -52.61 -27.5 17.25 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.084 0.954 . . . . 0.0 112.293 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -54.7 -17.87 3.94 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 177.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.57 -46.99 49.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.8 1.182 . . . . 0.0 112.223 171.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -60.32 -47.38 86.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.435 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.6 m -56.15 -49.83 72.86 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.732 0.696 . . . . 0.0 109.45 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.2 mt -58.89 -48.49 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.01 -38.42 91.13 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 121.326 -0.859 . . . . 0.0 112.235 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -48.85 80.05 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.54 -36.01 82.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.505 0.593 . . . . 0.0 111.354 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.83 -8.22 57.74 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.476 1.11 . . . . 0.0 112.05 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 57.12 33.49 64.69 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 125.44 1.495 . . . . 0.0 113.248 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.79 14.1 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.512 1.156 . . . . 0.0 110.36 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -41.37 97.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.186 0.994 . . . . 0.0 111.176 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 t -65.52 -31.02 71.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.688 -169.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.61 ' CD2' HD23 ' A' ' 93' ' ' LEU . 37.8 m-85 -56.01 -43.91 78.19 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.553 0.615 . . . . 0.0 111.461 174.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -97.19 95.58 7.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -166.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.4 m -44.66 -49.83 10.18 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.566 1.546 . . . . 0.0 109.682 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.44 147.44 34.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.96 119.31 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 134' ' ' SER . 4.3 mm? -82.0 163.94 21.79 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.582 0.705 . . . . 0.0 109.63 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.8 p -148.11 -174.2 4.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.239 1.019 . . . . 0.0 112.687 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.6 t -55.25 -15.51 2.47 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 162.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -73.32 -38.8 65.68 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 120.018 1.281 . . . . 0.0 110.499 173.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.713 ' HB3' HD12 ' A' ' 130' ' ' LEU . 2.6 p -77.71 77.6 4.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.25 45.76 1.21 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 125.058 1.313 . . . . 0.0 111.224 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -62.8 166.9 5.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.244 0.545 . . . . 0.0 111.227 168.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.9 m -53.35 161.43 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 127.149 2.18 . . . . 0.0 112.852 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.418 ' NE ' ' H ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -83.35 156.07 23.2 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.398 -0.814 . . . . 0.0 110.659 170.349 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -51.02 139.49 23.09 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.631 1.572 . . . . 0.0 110.442 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.71 123.58 5.74 Favored 'Cis proline' 0 CA--C 1.537 0.644 0 CA-C-N 120.416 1.184 . . . . 0.0 110.099 -9.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.72 ' H ' ' HB3' ' A' ' 171' ' ' PHE . 2.8 p -128.84 81.26 71.16 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 126.398 1.879 . . . . 0.0 110.954 -162.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.62 -9.12 16.0 Favored 'Trans proline' 0 CA--C 1.551 1.334 0 C-N-CA 123.556 2.838 . . . . 0.0 114.635 -173.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.13 -44.73 94.69 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.022 1.283 . . . . 0.0 111.875 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -51.58 -45.47 63.13 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 124.064 0.946 . . . . 0.0 110.669 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.13 -34.77 75.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.769 -0.582 . . . . 0.0 112.139 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.1 m -68.51 -32.21 72.01 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.636 0.774 . . . . 0.0 110.364 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -65.19 -49.73 68.65 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.47 -38.48 80.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.062 0.945 . . . . 0.0 111.332 -176.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -58.05 -68.12 0.28 Allowed 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 173.787 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -53.43 -46.56 69.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.852 0.72 . . . . 0.0 112.012 -171.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -51.72 -36.0 45.19 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -121.69 12.45 10.66 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.76 0.709 . . . . 0.0 111.539 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 47.16 50.35 14.3 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.84 2.456 . . . . 0.0 110.283 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 66.1 mt -76.85 -172.59 2.34 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.685 1.994 . . . . 0.0 110.105 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -129.34 134.42 47.89 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.79 1.236 . . . . 0.0 107.778 -170.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.8 p -59.35 -40.17 85.55 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 119.522 1.056 . . . . 0.0 111.198 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -75.12 -22.78 57.97 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.529 -0.732 . . . . 0.0 111.943 -172.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -95.82 2.53 53.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.462 -0.773 . . . . 0.0 109.43 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.6 m -96.57 126.56 41.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.702 1.201 . . . . 0.0 108.052 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -112.18 155.75 23.44 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -120.98 163.61 18.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.964 1.706 . . . . 0.0 106.694 161.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.4 mt -126.59 107.63 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 173.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -119.69 177.23 16.34 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.49 166.18 18.45 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 156.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 75.43 156.62 0.18 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 126.689 1.996 . . . . 0.0 111.389 -176.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 t -69.83 -30.1 67.52 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.83 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -25.06 45.29 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.437 1.095 . . . . 0.0 112.631 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -79.68 13.04 2.24 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.479 1.912 . . . . 0.0 111.558 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 1.2 p -109.12 -16.32 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.277 1.031 . . . . 0.0 110.553 163.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -73.9 -52.62 12.36 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.121 1.328 . . . . 0.0 110.805 -168.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.72 ' HB3' ' H ' ' A' ' 141' ' ' SER . 1.4 p90 -63.28 -29.39 70.72 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 120.971 -1.081 . . . . 0.0 111.916 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.47 -52.55 64.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 118.761 -0.637 . . . . 0.0 109.302 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -49.11 -60.88 2.41 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.127 1.371 . . . . 0.0 110.708 170.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -68.33 -14.51 63.05 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -170.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.5 p -95.62 -23.4 17.05 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 120.73 1.604 . . . . 0.0 112.229 165.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.1 22.42 38.36 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.145 1.355 . . . . 0.0 112.515 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.2 pp -99.16 175.2 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.855 1.327 . . . . 0.0 109.982 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -117.65 162.07 18.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.619 1.168 . . . . 0.0 110.29 -173.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 12.4 m -139.33 143.98 38.06 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.76 1.224 . . . . 0.0 110.348 -165.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 73.6 mt -119.95 92.11 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -111.5 158.98 18.54 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 121.819 0.819 . . . . 0.0 108.956 -172.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -74.18 -6.5 48.15 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.517 -1.365 . . . . 0.0 112.835 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.99 158.81 41.75 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 126.83 2.052 . . . . 0.0 109.159 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.84 160.86 28.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 19.0 t -147.22 174.83 11.25 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.6 169.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.4 p -83.95 63.98 7.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.023 2.529 . . . . 0.0 108.434 -173.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -144.6 178.86 7.67 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.771 2.028 . . . . 0.0 108.355 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -113.38 -35.95 5.13 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.431 1.469 . . . . 0.0 110.459 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -86.19 15.48 49.14 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 127.368 2.413 . . . . 0.0 112.77 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -84.75 152.87 23.39 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 120.621 2.211 . . . . 0.0 107.372 159.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -131.04 148.86 52.8 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 169.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 146.56 25.59 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.273 0.629 . . . . 0.0 110.85 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 18.6 pt -140.03 162.68 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.219 1.008 . . . . 0.0 112.0 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -108.86 -27.02 9.96 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -168.08 145.59 4.25 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -163.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 196' ' ' LEU . 2.9 tp -61.74 -30.91 71.09 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 127.186 2.194 . . . . 0.0 111.497 -158.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.92 -11.87 50.43 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -77.16 -13.14 59.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.816 0.846 . . . . 0.0 109.6 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 39.7 mt -56.34 -59.37 2.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 83.1 p -53.89 -37.9 64.22 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -175.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -61.35 -34.64 75.63 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.77 0.828 . . . . 0.0 112.141 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 76.0 mt -58.22 -34.69 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.985 0.914 . . . . 0.0 110.729 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -91.48 -4.91 55.03 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 120.974 -1.079 . . . . 0.0 112.291 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -120.55 4.54 10.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.828 1.651 . . . . 0.0 111.036 -171.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.13 33.93 2.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.844 1.258 . . . . 0.0 112.819 -173.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.284 27.1 pttt . . . . . 0 C--O 1.249 1.027 0 C-N-CA 126.969 2.107 . . . . 0.0 113.1 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.826 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -158.98 73.3 0.6 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.469 1.108 . . . . 0.0 111.169 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 mmm -119.1 34.24 5.31 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.278 -0.889 . . . . 0.0 112.549 -166.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.73 -169.04 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.508 1.523 . . . . 0.0 111.965 171.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -80.32 48.64 1.04 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 119.857 -1.777 . . . . 0.0 108.23 165.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.9 m -69.3 143.75 53.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.28 149.47 50.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -125.53 152.91 44.39 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.484 1.114 . . . . 0.0 108.972 -172.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.5 mt -134.49 146.04 31.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 169.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -123.78 171.64 9.47 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.809 2.044 . . . . 0.0 107.82 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.18 164.33 15.75 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 165.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -121.56 141.85 50.67 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.03 0.832 . . . . 0.0 109.185 -168.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 61.58 4.47 1.03 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.008 1.723 . . . . 0.0 112.687 -168.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -103.43 -88.67 2.07 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.296 2.9 t . . . . . 0 C--O 1.252 1.212 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 172.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 119.858 -0.115 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . 0.263 3.7 tpt 40.52 76.48 0.5 Allowed Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 124.688 1.195 . . . . 0.0 114.127 135.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -64.6 103.76 0.49 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 123.032 2.488 . . . . 0.0 108.246 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 124.68 -13.12 7.75 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.055 1.312 . . . . 0.0 113.71 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.18 70.85 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 121.009 2.404 . . . . 0.0 107.928 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.89 -24.08 67.6 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 118.402 -0.809 . . . . 0.0 112.697 -172.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -60.26 -58.46 8.41 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.64 -44.44 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 117.018 -1.468 . . . . 0.0 112.228 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.614 HD23 ' CG ' ' A' ' 125' ' ' TYR . 3.7 mp -52.68 -48.35 66.59 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 122.13 2.241 . . . . 0.0 112.368 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.89 -49.08 79.12 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 124.804 1.315 . . . . 0.0 109.552 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -53.57 -48.08 69.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.632 -0.699 . . . . 0.0 111.191 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.64 74.83 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.895 0.77 . . . . 0.0 111.752 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -73.45 -40.89 63.83 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.286 1.834 . . . . 0.0 110.711 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.25 -1.28 4.3 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.227 1.811 . . . . 0.0 111.309 168.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 58.3 m -118.88 -6.6 10.53 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.423 1.489 . . . . 0.0 114.273 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.38 9.14 77.1 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.101 -1.624 . . . . 0.0 115.654 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 93.5 mt -45.63 147.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 149.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -98.65 115.4 28.59 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 167.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.471 HE22 ' HA ' ' A' ' 93' ' ' LEU . 5.3 mt-30 -88.67 150.75 22.85 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -140.0 164.95 28.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 125.12 1.368 . . . . 0.0 107.967 171.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.6 mt -124.51 149.86 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 161.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -129.16 143.84 51.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 152.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.4 t -151.6 163.5 38.93 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.863 1.265 . . . . 0.0 109.585 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -92.64 -0.39 57.31 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.983 -0.448 . . . . 0.0 111.962 165.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -59.19 153.0 19.28 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 119.477 1.035 . . . . 0.0 108.571 166.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -80.93 -175.21 49.6 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.72 -18.18 7.6 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.501 1.521 . . . . 0.0 114.038 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -58.63 -18.1 27.68 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.617 1.099 . . . . 0.0 112.119 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.36 69.69 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.078 0.951 . . . . 0.0 110.366 175.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -57.15 -48.86 77.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -48.03 83.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.829 2.052 . . . . 0.0 111.252 -174.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.13 -50.61 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.481 1.112 . . . . 0.0 108.165 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.89 -37.28 87.11 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 122.16 -0.337 . . . . 0.0 111.162 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -49.1 77.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.517 1.127 . . . . 0.0 109.608 174.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -50.46 73.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 124.016 0.926 . . . . 0.0 110.679 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.54 -40.2 77.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.544 -174.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.41 50.82 0.79 Allowed Glycine 0 C--N 1.339 0.697 0 CA-C-O 121.563 0.535 . . . . 0.0 111.825 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.317 1.3 p -147.61 8.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 129.912 3.285 . . . . 0.0 109.384 -170.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -34.25 77.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 120.768 -1.208 . . . . 0.0 113.028 174.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -15.91 53.71 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.576 0.547 . . . . 0.0 111.774 -168.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.614 ' CG ' HD23 ' A' ' 93' ' ' LEU . 13.1 m-85 -66.23 -30.77 71.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -174.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 5.8 m-85 -110.8 129.4 55.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 -167.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.7 m -55.31 -30.87 61.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.383 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -154.28 151.83 29.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.229 1.012 . . . . 0.0 109.093 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.85 77.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 174.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.4 mt -66.2 147.19 53.7 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 57.8 p -122.96 177.96 5.27 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.061 0.944 . . . . 0.0 110.14 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 t -45.91 -37.61 6.56 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.993 0.917 . . . . 0.0 110.604 165.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -62.32 -18.37 61.2 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.3 p -48.37 -48.89 36.33 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.169 0.895 . . . . 0.0 112.277 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.96 -5.81 56.53 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 117.688 -1.618 . . . . 0.0 112.852 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -60.65 163.12 5.76 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.617 1.708 . . . . 0.0 110.904 172.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.2 m -52.73 156.29 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 126.973 2.109 . . . . 0.0 112.555 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -81.19 154.58 26.6 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.666 0.786 . . . . 0.0 108.924 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -54.66 144.29 45.52 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.282 1.033 . . . . 0.0 113.148 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.58 135.53 35.98 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 N-CA-C 108.261 -1.477 . . . . 0.0 108.261 -8.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 p -128.43 61.28 53.24 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.223 0.609 . . . . 0.0 111.84 -157.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.56 -24.22 77.65 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.164 2.576 . . . . 0.0 113.155 -167.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -51.33 -38.56 53.69 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 120.897 -1.127 . . . . 0.0 112.366 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.671 ' O ' HD13 ' A' ' 148' ' ' LEU . . . -74.3 4.86 5.15 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.236 1.014 . . . . 0.0 112.702 -178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.71 -40.67 5.67 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.686 163.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.2 m -55.21 -35.45 64.91 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.415 1.007 . . . . 0.0 110.65 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.694 ' HD1' HD12 ' A' ' 148' ' ' LEU . 47.8 t80 -66.07 -49.37 67.86 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.574 0.75 . . . . 0.0 110.922 171.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.694 HD12 ' HD1' ' A' ' 147' ' ' TYR . 8.1 mp -67.43 -14.11 62.63 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.441 1.496 . . . . 0.0 113.171 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 92.1 mt -84.22 -53.48 5.47 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.877 2.071 . . . . 0.0 107.826 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.28 -37.55 85.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -174.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -54.87 -20.0 7.81 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.478 1.911 . . . . 0.0 115.125 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -158.38 22.52 0.24 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.843 2.457 . . . . 0.0 112.71 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 49.25 46.8 22.76 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.004 1.721 . . . . 0.0 113.462 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 30.0 mt -78.45 169.18 18.66 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.251 1.02 . . . . 0.0 109.899 -177.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -108.37 130.94 55.2 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 123.229 0.611 . . . . 0.0 109.958 -174.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.4 m -60.14 -43.96 95.31 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.944 0.898 . . . . 0.0 110.16 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.83 -23.68 59.68 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.633 -1.292 . . . . 0.0 113.449 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -93.2 3.86 54.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.067 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -102.16 126.06 49.03 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -106.46 163.75 12.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -139.67 127.54 22.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 173.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 7.4 mt -98.91 116.92 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.884 1.674 . . . . 0.0 107.003 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.95 -164.97 10.1 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.466 1.508 . . . . 0.0 110.071 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -138.23 -1.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -172.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.09 169.14 13.71 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 122.404 1.097 . . . . 0.0 111.505 -160.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.1 t -59.63 -32.24 70.25 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.571 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.75 -17.25 64.0 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.566 -1.334 . . . . 0.0 111.864 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -83.95 1.7 42.31 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.076 -1.015 . . . . 0.0 111.933 -165.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.8 p -91.87 -28.44 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 O-C-N 121.401 -0.812 . . . . 0.0 112.148 158.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -67.23 -58.26 5.17 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 120.087 1.312 . . . . 0.0 111.399 -161.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -55.9 -45.12 78.75 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.645 1.178 . . . . 0.0 111.915 170.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.91 79.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 122.63 0.372 . . . . 0.0 111.409 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -59.12 -46.11 89.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.396 1.878 . . . . 0.0 109.822 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -59.71 -45.02 93.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.657 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 74.6 m -81.22 -22.14 39.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.87 61.75 2.99 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.474 1.035 . . . . 0.0 110.693 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.0 -173.22 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.749 2.02 . . . . 0.0 109.058 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -111.81 166.01 11.56 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.992 0.917 . . . . 0.0 110.146 -176.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 32.7 m -145.19 151.57 38.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.355 1.062 . . . . 0.0 112.387 -170.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.5 mt -138.0 101.95 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.06 160.88 36.92 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 120.867 -1.145 . . . . 0.0 109.209 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -73.52 0.42 12.54 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.297 -0.877 . . . . 0.0 111.362 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 22.8 mt -114.01 154.7 27.2 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 125.728 1.611 . . . . 0.0 109.54 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -79.94 154.13 28.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 164.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.8 m -136.67 163.85 29.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.876 1.671 . . . . 0.0 107.218 173.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 62.0 p -93.38 64.56 3.71 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -169.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -146.52 162.19 38.87 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.687 1.195 . . . . 0.0 109.8 -170.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.8 -54.86 6.55 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.893 0.877 . . . . 0.0 110.774 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.15 24.48 6.15 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 125.074 1.321 . . . . 0.0 113.774 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -85.45 111.27 19.81 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 125.407 1.483 . . . . 0.0 108.31 171.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -99.23 125.0 44.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 168.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.2 148.47 30.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.737 -0.649 . . . . 0.0 109.394 169.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 13.6 pt -133.96 156.94 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.982 0.913 . . . . 0.0 112.457 172.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 -97.06 -29.63 13.52 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.446 1.098 . . . . 0.0 111.913 164.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.72 162.15 39.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.64 1.576 . . . . 0.0 108.496 -167.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.49 -43.92 88.7 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -60.59 -19.63 58.23 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.79 0.723 . . . . 0.0 112.7 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.42 -21.53 66.67 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.038 0.835 . . . . 0.0 112.031 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 67.1 mt -50.91 -60.2 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.6 m -61.89 -32.27 72.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.164 0.893 . . . . 0.0 112.008 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -62.18 -35.33 78.5 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.204 -0.935 . . . . 0.0 111.231 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 36.1 mt -54.87 -55.08 17.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 124.767 1.227 . . . . 0.0 109.273 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -67.58 -5.65 16.4 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.285 0.634 . . . . 0.0 112.054 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -121.14 8.5 10.36 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.659 2.383 . . . . 0.0 109.953 -173.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.3 m -151.33 62.0 0.89 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.067 2.147 . . . . 0.0 106.347 170.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? . . . . . 0 C--O 1.25 1.1 0 C-N-CA 129.317 3.047 . . . . 0.0 112.399 176.375 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.855 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 44.81 62.82 1.93 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.235 1.814 . . . . 0.0 113.572 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' CE ' HD11 ' A' ' 101' ' ' ILE . 61.2 mmm -123.75 85.02 2.35 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 122.814 1.292 . . . . 0.0 107.552 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.01 175.24 0.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.413 162.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.66 101.14 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.72 1.208 . . . . 0.0 109.747 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.9 m -122.88 152.7 40.51 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -175.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.69 152.62 44.05 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.426 0.631 . . . . 0.0 110.154 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.428 ' CD2' HD11 ' A' ' 162' ' ' ILE . 1.6 m-85 -134.74 142.85 46.86 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 125.071 1.349 . . . . 0.0 108.854 -168.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.1 mt -145.98 77.83 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -165.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -69.08 172.19 7.13 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 118.196 0.453 . . . . 0.0 110.505 -173.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -127.08 -167.89 1.8 Allowed 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.578 -1.326 . . . . 0.0 108.559 170.071 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.426 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -142.66 66.56 1.32 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 127.921 2.489 . . . . 0.0 106.303 -159.491 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -162.65 -64.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 123.18 0.592 . . . . 0.0 109.547 -170.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -121.62 -1.54 10.84 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.859 1.218 . . . . 0.0 113.841 -173.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 C--O 1.26 1.628 0 C-N-CA 124.616 1.167 . . . . 0.0 108.859 168.055 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.625 HD13 ' N ' ' A' ' 86' ' ' MET . 3.1 tm? . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.625 ' N ' HD13 ' A' ' 85' ' ' LEU . 30.6 ttm -103.53 87.35 1.38 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 127.267 2.227 . . . . 0.0 108.793 -166.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -61.9 113.23 1.76 Allowed 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 124.341 3.361 . . . . 0.0 109.595 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.53 -50.25 0.9 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -166.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.9 88.54 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.988 0.915 . . . . 0.0 109.946 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.51 ' HA ' HD22 ' A' ' 93' ' ' LEU . 15.9 ttt180 -63.42 -25.43 68.28 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -164.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -55.68 -66.45 0.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 O-C-N 124.57 1.169 . . . . 0.0 109.211 165.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.36 -46.51 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 116.653 -1.642 . . . . 0.0 113.259 -172.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.51 HD22 ' HA ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -45.44 -53.39 8.82 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 120.365 1.438 . . . . 0.0 112.286 171.686 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.37 -41.47 76.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.856 0.723 . . . . 0.0 110.611 -170.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -61.88 -50.15 73.36 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.322 1.049 . . . . 0.0 109.812 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.43 74.73 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.809 1.643 . . . . 0.0 111.666 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -59.38 -60.57 3.65 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.631 0.772 . . . . 0.0 109.343 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.55 -13.92 6.84 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.2 -6.66 37.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 175.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.06 16.22 68.36 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.312 0.958 . . . . 0.0 111.927 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.413 HD11 ' CE ' ' A' ' 1' ' ' MET . 54.0 mt -66.65 99.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.424 1.49 . . . . 0.0 107.013 171.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.36 108.36 1.09 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -87.34 155.89 19.85 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -150.07 173.76 13.5 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 128.459 2.704 . . . . 0.0 107.325 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.473 HD12 HD11 ' A' ' 117' ' ' LEU . 13.7 mt -136.51 156.79 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.669 0.788 . . . . 0.0 109.438 171.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -135.37 140.44 45.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.11 0.964 . . . . 0.0 111.583 165.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.9 t -154.31 167.73 28.96 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.33 -0.856 . . . . 0.0 110.455 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -94.66 -1.39 53.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.199 1.8 . . . . 0.0 111.803 168.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HE2' ' CD1' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -78.43 171.02 15.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 121.365 1.893 . . . . 0.0 110.571 178.391 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.68 -178.16 20.6 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.738 1.161 . . . . 0.0 112.924 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -53.61 -18.98 3.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.556 1.542 . . . . 0.0 112.539 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.14 -27.34 0.95 Allowed 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 125.6 1.56 . . . . 0.0 113.379 172.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.83 -52.87 29.15 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.197 0.999 . . . . 0.0 111.506 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -56.7 -43.5 80.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.401 0.68 . . . . 0.0 110.311 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -59.89 -48.59 81.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.655 1.182 . . . . 0.0 110.898 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.401 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 62.0 mt -56.66 -46.84 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.825 0.85 . . . . 0.0 109.613 -177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 105' ' ' ILE . 94.1 mt -63.97 -44.6 92.26 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.78 0.832 . . . . 0.0 110.794 -174.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.96 -60.65 2.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 124.284 0.99 . . . . 0.0 108.943 169.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.61 -58.04 9.08 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.917 0.887 . . . . 0.0 112.185 -174.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.1 -32.17 73.47 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.68 -170.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.82 44.23 0.55 Allowed Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 157.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.722 HG23 ' HD2' ' A' ' 125' ' ' TYR . 2.0 p -166.22 52.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 -166.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -41.04 29.89 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 118.783 -2.448 . . . . 0.0 108.878 153.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.3 t -72.12 -8.29 53.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.349 1.46 . . . . 0.0 113.058 -158.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.722 ' HD2' HG23 ' A' ' 122' ' ' VAL . 75.7 m-85 -80.89 -31.8 35.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.005 0.522 . . . . 0.0 109.857 172.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.557 ' CE2' HG22 ' A' ' 122' ' ' VAL . 14.9 m-85 -105.58 101.97 11.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 120.624 -1.297 . . . . 0.0 108.229 -168.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.8 m -46.19 -51.28 14.51 Favored 'General case' 0 C--O 1.255 1.367 0 C-N-CA 126.117 1.767 . . . . 0.0 111.113 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -142.7 144.4 32.69 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.262 0.625 . . . . 0.0 109.553 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.3 mt -132.26 97.81 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 -166.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.41 162.13 29.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.9 p -144.48 -177.38 5.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.358 1.463 . . . . 0.0 108.559 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 96.8 p -51.1 -32.62 23.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.093 0.86 . . . . 0.0 111.856 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -21.87 63.88 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.499 1.92 . . . . 0.0 111.348 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 65.0 p -57.51 -23.37 49.81 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.05 -14.95 59.24 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.225 0.916 . . . . 0.0 111.936 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -66.05 167.74 9.41 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 123.968 1.842 . . . . 0.0 113.23 -173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -58.04 154.14 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 C-N-CA 129.676 3.191 . . . . 0.0 109.91 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.13 43.71 1.05 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.752 0.787 . . . . 0.0 110.808 -172.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 mttt 70.29 147.65 0.12 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 128.394 2.678 . . . . 0.0 110.633 -168.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -62.8 124.34 3.2 Favored 'Cis proline' 0 N--CA 1.45 -1.051 0 N-CA-C 107.619 -1.724 . . . . 0.0 107.619 -22.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -116.32 85.26 15.6 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.49 -22.5 28.67 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.295 1.997 . . . . 0.0 111.405 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -56.31 -38.11 70.82 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.647 1.579 . . . . 0.0 110.397 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.596 ' O ' HD13 ' A' ' 148' ' ' LEU . . . -65.45 -20.55 66.41 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.551 -169.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.66 -41.27 10.82 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 116.338 -1.791 . . . . 0.0 109.553 171.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.453 ' HA ' HD12 ' A' ' 149' ' ' LEU . 23.5 m -56.58 -36.05 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 120.95 1.705 . . . . 0.0 110.586 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.721 ' HD1' HD12 ' A' ' 148' ' ' LEU . 22.8 t80 -56.99 -52.62 64.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.826 0.85 . . . . 0.0 109.756 171.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.721 HD12 ' HD1' ' A' ' 147' ' ' TYR . 8.8 mp -60.34 -39.74 88.22 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.726 1.61 . . . . 0.0 111.343 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.509 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 71.4 mt -57.82 -61.07 2.79 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.83 -31.31 72.45 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.707 0.803 . . . . 0.0 111.56 -171.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.19 -43.08 78.12 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 120.91 -1.119 . . . . 0.0 113.276 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -137.26 26.56 2.9 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 45.93 50.92 11.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.409 2.283 . . . . 0.0 110.441 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 65.8 mt -81.68 167.86 18.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.231 -1.35 . . . . 0.0 109.698 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.07 130.41 51.76 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.92 1.288 . . . . 0.0 108.407 -172.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -52.7 62.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.433 1.111 . . . . 0.0 109.038 176.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.91 -10.74 59.73 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.998 -1.064 . . . . 0.0 112.834 -170.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -112.15 17.54 19.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 109.322 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -104.38 145.69 29.9 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 118.745 0.702 . . . . 0.0 109.501 169.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.474 ' CD1' ' HB2' ' A' ' 178' ' ' GLN . 95.8 m-85 -125.02 159.06 32.19 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.036 1.734 . . . . 0.0 109.856 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -116.03 -39.27 3.47 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.428 HD11 ' CD2' ' A' ' 6' ' ' PHE . 1.3 mp 57.09 75.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 125.604 1.562 . . . . 0.0 112.44 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -128.1 -175.97 14.28 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.367 0.984 . . . . 0.0 110.867 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.59 26.7 5.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.54 1.536 . . . . 0.0 114.106 -156.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.442 ' HD3' ' HB2' ' A' ' 167' ' ' LEU . 1.9 ptp85 -160.62 159.85 30.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.725 2.01 . . . . 0.0 107.899 -178.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 21.6 p -51.8 -37.56 52.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.761 0.791 . . . . 0.0 111.86 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.442 ' HB2' ' HD3' ' A' ' 165' ' ' ARG . 0.2 OUTLIER -62.1 -13.31 25.38 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -35.15 78.66 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 119.988 1.267 . . . . 0.0 110.546 172.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.5 p -104.36 -24.27 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.3 1.04 . . . . 0.0 110.783 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.73 -38.26 87.27 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 120.474 -1.392 . . . . 0.0 110.949 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -75.27 -38.12 60.59 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 118.36 -0.829 . . . . 0.0 110.287 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.26 69.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.978 1.311 . . . . 0.0 110.271 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.63 -43.09 56.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.946 1.299 . . . . 0.0 111.978 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -72.27 -22.12 61.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 118.419 -0.801 . . . . 0.0 113.057 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 t -96.1 -20.84 18.34 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.669 0.668 . . . . 0.0 110.314 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.9 49.8 6.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.15 178.0 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.038 1.735 . . . . 0.0 109.239 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.474 ' HB2' ' CD1' ' A' ' 160' ' ' TYR . 7.2 mm-40 -109.04 168.61 9.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.661 1.22 . . . . 0.0 111.815 -174.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.56 141.39 25.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.868 2.067 . . . . 0.0 108.785 -174.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 57.3 mt -121.01 86.5 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -95.43 176.58 6.14 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.835 -167.054 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -109.64 -6.42 15.35 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 119.654 -1.904 . . . . 0.0 111.469 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.494 ' H ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -118.96 146.2 45.18 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.644 1.978 . . . . 0.0 108.574 176.471 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.84 144.97 56.49 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 11.7 t -122.23 171.91 8.67 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 112.854 -1.976 . . . . 0.0 107.01 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 9.9 p -114.4 27.7 9.28 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.26 1.824 . . . . 0.0 109.666 -175.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -123.24 140.81 52.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.418 1.487 . . . . 0.0 110.014 -175.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -77.54 96.61 4.8 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.28 1.832 . . . . 0.0 109.415 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 133.76 -1.89 4.38 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.427 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.8 153.51 34.85 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 119.394 1.597 . . . . 0.0 108.407 168.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -138.12 99.95 4.01 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 181' ' ' ASN 0.292 0.2 OUTLIER -75.0 151.44 38.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 115.682 -2.407 . . . . 0.0 109.4 175.403 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.0 pt -126.27 -176.5 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 130.032 3.333 . . . . 0.0 107.982 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.83 -14.63 5.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 125.247 1.419 . . . . 0.0 111.75 167.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.93 165.0 36.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.52 0.6 . . . . 0.0 109.455 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.39 -25.89 63.45 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.146 -0.971 . . . . 0.0 110.474 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.34 -32.12 73.32 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.06 -1.025 . . . . 0.0 111.115 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.65 -22.17 63.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.036 2.534 . . . . 0.0 110.728 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.28 -56.7 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 C-N-CA 124.409 1.084 . . . . 0.0 109.009 171.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 96.3 p -52.45 -40.39 62.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.539 0.609 . . . . 0.0 111.384 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 34.0 mtt85 -64.03 -32.8 74.49 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.447 -1.263 . . . . 0.0 112.541 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.23 -45.57 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.088 1.313 . . . . 0.0 109.192 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.69 -5.45 53.12 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -117.1 5.94 12.83 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.823 1.249 . . . . 0.0 113.205 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.271 86.0 m -143.64 28.43 1.45 Allowed 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.893 -1.129 . . . . 0.0 110.816 -169.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.314 29.8 pttt . . . . . 0 N--CA 1.476 0.853 1 C-N-CA 132.07 4.148 . . . . 0.0 114.811 175.908 . . . . . . . . 2 1 . 1 . 020 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -123.49 15.39 9.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.049 0.925 . . . . 0.0 112.35 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mmm 50.19 74.11 0.23 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.735 1.214 . . . . 0.0 110.181 -172.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -62.63 173.51 1.25 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.13 -1.396 . . . . 0.0 109.095 173.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -44.17 83.74 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.029 2.132 . . . . 0.0 114.535 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.8 m -110.76 159.83 17.27 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.821 1.248 . . . . 0.0 107.651 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.514 ' HB2' HD22 ' A' ' 154' ' ' LEU . . . -136.92 158.5 44.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.411 0.624 . . . . 0.0 110.937 162.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -114.3 174.85 5.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.61 1.164 . . . . 0.0 108.38 169.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mt -139.84 137.2 39.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 163.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -119.07 178.2 4.59 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.485 1.914 . . . . 0.0 109.442 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.24 -179.8 6.47 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.246 1.819 . . . . 0.0 107.641 -170.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.57 -1.36 10.1 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.762 -1.211 . . . . 0.0 114.238 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.05 -42.05 27.37 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 120.743 -1.223 . . . . 0.0 111.6 -172.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.49 -155.89 7.37 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -170.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.41 1.3 t . . . . . 0 C--O 1.255 1.378 0 C-N-CA 127.828 2.451 . . . . 0.0 111.139 170.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.616 HD11 ' HG2' ' A' ' 90' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.532 ' H ' HD13 ' A' ' 85' ' ' LEU . 41.3 tpp -115.34 86.3 14.41 Favored Pre-proline 0 N--CA 1.448 -0.574 0 C-N-CA 125.849 1.659 . . . . 0.0 108.322 -175.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -64.94 100.92 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.474 3.45 . . . . 0.0 110.255 -172.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 132.83 -40.46 1.61 Allowed Glycine 0 C--O 1.227 -0.31 0 C-N-CA 124.66 1.124 . . . . 0.0 110.571 -175.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.86 -20.11 60.53 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.126 -1.22 . . . . 0.0 109.319 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.616 ' HG2' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -92.74 -9.8 39.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.952 1.701 . . . . 0.0 112.393 176.703 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -65.82 -38.98 90.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.425 1.09 . . . . 0.0 110.796 165.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.7 -39.72 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.351 -0.843 . . . . 0.0 110.772 -173.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.922 HD23 ' CD2' ' A' ' 125' ' ' TYR . 6.9 mp -44.35 -41.0 5.75 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 127.797 2.439 . . . . 0.0 111.549 166.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.17 -50.8 62.66 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.903 1.377 . . . . 0.0 109.581 -177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -56.71 -45.45 81.85 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.766 0.827 . . . . 0.0 110.475 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.31 -38.81 71.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.362 1.065 . . . . 0.0 113.138 -174.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.58 -52.11 59.26 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.613 1.165 . . . . 0.0 109.635 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -60.72 -38.12 84.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.336 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.0 m -71.86 -1.26 13.62 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.5 16.14 60.37 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.46 1.505 . . . . 0.0 113.259 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.9 mt -76.05 101.11 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -57.42 109.95 0.78 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.07 1.348 . . . . 0.0 108.913 -174.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -84.6 147.13 27.14 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 172.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -137.39 168.25 20.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 168.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mt -124.53 149.75 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.529 0.731 . . . . 0.0 109.132 171.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -134.04 128.11 33.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 157.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -145.97 -173.95 4.3 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 162.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.04 12.77 7.8 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.36 1.864 . . . . 0.0 112.229 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.491 ' HE2' ' CD1' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -73.28 -10.43 59.75 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -165.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 126.91 174.62 13.85 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 126.399 1.952 . . . . 0.0 109.764 -170.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -63.63 -29.08 70.37 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 117.491 0.645 . . . . 0.0 110.421 172.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -51.64 -14.81 0.37 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.435 2.294 . . . . 0.0 114.544 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.68 -44.53 69.81 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.528 1.058 . . . . 0.0 111.061 169.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -63.22 -7.82 6.84 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.317 1.847 . . . . 0.0 114.122 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 19.0 m -101.92 -49.3 4.0 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 120.521 -1.362 . . . . 0.0 108.501 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.491 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 52.4 mt -52.64 -48.92 47.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 C-N-CA 123.799 0.84 . . . . 0.0 109.367 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.9 mt -64.01 -35.99 82.52 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.0 -1.062 . . . . 0.0 111.366 -172.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.12 -50.45 73.65 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.064 1.345 . . . . 0.0 109.359 172.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.01 -48.11 79.26 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.56 1.544 . . . . 0.0 111.312 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 99.5 mt -58.81 -50.44 73.95 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.476 1.11 . . . . 0.0 108.391 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.9 36.16 3.04 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.065 1.317 . . . . 0.0 112.271 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.94 22.61 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.855 1.662 . . . . 0.0 110.314 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.25 -54.33 46.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.51 1.524 . . . . 0.0 112.657 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.7 m -76.56 -12.62 60.05 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -164.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.922 ' CD2' HD23 ' A' ' 93' ' ' LEU . 26.0 m-85 -54.82 -32.64 60.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.938 0.79 . . . . 0.0 110.943 164.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -98.37 106.18 18.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -172.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.4 m -45.08 -54.11 7.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.559 1.944 . . . . 0.0 110.752 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -142.93 150.24 39.49 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 mt -131.77 88.56 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -168.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.94 145.2 48.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.317 -0.864 . . . . 0.0 109.196 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.7 p -121.77 -173.31 2.62 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.766 0.826 . . . . 0.0 110.553 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 p -56.44 -20.0 17.81 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.001 -1.062 . . . . 0.0 113.31 167.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -77.21 -3.98 42.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.48 1.512 . . . . 0.0 111.918 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.3 p -58.76 -25.64 63.23 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.82 20.19 31.93 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.204 0.906 . . . . 0.0 114.824 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -78.16 -86.89 0.06 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.559 1.679 . . . . 0.0 107.667 168.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.0 t -150.87 168.42 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 126.177 1.791 . . . . 0.0 107.743 -170.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.604 ' H ' ' HD3' ' A' ' 138' ' ' ARG 0.255 0.0 OUTLIER -74.06 -85.16 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 117.817 -1.087 . . . . 0.0 109.583 166.798 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -160.15 139.23 7.94 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 121.32 1.873 . . . . 0.0 109.42 -172.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.86 -28.56 4.55 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 121.035 1.405 . . . . 0.0 115.12 7.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.9 t 59.98 62.3 3.55 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.667 1.187 . . . . 0.0 113.211 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -61.94 -24.42 76.93 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.549 2.166 . . . . 0.0 112.584 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -56.17 -28.77 59.35 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.939 1.296 . . . . 0.0 112.463 -171.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.08 -42.9 77.42 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.056 0.943 . . . . 0.0 110.055 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.26 92.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.693 -0.63 . . . . 0.0 111.288 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 m -55.37 -40.32 71.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.268 0.627 . . . . 0.0 110.514 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -66.64 -51.24 58.47 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.9 mp -56.06 -38.67 70.94 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 111.749 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -60.45 -61.85 2.29 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 126.823 2.049 . . . . 0.0 107.473 177.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -57.35 -36.89 71.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.53 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -48.65 -45.4 38.62 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.378 1.071 . . . . 0.0 112.545 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.75 21.71 10.69 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.411 1.005 . . . . 0.0 112.863 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 50.78 69.5 0.63 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.921 1.689 . . . . 0.0 110.112 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 5' ' ' ALA . 1.1 mt -122.41 178.87 4.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.544 1.537 . . . . 0.0 108.506 -173.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -120.0 151.49 38.91 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.689 1.996 . . . . 0.0 111.361 -176.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 53.5 m -55.91 -33.71 64.92 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.355 0.598 . . . . 0.0 110.084 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.93 -35.11 64.55 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 120.559 -1.338 . . . . 0.0 109.866 -176.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -77.83 1.15 21.24 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.977 -1.487 . . . . 0.0 113.639 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.709 HG23 ' HB ' ' A' ' 177' ' ' ILE . 4.6 t -97.78 140.03 32.77 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.322 1.419 . . . . 0.0 110.43 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -127.7 109.05 11.28 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.423 1.489 . . . . 0.0 110.559 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -91.83 131.31 37.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.838 0.455 . . . . 0.0 111.079 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.18 119.35 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 126.348 1.859 . . . . 0.0 109.011 -174.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -145.52 -21.49 0.14 Allowed Glycine 0 CA--C 1.535 1.299 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.404 ' HB2' ' CD1' ' A' ' 182' ' ' PHE . 19.2 t70 59.29 58.13 3.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.538 1.935 . . . . 0.0 112.886 -174.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -163.35 164.28 24.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.498 -1.376 . . . . 0.0 112.128 172.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.3 t -51.72 -53.07 43.35 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.906 1.282 . . . . 0.0 111.366 167.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.76 -20.59 66.45 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.602 1.561 . . . . 0.0 110.882 -165.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.18 -34.78 78.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.677 -0.64 . . . . 0.0 110.267 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.402 ' HA ' ' HB3' ' A' ' 172' ' ' ALA . 2.7 t -82.13 -11.98 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.5 0.72 . . . . 0.0 111.353 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.06 -55.89 18.91 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 169.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -54.05 -42.01 68.74 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.261 1.025 . . . . 0.0 111.479 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . . . -60.77 -26.48 67.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.767 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -90.14 -42.09 11.26 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.921 1.237 . . . . 0.0 109.225 -169.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -29.23 69.22 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.419 ' HB3' HG23 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -80.04 -41.23 26.12 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.23 0.923 . . . . 0.0 110.377 169.028 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 80.4 56.32 3.22 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -170.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.709 ' HB ' HG23 ' A' ' 159' ' ' THR . 41.7 pt -129.88 165.03 31.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 127.643 2.377 . . . . 0.0 106.146 -174.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -85.27 163.07 18.85 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.168 -0.958 . . . . 0.0 109.96 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.39 162.52 34.83 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.823 0.82 . . . . 0.0 109.834 172.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 36.0 mt -138.57 120.56 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -139.56 164.64 29.36 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' PHE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 164' ' ' ASP . 86.2 m-85 -74.69 9.02 2.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.5 151.81 36.99 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.009 1.324 . . . . 0.0 109.18 -166.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -70.55 147.55 49.18 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.15 26.19 2.03 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.522 1.129 . . . . 0.0 111.183 167.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 17.3 p 50.67 45.82 26.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.466 1.507 . . . . 0.0 111.734 164.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -136.28 157.06 47.71 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.983 2.113 . . . . 0.0 106.365 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -75.4 -45.63 37.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.619 0.645 . . . . 0.0 111.665 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -68.86 -9.02 58.69 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.063 -0.854 . . . . 0.0 112.878 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.09 100.92 12.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.041 1.92 . . . . 0.0 109.181 -173.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -79.74 134.07 36.37 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.28 0.632 . . . . 0.0 109.343 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ARG . . . . . 0.41 ' HB3' HH11 ' A' ' 192' ' ' ARG . 0.0 OUTLIER -77.72 151.56 34.1 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 166.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.83 166.68 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.409 1.883 . . . . 0.0 109.955 171.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -129.54 0.73 5.0 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.385 1.474 . . . . 0.0 112.799 168.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.05 165.56 34.32 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.289 1.436 . . . . 0.0 108.307 171.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 69.3 mt -73.62 -33.66 64.67 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 118.578 0.626 . . . . 0.0 110.154 176.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.51 -22.27 66.15 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -62.75 -21.72 66.04 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.367 -0.833 . . . . 0.0 110.799 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.49 -55.97 19.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 125.138 1.375 . . . . 0.0 109.087 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 95.0 p -60.02 -33.19 71.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.055 1.298 . . . . 0.0 110.877 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -63.24 -33.69 76.05 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.044 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.1 mt -50.31 -58.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -67.26 -12.76 60.94 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.584 1.153 . . . . 0.0 112.952 -174.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -106.23 5.73 30.11 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.184 1.394 . . . . 0.0 112.853 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.4 m -128.87 25.17 5.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.28 1.032 . . . . 0.0 112.236 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.271 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 C-N-CA 128.923 2.889 . . . . 0.0 111.19 -168.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mmm . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -52.63 -177.45 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.323 1.849 . . . . 0.0 113.184 164.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -61.2 100.03 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 O-C-N 120.449 -1.407 . . . . 0.0 107.676 168.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.3 m -128.35 148.25 50.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.89 150.01 52.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -127.74 149.75 50.1 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.613 1.565 . . . . 0.0 108.41 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mt -142.82 132.12 21.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -115.67 179.61 3.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.849 1.66 . . . . 0.0 109.999 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -133.92 175.91 9.04 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.517 2.327 . . . . 0.0 106.657 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.9 mt . . . . . 0 C--O 1.236 0.347 0 C-N-CA 124.803 1.241 . . . . 0.0 108.824 -177.056 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.33 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -60.33 -21.24 61.81 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -57.66 -69.81 0.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.366 1.466 . . . . 0.0 109.043 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.06 -40.48 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.638 1.175 . . . . 0.0 109.962 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.7 mt -55.52 -50.79 69.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.13 0.877 . . . . 0.0 110.047 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.26 -45.08 89.68 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.286 0.635 . . . . 0.0 111.695 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -57.28 -55.28 36.82 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.227 1.011 . . . . 0.0 109.021 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.26 -40.5 94.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.59 0.756 . . . . 0.0 111.049 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -59.22 -58.64 7.76 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.195 1.398 . . . . 0.0 110.017 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -62.1 -28.49 69.66 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.6 m -71.2 -5.66 33.61 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.468 -0.77 . . . . 0.0 112.672 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.83 9.93 71.32 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 119.639 1.109 . . . . 0.0 113.539 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.3 mt -56.03 149.69 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 119.307 1.553 . . . . 0.0 107.192 160.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.64 105.48 16.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 170.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -78.47 149.43 33.2 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.25 0.932 . . . . 0.0 109.065 172.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -139.81 174.16 10.8 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.203 1.801 . . . . 0.0 108.383 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.0 mt -136.31 150.42 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 4.8 t80 -134.5 141.44 46.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 152.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 109' ' ' LYS . 2.6 t -156.07 165.65 35.8 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -76.42 -12.95 60.13 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.189 -0.944 . . . . 0.0 112.882 174.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.45 ' H ' HG23 ' A' ' 107' ' ' THR . 1.5 ttmm -63.98 156.76 26.95 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.149 -0.969 . . . . 0.0 110.063 -174.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.49 -169.97 38.96 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.992 0.806 . . . . 0.0 114.252 -170.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -60.22 -12.52 9.0 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.949 1.3 . . . . 0.0 112.264 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -61.54 -12.44 15.35 Favored 'General case' 0 C--O 1.224 -0.238 0 O-C-N 119.781 -1.825 . . . . 0.0 112.384 168.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.44 -47.97 83.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 120.712 1.596 . . . . 0.0 107.804 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -56.46 -45.14 81.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.98 1.712 . . . . 0.0 110.098 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 m -67.46 -44.81 77.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.998 0.919 . . . . 0.0 111.209 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.72 -46.0 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.669 1.188 . . . . 0.0 108.308 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mp -57.36 -45.19 84.66 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.702 0.801 . . . . 0.0 110.504 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -49.9 75.53 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.257 1.023 . . . . 0.0 110.358 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.21 -57.5 7.64 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.755 1.622 . . . . 0.0 109.179 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.94 -12.86 61.78 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.785 1.634 . . . . 0.0 112.727 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 88.77 12.51 64.09 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.562 1.077 . . . . 0.0 113.976 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.4 m -119.87 16.27 6.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 125.105 1.362 . . . . 0.0 111.635 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -59.65 -40.6 88.21 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.267 -0.896 . . . . 0.0 113.37 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.03 -11.04 60.41 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.757 0.661 . . . . 0.0 112.486 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -74.71 4.57 6.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.857 1.208 . . . . 0.0 113.269 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -141.28 123.94 16.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -54.36 -45.96 72.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.284 1.434 . . . . 0.0 110.175 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -153.58 142.82 21.47 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.71 100.96 7.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 106' ' ' TYR . 3.5 mm? -76.1 155.23 34.91 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.9 p -140.91 -174.64 4.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.103 1.361 . . . . 0.0 109.848 -171.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 62.4 p -52.36 -24.51 7.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.534 1.061 . . . . 0.0 112.592 168.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -58.47 -35.22 71.84 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.144 1.378 . . . . 0.0 110.349 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.421 ' HB2' ' CD2' ' A' ' 136' ' ' PHE . 80.5 p -57.36 -35.82 70.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.54 -8.01 50.53 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.671 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.421 ' CD2' ' HB2' ' A' ' 134' ' ' SER . 29.5 m-85 -59.57 156.97 12.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.72 1.26 . . . . 0.0 111.087 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.74 HG23 ' HB2' ' A' ' 141' ' ' SER . 2.3 m -52.97 159.18 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.054 1.342 . . . . 0.0 113.398 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -67.53 160.64 27.24 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.585 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -61.09 133.01 92.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 117.258 -1.353 . . . . 0.0 108.744 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.66 135.68 41.4 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 121.33 1.511 . . . . 0.0 110.17 -3.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.74 ' HB2' HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -143.44 85.45 9.47 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -170.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.21 -16.61 22.27 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 N-CA-C 109.23 -1.104 . . . . 0.0 109.23 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -44.52 -49.96 9.76 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 126.857 2.063 . . . . 0.0 110.717 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.55 65.54 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.491 -171.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.4 -41.16 20.27 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.095 -1.628 . . . . 0.0 109.295 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.8 m -58.87 -30.52 67.79 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.902 0.774 . . . . 0.0 111.082 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.578 ' CZ ' ' HE3' ' A' ' 151' ' ' LYS . 34.4 t80 -60.62 -55.68 30.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.884 0.873 . . . . 0.0 109.389 166.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.437 HD12 ' HD1' ' A' ' 147' ' ' TYR . 4.5 mp -58.09 -28.09 64.27 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.705 1.602 . . . . 0.0 113.095 -173.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.7 mt -71.61 -63.97 1.02 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.467 1.507 . . . . 0.0 107.18 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.36 -20.05 65.97 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.273 0.629 . . . . 0.0 112.55 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.578 ' HE3' ' CZ ' ' A' ' 147' ' ' TYR . 12.5 mmtt -51.78 -41.64 61.82 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 121.345 -0.847 . . . . 0.0 111.897 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -144.46 17.28 1.68 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -172.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.6 mm-40 59.9 62.9 1.57 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.867 1.667 . . . . 0.0 110.983 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.89 173.19 6.42 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.347 1.459 . . . . 0.0 109.973 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -116.51 126.28 53.12 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.522 1.529 . . . . 0.0 108.07 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -44.6 77.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.2 1.0 . . . . 0.0 110.454 174.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.76 -9.32 58.51 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.326 -0.859 . . . . 0.0 112.607 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -117.33 17.44 14.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.819 0.848 . . . . 0.0 108.829 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -106.64 130.31 54.4 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 170.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -122.2 97.78 5.63 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.079 1.752 . . . . 0.0 106.802 -170.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -71.85 158.7 35.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.684 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 47.8 mt -130.03 97.62 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 -171.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -120.81 -179.0 16.12 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 125.562 1.554 . . . . 0.0 112.011 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -128.78 -5.48 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.516 1.126 . . . . 0.0 113.405 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -121.16 165.54 15.23 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 122.347 1.07 . . . . 0.0 112.126 -164.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.8 t -63.25 -39.53 94.85 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.992 1.317 . . . . 0.0 110.187 164.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -32.46 72.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.408 1.083 . . . . 0.0 110.421 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.38 8.45 0.61 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.623 1.969 . . . . 0.0 111.824 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -131.39 -25.06 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 125.296 1.439 . . . . 0.0 110.816 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.53 -56.66 19.02 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.665 -1.272 . . . . 0.0 109.344 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -66.5 -29.52 69.64 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.947 -1.095 . . . . 0.0 110.925 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.54 -51.29 67.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -52.76 -52.84 54.95 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 124.386 1.075 . . . . 0.0 111.027 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -52.63 -47.21 67.16 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.354 0.261 . . . . 0.0 111.496 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.8 m -72.79 -26.85 61.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.763 0.825 . . . . 0.0 112.048 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.96 32.54 39.7 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.561 1.553 . . . . 0.0 111.181 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 22.1 pt -109.83 167.61 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 124.985 1.314 . . . . 0.0 109.36 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -97.63 162.54 13.24 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -175.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 23.5 m -135.33 152.75 51.76 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.327 1.451 . . . . 0.0 109.787 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 42.2 mt -131.84 95.37 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -129.56 149.97 51.1 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.309 1.044 . . . . 0.0 109.117 -165.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -70.7 -12.28 61.46 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.071 -1.018 . . . . 0.0 113.542 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.37 151.64 47.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.658 1.583 . . . . 0.0 109.594 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -78.4 154.95 30.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.4 t -144.11 13.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.387 0.675 . . . . 0.0 110.946 -174.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 71.0 p 57.06 69.66 0.72 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.939 2.096 . . . . 0.0 110.406 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -150.78 135.19 17.07 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.402 1.081 . . . . 0.0 108.405 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -70.12 -7.08 38.61 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -108.19 8.08 35.47 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.297 1.427 . . . . 0.0 112.954 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -108.94 122.06 46.42 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 120.788 2.294 . . . . 0.0 110.437 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -101.21 119.17 38.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.364 1.065 . . . . 0.0 109.427 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -67.61 146.59 53.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.431 0.56 . . . . 0.0 111.273 171.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.2 pt -146.04 175.75 2.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 127.296 2.239 . . . . 0.0 109.594 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -136.38 -12.41 1.84 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.436 1.494 . . . . 0.0 113.142 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.15 160.8 39.14 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.148 1.379 . . . . 0.0 108.075 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.36 -31.8 73.15 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.231 1.412 . . . . 0.0 110.503 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.22 -9.18 51.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -19.02 61.0 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.384 0.993 . . . . 0.0 110.409 172.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 67.8 mt -55.86 -52.85 44.5 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.6 p -60.26 -35.67 76.05 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.113 0.415 . . . . 0.0 111.688 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -62.62 -36.28 82.27 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.876 0.871 . . . . 0.0 112.226 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.3 mt -59.37 -44.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 124.289 1.036 . . . . 0.0 108.8 -172.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -84.86 13.17 6.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.534 1.134 . . . . 0.0 112.55 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 125.295 1.438 . . . . 0.0 110.362 -172.236 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.2 mmm . . . . . 0 N--CA 1.438 -1.033 0 N-CA-C 102.306 -3.22 . . . . 0.0 102.306 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -169.36 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 112.551 -2.113 . . . . 0.0 110.625 158.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -50.22 115.0 1.24 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 156.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.6 m -131.52 157.77 42.68 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 163.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.95 150.71 51.97 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.878 -0.514 . . . . 0.0 109.683 165.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.66 149.28 52.32 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 126.273 1.829 . . . . 0.0 108.156 -173.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.0 mt -142.12 145.65 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -125.22 174.51 8.05 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.086 1.755 . . . . 0.0 109.979 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 -11.2 9.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.561 1.544 . . . . 0.0 111.723 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.3 tp . . . . . 0 N--CA 1.466 0.332 0 C-N-CA 128.437 2.695 . . . . 0.0 112.603 174.132 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.557 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -67.0 -25.31 66.24 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.39 -1.444 . . . . 0.0 114.266 -167.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.04 -53.94 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.108 0.563 . . . . 0.0 110.592 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.8 t -68.63 -34.95 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.713 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.832 HD23 ' CD2' ' A' ' 125' ' ' TYR . 7.4 mp -44.49 -50.51 9.43 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 121.529 1.968 . . . . 0.0 113.374 164.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.92 -50.47 64.32 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 124.15 0.906 . . . . 0.0 109.782 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -53.36 -50.53 64.88 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 123.836 0.71 . . . . 0.0 110.358 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.04 -39.79 82.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.314 1.046 . . . . 0.0 111.822 -177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -71.96 -41.52 67.64 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 118.455 0.571 . . . . 0.0 110.719 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -64.17 -28.56 69.84 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.508 -0.745 . . . . 0.0 111.547 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.5 m -76.49 -13.0 60.13 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.002 0.921 . . . . 0.0 112.235 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.62 37.38 75.82 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.027 1.299 . . . . 0.0 112.003 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.6 mt -68.12 121.85 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 159.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -68.08 113.6 5.88 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 170.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -94.13 144.13 25.76 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.406 1.482 . . . . 0.0 107.686 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -143.97 177.83 8.28 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.242 1.017 . . . . 0.0 109.298 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.9 mt -135.83 150.52 28.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 124.074 0.95 . . . . 0.0 108.591 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -133.24 113.16 12.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 156.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -133.06 175.52 9.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.315 1.446 . . . . 0.0 109.178 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . 0.274 2.1 p80 -125.99 22.42 7.35 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -72.42 -0.81 13.49 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.16 -177.9 38.42 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.912 1.244 . . . . 0.0 111.793 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -72.27 -2.77 20.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -162.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -70.85 -10.22 59.16 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.741 164.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.96 -52.96 17.62 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.731 1.212 . . . . 0.0 111.335 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -59.47 -44.79 92.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.055 0.542 . . . . 0.0 110.114 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -62.82 -40.82 98.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.938 1.295 . . . . 0.0 111.123 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.7 mt -63.64 -50.75 76.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.33 -38.93 92.78 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.57 -0.706 . . . . 0.0 111.324 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -63.51 -46.02 88.01 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.6 0.76 . . . . 0.0 110.379 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -48.68 -50.42 33.32 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.985 1.374 . . . . 0.0 110.111 172.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.4 mt -69.46 -18.67 63.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.844 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.99 33.32 69.97 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.869 0.759 . . . . 0.0 111.985 174.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.1 m -137.19 22.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 126.361 1.864 . . . . 0.0 108.841 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.81 -42.18 81.93 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.051 -0.405 . . . . 0.0 110.218 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.2 m -58.83 -24.27 61.78 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.935 0.772 . . . . 0.0 112.171 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.832 ' CD2' HD23 ' A' ' 93' ' ' LEU . 26.0 m-85 -68.47 6.35 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.123 1.369 . . . . 0.0 113.986 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -140.91 105.94 4.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 47.6 m -55.16 -41.32 71.7 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.521 1.528 . . . . 0.0 111.056 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -150.87 147.26 27.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.74 96.87 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -167.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.97 145.79 48.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.1 p -123.88 -176.26 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.493 1.117 . . . . 0.0 110.323 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.9 t -48.78 -34.88 13.13 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.273 1.429 . . . . 0.0 110.411 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -82.3 -2.58 53.14 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.286 1.434 . . . . 0.0 112.319 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 83.9 p -57.07 -63.13 1.31 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.304 1.411 . . . . 0.0 110.299 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 123.2 -16.0 8.16 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 125.598 1.57 . . . . 0.0 112.643 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -58.63 166.83 1.68 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.049 1.425 . . . . 0.0 112.83 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.484 HG23 ' CB ' ' A' ' 141' ' ' SER . 16.3 m -60.57 160.75 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.916 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.4 mtt-85 -84.89 147.71 26.63 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.061 -1.649 . . . . 0.0 109.01 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -48.44 131.79 13.38 Favored Pre-proline 0 C--O 1.243 0.743 0 CA-C-O 117.4 -1.286 . . . . 0.0 109.949 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.27 125.82 7.19 Favored 'Cis proline' 0 C--N 1.351 0.691 0 CA-C-N 121.018 1.399 . . . . 0.0 111.696 -3.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.484 ' CB ' HG23 ' A' ' 137' ' ' VAL . 10.4 p -141.94 85.43 11.12 Favored Pre-proline 0 N--CA 1.438 -1.026 0 C-N-CA 123.292 0.637 . . . . 0.0 111.893 -173.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.69 -18.51 32.57 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.376 . . . . 0.0 112.561 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -45.3 -43.84 11.0 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.285 1.834 . . . . 0.0 112.686 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.63 -7.6 21.67 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.537 0.939 . . . . 0.0 113.537 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.01 -61.05 1.93 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.046 0.938 . . . . 0.0 108.737 163.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.8 m -56.22 -40.29 73.85 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.475 1.91 . . . . 0.0 110.466 -170.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -53.91 -51.25 64.34 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.572 0.749 . . . . 0.0 110.907 174.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.51 -27.98 51.97 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.832 0.853 . . . . 0.0 112.159 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.49 -59.93 4.26 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -67.76 -22.41 65.21 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -61.13 -48.91 79.47 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.788 -1.195 . . . . 0.0 112.438 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -121.63 18.19 11.19 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.078 0.854 . . . . 0.0 112.013 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 54.07 51.96 13.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.335 1.854 . . . . 0.0 111.219 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.33 170.3 15.51 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.371 1.469 . . . . 0.0 110.224 175.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -105.73 130.25 53.78 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.038 1.735 . . . . 0.0 108.288 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 m -58.02 -29.47 65.34 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.261 0.937 . . . . 0.0 110.877 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.52 -27.83 23.75 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.84 -0.94 55.69 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -99.64 138.74 36.3 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.143 0.883 . . . . 0.0 108.654 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.444 ' CD1' ' HB2' ' A' ' 178' ' ' GLN . 92.6 m-85 -120.15 166.16 13.8 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.871 1.669 . . . . 0.0 107.554 173.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -139.39 157.25 46.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.455 1.902 . . . . 0.0 107.02 168.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 5.0 mt -135.82 128.73 47.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -161.72 10.01 0.11 Allowed Glycine 0 C--O 1.224 -0.482 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.026 -174.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . 0.293 1.5 p30 60.86 -1.85 0.22 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 129.799 3.24 . . . . 0.0 115.862 163.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -113.36 168.27 9.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.974 0.806 . . . . 0.0 112.858 -168.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.1 t -59.22 -35.39 73.56 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.077 -1.015 . . . . 0.0 111.642 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.727 HD12 ' CE1' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -66.94 -13.44 61.8 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.37 1.468 . . . . 0.0 112.419 -178.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.42 -39.15 88.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.634 0.731 . . . . 0.0 111.595 -167.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.91 -45.86 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 125.022 1.329 . . . . 0.0 108.655 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.526 ' HB2' HD13 ' A' ' 167' ' ' LEU . 59.8 mm-40 -59.81 -41.18 90.69 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.021 0.929 . . . . 0.0 110.938 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.727 ' CE1' HD12 ' A' ' 167' ' ' LEU . 19.5 m-85 -64.22 -51.81 61.87 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.229 0.922 . . . . 0.0 110.829 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.19 97.51 Favored 'General case' 0 C--O 1.224 -0.287 0 O-C-N 123.577 0.548 . . . . 0.0 111.259 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -62.78 -28.89 70.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.322 0.649 . . . . 0.0 111.81 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -60.04 -46.8 88.34 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.486 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.33 -23.36 32.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.879 1.672 . . . . 0.0 113.318 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 90.0 10.39 64.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.499 2.0 . . . . 0.0 113.847 -175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 23.7 pt -81.79 -173.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.221 1.51 . . . . 0.0 110.163 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.444 ' HB2' ' CD1' ' A' ' 160' ' ' TYR . 23.9 mm-40 -101.17 161.75 13.39 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.287 1.035 . . . . 0.0 110.419 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.05 160.58 40.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.885 1.274 . . . . 0.0 113.419 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.8 mt -142.9 83.34 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.823 1.649 . . . . 0.0 108.845 -172.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -97.66 -171.41 2.18 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.994 -1.066 . . . . 0.0 110.62 173.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -99.74 -5.9 27.95 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.514 -1.366 . . . . 0.0 112.704 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.677 HD22 ' H ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -112.61 137.58 50.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -176.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.96 162.04 29.97 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.958 1.703 . . . . 0.0 109.626 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 34.7 t -155.77 157.87 37.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 10.2 p -85.91 19.64 2.49 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.603 1.161 . . . . 0.0 111.795 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -67.82 -178.62 0.99 Allowed 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.612 -0.68 . . . . 0.0 110.27 168.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.04 5.5 7.93 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -165.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.92 23.39 1.01 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.1 1.81 . . . . 0.0 111.52 167.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -81.92 149.56 28.17 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 120.794 -1.415 . . . . 0.0 108.882 160.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -142.29 99.36 3.49 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.166 0.586 . . . . 0.0 109.612 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -73.93 162.63 28.86 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 118.438 -1.305 . . . . 0.0 112.035 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 6.7 pt -135.31 169.31 21.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.403 1.881 . . . . 0.0 110.099 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -117.57 -2.9 11.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.95 1.3 . . . . 0.0 112.862 168.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.56 167.52 28.34 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.852 1.261 . . . . 0.0 109.079 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 196' ' ' LEU . 7.5 tp -76.08 -40.39 53.2 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -173.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.48 -18.86 64.23 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.52 -11.24 60.17 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.811 0.844 . . . . 0.0 111.027 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.39 -55.62 23.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-O 117.835 -1.079 . . . . 0.0 108.484 166.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.2 m -54.27 -38.88 66.33 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.621 1.101 . . . . 0.0 110.158 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -64.14 -25.98 68.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.1 mt -56.44 -48.19 80.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -78.85 -41.07 30.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.436 1.094 . . . . 0.0 109.89 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 C--O 1.235 0.337 0 C-N-CA 126.67 1.988 . . . . 0.0 109.276 -174.928 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mmm . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 122.846 1.308 . . . . 0.0 107.478 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.35 114.59 28.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 113.985 -1.461 . . . . 0.0 107.588 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.53 83.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.329 1.852 . . . . 0.0 111.368 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 m -124.08 135.11 53.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.8 150.26 31.9 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 170.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -126.49 150.91 48.45 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.291 1.436 . . . . 0.0 108.464 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -138.56 135.47 43.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -125.8 163.05 23.73 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.841 2.057 . . . . 0.0 109.999 -169.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -86.51 -29.92 22.35 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.851 2.06 . . . . 0.0 112.491 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.535 0 C-N-CA 125.615 1.566 . . . . 0.0 111.195 -167.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -65.49 -30.08 70.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.676 1.125 . . . . 0.0 112.301 -175.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.46 -55.63 31.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.818 0.847 . . . . 0.0 110.489 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.47 -42.14 94.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.33 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.619 HD23 ' CD2' ' A' ' 125' ' ' TYR . 6.6 mp -44.55 -52.85 7.65 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 121.645 2.021 . . . . 0.0 112.544 168.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.69 80.68 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.588 1.18 . . . . 0.0 110.957 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -58.63 -46.66 86.61 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.101 0.96 . . . . 0.0 111.421 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.51 -38.0 68.21 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.293 -0.861 . . . . 0.0 112.418 -172.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.52 -40.75 93.33 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.945 0.793 . . . . 0.0 109.752 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -52.03 -54.74 26.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.639 1.176 . . . . 0.0 109.021 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.3 m -74.0 4.77 4.97 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 60.31 24.79 61.76 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.659 1.118 . . . . 0.0 113.151 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.4 mt -71.3 108.22 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 127.032 2.133 . . . . 0.0 107.47 169.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 2.8 pt20 -65.84 103.18 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.996 0.518 . . . . 0.0 110.165 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -84.8 151.58 24.25 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -145.32 169.64 17.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.943 1.697 . . . . 0.0 109.803 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 22.3 mt -138.79 157.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.774 1.629 . . . . 0.0 110.698 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -137.46 115.77 11.84 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.027 0.931 . . . . 0.0 109.383 163.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -134.42 161.07 36.04 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.454 1.502 . . . . 0.0 108.547 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -88.28 -2.43 58.6 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.283 1.033 . . . . 0.0 110.896 170.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.09 147.87 11.99 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.853 1.661 . . . . 0.0 108.233 172.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.95 -171.59 28.48 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 123.642 0.639 . . . . 0.0 111.616 -170.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -58.7 -22.38 57.18 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.787 -0.831 . . . . 0.0 111.432 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -57.6 -17.37 13.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.727 1.211 . . . . 0.0 114.008 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.79 -49.01 66.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.606 1.548 . . . . 0.0 111.123 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -59.55 -42.2 91.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.17 0.588 . . . . 0.0 110.233 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -62.79 -46.01 89.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.451 1.1 . . . . 0.0 110.906 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 39.6 mt -59.84 -45.61 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 124.421 1.088 . . . . 0.0 108.824 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -57.29 -44.98 84.53 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.463 0.705 . . . . 0.0 111.29 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -48.48 81.61 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.913 0.485 . . . . 0.0 110.267 174.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -51.05 -52.78 39.83 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.747 1.219 . . . . 0.0 110.473 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.47 -3.67 32.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.145 1.778 . . . . 0.0 113.307 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.25 32.98 84.57 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.751 1.167 . . . . 0.0 112.645 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.54 23.59 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.977 0.911 . . . . 0.0 109.706 174.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -48.54 76.85 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.035 -1.04 . . . . 0.0 110.304 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.9 m -70.87 -19.01 62.67 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.619 ' CD2' HD23 ' A' ' 93' ' ' LEU . 21.0 m-85 -66.17 -0.51 2.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 117.132 -1.414 . . . . 0.0 113.638 167.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -139.84 105.06 5.03 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 121.665 2.03 . . . . 0.0 108.97 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.4 m -51.73 -40.79 60.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.933 1.693 . . . . 0.0 112.254 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -157.28 145.55 19.35 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 -172.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.05 131.04 45.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -85.18 151.87 23.77 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 167.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.2 p -137.17 -168.3 2.26 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.608 1.563 . . . . 0.0 110.208 -172.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.4 t -53.78 -26.55 24.26 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.497 -1.377 . . . . 0.0 112.975 167.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -61.03 -33.92 74.05 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.983 0.896 . . . . 0.0 109.168 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.9 m -85.31 69.83 10.77 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 129.07 2.948 . . . . 0.0 104.793 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.51 44.59 1.99 Allowed Glycine 0 CA--C 1.522 0.494 0 CA-C-O 118.693 -1.059 . . . . 0.0 111.324 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -67.22 174.45 3.21 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 124.602 2.144 . . . . 0.0 112.191 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.8 t -76.75 157.64 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 128.261 2.624 . . . . 0.0 110.6 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -72.25 166.34 22.62 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.397 1.479 . . . . 0.0 110.467 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 mmpm? -73.04 149.02 89.5 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 120.36 -1.463 . . . . 0.0 107.967 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.88 -4.99 32.51 Favored 'Cis proline' 0 CA--C 1.533 0.434 0 N-CA-C 115.842 1.439 . . . . 0.0 115.842 11.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.2 t -43.09 91.39 0.05 OUTLIER Pre-proline 0 C--O 1.241 0.655 0 C-N-CA 127.366 2.266 . . . . 0.0 114.576 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.84 6.94 0.05 OUTLIER 'Trans proline' 0 CA--C 1.556 1.616 1 C-N-CA 128.068 5.845 . . . . 0.0 114.64 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -43.74 -71.65 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.333 2.653 . . . . 0.0 112.236 -172.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.8 -16.39 40.18 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -175.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.35 -54.82 6.21 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 119.68 1.127 . . . . 0.0 108.552 171.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 m -53.06 -38.72 62.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.665 1.186 . . . . 0.0 110.605 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -52.04 -50.38 61.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.346 1.058 . . . . 0.0 110.715 174.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.73 -35.85 72.89 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.302 1.041 . . . . 0.0 111.406 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.27 -58.44 8.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -64.47 -29.18 70.23 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.345 1.069 . . . . 0.0 111.758 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -63.77 -27.41 69.17 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.164 -1.585 . . . . 0.0 114.842 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.42 ' HB3' HD13 ' A' ' 154' ' ' LEU . 2.7 t80 -141.6 8.73 1.97 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.994 0.816 . . . . 0.0 111.862 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 55.43 74.1 0.39 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.709 1.604 . . . . 0.0 109.634 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.42 HD13 ' HB3' ' A' ' 152' ' ' TYR . 5.1 mp -101.14 178.19 4.73 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.846 1.259 . . . . 0.0 109.536 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -109.07 130.91 55.49 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 159' ' ' THR . 0.7 OUTLIER -44.84 -53.77 7.13 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 124.579 1.175 . . . . 0.0 108.678 173.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -76.48 -20.88 56.53 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 125.741 1.616 . . . . 0.0 112.732 -159.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -90.53 4.13 52.03 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.679 0.792 . . . . 0.0 109.943 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 156' ' ' SER . 1.2 t -92.93 162.06 14.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.791 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -146.65 118.01 7.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.694 0.797 . . . . 0.0 109.133 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -82.83 155.33 24.22 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.084 0.402 . . . . 0.0 110.33 167.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.6 mp -127.61 114.32 35.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.826 1.25 . . . . 0.0 107.94 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.74 158.64 31.61 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 123.469 0.48 . . . . 0.0 112.254 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.44 3.29 34.82 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -163.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -101.69 164.75 11.58 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.05 1.295 . . . . 0.0 111.581 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 6.5 t -72.57 -14.6 61.66 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.665 -0.647 . . . . 0.0 112.295 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -16.24 48.2 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.811 0.732 . . . . 0.0 110.023 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -78.01 11.41 2.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.178 1.791 . . . . 0.0 112.235 -173.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.1 p -120.76 -19.82 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.483 1.513 . . . . 0.0 110.922 170.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.9 -38.87 89.87 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 120.729 -1.232 . . . . 0.0 110.221 -171.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -78.87 -28.9 44.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.301 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.84 -51.45 69.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -50.88 -42.15 58.81 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.048 1.339 . . . . 0.0 112.136 171.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -50.29 63.0 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.649 -0.657 . . . . 0.0 111.241 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 8.6 t -69.78 -17.85 63.44 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.709 0.803 . . . . 0.0 110.769 174.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.47 33.49 38.85 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.86 2.171 . . . . 0.0 112.525 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.46 171.58 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.591 1.557 . . . . 0.0 111.908 -165.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -92.06 154.57 18.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.715 1.206 . . . . 0.0 111.964 -173.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.7 m -136.46 151.54 49.58 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.198 1.399 . . . . 0.0 110.275 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 46.3 mt -123.6 111.67 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.71 160.26 31.3 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 123.535 0.734 . . . . 0.0 109.027 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -79.63 -16.91 54.94 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.503 -1.373 . . . . 0.0 111.723 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.24 160.93 19.75 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 128.192 2.597 . . . . 0.0 108.655 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -61.22 156.48 18.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.8 m -149.34 22.12 0.94 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.444 1.098 . . . . 0.0 111.184 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 73.7 p 52.29 46.81 25.98 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.966 0.906 . . . . 0.0 111.625 158.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -145.66 176.96 9.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.423 1.489 . . . . 0.0 108.572 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -102.06 -20.64 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.269 1.028 . . . . 0.0 112.447 -177.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -106.57 0.0 37.05 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.211 1.386 . . . . 0.0 111.816 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.72 152.29 22.25 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 119.606 1.703 . . . . 0.0 109.411 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -127.69 148.15 50.4 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.511 1.124 . . . . 0.0 108.539 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -85.87 153.51 22.18 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.487 0.585 . . . . 0.0 112.253 166.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.5 169.26 17.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 126.366 1.866 . . . . 0.0 110.244 168.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -123.3 -9.29 8.09 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.547 1.539 . . . . 0.0 112.827 170.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.51 167.85 29.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.259 1.424 . . . . 0.0 108.56 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.3 tp -69.52 -37.93 77.34 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.28 -15.09 59.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -69.64 -21.12 63.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.409 0.55 . . . . 0.0 109.786 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 86.3 mt -58.53 -59.04 4.16 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 125.411 1.485 . . . . 0.0 108.433 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.0 m -55.7 -39.94 71.72 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.709 0.686 . . . . 0.0 110.86 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -59.9 -33.3 71.67 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.888 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.6 mt -55.34 -47.55 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 119.664 1.12 . . . . 0.0 109.433 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.65 -18.21 51.96 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 . . . . . 0 CA--C 1.536 0.426 0 C-N-CA 126.272 1.829 . . . . 0.0 111.923 -174.714 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm . . . . . 0 C--O 1.235 0.339 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -62.98 -164.8 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.716 1.206 . . . . 0.0 109.864 167.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 69.91 0.07 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.887 1.675 . . . . 0.0 112.178 -176.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.4 m -81.17 153.37 27.26 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.41 147.99 45.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.11 152.94 43.73 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.2 mt -127.99 173.92 12.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 163.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -145.4 164.4 31.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.945 0.898 . . . . 0.0 109.142 167.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -93.01 -24.8 18.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.303 1.441 . . . . 0.0 113.647 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.7 tp . . . . . 0 N--CA 1.475 0.78 0 C-N-CA 129.205 3.002 . . . . 0.0 115.814 -174.814 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.82 -23.19 28.92 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.43 -57.03 6.47 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.661 0.784 . . . . 0.0 110.575 170.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.6 t -53.88 -44.07 59.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 123.604 0.761 . . . . 0.0 109.466 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.1 mt -56.0 -49.33 73.95 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.161 0.891 . . . . 0.0 110.532 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.7 73.97 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.149 0.58 . . . . 0.0 110.95 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -53.31 -46.97 69.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.774 1.23 . . . . 0.0 111.149 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.81 -45.85 66.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.112 1.365 . . . . 0.0 111.323 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -59.97 -48.58 81.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.165 1.386 . . . . 0.0 110.464 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.1 -42.1 80.16 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.569 0.748 . . . . 0.0 110.242 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.6 m -69.76 -6.56 32.9 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.216 1.006 . . . . 0.0 113.67 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.23 -5.57 84.87 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.575 1.56 . . . . 0.0 114.33 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mt -53.36 118.61 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 128.39 2.676 . . . . 0.0 110.268 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -68.15 101.05 1.09 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.368 1.067 . . . . 0.0 108.252 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -84.9 148.81 26.06 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -141.18 179.19 6.9 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.618 1.567 . . . . 0.0 107.525 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.1 mt -131.73 143.74 39.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 167.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -128.52 109.21 11.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 166.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -141.68 150.91 42.49 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -171.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -77.56 -1.95 33.22 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.504 -0.747 . . . . 0.0 112.343 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -63.31 164.22 9.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.043 0.937 . . . . 0.0 110.233 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.47 -176.25 49.61 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -55.58 -25.59 39.07 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.603 0.761 . . . . 0.0 111.74 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -16.81 11.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.752 -1.218 . . . . 0.0 112.576 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.68 -36.59 74.43 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.724 1.147 . . . . 0.0 112.153 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -60.79 -53.88 51.98 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -59.05 -41.49 88.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.519 1.528 . . . . 0.0 111.173 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.94 -50.72 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.748 0.819 . . . . 0.0 109.421 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mp -58.83 -47.87 83.31 Favored 'General case' 0 C--O 1.228 -0.074 0 O-C-N 121.487 -0.758 . . . . 0.0 110.757 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -56.81 -46.48 81.59 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.723 0.809 . . . . 0.0 110.145 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -54.93 -52.22 63.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.184 1.394 . . . . 0.0 109.939 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.42 -7.01 39.87 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.029 1.332 . . . . 0.0 113.592 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.48 28.71 63.03 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.385 0.993 . . . . 0.0 112.469 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.7 m -128.79 28.74 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 124.82 1.248 . . . . 0.0 111.175 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.49 -57.61 12.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.533 1.133 . . . . 0.0 112.004 172.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.7 m -73.22 -22.41 60.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.19 0.596 . . . . 0.0 111.615 -165.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.29 -29.57 58.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.86 -0.59 . . . . 0.0 112.564 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -109.17 110.93 22.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 66.5 m -46.77 -47.74 20.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.147 1.379 . . . . 0.0 109.123 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.47 159.25 42.59 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.74 134.92 65.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 171.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.6 mt -99.01 151.08 21.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 42.4 p -145.55 174.3 11.28 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.561 1.544 . . . . 0.0 107.636 -170.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.2 t -57.51 -13.45 3.72 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 121.215 -0.928 . . . . 0.0 113.272 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -59.31 -48.33 82.03 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.387 1.475 . . . . 0.0 109.197 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 95.8 p -54.54 -36.97 64.86 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.204 1.802 . . . . 0.0 113.037 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.03 -4.87 78.96 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.394 -1.226 . . . . 0.0 114.8 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -50.74 158.71 0.62 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.627 1.213 . . . . 0.0 112.438 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 141' ' ' SER . 18.6 m -52.93 154.8 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 122.903 1.335 . . . . 0.0 112.296 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -85.55 160.38 19.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.241 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 136.93 87.25 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.621 -1.181 . . . . 0.0 108.865 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.25 122.35 7.89 Favored 'Cis proline' 0 N--CA 1.454 -0.805 0 CA-C-N 120.755 1.305 . . . . 0.0 110.732 -0.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.402 ' HA ' HG23 ' A' ' 137' ' ' VAL . 12.0 p -123.32 85.6 51.96 Favored Pre-proline 0 N--CA 1.446 -0.666 0 C-N-CA 125.252 1.421 . . . . 0.0 111.283 -163.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.14 -27.51 8.17 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.709 2.273 . . . . 0.0 113.441 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -53.8 -54.68 34.98 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.364 -0.835 . . . . 0.0 112.191 -166.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.0 -7.75 43.42 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.231 -0.918 . . . . 0.0 113.038 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.97 -48.4 11.5 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 m -55.62 -41.49 73.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.533 1.133 . . . . 0.0 109.946 171.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -58.45 -58.54 8.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.873 0.869 . . . . 0.0 109.996 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -67.12 -19.74 65.66 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.124 0.97 . . . . 0.0 112.855 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -63.14 1.14 Allowed 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 173.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.07 -22.92 65.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.31 -26.46 66.56 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 120.898 -1.126 . . . . 0.0 113.34 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.417 ' HB3' HD13 ' A' ' 154' ' ' LEU . 13.0 t80 -148.69 23.07 1.0 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.451 1.023 . . . . 0.0 112.232 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 50.14 67.2 0.95 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.584 1.553 . . . . 0.0 111.576 -174.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 152' ' ' TYR . 4.5 mp -100.23 170.7 8.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.791 1.282 . . . . 0.0 111.024 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.81 123.14 42.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.861 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 m -59.92 -39.31 85.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.17 1.388 . . . . 0.0 110.816 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -83.25 -13.2 55.79 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.167 -0.958 . . . . 0.0 112.997 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -109.86 13.41 23.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -92.25 149.42 21.47 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -141.43 113.84 8.19 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -73.15 -40.87 64.51 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.0 mp 56.17 99.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 126.461 1.904 . . . . 0.0 111.73 -169.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -122.96 -171.86 13.78 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.87 148.09 32.49 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 169.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER 58.23 171.12 0.05 Allowed 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 126.595 1.958 . . . . 0.0 114.461 -165.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.49 169.91 1.57 Allowed 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 127.382 2.273 . . . . 0.0 110.119 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 tm? 68.4 -27.1 0.14 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 130.409 3.484 . . . . 0.0 113.339 -164.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -73.63 8.11 2.06 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.726 1.603 . . . . 0.0 114.413 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.54 -13.03 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.0 -1.062 . . . . 0.0 110.823 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -66.52 -40.75 89.31 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.711 -1.243 . . . . 0.0 111.026 -173.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -69.22 -32.74 72.19 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.287 -0.883 . . . . 0.0 111.516 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.28 -45.94 89.09 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.458 0.572 . . . . 0.0 109.52 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -49.89 -53.05 28.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.69 0.796 . . . . 0.0 110.622 168.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -58.25 -47.65 82.9 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.9 m -69.58 -20.79 63.65 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.573 1.079 . . . . 0.0 112.265 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.02 58.59 10.36 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -167.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.8 pt -130.36 169.91 20.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.27 1.428 . . . . 0.0 109.065 173.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -96.27 167.74 11.0 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.838 0.855 . . . . 0.0 110.938 -172.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 11.8 m -147.6 158.72 44.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.568 1.547 . . . . 0.0 111.033 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.8 mt -131.74 124.93 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 168.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -144.6 155.73 43.78 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -69.36 -26.46 64.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.169 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.86 156.96 32.18 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.255 0.934 . . . . 0.0 111.851 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.43 165.25 6.32 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.421 1.105 . . . . 0.0 109.971 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 29.7 t -145.19 172.89 12.47 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 161.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 21.8 p -69.93 24.63 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.202 2.201 . . . . 0.0 113.365 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -133.96 108.02 8.15 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.26 1.424 . . . . 0.0 108.071 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -69.58 -16.67 63.45 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.755 1.222 . . . . 0.0 113.781 -166.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -51.52 -53.31 29.27 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 168.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -53.19 114.56 1.51 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.996 2.119 . . . . 0.0 113.778 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -79.32 118.22 21.03 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.802 0.841 . . . . 0.0 111.052 -176.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -67.14 142.56 57.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.05 0.386 . . . . 0.0 111.514 169.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.6 pt -141.93 168.65 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 126.632 1.973 . . . . 0.0 111.511 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -128.1 -6.09 5.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.476 1.51 . . . . 0.0 111.941 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.13 157.59 40.59 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.777 1.231 . . . . 0.0 108.306 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.73 -34.15 73.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -55.32 -34.95 64.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.355 0.662 . . . . 0.0 112.385 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -64.9 -17.67 64.53 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.327 0.651 . . . . 0.0 111.397 -174.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.2 mt -50.44 -61.6 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.362 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 87.8 p -55.38 -34.71 64.57 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.76 0.791 . . . . 0.0 110.698 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -74.45 -25.62 59.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.241 1.416 . . . . 0.0 112.722 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 61.5 mt -53.54 -60.14 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -70.63 8.93 0.73 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.656 1.982 . . . . 0.0 113.792 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 N--CA 1.453 -0.287 0 C-N-CA 125.373 1.469 . . . . 0.0 112.32 177.069 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -60.01 176.76 0.29 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.129 161.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -53.17 82.74 0.0 OUTLIER 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.09 2.156 . . . . 0.0 111.455 172.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.4 m -100.17 153.8 18.96 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.68 150.69 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.139 -0.976 . . . . 0.0 109.314 171.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.97 149.68 51.59 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 126.597 1.959 . . . . 0.0 107.881 -169.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.6 mt -141.92 132.31 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -117.07 167.85 10.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.557 1.543 . . . . 0.0 110.285 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -121.5 -12.8 8.5 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -167.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 127.902 2.481 . . . . 0.0 116.818 174.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.353 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.664 ' HA ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -55.88 -28.3 55.94 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.229 1.012 . . . . 0.0 113.295 -176.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -54.32 -64.83 0.7 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.269 1.428 . . . . 0.0 110.289 173.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.2 t -59.28 -44.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.506 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 90' ' ' ARG . 77.1 mt -52.04 -45.76 64.8 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 119.025 0.83 . . . . 0.0 110.307 -176.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.21 -48.21 58.08 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.094 0.558 . . . . 0.0 111.62 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.3 t90 -54.39 -37.77 65.4 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.7 0.8 . . . . 0.0 110.654 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.63 -42.77 27.92 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.456 1.502 . . . . 0.0 112.379 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -58.17 -51.06 71.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.461 1.104 . . . . 0.0 110.372 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -61.82 -23.9 66.54 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.158 1.383 . . . . 0.0 112.587 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 m -92.41 -0.41 57.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.06 0.944 . . . . 0.0 113.223 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.96 25.96 71.07 Favored Glycine 0 CA--C 1.527 0.837 0 O-C-N 121.356 -0.84 . . . . 0.0 112.942 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.9 mt -67.92 125.67 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 164.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -72.33 97.5 2.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 170.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -79.75 151.85 30.16 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.416 ' CG ' HD13 ' A' ' 148' ' ' LEU . 86.9 m-85 -145.01 169.56 17.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.8 mt -130.99 157.42 43.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 169.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -147.34 134.74 20.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.946 1.298 . . . . 0.0 107.993 159.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 t -163.44 -179.02 6.23 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -108.28 -7.5 15.93 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -0.87 0.08 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 117.654 2.465 . . . . 0.0 117.654 -172.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.68 -175.69 54.21 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.005 -1.06 . . . . 0.0 111.533 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.446 HD22 ' CD ' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -64.91 -12.24 47.03 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -168.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -66.75 -12.96 60.74 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.343 -1.473 . . . . 0.0 111.688 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.16 -55.92 27.17 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.481 1.037 . . . . 0.0 111.44 176.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -54.85 -45.85 74.57 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.996 0.918 . . . . 0.0 109.77 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 m -59.39 -42.43 91.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.925 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.2 mt -64.88 -49.46 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 119.199 0.909 . . . . 0.0 109.344 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mp -60.11 -42.88 95.65 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.894 -0.504 . . . . 0.0 111.754 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -57.23 -53.42 58.31 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.486 1.115 . . . . 0.0 109.27 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.1 -54.23 21.93 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.9 1.68 . . . . 0.0 109.264 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.47 -39.08 65.19 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.777 0.831 . . . . 0.0 111.267 -170.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.25 27.89 1.06 Allowed Glycine 0 CA--C 1.535 1.338 0 CA-C-O 121.637 0.576 . . . . 0.0 112.015 163.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.648 HG23 ' CD2' ' A' ' 125' ' ' TYR 0.303 2.0 p -133.41 12.66 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 127.191 2.196 . . . . 0.0 110.106 -160.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -67.35 -34.34 77.1 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 121.393 -0.817 . . . . 0.0 110.334 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.4 m -77.83 -22.71 49.55 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 120.037 1.289 . . . . 0.0 113.087 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.648 ' CD2' HG23 ' A' ' 122' ' ' VAL . 19.1 m-85 -60.77 -18.57 55.79 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -116.11 126.68 54.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.0 m -62.32 -30.97 71.54 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.821 0.849 . . . . 0.0 111.652 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.476 ' OE1' ' HE2' ' A' ' 151' ' ' LYS . 7.5 tt0 -154.13 159.93 41.69 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 169.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mp -131.88 111.57 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 mt -80.72 159.34 25.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.844 0.831 . . . . 0.0 109.383 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.9 p -142.17 177.47 8.21 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.337 1.855 . . . . 0.0 108.12 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -61.55 -6.58 2.52 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.4 -0.813 . . . . 0.0 112.868 169.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.446 ' CD ' HD22 ' A' ' 111' ' ' ASN . 22.1 mm-40 -57.8 -28.22 63.83 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.669 -1.269 . . . . 0.0 110.703 166.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 58.0 p -58.0 -54.29 48.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.434 0.694 . . . . 0.0 112.394 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.33 -2.88 71.67 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 117.295 -1.836 . . . . 0.0 115.45 -173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -53.92 164.51 0.58 Allowed 'General case' 0 C--O 1.242 0.694 0 CA-C-N 120.03 1.915 . . . . 0.0 112.235 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.1 176.76 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.407 1.099 . . . . 0.0 113.288 -172.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -65.06 147.08 54.12 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.245 -0.909 . . . . 0.0 110.058 174.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -52.1 127.44 37.36 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.984 1.714 . . . . 0.0 107.612 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.01 -40.03 1.31 Allowed 'Cis proline' 0 C--N 1.348 0.531 0 CA-C-N 121.548 1.588 . . . . 0.0 115.25 22.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.267 43.2 p 51.25 72.25 1.28 Allowed Pre-proline 0 N--CA 1.441 -0.897 0 C-N-CA 125.194 1.397 . . . . 0.0 113.077 -172.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -62.14 -18.44 62.02 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.616 2.877 . . . . 0.0 111.907 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -47.71 -43.51 26.9 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.863 1.665 . . . . 0.0 111.273 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.46 -21.66 65.62 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.23 -58.45 3.31 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.188 -0.911 . . . . 0.0 109.392 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.6 m -56.2 -36.16 68.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.552 0.615 . . . . 0.0 110.292 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -50.89 -63.0 1.27 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 124.649 1.18 . . . . 0.0 110.339 170.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.416 HD13 ' CG ' ' A' ' 104' ' ' PHE . 71.2 mt -69.18 -24.46 64.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -174.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.26 -67.43 0.44 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -57.46 -41.29 80.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.873 0.469 . . . . 0.0 110.514 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.476 ' HE2' ' OE1' ' A' ' 128' ' ' GLU . 7.0 tmtm? -47.93 -37.32 14.08 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.581 1.552 . . . . 0.0 114.148 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.54 24.81 5.43 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.221 0.919 . . . . 0.0 112.743 173.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 47.71 58.11 5.31 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.46 1.904 . . . . 0.0 112.946 -175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.6 mp -94.68 172.82 7.94 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.75 1.22 . . . . 0.0 111.725 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -102.11 136.08 42.58 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.691 1.196 . . . . 0.0 108.846 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.2 m -62.13 -50.23 72.73 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.93 1.292 . . . . 0.0 108.91 173.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 1.04 53.07 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.99 -1.069 . . . . 0.0 112.645 -167.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -120.39 12.73 11.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.94 1.296 . . . . 0.0 108.999 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 t -107.35 146.63 31.36 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.156 0.889 . . . . 0.0 109.685 168.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.419 ' CD2' ' HB2' ' A' ' 178' ' ' GLN . 88.9 m-85 -137.22 116.99 13.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.916 1.686 . . . . 0.0 107.633 -167.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -84.84 153.55 22.87 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 170.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.7 mt -128.66 102.4 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.45 124.43 3.33 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.65 37.1 0.4 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.253 1.821 . . . . 0.0 112.139 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.48 158.41 44.31 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.398 1.479 . . . . 0.0 108.304 -176.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.5 t -64.32 -15.27 59.98 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.89 -12.87 60.8 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.597 1.159 . . . . 0.0 112.539 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -48.01 80.11 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.084 0.856 . . . . 0.0 112.202 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.4 -31.59 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.82 -37.48 87.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.131 0.572 . . . . 0.0 109.857 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.74 -53.4 15.67 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.084 -1.01 . . . . 0.0 109.905 172.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.75 -48.11 78.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.319 0.648 . . . . 0.0 111.68 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -56.47 -53.49 56.82 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.362 1.865 . . . . 0.0 111.46 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -73.78 -23.52 59.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 119.383 -0.341 . . . . 0.0 111.778 -172.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.0 p -86.06 -21.28 27.79 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 170.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 76.06 46.94 12.07 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.885 1.231 . . . . 0.0 111.243 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 15.4 pt -131.0 -177.4 2.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 125.985 1.714 . . . . 0.0 109.096 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.419 ' HB2' ' CD2' ' A' ' 160' ' ' TYR . 18.6 mm-40 -92.53 162.21 14.3 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.774 0.83 . . . . 0.0 110.489 -175.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.06 139.47 43.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.51 1.524 . . . . 0.0 111.172 -171.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.88 75.13 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 123.07 1.414 . . . . 0.0 109.347 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -93.79 -171.71 2.67 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.801 1.64 . . . . 0.0 111.362 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -106.57 -8.84 16.82 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.485 ' H ' HD12 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -118.66 154.86 32.02 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.728 -1.232 . . . . 0.0 110.275 177.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.62 140.07 58.48 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 120.832 -1.167 . . . . 0.0 109.277 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.406 ' H ' ' ND2' ' A' ' 190' ' ' ASN . 19.5 m -127.52 147.35 50.32 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.881 1.324 . . . . 0.0 112.233 168.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.23 47.94 1.58 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.803 2.841 . . . . 0.0 110.513 -167.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -138.22 159.72 41.32 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.101 1.361 . . . . 0.0 109.663 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -99.06 98.45 9.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 115.89 16.64 6.74 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.667 1.127 . . . . 0.0 112.419 -171.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.406 ' ND2' ' H ' ' A' ' 185' ' ' SER . 12.0 t30 -89.3 138.32 31.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.847 0.823 . . . . 0.0 109.411 166.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -135.04 90.38 2.63 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.202 1.001 . . . . 0.0 110.564 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . 0.262 0.2 OUTLIER -80.54 152.52 28.61 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.059 -172.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.1 pt -127.01 170.36 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.924 1.689 . . . . 0.0 111.93 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.84 -27.15 12.83 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.716 0.807 . . . . 0.0 112.177 161.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.56 155.84 42.79 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.045 0.938 . . . . 0.0 108.951 -166.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 196' ' ' LEU . 3.3 tp -64.63 -35.51 81.23 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.273 1.029 . . . . 0.0 109.035 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -60.18 -30.46 69.36 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -60.91 -20.61 62.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.408 1.004 . . . . 0.0 111.306 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 95.1 mt -53.98 -53.68 25.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 88.1 p -59.68 -39.1 83.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -59.03 -40.88 86.41 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.342 1.057 . . . . 0.0 109.593 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.4 mt -51.81 -49.84 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.761 1.224 . . . . 0.0 110.851 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.76 -5.61 55.63 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.941 0.896 . . . . 0.0 112.514 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 . . . . . 0 N--CA 1.451 -0.42 0 C-N-CA 127.101 2.16 . . . . 0.0 110.104 -174.243 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mmm . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.9 175.98 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.958 2.103 . . . . 0.0 110.649 166.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.1 102.67 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.976 1.71 . . . . 0.0 110.234 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.6 m -133.55 142.41 48.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.54 142.25 51.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.253 1.021 . . . . 0.0 108.294 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.69 153.33 34.53 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.2 mt -141.92 128.01 18.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -115.61 155.97 26.68 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.323 0.649 . . . . 0.0 110.49 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -78.37 -11.13 59.92 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.367 1.067 . . . . 0.0 112.301 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.473 0.693 0 C-N-CA 129.448 3.099 . . . . 0.0 111.466 -164.582 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -59.06 -35.13 72.82 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.751 1.16 . . . . 0.0 113.597 -159.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -59.93 -58.33 9.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 124.096 0.873 . . . . 0.0 110.27 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.6 t -52.62 -41.43 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.085 0.954 . . . . 0.0 110.713 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 85.6 mt -57.61 -48.18 80.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.104 0.866 . . . . 0.0 110.13 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.51 -46.35 83.33 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.607 0.763 . . . . 0.0 111.901 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -57.4 -48.24 79.61 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.57 98.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.63 0.772 . . . . 0.0 111.309 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -54.84 -61.07 2.55 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.68 1.592 . . . . 0.0 110.35 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -60.97 -20.33 62.23 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.3 m -86.75 -4.08 59.13 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.79 1.236 . . . . 0.0 112.815 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.17 22.61 70.94 Favored Glycine 0 CA--C 1.528 0.872 0 O-C-N 120.868 -1.145 . . . . 0.0 112.688 175.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.8 mt -55.54 165.44 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 126.674 1.99 . . . . 0.0 107.433 158.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -118.04 112.72 20.61 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 161.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -80.81 143.34 32.9 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -132.34 168.5 18.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.539 1.536 . . . . 0.0 108.643 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 60.5 mt -140.0 158.86 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.361 1.464 . . . . 0.0 108.309 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -139.88 125.17 18.9 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.882 0.873 . . . . 0.0 108.758 162.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -137.41 164.19 29.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.481 1.112 . . . . 0.0 109.822 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -104.39 -0.03 28.53 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.674 1.19 . . . . 0.0 111.634 172.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -69.04 -0.19 5.42 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.27 -176.61 30.48 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.808 1.194 . . . . 0.0 110.615 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -27.06 61.36 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.653 0.781 . . . . 0.0 111.016 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -60.65 -14.98 23.88 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.1 -49.64 40.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.823 0.738 . . . . 0.0 110.605 168.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -57.43 -44.74 84.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.697 0.68 . . . . 0.0 111.197 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -57.27 -43.96 83.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.731 0.812 . . . . 0.0 110.594 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.83 -53.44 48.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.977 1.311 . . . . 0.0 109.26 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.05 -36.88 84.43 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.005 0.82 . . . . 0.0 110.516 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -61.0 -51.44 69.25 Favored 'General case' 0 C--N 1.337 0.052 0 CA-C-N 118.671 0.669 . . . . 0.0 110.476 175.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -53.46 -51.72 61.79 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 110.168 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.12 -21.01 63.14 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.594 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.95 47.16 5.13 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.913 1.244 . . . . 0.0 111.504 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.0 m -147.51 23.22 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.956 1.702 . . . . 0.0 110.991 -174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.01 -35.27 59.61 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.99 -1.069 . . . . 0.0 110.792 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.9 m -63.64 -27.69 69.4 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.191 0.596 . . . . 0.0 110.79 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.82 7.95 1.01 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -137.78 112.03 8.57 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.0 m -49.44 -39.59 33.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.422 1.089 . . . . 0.0 109.684 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.44 156.36 33.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 118.964 0.802 . . . . 0.0 110.017 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 44.1 mt -139.06 93.41 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.438 HD22 ' OG ' ' A' ' 134' ' ' SER . 45.2 mt -65.98 146.88 54.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 70.0 p -127.45 -177.81 4.22 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.287 1.035 . . . . 0.0 110.246 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 t -60.28 -18.04 46.46 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.519 -0.738 . . . . 0.0 112.215 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -61.29 -37.13 82.1 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.971 0.805 . . . . 0.0 108.934 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.438 ' OG ' HD22 ' A' ' 130' ' ' LEU . 12.7 t -56.92 -35.51 69.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.099 0.96 . . . . 0.0 111.704 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.83 -8.48 65.96 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 117.068 -1.962 . . . . 0.0 113.872 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -57.4 164.52 1.84 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 120.047 1.923 . . . . 0.0 111.102 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 t -61.4 162.32 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-N 112.528 -2.124 . . . . 0.0 110.149 166.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -90.69 172.45 8.65 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.51 1.524 . . . . 0.0 109.557 170.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -68.18 150.63 97.66 Favored Pre-proline 0 C--O 1.237 0.441 0 O-C-N 120.774 -1.203 . . . . 0.0 108.942 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.29 -18.12 16.88 Favored 'Cis proline' 0 C--N 1.347 0.492 0 N-CA-C 115.759 1.407 . . . . 0.0 115.759 16.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.67 91.16 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 131.371 3.868 . . . . 0.0 114.604 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -54.13 -7.11 0.61 Allowed 'Trans proline' 0 CA--C 1.544 0.975 1 C-N-CA 126.206 4.604 . . . . 0.0 114.558 -172.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -43.83 -52.05 7.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.819 2.848 . . . . 0.0 113.213 -165.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.96 -3.01 11.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.278 1.031 . . . . 0.0 113.675 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.06 -40.03 7.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.374 1.469 . . . . 0.0 109.869 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 m -51.69 -39.67 58.72 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.337 0.971 . . . . 0.0 109.489 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.96 -53.02 61.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.928 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.7 mt -68.51 -21.2 64.59 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.344 1.457 . . . . 0.0 113.007 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.407 HD11 ' HA ' ' A' ' 156' ' ' SER . 0.0 OUTLIER -67.08 -69.73 0.29 Allowed 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 175.163 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -54.84 -39.77 68.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -23.38 43.42 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.664 -1.272 . . . . 0.0 113.898 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . 0.475 ' HB3' HD13 ' A' ' 154' ' ' LEU . 6.3 t80 -138.4 17.04 2.75 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 172.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 49.26 38.73 14.19 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.625 1.97 . . . . 0.0 112.185 -170.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -68.71 165.4 19.57 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.956 0.902 . . . . 0.0 109.754 176.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.605 ' ND2' HD21 ' A' ' 158' ' ' ASN . 6.6 m-20 -101.17 -5.89 25.0 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 -160.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.407 ' HA ' HD11 ' A' ' 149' ' ' LEU . 1.4 m 76.43 -36.14 0.26 Allowed 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 108.813 -3.812 . . . . 0.0 112.179 -166.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -25.04 56.67 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 120.943 -1.098 . . . . 0.0 112.8 -171.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.605 HD21 ' ND2' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -85.77 -3.16 58.83 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 116.362 -1.78 . . . . 0.0 110.694 -178.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -102.27 123.61 46.39 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.401 1.455 . . . . 0.0 108.712 -170.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -120.81 101.01 7.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.045 2.138 . . . . 0.0 108.903 -170.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -74.68 150.6 39.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.44 129.13 68.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -149.69 172.28 29.66 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.431 0.539 . . . . 0.0 111.883 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.42 3.02 4.22 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.525 1.53 . . . . 0.0 113.564 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -144.09 133.7 23.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 t -47.56 166.71 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.986 2.114 . . . . 0.0 110.858 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 tp 67.74 -5.03 0.86 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 131.404 3.882 . . . . 0.0 112.979 -152.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -58.1 -41.16 82.9 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.355 0.979 . . . . 0.0 110.826 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 185' ' ' SER . 13.2 p -104.13 -18.21 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 126.261 1.824 . . . . 0.0 110.849 -171.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -68.0 -22.72 64.98 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.46 -0.775 . . . . 0.0 111.851 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.427 ' CE1' HD11 ' A' ' 177' ' ' ILE . 7.2 p90 -88.08 -23.27 23.76 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.292 -0.88 . . . . 0.0 112.331 173.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.14 90.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.967 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -64.22 -40.68 96.55 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.446 0.566 . . . . 0.0 111.061 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.49 -55.52 34.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.198 0.454 . . . . 0.0 110.356 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 t -75.15 -24.75 57.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.097 -0.477 . . . . 0.0 111.555 -172.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 67.3 61.33 5.2 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -166.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.427 HD11 ' CE1' ' A' ' 171' ' ' PHE . 50.5 pt -128.88 177.55 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.976 1.711 . . . . 0.0 108.002 172.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -94.99 179.07 5.35 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.184 0.594 . . . . 0.0 109.748 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.51 160.75 34.96 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.633 -1.292 . . . . 0.0 109.436 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.0 mt -142.56 101.91 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.282 1.433 . . . . 0.0 107.158 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -128.24 165.37 20.63 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 123.134 1.445 . . . . 0.0 111.705 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -78.78 -29.84 45.21 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.765 -1.562 . . . . 0.0 111.297 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.79 13.99 27.26 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -157.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . 0.287 12.3 pt-20 50.93 -170.85 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.858 1 C-N-CA 134.999 5.32 . . . . 0.0 114.09 -170.187 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.448 ' HB2' HG11 ' A' ' 169' ' ' VAL . 48.3 t -164.12 167.99 19.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.097 2.159 . . . . 0.0 107.121 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 16.6 p -100.33 66.14 1.26 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.819 1.248 . . . . 0.0 108.185 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -143.46 177.28 8.56 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.792 1.637 . . . . 0.0 108.989 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -106.26 -30.87 8.92 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.597 1.159 . . . . 0.0 112.893 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.09 5.84 82.91 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.235 0.921 . . . . 0.0 111.568 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -72.86 155.19 40.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 118.749 1.274 . . . . 0.0 108.712 168.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -134.75 109.02 8.3 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.31 143.01 58.21 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 122.955 0.502 . . . . 0.0 111.211 177.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.2 pt -146.39 173.37 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.684 1.594 . . . . 0.0 112.746 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -127.89 -17.85 4.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.793 1.637 . . . . 0.0 113.417 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.24 165.84 28.02 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.0 1.32 . . . . 0.0 109.802 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.01 -37.56 88.06 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.83 -15.58 54.8 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -75.11 -17.85 60.36 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.168 -0.958 . . . . 0.0 110.796 174.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.408 ' HA ' HD12 ' A' ' 202' ' ' ILE . 70.5 mt -58.25 -53.49 45.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 77.4 p -58.76 -34.3 71.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.928 0.786 . . . . 0.0 111.092 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -62.43 -35.05 78.05 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 116.728 -1.606 . . . . 0.0 111.603 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 199' ' ' ILE . 77.4 mt -50.75 -52.59 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.726 1.148 . . . . 0.0 108.804 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -81.34 -5.22 57.6 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.935 -0.555 . . . . 0.0 112.422 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 . . . . . 0 CA--C 1.53 0.185 0 C-N-CA 125.77 1.628 . . . . 0.0 112.27 -171.978 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mmm . . . . . 0 CA--C 1.516 -0.364 0 CA-C-O 124.049 1.88 . . . . 0.0 108.486 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.97 177.86 0.11 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 111.608 -2.542 . . . . 0.0 111.389 167.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -54.78 69.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 129.148 2.979 . . . . 0.0 114.556 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.6 m -96.28 141.92 29.04 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.06 147.33 50.16 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.438 ' CD2' HD11 ' A' ' 162' ' ' ILE . 0.8 OUTLIER -130.7 144.43 51.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 124.562 1.145 . . . . 0.0 108.108 -170.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.8 mt -133.57 120.44 37.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -105.71 -177.51 3.38 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.674 1.59 . . . . 0.0 108.202 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.2 174.22 9.45 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.301 1.04 . . . . 0.0 109.603 170.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -175.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.505 ' N ' HD11 ' A' ' 196' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.6 tpt85 -58.15 -32.7 68.44 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.663 0.665 . . . . 0.0 112.649 -158.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -48.96 -70.3 0.09 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.253 1.421 . . . . 0.0 109.889 168.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.4 t -63.52 -36.02 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 126.836 2.054 . . . . 0.0 110.666 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.3 mt -51.72 -46.31 63.91 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.05 1.295 . . . . 0.0 110.572 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.66 -46.43 85.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.067 0.947 . . . . 0.0 111.657 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -61.65 -42.55 99.06 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.479 0.712 . . . . 0.0 112.227 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.98 -32.79 72.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.157 0.983 . . . . 0.0 111.315 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.41 -43.8 72.66 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.189 1.795 . . . . 0.0 111.857 173.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.3 -13.99 3.95 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.802 1.241 . . . . 0.0 112.004 168.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.3 m -113.96 -5.25 13.17 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.773 1.629 . . . . 0.0 112.241 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.57 19.73 49.3 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.137 1.827 . . . . 0.0 113.862 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mt -51.83 124.74 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 160.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -75.34 111.58 10.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -96.05 153.92 17.52 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 127' ' ' THR . 66.9 m-85 -148.61 165.79 30.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.487 1.515 . . . . 0.0 109.135 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.457 ' HB ' HG23 ' A' ' 129' ' ' ILE . 36.8 mt -137.72 153.66 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.998 1.719 . . . . 0.0 108.177 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -132.58 143.09 49.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.492 1.517 . . . . 0.0 107.795 160.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 t -169.74 173.11 6.41 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.796 1.638 . . . . 0.0 108.835 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -131.77 66.42 1.55 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.234 1.814 . . . . 0.0 110.106 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.27 6.58 17.44 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.483 1.513 . . . . 0.0 111.646 166.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.77 178.4 43.67 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.695 1.14 . . . . 0.0 111.28 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.47 -18.55 52.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.286 1.034 . . . . 0.0 111.837 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.65 -23.14 49.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.876 0.87 . . . . 0.0 111.652 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.28 -45.45 72.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.474 0.709 . . . . 0.0 111.922 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -62.63 -39.95 95.44 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.984 0.811 . . . . 0.0 109.904 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -62.25 -45.83 91.53 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.78 0.832 . . . . 0.0 110.262 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.21 -43.29 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.534 1.134 . . . . 0.0 109.14 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.84 -40.59 95.85 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.482 -0.761 . . . . 0.0 111.36 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -53.35 58.55 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.702 0.683 . . . . 0.0 110.162 169.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -49.47 -53.44 23.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.047 0.939 . . . . 0.0 111.597 -174.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.57 -11.07 60.11 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.17 1.388 . . . . 0.0 114.051 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 59.97 54.51 36.82 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.67 1.129 . . . . 0.0 110.678 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.7 6.08 2.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 125.085 1.354 . . . . 0.0 111.993 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.03 -53.01 56.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.564 0.697 . . . . 0.0 109.988 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 m -72.46 -11.26 60.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.818 -162.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -62.69 -28.69 70.11 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.172 0.989 . . . . 0.0 112.71 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -107.87 136.12 48.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -174.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.455 ' HB ' ' CE2' ' A' ' 104' ' ' PHE . 78.5 m -61.58 -43.62 98.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.85 157.12 38.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -173.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.457 HG23 ' HB ' ' A' ' 105' ' ' ILE . 5.0 mp -137.15 143.35 34.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.5 HD21 ' CE1' ' A' ' 147' ' ' TYR . 76.8 mt -99.57 158.87 15.45 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.764 1.225 . . . . 0.0 109.778 174.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 p -137.36 -174.22 3.69 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.136 0.574 . . . . 0.0 111.101 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.9 -30.18 13.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.512 1.125 . . . . 0.0 111.695 166.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -65.71 -19.83 66.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.994 1.318 . . . . 0.0 111.113 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.2 m -89.47 69.53 7.96 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.75 47.75 1.54 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 127.34 2.4 . . . . 0.0 112.116 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -56.66 169.32 0.49 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.367 0.667 . . . . 0.0 110.995 164.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' CB ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -50.67 166.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 122.634 1.207 . . . . 0.0 112.922 177.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -61.23 157.44 16.23 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.363 163.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -42.58 147.87 0.58 Allowed Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 124.745 1.218 . . . . 0.0 110.343 166.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.56 -27.3 4.95 Favored 'Cis proline' 0 CA--C 1.533 0.461 0 CA-C-N 119.342 0.801 . . . . 0.0 113.407 -3.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.503 ' CB ' HG23 ' A' ' 137' ' ' VAL . 3.3 t 49.39 82.18 0.24 Allowed Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.012 1.325 . . . . 0.0 112.079 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.57 -23.02 70.59 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 121.494 1.462 . . . . 0.0 111.286 165.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -54.03 -50.47 66.6 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.892 1.277 . . . . 0.0 112.713 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.02 -17.11 22.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.88 -47.77 6.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.546 1.138 . . . . 0.0 111.203 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 m -57.27 -39.02 74.8 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.885 0.874 . . . . 0.0 109.585 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.5 ' CE1' HD21 ' A' ' 130' ' ' LEU . 30.6 t80 -57.87 -51.02 71.31 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.544 0.738 . . . . 0.0 110.274 173.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.1 mt -65.95 -36.42 83.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.275 1.03 . . . . 0.0 110.761 -171.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 89.2 mt -60.59 -64.84 0.81 Allowed 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.36 1.864 . . . . 0.0 106.031 175.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.81 -37.26 75.98 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -172.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.32 -23.02 21.37 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 117.299 -1.334 . . . . 0.0 114.325 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -134.52 20.46 3.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.593 1.542 . . . . 0.0 110.612 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 44.14 62.87 1.82 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.679 2.392 . . . . 0.0 110.614 -172.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 67.5 mt -103.08 165.13 11.2 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.499 1.12 . . . . 0.0 110.647 -170.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -100.67 132.25 46.16 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.792 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 m -58.13 -49.37 77.22 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.546 1.138 . . . . 0.0 110.166 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.6 -4.18 41.6 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.133 -1.605 . . . . 0.0 112.818 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -113.6 10.88 18.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 117.876 -1.059 . . . . 0.0 108.838 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -109.9 111.26 22.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.98 0.809 . . . . 0.0 109.406 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -114.87 108.54 16.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.491 1.517 . . . . 0.0 110.152 -168.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -78.39 152.46 32.23 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.415 0.686 . . . . 0.0 109.68 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.438 HD11 ' CD2' ' A' ' 6' ' ' PHE . 2.5 mp -127.17 127.84 69.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 172.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -167.13 -177.68 38.96 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 121.511 0.506 . . . . 0.0 112.908 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -126.22 9.9 7.39 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.209 1.404 . . . . 0.0 112.452 -165.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -136.32 126.85 26.93 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.038 0.935 . . . . 0.0 110.03 -171.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 6.2 t -46.34 -23.87 0.41 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.133 2.573 . . . . 0.0 115.216 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -12.95 59.79 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.139 1.776 . . . . 0.0 112.312 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -51.64 69.16 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.637 0.775 . . . . 0.0 110.743 174.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.96 -29.68 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 O-C-N 121.811 -0.556 . . . . 0.0 109.611 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.52 -21.26 66.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.475 -0.774 . . . . 0.0 112.238 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -97.32 -39.77 9.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.548 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -57.2 -43.04 82.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 123.698 0.624 . . . . 0.0 111.153 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -59.1 -48.48 81.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.604 1.161 . . . . 0.0 110.934 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -71.1 -33.53 70.25 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 118.234 -0.889 . . . . 0.0 112.298 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 45.9 m -82.66 -21.39 35.0 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.514 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.72 63.67 3.11 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.462 1.506 . . . . 0.0 110.505 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.2 pt -135.73 -166.5 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.863 1.665 . . . . 0.0 108.948 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -120.38 158.64 26.73 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.548 1.067 . . . . 0.0 111.541 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.8 m -139.0 149.82 45.13 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.105 1.762 . . . . 0.0 109.367 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.1 mt -138.7 94.99 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -122.81 158.6 29.91 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.458 1.103 . . . . 0.0 110.938 -170.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -85.87 -26.33 25.7 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.705 -0.622 . . . . 0.0 111.391 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.412 ' H ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -73.04 175.55 6.58 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 161.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 192' ' ' ARG . 6.1 pt-20 -108.06 170.53 7.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 164.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.3 t -151.99 -168.97 3.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.9 p -127.78 81.26 2.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.874 1.27 . . . . 0.0 108.054 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -151.26 153.68 35.33 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.62 1.568 . . . . 0.0 108.465 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.87 108.14 16.69 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.775 1.63 . . . . 0.0 110.313 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 117.91 -7.42 15.11 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 123.972 0.796 . . . . 0.0 111.81 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.97 118.91 24.33 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.302 1.441 . . . . 0.0 108.293 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -114.21 136.47 52.92 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.139 1.376 . . . . 0.0 110.674 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.509 ' HD2' ' HB3' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -83.85 146.66 27.98 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.416 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.446 HG22 ' HB3' ' A' ' 198' ' ' ASP . 22.5 pt -132.82 167.67 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.39 1.476 . . . . 0.0 112.303 165.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -124.75 -12.12 7.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.549 1.539 . . . . 0.0 112.172 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.07 172.09 19.29 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.502 1.521 . . . . 0.0 109.454 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.505 HD11 ' N ' ' A' ' 89' ' ' ALA . 10.2 mt -68.78 -37.18 79.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.95 1.3 . . . . 0.0 110.352 -176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.39 -22.43 66.79 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.874 0.845 . . . . 0.0 112.196 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.446 ' HB3' HG22 ' A' ' 193' ' ' ILE . 0.5 OUTLIER -74.83 -5.77 45.35 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.825 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 78.5 mt -77.65 -63.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.348 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 168.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.9 p -55.96 -28.03 55.15 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -60.03 -38.69 83.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.145 1.778 . . . . 0.0 112.996 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.91 -50.16 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 C-N-CA 126.632 1.973 . . . . 0.0 106.563 -168.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -71.69 -4.26 26.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.352 1.061 . . . . 0.0 113.338 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 . . . . . 0 N--CA 1.451 -0.415 0 C-N-CA 123.417 0.687 . . . . 0.0 112.389 -179.362 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.0 mmm . . . . . 0 C--O 1.238 0.47 0 CA-C-O 123.267 1.508 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -60.92 -172.31 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.22 1.408 . . . . 0.0 110.214 155.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -66.53 82.99 0.1 Allowed 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.926 1.29 . . . . 0.0 110.141 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.8 m -92.74 158.91 15.66 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 166.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.54 157.33 45.64 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 120.584 -1.323 . . . . 0.0 110.636 164.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -128.42 162.48 27.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.203 2.201 . . . . 0.0 108.587 -172.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.5 mt -138.99 144.5 29.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 126.224 1.81 . . . . 0.0 107.033 166.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -117.13 166.35 12.33 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.983 2.113 . . . . 0.0 110.398 170.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -105.21 171.88 7.09 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 162.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.546 0.792 0 C-N-CA 127.403 2.281 . . . . 0.0 110.736 172.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.371 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.319 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -51.65 -36.65 47.0 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.8 0.84 . . . . 0.0 112.219 -175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -56.7 -51.02 70.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.836 1.254 . . . . 0.0 111.047 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.39 -43.88 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.399 1.479 . . . . 0.0 109.815 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.726 HD23 ' CD2' ' A' ' 125' ' ' TYR . 8.3 mp -50.39 -50.78 50.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 121.344 1.884 . . . . 0.0 111.205 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.59 -43.97 85.03 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.446 0.466 . . . . 0.0 111.951 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -68.72 -39.66 80.32 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.005 1.322 . . . . 0.0 112.089 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.91 -29.13 60.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.209 1.404 . . . . 0.0 111.597 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -64.38 -59.2 4.64 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 127.401 2.281 . . . . 0.0 110.166 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -55.72 -27.27 49.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.559 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.7 m -90.66 3.5 54.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.93 8.93 44.49 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.127 1.346 . . . . 0.0 114.334 173.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mt -66.37 104.17 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -60.71 111.92 1.81 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.61 150.1 21.85 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 172.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.519 ' CD2' HD22 ' A' ' 148' ' ' LEU . 79.5 m-85 -142.95 166.4 24.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.503 1.121 . . . . 0.0 110.53 175.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 9.2 mt -127.49 158.25 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 121.041 1.746 . . . . 0.0 109.43 173.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -133.58 112.0 11.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.747 1.219 . . . . 0.0 108.893 167.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -143.11 173.63 11.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -127.68 14.16 6.97 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.759 2.023 . . . . 0.0 110.887 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -3.07 28.98 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.99 173.0 34.4 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.703 1.62 . . . . 0.0 112.557 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.74 -19.99 19.72 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.777 1.631 . . . . 0.0 112.653 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -22.76 20.98 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.419 1.488 . . . . 0.0 111.944 173.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.91 -44.57 78.38 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.027 -1.045 . . . . 0.0 111.576 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -56.79 -46.25 81.66 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.75 0.42 . . . . 0.0 110.506 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -61.3 -47.37 86.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.747 0.819 . . . . 0.0 110.486 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.8 mt -55.59 -50.63 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.83 -32.27 73.45 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.802 -1.186 . . . . 0.0 110.843 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -72.33 -27.2 62.28 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 171.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -63.81 1.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 123.365 1.555 . . . . 0.0 107.08 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.31 -35.59 80.88 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.785 3.234 . . . . 0.0 112.254 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.8 61.93 1.57 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 124.512 1.053 . . . . 0.0 110.495 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.9 m -139.64 5.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.223 1.009 . . . . 0.0 110.856 170.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.11 -30.75 63.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.086 -1.009 . . . . 0.0 111.37 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.3 m -70.36 -26.93 63.96 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 118.801 0.728 . . . . 0.0 111.73 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.726 ' CD2' HD23 ' A' ' 93' ' ' LEU . 24.6 m-85 -51.5 -60.33 3.26 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.297 0.639 . . . . 0.0 110.11 164.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.53 ' CE1' HD21 ' A' ' 93' ' ' LEU . 28.9 m-85 -84.9 114.23 21.97 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -152.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.2 m -64.5 -31.85 73.24 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.733 -0.604 . . . . 0.0 111.629 -172.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -158.89 156.72 30.1 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.957 1.253 . . . . 0.0 109.838 167.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.79 105.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 103.871 -2.64 . . . . 0.0 103.871 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.22 158.24 26.7 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.3 p -131.75 179.73 5.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.053 1.341 . . . . 0.0 109.15 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -31.03 42.33 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.155 1.382 . . . . 0.0 112.168 165.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -63.71 -21.55 66.46 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.921 1.288 . . . . 0.0 110.676 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.6 p -57.24 -30.39 64.58 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.0 1.32 . . . . 0.0 114.063 -165.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.75 2.31 44.06 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.538 -1.146 . . . . 0.0 113.954 169.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -63.51 158.47 20.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.318 1.559 . . . . 0.0 111.613 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 137' ' ' VAL . 8.7 t -57.61 157.85 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.564 161.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -136.78 59.8 1.68 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.277 1.431 . . . . 0.0 111.207 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -49.66 -54.84 27.29 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-O 114.834 -2.508 . . . . 0.0 114.344 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.78 114.08 0.19 OUTLIER 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 123.313 2.219 . . . . 0.0 117.016 10.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 m -92.73 154.94 42.2 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 124.873 1.269 . . . . 0.0 112.547 -173.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -81.53 5.25 6.4 Favored 'Trans proline' 0 CA--C 1.549 1.261 1 C-N-CA 125.585 4.19 . . . . 0.0 113.883 170.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -46.77 -63.92 0.9 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.479 1.912 . . . . 0.0 110.942 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.54 -20.96 64.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.461 0.705 . . . . 0.0 111.934 -169.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.18 -60.38 2.32 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.297 1.039 . . . . 0.0 108.766 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.3 m -54.93 -40.57 70.04 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.025 1.33 . . . . 0.0 110.407 -174.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.512 ' CE1' ' HE2' ' A' ' 151' ' ' LYS . 72.0 t80 -52.1 -58.0 7.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.474 1.11 . . . . 0.0 110.633 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.519 HD22 ' CD2' ' A' ' 104' ' ' PHE . 23.3 mt -71.02 -25.19 62.56 Favored 'General case' 0 CA--C 1.521 -0.137 0 O-C-N 121.866 -0.521 . . . . 0.0 112.144 -172.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 87.2 mt -66.48 -61.15 2.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.99 -36.19 72.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.963 0.505 . . . . 0.0 111.699 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.512 ' HE2' ' CE1' ' A' ' 147' ' ' TYR . 7.9 mmtm -57.31 -22.85 44.74 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 114.276 1.214 . . . . 0.0 114.276 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.97 27.43 1.46 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 119.037 0.835 . . . . 0.0 111.822 169.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 67.9 mm-40 44.41 54.56 6.22 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.648 2.379 . . . . 0.0 111.494 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 4.3 mp -75.46 -169.59 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.188 1.395 . . . . 0.0 110.592 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -121.78 129.15 52.44 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.236 1.414 . . . . 0.0 108.751 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.0 m -52.5 -49.1 65.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.985 1.714 . . . . 0.0 110.445 175.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -88.43 9.2 24.4 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 120.791 -1.193 . . . . 0.0 111.881 -169.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.94 8.75 7.45 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.353 1.861 . . . . 0.0 108.733 173.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -107.65 142.42 37.64 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.743 1.156 . . . . 0.0 109.539 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -129.46 156.55 43.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.952 2.101 . . . . 0.0 108.243 -170.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -139.17 128.17 23.7 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.93 116.05 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.152 1.381 . . . . 0.0 107.309 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -142.09 -172.26 13.48 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 174.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -132.51 5.83 4.05 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.404 1.882 . . . . 0.0 113.393 -169.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.405 ' HG2' HH11 ' A' ' 165' ' ' ARG . 0.6 OUTLIER -131.83 155.82 47.13 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 120.0 1.273 . . . . 0.0 109.95 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t -72.94 -13.69 61.3 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.584 -1.323 . . . . 0.0 111.059 -169.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.26 -33.18 52.02 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.739 1.616 . . . . 0.0 111.167 167.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -74.06 10.12 1.33 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.376 1.47 . . . . 0.0 113.601 -164.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.22 -13.71 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.288 1.035 . . . . 0.0 110.686 167.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.32 -47.83 77.92 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.803 1.638 . . . . 0.0 110.018 -173.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -76.94 -34.44 57.65 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 121.595 -0.691 . . . . 0.0 111.809 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.48 -58.11 8.29 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.598 0.759 . . . . 0.0 109.867 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -49.84 -45.74 50.57 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.699 2.0 . . . . 0.0 110.841 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -62.49 -26.08 68.35 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.5 p -93.98 -26.01 17.0 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.055 0.843 . . . . 0.0 112.769 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 92.46 9.57 61.48 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.198 1.38 . . . . 0.0 112.556 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 178' ' ' GLN . 1.7 pp -88.21 175.66 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.721 1.209 . . . . 0.0 109.39 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.411 ' N ' HD12 ' A' ' 177' ' ' ILE . 32.5 mt-30 -112.37 163.73 14.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.865 0.841 . . . . 0.0 111.694 -165.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 8.8 m -137.39 149.82 47.22 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.665 1.586 . . . . 0.0 110.175 -168.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 47.6 mt -140.4 78.02 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -114.16 165.13 12.97 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.507 1.146 . . . . 0.0 110.693 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -73.4 -13.3 61.06 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.283 -0.885 . . . . 0.0 113.157 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.59 157.12 39.71 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.442 1.019 . . . . 0.0 110.727 -174.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -89.51 159.23 17.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.939 -0.476 . . . . 0.0 111.435 -171.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.25 8.38 1.2 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -169.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 47.7 p 52.81 49.66 19.78 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.101 1.36 . . . . 0.0 113.257 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -131.27 162.65 29.55 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.4 1.88 . . . . 0.0 109.105 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -80.13 -42.87 22.67 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.639 0.776 . . . . 0.0 111.812 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.73 47.4 3.57 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -130.43 125.94 35.72 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.922 1.289 . . . . 0.0 109.52 -164.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -127.2 108.39 10.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.004 0.921 . . . . 0.0 109.156 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -63.94 142.01 58.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 118.149 -1.42 . . . . 0.0 109.699 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 13.7 pt -114.96 159.67 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.3 1.04 . . . . 0.0 110.564 165.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -115.15 -8.17 12.4 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.839 1.256 . . . . 0.0 112.535 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.76 161.62 41.43 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.869 2.468 . . . . 0.0 107.154 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 tp -71.16 -32.94 69.55 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.408 -0.808 . . . . 0.0 110.268 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.77 -18.69 63.06 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.098 -0.953 . . . . 0.0 112.196 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -66.32 -20.02 65.97 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.422 1.01 . . . . 0.0 110.316 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 76.8 mt -62.46 -53.61 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 124.607 1.163 . . . . 0.0 108.96 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 80.7 p -56.27 -39.59 72.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.185 0.902 . . . . 0.0 109.662 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -60.2 -25.71 65.8 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.349 2.26 . . . . 0.0 111.591 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 80.0 mt -61.64 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 120.498 -1.376 . . . . 0.0 109.454 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -89.91 -26.26 20.54 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.492 1.117 . . . . 0.0 110.944 -175.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 . . . . . 0 CA--C 1.535 0.395 0 C-N-CA 125.716 1.606 . . . . 0.0 112.587 -176.216 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mmm . . . . . 0 N--CA 1.451 -0.382 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.16 169.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.901 2.081 . . . . 0.0 109.687 162.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 106.72 0.09 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.476 1.51 . . . . 0.0 108.813 174.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.8 m -134.86 147.18 49.82 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.27 153.96 46.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.402 1.081 . . . . 0.0 108.645 171.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.04 153.31 48.56 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.176 1.79 . . . . 0.0 107.609 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 mt -143.22 138.46 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -128.97 179.96 5.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.43 1.092 . . . . 0.0 110.443 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -130.71 172.35 12.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.172 2.189 . . . . 0.0 109.596 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.411 HD12 HG21 ' A' ' 107' ' ' THR . 76.0 mt . . . . . 0 CA--C 1.535 0.389 0 C-N-CA 126.501 1.921 . . . . 0.0 111.508 -174.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttt-85 -60.75 -28.69 68.89 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.66 0.664 . . . . 0.0 112.208 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -58.77 7.07 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.637 1.575 . . . . 0.0 110.304 170.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.06 -47.47 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.637 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.522 ' HA ' HE22 ' A' ' 103' ' ' GLN . 3.9 mp -44.68 -54.95 5.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 120.835 1.652 . . . . 0.0 113.237 169.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.57 68.89 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 123.417 0.448 . . . . 0.0 110.563 -176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -54.01 -50.54 66.4 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.989 0.916 . . . . 0.0 110.918 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.4 73.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.089 1.356 . . . . 0.0 112.588 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.82 -54.26 20.46 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 124.556 1.142 . . . . 0.0 110.562 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -67.48 -16.67 64.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.198 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.2 m -84.69 -1.63 56.44 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.783 1.633 . . . . 0.0 113.272 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.47 4.81 87.63 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.845 1.202 . . . . 0.0 114.179 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.2 mt -66.6 138.07 23.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 O-C-N 121.143 -1.21 . . . . 0.0 108.169 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.63 114.83 24.61 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 163.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.522 HE22 ' HA ' ' A' ' 93' ' ' LEU . 11.8 mt-30 -86.36 151.69 23.35 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 170.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.2 174.99 10.22 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.463 1.905 . . . . 0.0 107.11 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 33.9 mt -133.56 154.9 39.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 170.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.413 ' CD1' ' HB3' ' A' ' 130' ' ' LEU . 9.8 t80 -142.47 119.3 11.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 159.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.696 HG23 ' H ' ' A' ' 109' ' ' LYS . 6.0 t -145.63 175.63 10.23 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.055 0.542 . . . . 0.0 110.455 170.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -84.39 1.55 44.72 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.125 0.97 . . . . 0.0 113.487 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.696 ' H ' HG23 ' A' ' 107' ' ' THR . 11.9 ttmm -64.6 160.8 18.85 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.6 -168.85 43.6 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.367 0.984 . . . . 0.0 111.677 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -62.9 -16.72 60.03 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 122.117 -0.637 . . . . 0.0 112.579 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -55.47 -23.44 25.68 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.951 -1.023 . . . . 0.0 112.389 168.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.97 -49.47 63.15 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.409 1.459 . . . . 0.0 112.791 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -60.67 -48.8 80.18 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.219 1.008 . . . . 0.0 109.493 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.5 m -58.96 -41.1 86.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.426 1.49 . . . . 0.0 111.715 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -64.35 -44.05 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 121.344 -0.847 . . . . 0.0 108.83 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -60.52 -45.54 93.44 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.925 0.89 . . . . 0.0 111.796 177.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -58.84 -48.42 81.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.429 1.092 . . . . 0.0 109.226 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -58.25 -49.91 75.45 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.834 1.654 . . . . 0.0 111.857 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.39 -4.54 34.14 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.889 1.276 . . . . 0.0 112.667 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 65.62 39.43 95.43 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.313 0.959 . . . . 0.0 112.296 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.68 15.11 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.81 1.244 . . . . 0.0 110.898 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -61.55 -41.71 97.77 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.877 -0.514 . . . . 0.0 110.738 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 m -57.75 -27.36 62.96 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.437 ' CD2' HD23 ' A' ' 93' ' ' LEU . 32.4 m-85 -63.71 -34.19 77.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 118.988 -0.529 . . . . 0.0 111.897 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -110.37 96.83 6.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -166.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.7 m -51.01 -44.86 61.05 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.581 0.753 . . . . 0.0 110.699 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.45 153.2 44.83 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.501 1.12 . . . . 0.0 108.816 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.59 93.14 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 106' ' ' TYR . 16.6 mt -68.62 146.72 52.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.3 p -151.24 179.45 8.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.731 -162.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.4 t -47.56 -34.97 8.36 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.247 1.819 . . . . 0.0 112.15 173.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -59.27 -30.0 67.98 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.08 1.352 . . . . 0.0 112.137 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.7 p -58.34 -49.46 77.12 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.597 1.189 . . . . 0.0 110.322 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.93 -1.18 87.29 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-O 116.83 -2.095 . . . . 0.0 113.437 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -56.63 162.61 2.18 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.303 1.552 . . . . 0.0 111.286 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.46 HG23 ' HA ' ' A' ' 141' ' ' SER . 6.1 m -50.64 153.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.73 2.012 . . . . 0.0 112.205 170.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.425 ' HG3' ' H ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -83.88 -77.27 0.26 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.582 1.553 . . . . 0.0 111.702 -168.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.425 ' H ' ' HG3' ' A' ' 138' ' ' ARG . 9.0 mttp -163.59 117.99 1.09 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 128.815 2.846 . . . . 0.0 104.923 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.26 160.42 75.81 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.257 1.127 . . . . 0.0 111.68 -4.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.464 ' H ' ' HB2' ' A' ' 171' ' ' PHE . 2.6 p -156.18 54.94 0.99 Allowed Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -68.11 -14.74 41.61 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 121.37 1.38 . . . . 0.0 113.056 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -55.43 -39.62 70.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.837 1.255 . . . . 0.0 110.761 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.66 -15.19 62.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.921 -0.487 . . . . 0.0 112.024 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.27 -55.91 5.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.0 m -59.26 -37.74 78.34 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.198 0.599 . . . . 0.0 110.777 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -55.48 -56.33 21.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.8 mt -61.17 -38.23 85.76 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.241 -175.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -67.1 0.42 Allowed 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 125.126 1.37 . . . . 0.0 107.385 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.06 -34.31 68.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -47.38 72.96 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 114.957 -2.449 . . . . 0.0 114.198 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -124.55 18.36 8.83 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 121.633 2.015 . . . . 0.0 110.069 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 64.27 56.96 1.26 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 127.013 2.125 . . . . 0.0 108.686 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . 0.26 0.0 OUTLIER -109.58 176.19 5.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 114.7 1.371 . . . . 0.0 114.7 -175.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -108.21 150.02 27.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.426 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.1 p -66.75 -48.33 69.45 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 122.309 1.052 . . . . 0.0 110.765 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.29 -9.47 58.58 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 120.772 -1.205 . . . . 0.0 112.326 -170.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -116.67 21.7 13.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 118.098 -0.953 . . . . 0.0 108.804 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -113.01 136.08 53.08 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.989 0.813 . . . . 0.0 111.397 163.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -120.24 105.0 10.53 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.117 2.167 . . . . 0.0 111.003 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -78.4 148.64 33.57 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.299 1.04 . . . . 0.0 108.83 168.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.98 123.4 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -155.5 -5.53 0.09 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 116.926 1.531 . . . . 0.0 116.926 -172.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.3 5.54 2.6 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.53 1.932 . . . . 0.0 115.953 163.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -115.94 10.04 15.09 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -156.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t 52.6 5.41 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.805 3.242 . . . . 0.0 115.361 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.2 tt -112.27 -16.23 13.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.055 2.542 . . . . 0.0 110.099 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.64 -52.29 64.95 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 129.167 2.987 . . . . 0.0 107.852 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.4 HG11 ' CB ' ' A' ' 185' ' ' SER . 7.7 p -52.65 -46.07 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 127.081 2.152 . . . . 0.0 112.267 171.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -62.02 -45.17 94.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -169.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.464 ' HB2' ' H ' ' A' ' 141' ' ' SER . 3.3 p90 -79.78 -32.88 40.91 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.025 -1.047 . . . . 0.0 112.346 175.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.28 -52.35 53.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.217 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -50.49 -51.59 45.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.272 1.829 . . . . 0.0 110.454 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -65.25 -28.15 69.15 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.29 -22.86 28.38 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.715 -1.241 . . . . 0.0 112.735 170.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.63 55.86 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.538 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 17.3 pt -97.54 167.06 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.132 0.973 . . . . 0.0 109.385 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -87.93 178.97 6.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.985 0.514 . . . . 0.0 109.955 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.17 151.9 19.99 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.69 -1.256 . . . . 0.0 111.645 173.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 35.8 mt -124.96 128.08 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -144.15 139.62 28.91 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 124.192 0.997 . . . . 0.0 108.349 -167.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -68.25 -17.8 64.39 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.499 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.35 166.58 10.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.242 1.417 . . . . 0.0 111.235 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -72.73 169.16 17.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.82 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.4 ' CB ' HG11 ' A' ' 169' ' ' VAL . 45.5 t -156.49 171.85 19.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 157.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.1 p -73.1 4.65 4.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.347 2.259 . . . . 0.0 114.242 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -112.07 153.16 27.33 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.29 1.036 . . . . 0.0 110.569 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.58 -45.58 68.33 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.72 1.208 . . . . 0.0 112.627 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.44 36.62 2.6 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.752 1.167 . . . . 0.0 110.311 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -111.35 93.13 4.32 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 174.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -86.06 108.46 18.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -62.08 149.33 41.5 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.34 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.7 pt -142.22 166.19 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.159 1.384 . . . . 0.0 110.675 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . 0.422 HE21 ' CG ' ' A' ' 198' ' ' ASP . 2.1 pp0? -122.85 -2.68 8.74 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.129 1.772 . . . . 0.0 112.949 170.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.32 166.23 34.05 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.839 1.656 . . . . 0.0 108.788 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 63.6 mt -69.29 -41.92 76.15 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.34 -0.05 1.67 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.41 1.084 . . . . 0.0 113.892 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.422 ' CG ' HE21 ' A' ' 194' ' ' GLN . 17.3 t0 -81.78 -18.89 42.55 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.053 -1.654 . . . . 0.0 109.924 172.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 77.7 mt -58.47 -52.14 62.98 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.3 p -50.67 -43.48 57.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.26 0.482 . . . . 0.0 111.44 177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 63.8 mtt85 -62.86 -21.62 66.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.503 1.521 . . . . 0.0 113.296 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 75.0 mt -60.54 -47.98 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -84.61 -34.89 23.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.729 1.211 . . . . 0.0 111.336 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 . . . . . 0 CA--C 1.536 0.439 0 C-N-CA 124.904 1.282 . . . . 0.0 111.413 -169.902 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.8 mmm . . . . . 0 C--O 1.236 0.348 0 CA-C-O 122.846 1.307 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -45.49 160.3 0.05 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.851 2.06 . . . . 0.0 111.292 166.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -44.24 97.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.347 1.859 . . . . 0.0 111.722 -172.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.2 m -125.82 155.81 40.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.23 150.55 50.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.484 0.714 . . . . 0.0 109.091 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -123.27 155.16 37.74 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.205 1.402 . . . . 0.0 108.333 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.4 mt -140.39 133.82 33.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -131.03 147.16 52.59 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.149 1.38 . . . . 0.0 111.737 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -81.65 -22.3 37.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.655 1.582 . . . . 0.0 111.604 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 127.416 2.286 . . . . 0.0 110.343 -169.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.276 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -39.06 70.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.149 0.886 . . . . 0.0 110.992 -166.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.28 -53.46 58.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.624 0.769 . . . . 0.0 110.699 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -61.33 -40.76 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 118.745 0.702 . . . . 0.0 110.266 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.74 -48.89 78.35 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 118.857 0.753 . . . . 0.0 109.519 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.29 -49.57 75.65 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.977 0.511 . . . . 0.0 111.669 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -57.19 -52.61 64.6 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.741 0.817 . . . . 0.0 110.263 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.43 91.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.059 1.343 . . . . 0.0 111.874 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.13 -46.12 71.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.388 1.875 . . . . 0.0 111.399 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.63 -33.61 76.01 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.744 -0.597 . . . . 0.0 110.865 170.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.3 m -71.9 -2.82 19.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.495 1.118 . . . . 0.0 112.861 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.89 17.06 62.55 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.971 1.272 . . . . 0.0 112.283 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -67.6 116.25 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -67.87 97.02 0.62 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -81.76 137.79 35.28 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.784 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -131.28 172.77 11.76 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.451 1.5 . . . . 0.0 110.366 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.3 mt -138.06 156.31 30.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.438 1.495 . . . . 0.0 108.358 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -138.08 126.61 23.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 167.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.1 t -142.49 169.86 16.79 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.909 0.861 . . . . 0.0 110.242 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -105.07 -5.5 20.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.159 1.784 . . . . 0.0 111.85 169.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -68.33 -5.04 16.58 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 -167.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.52 -179.72 38.95 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.38 -17.85 64.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -172.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.89 -14.14 5.66 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.41 -44.53 68.81 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.391 0.996 . . . . 0.0 111.728 169.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.3 -46.68 87.65 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.198 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -56.04 -46.02 78.99 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.698 0.799 . . . . 0.0 109.95 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.7 mt -60.69 -49.02 86.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.32 -38.9 85.67 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.525 -0.734 . . . . 0.0 111.175 -175.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -62.56 -47.35 84.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.79 -32.35 73.5 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.077 0.951 . . . . 0.0 112.854 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.3 mt -90.17 1.54 56.32 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.379 1.472 . . . . 0.0 112.344 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.51 36.22 92.26 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.279 0.942 . . . . 0.0 112.842 174.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.84 20.57 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 110.648 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -73.53 -36.47 65.69 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 120.6 -1.312 . . . . 0.0 113.188 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -28.79 69.93 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.065 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -67.32 -2.84 6.66 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.026 -0.988 . . . . 0.0 113.292 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -138.23 81.83 1.88 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.719 1.6 . . . . 0.0 108.577 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 m -44.9 -44.89 10.01 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.685 2.394 . . . . 0.0 114.514 -171.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -154.58 91.29 1.38 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-N 120.234 1.379 . . . . 0.0 112.1 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.69 122.78 26.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.021 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.62 154.66 26.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.64 -0.663 . . . . 0.0 110.366 165.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.4 p -138.29 -174.67 3.87 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.296 1.839 . . . . 0.0 108.424 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.9 m -60.77 -13.79 17.36 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.903 -1.123 . . . . 0.0 112.802 164.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.93 -22.34 64.15 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.889 1.677 . . . . 0.0 109.739 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.5 p -53.63 -47.79 69.94 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 123.757 0.66 . . . . 0.0 110.354 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.86 -12.21 68.82 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 117.603 -1.665 . . . . 0.0 111.938 -171.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -52.66 148.54 7.09 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.004 1.402 . . . . 0.0 111.397 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' A' ' 141' ' ' SER . 22.9 m -66.1 169.16 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-O 122.322 1.058 . . . . 0.0 113.059 -163.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -60.45 143.22 53.88 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 121.308 -0.87 . . . . 0.0 109.697 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -59.09 150.46 61.87 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.588 -1.196 . . . . 0.0 110.604 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -61.18 120.25 1.21 Allowed 'Cis proline' 0 CA--C 1.538 0.701 0 CA-C-N 120.618 1.256 . . . . 0.0 110.685 -17.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 137' ' ' VAL . 6.1 p -126.68 81.8 68.13 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.712 1.605 . . . . 0.0 112.546 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -71.28 -10.76 27.73 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.968 2.446 . . . . 0.0 112.415 -170.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -44.91 -50.26 10.55 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.597 2.359 . . . . 0.0 110.918 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.04 -15.61 63.83 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.06 -51.89 6.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.511 0.725 . . . . 0.0 109.521 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 m -50.59 -43.84 56.72 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.315 1.446 . . . . 0.0 109.853 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -57.7 -60.07 4.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.336 0.655 . . . . 0.0 109.604 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.57 -25.38 67.28 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.41 -71.66 0.14 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 172.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -28.34 69.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.609 1.164 . . . . 0.0 113.011 -171.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -31.24 65.67 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.168 1.387 . . . . 0.0 112.142 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -140.8 11.61 2.25 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 44.99 73.55 0.15 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 127.912 2.485 . . . . 0.0 111.565 -163.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.5 mp -103.08 154.92 18.78 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 166.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -93.42 136.96 33.19 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 126.108 1.763 . . . . 0.0 107.969 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -41.89 97.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.095 0.474 . . . . 0.0 111.938 174.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.23 -19.27 60.57 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.997 -1.064 . . . . 0.0 112.396 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -101.87 16.07 27.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -110.1 133.95 52.68 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.272 1.396 . . . . 0.0 108.228 169.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -125.64 117.48 23.62 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.721 1.208 . . . . 0.0 108.327 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -97.84 132.11 43.74 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.011 0.924 . . . . 0.0 109.172 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 7.2 mt -114.91 78.93 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -160.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.49 -177.94 37.01 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.494 1.521 . . . . 0.0 113.549 -170.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -134.82 1.88 3.08 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.665 1.186 . . . . 0.0 113.396 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.05 178.08 6.96 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 122.619 1.199 . . . . 0.0 111.344 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.12 -37.45 61.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.536 -177.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.78 -33.46 64.38 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 125.665 1.586 . . . . 0.0 111.865 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -57.43 -33.29 67.75 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.097 0.959 . . . . 0.0 111.481 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.401 HG21 ' CB ' ' A' ' 185' ' ' SER . 8.2 t -92.31 -18.24 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.456 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -61.3 -31.51 71.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.311 0.96 . . . . 0.0 108.502 168.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -64.34 -56.27 15.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.59 -44.73 77.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.836 0.854 . . . . 0.0 111.578 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -55.44 -44.97 76.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.575 1.55 . . . . 0.0 111.503 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -69.25 -52.49 27.09 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.756 -0.59 . . . . 0.0 110.793 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.1 m -66.96 -19.55 65.74 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.147 1.379 . . . . 0.0 112.48 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 67.15 49.77 50.67 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 126.233 1.873 . . . . 0.0 110.799 -173.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.7 pt -117.9 -164.69 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.149 1.379 . . . . 0.0 109.224 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -117.94 163.96 15.79 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.512 0.725 . . . . 0.0 110.265 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 7.1 m -133.29 153.47 51.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.649 1.58 . . . . 0.0 110.005 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 55.1 mt -139.46 90.55 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -119.62 153.93 34.74 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.597 0.713 . . . . 0.0 109.399 -172.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -66.47 -17.13 64.62 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 pp -123.27 157.67 32.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 126.055 1.742 . . . . 0.0 110.339 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.41 139.72 51.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.401 ' CB ' HG21 ' A' ' 169' ' ' VAL . 16.5 m -126.67 -178.39 4.36 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p -72.48 4.97 3.3 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -169.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -142.79 133.01 24.61 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.27 1.428 . . . . 0.0 107.172 -160.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -69.84 -28.96 66.12 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.503 1.521 . . . . 0.0 110.967 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -72.88 10.67 5.23 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.686 1.612 . . . . 0.0 113.865 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -98.12 105.06 17.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.206 1.503 . . . . 0.0 108.364 167.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -79.1 126.67 31.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -69.62 152.65 44.49 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.405 1.002 . . . . 0.0 111.961 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.6 pt -134.42 163.07 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.326 1.451 . . . . 0.0 111.085 168.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -118.45 -14.9 9.69 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.746 1.218 . . . . 0.0 113.105 170.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.72 168.29 21.71 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.43 -42.26 79.14 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.75 -27.24 68.58 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -59.92 -21.12 60.69 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.336 1.854 . . . . 0.0 111.319 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 87.7 mt -57.09 -54.79 25.62 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 C-N-CA 125.557 1.543 . . . . 0.0 108.75 170.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 92.2 p -52.66 -42.24 64.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.481 1.037 . . . . 0.0 110.46 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -17.66 64.35 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.567 1.147 . . . . 0.0 112.995 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.25 -55.59 18.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -78.07 -34.47 50.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.51 1.124 . . . . 0.0 111.685 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 124.648 1.179 . . . . 0.0 112.175 -171.682 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 mmm . . . . . 0 N--CA 1.451 -0.419 0 CA-C-O 122.734 1.255 . . . . 0.0 107.666 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.58 171.51 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.381 159.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -44.43 100.4 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.334 1.854 . . . . 0.0 110.348 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.1 m -127.63 149.82 50.01 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.64 147.26 49.94 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.552 -0.717 . . . . 0.0 109.948 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -126.85 149.93 49.48 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.899 1.28 . . . . 0.0 109.399 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.484 ' O ' HD12 ' A' ' 162' ' ' ILE . 32.1 mt -149.54 121.29 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -173.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . 0.588 ' CD2' HD13 ' A' ' 162' ' ' ILE . 76.1 m95 -112.12 -174.56 2.49 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.014 1.326 . . . . 0.0 110.493 -175.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -130.94 -173.41 3.08 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.96 1.304 . . . . 0.0 108.873 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.6 0 C-N-CA 126.654 1.981 . . . . 0.0 110.101 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.372 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.711 ' HA ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -52.01 -31.42 29.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.111 1.364 . . . . 0.0 113.733 -174.018 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.33 -45.81 80.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.502 0.721 . . . . 0.0 110.963 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.421 HG11 ' CH2' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -71.0 -41.07 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -177.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' A' ' 90' ' ' ARG . 60.4 mt -62.37 -43.56 98.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -174.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.55 -52.45 57.6 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 125.917 1.687 . . . . 0.0 109.649 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -54.43 -45.39 73.01 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.134 0.573 . . . . 0.0 112.155 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.84 64.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.908 0.883 . . . . 0.0 112.124 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -56.97 -48.72 77.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.463 1.905 . . . . 0.0 109.926 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.3 -2.61 13.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.577 2.351 . . . . 0.0 113.407 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.5 m -120.54 7.63 10.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.809 1.644 . . . . 0.0 113.175 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.4 11.09 61.35 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 121.441 -0.787 . . . . 0.0 114.385 171.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.8 mt -60.18 121.27 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -69.58 106.53 3.05 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 167.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -91.17 151.18 21.06 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.414 ' CD1' HD22 ' A' ' 148' ' ' LEU . 80.6 m-85 -145.25 177.43 8.81 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.344 1.458 . . . . 0.0 109.609 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.586 ' HB ' HG23 ' A' ' 129' ' ' ILE . 18.8 mt -141.55 145.7 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.404 1.082 . . . . 0.0 108.559 172.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -132.3 141.63 49.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.769 1.228 . . . . 0.0 107.81 163.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 109' ' ' LYS . 5.7 t -167.05 -175.46 3.01 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -104.98 8.13 34.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.376 1.47 . . . . 0.0 112.61 172.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.628 ' H ' HG23 ' A' ' 107' ' ' THR . 6.9 tttm -57.58 153.12 13.68 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.116 -0.99 . . . . 0.0 109.866 171.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.56 175.91 43.02 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.505 1.05 . . . . 0.0 111.341 174.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.69 -17.0 45.29 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.534 -0.98 . . . . 0.0 112.433 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.31 -26.76 8.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.7 1.2 . . . . 0.0 112.284 169.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.36 -53.06 18.93 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.761 1.224 . . . . 0.0 111.24 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -53.42 -42.89 67.51 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.382 1.073 . . . . 0.0 110.027 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.9 m -63.07 -49.34 74.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.189 0.595 . . . . 0.0 110.425 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.5 mt -59.14 -46.58 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.719 0.69 . . . . 0.0 109.769 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 mt -66.96 -35.89 80.98 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.075 -0.391 . . . . 0.0 110.559 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -60.24 -45.18 94.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.232 1.013 . . . . 0.0 109.124 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.7 -61.29 2.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.123 1.769 . . . . 0.0 111.654 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.99 -32.97 63.64 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.212 -165.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 125.89 47.11 0.21 Allowed Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 148.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.772 HG23 ' CD2' ' A' ' 125' ' ' TYR . 3.6 p -159.4 44.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-O 123.796 1.76 . . . . 0.0 107.425 -169.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.79 -25.02 26.59 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 118.731 -2.481 . . . . 0.0 112.357 173.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.05 -20.29 17.46 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.553 1.158 . . . . 0.0 111.37 -165.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.772 ' CD2' HG23 ' A' ' 122' ' ' VAL . 35.6 m-85 -62.5 1.94 0.32 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 128.578 2.751 . . . . 0.0 114.245 165.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.518 ' CE2' HG22 ' A' ' 122' ' ' VAL . 8.3 m-85 -141.37 109.02 5.62 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 174.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -53.44 -38.92 64.0 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.809 1.644 . . . . 0.0 111.153 -170.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -150.73 148.48 28.6 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.586 HG23 ' HB ' ' A' ' 105' ' ' ILE . 4.9 mp -126.84 126.48 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.9 mt -84.33 160.93 20.59 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 167.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.1 p -138.51 -177.59 4.92 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.428 1.091 . . . . 0.0 109.177 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.58 -30.1 19.71 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.485 -0.759 . . . . 0.0 111.159 161.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -72.23 -9.31 58.29 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.208 -0.933 . . . . 0.0 112.79 -169.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.8 m -56.73 -60.38 3.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.167 1.387 . . . . 0.0 110.758 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.75 -21.43 23.25 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 117.499 -1.723 . . . . 0.0 112.66 -171.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -51.22 154.53 1.62 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.802 1.801 . . . . 0.0 111.336 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 141' ' ' SER . 1.2 m -45.05 156.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.362 1.465 . . . . 0.0 112.257 170.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -70.66 166.99 19.6 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.603 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -43.69 142.36 1.92 Allowed Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 123.138 0.575 . . . . 0.0 110.669 170.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.98 -26.98 8.51 Favored 'Cis proline' 0 CA--C 1.55 1.282 0 CA-C-N 119.619 0.9 . . . . 0.0 114.154 2.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.495 ' HB2' HG23 ' A' ' 137' ' ' VAL 0.298 2.7 t 53.77 86.47 0.16 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.227 1.811 . . . . 0.0 115.606 172.107 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.15 -19.3 29.85 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.397 2.065 . . . . 0.0 111.843 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.98 -43.57 98.56 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.175 0.898 . . . . 0.0 110.155 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.59 -23.79 67.53 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.31 -55.17 5.46 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.224 -0.923 . . . . 0.0 109.464 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 98.7 m -52.47 -39.84 61.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.302 1.041 . . . . 0.0 110.548 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -50.29 -64.89 0.67 Allowed 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 125.312 1.445 . . . . 0.0 109.735 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.414 HD22 ' CD1' ' A' ' 104' ' ' PHE . 52.2 mt -55.76 -39.71 71.58 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.547 0.612 . . . . 0.0 112.495 -173.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 75.5 mt -65.1 -50.82 64.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.329 1.452 . . . . 0.0 108.506 -176.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.6 -41.35 85.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.387 0.613 . . . . 0.0 111.217 172.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -56.91 -46.37 82.0 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.788 -1.195 . . . . 0.0 112.787 -172.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -121.72 21.36 10.81 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.055 0.843 . . . . 0.0 112.479 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 54.96 67.51 1.01 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.571 1.148 . . . . 0.0 108.973 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 14.7 mt -109.84 -179.74 3.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.09 1.356 . . . . 0.0 108.226 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -121.28 140.04 52.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.337 0.655 . . . . 0.0 110.077 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.9 m -51.03 -46.82 61.73 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.508 1.523 . . . . 0.0 111.84 175.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.28 -30.62 62.18 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.082 -1.011 . . . . 0.0 112.068 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.89 13.67 12.16 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -175.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.1 t -108.74 154.6 21.81 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -133.97 143.08 47.95 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 174.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -114.2 159.8 19.71 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.617 1.167 . . . . 0.0 110.825 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.588 HD13 ' CD2' ' A' ' 8' ' ' TRP . 2.7 mp -132.42 125.86 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 119.946 1.248 . . . . 0.0 109.685 177.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -146.63 -170.36 15.04 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 170.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.18 15.8 2.61 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -166.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 -165.0 1.74 Allowed 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.357 1.063 . . . . 0.0 109.848 -164.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.7 t -87.74 -25.06 23.62 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.302 0.641 . . . . 0.0 111.418 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -23.45 51.07 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.969 0.508 . . . . 0.0 111.03 -172.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.64 -30.55 61.17 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.249 1.419 . . . . 0.0 113.141 -172.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -111.49 -8.6 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.055 0.942 . . . . 0.0 110.666 -170.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -64.9 -38.63 91.6 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.757 -1.214 . . . . 0.0 110.041 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.94 -32.24 63.41 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.052 -1.03 . . . . 0.0 110.761 174.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.39 65.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.576 0.625 . . . . 0.0 110.418 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -61.3 -54.09 48.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.596 1.159 . . . . 0.0 113.285 174.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -63.21 -48.61 77.58 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.682 1.128 . . . . 0.0 111.628 -167.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 67.6 m -64.48 -38.06 89.71 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.211 0.604 . . . . 0.0 110.955 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.88 71.23 1.26 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 -169.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 41.3 pt -126.78 -172.84 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 127.477 2.311 . . . . 0.0 107.032 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -95.17 -176.21 3.74 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.994 1.318 . . . . 0.0 109.875 173.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.72 162.92 40.46 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.563 -1.336 . . . . 0.0 109.799 168.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 53.1 mt -132.47 129.14 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -149.86 160.06 43.88 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 120.992 -1.067 . . . . 0.0 110.291 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -74.62 -15.81 60.81 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.37 -0.831 . . . . 0.0 112.002 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 5.7 mt -116.04 156.83 25.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.08 1.752 . . . . 0.0 109.86 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -76.01 153.55 36.42 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.56 -167.83 2.51 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.39 1.076 . . . . 0.0 109.383 165.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.8 p -82.35 -10.97 58.87 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -81.43 177.59 8.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.167 0.987 . . . . 0.0 109.596 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 190' ' ' ASN . 14.3 pt-20 -125.74 -36.32 2.42 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -172.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -75.22 28.37 1.18 Allowed Glycine 0 C--N 1.338 0.678 0 CA-C-N 119.375 0.989 . . . . 0.0 111.621 172.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -100.73 140.49 34.94 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 127.962 2.505 . . . . 0.0 106.397 177.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -121.16 109.32 14.85 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -64.52 129.38 39.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 195' ' ' ALA . 36.0 pt -131.05 176.32 9.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 124.301 1.04 . . . . 0.0 110.167 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -134.72 -16.39 2.02 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.971 1.308 . . . . 0.0 111.888 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 193' ' ' ILE . . . -128.74 -154.59 0.65 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.041 0.837 . . . . 0.0 111.115 173.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -98.9 -27.46 13.89 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.388 0.54 . . . . 0.0 110.409 163.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.02 -25.66 62.77 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 121.156 -0.965 . . . . 0.0 111.997 -167.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -31.6 65.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 129.313 3.045 . . . . 0.0 109.58 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.34 -54.22 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 119.289 0.95 . . . . 0.0 109.388 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.6 m -55.69 -37.68 68.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -60.39 -32.26 71.15 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.177 1.391 . . . . 0.0 112.028 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 93.9 mt -53.56 -43.64 54.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 119.378 0.99 . . . . 0.0 109.556 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -85.09 -41.33 15.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.57 1.548 . . . . 0.0 109.426 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 125.899 1.68 . . . . 0.0 111.027 -171.242 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.8 mmm . . . . . 0 C--O 1.234 0.272 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 173.39 0.57 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.029 1.332 . . . . 0.0 109.689 168.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -45.06 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.483 1.913 . . . . 0.0 112.294 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.4 m -117.49 141.68 48.06 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -176.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.7 144.94 51.05 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.313 0.577 . . . . 0.0 109.942 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.59 ' CD2' HD11 ' A' ' 162' ' ' ILE . 2.0 m-85 -131.39 145.47 51.83 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.872 1.669 . . . . 0.0 108.07 -172.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.2 mt -145.22 89.74 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -171.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -78.36 -171.63 2.51 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 119.769 1.168 . . . . 0.0 110.383 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -131.28 164.42 25.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.516 1.526 . . . . 0.0 111.788 172.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.536 0.416 0 C-N-CA 127.327 2.251 . . . . 0.0 112.824 176.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.413 ' HA ' HD23 ' A' ' 196' ' ' LEU . . . . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -59.91 -28.37 67.53 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.835 0.743 . . . . 0.0 112.177 -171.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -58.47 -60.66 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.832 1.653 . . . . 0.0 110.63 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.4 t -60.56 -47.63 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 117.843 -1.075 . . . . 0.0 108.952 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.54 ' HA ' HE22 ' A' ' 103' ' ' GLN . 4.6 mp -44.37 -54.23 6.05 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 120.857 1.662 . . . . 0.0 113.521 171.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.82 -38.43 91.08 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.874 0.469 . . . . 0.0 112.085 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -64.73 -54.23 34.8 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.084 0.954 . . . . 0.0 109.173 174.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.75 94.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.537 1.935 . . . . 0.0 112.957 -172.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.78 -55.01 34.68 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.663 1.585 . . . . 0.0 110.774 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.19 -36.72 80.02 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 111.429 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.6 m -65.65 -2.39 3.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.545 1.138 . . . . 0.0 113.272 168.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.81 19.62 73.55 Favored Glycine 0 CA--C 1.525 0.706 0 O-C-N 119.874 -1.766 . . . . 0.0 112.161 174.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.3 mt -75.08 115.53 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -71.0 133.99 46.78 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.54 HE22 ' HA ' ' A' ' 93' ' ' LEU . 8.1 mt-30 -112.83 151.0 30.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -144.32 175.87 9.78 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 126.763 2.025 . . . . 0.0 106.838 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.3 mt -139.88 148.47 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -132.78 100.5 4.95 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.908 0.777 . . . . 0.0 110.323 168.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -103.44 170.84 7.7 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.428 1.109 . . . . 0.0 108.322 169.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -96.16 -9.24 31.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.042 1.337 . . . . 0.0 111.396 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 178.62 5.85 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.184 1.356 . . . . 0.0 112.152 -172.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.62 176.03 36.33 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.13 1.347 . . . . 0.0 112.579 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.57 -16.57 10.55 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.543 2.337 . . . . 0.0 111.792 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -44.56 -30.56 0.92 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.236 1.814 . . . . 0.0 111.3 164.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -44.96 -62.79 1.1 Allowed 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.106 1.763 . . . . 0.0 110.81 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.444 ' CE1' ' HB ' ' A' ' 129' ' ' ILE . 63.4 m-85 -57.07 -38.35 73.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.529 0.732 . . . . 0.0 111.226 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.7 m -63.43 -39.95 95.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.876 0.87 . . . . 0.0 110.701 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.6 mt -57.83 -57.18 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.493 1.042 . . . . 0.0 109.731 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.61 -37.52 84.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.569 1.077 . . . . 0.0 111.31 -173.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -64.69 -45.81 85.06 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.527 0.731 . . . . 0.0 110.582 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -54.46 -53.64 51.52 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.794 0.838 . . . . 0.0 109.437 174.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.0 -14.81 63.26 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.249 1.02 . . . . 0.0 112.894 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.93 32.84 52.24 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.693 171.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.9 14.5 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.407 1.483 . . . . 0.0 111.672 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -44.61 55.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 m -61.6 -26.28 67.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CD2' HD23 ' A' ' 93' ' ' LEU . 49.3 m-85 -60.55 -34.12 73.68 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.004 -0.435 . . . . 0.0 111.112 173.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -99.99 94.51 6.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.524 1.53 . . . . 0.0 107.259 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 39.0 m -52.96 -43.46 66.39 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.819 1.648 . . . . 0.0 111.13 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.28 156.81 44.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.824 1.65 . . . . 0.0 107.262 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.444 ' HB ' ' CE1' ' A' ' 114' ' ' PHE . 5.0 mp -137.93 157.03 32.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.5 mt -131.18 156.02 46.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.259 1.824 . . . . 0.0 108.699 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.3 p -158.89 -174.87 4.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.47 1.508 . . . . 0.0 110.367 -151.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.8 p -59.49 -30.87 68.86 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.975 -1.078 . . . . 0.0 112.255 162.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -63.38 -31.3 72.42 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.254 0.934 . . . . 0.0 111.044 -177.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -63.45 -37.24 86.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.006 1.323 . . . . 0.0 111.289 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.97 5.47 70.38 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.458 170.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -58.26 168.46 1.06 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.214 1.507 . . . . 0.0 111.793 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.3 m -53.27 161.79 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.599 1.16 . . . . 0.0 113.407 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -78.1 160.73 27.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.865 1.266 . . . . 0.0 110.526 169.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -58.53 137.9 85.83 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 117.616 -1.183 . . . . 0.0 109.303 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.9 121.72 5.16 Favored 'Cis proline' 0 CA--C 1.536 0.586 0 CA-C-N 120.405 1.181 . . . . 0.0 110.845 -8.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 p -122.08 68.2 26.24 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 125.604 1.562 . . . . 0.0 110.98 -165.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.74 -24.29 47.49 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 CA-C-N 120.127 1.081 . . . . 0.0 112.198 -163.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.5 -44.11 8.38 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 130.08 3.352 . . . . 0.0 111.117 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.31 -19.94 64.71 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.55 -60.25 2.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 m -56.87 -33.59 67.0 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.332 1.053 . . . . 0.0 111.495 -167.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -54.27 -49.37 69.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.595 0.758 . . . . 0.0 111.197 173.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.44 -31.64 65.64 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 124.914 1.286 . . . . 0.0 111.794 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 81.9 mt -61.49 -59.86 4.58 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -174.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -70.54 -17.24 62.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.19 -177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -54.34 -49.1 70.54 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.353 0.979 . . . . 0.0 109.962 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.92 23.57 5.33 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.487 0.66 . . . . 0.0 112.561 -171.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.0 mp0 45.17 46.69 9.87 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.867 2.067 . . . . 0.0 110.648 -171.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 29.0 mt -77.0 164.68 25.53 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 172.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.438 ' CG ' ' H ' ' A' ' 158' ' ' ASN . 26.1 p-10 -104.24 153.53 20.87 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 128.572 2.749 . . . . 0.0 108.533 176.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 48.2 m -62.15 -27.36 68.89 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.645 0.736 . . . . 0.0 109.715 165.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.74 -29.37 25.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.724 -1.235 . . . . 0.0 111.966 -156.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.438 ' H ' ' CG ' ' A' ' 155' ' ' ASN . 3.3 m-80 -102.05 20.64 16.21 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.458 -0.776 . . . . 0.0 109.732 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.8 m -100.4 122.84 43.8 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 178' ' ' GLN . 97.7 m-85 -125.15 148.13 48.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.736 1.614 . . . . 0.0 110.077 -174.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -115.53 -20.22 10.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -168.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.59 HD11 ' CD2' ' A' ' 6' ' ' PHE . 1.6 mp 44.68 74.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 126.944 2.098 . . . . 0.0 112.797 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.56 173.17 17.54 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -125.19 25.6 7.15 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.521 -0.988 . . . . 0.0 112.573 -153.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -145.96 176.59 9.58 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t -70.97 -29.46 65.47 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.82 1.248 . . . . 0.0 111.038 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.67 11.64 14.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.035 0.934 . . . . 0.0 110.481 -177.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.75 -54.47 6.9 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 76.7 t -71.33 -17.1 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 O-C-N 121.382 -0.824 . . . . 0.0 111.762 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -59.94 -61.16 2.82 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.026 1.73 . . . . 0.0 111.355 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -68.95 -31.76 70.87 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 120.391 -1.443 . . . . 0.0 109.959 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.62 72.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.171 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.5 -52.58 16.85 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.195 1.398 . . . . 0.0 110.618 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.1 -21.41 60.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.766 -171.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.0 m -81.66 -33.47 31.31 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.446 -0.784 . . . . 0.0 111.072 169.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.11 19.81 54.61 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.278 1.418 . . . . 0.0 112.521 -166.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.7 pt -102.14 174.01 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.331 0 CA-C-N 118.982 1.391 . . . . 0.0 111.51 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 160' ' ' TYR . 23.8 mm-40 -87.74 176.45 7.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.766 1.226 . . . . 0.0 110.338 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 5.5 m -153.09 139.48 18.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.86 1.264 . . . . 0.0 109.768 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.437 HG21 HG12 ' A' ' 199' ' ' ILE . 61.2 mt -123.0 84.25 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -114.63 149.84 36.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.925 0.869 . . . . 0.0 109.972 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -64.42 -14.79 58.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.608 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.74 166.94 10.62 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.254 1.422 . . . . 0.0 110.183 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -95.07 163.55 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.563 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.0 t -151.14 -175.04 5.0 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.239 1.816 . . . . 0.0 107.352 168.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.6 p -115.57 71.8 0.78 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 170.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -142.28 137.11 30.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.99 91.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.412 1.885 . . . . 0.0 108.695 167.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 133.98 -3.51 4.52 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 117.941 -1.477 . . . . 0.0 113.255 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.46 131.28 34.41 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.525 2.163 . . . . 0.0 106.422 171.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.61 118.76 25.47 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.782 1.233 . . . . 0.0 108.804 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -67.23 147.63 52.79 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.471 0.578 . . . . 0.0 112.039 176.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.5 pt -141.59 164.88 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.876 1.67 . . . . 0.0 111.505 168.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -121.09 -15.37 8.23 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.833 1.653 . . . . 0.0 112.468 171.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.72 164.99 33.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.009 1.724 . . . . 0.0 107.192 171.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 89' ' ' ALA . 1.4 mp -61.14 -30.69 70.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.114 0.966 . . . . 0.0 109.787 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.07 64.92 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -64.77 -22.64 67.03 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.943 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.437 HG12 HG21 ' A' ' 180' ' ' ILE . 96.7 mt -55.27 -57.36 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 83.5 p -50.09 -39.4 42.44 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.444 0.64 . . . . 0.0 112.237 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -67.7 -29.4 68.65 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 125.499 1.52 . . . . 0.0 111.515 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.9 mt -52.37 -48.03 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -86.72 -0.88 57.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.263 1.425 . . . . 0.0 112.226 -173.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 . . . . . 0 CA--C 1.53 0.205 0 C-N-CA 125.276 1.43 . . . . 0.0 111.543 -175.608 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.1 mmm . . . . . 0 C--O 1.234 0.268 0 CA-C-O 123.306 1.527 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -80.77 122.05 26.68 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.3 mtpp 43.08 58.94 3.1 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 161.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.3 m -103.69 149.56 24.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.43 146.14 51.32 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 121.7 -0.625 . . . . 0.0 109.962 173.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.14 149.93 51.63 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 125.29 1.436 . . . . 0.0 108.373 -173.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.7 mt -140.56 131.94 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -120.82 148.49 43.95 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.524 1.53 . . . . 0.0 110.371 -173.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -89.48 -37.73 14.56 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.277 -0.889 . . . . 0.0 112.315 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.51 0 C-N-CA 129.374 3.07 . . . . 0.0 114.157 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 120.531 0.205 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -51.73 -35.44 43.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.325 1.05 . . . . 0.0 111.969 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -45.09 -56.93 4.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.819 2.448 . . . . 0.0 111.079 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.99 -39.83 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.985 1.714 . . . . 0.0 110.052 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.2 mt -51.52 -46.65 63.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.939 1.245 . . . . 0.0 110.078 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.66 -56.03 26.17 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 123.694 0.797 . . . . 0.0 111.257 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.46 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 15.4 t90 -52.57 -46.75 67.0 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.925 1.29 . . . . 0.0 111.198 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.62 82.78 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.159 0.984 . . . . 0.0 111.75 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.94 -42.65 69.57 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.664 0.786 . . . . 0.0 111.017 -177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -60.4 -34.14 73.49 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.54 1.136 . . . . 0.0 110.701 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 m -78.09 -4.52 47.75 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.587 1.155 . . . . 0.0 113.549 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.71 27.26 58.73 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 119.768 1.167 . . . . 0.0 112.969 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.7 mt -60.81 124.67 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 163.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -74.04 103.32 4.47 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -91.29 137.87 32.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.235 0.47 . . . . 0.0 110.21 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -138.44 173.15 11.91 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.036 1.735 . . . . 0.0 110.51 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.417 ' HB ' HG23 ' A' ' 129' ' ' ILE . 17.6 mt -146.62 150.83 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.229 1.412 . . . . 0.0 108.777 -172.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -158.44 124.94 4.72 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.329 1.452 . . . . 0.0 111.935 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 t -155.8 171.39 20.11 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.642 1.177 . . . . 0.0 111.579 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -65.05 -26.36 68.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.263 1.825 . . . . 0.0 111.917 165.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -61.91 136.38 57.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.43 -161.95 28.29 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 124.146 0.879 . . . . 0.0 112.705 -170.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.406 ' ND2' ' HG3' ' A' ' 133' ' ' GLN . 32.0 m120 -47.24 -30.8 3.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.982 2.113 . . . . 0.0 111.999 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -58.45 -24.91 61.52 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.926 -1.109 . . . . 0.0 113.374 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.64 -35.31 77.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.333 0.97 . . . . 0.0 111.636 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -62.06 -40.77 96.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.312 0.96 . . . . 0.0 109.699 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.2 m -63.44 -41.9 98.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.975 1.31 . . . . 0.0 109.533 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 93.0 mt -57.56 -52.39 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.262 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.26 -41.17 96.46 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 120.834 1.652 . . . . 0.0 111.828 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -66.44 -27.81 68.11 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.786 0.721 . . . . 0.0 112.429 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -65.19 -49.1 71.07 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.534 1.159 . . . . 0.0 109.134 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 53.5 mt -73.89 -11.94 60.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.428 1.891 . . . . 0.0 112.123 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.15 19.37 78.59 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 118.878 -0.957 . . . . 0.0 113.253 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.6 18.17 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 119.072 1.436 . . . . 0.0 111.143 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -49.78 67.7 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.866 -0.521 . . . . 0.0 111.021 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.0 t -67.5 -22.44 65.45 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.724 0.64 . . . . 0.0 112.422 -168.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -59.7 -32.35 70.43 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 119.024 0.829 . . . . 0.0 111.644 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.12 122.68 45.19 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -173.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -61.48 -45.12 95.57 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -157.69 145.24 18.54 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -169.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.417 HG23 ' HB ' ' A' ' 105' ' ' ILE . 4.3 mp -135.14 131.54 52.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.406 0.622 . . . . 0.0 109.879 -170.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -89.23 162.92 15.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.034 0.921 . . . . 0.0 110.265 170.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 41.7 p -155.46 -179.06 7.73 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.555 1.542 . . . . 0.0 107.556 -171.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -22.12 1.7 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 168.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.406 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 91.5 mm-40 -67.39 -58.8 4.12 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.004 0.82 . . . . 0.0 110.357 173.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 61.6 m -99.95 55.36 0.93 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.91 -20.74 75.62 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.12 -171.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 45.0 -167.56 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 126.407 1.883 . . . . 0.0 112.863 -165.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.488 HG23 ' CB ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -54.68 172.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 127.281 2.232 . . . . 0.0 112.252 173.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -59.54 152.71 21.33 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.743 169.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -48.23 138.14 11.0 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 117.666 -1.159 . . . . 0.0 108.968 162.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.87 -43.97 0.42 Allowed 'Cis proline' 0 CA--C 1.533 0.458 0 CA-C-N 120.453 1.198 . . . . 0.0 113.822 6.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.488 ' CB ' HG23 ' A' ' 137' ' ' VAL . 3.6 t 55.17 81.45 0.26 Allowed Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.672 1.189 . . . . 0.0 111.679 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.3 -16.62 52.2 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.487 2.125 . . . . 0.0 111.462 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -55.4 -48.53 74.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.261 1.391 . . . . 0.0 110.824 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.99 -18.83 64.68 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.76 -52.9 5.72 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 118.194 -0.907 . . . . 0.0 108.982 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.5 m -54.44 -38.33 66.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.455 0.702 . . . . 0.0 110.157 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -54.52 -58.53 7.1 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.612 1.165 . . . . 0.0 110.403 171.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 22.2 mt -65.59 -27.72 68.62 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.561 1.073 . . . . 0.0 112.093 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 75.8 mt -65.9 -59.75 3.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.52 -30.72 69.92 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.314 1.046 . . . . 0.0 113.131 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.544 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 5.6 mmpt? -57.42 -35.31 69.91 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.09 -1.006 . . . . 0.0 112.092 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.99 24.23 2.18 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 49.94 47.73 22.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.195 1.798 . . . . 0.0 110.235 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 59.3 mt -83.6 165.55 18.94 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.441 1.096 . . . . 0.0 109.395 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -106.34 134.43 49.48 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 124.144 0.977 . . . . 0.0 108.829 -171.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 m -60.47 -42.2 95.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.492 0.663 . . . . 0.0 109.74 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -74.02 -24.82 59.62 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 120.793 -1.192 . . . . 0.0 112.58 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -92.95 5.59 50.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.917 -1.039 . . . . 0.0 109.429 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -107.32 146.97 30.89 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -132.04 167.45 19.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.873 1.669 . . . . 0.0 107.612 -176.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -143.37 151.38 40.37 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.593 0.757 . . . . 0.0 109.968 173.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.6 mt -138.45 118.82 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.49 -6.55 0.03 OUTLIER Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.904 -175.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.456 ' HB2' ' CD1' ' A' ' 182' ' ' PHE . 40.5 t0 56.16 67.69 0.97 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.132 2.573 . . . . 0.0 112.356 169.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -153.94 167.96 27.99 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 120.879 -1.138 . . . . 0.0 110.936 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.0 t -61.25 -44.53 97.09 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.293 0.568 . . . . 0.0 109.989 167.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -5.21 14.28 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.755 1.622 . . . . 0.0 112.3 -171.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -54.52 38.5 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.526 1.13 . . . . 0.0 109.786 171.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 185' ' ' SER . 25.7 m -70.76 -30.45 42.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 118.248 -1.381 . . . . 0.0 111.688 -170.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -61.5 -48.69 79.94 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.825 0.85 . . . . 0.0 109.827 -172.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -80.02 -39.95 28.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.601 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.0 78.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.622 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -61.2 -53.77 52.71 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.833 0.853 . . . . 0.0 110.833 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -64.81 -34.96 79.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.574 -0.25 . . . . 0.0 110.975 -172.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.4 m -69.96 -34.98 74.1 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.096 0.862 . . . . 0.0 112.826 168.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.07 44.93 6.11 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.865 1.222 . . . . 0.0 111.785 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 10.9 pt -116.09 -179.14 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.565 1.546 . . . . 0.0 108.806 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -103.52 165.75 10.84 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.371 0.605 . . . . 0.0 109.745 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 143.27 38.55 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.987 0.915 . . . . 0.0 108.804 -163.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 62.7 mt -133.92 100.18 3.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.454 ' HB2' HD12 ' A' ' 183' ' ' LEU . 18.6 p30 -123.78 158.12 32.46 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.634 1.174 . . . . 0.0 109.947 -176.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 164' ' ' ASP . 64.3 m-85 -86.33 -3.16 58.94 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.229 -1.544 . . . . 0.0 111.218 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 181' ' ' ASN . 0.3 OUTLIER -129.34 155.8 45.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.427 1.891 . . . . 0.0 110.432 -174.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -74.79 142.24 44.27 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.451 ' HB3' HG21 ' A' ' 169' ' ' VAL . 0.6 OUTLIER -144.73 177.68 8.53 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.412 1.485 . . . . 0.0 107.996 173.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 32.8 p -93.15 59.65 3.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.126 1.37 . . . . 0.0 110.774 -160.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -142.93 175.06 10.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.972 0.509 . . . . 0.0 112.238 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.84 -3.37 12.2 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 0.0 113.588 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -118.94 9.1 12.43 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.434 1.492 . . . . 0.0 112.417 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.12 138.02 33.24 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 119.15 1.475 . . . . 0.0 107.462 173.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -112.64 107.08 15.64 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -59.69 142.64 52.65 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.438 168.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.6 pt -131.64 165.59 31.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.635 1.574 . . . . 0.0 110.126 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -117.83 -16.3 9.97 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.011 0.924 . . . . 0.0 113.401 169.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.35 165.18 32.78 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.584 1.154 . . . . 0.0 109.021 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 30.6 mt -63.44 -44.55 94.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.232 1.813 . . . . 0.0 107.63 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.42 -15.01 63.4 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.88 -22.89 64.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.337 1.426 . . . . 0.0 110.407 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 19.8 mt -55.83 -53.43 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.049 1.34 . . . . 0.0 109.55 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.46 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 8.6 m -60.06 -32.89 71.36 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.93 1.241 . . . . 0.0 111.898 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -65.02 -26.65 68.37 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 118.3 -0.857 . . . . 0.0 112.227 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.55 -55.97 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.0 10.45 18.95 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.019 1.328 . . . . 0.0 113.62 -169.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 . . . . . 0 C--N 1.333 -0.138 0 C-N-CA 124.552 1.141 . . . . 0.0 112.458 178.03 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 mmm . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 55.49 -171.46 0.07 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.938 1.295 . . . . 0.0 113.117 175.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -78.8 79.4 5.21 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 152.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 m -101.99 146.59 27.67 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.97 149.41 51.71 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 121.501 -0.749 . . . . 0.0 109.242 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -123.13 156.73 34.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.903 1.281 . . . . 0.0 108.03 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.2 mt -140.74 135.84 34.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -120.54 161.66 20.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.011 0.924 . . . . 0.0 111.068 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -102.91 -4.18 25.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.549 1.54 . . . . 0.0 111.941 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.2 tp . . . . . 0 C--O 1.235 0.314 0 C-N-CA 128.837 2.855 . . . . 0.0 111.347 -175.884 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.516 0 CA-C-O 120.453 0.168 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -32.16 67.45 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.637 -176.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.32 -49.1 77.18 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.425 1.09 . . . . 0.0 111.563 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.9 t -77.55 -43.82 29.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 CA-C-O 117.552 -1.214 . . . . 0.0 109.678 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 mp -44.0 -56.18 4.15 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.649 1.58 . . . . 0.0 111.153 170.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.55 -54.92 41.38 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.74 0.416 . . . . 0.0 110.874 -177.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -56.71 -43.25 80.4 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.106 1.363 . . . . 0.0 112.502 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.5 -38.36 49.14 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.368 1.067 . . . . 0.0 112.049 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.89 -41.47 74.69 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.676 0.79 . . . . 0.0 110.845 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -61.03 -15.53 33.16 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.76 -0.587 . . . . 0.0 111.4 170.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.0 m -108.24 5.96 26.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.182 1.793 . . . . 0.0 113.468 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.06 8.72 55.05 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.671 1.129 . . . . 0.0 113.695 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.4 mt -55.5 120.5 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -71.05 92.68 0.97 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 172.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -71.95 151.56 43.17 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 168.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -141.78 172.59 12.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.008 2.123 . . . . 0.0 107.383 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.535 ' HB ' HG23 ' A' ' 129' ' ' ILE . 16.9 mt -136.4 155.07 33.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 171.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -136.46 115.38 12.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 164.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.3 t -121.88 157.04 32.02 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.206 1.003 . . . . 0.0 108.971 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -63.57 -30.2 71.35 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.014 165.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -61.58 142.2 57.27 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.198 1.799 . . . . 0.0 109.898 -166.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.5 -170.02 39.09 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.351 -0.843 . . . . 0.0 112.348 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -52.05 -24.94 7.51 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 128.387 2.675 . . . . 0.0 116.015 -163.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -69.91 -11.46 60.89 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.982 0.81 . . . . 0.0 112.154 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.37 80.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.23 1.012 . . . . 0.0 110.953 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -48.4 -46.39 37.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.038 1.335 . . . . 0.0 110.454 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 m -70.88 -37.92 73.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.383 1.073 . . . . 0.0 111.382 -171.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.4 mt -60.77 -45.95 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.13 1.372 . . . . 0.0 108.9 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.33 -35.5 75.98 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.012 -1.055 . . . . 0.0 111.582 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -50.17 73.44 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.289 0.635 . . . . 0.0 109.692 170.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -48.96 -48.13 43.37 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.962 0.905 . . . . 0.0 111.544 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.35 -10.36 59.39 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.097 1.359 . . . . 0.0 113.281 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.01 23.48 78.07 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.78 0.705 . . . . 0.0 114.27 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.3 m -124.23 13.46 4.86 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 C-N-CA 125.027 1.331 . . . . 0.0 110.471 176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -43.06 99.51 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.885 1.22 . . . . 0.0 110.617 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.1 m -74.21 3.0 7.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.458 1.503 . . . . 0.0 112.68 -175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -80.12 -0.28 35.17 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.605 164.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -144.58 133.02 21.95 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.532 1.515 . . . . 0.0 108.728 -173.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.2 m -60.75 -68.86 0.26 Allowed 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 127.979 2.512 . . . . 0.0 112.072 -174.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -138.81 123.61 18.73 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.155 1.382 . . . . 0.0 107.726 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.535 HG23 ' HB ' ' A' ' 105' ' ' ILE . 5.1 mp -105.54 98.16 6.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 -172.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.73 HD12 ' CB ' ' A' ' 134' ' ' SER . 4.2 mm? -70.55 147.41 49.32 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.1 p -127.63 -168.78 1.94 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.506 2.322 . . . . 0.0 110.696 -172.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 t -56.96 -23.12 43.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.072 1.349 . . . . 0.0 113.426 166.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -64.98 -22.51 67.01 Favored 'General case' 0 C--O 1.228 -0.079 0 C-N-CA 124.014 0.926 . . . . 0.0 111.073 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.73 ' CB ' HD12 ' A' ' 130' ' ' LEU . 1.0 OUTLIER -110.07 72.52 0.8 Allowed 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 128.719 2.807 . . . . 0.0 105.597 177.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.36 48.68 3.67 Favored Glycine 0 N--CA 1.458 0.13 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -61.49 117.57 5.88 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.823 0.312 . . . . 0.0 110.723 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 138' ' ' ARG . 18.1 t 54.75 -165.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 124.906 1.283 . . . . 0.0 109.982 167.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.695 ' H ' HG12 ' A' ' 137' ' ' VAL . 82.6 mtt180 -128.12 0.4 5.84 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.036 -1.665 . . . . 0.0 114.521 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt 98.23 112.73 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.486 0 C-N-CA 129.003 2.921 . . . . 0.0 107.532 166.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -61.17 154.63 56.4 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 120.729 1.296 . . . . 0.0 111.79 6.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.406 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 3.0 p -142.17 82.2 13.46 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.726 1.211 . . . . 0.0 111.57 -171.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.42 -20.24 24.22 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.08 2.52 . . . . 0.0 113.965 -177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -69.57 -27.16 64.89 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.209 -0.932 . . . . 0.0 112.034 -170.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.65 94.99 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.79 85.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.34 -0.85 . . . . 0.0 110.144 173.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.9 m -53.85 -40.38 66.44 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.155 1.343 . . . . 0.0 111.158 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -61.76 -48.97 78.27 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.7 mp -62.59 -37.98 88.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.809 1.244 . . . . 0.0 111.496 -172.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 86.7 mt -64.51 -54.13 37.11 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.12 -35.94 76.38 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -56.92 -29.01 62.7 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 120.714 -1.241 . . . . 0.0 112.856 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -138.07 19.52 2.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 48.59 70.19 0.48 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.862 1.665 . . . . 0.0 110.654 -173.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 76.0 mt -109.33 -176.2 2.96 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.184 1.394 . . . . 0.0 109.99 -172.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.08 129.1 52.08 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.465 1.106 . . . . 0.0 109.905 -172.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.37 -17.47 20.42 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 125.165 1.386 . . . . 0.0 112.007 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.413 ' HA ' HE22 ' A' ' 178' ' ' GLN . 0.3 OUTLIER -118.49 19.36 13.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.498 -0.751 . . . . 0.0 109.839 -174.024 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -128.3 8.61 6.05 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.87 1.668 . . . . 0.0 110.917 170.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 159' ' ' THR . 1.8 t -91.23 158.95 16.3 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.897 1.679 . . . . 0.0 109.783 176.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -147.84 105.47 3.69 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.015 -1.053 . . . . 0.0 109.64 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -85.6 133.07 34.07 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.093 0.957 . . . . 0.0 111.571 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.78 105.53 18.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.681 1.192 . . . . 0.0 109.056 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.37 -164.45 11.76 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.879 1.704 . . . . 0.0 110.859 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -136.91 -9.67 1.8 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.9 158.07 32.78 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.904 1.683 . . . . 0.0 110.912 -170.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.9 t -54.82 -32.3 60.22 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.618 -0.676 . . . . 0.0 112.489 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.6 -28.55 69.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.894 0.878 . . . . 0.0 110.507 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -69.9 -0.99 8.27 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.908 1.683 . . . . 0.0 112.024 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.2 t -120.48 -17.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 125.284 1.434 . . . . 0.0 109.61 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -65.93 -58.5 5.41 Favored 'General case' 0 C--N 1.338 0.101 0 O-C-N 120.916 -1.115 . . . . 0.0 108.734 168.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -63.75 -33.86 76.61 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.202 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.58 97.58 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.913 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -62.54 -43.59 98.43 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.338 0.972 . . . . 0.0 111.08 171.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -64.61 -37.9 89.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 117.705 -1.141 . . . . 0.0 112.464 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.4 p -79.14 -36.8 39.92 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.834 1.652 . . . . 0.0 110.778 168.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.26 65.61 1.26 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -172.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.39 174.61 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 127.295 2.238 . . . . 0.0 108.587 174.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.413 HE22 ' HA ' ' A' ' 157' ' ' ASP . 14.0 mp0 -96.16 170.08 9.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.81 1.644 . . . . 0.0 111.96 -176.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.6 m -143.36 156.92 44.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.842 1.657 . . . . 0.0 111.729 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.2 mt -136.47 104.28 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -126.32 161.65 27.33 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.677 1.591 . . . . 0.0 107.43 -173.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -75.48 -13.19 60.36 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.685 -1.259 . . . . 0.0 112.903 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.3 pp -129.9 166.13 20.64 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.44 1.896 . . . . 0.0 110.16 -175.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -96.29 159.04 15.16 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.123 0.487 . . . . 0.0 111.268 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 38.6 m -151.65 27.91 0.63 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.821 1.649 . . . . 0.0 111.081 -168.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 63.4 p 56.5 10.44 0.68 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.917 2.887 . . . . 0.0 116.037 173.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -106.07 153.26 22.31 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.616 1.567 . . . . 0.0 110.465 -168.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.502 ' HG3' ' H ' ' A' ' 189' ' ' GLY . 0.3 OUTLIER -56.5 -77.48 0.03 OUTLIER 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.756 2.022 . . . . 0.0 112.215 -175.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . 0.502 ' H ' ' HG3' ' A' ' 188' ' ' GLU . . . -75.93 18.33 3.26 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.448 1.975 . . . . 0.0 112.978 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -90.91 112.27 24.05 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.586 1.693 . . . . 0.0 107.28 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -101.84 127.87 48.46 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 25.0 mtm105 -68.57 148.12 50.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.283 0.492 . . . . 0.0 110.384 166.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.3 pt -135.36 170.19 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.325 1.85 . . . . 0.0 110.243 167.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -126.59 -10.75 6.21 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.554 1.142 . . . . 0.0 113.043 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.27 171.54 18.97 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.11 1.764 . . . . 0.0 108.117 172.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.53 -42.42 87.27 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.334 1.054 . . . . 0.0 109.703 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.1 -27.43 69.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.94 -22.78 62.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.238 1.815 . . . . 0.0 111.07 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 94.1 mt -57.4 -56.9 12.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 125.341 1.456 . . . . 0.0 108.863 171.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 80.3 p -53.06 -43.61 66.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.96 0.8 . . . . 0.0 111.483 -172.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -63.1 -21.99 66.56 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.912 1.685 . . . . 0.0 112.973 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.87 -42.96 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.838 0.744 . . . . 0.0 109.581 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -89.66 -32.57 16.99 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.62 0.768 . . . . 0.0 110.897 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 . . . . . 0 N--CA 1.468 0.463 0 C-N-CA 124.443 1.097 . . . . 0.0 112.878 -173.962 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mmm . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 122.131 0.967 . . . . 0.0 111.635 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.5 167.04 0.07 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.419 1.888 . . . . 0.0 110.106 164.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 73.78 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.812 2.445 . . . . 0.0 114.365 -171.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.7 m -86.63 160.84 18.77 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 119.46 -2.025 . . . . 0.0 107.875 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.8 151.02 48.7 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.738 -1.226 . . . . 0.0 109.338 165.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -122.74 154.01 38.7 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.214 1.406 . . . . 0.0 108.857 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.46 135.3 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -120.52 143.47 48.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.346 1.858 . . . . 0.0 109.046 -176.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.36 -32.81 66.78 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.446 1.021 . . . . 0.0 111.341 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tm? . . . . . 0 N--CA 1.467 0.375 0 C-N-CA 128.81 2.844 . . . . 0.0 112.723 -178.415 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -61.9 -37.86 86.18 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.473 -1.392 . . . . 0.0 112.823 -171.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.28 -54.6 29.26 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.533 1.933 . . . . 0.0 112.203 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.04 -33.54 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.634 1.107 . . . . 0.0 110.732 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.2 mt -57.1 -55.26 36.97 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.97 -13.69 62.35 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.636 1.175 . . . . 0.0 113.542 -174.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -79.74 -55.49 4.96 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 120.486 -1.384 . . . . 0.0 108.426 170.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.99 -37.81 86.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.236 1.414 . . . . 0.0 111.779 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.36 -51.34 66.32 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.789 1.636 . . . . 0.0 111.12 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -65.1 -17.5 64.51 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.163 1.385 . . . . 0.0 110.743 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.7 m -94.61 -1.58 52.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.292 1.437 . . . . 0.0 112.799 176.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.54 5.11 72.2 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.036 1.303 . . . . 0.0 113.571 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.1 mt -56.51 112.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -64.81 101.82 0.52 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 171.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.58 150.18 26.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.325 0.966 . . . . 0.0 108.413 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -146.5 171.84 14.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.413 1.885 . . . . 0.0 108.834 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 129' ' ' ILE . 18.6 mt -136.12 156.88 37.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.692 1.197 . . . . 0.0 109.222 171.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -139.76 125.45 19.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.131 0.973 . . . . 0.0 109.112 164.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.7 t -154.09 178.3 10.12 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.552 2.341 . . . . 0.0 108.26 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -137.27 15.53 3.0 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.883 -1.136 . . . . 0.0 113.805 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -11.08 3.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 121.73 167.23 13.09 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 128.043 2.735 . . . . 0.0 110.118 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -52.02 -31.68 30.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.961 1.704 . . . . 0.0 111.367 170.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -53.0 -17.37 1.41 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.436 1.494 . . . . 0.0 114.026 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.19 -47.22 62.27 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.488 1.115 . . . . 0.0 111.028 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -56.78 -48.61 77.49 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.854 1.661 . . . . 0.0 109.93 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.6 m -55.43 -49.78 71.53 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.275 0.489 . . . . 0.0 109.795 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.8 mt -59.33 -47.91 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.79 -37.36 84.41 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.837 -1.165 . . . . 0.0 112.045 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.424 ' HE2' ' OE2' ' A' ' 123' ' ' GLU . 19.5 mtmt -59.71 -48.03 83.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.138 -0.934 . . . . 0.0 109.668 175.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -43.62 95.53 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.532 1.133 . . . . 0.0 111.303 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.87 -4.1 35.93 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.194 0.998 . . . . 0.0 112.531 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.17 -3.22 58.8 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 126.192 1.853 . . . . 0.0 114.993 173.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.5 m -92.53 3.33 7.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 118.921 1.36 . . . . 0.0 110.064 -170.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.424 ' OE2' ' HE2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -63.51 -27.34 69.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.433 1.015 . . . . 0.0 111.052 171.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.3 m -58.86 -15.26 11.75 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.465 -0.778 . . . . 0.0 112.684 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -96.9 3.05 52.33 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.043 -1.456 . . . . 0.0 114.295 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.449 ' HB2' HD11 ' A' ' 129' ' ' ILE . 52.3 m-85 -133.7 111.71 10.8 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 122.06 2.209 . . . . 0.0 109.471 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.2 m -58.14 -39.91 79.97 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.92 1.688 . . . . 0.0 110.466 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -145.5 158.82 43.78 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.673 1.189 . . . . 0.0 108.007 167.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.536 HG23 ' HB ' ' A' ' 105' ' ' ILE . 5.3 mp -130.99 117.6 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.439 HD21 ' CE1' ' A' ' 147' ' ' TYR . 12.2 mt -71.63 165.98 22.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.719 0.771 . . . . 0.0 110.218 174.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.8 p -151.06 176.95 10.66 Favored 'General case' 0 C--O 1.231 0.088 0 O-C-N 121.466 -0.771 . . . . 0.0 110.498 -170.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.0 t -48.7 -33.84 10.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.037 0.935 . . . . 0.0 111.978 163.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -71.82 -6.67 43.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.204 1.402 . . . . 0.0 112.21 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.0 m -147.94 49.12 1.06 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 128.121 2.569 . . . . 0.0 105.229 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.05 -29.67 72.27 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.894 -166.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 45.23 -164.65 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.314 1.846 . . . . 0.0 112.595 -163.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.43 162.1 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.631 1.172 . . . . 0.0 112.224 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -65.77 146.02 55.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.13 0.572 . . . . 0.0 110.374 168.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.41 133.52 13.11 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 116.872 -1.537 . . . . 0.0 110.194 166.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.29 126.07 9.55 Favored 'Cis proline' 0 C--N 1.348 0.552 0 CA-C-N 120.487 1.21 . . . . 0.0 111.498 -5.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 p -130.29 78.63 74.11 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 124.779 1.232 . . . . 0.0 112.035 -158.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.89 -30.41 48.93 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 121.916 1.744 . . . . 0.0 113.323 -174.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -53.41 -44.81 69.04 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.713 -1.242 . . . . 0.0 113.333 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.74 -18.72 63.05 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.86 -0.59 . . . . 0.0 112.527 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.08 -53.41 7.04 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 119.115 0.87 . . . . 0.0 109.523 172.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 m -56.73 -41.46 77.52 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.371 1.469 . . . . 0.0 110.503 -174.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.439 ' CE1' HD21 ' A' ' 130' ' ' LEU . 4.0 t80 -56.86 -43.25 81.0 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.422 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.4 mt -78.35 -27.56 47.03 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 78.8 mt -59.37 -61.78 2.37 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 168.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.12 -17.84 64.97 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -64.78 -29.52 70.49 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.43 -1.419 . . . . 0.0 112.789 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -147.07 29.7 0.97 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.092 1.314 . . . . 0.0 112.468 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 54.82 45.12 27.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.608 1.563 . . . . 0.0 111.321 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 68.1 mt -95.34 170.87 9.07 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.422 -0.799 . . . . 0.0 110.0 -170.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -112.07 141.55 45.61 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.244 -0.91 . . . . 0.0 113.111 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 m -57.23 -49.87 74.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.817 0.847 . . . . 0.0 110.252 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.99 -16.83 60.61 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.532 0.682 . . . . 0.0 112.356 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -92.4 -3.09 55.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.701 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 t -101.36 135.61 42.58 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.62 1.1 . . . . 0.0 109.664 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -125.91 112.9 16.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -77.69 159.04 29.39 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.792 0.437 . . . . 0.0 110.525 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 49.4 mt -131.09 92.82 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 127.917 2.487 . . . . 0.0 104.511 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -124.41 169.31 16.46 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.786 1.184 . . . . 0.0 110.388 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -135.21 3.15 3.1 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.915 1.286 . . . . 0.0 113.225 -166.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.28 144.41 25.54 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 119.182 0.901 . . . . 0.0 111.231 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 88.68 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.01 2.124 . . . . 0.0 111.822 -170.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 174.05 -29.62 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 128.691 2.796 . . . . 0.0 107.664 -176.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -52.55 -43.64 65.34 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 126.368 1.867 . . . . 0.0 111.436 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 79.7 t -77.8 -26.19 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 125.184 1.394 . . . . 0.0 111.821 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.32 -38.42 91.08 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.526 -0.734 . . . . 0.0 111.614 -165.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -82.52 -30.77 29.58 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.686 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.34 89.99 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.838 0.855 . . . . 0.0 109.183 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -54.24 -49.67 68.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.655 1.582 . . . . 0.0 111.08 173.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -63.84 -44.24 93.75 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.83 -0.544 . . . . 0.0 110.811 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.0 m -75.0 -21.04 59.38 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.26 44.03 77.06 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.314 0.959 . . . . 0.0 112.171 -169.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.3 pt -110.6 168.73 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 118.094 0.947 . . . . 0.0 108.737 169.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -105.22 171.05 7.53 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.625 0.726 . . . . 0.0 110.626 -170.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.74 135.06 18.2 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 121.672 -0.643 . . . . 0.0 110.224 -157.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 42.9 mt -130.54 105.08 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -136.98 157.59 46.39 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.233 1.413 . . . . 0.0 111.148 -168.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -77.36 -12.43 59.95 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.32 -0.863 . . . . 0.0 112.371 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.14 156.61 38.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.984 0.914 . . . . 0.0 109.99 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.644 ' HA ' HD21 ' A' ' 190' ' ' ASN . 8.7 pt-20 -93.03 163.36 13.68 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.313 0.578 . . . . 0.0 110.835 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 44.8 t -145.6 179.8 7.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.13 1.772 . . . . 0.0 108.521 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . 0.303 0.2 OUTLIER -78.06 -22.36 49.19 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.701 -1.249 . . . . 0.0 111.333 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -71.19 121.8 19.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.1 1.36 . . . . 0.0 109.909 -174.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -64.79 -17.51 64.27 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.25 8.5 60.86 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.778 -1.012 . . . . 0.0 113.028 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . 0.644 HD21 ' HA ' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -104.51 105.37 15.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 120.11 1.955 . . . . 0.0 110.043 -177.279 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -94.99 111.75 23.52 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.023 0.929 . . . . 0.0 109.613 -174.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 144.28 56.85 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.526 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.6 pt -137.42 171.36 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 126.922 2.089 . . . . 0.0 112.556 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -122.36 -21.29 5.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.475 1.51 . . . . 0.0 113.227 167.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -151.23 167.49 27.64 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.71 0.686 . . . . 0.0 109.244 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 62.3 mt -74.32 -26.46 60.17 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 119.158 0.89 . . . . 0.0 110.277 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.45 -13.54 62.41 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.234 0.925 . . . . 0.0 112.514 174.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 201' ' ' ARG . 31.5 t0 -79.06 -13.53 59.71 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.667 -1.27 . . . . 0.0 108.864 174.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.76 -57.07 11.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 167.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.6 p -59.96 -36.05 76.29 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.021 0.828 . . . . 0.0 111.499 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . 0.413 ' HG2' ' HA ' ' A' ' 198' ' ' ASP . 18.0 ptt180 -64.78 -34.78 79.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.101 0.864 . . . . 0.0 111.477 -172.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.8 mt -50.07 -57.63 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.144 1.777 . . . . 0.0 108.812 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -72.14 -0.67 12.5 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.821 0.849 . . . . 0.0 113.276 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 125.083 1.353 . . . . 0.0 110.892 -176.232 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mmm . . . . . 0 CA--C 1.516 -0.337 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.53 179.64 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.045 164.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -44.36 106.49 0.07 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.499 1.12 . . . . 0.0 108.797 169.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.3 m -129.83 151.34 50.52 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 170.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.35 156.9 48.18 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.43 0.692 . . . . 0.0 109.44 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 199' ' ' ILE . 1.4 m-85 -132.36 147.93 52.41 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.396 1.479 . . . . 0.0 109.213 -173.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp -132.1 129.46 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -103.49 164.75 11.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.301 1.04 . . . . 0.0 109.009 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.79 176.33 6.67 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.807 0.843 . . . . 0.0 109.891 171.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.6 mt . . . . . 0 CA--C 1.534 0.356 0 C-N-CA 124.771 1.228 . . . . 0.0 111.147 -171.394 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 119.093 -0.48 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -54.11 -36.37 63.16 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 119.109 0.868 . . . . 0.0 111.725 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.81 -35.97 79.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.724 1.21 . . . . 0.0 112.882 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.3 -48.95 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 118.293 -0.86 . . . . 0.0 108.949 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.448 ' HA ' HE22 ' A' ' 103' ' ' GLN . 2.4 mp -44.3 -52.39 7.61 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 120.636 1.562 . . . . 0.0 113.287 170.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.82 96.29 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.41 0.684 . . . . 0.0 111.22 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 20.6 t90 -57.95 -49.44 76.78 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.551 1.141 . . . . 0.0 110.812 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.7 78.78 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.929 1.291 . . . . 0.0 113.24 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.95 -44.42 85.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 122.941 0.496 . . . . 0.0 110.374 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -51.15 -49.8 60.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.194 1.397 . . . . 0.0 110.154 168.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.2 m -68.94 -12.81 61.99 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.03 16.06 77.59 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 120.014 1.279 . . . . 0.0 113.605 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.1 mt -68.44 133.16 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.025 1.33 . . . . 0.0 108.32 170.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -83.14 118.67 23.74 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.448 HE22 ' HA ' ' A' ' 93' ' ' LEU . 12.4 mt-30 -99.07 154.24 18.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -147.84 166.33 27.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.909 1.684 . . . . 0.0 108.565 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 42.6 mt -137.43 158.94 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.754 1.622 . . . . 0.0 107.14 166.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.522 ' O ' HG22 ' A' ' 107' ' ' THR . 4.3 t80 -131.77 -85.9 0.48 Allowed 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 124.779 1.231 . . . . 0.0 108.034 166.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 106' ' ' TYR 0.255 15.3 t 65.04 164.98 0.16 Allowed 'General case' 0 C--N 1.315 -0.894 1 C-N-CA 136.816 6.047 . . . . 0.0 113.958 177.772 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -80.41 4.04 19.37 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.395 1.078 . . . . 0.0 111.346 166.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -57.87 156.05 9.57 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.201 -1.562 . . . . 0.0 108.221 167.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.07 171.36 53.58 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-O 122.19 0.884 . . . . 0.0 111.107 173.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -44.87 -28.15 0.61 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 130.025 3.33 . . . . 0.0 114.944 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -63.89 -12.79 39.86 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 120.279 1.399 . . . . 0.0 112.311 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.52 -47.88 38.75 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.88 1.218 . . . . 0.0 111.573 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -56.8 -49.59 74.89 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.606 0.639 . . . . 0.0 110.238 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.7 m -59.39 -42.62 92.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.793 0.837 . . . . 0.0 111.129 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.73 -48.8 87.03 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 119.319 0.963 . . . . 0.0 108.716 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.28 -44.24 95.62 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.878 -0.514 . . . . 0.0 110.457 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -59.26 -51.3 70.54 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.403 1.081 . . . . 0.0 110.836 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -51.13 -56.52 12.3 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.26 1.424 . . . . 0.0 110.583 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.49 -9.73 37.43 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.046 1.338 . . . . 0.0 113.613 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.61 25.81 69.08 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 123.983 0.801 . . . . 0.0 112.525 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.53 57.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.43 -46.94 10.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.901 160.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.9 m -73.62 -14.59 61.2 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -164.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -63.44 -33.83 76.43 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.393 1.451 . . . . 0.0 110.507 170.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -90.82 115.48 27.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.5 m -44.74 -65.95 0.46 Allowed 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 127.016 2.126 . . . . 0.0 108.669 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.07 140.07 43.5 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.5 mt -110.36 148.69 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 171.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 45.9 mt -119.13 -166.89 1.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -173.26 -178.96 1.83 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.607 1.963 . . . . 0.0 107.888 167.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 m -44.53 -45.27 9.25 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.119 0.872 . . . . 0.0 110.458 167.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -70.2 -9.38 55.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.096 1.758 . . . . 0.0 112.96 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.7 m -59.35 -24.04 63.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.839 1.256 . . . . 0.0 110.973 163.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.12 -8.18 77.96 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-O 118.019 -1.434 . . . . 0.0 114.018 170.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -56.56 165.99 1.01 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.783 1.292 . . . . 0.0 111.161 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 m -44.73 155.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.158 1.783 . . . . 0.0 111.786 170.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -69.84 -76.77 0.09 Allowed 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -165.47 159.59 13.84 Favored Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 124.33 1.052 . . . . 0.0 109.804 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -64.16 136.97 26.24 Favored 'Cis proline' 0 N--CA 1.458 -0.601 0 N-CA-C 108.703 -1.307 . . . . 0.0 108.703 -17.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.0 p -124.99 68.78 56.82 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.621 0.768 . . . . 0.0 111.917 -157.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -61.95 -29.45 82.06 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.388 2.059 . . . . 0.0 111.98 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -48.41 -41.08 28.04 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.624 1.97 . . . . 0.0 112.39 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.61 2.47 16.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.518 1.527 . . . . 0.0 112.623 -175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.84 -39.42 2.73 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.868 1.667 . . . . 0.0 108.727 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 m -49.99 -38.78 38.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.086 1.312 . . . . 0.0 110.456 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.653 ' HD1' HD12 ' A' ' 148' ' ' LEU . 53.7 t80 -52.01 -57.94 7.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.099 1.36 . . . . 0.0 110.76 171.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.653 HD12 ' HD1' ' A' ' 147' ' ' TYR . 9.0 mp -58.58 -37.96 76.88 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.896 1.678 . . . . 0.0 112.755 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.0 mt -59.83 -57.96 10.65 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -175.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -75.18 -32.98 61.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.754 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 4.0 mmpt? -50.76 -53.32 32.63 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.801 -1.187 . . . . 0.0 111.8 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -115.23 8.86 15.62 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 54.26 66.71 1.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 123.064 1.411 . . . . 0.0 109.235 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.17 162.17 13.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.899 1.68 . . . . 0.0 107.784 169.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -106.39 -4.82 19.51 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 125.235 2.445 . . . . 0.0 117.458 -161.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.0 m 76.27 -55.95 0.58 Allowed 'General case' 0 N--CA 1.411 -2.381 0 CA-C-N 110.647 -2.978 . . . . 0.0 109.07 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.84 -2.13 38.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 O-C-N 120.881 -1.137 . . . . 0.0 112.941 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -98.35 -5.34 33.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 116.916 -1.516 . . . . 0.0 111.186 168.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -103.45 137.37 41.64 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.669 1.577 . . . . 0.0 108.099 -174.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -128.42 111.17 13.02 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.963 1.705 . . . . 0.0 109.263 -172.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -85.89 153.38 22.26 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.406 HD11 ' CD2' ' A' ' 6' ' ' PHE . 3.5 mt -133.01 119.55 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.85 -161.68 9.64 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -139.53 12.88 2.54 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.456 ' HB3' ' H ' ' A' ' 167' ' ' LEU . 3.0 mmt-85 -115.68 162.67 16.92 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 122.839 1.304 . . . . 0.0 111.489 -172.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 t -62.46 -26.95 68.79 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.297 -0.877 . . . . 0.0 109.538 163.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.456 ' H ' ' HB3' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -60.27 -29.82 69.05 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.487 1.515 . . . . 0.0 111.529 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -45.7 -44.93 13.97 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.104 1.762 . . . . 0.0 110.852 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.628 HG21 ' HB2' ' A' ' 185' ' ' SER . 28.4 m -90.69 -15.5 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.55 -50.79 49.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.081 -1.012 . . . . 0.0 108.69 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -79.3 -33.4 43.3 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.343 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.92 -42.64 90.17 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.378 172.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -61.16 -49.77 75.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.866 1.212 . . . . 0.0 111.151 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -58.32 -25.37 61.82 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 74.9 m -86.03 -50.86 6.73 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.795 1.18 . . . . 0.0 110.615 165.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 96.09 63.17 0.95 Allowed Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -164.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.9 pt -131.11 173.14 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.577 1.951 . . . . 0.0 106.286 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -99.65 165.83 11.42 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 -171.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 39.4 m -136.26 155.36 50.22 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.637 1.175 . . . . 0.0 110.57 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 34.3 mt -140.66 74.81 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -96.14 169.64 9.81 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.842 0.829 . . . . 0.0 110.157 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -88.25 2.14 52.98 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.532 -1.355 . . . . 0.0 111.951 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.06 132.78 19.96 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 124.72 2.2 . . . . 0.0 115.414 -175.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.24 138.65 58.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.568 -2.105 . . . . 0.0 109.4 -167.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . 0.628 ' HB2' HG21 ' A' ' 169' ' ' VAL . 74.9 p -137.91 163.4 31.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.093 0.557 . . . . 0.0 110.704 -162.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 24.4 p -75.68 45.16 0.31 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.527 1.931 . . . . 0.0 111.55 173.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -131.34 175.67 8.93 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.95 -1.094 . . . . 0.0 109.717 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -98.26 -67.84 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.768 0.827 . . . . 0.0 109.202 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -73.15 51.49 1.68 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.984 2.231 . . . . 0.0 113.319 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -121.26 119.6 32.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.376 1.07 . . . . 0.0 108.766 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -106.67 106.56 17.15 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.815 0.846 . . . . 0.0 109.94 -172.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.66 139.85 58.81 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.8 pt -129.98 167.66 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.142 1.377 . . . . 0.0 113.084 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.26 -17.59 8.22 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.972 1.309 . . . . 0.0 113.52 168.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.63 168.69 26.62 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 18.4 mt -70.37 -38.58 74.79 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -171.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.12 -18.07 63.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.82 -0.55 . . . . 0.0 112.329 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.94 -21.34 66.81 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.223 -0.923 . . . . 0.0 110.686 176.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.436 HG21 ' CE2' ' A' ' 6' ' ' PHE . 72.7 mt -61.46 -50.52 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 118.161 -0.924 . . . . 0.0 109.132 176.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 94.4 p -58.04 -41.09 82.54 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.32 0.964 . . . . 0.0 110.364 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.5 mtp-105 -58.98 -39.59 82.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.329 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.6 mt -52.62 -51.96 30.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 118.983 0.81 . . . . 0.0 109.988 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -73.78 -35.76 64.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 . . . . . 0 N--CA 1.455 -0.193 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -174.98 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mmm . . . . . 0 N--CA 1.445 -0.675 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -167.13 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 129.402 3.081 . . . . 0.0 111.272 161.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -57.28 109.94 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 119.543 -1.973 . . . . 0.0 107.72 168.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.5 m -130.37 152.59 49.61 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 166.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.57 150.3 46.19 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.262 -0.899 . . . . 0.0 109.652 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -124.9 160.9 27.77 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.588 1.555 . . . . 0.0 110.211 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 mt -138.19 149.53 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -134.95 168.15 19.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.635 2.374 . . . . 0.0 109.598 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -123.46 24.67 8.55 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.721 2.008 . . . . 0.0 111.666 -171.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 CA--C 1.54 0.558 0 C-N-CA 128.438 2.695 . . . . 0.0 112.791 172.285 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.4 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.464 ' HA ' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -68.11 -24.13 64.99 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 118.974 -2.329 . . . . 0.0 111.97 -176.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -61.01 -45.72 93.67 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.952 0.901 . . . . 0.0 109.745 174.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.75 -44.39 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 123.88 0.872 . . . . 0.0 109.486 -170.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.61 HD23 ' CD2' ' A' ' 125' ' ' TYR . 4.4 mp -44.3 -44.73 8.28 Favored 'General case' 0 N--CA 1.418 -2.068 0 C-N-CA 126.125 1.77 . . . . 0.0 111.519 169.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.57 -33.57 66.85 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.593 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -65.09 -55.3 19.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.853 1.261 . . . . 0.0 109.827 170.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.28 -36.42 77.8 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.752 1.621 . . . . 0.0 112.527 -174.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.19 -57.96 8.79 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.744 1.218 . . . . 0.0 111.687 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -60.82 -24.39 65.82 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.617 0.723 . . . . 0.0 112.363 175.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.1 m -78.28 -6.02 53.77 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.33 -0.856 . . . . 0.0 112.634 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.39 15.34 81.08 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 124.228 0.918 . . . . 0.0 112.653 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.5 mt -70.5 120.7 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 118.834 1.317 . . . . 0.0 107.726 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -75.13 105.28 6.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 167.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.452 HE22 ' HA ' ' A' ' 93' ' ' LEU . 19.4 mt-30 -88.65 150.56 22.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -142.28 169.16 18.11 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.432 1.093 . . . . 0.0 108.94 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.3 mt -131.63 149.67 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -121.7 141.87 50.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 157.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.4 t -163.25 -176.0 4.57 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.196 2.199 . . . . 0.0 105.719 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -134.11 9.22 3.79 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.844 0.858 . . . . 0.0 112.755 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -1.55 8.11 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.47 174.31 34.01 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 125.821 1.677 . . . . 0.0 111.019 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -52.61 -27.5 17.25 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.084 0.954 . . . . 0.0 112.293 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.7 -17.87 3.94 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 177.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.57 -46.99 49.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.8 1.182 . . . . 0.0 112.223 171.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -60.32 -47.38 86.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.435 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.6 m -56.15 -49.83 72.86 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.732 0.696 . . . . 0.0 109.45 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.2 mt -58.89 -48.49 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.01 -38.42 91.13 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 121.326 -0.859 . . . . 0.0 112.235 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -48.85 80.05 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.54 -36.01 82.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.505 0.593 . . . . 0.0 111.354 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.83 -8.22 57.74 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.476 1.11 . . . . 0.0 112.05 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 57.12 33.49 64.69 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 125.44 1.495 . . . . 0.0 113.248 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.79 14.1 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.512 1.156 . . . . 0.0 110.36 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -41.37 97.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.186 0.994 . . . . 0.0 111.176 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 t -65.52 -31.02 71.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.688 -169.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.61 ' CD2' HD23 ' A' ' 93' ' ' LEU . 37.8 m-85 -56.01 -43.91 78.19 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.553 0.615 . . . . 0.0 111.461 174.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -97.19 95.58 7.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -166.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.4 m -44.66 -49.83 10.18 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.566 1.546 . . . . 0.0 109.682 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.44 147.44 34.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.96 119.31 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 134' ' ' SER . 4.3 mm? -82.0 163.94 21.79 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.582 0.705 . . . . 0.0 109.63 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.8 p -148.11 -174.2 4.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.239 1.019 . . . . 0.0 112.687 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.6 t -55.25 -15.51 2.47 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 162.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -73.32 -38.8 65.68 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 120.018 1.281 . . . . 0.0 110.499 173.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.713 ' HB3' HD12 ' A' ' 130' ' ' LEU . 2.6 p -77.71 77.6 4.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.25 45.76 1.21 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 125.058 1.313 . . . . 0.0 111.224 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -62.8 166.9 5.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.244 0.545 . . . . 0.0 111.227 168.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.9 m -53.35 161.43 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 127.149 2.18 . . . . 0.0 112.852 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.418 ' NE ' ' H ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -83.35 156.07 23.2 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.398 -0.814 . . . . 0.0 110.659 170.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -51.02 139.49 23.09 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.631 1.572 . . . . 0.0 110.442 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.71 123.58 5.74 Favored 'Cis proline' 0 CA--C 1.537 0.644 0 CA-C-N 120.416 1.184 . . . . 0.0 110.099 -9.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.72 ' H ' ' HB3' ' A' ' 171' ' ' PHE . 2.8 p -128.84 81.26 71.16 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 126.398 1.879 . . . . 0.0 110.954 -162.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.62 -9.12 16.0 Favored 'Trans proline' 0 CA--C 1.551 1.334 0 C-N-CA 123.556 2.838 . . . . 0.0 114.635 -173.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.13 -44.73 94.69 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.022 1.283 . . . . 0.0 111.875 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -51.58 -45.47 63.13 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 124.064 0.946 . . . . 0.0 110.669 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.13 -34.77 75.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.769 -0.582 . . . . 0.0 112.139 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.1 m -68.51 -32.21 72.01 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.636 0.774 . . . . 0.0 110.364 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -65.19 -49.73 68.65 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.47 -38.48 80.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.062 0.945 . . . . 0.0 111.332 -176.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -58.05 -68.12 0.28 Allowed 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 173.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -53.43 -46.56 69.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.852 0.72 . . . . 0.0 112.012 -171.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -51.72 -36.0 45.19 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -121.69 12.45 10.66 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.76 0.709 . . . . 0.0 111.539 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 47.16 50.35 14.3 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.84 2.456 . . . . 0.0 110.283 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 66.1 mt -76.85 -172.59 2.34 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.685 1.994 . . . . 0.0 110.105 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -129.34 134.42 47.89 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.79 1.236 . . . . 0.0 107.778 -170.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.8 p -59.35 -40.17 85.55 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 119.522 1.056 . . . . 0.0 111.198 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -75.12 -22.78 57.97 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.529 -0.732 . . . . 0.0 111.943 -172.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -95.82 2.53 53.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.462 -0.773 . . . . 0.0 109.43 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.6 m -96.57 126.56 41.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.702 1.201 . . . . 0.0 108.052 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -112.18 155.75 23.44 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -120.98 163.61 18.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.964 1.706 . . . . 0.0 106.694 161.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.4 mt -126.59 107.63 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 173.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -119.69 177.23 16.34 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.49 166.18 18.45 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 156.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 75.43 156.62 0.18 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 126.689 1.996 . . . . 0.0 111.389 -176.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 t -69.83 -30.1 67.52 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.83 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -25.06 45.29 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.437 1.095 . . . . 0.0 112.631 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -79.68 13.04 2.24 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.479 1.912 . . . . 0.0 111.558 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 1.2 p -109.12 -16.32 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.277 1.031 . . . . 0.0 110.553 163.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -73.9 -52.62 12.36 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.121 1.328 . . . . 0.0 110.805 -168.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.72 ' HB3' ' H ' ' A' ' 141' ' ' SER . 1.4 p90 -63.28 -29.39 70.72 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 120.971 -1.081 . . . . 0.0 111.916 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.47 -52.55 64.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 118.761 -0.637 . . . . 0.0 109.302 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -49.11 -60.88 2.41 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.127 1.371 . . . . 0.0 110.708 170.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -68.33 -14.51 63.05 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -170.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.5 p -95.62 -23.4 17.05 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 120.73 1.604 . . . . 0.0 112.229 165.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.1 22.42 38.36 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.145 1.355 . . . . 0.0 112.515 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.2 pp -99.16 175.2 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.855 1.327 . . . . 0.0 109.982 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.65 162.07 18.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.619 1.168 . . . . 0.0 110.29 -173.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 12.4 m -139.33 143.98 38.06 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.76 1.224 . . . . 0.0 110.348 -165.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 73.6 mt -119.95 92.11 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -111.5 158.98 18.54 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 121.819 0.819 . . . . 0.0 108.956 -172.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -74.18 -6.5 48.15 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.517 -1.365 . . . . 0.0 112.835 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.99 158.81 41.75 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 126.83 2.052 . . . . 0.0 109.159 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.84 160.86 28.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 19.0 t -147.22 174.83 11.25 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.6 169.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.4 p -83.95 63.98 7.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.023 2.529 . . . . 0.0 108.434 -173.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -144.6 178.86 7.67 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.771 2.028 . . . . 0.0 108.355 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -113.38 -35.95 5.13 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.431 1.469 . . . . 0.0 110.459 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -86.19 15.48 49.14 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 127.368 2.413 . . . . 0.0 112.77 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -84.75 152.87 23.39 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 120.621 2.211 . . . . 0.0 107.372 159.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -131.04 148.86 52.8 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 169.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 146.56 25.59 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.273 0.629 . . . . 0.0 110.85 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 18.6 pt -140.03 162.68 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.219 1.008 . . . . 0.0 112.0 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -108.86 -27.02 9.96 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -168.08 145.59 4.25 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -163.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 196' ' ' LEU . 2.9 tp -61.74 -30.91 71.09 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 127.186 2.194 . . . . 0.0 111.497 -158.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.92 -11.87 50.43 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -77.16 -13.14 59.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.816 0.846 . . . . 0.0 109.6 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 39.7 mt -56.34 -59.37 2.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 83.1 p -53.89 -37.9 64.22 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -175.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -61.35 -34.64 75.63 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.77 0.828 . . . . 0.0 112.141 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 76.0 mt -58.22 -34.69 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.985 0.914 . . . . 0.0 110.729 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -91.48 -4.91 55.03 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 120.974 -1.079 . . . . 0.0 112.291 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 CA--C 1.539 0.522 0 C-N-CA 125.828 1.651 . . . . 0.0 111.036 -171.395 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 mmm . . . . . 0 CA--C 1.52 -0.181 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.73 -169.04 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.508 1.523 . . . . 0.0 111.965 171.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -80.32 48.64 1.04 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 119.857 -1.777 . . . . 0.0 108.23 165.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.9 m -69.3 143.75 53.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.28 149.47 50.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -125.53 152.91 44.39 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.484 1.114 . . . . 0.0 108.972 -172.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.5 mt -134.49 146.04 31.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 169.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -123.78 171.64 9.47 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.809 2.044 . . . . 0.0 107.82 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.18 164.33 15.75 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 165.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.466 0.349 0 CA-C-N 119.03 0.832 . . . . 0.0 109.185 -168.852 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.304 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.89 -24.08 67.6 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 118.402 -0.809 . . . . 0.0 112.697 -172.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -60.26 -58.46 8.41 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.64 -44.44 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 117.018 -1.468 . . . . 0.0 112.228 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.614 HD23 ' CG ' ' A' ' 125' ' ' TYR . 3.7 mp -52.68 -48.35 66.59 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 122.13 2.241 . . . . 0.0 112.368 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.89 -49.08 79.12 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 124.804 1.315 . . . . 0.0 109.552 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -53.57 -48.08 69.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.632 -0.699 . . . . 0.0 111.191 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.64 74.83 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.895 0.77 . . . . 0.0 111.752 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -73.45 -40.89 63.83 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.286 1.834 . . . . 0.0 110.711 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.25 -1.28 4.3 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.227 1.811 . . . . 0.0 111.309 168.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 58.3 m -118.88 -6.6 10.53 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.423 1.489 . . . . 0.0 114.273 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.38 9.14 77.1 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.101 -1.624 . . . . 0.0 115.654 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 93.5 mt -45.63 147.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 149.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -98.65 115.4 28.59 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 167.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.471 HE22 ' HA ' ' A' ' 93' ' ' LEU . 5.3 mt-30 -88.67 150.75 22.85 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -140.0 164.95 28.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 125.12 1.368 . . . . 0.0 107.967 171.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.6 mt -124.51 149.86 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 161.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -129.16 143.84 51.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 152.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.4 t -151.6 163.5 38.93 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.863 1.265 . . . . 0.0 109.585 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -92.64 -0.39 57.31 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.983 -0.448 . . . . 0.0 111.962 165.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -59.19 153.0 19.28 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 119.477 1.035 . . . . 0.0 108.571 166.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -80.93 -175.21 49.6 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.72 -18.18 7.6 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.501 1.521 . . . . 0.0 114.038 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -58.63 -18.1 27.68 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.617 1.099 . . . . 0.0 112.119 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.36 69.69 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.078 0.951 . . . . 0.0 110.366 175.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -57.15 -48.86 77.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -48.03 83.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.829 2.052 . . . . 0.0 111.252 -174.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.13 -50.61 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.481 1.112 . . . . 0.0 108.165 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.89 -37.28 87.11 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 122.16 -0.337 . . . . 0.0 111.162 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -49.1 77.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.517 1.127 . . . . 0.0 109.608 174.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -50.46 73.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 124.016 0.926 . . . . 0.0 110.679 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.54 -40.2 77.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.544 -174.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.41 50.82 0.79 Allowed Glycine 0 C--N 1.339 0.697 0 CA-C-O 121.563 0.535 . . . . 0.0 111.825 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.317 1.3 p -147.61 8.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 129.912 3.285 . . . . 0.0 109.384 -170.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -34.25 77.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 120.768 -1.208 . . . . 0.0 113.028 174.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -15.91 53.71 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.576 0.547 . . . . 0.0 111.774 -168.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.614 ' CG ' HD23 ' A' ' 93' ' ' LEU . 13.1 m-85 -66.23 -30.77 71.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -174.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 5.8 m-85 -110.8 129.4 55.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 -167.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.7 m -55.31 -30.87 61.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.383 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -154.28 151.83 29.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.229 1.012 . . . . 0.0 109.093 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.85 77.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 174.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.4 mt -66.2 147.19 53.7 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 57.8 p -122.96 177.96 5.27 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.061 0.944 . . . . 0.0 110.14 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 t -45.91 -37.61 6.56 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.993 0.917 . . . . 0.0 110.604 165.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -62.32 -18.37 61.2 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.3 p -48.37 -48.89 36.33 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.169 0.895 . . . . 0.0 112.277 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.96 -5.81 56.53 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 117.688 -1.618 . . . . 0.0 112.852 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -60.65 163.12 5.76 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.617 1.708 . . . . 0.0 110.904 172.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.2 m -52.73 156.29 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 126.973 2.109 . . . . 0.0 112.555 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -81.19 154.58 26.6 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.666 0.786 . . . . 0.0 108.924 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -54.66 144.29 45.52 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.282 1.033 . . . . 0.0 113.148 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.58 135.53 35.98 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 N-CA-C 108.261 -1.477 . . . . 0.0 108.261 -8.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 p -128.43 61.28 53.24 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.223 0.609 . . . . 0.0 111.84 -157.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.56 -24.22 77.65 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.164 2.576 . . . . 0.0 113.155 -167.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -51.33 -38.56 53.69 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 120.897 -1.127 . . . . 0.0 112.366 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.671 ' O ' HD13 ' A' ' 148' ' ' LEU . . . -74.3 4.86 5.15 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.236 1.014 . . . . 0.0 112.702 -178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.71 -40.67 5.67 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.686 163.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.2 m -55.21 -35.45 64.91 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.415 1.007 . . . . 0.0 110.65 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.694 ' HD1' HD12 ' A' ' 148' ' ' LEU . 47.8 t80 -66.07 -49.37 67.86 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.574 0.75 . . . . 0.0 110.922 171.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.694 HD12 ' HD1' ' A' ' 147' ' ' TYR . 8.1 mp -67.43 -14.11 62.63 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.441 1.496 . . . . 0.0 113.171 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 92.1 mt -84.22 -53.48 5.47 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.877 2.071 . . . . 0.0 107.826 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.28 -37.55 85.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -174.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -54.87 -20.0 7.81 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.478 1.911 . . . . 0.0 115.125 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -158.38 22.52 0.24 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.843 2.457 . . . . 0.0 112.71 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 49.25 46.8 22.76 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.004 1.721 . . . . 0.0 113.462 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 30.0 mt -78.45 169.18 18.66 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.251 1.02 . . . . 0.0 109.899 -177.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -108.37 130.94 55.2 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 123.229 0.611 . . . . 0.0 109.958 -174.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.4 m -60.14 -43.96 95.31 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.944 0.898 . . . . 0.0 110.16 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.83 -23.68 59.68 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.633 -1.292 . . . . 0.0 113.449 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -93.2 3.86 54.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.067 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -102.16 126.06 49.03 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -106.46 163.75 12.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -139.67 127.54 22.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 173.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 7.4 mt -98.91 116.92 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.884 1.674 . . . . 0.0 107.003 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.95 -164.97 10.1 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.466 1.508 . . . . 0.0 110.071 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -138.23 -1.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -172.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.09 169.14 13.71 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 122.404 1.097 . . . . 0.0 111.505 -160.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.1 t -59.63 -32.24 70.25 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.571 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.75 -17.25 64.0 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.566 -1.334 . . . . 0.0 111.864 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -83.95 1.7 42.31 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.076 -1.015 . . . . 0.0 111.933 -165.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.8 p -91.87 -28.44 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 O-C-N 121.401 -0.812 . . . . 0.0 112.148 158.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -67.23 -58.26 5.17 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 120.087 1.312 . . . . 0.0 111.399 -161.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -55.9 -45.12 78.75 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.645 1.178 . . . . 0.0 111.915 170.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.91 79.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 122.63 0.372 . . . . 0.0 111.409 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -59.12 -46.11 89.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.396 1.878 . . . . 0.0 109.822 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -59.71 -45.02 93.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.657 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 74.6 m -81.22 -22.14 39.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.87 61.75 2.99 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.474 1.035 . . . . 0.0 110.693 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.0 -173.22 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.749 2.02 . . . . 0.0 109.058 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -111.81 166.01 11.56 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.992 0.917 . . . . 0.0 110.146 -176.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 32.7 m -145.19 151.57 38.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.355 1.062 . . . . 0.0 112.387 -170.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.5 mt -138.0 101.95 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.06 160.88 36.92 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 120.867 -1.145 . . . . 0.0 109.209 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -73.52 0.42 12.54 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.297 -0.877 . . . . 0.0 111.362 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 22.8 mt -114.01 154.7 27.2 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 125.728 1.611 . . . . 0.0 109.54 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -79.94 154.13 28.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 164.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.8 m -136.67 163.85 29.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.876 1.671 . . . . 0.0 107.218 173.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 62.0 p -93.38 64.56 3.71 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -169.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -146.52 162.19 38.87 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.687 1.195 . . . . 0.0 109.8 -170.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.8 -54.86 6.55 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.893 0.877 . . . . 0.0 110.774 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.15 24.48 6.15 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 125.074 1.321 . . . . 0.0 113.774 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -85.45 111.27 19.81 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 125.407 1.483 . . . . 0.0 108.31 171.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -99.23 125.0 44.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 168.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.2 148.47 30.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.737 -0.649 . . . . 0.0 109.394 169.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 13.6 pt -133.96 156.94 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.982 0.913 . . . . 0.0 112.457 172.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 -97.06 -29.63 13.52 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.446 1.098 . . . . 0.0 111.913 164.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.72 162.15 39.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.64 1.576 . . . . 0.0 108.496 -167.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.49 -43.92 88.7 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -60.59 -19.63 58.23 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.79 0.723 . . . . 0.0 112.7 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.42 -21.53 66.67 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.038 0.835 . . . . 0.0 112.031 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 67.1 mt -50.91 -60.2 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.6 m -61.89 -32.27 72.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.164 0.893 . . . . 0.0 112.008 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -62.18 -35.33 78.5 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.204 -0.935 . . . . 0.0 111.231 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 36.1 mt -54.87 -55.08 17.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 124.767 1.227 . . . . 0.0 109.273 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -67.58 -5.65 16.4 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.285 0.634 . . . . 0.0 112.054 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 . . . . . 0 N--CA 1.45 -0.455 0 C-N-CA 127.659 2.383 . . . . 0.0 109.953 -173.657 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.413 ' CE ' HD11 ' A' ' 101' ' ' ILE . 61.2 mmm . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 122.814 1.292 . . . . 0.0 107.552 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.01 175.24 0.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.413 162.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.66 101.14 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.72 1.208 . . . . 0.0 109.747 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.9 m -122.88 152.7 40.51 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -175.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.69 152.62 44.05 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.426 0.631 . . . . 0.0 110.154 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.428 ' CD2' HD11 ' A' ' 162' ' ' ILE . 1.6 m-85 -134.74 142.85 46.86 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 125.071 1.349 . . . . 0.0 108.854 -168.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.1 mt -145.98 77.83 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -165.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -69.08 172.19 7.13 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 118.196 0.453 . . . . 0.0 110.505 -173.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -127.08 -167.89 1.8 Allowed 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.578 -1.326 . . . . 0.0 108.559 170.071 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.426 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--O 1.236 0.369 0 C-N-CA 127.921 2.489 . . . . 0.0 106.303 -159.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.29 0 CA-C-O 121.08 0.467 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.51 ' HA ' HD22 ' A' ' 93' ' ' LEU . 15.9 ttt180 -63.42 -25.43 68.28 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -164.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -55.68 -66.45 0.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 O-C-N 124.57 1.169 . . . . 0.0 109.211 165.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.36 -46.51 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 116.653 -1.642 . . . . 0.0 113.259 -172.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.51 HD22 ' HA ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -45.44 -53.39 8.82 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 120.365 1.438 . . . . 0.0 112.286 171.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.37 -41.47 76.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.856 0.723 . . . . 0.0 110.611 -170.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -61.88 -50.15 73.36 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.322 1.049 . . . . 0.0 109.812 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.43 74.73 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.809 1.643 . . . . 0.0 111.666 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -59.38 -60.57 3.65 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.631 0.772 . . . . 0.0 109.343 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.55 -13.92 6.84 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.2 -6.66 37.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 175.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.06 16.22 68.36 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.312 0.958 . . . . 0.0 111.927 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.413 HD11 ' CE ' ' A' ' 1' ' ' MET . 54.0 mt -66.65 99.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.424 1.49 . . . . 0.0 107.013 171.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.36 108.36 1.09 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -87.34 155.89 19.85 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -150.07 173.76 13.5 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 128.459 2.704 . . . . 0.0 107.325 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.473 HD12 HD11 ' A' ' 117' ' ' LEU . 13.7 mt -136.51 156.79 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.669 0.788 . . . . 0.0 109.438 171.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -135.37 140.44 45.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.11 0.964 . . . . 0.0 111.583 165.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.9 t -154.31 167.73 28.96 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.33 -0.856 . . . . 0.0 110.455 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -94.66 -1.39 53.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.199 1.8 . . . . 0.0 111.803 168.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HE2' ' CD1' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -78.43 171.02 15.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 121.365 1.893 . . . . 0.0 110.571 178.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.446 ' HA2' HE22 ' A' ' 133' ' ' GLN . . . -69.68 -178.16 20.6 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.738 1.161 . . . . 0.0 112.924 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -53.61 -18.98 3.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.556 1.542 . . . . 0.0 112.539 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.14 -27.34 0.95 Allowed 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 125.6 1.56 . . . . 0.0 113.379 172.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.83 -52.87 29.15 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.197 0.999 . . . . 0.0 111.506 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -56.7 -43.5 80.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.401 0.68 . . . . 0.0 110.311 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -59.89 -48.59 81.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.655 1.182 . . . . 0.0 110.898 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.401 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 62.0 mt -56.66 -46.84 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.825 0.85 . . . . 0.0 109.613 -177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 105' ' ' ILE . 94.1 mt -63.97 -44.6 92.26 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.78 0.832 . . . . 0.0 110.794 -174.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.96 -60.65 2.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 124.284 0.99 . . . . 0.0 108.943 169.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.61 -58.04 9.08 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.917 0.887 . . . . 0.0 112.185 -174.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.1 -32.17 73.47 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.68 -170.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.82 44.23 0.55 Allowed Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 157.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.722 HG23 ' HD2' ' A' ' 125' ' ' TYR . 2.0 p -166.22 52.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 -166.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -41.04 29.89 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 118.783 -2.448 . . . . 0.0 108.878 153.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.3 t -72.12 -8.29 53.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.349 1.46 . . . . 0.0 113.058 -158.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.722 ' HD2' HG23 ' A' ' 122' ' ' VAL . 75.7 m-85 -80.89 -31.8 35.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.005 0.522 . . . . 0.0 109.857 172.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . 0.557 ' CE2' HG22 ' A' ' 122' ' ' VAL . 14.9 m-85 -105.58 101.97 11.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 120.624 -1.297 . . . . 0.0 108.229 -168.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.8 m -46.19 -51.28 14.51 Favored 'General case' 0 C--O 1.255 1.367 0 C-N-CA 126.117 1.767 . . . . 0.0 111.113 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -142.7 144.4 32.69 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.262 0.625 . . . . 0.0 109.553 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.3 mt -132.26 97.81 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 -166.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.41 162.13 29.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.9 p -144.48 -177.38 5.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.358 1.463 . . . . 0.0 108.559 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 96.8 p -51.1 -32.62 23.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.093 0.86 . . . . 0.0 111.856 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.446 HE22 ' HA2' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -60.95 -21.87 63.88 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.499 1.92 . . . . 0.0 111.348 -178.032 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 65.0 p -57.51 -23.37 49.81 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.05 -14.95 59.24 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.225 0.916 . . . . 0.0 111.936 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -66.05 167.74 9.41 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 123.968 1.842 . . . . 0.0 113.23 -173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -58.04 154.14 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 C-N-CA 129.676 3.191 . . . . 0.0 109.91 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.13 43.71 1.05 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.752 0.787 . . . . 0.0 110.808 -172.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 mttt 70.29 147.65 0.12 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 128.394 2.678 . . . . 0.0 110.633 -168.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -62.8 124.34 3.2 Favored 'Cis proline' 0 N--CA 1.45 -1.051 0 N-CA-C 107.619 -1.724 . . . . 0.0 107.619 -22.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -116.32 85.26 15.6 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.49 -22.5 28.67 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.295 1.997 . . . . 0.0 111.405 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -56.31 -38.11 70.82 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.647 1.579 . . . . 0.0 110.397 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.596 ' O ' HD13 ' A' ' 148' ' ' LEU . . . -65.45 -20.55 66.41 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.551 -169.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.66 -41.27 10.82 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 116.338 -1.791 . . . . 0.0 109.553 171.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.453 ' HA ' HD12 ' A' ' 149' ' ' LEU . 23.5 m -56.58 -36.05 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 120.95 1.705 . . . . 0.0 110.586 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.721 ' HD1' HD12 ' A' ' 148' ' ' LEU . 22.8 t80 -56.99 -52.62 64.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.826 0.85 . . . . 0.0 109.756 171.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.721 HD12 ' HD1' ' A' ' 147' ' ' TYR . 8.8 mp -60.34 -39.74 88.22 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.726 1.61 . . . . 0.0 111.343 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.509 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 71.4 mt -57.82 -61.07 2.79 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.83 -31.31 72.45 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.707 0.803 . . . . 0.0 111.56 -171.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.19 -43.08 78.12 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 120.91 -1.119 . . . . 0.0 113.276 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -137.26 26.56 2.9 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 45.93 50.92 11.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.409 2.283 . . . . 0.0 110.441 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 65.8 mt -81.68 167.86 18.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.231 -1.35 . . . . 0.0 109.698 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.07 130.41 51.76 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.92 1.288 . . . . 0.0 108.407 -172.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -52.7 62.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.433 1.111 . . . . 0.0 109.038 176.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.91 -10.74 59.73 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.998 -1.064 . . . . 0.0 112.834 -170.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -112.15 17.54 19.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 109.322 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -104.38 145.69 29.9 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 118.745 0.702 . . . . 0.0 109.501 169.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.474 ' CD1' ' HB2' ' A' ' 178' ' ' GLN . 95.8 m-85 -125.02 159.06 32.19 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.036 1.734 . . . . 0.0 109.856 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -116.03 -39.27 3.47 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.428 HD11 ' CD2' ' A' ' 6' ' ' PHE . 1.3 mp 57.09 75.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 125.604 1.562 . . . . 0.0 112.44 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -128.1 -175.97 14.28 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.367 0.984 . . . . 0.0 110.867 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.59 26.7 5.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.54 1.536 . . . . 0.0 114.106 -156.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.442 ' HD3' ' HB2' ' A' ' 167' ' ' LEU . 1.9 ptp85 -160.62 159.85 30.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.725 2.01 . . . . 0.0 107.899 -178.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 21.6 p -51.8 -37.56 52.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.761 0.791 . . . . 0.0 111.86 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.442 ' HB2' ' HD3' ' A' ' 165' ' ' ARG . 0.2 OUTLIER -62.1 -13.31 25.38 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -35.15 78.66 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 119.988 1.267 . . . . 0.0 110.546 172.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.5 p -104.36 -24.27 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.3 1.04 . . . . 0.0 110.783 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.73 -38.26 87.27 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 120.474 -1.392 . . . . 0.0 110.949 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -75.27 -38.12 60.59 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 118.36 -0.829 . . . . 0.0 110.287 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.26 69.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.978 1.311 . . . . 0.0 110.271 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.63 -43.09 56.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.946 1.299 . . . . 0.0 111.978 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -72.27 -22.12 61.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 118.419 -0.801 . . . . 0.0 113.057 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 t -96.1 -20.84 18.34 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.669 0.668 . . . . 0.0 110.314 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.9 49.8 6.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.15 178.0 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.038 1.735 . . . . 0.0 109.239 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.474 ' HB2' ' CD1' ' A' ' 160' ' ' TYR . 7.2 mm-40 -109.04 168.61 9.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.661 1.22 . . . . 0.0 111.815 -174.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.56 141.39 25.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.868 2.067 . . . . 0.0 108.785 -174.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 57.3 mt -121.01 86.5 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -95.43 176.58 6.14 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.835 -167.054 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -109.64 -6.42 15.35 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 119.654 -1.904 . . . . 0.0 111.469 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.494 ' H ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -118.96 146.2 45.18 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.644 1.978 . . . . 0.0 108.574 176.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.84 144.97 56.49 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 11.7 t -122.23 171.91 8.67 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 112.854 -1.976 . . . . 0.0 107.01 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 9.9 p -114.4 27.7 9.28 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.26 1.824 . . . . 0.0 109.666 -175.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -123.24 140.81 52.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.418 1.487 . . . . 0.0 110.014 -175.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -77.54 96.61 4.8 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.28 1.832 . . . . 0.0 109.415 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 133.76 -1.89 4.38 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.427 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.8 153.51 34.85 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 119.394 1.597 . . . . 0.0 108.407 168.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -138.12 99.95 4.01 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 181' ' ' ASN 0.292 0.2 OUTLIER -75.0 151.44 38.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 115.682 -2.407 . . . . 0.0 109.4 175.403 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.0 pt -126.27 -176.5 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 130.032 3.333 . . . . 0.0 107.982 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -126.83 -14.63 5.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 125.247 1.419 . . . . 0.0 111.75 167.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.93 165.0 36.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.52 0.6 . . . . 0.0 109.455 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.39 -25.89 63.45 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.146 -0.971 . . . . 0.0 110.474 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.34 -32.12 73.32 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.06 -1.025 . . . . 0.0 111.115 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.65 -22.17 63.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.036 2.534 . . . . 0.0 110.728 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.28 -56.7 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 C-N-CA 124.409 1.084 . . . . 0.0 109.009 171.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 96.3 p -52.45 -40.39 62.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.539 0.609 . . . . 0.0 111.384 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 34.0 mtt85 -64.03 -32.8 74.49 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.447 -1.263 . . . . 0.0 112.541 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.23 -45.57 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.088 1.313 . . . . 0.0 109.192 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.69 -5.45 53.12 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 CA--C 1.53 0.207 0 C-N-CA 124.823 1.249 . . . . 0.0 113.205 -177.176 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mmm . . . . . 0 C--O 1.232 0.142 0 CA-C-O 122.478 1.132 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -62.63 173.51 1.25 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.13 -1.396 . . . . 0.0 109.095 173.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -44.17 83.74 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.029 2.132 . . . . 0.0 114.535 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.8 m -110.76 159.83 17.27 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.821 1.248 . . . . 0.0 107.651 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.514 ' HB2' HD22 ' A' ' 154' ' ' LEU . . . -136.92 158.5 44.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.411 0.624 . . . . 0.0 110.937 162.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -114.3 174.85 5.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.61 1.164 . . . . 0.0 108.38 169.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mt -139.84 137.2 39.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 163.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -119.07 178.2 4.59 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.485 1.914 . . . . 0.0 109.442 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.24 -179.8 6.47 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.246 1.819 . . . . 0.0 107.641 -170.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.475 0.784 0 O-C-N 120.762 -1.211 . . . . 0.0 114.238 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.28 0 CA-C-O 121.537 0.684 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.552 ' HG3' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -92.74 -9.8 39.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.952 1.701 . . . . 0.0 112.393 176.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -65.82 -38.98 90.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.425 1.09 . . . . 0.0 110.796 165.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.7 -39.72 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.351 -0.843 . . . . 0.0 110.772 -173.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.922 HD23 ' CD2' ' A' ' 125' ' ' TYR . 6.9 mp -44.35 -41.0 5.75 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 127.797 2.439 . . . . 0.0 111.549 166.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.17 -50.8 62.66 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.903 1.377 . . . . 0.0 109.581 -177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -56.71 -45.45 81.85 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.766 0.827 . . . . 0.0 110.475 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.31 -38.81 71.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.362 1.065 . . . . 0.0 113.138 -174.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.58 -52.11 59.26 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.613 1.165 . . . . 0.0 109.635 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -60.72 -38.12 84.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.336 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.0 m -71.86 -1.26 13.62 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.5 16.14 60.37 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.46 1.505 . . . . 0.0 113.259 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.9 mt -76.05 101.11 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -57.42 109.95 0.78 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.07 1.348 . . . . 0.0 108.913 -174.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -84.6 147.13 27.14 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 172.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -137.39 168.25 20.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 168.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mt -124.53 149.75 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.529 0.731 . . . . 0.0 109.132 171.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -134.04 128.11 33.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 157.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -145.97 -173.95 4.3 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 162.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -126.04 12.77 7.8 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.36 1.864 . . . . 0.0 112.229 -175.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.491 ' HE2' ' CD1' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -73.28 -10.43 59.75 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -165.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 126.91 174.62 13.85 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 126.399 1.952 . . . . 0.0 109.764 -170.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -29.08 70.37 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 117.491 0.645 . . . . 0.0 110.421 172.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -51.64 -14.81 0.37 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.435 2.294 . . . . 0.0 114.544 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.68 -44.53 69.81 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.528 1.058 . . . . 0.0 111.061 169.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -63.22 -7.82 6.84 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.317 1.847 . . . . 0.0 114.122 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 19.0 m -101.92 -49.3 4.0 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 120.521 -1.362 . . . . 0.0 108.501 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.491 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 52.4 mt -52.64 -48.92 47.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 C-N-CA 123.799 0.84 . . . . 0.0 109.367 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.9 mt -64.01 -35.99 82.52 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.0 -1.062 . . . . 0.0 111.366 -172.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.12 -50.45 73.65 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.064 1.345 . . . . 0.0 109.359 172.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.01 -48.11 79.26 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.56 1.544 . . . . 0.0 111.312 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 99.5 mt -58.81 -50.44 73.95 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.476 1.11 . . . . 0.0 108.391 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.9 36.16 3.04 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.065 1.317 . . . . 0.0 112.271 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.94 22.61 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.855 1.662 . . . . 0.0 110.314 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.25 -54.33 46.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.51 1.524 . . . . 0.0 112.657 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.7 m -76.56 -12.62 60.05 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -164.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.922 ' CD2' HD23 ' A' ' 93' ' ' LEU . 26.0 m-85 -54.82 -32.64 60.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.938 0.79 . . . . 0.0 110.943 164.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -98.37 106.18 18.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -172.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.4 m -45.08 -54.11 7.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.559 1.944 . . . . 0.0 110.752 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -142.93 150.24 39.49 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 mt -131.77 88.56 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -168.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.94 145.2 48.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.317 -0.864 . . . . 0.0 109.196 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.7 p -121.77 -173.31 2.62 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.766 0.826 . . . . 0.0 110.553 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 p -56.44 -20.0 17.81 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.001 -1.062 . . . . 0.0 113.31 167.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -77.21 -3.98 42.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.48 1.512 . . . . 0.0 111.918 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.3 p -58.76 -25.64 63.23 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.82 20.19 31.93 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.204 0.906 . . . . 0.0 114.824 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -78.16 -86.89 0.06 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.559 1.679 . . . . 0.0 107.667 168.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.0 t -150.87 168.42 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 126.177 1.791 . . . . 0.0 107.743 -170.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.604 ' H ' ' HD3' ' A' ' 138' ' ' ARG 0.255 0.0 OUTLIER -74.06 -85.16 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 117.817 -1.087 . . . . 0.0 109.583 166.798 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -160.15 139.23 7.94 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 121.32 1.873 . . . . 0.0 109.42 -172.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.86 -28.56 4.55 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 121.035 1.405 . . . . 0.0 115.12 7.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.9 t 59.98 62.3 3.55 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.667 1.187 . . . . 0.0 113.211 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -61.94 -24.42 76.93 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.549 2.166 . . . . 0.0 112.584 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -56.17 -28.77 59.35 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.939 1.296 . . . . 0.0 112.463 -171.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.08 -42.9 77.42 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.056 0.943 . . . . 0.0 110.055 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.26 92.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.693 -0.63 . . . . 0.0 111.288 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 m -55.37 -40.32 71.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.268 0.627 . . . . 0.0 110.514 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -66.64 -51.24 58.47 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.9 mp -56.06 -38.67 70.94 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 111.749 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -60.45 -61.85 2.29 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 126.823 2.049 . . . . 0.0 107.473 177.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -57.35 -36.89 71.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.53 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -48.65 -45.4 38.62 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.378 1.071 . . . . 0.0 112.545 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.75 21.71 10.69 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.411 1.005 . . . . 0.0 112.863 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 50.78 69.5 0.63 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.921 1.689 . . . . 0.0 110.112 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 5' ' ' ALA . 1.1 mt -122.41 178.87 4.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.544 1.537 . . . . 0.0 108.506 -173.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.0 151.49 38.91 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.689 1.996 . . . . 0.0 111.361 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 53.5 m -55.91 -33.71 64.92 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.355 0.598 . . . . 0.0 110.084 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.93 -35.11 64.55 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 120.559 -1.338 . . . . 0.0 109.866 -176.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -77.83 1.15 21.24 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.977 -1.487 . . . . 0.0 113.639 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.709 HG23 ' HB ' ' A' ' 177' ' ' ILE . 4.6 t -97.78 140.03 32.77 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.322 1.419 . . . . 0.0 110.43 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -127.7 109.05 11.28 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.423 1.489 . . . . 0.0 110.559 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -91.83 131.31 37.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.838 0.455 . . . . 0.0 111.079 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.18 119.35 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 126.348 1.859 . . . . 0.0 109.011 -174.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -145.52 -21.49 0.14 Allowed Glycine 0 CA--C 1.535 1.299 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.404 ' HB2' ' CD1' ' A' ' 182' ' ' PHE . 19.2 t70 59.29 58.13 3.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.538 1.935 . . . . 0.0 112.886 -174.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -163.35 164.28 24.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.498 -1.376 . . . . 0.0 112.128 172.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.3 t -51.72 -53.07 43.35 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.906 1.282 . . . . 0.0 111.366 167.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.76 -20.59 66.45 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.602 1.561 . . . . 0.0 110.882 -165.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.18 -34.78 78.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.677 -0.64 . . . . 0.0 110.267 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.402 ' HA ' ' HB3' ' A' ' 172' ' ' ALA . 2.7 t -82.13 -11.98 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.5 0.72 . . . . 0.0 111.353 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.06 -55.89 18.91 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 169.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -54.05 -42.01 68.74 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.261 1.025 . . . . 0.0 111.479 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . . . -60.77 -26.48 67.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.767 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -90.14 -42.09 11.26 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.921 1.237 . . . . 0.0 109.225 -169.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -29.23 69.22 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.419 ' HB3' HG23 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -80.04 -41.23 26.12 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.23 0.923 . . . . 0.0 110.377 169.028 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 80.4 56.32 3.22 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -170.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.709 ' HB ' HG23 ' A' ' 159' ' ' THR . 41.7 pt -129.88 165.03 31.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 127.643 2.377 . . . . 0.0 106.146 -174.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -85.27 163.07 18.85 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.168 -0.958 . . . . 0.0 109.96 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.39 162.52 34.83 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.823 0.82 . . . . 0.0 109.834 172.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 36.0 mt -138.57 120.56 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -139.56 164.64 29.36 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' PHE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 164' ' ' ASP . 86.2 m-85 -74.69 9.02 2.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.5 151.81 36.99 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.009 1.324 . . . . 0.0 109.18 -166.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -70.55 147.55 49.18 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.15 26.19 2.03 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.522 1.129 . . . . 0.0 111.183 167.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 17.3 p 50.67 45.82 26.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.466 1.507 . . . . 0.0 111.734 164.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -136.28 157.06 47.71 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.983 2.113 . . . . 0.0 106.365 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -75.4 -45.63 37.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.619 0.645 . . . . 0.0 111.665 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -68.86 -9.02 58.69 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.063 -0.854 . . . . 0.0 112.878 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.09 100.92 12.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.041 1.92 . . . . 0.0 109.181 -173.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -79.74 134.07 36.37 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.28 0.632 . . . . 0.0 109.343 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ARG . . . . . 0.41 ' HB3' HH11 ' A' ' 192' ' ' ARG . 0.0 OUTLIER -77.72 151.56 34.1 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 166.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.83 166.68 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.409 1.883 . . . . 0.0 109.955 171.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -129.54 0.73 5.0 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.385 1.474 . . . . 0.0 112.799 168.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.05 165.56 34.32 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.289 1.436 . . . . 0.0 108.307 171.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 69.3 mt -73.62 -33.66 64.67 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 118.578 0.626 . . . . 0.0 110.154 176.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.51 -22.27 66.15 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -62.75 -21.72 66.04 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.367 -0.833 . . . . 0.0 110.799 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.49 -55.97 19.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 125.138 1.375 . . . . 0.0 109.087 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 95.0 p -60.02 -33.19 71.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.055 1.298 . . . . 0.0 110.877 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -63.24 -33.69 76.05 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.044 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.1 mt -50.31 -58.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -67.26 -12.76 60.94 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.584 1.153 . . . . 0.0 112.952 -174.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 CA--C 1.533 0.322 0 C-N-CA 125.184 1.394 . . . . 0.0 112.853 -176.859 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.93 0 N-CA-C 111.672 -0.571 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 55.0 -86.79 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 128.827 2.851 . . . . 0.0 112.322 -168.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.2 mmm 59.2 102.12 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 127.825 2.45 . . . . 0.0 113.57 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -52.63 -177.45 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.323 1.849 . . . . 0.0 113.184 164.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.8 mmmm -61.2 100.03 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 O-C-N 120.449 -1.407 . . . . 0.0 107.676 168.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.3 m -128.35 148.25 50.67 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.89 150.01 52.25 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -127.74 149.75 50.1 Favored 'General case' 0 CA--C 1.505 -0.757 0 C-N-CA 125.613 1.565 . . . . 0.0 108.41 -174.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.3 mt -142.82 132.12 21.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -115.67 179.61 3.92 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.849 1.66 . . . . 0.0 109.999 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -133.92 175.91 9.04 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.517 2.327 . . . . 0.0 106.657 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 82.9 mt -130.16 52.6 2.0 Allowed 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.803 1.241 . . . . 0.0 108.824 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -130.11 -11.44 4.19 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.916 1.286 . . . . 0.0 112.638 -172.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.99 -34.72 0.49 Allowed Glycine 0 CA--C 1.526 0.729 0 O-C-N 121.21 -0.931 . . . . 0.0 112.123 171.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.1 m . . . . . 0 C--O 1.256 1.417 0 C-N-CA 127.42 2.288 . . . . 0.0 110.054 174.516 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 tm? . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . 0.276 4.7 tpt 41.82 75.42 0.62 Allowed Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 127.107 2.163 . . . . 0.0 111.897 157.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -57.65 103.15 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.861 3.04 . . . . 0.0 110.184 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.86 -17.41 7.69 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.204 1.383 . . . . 0.0 113.803 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.71 -31.79 22.27 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 120.388 2.094 . . . . 0.0 112.129 -173.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -60.33 -21.24 61.81 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -57.66 -69.81 0.16 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.366 1.466 . . . . 0.0 109.043 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.06 -40.48 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.638 1.175 . . . . 0.0 109.962 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 49.7 mt -55.52 -50.79 69.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 119.13 0.877 . . . . 0.0 110.047 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.26 -45.08 89.68 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.286 0.635 . . . . 0.0 111.695 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -57.28 -55.28 36.82 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 124.227 1.011 . . . . 0.0 109.021 176.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.26 -40.5 94.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.59 0.756 . . . . 0.0 111.049 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -59.22 -58.64 7.76 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.195 1.398 . . . . 0.0 110.017 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -62.1 -28.49 69.66 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.6 m -71.2 -5.66 33.61 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.468 -0.77 . . . . 0.0 112.672 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.83 9.93 71.32 Favored Glycine 0 CA--C 1.524 0.655 0 CA-C-N 119.639 1.109 . . . . 0.0 113.539 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 87.3 mt -56.03 149.69 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 119.307 1.553 . . . . 0.0 107.192 160.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -100.64 105.48 16.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 170.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -78.47 149.43 33.2 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.25 0.932 . . . . 0.0 109.065 172.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -139.81 174.16 10.8 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.203 1.801 . . . . 0.0 108.383 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 23.0 mt -136.31 150.42 27.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 169.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 130' ' ' LEU . 4.8 t80 -134.5 141.44 46.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 152.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.45 HG23 ' H ' ' A' ' 109' ' ' LYS . 2.6 t -156.07 165.65 35.8 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.3 m80 -76.42 -12.95 60.13 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.189 -0.944 . . . . 0.0 112.882 174.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.45 ' H ' HG23 ' A' ' 107' ' ' THR . 1.5 ttmm -63.98 156.76 26.95 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.149 -0.969 . . . . 0.0 110.063 -174.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.49 -169.97 38.96 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 123.992 0.806 . . . . 0.0 114.252 -170.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -60.22 -12.52 9.0 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.949 1.3 . . . . 0.0 112.264 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -61.54 -12.44 15.35 Favored 'General case' 0 C--O 1.224 -0.238 0 O-C-N 119.781 -1.825 . . . . 0.0 112.384 168.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.44 -47.97 83.78 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 120.712 1.596 . . . . 0.0 107.804 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -56.46 -45.14 81.0 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.98 1.712 . . . . 0.0 110.098 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.2 m -67.46 -44.81 77.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.998 0.919 . . . . 0.0 111.209 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 61.4 mt -59.72 -46.0 93.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 124.669 1.188 . . . . 0.0 108.308 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mp -57.36 -45.19 84.66 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.702 0.801 . . . . 0.0 110.504 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -49.9 75.53 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.257 1.023 . . . . 0.0 110.358 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -50.21 -57.5 7.64 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.755 1.622 . . . . 0.0 109.179 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.94 -12.86 61.78 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.785 1.634 . . . . 0.0 112.727 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 88.77 12.51 64.09 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.562 1.077 . . . . 0.0 113.976 170.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 16.4 m -119.87 16.27 6.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 C-N-CA 125.105 1.362 . . . . 0.0 111.635 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -59.65 -40.6 88.21 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 121.267 -0.896 . . . . 0.0 113.37 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.03 -11.04 60.41 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.757 0.661 . . . . 0.0 112.486 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -74.71 4.57 6.06 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.857 1.208 . . . . 0.0 113.269 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -141.28 123.94 16.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.1 m -54.36 -45.96 72.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.284 1.434 . . . . 0.0 110.175 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -153.58 142.82 21.47 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.6 mp -125.71 100.96 7.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 -175.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.441 ' HB2' ' CD1' ' A' ' 106' ' ' TYR . 3.5 mm? -76.1 155.23 34.91 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 175.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.9 p -140.91 -174.64 4.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.103 1.361 . . . . 0.0 109.848 -171.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 62.4 p -52.36 -24.51 7.77 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.534 1.061 . . . . 0.0 112.592 168.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -58.47 -35.22 71.84 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.144 1.378 . . . . 0.0 110.349 178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.421 ' HB2' ' CD2' ' A' ' 136' ' ' PHE . 80.5 p -57.36 -35.82 70.43 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 -169.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.54 -8.01 50.53 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.608 -1.107 . . . . 0.0 113.671 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.421 ' CD2' ' HB2' ' A' ' 134' ' ' SER . 29.5 m-85 -59.57 156.97 12.38 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.72 1.26 . . . . 0.0 111.087 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.74 HG23 ' HB2' ' A' ' 141' ' ' SER . 2.3 m -52.97 159.18 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.054 1.342 . . . . 0.0 113.398 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -67.53 160.64 27.24 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.585 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 37.8 mttp -61.09 133.01 92.53 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 117.258 -1.353 . . . . 0.0 108.744 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -75.66 135.68 41.4 Favored 'Cis proline' 0 C--N 1.35 0.648 0 CA-C-N 121.33 1.511 . . . . 0.0 110.17 -3.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.74 ' HB2' HG23 ' A' ' 137' ' ' VAL . 0.3 OUTLIER -143.44 85.45 9.47 Favored Pre-proline 0 N--CA 1.441 -0.894 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -170.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.21 -16.61 22.27 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 N-CA-C 109.23 -1.104 . . . . 0.0 109.23 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -44.52 -49.96 9.76 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 126.857 2.063 . . . . 0.0 110.717 176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.06 -28.55 65.54 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.491 -171.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.4 -41.16 20.27 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 120.095 -1.628 . . . . 0.0 109.295 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 72.8 m -58.87 -30.52 67.79 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 118.902 0.774 . . . . 0.0 111.082 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.578 ' CZ ' ' HE3' ' A' ' 151' ' ' LYS . 34.4 t80 -60.62 -55.68 30.43 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.884 0.873 . . . . 0.0 109.389 166.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.437 HD12 ' HD1' ' A' ' 147' ' ' TYR . 4.5 mp -58.09 -28.09 64.27 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.705 1.602 . . . . 0.0 113.095 -173.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.7 mt -71.61 -63.97 1.02 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.467 1.507 . . . . 0.0 107.18 177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -66.36 -20.05 65.97 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.273 0.629 . . . . 0.0 112.55 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.578 ' HE3' ' CZ ' ' A' ' 147' ' ' TYR . 12.5 mmtt -51.78 -41.64 61.82 Favored 'General case' 0 C--O 1.231 0.109 0 O-C-N 121.345 -0.847 . . . . 0.0 111.897 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -144.46 17.28 1.68 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -172.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.6 mm-40 59.9 62.9 1.57 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.867 1.667 . . . . 0.0 110.983 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.89 173.19 6.42 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 125.347 1.459 . . . . 0.0 109.973 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -116.51 126.28 53.12 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 125.522 1.529 . . . . 0.0 108.07 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -44.6 77.98 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.2 1.0 . . . . 0.0 110.454 174.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.76 -9.32 58.51 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.326 -0.859 . . . . 0.0 112.607 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -117.33 17.44 14.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 123.819 0.848 . . . . 0.0 108.829 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -106.64 130.31 54.4 Favored 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 170.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -122.2 97.78 5.63 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 126.079 1.752 . . . . 0.0 106.802 -170.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -71.85 158.7 35.59 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.684 173.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 47.8 mt -130.03 97.62 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.162 -2.533 . . . . 0.0 104.162 -171.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -120.81 -179.0 16.12 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 125.562 1.554 . . . . 0.0 112.011 -173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -128.78 -5.48 5.14 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.516 1.126 . . . . 0.0 113.405 173.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 11.3 ttt180 -121.16 165.54 15.23 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 122.347 1.07 . . . . 0.0 112.126 -164.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.8 t -63.25 -39.53 94.85 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.992 1.317 . . . . 0.0 110.187 164.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -32.46 72.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.408 1.083 . . . . 0.0 110.421 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -69.38 8.45 0.61 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.623 1.969 . . . . 0.0 111.824 174.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 4.1 t -131.39 -25.06 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 125.296 1.439 . . . . 0.0 110.816 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -57.53 -56.66 19.02 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.665 -1.272 . . . . 0.0 109.344 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -66.5 -29.52 69.64 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 120.947 -1.095 . . . . 0.0 110.925 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -62.54 -51.29 67.98 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -52.76 -52.84 54.95 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 124.386 1.075 . . . . 0.0 111.027 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -52.63 -47.21 67.16 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.354 0.261 . . . . 0.0 111.496 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.8 m -72.79 -26.85 61.68 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.763 0.825 . . . . 0.0 112.048 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.96 32.54 39.7 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.561 1.553 . . . . 0.0 111.181 -172.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 22.1 pt -109.83 167.61 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 C-N-CA 124.985 1.314 . . . . 0.0 109.36 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -97.63 162.54 13.24 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 -175.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 23.5 m -135.33 152.75 51.76 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.327 1.451 . . . . 0.0 109.787 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 42.2 mt -131.84 95.37 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -129.56 149.97 51.1 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 124.309 1.044 . . . . 0.0 109.117 -165.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -70.7 -12.28 61.46 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.071 -1.018 . . . . 0.0 113.542 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.5 pp -126.37 151.64 47.36 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.658 1.583 . . . . 0.0 109.594 178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -78.4 154.95 30.26 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 172.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.4 t -144.11 13.55 1.64 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.387 0.675 . . . . 0.0 110.946 -174.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 71.0 p 57.06 69.66 0.72 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.939 2.096 . . . . 0.0 110.406 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -150.78 135.19 17.07 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 124.402 1.081 . . . . 0.0 108.405 176.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -70.12 -7.08 38.61 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -108.19 8.08 35.47 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.297 1.427 . . . . 0.0 112.954 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -108.94 122.06 46.42 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 120.788 2.294 . . . . 0.0 110.437 -175.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -101.21 119.17 38.36 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.364 1.065 . . . . 0.0 109.427 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -67.61 146.59 53.71 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 118.431 0.56 . . . . 0.0 111.273 171.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 9.2 pt -146.04 175.75 2.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 127.296 2.239 . . . . 0.0 109.594 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -136.38 -12.41 1.84 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.436 1.494 . . . . 0.0 113.142 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.15 160.8 39.14 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.148 1.379 . . . . 0.0 108.075 178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 tp -64.36 -31.8 73.15 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 125.231 1.412 . . . . 0.0 110.503 -177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.22 -9.18 51.8 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -19.02 61.0 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.384 0.993 . . . . 0.0 110.409 172.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 67.8 mt -55.86 -52.85 44.5 Favored 'Isoleucine or valine' 0 C--N 1.345 0.385 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 89.6 p -60.26 -35.67 76.05 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.113 0.415 . . . . 0.0 111.688 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -62.62 -36.28 82.27 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.876 0.871 . . . . 0.0 112.226 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 49.3 mt -59.37 -44.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 124.289 1.036 . . . . 0.0 108.8 -172.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -84.86 13.17 6.19 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.534 1.134 . . . . 0.0 112.55 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -131.73 16.39 4.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.295 1.438 . . . . 0.0 110.362 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.285 5.7 t -154.34 47.62 0.59 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.327 0.967 . . . . 0.0 112.025 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 40.4 pttt . . . . . 0 C--O 1.249 1.065 0 C-N-CA 126.719 2.008 . . . . 0.0 111.11 -175.082 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.707 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 25.2 p80 44.3 55.36 5.62 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.926 1.69 . . . . 0.0 112.483 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.2 mmm -117.17 96.7 5.56 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 102.306 -3.22 . . . . 0.0 102.306 168.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -169.36 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 112.551 -2.113 . . . . 0.0 110.625 158.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -50.22 115.0 1.24 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 156.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.6 m -131.52 157.77 42.68 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 163.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.95 150.71 51.97 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 121.878 -0.514 . . . . 0.0 109.683 165.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -132.66 149.28 52.32 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 126.273 1.829 . . . . 0.0 108.156 -173.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.0 mt -142.12 145.65 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -125.22 174.51 8.05 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.086 1.755 . . . . 0.0 109.979 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -120.71 -11.2 9.06 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.561 1.544 . . . . 0.0 111.723 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.3 tp 71.91 9.91 6.16 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 128.437 2.695 . . . . 0.0 112.603 174.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -130.69 8.79 4.94 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -159.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.99 -79.16 0.05 OUTLIER Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 172.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.251 1.14 0 CA-C-O 117.765 -1.112 . . . . 0.0 108.346 161.199 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.424 ' N ' HD13 ' A' ' 85' ' ' LEU 0.51 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 62.3 tpp 45.27 81.47 0.25 Allowed Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 124.909 1.283 . . . . 0.0 111.44 -165.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -61.23 103.39 0.25 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 123.46 2.773 . . . . 0.0 109.702 -176.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 169.25 -35.77 0.19 Allowed Glycine 0 CA--C 1.521 0.45 0 C-N-CA 128.424 2.916 . . . . 0.0 107.667 -175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.33 -15.01 31.98 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -169.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -67.0 -25.31 66.24 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 120.39 -1.444 . . . . 0.0 114.266 -167.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -62.04 -53.94 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 123.108 0.563 . . . . 0.0 110.592 175.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.8 t -68.63 -34.95 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 117.942 -1.027 . . . . 0.0 111.713 -176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.832 HD23 ' CD2' ' A' ' 125' ' ' TYR . 7.4 mp -44.49 -50.51 9.43 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 121.529 1.968 . . . . 0.0 113.374 164.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -65.92 -50.47 64.32 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 124.15 0.906 . . . . 0.0 109.782 -177.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -53.36 -50.53 64.88 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 123.836 0.71 . . . . 0.0 110.358 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.04 -39.79 82.98 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.314 1.046 . . . . 0.0 111.822 -177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -71.96 -41.52 67.64 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 118.455 0.571 . . . . 0.0 110.719 -177.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -64.17 -28.56 69.84 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.508 -0.745 . . . . 0.0 111.547 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.5 m -76.49 -13.0 60.13 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.002 0.921 . . . . 0.0 112.235 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 56.62 37.38 75.82 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.027 1.299 . . . . 0.0 112.003 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 33.6 mt -68.12 121.85 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 159.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -68.08 113.6 5.88 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 170.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -94.13 144.13 25.76 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.406 1.482 . . . . 0.0 107.686 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -143.97 177.83 8.28 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.242 1.017 . . . . 0.0 109.298 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.9 mt -135.83 150.52 28.55 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 C-N-CA 124.074 0.95 . . . . 0.0 108.591 173.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -133.24 113.16 12.33 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 156.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -133.06 175.52 9.31 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.315 1.446 . . . . 0.0 109.178 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . 0.274 2.1 p80 -125.99 22.42 7.35 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -72.42 -0.81 13.49 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.16 -177.9 38.42 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.912 1.244 . . . . 0.0 111.793 -177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -72.27 -2.77 20.25 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -162.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -70.85 -10.22 59.16 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.741 164.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -47.96 -52.96 17.62 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 124.731 1.212 . . . . 0.0 111.335 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -59.47 -44.79 92.93 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.055 0.542 . . . . 0.0 110.114 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -62.82 -40.82 98.58 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.938 1.295 . . . . 0.0 111.123 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 69.7 mt -63.64 -50.75 76.78 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.33 -38.93 92.78 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.57 -0.706 . . . . 0.0 111.324 -175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -63.51 -46.02 88.01 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 123.6 0.76 . . . . 0.0 110.379 175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -48.68 -50.42 33.32 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 122.985 1.374 . . . . 0.0 110.111 172.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.4 mt -69.46 -18.67 63.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.844 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 69.99 33.32 69.97 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.869 0.759 . . . . 0.0 111.985 174.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.1 m -137.19 22.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 126.361 1.864 . . . . 0.0 108.841 174.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.81 -42.18 81.93 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 122.051 -0.405 . . . . 0.0 110.218 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.2 m -58.83 -24.27 61.78 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 123.935 0.772 . . . . 0.0 112.171 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.832 ' CD2' HD23 ' A' ' 93' ' ' LEU . 26.0 m-85 -68.47 6.35 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.123 1.369 . . . . 0.0 113.986 175.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -140.91 105.94 4.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 47.6 m -55.16 -41.32 71.7 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.521 1.528 . . . . 0.0 111.056 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -150.87 147.26 27.01 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.8 mp -135.74 96.87 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.46 0.063 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -167.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.97 145.79 48.17 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 175.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 62.1 p -123.88 -176.26 3.43 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.493 1.117 . . . . 0.0 110.323 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.9 t -48.78 -34.88 13.13 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.273 1.429 . . . . 0.0 110.411 164.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.7 mm100 -82.3 -2.58 53.14 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.286 1.434 . . . . 0.0 112.319 -171.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 83.9 p -57.07 -63.13 1.31 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 120.304 1.411 . . . . 0.0 110.299 176.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 123.2 -16.0 8.16 Favored Glycine 0 CA--C 1.521 0.44 0 C-N-CA 125.598 1.57 . . . . 0.0 112.643 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -58.63 166.83 1.68 Allowed 'General case' 0 C--O 1.238 0.486 0 CA-C-N 119.049 1.425 . . . . 0.0 112.83 -173.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.484 HG23 ' CB ' ' A' ' 141' ' ' SER . 16.3 m -60.57 160.75 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.916 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 74.4 mtt-85 -84.89 147.71 26.63 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.061 -1.649 . . . . 0.0 109.01 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -48.44 131.79 13.38 Favored Pre-proline 0 C--O 1.243 0.743 0 CA-C-O 117.4 -1.286 . . . . 0.0 109.949 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.27 125.82 7.19 Favored 'Cis proline' 0 C--N 1.351 0.691 0 CA-C-N 121.018 1.399 . . . . 0.0 111.696 -3.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.484 ' CB ' HG23 ' A' ' 137' ' ' VAL . 10.4 p -141.94 85.43 11.12 Favored Pre-proline 0 N--CA 1.438 -1.026 0 C-N-CA 123.292 0.637 . . . . 0.0 111.893 -173.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.69 -18.51 32.57 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.376 . . . . 0.0 112.561 -173.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -45.3 -43.84 11.0 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.285 1.834 . . . . 0.0 112.686 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.63 -7.6 21.67 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 113.537 0.939 . . . . 0.0 113.537 -178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.01 -61.05 1.93 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.046 0.938 . . . . 0.0 108.737 163.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.8 m -56.22 -40.29 73.85 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 126.475 1.91 . . . . 0.0 110.466 -170.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -53.91 -51.25 64.34 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.572 0.749 . . . . 0.0 110.907 174.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.8 mt -77.51 -27.98 51.97 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.832 0.853 . . . . 0.0 112.159 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.8 mt -62.49 -59.93 4.26 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -67.76 -22.41 65.21 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -61.13 -48.91 79.47 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 120.788 -1.195 . . . . 0.0 112.438 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -121.63 18.19 11.19 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.078 0.854 . . . . 0.0 112.013 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 54.07 51.96 13.63 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 126.335 1.854 . . . . 0.0 111.219 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.33 170.3 15.51 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.371 1.469 . . . . 0.0 110.224 175.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -105.73 130.25 53.78 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.038 1.735 . . . . 0.0 108.288 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 m -58.02 -29.47 65.34 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 119.261 0.937 . . . . 0.0 110.877 178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.52 -27.83 23.75 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -84.84 -0.94 55.69 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -99.64 138.74 36.3 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.143 0.883 . . . . 0.0 108.654 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.444 ' CD1' ' HB2' ' A' ' 178' ' ' GLN . 92.6 m-85 -120.15 166.16 13.8 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.871 1.669 . . . . 0.0 107.554 173.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -139.39 157.25 46.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.455 1.902 . . . . 0.0 107.02 168.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 5.0 mt -135.82 128.73 47.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -176.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -161.72 10.01 0.11 Allowed Glycine 0 C--O 1.224 -0.482 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.026 -174.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . 0.293 1.5 p30 60.86 -1.85 0.22 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 129.799 3.24 . . . . 0.0 115.862 163.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 29.5 ttp180 -113.36 168.27 9.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 118.974 0.806 . . . . 0.0 112.858 -168.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.1 t -59.22 -35.39 73.56 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.077 -1.015 . . . . 0.0 111.642 175.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.727 HD12 ' CE1' ' A' ' 171' ' ' PHE . 0.2 OUTLIER -66.94 -13.44 61.8 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.37 1.468 . . . . 0.0 112.419 -178.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -66.42 -39.15 88.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.634 0.731 . . . . 0.0 111.595 -167.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.91 -45.86 90.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 125.022 1.329 . . . . 0.0 108.655 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.526 ' HB2' HD13 ' A' ' 167' ' ' LEU . 59.8 mm-40 -59.81 -41.18 90.69 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.021 0.929 . . . . 0.0 110.938 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.727 ' CE1' HD12 ' A' ' 167' ' ' LEU . 19.5 m-85 -64.22 -51.81 61.87 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.229 0.922 . . . . 0.0 110.829 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.19 97.51 Favored 'General case' 0 C--O 1.224 -0.287 0 O-C-N 123.577 0.548 . . . . 0.0 111.259 -176.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -62.78 -28.89 70.3 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.322 0.649 . . . . 0.0 111.81 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -60.04 -46.8 88.34 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 119.365 -0.35 . . . . 0.0 110.486 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.33 -23.36 32.56 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.879 1.672 . . . . 0.0 113.318 177.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 90.0 10.39 64.62 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 126.499 2.0 . . . . 0.0 113.847 -175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 23.7 pt -81.79 -173.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 CA-C-N 119.221 1.51 . . . . 0.0 110.163 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.444 ' HB2' ' CD1' ' A' ' 160' ' ' TYR . 23.9 mm-40 -101.17 161.75 13.39 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.287 1.035 . . . . 0.0 110.419 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.05 160.58 40.12 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.885 1.274 . . . . 0.0 113.419 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 25.8 mt -142.9 83.34 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 125.823 1.649 . . . . 0.0 108.845 -172.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -97.66 -171.41 2.18 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 120.994 -1.066 . . . . 0.0 110.62 173.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -99.74 -5.9 27.95 Favored 'General case' 0 N--CA 1.482 1.166 0 O-C-N 120.514 -1.366 . . . . 0.0 112.704 172.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.677 HD22 ' H ' ' A' ' 183' ' ' LEU . 0.0 OUTLIER -112.61 137.58 50.66 Favored 'General case' 0 CA--C 1.503 -0.859 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -176.576 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -72.96 162.04 29.97 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 125.958 1.703 . . . . 0.0 109.626 -178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 34.7 t -155.77 157.87 37.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 10.2 p -85.91 19.64 2.49 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 124.603 1.161 . . . . 0.0 111.795 175.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -67.82 -178.62 0.99 Allowed 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.612 -0.68 . . . . 0.0 110.27 168.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.04 5.5 7.93 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -165.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.92 23.39 1.01 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 126.1 1.81 . . . . 0.0 111.52 167.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -81.92 149.56 28.17 Favored 'General case' 0 N--CA 1.438 -1.039 0 O-C-N 120.794 -1.415 . . . . 0.0 108.882 160.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 35.7 m-70 -142.29 99.36 3.49 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 123.166 0.586 . . . . 0.0 109.612 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -73.93 162.63 28.86 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 118.438 -1.305 . . . . 0.0 112.035 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 6.7 pt -135.31 169.31 21.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 126.403 1.881 . . . . 0.0 110.099 176.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -117.57 -2.9 11.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.95 1.3 . . . . 0.0 112.862 168.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -159.56 167.52 28.34 Favored 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 124.852 1.261 . . . . 0.0 109.079 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' A' ' 196' ' ' LEU . 7.5 tp -76.08 -40.39 53.2 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -173.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.48 -18.86 64.23 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.52 -11.24 60.17 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.811 0.844 . . . . 0.0 111.027 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.39 -55.62 23.09 Favored 'Isoleucine or valine' 0 C--N 1.343 0.325 0 CA-C-O 117.835 -1.079 . . . . 0.0 108.484 166.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.2 m -54.27 -38.88 66.33 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 119.621 1.101 . . . . 0.0 110.158 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -64.14 -25.98 68.33 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.1 mt -56.44 -48.19 80.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 175.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -78.85 -41.07 30.93 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.436 1.094 . . . . 0.0 109.89 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.85 49.2 1.68 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 126.67 1.988 . . . . 0.0 109.276 -174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 3.2 m 45.35 68.16 0.61 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.252 2.221 . . . . 0.0 113.428 165.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? . . . . . 0 C--O 1.249 1.067 0 C-N-CA 129.997 3.319 . . . . 0.0 113.822 160.643 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.936 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 -117.92 83.06 1.93 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.633 1.173 . . . . 0.0 108.374 -174.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.2 mmm -107.49 73.36 0.91 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 122.846 1.308 . . . . 0.0 107.478 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -109.35 114.59 28.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 113.985 -1.461 . . . . 0.0 107.588 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.53 83.4 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 126.329 1.852 . . . . 0.0 111.368 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 m -124.08 135.11 53.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.8 150.26 31.9 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 170.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -126.49 150.91 48.45 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.291 1.436 . . . . 0.0 108.464 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -138.56 135.47 43.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -125.8 163.05 23.73 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.841 2.057 . . . . 0.0 109.999 -169.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -86.51 -29.92 22.35 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.851 2.06 . . . . 0.0 112.491 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 45.53 58.49 4.2 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.615 1.566 . . . . 0.0 111.195 -167.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.82 -58.2 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 117.855 -1.069 . . . . 0.0 110.503 164.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.44 148.45 18.96 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 120.234 1.379 . . . . 0.0 112.761 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.818 0 C-N-CA 126.979 2.111 . . . . 0.0 109.386 -177.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.457 HD21 HG21 ' A' ' 122' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.827 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -105.0 86.85 1.64 Allowed Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 125.674 1.59 . . . . 0.0 109.433 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -56.63 111.95 0.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.46 2.107 . . . . 0.0 108.118 166.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.37 -15.07 8.71 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 117.938 -1.479 . . . . 0.0 113.251 -170.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.6 -19.47 10.56 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 116.13 1.9 . . . . 0.0 116.13 -175.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -65.49 -30.08 70.81 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 119.676 1.125 . . . . 0.0 112.301 -175.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -56.46 -55.63 31.22 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.818 0.847 . . . . 0.0 110.489 175.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.47 -42.14 94.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.33 -178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.619 HD23 ' CD2' ' A' ' 125' ' ' TYR . 6.6 mp -44.55 -52.85 7.65 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 121.645 2.021 . . . . 0.0 112.544 168.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.35 -48.69 80.68 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.588 1.18 . . . . 0.0 110.957 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -58.63 -46.66 86.61 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.101 0.96 . . . . 0.0 111.421 178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.51 -38.0 68.21 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 118.293 -0.861 . . . . 0.0 112.418 -172.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.52 -40.75 93.33 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 118.945 0.793 . . . . 0.0 109.752 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -52.03 -54.74 26.41 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.639 1.176 . . . . 0.0 109.021 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.3 m -74.0 4.77 4.97 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 60.31 24.79 61.76 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.659 1.118 . . . . 0.0 113.151 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.4 mt -71.3 108.22 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 127.032 2.133 . . . . 0.0 107.47 169.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 102' ' ' GLN . 2.8 pt20 -65.84 103.18 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 122.996 0.518 . . . . 0.0 110.165 174.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -84.8 151.58 24.25 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -145.32 169.64 17.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.943 1.697 . . . . 0.0 109.803 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 22.3 mt -138.79 157.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.774 1.629 . . . . 0.0 110.698 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -137.46 115.77 11.84 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 124.027 0.931 . . . . 0.0 109.383 163.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -134.42 161.07 36.04 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.454 1.502 . . . . 0.0 108.547 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -88.28 -2.43 58.6 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.283 1.033 . . . . 0.0 110.896 170.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -54.09 147.87 11.99 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.853 1.661 . . . . 0.0 108.233 172.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.95 -171.59 28.48 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 123.642 0.639 . . . . 0.0 111.616 -170.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -58.7 -22.38 57.18 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.787 -0.831 . . . . 0.0 111.432 174.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -57.6 -17.37 13.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.727 1.211 . . . . 0.0 114.008 169.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -52.79 -49.01 66.47 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 120.606 1.548 . . . . 0.0 111.123 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -59.55 -42.2 91.83 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.17 0.588 . . . . 0.0 110.233 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -62.79 -46.01 89.98 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.451 1.1 . . . . 0.0 110.906 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 39.6 mt -59.84 -45.61 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 124.421 1.088 . . . . 0.0 108.824 177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.8 mp -57.29 -44.98 84.53 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.463 0.705 . . . . 0.0 111.29 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -48.48 81.61 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 122.913 0.485 . . . . 0.0 110.267 174.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -51.05 -52.78 39.83 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.747 1.219 . . . . 0.0 110.473 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.5 mt -74.47 -3.67 32.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.145 1.778 . . . . 0.0 113.307 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 62.25 32.98 84.57 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.751 1.167 . . . . 0.0 112.645 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.457 HG21 HD21 ' A' ' 85' ' ' LEU . 35.7 m -124.54 23.59 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.977 0.911 . . . . 0.0 109.706 174.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.64 -48.54 76.85 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.035 -1.04 . . . . 0.0 110.304 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.9 m -70.87 -19.01 62.67 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.619 ' CD2' HD23 ' A' ' 93' ' ' LEU . 21.0 m-85 -66.17 -0.51 2.54 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 117.132 -1.414 . . . . 0.0 113.638 167.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -139.84 105.06 5.03 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 121.665 2.03 . . . . 0.0 108.97 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 44.4 m -51.73 -40.79 60.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.933 1.693 . . . . 0.0 112.254 -175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -157.28 145.55 19.35 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 -172.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.05 131.04 45.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -174.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -85.18 151.87 23.77 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 167.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 39.2 p -137.17 -168.3 2.26 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.608 1.563 . . . . 0.0 110.208 -172.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.4 t -53.78 -26.55 24.26 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 120.497 -1.377 . . . . 0.0 112.975 167.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 82.6 mm-40 -61.03 -33.92 74.05 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.983 0.896 . . . . 0.0 109.168 176.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.9 m -85.31 69.83 10.77 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 129.07 2.948 . . . . 0.0 104.793 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.51 44.59 1.99 Allowed Glycine 0 CA--C 1.522 0.494 0 CA-C-O 118.693 -1.059 . . . . 0.0 111.324 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -67.22 174.45 3.21 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 124.602 2.144 . . . . 0.0 112.191 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 43.8 t -76.75 157.64 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 C-N-CA 128.261 2.624 . . . . 0.0 110.6 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -72.25 166.34 22.62 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 125.397 1.479 . . . . 0.0 110.467 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.4 mmpm? -73.04 149.02 89.5 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 120.36 -1.463 . . . . 0.0 107.967 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -77.88 -4.99 32.51 Favored 'Cis proline' 0 CA--C 1.533 0.434 0 N-CA-C 115.842 1.439 . . . . 0.0 115.842 11.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.2 t -43.09 91.39 0.05 OUTLIER Pre-proline 0 C--O 1.241 0.655 0 C-N-CA 127.366 2.266 . . . . 0.0 114.576 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -56.84 6.94 0.05 OUTLIER 'Trans proline' 0 CA--C 1.556 1.616 1 C-N-CA 128.068 5.845 . . . . 0.0 114.64 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -43.74 -71.65 0.07 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 128.333 2.653 . . . . 0.0 112.236 -172.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -60.8 -16.39 40.18 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -175.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.35 -54.82 6.21 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 119.68 1.127 . . . . 0.0 108.552 171.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.6 m -53.06 -38.72 62.71 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.665 1.186 . . . . 0.0 110.605 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -52.04 -50.38 61.58 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.346 1.058 . . . . 0.0 110.715 174.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.73 -35.85 72.89 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.302 1.041 . . . . 0.0 111.406 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.2 mt -60.27 -58.44 8.52 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -64.47 -29.18 70.23 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 122.345 1.069 . . . . 0.0 111.758 -178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -63.77 -27.41 69.17 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 120.164 -1.585 . . . . 0.0 114.842 -177.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.42 ' HB3' HD13 ' A' ' 154' ' ' LEU . 2.7 t80 -141.6 8.73 1.97 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.994 0.816 . . . . 0.0 111.862 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 55.43 74.1 0.39 Allowed 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.709 1.604 . . . . 0.0 109.634 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.42 HD13 ' HB3' ' A' ' 152' ' ' TYR . 5.1 mp -101.14 178.19 4.73 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.846 1.259 . . . . 0.0 109.536 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -109.07 130.91 55.49 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 159' ' ' THR . 0.7 OUTLIER -44.84 -53.77 7.13 Favored 'General case' 0 C--O 1.222 -0.352 0 O-C-N 124.579 1.175 . . . . 0.0 108.678 173.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -76.48 -20.88 56.53 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 125.741 1.616 . . . . 0.0 112.732 -159.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -90.53 4.13 52.03 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.679 0.792 . . . . 0.0 109.943 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 156' ' ' SER . 1.2 t -92.93 162.06 14.22 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.791 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -146.65 118.01 7.91 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.694 0.797 . . . . 0.0 109.133 177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -82.83 155.33 24.22 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 118.084 0.402 . . . . 0.0 110.33 167.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.6 mp -127.61 114.32 35.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.826 1.25 . . . . 0.0 107.94 172.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.74 158.64 31.61 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 123.469 0.48 . . . . 0.0 112.254 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.44 3.29 34.82 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -163.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -101.69 164.75 11.58 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 120.05 1.295 . . . . 0.0 111.581 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 6.5 t -72.57 -14.6 61.66 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.665 -0.647 . . . . 0.0 112.295 168.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.92 -16.24 48.2 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.811 0.732 . . . . 0.0 110.023 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -78.01 11.41 2.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 126.178 1.791 . . . . 0.0 112.235 -173.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.1 p -120.76 -19.82 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.483 1.513 . . . . 0.0 110.922 170.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -65.9 -38.87 89.87 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 120.729 -1.232 . . . . 0.0 110.221 -171.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -78.87 -28.9 44.19 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.301 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.84 -51.45 69.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 178.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -50.88 -42.15 58.81 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.048 1.339 . . . . 0.0 112.136 171.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.85 -50.29 63.0 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.649 -0.657 . . . . 0.0 111.241 -176.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 8.6 t -69.78 -17.85 63.44 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.709 0.803 . . . . 0.0 110.769 174.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.47 33.49 38.85 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 126.86 2.171 . . . . 0.0 112.525 -178.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.46 171.58 11.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.591 1.557 . . . . 0.0 111.908 -165.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -92.06 154.57 18.66 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.715 1.206 . . . . 0.0 111.964 -173.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 1.7 m -136.46 151.54 49.58 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.198 1.399 . . . . 0.0 110.275 177.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 46.3 mt -123.6 111.67 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 178.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -126.71 160.26 31.3 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 123.535 0.734 . . . . 0.0 109.027 -177.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -79.63 -16.91 54.94 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 120.503 -1.373 . . . . 0.0 111.723 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -116.24 160.93 19.75 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 128.192 2.597 . . . . 0.0 108.655 -176.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -61.22 156.48 18.4 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.8 m -149.34 22.12 0.94 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.444 1.098 . . . . 0.0 111.184 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 73.7 p 52.29 46.81 25.98 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.966 0.906 . . . . 0.0 111.625 158.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -145.66 176.96 9.24 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.423 1.489 . . . . 0.0 108.572 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -102.06 -20.64 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.269 1.028 . . . . 0.0 112.447 -177.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -106.57 0.0 37.05 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 125.211 1.386 . . . . 0.0 111.816 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.72 152.29 22.25 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 119.606 1.703 . . . . 0.0 109.411 173.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -127.69 148.15 50.4 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 124.511 1.124 . . . . 0.0 108.539 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 39.0 mtp180 -85.87 153.51 22.18 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 118.487 0.585 . . . . 0.0 112.253 166.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.1 pt -139.5 169.26 17.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 126.366 1.866 . . . . 0.0 110.244 168.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -123.3 -9.29 8.09 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.547 1.539 . . . . 0.0 112.827 170.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.51 167.85 29.19 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.259 1.424 . . . . 0.0 108.56 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.3 tp -69.52 -37.93 77.34 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.28 -15.09 59.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -69.64 -21.12 63.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.409 0.55 . . . . 0.0 109.786 177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 86.3 mt -58.53 -59.04 4.16 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 C-N-CA 125.411 1.485 . . . . 0.0 108.433 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 5.0 m -55.7 -39.94 71.72 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.709 0.686 . . . . 0.0 110.86 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -59.9 -33.3 71.67 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.269 -0.872 . . . . 0.0 111.888 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 63.6 mt -55.34 -47.55 77.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 119.664 1.12 . . . . 0.0 109.433 176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -79.65 -18.21 51.96 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -108.41 17.3 22.27 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.272 1.829 . . . . 0.0 111.923 -174.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 92.5 m 56.78 81.87 0.13 Allowed 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.072 2.149 . . . . 0.0 111.931 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.9 tmtt? . . . . . 0 C--O 1.245 0.859 0 CA-C-N 112.868 -1.969 . . . . 0.0 111.647 144.77 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.774 0 N-CA-C 111.149 -0.781 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -159.52 77.4 0.69 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.558 1.943 . . . . 0.0 107.212 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.9 mmm -126.12 84.18 2.24 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -62.98 -164.8 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.716 1.206 . . . . 0.0 109.864 167.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.65 69.91 0.07 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.887 1.675 . . . . 0.0 112.178 -176.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.4 m -81.17 153.37 27.26 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -137.41 147.99 45.84 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 175.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -125.11 152.94 43.73 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.2 mt -127.99 173.92 12.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 163.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 79.8 m95 -145.4 164.4 31.63 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.945 0.898 . . . . 0.0 109.142 167.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -93.01 -24.8 18.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.303 1.441 . . . . 0.0 113.647 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 24.7 tp 60.77 -23.86 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 129.205 3.002 . . . . 0.0 115.814 -174.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.74 -38.03 6.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 118.98 0.809 . . . . 0.0 111.244 -166.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.55 -89.83 1.06 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 164.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.249 1.063 0 C-N-CA 125.458 1.503 . . . . 0.0 111.345 -178.591 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.695 ' O ' HD13 ' A' ' 85' ' ' LEU . 1.9 tm? . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 113.842 1.053 . . . . 0.0 113.842 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 8.2 tpt 44.55 75.78 0.61 Allowed Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -165.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -56.53 109.24 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.9 3.066 . . . . 0.0 109.962 -170.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.25 -29.76 2.59 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 123.877 0.751 . . . . 0.0 111.602 -161.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.56 -37.67 35.89 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 121.341 -1.093 . . . . 0.0 110.017 -176.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.478 ' CG ' HD11 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -55.82 -23.19 28.92 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -174.03 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -68.43 -57.03 6.47 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.661 0.784 . . . . 0.0 110.575 170.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.6 t -53.88 -44.07 59.38 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.246 0 C-N-CA 123.604 0.761 . . . . 0.0 109.466 176.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.1 mt -56.0 -49.33 73.95 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.161 0.891 . . . . 0.0 110.532 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.59 -48.7 73.97 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.149 0.58 . . . . 0.0 110.95 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.5 t90 -53.31 -46.97 69.61 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.774 1.23 . . . . 0.0 111.149 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.81 -45.85 66.98 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.112 1.365 . . . . 0.0 111.323 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -59.97 -48.58 81.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.165 1.386 . . . . 0.0 110.464 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -57.1 -42.1 80.16 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.569 0.748 . . . . 0.0 110.242 173.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.6 m -69.76 -6.56 32.9 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.216 1.006 . . . . 0.0 113.67 176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 87.23 -5.57 84.87 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.575 1.56 . . . . 0.0 114.33 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mt -53.36 118.61 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 128.39 2.676 . . . . 0.0 110.268 177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -68.15 101.05 1.09 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.368 1.067 . . . . 0.0 108.252 170.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -84.9 148.81 26.06 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 170.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -141.18 179.19 6.9 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.618 1.567 . . . . 0.0 107.525 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.1 mt -131.73 143.74 39.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 167.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -128.52 109.21 11.18 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 166.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.0 t -141.68 150.91 42.49 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -171.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 51.2 p-80 -77.56 -1.95 33.22 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.504 -0.747 . . . . 0.0 112.343 176.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -63.31 164.22 9.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.043 0.937 . . . . 0.0 110.233 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.47 -176.25 49.61 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -55.58 -25.59 39.07 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.603 0.761 . . . . 0.0 111.74 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.61 -16.81 11.46 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 120.752 -1.218 . . . . 0.0 112.576 176.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.68 -36.59 74.43 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 119.724 1.147 . . . . 0.0 112.153 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -60.79 -53.88 51.98 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -59.05 -41.49 88.02 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.519 1.528 . . . . 0.0 111.173 -176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.94 -50.72 76.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 C-N-CA 123.748 0.819 . . . . 0.0 109.421 175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.7 mp -58.83 -47.87 83.31 Favored 'General case' 0 C--O 1.228 -0.074 0 O-C-N 121.487 -0.758 . . . . 0.0 110.757 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -56.81 -46.48 81.59 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 123.723 0.809 . . . . 0.0 110.145 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -54.93 -52.22 63.63 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.184 1.394 . . . . 0.0 109.939 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 97.6 mt -70.42 -7.01 39.87 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.029 1.332 . . . . 0.0 113.592 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.48 28.71 63.03 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 124.385 0.993 . . . . 0.0 112.469 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 33.7 m -128.79 28.74 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 124.82 1.248 . . . . 0.0 111.175 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.49 -57.61 12.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.533 1.133 . . . . 0.0 112.004 172.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 73.7 m -73.22 -22.41 60.45 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.19 0.596 . . . . 0.0 111.615 -165.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.29 -29.57 58.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 118.86 -0.59 . . . . 0.0 112.564 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -109.17 110.93 22.28 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.933 -2.247 . . . . 0.0 104.933 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 66.5 m -46.77 -47.74 20.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.147 1.379 . . . . 0.0 109.123 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.47 159.25 42.59 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 175.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.74 134.92 65.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 171.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 28.6 mt -99.01 151.08 21.33 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 166.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 42.4 p -145.55 174.3 11.28 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.561 1.544 . . . . 0.0 107.636 -170.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 27.2 t -57.51 -13.45 3.72 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 121.215 -0.928 . . . . 0.0 113.272 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -59.31 -48.33 82.03 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.387 1.475 . . . . 0.0 109.197 169.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 95.8 p -54.54 -36.97 64.86 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.204 1.802 . . . . 0.0 113.037 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.03 -4.87 78.96 Favored Glycine 0 C--N 1.336 0.538 0 CA-C-O 118.394 -1.226 . . . . 0.0 114.8 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -50.74 158.71 0.62 Allowed 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.627 1.213 . . . . 0.0 112.438 178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.402 HG23 ' HA ' ' A' ' 141' ' ' SER . 18.6 m -52.93 154.8 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 122.903 1.335 . . . . 0.0 112.296 -178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -85.55 160.38 19.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.241 176.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 136.93 87.25 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-O 117.621 -1.181 . . . . 0.0 108.865 -176.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.25 122.35 7.89 Favored 'Cis proline' 0 N--CA 1.454 -0.805 0 CA-C-N 120.755 1.305 . . . . 0.0 110.732 -0.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.402 ' HA ' HG23 ' A' ' 137' ' ' VAL . 12.0 p -123.32 85.6 51.96 Favored Pre-proline 0 N--CA 1.446 -0.666 0 C-N-CA 125.252 1.421 . . . . 0.0 111.283 -163.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.14 -27.51 8.17 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.709 2.273 . . . . 0.0 113.441 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -53.8 -54.68 34.98 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.364 -0.835 . . . . 0.0 112.191 -166.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.0 -7.75 43.42 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.231 -0.918 . . . . 0.0 113.038 -174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -81.97 -48.4 11.5 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 m -55.62 -41.49 73.57 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.533 1.133 . . . . 0.0 109.946 171.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -58.45 -58.54 8.06 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.873 0.869 . . . . 0.0 109.996 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -67.12 -19.74 65.66 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.124 0.97 . . . . 0.0 112.855 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.34 -63.14 1.14 Allowed 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 173.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.07 -22.92 65.83 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -60.31 -26.46 66.56 Favored 'General case' 0 C--O 1.233 0.227 0 O-C-N 120.898 -1.126 . . . . 0.0 113.34 178.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.417 ' HB3' HD13 ' A' ' 154' ' ' LEU . 13.0 t80 -148.69 23.07 1.0 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.451 1.023 . . . . 0.0 112.232 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.1 mm-40 50.14 67.2 0.95 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.584 1.553 . . . . 0.0 111.576 -174.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 152' ' ' TYR . 4.5 mp -100.23 170.7 8.27 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 122.791 1.282 . . . . 0.0 111.024 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.81 123.14 42.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.01 -1.45 . . . . 0.0 108.861 -175.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 m -59.92 -39.31 85.01 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 125.17 1.388 . . . . 0.0 110.816 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -83.25 -13.2 55.79 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.167 -0.958 . . . . 0.0 112.997 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -109.86 13.41 23.56 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -92.25 149.42 21.47 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -141.43 113.84 8.19 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -73.15 -40.87 64.51 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.0 mp 56.17 99.62 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 126.461 1.904 . . . . 0.0 111.73 -169.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -122.96 -171.86 13.78 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 170.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -145.87 148.09 32.49 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 169.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . 0.321 0.0 OUTLIER 58.23 171.12 0.05 Allowed 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 126.595 1.958 . . . . 0.0 114.461 -165.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.49 169.91 1.57 Allowed 'General case' 0 N--CA 1.42 -1.968 0 C-N-CA 127.382 2.273 . . . . 0.0 110.119 -178.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 tm? 68.4 -27.1 0.14 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 130.409 3.484 . . . . 0.0 113.339 -164.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -73.63 8.11 2.06 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 120.726 1.603 . . . . 0.0 114.413 -175.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 59.5 t -124.54 -13.03 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.0 -1.062 . . . . 0.0 110.823 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -66.52 -40.75 89.31 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 120.711 -1.243 . . . . 0.0 111.026 -173.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -69.22 -32.74 72.19 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.287 -0.883 . . . . 0.0 111.516 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.28 -45.94 89.09 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.458 0.572 . . . . 0.0 109.52 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -49.89 -53.05 28.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.69 0.796 . . . . 0.0 110.622 168.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -58.25 -47.65 82.9 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.9 m -69.58 -20.79 63.65 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 119.573 1.079 . . . . 0.0 112.265 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.02 58.59 10.36 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -167.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.8 pt -130.36 169.91 20.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.27 1.428 . . . . 0.0 109.065 173.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 62.1 mm-40 -96.27 167.74 11.0 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.838 0.855 . . . . 0.0 110.938 -172.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 11.8 m -147.6 158.72 44.13 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 125.568 1.547 . . . . 0.0 111.033 -168.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 20.8 mt -131.74 124.93 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 168.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -144.6 155.73 43.78 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -69.36 -26.46 64.68 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.169 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.86 156.96 32.18 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.255 0.934 . . . . 0.0 111.851 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -62.43 165.25 6.32 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.421 1.105 . . . . 0.0 109.971 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 29.7 t -145.19 172.89 12.47 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 161.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 21.8 p -69.93 24.63 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.202 2.201 . . . . 0.0 113.365 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -133.96 108.02 8.15 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 125.26 1.424 . . . . 0.0 108.071 176.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -69.58 -16.67 63.45 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.755 1.222 . . . . 0.0 113.781 -166.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -51.52 -53.31 29.27 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 168.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -53.19 114.56 1.51 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 126.996 2.119 . . . . 0.0 113.778 -166.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -79.32 118.22 21.03 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.802 0.841 . . . . 0.0 111.052 -176.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -67.14 142.56 57.02 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.05 0.386 . . . . 0.0 111.514 169.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.6 pt -141.93 168.65 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 126.632 1.973 . . . . 0.0 111.511 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -128.1 -6.09 5.5 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.476 1.51 . . . . 0.0 111.941 174.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -153.13 157.59 40.59 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.777 1.231 . . . . 0.0 108.306 176.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.73 -34.15 73.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -55.32 -34.95 64.62 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.355 0.662 . . . . 0.0 112.385 178.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -64.9 -17.67 64.53 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.327 0.651 . . . . 0.0 111.397 -174.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.2 mt -50.44 -61.6 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.362 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 167.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 87.8 p -55.38 -34.71 64.57 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.76 0.791 . . . . 0.0 110.698 -174.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 43.0 mtp85 -74.45 -25.62 59.54 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.241 1.416 . . . . 0.0 112.722 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 61.5 mt -53.54 -60.14 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 170.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -70.63 8.93 0.73 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.656 1.982 . . . . 0.0 113.792 -176.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -121.19 -2.48 9.6 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.373 1.469 . . . . 0.0 112.32 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.09 61.66 1.02 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.331 0.652 . . . . 0.0 109.601 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.282 17.2 ptpt . . . . . 0 C--O 1.246 0.903 0 C-N-CA 129.497 3.119 . . . . 0.0 112.496 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.555 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -132.72 99.42 4.61 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.768 1.227 . . . . 0.0 108.004 173.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mmm -132.61 95.26 3.57 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -60.01 176.76 0.29 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.529 -1.214 . . . . 0.0 110.129 161.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -53.17 82.74 0.0 OUTLIER 'General case' 0 C--O 1.233 0.204 0 C-N-CA 127.09 2.156 . . . . 0.0 111.455 172.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.4 m -100.17 153.8 18.96 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -132.68 150.69 52.12 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.139 -0.976 . . . . 0.0 109.314 171.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -129.97 149.68 51.59 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 126.597 1.959 . . . . 0.0 107.881 -169.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.6 mt -141.92 132.31 25.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -117.07 167.85 10.79 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.557 1.543 . . . . 0.0 110.285 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -121.5 -12.8 8.5 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -167.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.02 -5.82 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.902 2.481 . . . . 0.0 116.818 174.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -129.36 32.22 4.71 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.811 1.645 . . . . 0.0 109.945 -167.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.6 -75.76 0.04 OUTLIER Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 C--O 1.246 0.904 0 C-N-CA 124.896 1.278 . . . . 0.0 110.778 168.83 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.562 HD13 ' H ' ' A' ' 86' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.562 ' H ' HD13 ' A' ' 85' ' ' LEU . 33.0 ttm -122.3 85.92 47.56 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 126.621 1.968 . . . . 0.0 107.686 -170.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.16 94.19 0.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.589 2.86 . . . . 0.0 110.198 -172.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 145.73 -9.22 1.6 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-O 117.273 -1.849 . . . . 0.0 113.009 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.34 -40.45 4.66 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 127.539 2.336 . . . . 0.0 114.573 -168.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.664 ' HA ' HD12 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -55.88 -28.3 55.94 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.229 1.012 . . . . 0.0 113.295 -176.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -54.32 -64.83 0.7 Allowed 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 125.269 1.428 . . . . 0.0 110.289 173.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.2 t -59.28 -44.1 91.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.506 177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 90' ' ' ARG . 77.1 mt -52.04 -45.76 64.8 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 119.025 0.83 . . . . 0.0 110.307 -176.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.21 -48.21 58.08 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.094 0.558 . . . . 0.0 111.62 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.3 t90 -54.39 -37.77 65.4 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.7 0.8 . . . . 0.0 110.654 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -78.63 -42.77 27.92 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 125.456 1.502 . . . . 0.0 112.379 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -58.17 -51.06 71.32 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.461 1.104 . . . . 0.0 110.372 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -61.82 -23.9 66.54 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.158 1.383 . . . . 0.0 112.587 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 m -92.41 -0.41 57.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.06 0.944 . . . . 0.0 113.223 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.96 25.96 71.07 Favored Glycine 0 CA--C 1.527 0.837 0 O-C-N 121.356 -0.84 . . . . 0.0 112.942 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.9 mt -67.92 125.67 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 164.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.2 mm100 -72.33 97.5 2.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 170.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -79.75 151.85 30.16 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.416 ' CG ' HD13 ' A' ' 148' ' ' LEU . 86.9 m-85 -145.01 169.56 17.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 175.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 5.8 mt -130.99 157.42 43.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 169.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -147.34 134.74 20.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.946 1.298 . . . . 0.0 107.993 159.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.3 t -163.44 -179.02 6.23 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.8 p80 -108.28 -7.5 15.93 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.6 -0.87 0.08 Allowed 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 117.654 2.465 . . . . 0.0 117.654 -172.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.68 -175.69 54.21 Favored Glycine 0 CA--C 1.525 0.695 0 O-C-N 121.005 -1.06 . . . . 0.0 111.533 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.446 HD22 ' CD ' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -64.91 -12.24 47.03 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 -168.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -66.75 -12.96 60.74 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.343 -1.473 . . . . 0.0 111.688 174.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -56.16 -55.92 27.17 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.481 1.037 . . . . 0.0 111.44 176.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -54.85 -45.85 74.57 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.996 0.918 . . . . 0.0 109.77 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 56.7 m -59.39 -42.43 91.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.925 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.2 mt -64.88 -49.46 79.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 119.199 0.909 . . . . 0.0 109.344 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 mp -60.11 -42.88 95.65 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.894 -0.504 . . . . 0.0 111.754 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.6 mttm -57.23 -53.42 58.31 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.486 1.115 . . . . 0.0 109.27 173.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.1 -54.23 21.93 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.9 1.68 . . . . 0.0 109.264 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.5 mt -73.47 -39.08 65.19 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.777 0.831 . . . . 0.0 111.267 -170.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 126.25 27.89 1.06 Allowed Glycine 0 CA--C 1.535 1.338 0 CA-C-O 121.637 0.576 . . . . 0.0 112.015 163.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.648 HG23 ' CD2' ' A' ' 125' ' ' TYR 0.303 2.0 p -133.41 12.66 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 127.191 2.196 . . . . 0.0 110.106 -160.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -67.35 -34.34 77.1 Favored 'General case' 0 C--O 1.217 -0.615 0 O-C-N 121.393 -0.817 . . . . 0.0 110.334 177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.4 m -77.83 -22.71 49.55 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 120.037 1.289 . . . . 0.0 113.087 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.648 ' CD2' HG23 ' A' ' 122' ' ' VAL . 19.1 m-85 -60.77 -18.57 55.79 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -116.11 126.68 54.06 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.0 m -62.32 -30.97 71.54 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.821 0.849 . . . . 0.0 111.652 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.476 ' OE1' ' HE2' ' A' ' 151' ' ' LYS . 7.5 tt0 -154.13 159.93 41.69 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 169.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.4 mp -131.88 111.57 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 mt -80.72 159.34 25.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.844 0.831 . . . . 0.0 109.383 172.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.9 p -142.17 177.47 8.21 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.337 1.855 . . . . 0.0 108.12 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.3 t -61.55 -6.58 2.52 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.4 -0.813 . . . . 0.0 112.868 169.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.446 ' CD ' HD22 ' A' ' 111' ' ' ASN . 22.1 mm-40 -57.8 -28.22 63.83 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.669 -1.269 . . . . 0.0 110.703 166.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 58.0 p -58.0 -54.29 48.64 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.434 0.694 . . . . 0.0 112.394 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.33 -2.88 71.67 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 117.295 -1.836 . . . . 0.0 115.45 -173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -53.92 164.51 0.58 Allowed 'General case' 0 C--O 1.242 0.694 0 CA-C-N 120.03 1.915 . . . . 0.0 112.235 -176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 28.9 m -63.1 176.76 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.407 1.099 . . . . 0.0 113.288 -172.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -65.06 147.08 54.12 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 121.245 -0.909 . . . . 0.0 110.058 174.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -52.1 127.44 37.36 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.984 1.714 . . . . 0.0 107.612 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -73.01 -40.03 1.31 Allowed 'Cis proline' 0 C--N 1.348 0.531 0 CA-C-N 121.548 1.588 . . . . 0.0 115.25 22.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . 0.267 43.2 p 51.25 72.25 1.28 Allowed Pre-proline 0 N--CA 1.441 -0.897 0 C-N-CA 125.194 1.397 . . . . 0.0 113.077 -172.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -62.14 -18.44 62.02 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.616 2.877 . . . . 0.0 111.907 -178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -47.71 -43.51 26.9 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 125.863 1.665 . . . . 0.0 111.273 176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.46 -21.66 65.62 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -73.23 -58.45 3.31 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 118.188 -0.911 . . . . 0.0 109.392 170.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.6 m -56.2 -36.16 68.11 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 118.552 0.615 . . . . 0.0 110.292 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -50.89 -63.0 1.27 Allowed 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 124.649 1.18 . . . . 0.0 110.339 170.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.416 HD13 ' CG ' ' A' ' 104' ' ' PHE . 71.2 mt -69.18 -24.46 64.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -174.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.26 -67.43 0.44 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -57.46 -41.29 80.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 122.873 0.469 . . . . 0.0 110.514 -175.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.476 ' HE2' ' OE1' ' A' ' 128' ' ' GLU . 7.0 tmtm? -47.93 -37.32 14.08 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.581 1.552 . . . . 0.0 114.148 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.54 24.81 5.43 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.221 0.919 . . . . 0.0 112.743 173.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 47.71 58.11 5.31 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.46 1.904 . . . . 0.0 112.946 -175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.6 mp -94.68 172.82 7.94 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.75 1.22 . . . . 0.0 111.725 -178.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -102.11 136.08 42.58 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 124.691 1.196 . . . . 0.0 108.846 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.2 m -62.13 -50.23 72.73 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.93 1.292 . . . . 0.0 108.91 173.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.55 1.04 53.07 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.99 -1.069 . . . . 0.0 112.645 -167.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -120.39 12.73 11.72 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.94 1.296 . . . . 0.0 108.999 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 t -107.35 146.63 31.36 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.156 0.889 . . . . 0.0 109.685 168.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.419 ' CD2' ' HB2' ' A' ' 178' ' ' GLN . 88.9 m-85 -137.22 116.99 13.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.916 1.686 . . . . 0.0 107.633 -167.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -84.84 153.55 22.87 Favored 'General case' 0 N--CA 1.462 0.135 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 170.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 10.7 mt -128.66 102.4 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.45 124.43 3.33 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -80.65 37.1 0.4 Allowed 'General case' 0 C--O 1.238 0.49 0 C-N-CA 126.253 1.821 . . . . 0.0 112.139 178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.48 158.41 44.31 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.398 1.479 . . . . 0.0 108.304 -176.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.5 t -64.32 -15.27 59.98 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 170.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.89 -12.87 60.8 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.597 1.159 . . . . 0.0 112.539 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -48.01 80.11 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 119.084 0.856 . . . . 0.0 112.202 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.2 p -68.4 -31.59 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.82 -37.48 87.54 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.131 0.572 . . . . 0.0 109.857 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -70.74 -53.4 15.67 Favored 'General case' 0 C--O 1.234 0.255 0 O-C-N 121.084 -1.01 . . . . 0.0 109.905 172.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -56.75 -48.11 78.54 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.319 0.648 . . . . 0.0 111.68 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -56.47 -53.49 56.82 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.362 1.865 . . . . 0.0 111.46 177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -73.78 -23.52 59.71 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 119.383 -0.341 . . . . 0.0 111.778 -172.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.0 p -86.06 -21.28 27.79 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 170.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 76.06 46.94 12.07 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.885 1.231 . . . . 0.0 111.243 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 15.4 pt -131.0 -177.4 2.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 C-N-CA 125.985 1.714 . . . . 0.0 109.096 -177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.419 ' HB2' ' CD2' ' A' ' 160' ' ' TYR . 18.6 mm-40 -92.53 162.21 14.3 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.774 0.83 . . . . 0.0 110.489 -175.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.06 139.47 43.06 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.51 1.524 . . . . 0.0 111.172 -171.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.6 mt -140.88 75.13 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 123.07 1.414 . . . . 0.0 109.347 -176.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -93.79 -171.71 2.67 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 125.801 1.64 . . . . 0.0 111.362 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -106.57 -8.84 16.82 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.485 ' H ' HD12 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -118.66 154.86 32.02 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 120.728 -1.232 . . . . 0.0 110.275 177.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -65.62 140.07 58.48 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 120.832 -1.167 . . . . 0.0 109.277 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.406 ' H ' ' ND2' ' A' ' 190' ' ' ASN . 19.5 m -127.52 147.35 50.32 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.881 1.324 . . . . 0.0 112.233 168.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.23 47.94 1.58 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.803 2.841 . . . . 0.0 110.513 -167.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -138.22 159.72 41.32 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.101 1.361 . . . . 0.0 109.663 -170.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -99.06 98.45 9.47 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 -175.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 115.89 16.64 6.74 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 124.667 1.127 . . . . 0.0 112.419 -171.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.406 ' ND2' ' H ' ' A' ' 185' ' ' SER . 12.0 t30 -89.3 138.32 31.54 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.847 0.823 . . . . 0.0 109.411 166.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -135.04 90.38 2.63 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.202 1.001 . . . . 0.0 110.564 -178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . 0.262 0.2 OUTLIER -80.54 152.52 28.61 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.059 -172.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.1 pt -127.01 170.36 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.924 1.689 . . . . 0.0 111.93 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -102.84 -27.15 12.83 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.716 0.807 . . . . 0.0 112.177 161.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.56 155.84 42.79 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 124.045 0.938 . . . . 0.0 108.951 -166.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 196' ' ' LEU . 3.3 tp -64.63 -35.51 81.23 Favored 'General case' 0 C--O 1.222 -0.354 0 C-N-CA 124.273 1.029 . . . . 0.0 109.035 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -60.18 -30.46 69.36 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -60.91 -20.61 62.33 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.408 1.004 . . . . 0.0 111.306 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 95.1 mt -53.98 -53.68 25.97 Favored 'Isoleucine or valine' 0 C--N 1.344 0.336 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 88.1 p -59.68 -39.1 83.38 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 -177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -59.03 -40.88 86.41 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.342 1.057 . . . . 0.0 109.593 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.4 mt -51.81 -49.84 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.761 1.224 . . . . 0.0 110.851 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -79.76 -5.61 55.63 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.941 0.896 . . . . 0.0 112.514 -176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -111.65 10.97 21.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.101 2.16 . . . . 0.0 110.104 -174.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.0 t -149.76 22.68 0.89 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -171.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.919 176.099 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.538 0 N-CA-C 112.042 -0.423 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -67.38 96.52 0.51 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 117.859 0.829 . . . . 0.0 109.555 -177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mmm -138.05 80.9 1.83 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 126.918 2.087 . . . . 0.0 106.369 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.9 175.98 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.958 2.103 . . . . 0.0 110.649 166.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.1 102.67 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.976 1.71 . . . . 0.0 110.234 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.6 m -133.55 142.41 48.16 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.54 142.25 51.43 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.253 1.021 . . . . 0.0 108.294 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -118.69 153.33 34.53 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 31.2 mt -141.92 128.01 18.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -115.61 155.97 26.68 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.323 0.649 . . . . 0.0 110.49 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -78.37 -11.13 59.92 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.367 1.067 . . . . 0.0 112.301 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt 65.77 -48.94 0.4 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 129.448 3.099 . . . . 0.0 111.466 -164.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -139.17 81.71 1.85 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -159.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.39 73.94 0.07 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -171.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.242 0.674 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 167.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.463 ' C ' HD13 ' A' ' 85' ' ' LEU 0.727 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.309 0 N-CA-C 116.889 2.181 . . . . 0.0 116.889 . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 7.1 tpt 47.0 77.67 0.45 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 127.062 2.145 . . . . 0.0 111.42 -175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -60.77 115.13 2.48 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.765 2.976 . . . . 0.0 109.187 -173.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 146.45 -44.99 0.81 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -161.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.14 -19.19 61.18 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -169.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -59.06 -35.13 72.82 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 119.751 1.16 . . . . 0.0 113.597 -159.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -59.93 -58.33 9.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 124.096 0.873 . . . . 0.0 110.27 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.6 t -52.62 -41.43 37.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 124.085 0.954 . . . . 0.0 110.713 175.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 85.6 mt -57.61 -48.18 80.11 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.104 0.866 . . . . 0.0 110.13 177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.51 -46.35 83.33 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 123.607 0.763 . . . . 0.0 111.901 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -57.4 -48.24 79.61 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.57 98.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.63 0.772 . . . . 0.0 111.309 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -54.84 -61.07 2.55 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.68 1.592 . . . . 0.0 110.35 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -60.97 -20.33 62.23 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.596 0.962 . . . . 0.0 113.596 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 68.3 m -86.75 -4.08 59.13 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.79 1.236 . . . . 0.0 112.815 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.17 22.61 70.94 Favored Glycine 0 CA--C 1.528 0.872 0 O-C-N 120.868 -1.145 . . . . 0.0 112.688 175.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.8 mt -55.54 165.44 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 126.674 1.99 . . . . 0.0 107.433 158.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -118.04 112.72 20.61 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 161.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -80.81 143.34 32.9 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 169.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -132.34 168.5 18.01 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.539 1.536 . . . . 0.0 108.643 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 60.5 mt -140.0 158.86 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.361 1.464 . . . . 0.0 108.309 172.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -139.88 125.17 18.9 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 123.882 0.873 . . . . 0.0 108.758 162.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -137.41 164.19 29.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.481 1.112 . . . . 0.0 109.822 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -104.39 -0.03 28.53 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.674 1.19 . . . . 0.0 111.634 172.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 11.3 ptmt -69.04 -0.19 5.42 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -173.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.27 -176.61 30.48 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.808 1.194 . . . . 0.0 110.615 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.06 -27.06 61.36 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.653 0.781 . . . . 0.0 111.016 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -60.65 -14.98 23.88 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 -177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.1 -49.64 40.92 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 118.823 0.738 . . . . 0.0 110.605 168.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -57.43 -44.74 84.94 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.697 0.68 . . . . 0.0 111.197 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -57.27 -43.96 83.55 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.731 0.812 . . . . 0.0 110.594 -178.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 77.6 mt -59.83 -53.44 48.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 C-N-CA 124.977 1.311 . . . . 0.0 109.26 -177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.05 -36.88 84.43 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.005 0.82 . . . . 0.0 110.516 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.4 mtmt -61.0 -51.44 69.25 Favored 'General case' 0 C--N 1.337 0.052 0 CA-C-N 118.671 0.669 . . . . 0.0 110.476 175.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -53.46 -51.72 61.79 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 125.225 1.41 . . . . 0.0 110.168 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.12 -21.01 63.14 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.594 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.95 47.16 5.13 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.913 1.244 . . . . 0.0 111.504 174.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.0 m -147.51 23.22 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.956 1.702 . . . . 0.0 110.991 -174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.01 -35.27 59.61 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.99 -1.069 . . . . 0.0 110.792 -175.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.9 m -63.64 -27.69 69.4 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 123.191 0.596 . . . . 0.0 110.79 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.82 7.95 1.01 Allowed 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 175.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -137.78 112.03 8.57 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.0 m -49.44 -39.59 33.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.422 1.089 . . . . 0.0 109.684 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -156.44 156.36 33.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 118.964 0.802 . . . . 0.0 110.017 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 44.1 mt -139.06 93.41 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 -174.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.438 HD22 ' OG ' ' A' ' 134' ' ' SER . 45.2 mt -65.98 146.88 54.17 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 70.0 p -127.45 -177.81 4.22 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.287 1.035 . . . . 0.0 110.246 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 t -60.28 -18.04 46.46 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.519 -0.738 . . . . 0.0 112.215 168.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 55.3 mm-40 -61.29 -37.13 82.1 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 118.971 0.805 . . . . 0.0 108.934 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.438 ' OG ' HD22 ' A' ' 130' ' ' LEU . 12.7 t -56.92 -35.51 69.12 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.099 0.96 . . . . 0.0 111.704 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 83.83 -8.48 65.96 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-O 117.068 -1.962 . . . . 0.0 113.872 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -57.4 164.52 1.84 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-N 120.047 1.923 . . . . 0.0 111.102 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.4 t -61.4 162.32 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.351 0 CA-C-N 112.528 -2.124 . . . . 0.0 110.149 166.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -90.69 172.45 8.65 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.51 1.524 . . . . 0.0 109.557 170.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -68.18 150.63 97.66 Favored Pre-proline 0 C--O 1.237 0.441 0 O-C-N 120.774 -1.203 . . . . 0.0 108.942 178.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.29 -18.12 16.88 Favored 'Cis proline' 0 C--N 1.347 0.492 0 N-CA-C 115.759 1.407 . . . . 0.0 115.759 16.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -44.67 91.16 0.04 OUTLIER Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 131.371 3.868 . . . . 0.0 114.604 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -54.13 -7.11 0.61 Allowed 'Trans proline' 0 CA--C 1.544 0.975 1 C-N-CA 126.206 4.604 . . . . 0.0 114.558 -172.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -43.83 -52.05 7.0 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 128.819 2.848 . . . . 0.0 113.213 -165.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.96 -3.01 11.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.278 1.031 . . . . 0.0 113.675 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.06 -40.03 7.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.374 1.469 . . . . 0.0 109.869 170.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.7 m -51.69 -39.67 58.72 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.337 0.971 . . . . 0.0 109.489 170.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -55.96 -53.02 61.94 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.928 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.7 mt -68.51 -21.2 64.59 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.344 1.457 . . . . 0.0 113.007 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.407 HD11 ' HA ' ' A' ' 156' ' ' SER . 0.0 OUTLIER -67.08 -69.73 0.29 Allowed 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 175.163 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -54.84 -39.77 68.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -23.38 43.42 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.664 -1.272 . . . . 0.0 113.898 -176.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . 0.475 ' HB3' HD13 ' A' ' 154' ' ' LEU . 6.3 t80 -138.4 17.04 2.75 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 172.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 49.26 38.73 14.19 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.625 1.97 . . . . 0.0 112.185 -170.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.475 HD13 ' HB3' ' A' ' 152' ' ' TYR . 0.2 OUTLIER -68.71 165.4 19.57 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 123.956 0.902 . . . . 0.0 109.754 176.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.605 ' ND2' HD21 ' A' ' 158' ' ' ASN . 6.6 m-20 -101.17 -5.89 25.0 Favored 'General case' 0 CA--C 1.479 -1.755 0 N-CA-C 119.26 3.059 . . . . 0.0 119.26 -160.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.407 ' HA ' HD11 ' A' ' 149' ' ' LEU . 1.4 m 76.43 -36.14 0.26 Allowed 'General case' 0 N--CA 1.398 -3.065 0 CA-C-N 108.813 -3.812 . . . . 0.0 112.179 -166.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -25.04 56.67 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 120.943 -1.098 . . . . 0.0 112.8 -171.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.605 HD21 ' ND2' ' A' ' 155' ' ' ASN . 0.0 OUTLIER -85.77 -3.16 58.83 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 116.362 -1.78 . . . . 0.0 110.694 -178.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -102.27 123.61 46.39 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 120.401 1.455 . . . . 0.0 108.712 -170.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -120.81 101.01 7.43 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 127.045 2.138 . . . . 0.0 108.903 -170.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -74.68 150.6 39.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 170.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 2.9 mp -128.44 129.13 68.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -149.69 172.28 29.66 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 123.431 0.539 . . . . 0.0 111.883 176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.42 3.02 4.22 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.525 1.53 . . . . 0.0 113.564 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -144.09 133.7 23.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 3.2 t -47.56 166.71 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 126.986 2.114 . . . . 0.0 110.858 -175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.5 tp 67.74 -5.03 0.86 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 131.404 3.882 . . . . 0.0 112.979 -152.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -58.1 -41.16 82.9 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 119.355 0.979 . . . . 0.0 110.826 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.448 HG11 ' HB2' ' A' ' 185' ' ' SER . 13.2 p -104.13 -18.21 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 C-N-CA 126.261 1.824 . . . . 0.0 110.849 -171.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -68.0 -22.72 64.98 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.46 -0.775 . . . . 0.0 111.851 -173.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.427 ' CE1' HD11 ' A' ' 177' ' ' ILE . 7.2 p90 -88.08 -23.27 23.76 Favored 'General case' 0 C--O 1.233 0.216 0 O-C-N 121.292 -0.88 . . . . 0.0 112.331 173.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.14 90.09 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.422 -0.799 . . . . 0.0 109.967 173.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -64.22 -40.68 96.55 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 118.446 0.566 . . . . 0.0 111.061 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -58.49 -55.52 34.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.198 0.454 . . . . 0.0 110.356 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 t -75.15 -24.75 57.99 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 119.097 -0.477 . . . . 0.0 111.555 -172.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 67.3 61.33 5.2 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -166.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.427 HD11 ' CE1' ' A' ' 171' ' ' PHE . 50.5 pt -128.88 177.55 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.976 1.711 . . . . 0.0 108.002 172.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -94.99 179.07 5.35 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.184 0.594 . . . . 0.0 109.748 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -159.51 160.75 34.96 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 120.633 -1.292 . . . . 0.0 109.436 -179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 21.0 mt -142.56 101.91 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 125.282 1.433 . . . . 0.0 107.158 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -128.24 165.37 20.63 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 123.134 1.445 . . . . 0.0 111.705 172.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -78.78 -29.84 45.21 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 113.765 -1.562 . . . . 0.0 111.297 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.79 13.99 27.26 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 -157.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . 0.287 12.3 pt-20 50.93 -170.85 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.858 1 C-N-CA 134.999 5.32 . . . . 0.0 114.09 -170.187 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.448 ' HB2' HG11 ' A' ' 169' ' ' VAL . 48.3 t -164.12 167.99 19.56 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.097 2.159 . . . . 0.0 107.121 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 16.6 p -100.33 66.14 1.26 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.819 1.248 . . . . 0.0 108.185 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -143.46 177.28 8.56 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.792 1.637 . . . . 0.0 108.989 175.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -106.26 -30.87 8.92 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.597 1.159 . . . . 0.0 112.893 -176.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -90.09 5.84 82.91 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.235 0.921 . . . . 0.0 111.568 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -72.86 155.19 40.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 118.749 1.274 . . . . 0.0 108.712 168.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -134.75 109.02 8.3 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 171.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.31 143.01 58.21 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 122.955 0.502 . . . . 0.0 111.211 177.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 12.2 pt -146.39 173.37 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.684 1.594 . . . . 0.0 112.746 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -127.89 -17.85 4.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.793 1.637 . . . . 0.0 113.417 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.24 165.84 28.02 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.0 1.32 . . . . 0.0 109.802 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 58.0 mt -65.01 -37.56 88.06 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 171.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.83 -15.58 54.8 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 175.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -75.11 -17.85 60.36 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.168 -0.958 . . . . 0.0 110.796 174.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.408 ' HA ' HD12 ' A' ' 202' ' ' ILE . 70.5 mt -58.25 -53.49 45.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 174.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 77.4 p -58.76 -34.3 71.26 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.928 0.786 . . . . 0.0 111.092 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -62.43 -35.05 78.05 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 116.728 -1.606 . . . . 0.0 111.603 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.408 HD12 ' HA ' ' A' ' 199' ' ' ILE . 77.4 mt -50.75 -52.59 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.726 1.148 . . . . 0.0 108.804 178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -81.34 -5.22 57.6 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.935 -0.555 . . . . 0.0 112.422 -172.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -109.78 2.44 20.01 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.77 1.628 . . . . 0.0 112.27 -171.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.7 t -129.87 24.09 5.34 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.712 0.767 . . . . 0.0 111.255 -168.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? . . . . . 0 C--O 1.247 0.97 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 -176.821 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.69 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -153.01 61.43 0.78 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.427 1.091 . . . . 0.0 108.4 172.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mmm -112.58 78.56 1.14 Allowed 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 124.049 1.88 . . . . 0.0 108.486 -162.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.97 177.86 0.11 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 111.608 -2.542 . . . . 0.0 111.389 167.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 mtpp -54.78 69.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 129.148 2.979 . . . . 0.0 114.556 -175.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 48.6 m -96.28 141.92 29.04 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.06 147.33 50.16 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.438 ' CD2' HD11 ' A' ' 162' ' ' ILE . 0.8 OUTLIER -130.7 144.43 51.43 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 124.562 1.145 . . . . 0.0 108.108 -170.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.8 mt -133.57 120.44 37.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -105.71 -177.51 3.38 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.674 1.59 . . . . 0.0 108.202 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -128.2 174.22 9.45 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.301 1.04 . . . . 0.0 109.603 170.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.36 117.34 29.69 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.219 -1.771 . . . . 0.0 106.219 -175.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 61.08 60.9 1.7 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 122.611 1.196 . . . . 0.0 110.099 -175.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -137.88 -106.73 0.76 Allowed Glycine 0 C--O 1.239 0.421 0 N-CA-C 105.106 -3.197 . . . . 0.0 105.106 164.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 C--O 1.25 1.093 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 169.806 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.748 HD22 ' CD ' ' A' ' 87' ' ' PRO 0.542 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.7 ttp -158.43 84.4 2.57 Favored Pre-proline 0 C--O 1.223 -0.307 0 C-N-CA 125.006 1.322 . . . . 0.0 110.067 147.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.748 ' CD ' HD22 ' A' ' 85' ' ' LEU . 62.9 Cg_endo -94.67 91.71 0.12 Allowed 'Trans proline' 0 N--CA 1.439 -1.734 0 C-N-CA 123.534 2.822 . . . . 0.0 110.948 173.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.679 ' C ' HD11 ' A' ' 196' ' ' LEU . . . 44.59 30.02 2.04 Favored Glycine 0 CA--C 1.504 -0.643 0 C-N-CA 126.367 1.937 . . . . 0.0 112.461 172.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.505 ' N ' HD11 ' A' ' 196' ' ' LEU . . . -156.58 -46.73 0.07 Allowed 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -169.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 25.6 tpt85 -58.15 -32.7 68.44 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.663 0.665 . . . . 0.0 112.649 -158.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -48.96 -70.3 0.09 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 125.253 1.421 . . . . 0.0 109.889 168.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.4 t -63.52 -36.02 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 126.836 2.054 . . . . 0.0 110.666 -174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 41.3 mt -51.72 -46.31 63.91 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.05 1.295 . . . . 0.0 110.572 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.66 -46.43 85.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.067 0.947 . . . . 0.0 111.657 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -61.65 -42.55 99.06 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.479 0.712 . . . . 0.0 112.227 175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.98 -32.79 72.61 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.157 0.983 . . . . 0.0 111.315 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -69.41 -43.8 72.66 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 126.189 1.795 . . . . 0.0 111.857 173.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.3 -13.99 3.95 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.802 1.241 . . . . 0.0 112.004 168.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 32.3 m -113.96 -5.25 13.17 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.773 1.629 . . . . 0.0 112.241 -177.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.57 19.73 49.3 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.137 1.827 . . . . 0.0 113.862 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 12.2 mt -51.83 124.74 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 160.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -75.34 111.58 10.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -96.05 153.92 17.52 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 127' ' ' THR . 66.9 m-85 -148.61 165.79 30.23 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.487 1.515 . . . . 0.0 109.135 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.457 ' HB ' HG23 ' A' ' 129' ' ' ILE . 36.8 mt -137.72 153.66 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 125.998 1.719 . . . . 0.0 108.177 173.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -132.58 143.09 49.46 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.492 1.517 . . . . 0.0 107.795 160.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 11.5 t -169.74 173.11 6.41 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.796 1.638 . . . . 0.0 108.835 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -131.77 66.42 1.55 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.234 1.814 . . . . 0.0 110.106 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.27 6.58 17.44 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.483 1.513 . . . . 0.0 111.646 166.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.77 178.4 43.67 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.695 1.14 . . . . 0.0 111.28 175.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.47 -18.55 52.24 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.286 1.034 . . . . 0.0 111.837 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.65 -23.14 49.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.876 0.87 . . . . 0.0 111.652 176.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -54.28 -45.45 72.48 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.474 0.709 . . . . 0.0 111.922 174.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -62.63 -39.95 95.44 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.984 0.811 . . . . 0.0 109.904 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.7 m -62.25 -45.83 91.53 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.78 0.832 . . . . 0.0 110.262 178.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 60.5 mt -60.21 -43.29 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.534 1.134 . . . . 0.0 109.14 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.84 -40.59 95.85 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.482 -0.761 . . . . 0.0 111.36 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -53.35 58.55 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.702 0.683 . . . . 0.0 110.162 169.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -49.47 -53.44 23.11 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.047 0.939 . . . . 0.0 111.597 -174.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.57 -11.07 60.11 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.17 1.388 . . . . 0.0 114.051 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 59.97 54.51 36.82 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 124.67 1.129 . . . . 0.0 110.678 -175.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.7 6.08 2.43 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 125.085 1.354 . . . . 0.0 111.993 170.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.03 -53.01 56.54 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.564 0.697 . . . . 0.0 109.988 175.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.5 m -72.46 -11.26 60.6 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.818 -162.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -62.69 -28.69 70.11 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.172 0.989 . . . . 0.0 112.71 171.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -107.87 136.12 48.11 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -174.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.455 ' HB ' ' CE2' ' A' ' 104' ' ' PHE . 78.5 m -61.58 -43.62 98.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.85 157.12 38.83 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -173.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.457 HG23 ' HB ' ' A' ' 105' ' ' ILE . 5.0 mp -137.15 143.35 34.89 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 176.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.5 HD21 ' CE1' ' A' ' 147' ' ' TYR . 76.8 mt -99.57 158.87 15.45 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.764 1.225 . . . . 0.0 109.778 174.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.3 p -137.36 -174.22 3.69 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.136 0.574 . . . . 0.0 111.101 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.9 -30.18 13.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.512 1.125 . . . . 0.0 111.695 166.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -65.71 -19.83 66.05 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.994 1.318 . . . . 0.0 111.113 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 13.2 m -89.47 69.53 7.96 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 104.689 -2.337 . . . . 0.0 104.689 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.75 47.75 1.54 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 127.34 2.4 . . . . 0.0 112.116 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -56.66 169.32 0.49 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.367 0.667 . . . . 0.0 110.995 164.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.503 HG23 ' CB ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -50.67 166.78 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 122.634 1.207 . . . . 0.0 112.922 177.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -61.23 157.44 16.23 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.363 163.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -42.58 147.87 0.58 Allowed Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 124.745 1.218 . . . . 0.0 110.343 166.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -65.56 -27.3 4.95 Favored 'Cis proline' 0 CA--C 1.533 0.461 0 CA-C-N 119.342 0.801 . . . . 0.0 113.407 -3.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.503 ' CB ' HG23 ' A' ' 137' ' ' VAL . 3.3 t 49.39 82.18 0.24 Allowed Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.012 1.325 . . . . 0.0 112.079 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -63.57 -23.02 70.59 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 121.494 1.462 . . . . 0.0 111.286 165.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -54.03 -50.47 66.6 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.892 1.277 . . . . 0.0 112.713 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.02 -17.11 22.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -92.88 -47.77 6.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.546 1.138 . . . . 0.0 111.203 174.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 m -57.27 -39.02 74.8 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.885 0.874 . . . . 0.0 109.585 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.5 ' CE1' HD21 ' A' ' 130' ' ' LEU . 30.6 t80 -57.87 -51.02 71.31 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.544 0.738 . . . . 0.0 110.274 173.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 13.1 mt -65.95 -36.42 83.3 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.275 1.03 . . . . 0.0 110.761 -171.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 89.2 mt -60.59 -64.84 0.81 Allowed 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.36 1.864 . . . . 0.0 106.031 175.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.81 -37.26 75.98 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -172.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -55.32 -23.02 21.37 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 117.299 -1.334 . . . . 0.0 114.325 -178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -134.52 20.46 3.62 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 120.593 1.542 . . . . 0.0 110.612 172.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 44.14 62.87 1.82 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.679 2.392 . . . . 0.0 110.614 -172.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 67.5 mt -103.08 165.13 11.2 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.499 1.12 . . . . 0.0 110.647 -170.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -100.67 132.25 46.16 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.792 -168.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 m -58.13 -49.37 77.22 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.546 1.138 . . . . 0.0 110.166 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -76.6 -4.18 41.6 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.133 -1.605 . . . . 0.0 112.818 -177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -113.6 10.88 18.14 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 117.876 -1.059 . . . . 0.0 108.838 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -109.9 111.26 22.56 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 118.98 0.809 . . . . 0.0 109.406 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -114.87 108.54 16.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.491 1.517 . . . . 0.0 110.152 -168.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -78.39 152.46 32.23 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.415 0.686 . . . . 0.0 109.68 176.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.438 HD11 ' CD2' ' A' ' 6' ' ' PHE . 2.5 mp -127.17 127.84 69.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 172.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -167.13 -177.68 38.96 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-O 121.511 0.506 . . . . 0.0 112.908 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -126.22 9.9 7.39 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.209 1.404 . . . . 0.0 112.452 -165.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 13.0 ttt85 -136.32 126.85 26.93 Favored 'General case' 0 CA--C 1.517 -0.292 0 C-N-CA 124.038 0.935 . . . . 0.0 110.03 -171.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 6.2 t -46.34 -23.87 0.41 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.133 2.573 . . . . 0.0 115.216 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.4 -12.95 59.79 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.139 1.776 . . . . 0.0 112.312 177.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -51.64 69.16 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 123.637 0.775 . . . . 0.0 110.743 174.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.7 t -65.96 -29.68 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 O-C-N 121.811 -0.556 . . . . 0.0 109.611 -173.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.52 -21.26 66.6 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.475 -0.774 . . . . 0.0 112.238 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -97.32 -39.77 9.06 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.548 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -57.2 -43.04 82.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 123.698 0.624 . . . . 0.0 111.153 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -59.1 -48.48 81.45 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.604 1.161 . . . . 0.0 110.934 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -71.1 -33.53 70.25 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 118.234 -0.889 . . . . 0.0 112.298 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 45.9 m -82.66 -21.39 35.0 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.514 170.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.72 63.67 3.11 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.462 1.506 . . . . 0.0 110.505 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.2 pt -135.73 -166.5 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 125.863 1.665 . . . . 0.0 108.948 -173.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.0 mm-40 -120.38 158.64 26.73 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.548 1.067 . . . . 0.0 111.541 -174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 3.8 m -139.0 149.82 45.13 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.105 1.762 . . . . 0.0 109.367 -175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 26.1 mt -138.7 94.99 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 50.3 p30 -122.81 158.6 29.91 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.458 1.103 . . . . 0.0 110.938 -170.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -85.87 -26.33 25.7 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.705 -0.622 . . . . 0.0 111.391 -174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.412 ' H ' HD12 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -73.04 175.55 6.58 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 161.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.509 ' HB3' ' HD2' ' A' ' 192' ' ' ARG . 6.1 pt-20 -108.06 170.53 7.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 164.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.3 t -151.99 -168.97 3.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.9 p -127.78 81.26 2.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.874 1.27 . . . . 0.0 108.054 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -151.26 153.68 35.33 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.62 1.568 . . . . 0.0 108.465 175.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.87 108.14 16.69 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.775 1.63 . . . . 0.0 110.313 175.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 117.91 -7.42 15.11 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 123.972 0.796 . . . . 0.0 111.81 -176.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.97 118.91 24.33 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 125.302 1.441 . . . . 0.0 108.293 172.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -114.21 136.47 52.92 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.139 1.376 . . . . 0.0 110.674 176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.509 ' HD2' ' HB3' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -83.85 146.66 27.98 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.416 177.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.446 HG22 ' HB3' ' A' ' 198' ' ' ASP . 22.5 pt -132.82 167.67 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.39 1.476 . . . . 0.0 112.303 165.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -124.75 -12.12 7.15 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.549 1.539 . . . . 0.0 112.172 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.07 172.09 19.29 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.502 1.521 . . . . 0.0 109.454 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.679 HD11 ' C ' ' A' ' 88' ' ' GLY . 10.2 mt -68.78 -37.18 79.14 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.95 1.3 . . . . 0.0 110.352 -176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.39 -22.43 66.79 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.874 0.845 . . . . 0.0 112.196 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.446 ' HB3' HG22 ' A' ' 193' ' ' ILE . 0.5 OUTLIER -74.83 -5.77 45.35 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.825 177.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 78.5 mt -77.65 -63.16 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.348 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 168.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.9 p -55.96 -28.03 55.15 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -170.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -60.03 -38.69 83.46 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.145 1.778 . . . . 0.0 112.996 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 67.5 mt -60.91 -50.16 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 C-N-CA 126.632 1.973 . . . . 0.0 106.563 -168.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -71.69 -4.26 26.41 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.352 1.061 . . . . 0.0 113.338 -170.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -123.31 2.87 9.16 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.417 0.687 . . . . 0.0 112.389 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.65 27.97 1.82 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.054 0.542 . . . . 0.0 112.239 -173.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 14.8 mttp . . . . . 0 C--O 1.246 0.869 0 C-N-CA 129.947 3.299 . . . . 0.0 113.103 174.9 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.626 0 N-CA-C 112.26 -0.336 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . 0.337 0.3 OUTLIER 52.22 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 128.582 2.753 . . . . 0.0 115.964 177.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.0 mmm 44.1 89.09 0.01 OUTLIER 'General case' 0 C--O 1.238 0.47 0 C-N-CA 127.287 2.235 . . . . 0.0 112.694 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -60.92 -172.31 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.22 1.408 . . . . 0.0 110.214 155.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.3 mmmt -66.53 82.99 0.1 Allowed 'General case' 0 C--O 1.232 0.163 0 C-N-CA 124.926 1.29 . . . . 0.0 110.141 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.8 m -92.74 158.91 15.66 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 166.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.54 157.33 45.64 Favored 'General case' 0 CA--C 1.521 -0.159 0 O-C-N 120.584 -1.323 . . . . 0.0 110.636 164.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -128.42 162.48 27.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.203 2.201 . . . . 0.0 108.587 -172.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.5 mt -138.99 144.5 29.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 126.224 1.81 . . . . 0.0 107.033 166.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -117.13 166.35 12.33 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.983 2.113 . . . . 0.0 110.398 170.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -105.21 171.88 7.09 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 162.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.33 18.89 10.28 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 127.403 2.281 . . . . 0.0 110.736 172.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -110.43 -153.91 0.53 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.491 1.916 . . . . 0.0 110.256 -167.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.09 -11.84 83.77 Favored Glycine 0 CA--C 1.528 0.845 0 O-C-N 120.17 -1.581 . . . . 0.0 115.949 -163.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.259 13.3 t . . . . . 0 C--O 1.25 1.094 0 C-N-CA 124.458 1.103 . . . . 0.0 108.955 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.644 HD23 HG21 ' A' ' 122' ' ' VAL . 1.7 tm? . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.414 ' H ' HD22 ' A' ' 85' ' ' LEU . 0.2 OUTLIER -104.09 87.3 1.54 Allowed Pre-proline 0 C--O 1.243 0.719 1 C-N-CA 132.208 4.203 . . . . 0.0 104.467 179.846 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.43 93.05 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 124.652 3.568 . . . . 0.0 111.983 -163.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 153.38 -34.77 0.76 Allowed Glycine 0 CA--C 1.524 0.633 0 CA-C-N 113.175 -1.83 . . . . 0.0 109.725 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.39 -26.18 65.43 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 124.146 0.979 . . . . 0.0 110.319 175.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -51.65 -36.65 47.0 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.8 0.84 . . . . 0.0 112.219 -175.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -56.7 -51.02 70.4 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.836 1.254 . . . . 0.0 111.047 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.1 t -65.39 -43.88 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.399 1.479 . . . . 0.0 109.815 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.726 HD23 ' CD2' ' A' ' 125' ' ' TYR . 8.3 mp -50.39 -50.78 50.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 121.344 1.884 . . . . 0.0 111.205 172.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.59 -43.97 85.03 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 123.446 0.466 . . . . 0.0 111.951 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.5 t90 -68.72 -39.66 80.32 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.005 1.322 . . . . 0.0 112.089 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.91 -29.13 60.88 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.209 1.404 . . . . 0.0 111.597 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -64.38 -59.2 4.64 Favored 'General case' 0 CA--C 1.509 -0.614 0 C-N-CA 127.401 2.281 . . . . 0.0 110.166 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -55.72 -27.27 49.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.559 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 48.7 m -90.66 3.5 54.03 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.93 8.93 44.49 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.127 1.346 . . . . 0.0 114.334 173.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 24.5 mt -66.37 104.17 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -60.71 111.92 1.81 Allowed 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.61 150.1 21.85 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 172.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.519 ' CD2' HD22 ' A' ' 148' ' ' LEU . 79.5 m-85 -142.95 166.4 24.73 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.503 1.121 . . . . 0.0 110.53 175.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 9.2 mt -127.49 158.25 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 121.041 1.746 . . . . 0.0 109.43 173.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -133.58 112.0 11.12 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.747 1.219 . . . . 0.0 108.893 167.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -143.11 173.63 11.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -127.68 14.16 6.97 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.759 2.023 . . . . 0.0 110.887 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.62 -3.07 28.98 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.99 173.0 34.4 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 125.703 1.62 . . . . 0.0 112.557 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -56.74 -19.99 19.72 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.777 1.631 . . . . 0.0 112.653 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -55.37 -22.76 20.98 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.419 1.488 . . . . 0.0 111.944 173.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -55.91 -44.57 78.38 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.027 -1.045 . . . . 0.0 111.576 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -56.79 -46.25 81.66 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.75 0.42 . . . . 0.0 110.506 175.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.2 m -61.3 -47.37 86.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.747 0.819 . . . . 0.0 110.486 -178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.8 mt -55.59 -50.63 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.83 -32.27 73.45 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.802 -1.186 . . . . 0.0 110.843 -175.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.0 mtmt -72.33 -27.2 62.28 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 171.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -63.81 1.09 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 123.365 1.555 . . . . 0.0 107.08 174.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -63.31 -35.59 80.88 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 129.785 3.234 . . . . 0.0 112.254 -172.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 86.8 61.93 1.57 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 124.512 1.053 . . . . 0.0 110.495 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.644 HG21 HD23 ' A' ' 85' ' ' LEU . 5.9 m -139.64 5.79 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.223 1.009 . . . . 0.0 110.856 170.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.11 -30.75 63.86 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 121.086 -1.009 . . . . 0.0 111.37 -175.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 2.3 m -70.36 -26.93 63.96 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 118.801 0.728 . . . . 0.0 111.73 -173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.726 ' CD2' HD23 ' A' ' 93' ' ' LEU . 24.6 m-85 -51.5 -60.33 3.26 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.297 0.639 . . . . 0.0 110.11 164.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.53 ' CE1' HD21 ' A' ' 93' ' ' LEU . 28.9 m-85 -84.9 114.23 21.97 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -152.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 89.2 m -64.5 -31.85 73.24 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.733 -0.604 . . . . 0.0 111.629 -172.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -158.89 156.72 30.1 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 119.957 1.253 . . . . 0.0 109.838 167.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.79 105.1 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 103.871 -2.64 . . . . 0.0 103.871 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -65.22 158.24 26.7 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 172.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.3 p -131.75 179.73 5.89 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.053 1.341 . . . . 0.0 109.15 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.33 -31.03 42.33 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.155 1.382 . . . . 0.0 112.168 165.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -63.71 -21.55 66.46 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.921 1.288 . . . . 0.0 110.676 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.6 p -57.24 -30.39 64.58 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.0 1.32 . . . . 0.0 114.063 -165.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 70.75 2.31 44.06 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-O 118.538 -1.146 . . . . 0.0 113.954 169.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -63.51 158.47 20.89 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 119.318 1.559 . . . . 0.0 111.613 -177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 137' ' ' VAL . 8.7 t -57.61 157.85 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.564 161.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -136.78 59.8 1.68 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.277 1.431 . . . . 0.0 111.207 175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.3 tptp -49.66 -54.84 27.29 Favored Pre-proline 0 N--CA 1.471 0.607 0 CA-C-O 114.834 -2.508 . . . . 0.0 114.344 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.78 114.08 0.19 OUTLIER 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 123.313 2.219 . . . . 0.0 117.016 10.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 m -92.73 154.94 42.2 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 124.873 1.269 . . . . 0.0 112.547 -173.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -81.53 5.25 6.4 Favored 'Trans proline' 0 CA--C 1.549 1.261 1 C-N-CA 125.585 4.19 . . . . 0.0 113.883 170.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -46.77 -63.92 0.9 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.479 1.912 . . . . 0.0 110.942 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.54 -20.96 64.58 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.461 0.705 . . . . 0.0 111.934 -169.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -70.18 -60.38 2.32 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.297 1.039 . . . . 0.0 108.766 169.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.3 m -54.93 -40.57 70.04 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.025 1.33 . . . . 0.0 110.407 -174.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.512 ' CE1' ' HE2' ' A' ' 151' ' ' LYS . 72.0 t80 -52.1 -58.0 7.86 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.474 1.11 . . . . 0.0 110.633 175.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.519 HD22 ' CD2' ' A' ' 104' ' ' PHE . 23.3 mt -71.02 -25.19 62.56 Favored 'General case' 0 CA--C 1.521 -0.137 0 O-C-N 121.866 -0.521 . . . . 0.0 112.144 -172.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.439 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 87.2 mt -66.48 -61.15 2.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 175.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.99 -36.19 72.28 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.963 0.505 . . . . 0.0 111.699 -176.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.512 ' HE2' ' CE1' ' A' ' 147' ' ' TYR . 7.9 mmtm -57.31 -22.85 44.74 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 114.276 1.214 . . . . 0.0 114.276 -177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -143.97 27.43 1.46 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 119.037 0.835 . . . . 0.0 111.822 169.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 67.9 mm-40 44.41 54.56 6.22 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.648 2.379 . . . . 0.0 111.494 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 4.3 mp -75.46 -169.59 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.188 1.395 . . . . 0.0 110.592 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -121.78 129.15 52.44 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.236 1.414 . . . . 0.0 108.751 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.0 m -52.5 -49.1 65.42 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.985 1.714 . . . . 0.0 110.445 175.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -88.43 9.2 24.4 Favored 'General case' 0 C--N 1.328 -0.349 0 O-C-N 120.791 -1.193 . . . . 0.0 111.881 -169.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.94 8.75 7.45 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.353 1.861 . . . . 0.0 108.733 173.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -107.65 142.42 37.64 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.743 1.156 . . . . 0.0 109.539 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -129.46 156.55 43.94 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 126.952 2.101 . . . . 0.0 108.243 -170.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -139.17 128.17 23.7 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 172.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 6.1 mt -102.93 116.05 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 125.152 1.381 . . . . 0.0 107.309 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -142.09 -172.26 13.48 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.023 -1.231 . . . . 0.0 110.023 174.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -132.51 5.83 4.05 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.404 1.882 . . . . 0.0 113.393 -169.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.405 ' HG2' HH11 ' A' ' 165' ' ' ARG . 0.6 OUTLIER -131.83 155.82 47.13 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 120.0 1.273 . . . . 0.0 109.95 -176.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t -72.94 -13.69 61.3 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.584 -1.323 . . . . 0.0 111.059 -169.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.26 -33.18 52.02 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 125.739 1.616 . . . . 0.0 111.167 167.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -74.06 10.12 1.33 Allowed 'General case' 0 C--O 1.236 0.388 0 C-N-CA 125.376 1.47 . . . . 0.0 113.601 -164.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.22 -13.71 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.288 1.035 . . . . 0.0 110.686 167.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -64.32 -47.83 77.92 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 120.803 1.638 . . . . 0.0 110.018 -173.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -76.94 -34.44 57.65 Favored 'General case' 0 C--O 1.23 0.066 0 O-C-N 121.595 -0.691 . . . . 0.0 111.809 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.48 -58.11 8.29 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.598 0.759 . . . . 0.0 109.867 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -49.84 -45.74 50.57 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 126.699 2.0 . . . . 0.0 110.841 173.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 -62.49 -26.08 68.35 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.5 p -93.98 -26.01 17.0 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 119.055 0.843 . . . . 0.0 112.769 174.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 92.46 9.57 61.48 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.198 1.38 . . . . 0.0 112.556 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 178' ' ' GLN . 1.7 pp -88.21 175.66 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.721 1.209 . . . . 0.0 109.39 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.411 ' N ' HD12 ' A' ' 177' ' ' ILE . 32.5 mt-30 -112.37 163.73 14.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.865 0.841 . . . . 0.0 111.694 -165.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 8.8 m -137.39 149.82 47.22 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.665 1.586 . . . . 0.0 110.175 -168.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 47.6 mt -140.4 78.02 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -114.16 165.13 12.97 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.507 1.146 . . . . 0.0 110.693 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -73.4 -13.3 61.06 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 121.283 -0.885 . . . . 0.0 113.157 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.59 157.12 39.71 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 119.442 1.019 . . . . 0.0 110.727 -174.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -89.51 159.23 17.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.939 -0.476 . . . . 0.0 111.435 -171.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.25 8.38 1.2 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 -169.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 47.7 p 52.81 49.66 19.78 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.101 1.36 . . . . 0.0 113.257 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -131.27 162.65 29.55 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.4 1.88 . . . . 0.0 109.105 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -80.13 -42.87 22.67 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 123.639 0.776 . . . . 0.0 111.812 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.73 47.4 3.57 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -130.43 125.94 35.72 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.922 1.289 . . . . 0.0 109.52 -164.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -127.2 108.39 10.84 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 124.004 0.921 . . . . 0.0 109.156 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -63.94 142.01 58.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 118.149 -1.42 . . . . 0.0 109.699 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 13.7 pt -114.96 159.67 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.3 1.04 . . . . 0.0 110.564 165.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -115.15 -8.17 12.4 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.839 1.256 . . . . 0.0 112.535 172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -154.76 161.62 41.43 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.869 2.468 . . . . 0.0 107.154 177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 tp -71.16 -32.94 69.55 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.408 -0.808 . . . . 0.0 110.268 172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.77 -18.69 63.06 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-O 118.098 -0.953 . . . . 0.0 112.196 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -66.32 -20.02 65.97 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.422 1.01 . . . . 0.0 110.316 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 76.8 mt -62.46 -53.61 44.99 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.324 0 C-N-CA 124.607 1.163 . . . . 0.0 108.96 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 80.7 p -56.27 -39.59 72.89 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.185 0.902 . . . . 0.0 109.662 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -60.2 -25.71 65.8 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 127.349 2.26 . . . . 0.0 111.591 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 80.0 mt -61.64 -46.38 96.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 O-C-N 120.498 -1.376 . . . . 0.0 109.454 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -89.91 -26.26 20.54 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.492 1.117 . . . . 0.0 110.944 -175.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -83.61 4.55 27.88 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.716 1.606 . . . . 0.0 112.587 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.312 87.2 m 59.69 60.67 2.16 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 123.53 1.633 . . . . 0.0 109.93 -177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.375 9.2 ptmt . . . . . 0 C--O 1.252 1.222 1 C-N-CA 134.42 5.088 . . . . 0.0 116.213 173.136 . . . . . . . . 2 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.751 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -164.15 97.42 0.82 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 117.807 0.803 . . . . 0.0 110.06 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.3 mmm -129.41 87.85 2.61 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.16 169.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.901 2.081 . . . . 0.0 109.687 162.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.36 106.72 0.09 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.476 1.51 . . . . 0.0 108.813 174.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.8 m -134.86 147.18 49.82 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.27 153.96 46.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.402 1.081 . . . . 0.0 108.645 171.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -130.04 153.31 48.56 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.176 1.79 . . . . 0.0 107.609 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.4 mt -143.22 138.46 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -128.97 179.96 5.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.43 1.092 . . . . 0.0 110.443 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -130.71 172.35 12.07 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.172 2.189 . . . . 0.0 109.596 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.411 HD12 HG21 ' A' ' 107' ' ' THR . 76.0 mt -123.6 25.05 8.33 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.501 1.921 . . . . 0.0 111.508 -174.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -146.39 74.02 1.35 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.108 -0.995 . . . . 0.0 111.794 174.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.2 -65.83 0.58 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 109.076 -1.609 . . . . 0.0 109.076 175.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.047 0 C-N-CA 127.241 2.217 . . . . 0.0 111.257 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.734 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.415 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 8.6 tpt 46.71 85.4 0.17 Allowed Pre-proline 0 CA--C 1.533 0.324 0 C-N-CA 126.938 2.095 . . . . 0.0 111.818 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 86' ' ' MET . 19.8 Cg_endo -49.43 124.74 12.48 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.128 1.886 . . . . 0.0 110.432 174.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.93 -21.54 33.71 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.974 1.749 . . . . 0.0 112.186 -174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.14 -37.92 66.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.478 1.639 . . . . 0.0 109.117 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 32.6 ttt-85 -60.75 -28.69 68.89 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.66 0.664 . . . . 0.0 112.208 -176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.5 -58.77 7.07 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.637 1.575 . . . . 0.0 110.304 170.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.8 t -59.06 -47.47 89.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.637 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.522 ' HA ' HE22 ' A' ' 103' ' ' GLN . 3.9 mp -44.68 -54.95 5.67 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 120.835 1.652 . . . . 0.0 113.237 169.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.51 -51.57 68.89 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 123.417 0.448 . . . . 0.0 110.563 -176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.5 t90 -54.01 -50.54 66.4 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.989 0.916 . . . . 0.0 110.918 176.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -65.49 -32.4 73.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.089 1.356 . . . . 0.0 112.588 -174.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.82 -54.26 20.46 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 124.556 1.142 . . . . 0.0 110.562 -178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -67.48 -16.67 64.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.198 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.2 m -84.69 -1.63 56.44 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.783 1.633 . . . . 0.0 113.272 173.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.47 4.81 87.63 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 119.845 1.202 . . . . 0.0 114.179 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.2 mt -66.6 138.07 23.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 O-C-N 121.143 -1.21 . . . . 0.0 108.169 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -87.63 114.83 24.61 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 163.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.522 HE22 ' HA ' ' A' ' 93' ' ' LEU . 11.8 mt-30 -86.36 151.69 23.35 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 170.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -143.2 174.99 10.22 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.463 1.905 . . . . 0.0 107.11 177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 33.9 mt -133.56 154.9 39.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 170.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.413 ' CD1' ' HB3' ' A' ' 130' ' ' LEU . 9.8 t80 -142.47 119.3 11.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 159.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.696 HG23 ' H ' ' A' ' 109' ' ' LYS . 6.0 t -145.63 175.63 10.23 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.055 0.542 . . . . 0.0 110.455 170.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -84.39 1.55 44.72 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.125 0.97 . . . . 0.0 113.487 175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.696 ' H ' HG23 ' A' ' 107' ' ' THR . 11.9 ttmm -64.6 160.8 18.85 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 121.266 -0.896 . . . . 0.0 109.834 175.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -89.6 -168.85 43.6 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.367 0.984 . . . . 0.0 111.677 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -62.9 -16.72 60.03 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 122.117 -0.637 . . . . 0.0 112.579 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -55.47 -23.44 25.68 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.951 -1.023 . . . . 0.0 112.389 168.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.97 -49.47 63.15 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 120.409 1.459 . . . . 0.0 112.791 173.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -60.67 -48.8 80.18 Favored 'General case' 0 C--O 1.225 -0.196 0 C-N-CA 124.219 1.008 . . . . 0.0 109.493 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 84.5 m -58.96 -41.1 86.67 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.426 1.49 . . . . 0.0 111.715 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 36.3 mt -64.35 -44.05 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 O-C-N 121.344 -0.847 . . . . 0.0 108.83 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 117' ' ' LEU . 0.3 OUTLIER -60.52 -45.54 93.44 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 123.925 0.89 . . . . 0.0 111.796 177.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -58.84 -48.42 81.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.429 1.092 . . . . 0.0 109.226 177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -58.25 -49.91 75.45 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.834 1.654 . . . . 0.0 111.857 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -73.39 -4.54 34.14 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.889 1.276 . . . . 0.0 112.667 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 65.62 39.43 95.43 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 124.313 0.959 . . . . 0.0 112.296 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.68 15.11 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 124.81 1.244 . . . . 0.0 110.898 177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -61.55 -41.71 97.77 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.877 -0.514 . . . . 0.0 110.738 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.6 m -57.75 -27.36 62.96 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.437 ' CD2' HD23 ' A' ' 93' ' ' LEU . 32.4 m-85 -63.71 -34.19 77.31 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 118.988 -0.529 . . . . 0.0 111.897 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -110.37 96.83 6.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -166.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.7 m -51.01 -44.86 61.05 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.581 0.753 . . . . 0.0 110.699 -174.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.45 153.2 44.83 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.501 1.12 . . . . 0.0 108.816 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.59 93.14 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -170.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 106' ' ' TYR . 16.6 mt -68.62 146.72 52.78 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.3 p -151.24 179.45 8.3 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.731 -162.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 2.4 t -47.56 -34.97 8.36 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.247 1.819 . . . . 0.0 112.15 173.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -59.27 -30.0 67.98 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.08 1.352 . . . . 0.0 112.137 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 82.7 p -58.34 -49.46 77.12 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.597 1.189 . . . . 0.0 110.322 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 81.93 -1.18 87.29 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-O 116.83 -2.095 . . . . 0.0 113.437 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -56.63 162.61 2.18 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 119.303 1.552 . . . . 0.0 111.286 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.46 HG23 ' HA ' ' A' ' 141' ' ' SER . 6.1 m -50.64 153.64 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 126.73 2.012 . . . . 0.0 112.205 170.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.425 ' HG3' ' H ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -83.88 -77.27 0.26 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.582 1.553 . . . . 0.0 111.702 -168.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.425 ' H ' ' HG3' ' A' ' 138' ' ' ARG . 9.0 mttp -163.59 117.99 1.09 Allowed Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 128.815 2.846 . . . . 0.0 104.923 -178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.26 160.42 75.81 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 CA-C-N 120.257 1.127 . . . . 0.0 111.68 -4.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.464 ' H ' ' HB2' ' A' ' 171' ' ' PHE . 2.6 p -156.18 54.94 0.99 Allowed Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -169.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -68.11 -14.74 41.61 Favored 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 121.37 1.38 . . . . 0.0 113.056 -171.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -55.43 -39.62 70.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.837 1.255 . . . . 0.0 110.761 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.66 -15.19 62.22 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 121.921 -0.487 . . . . 0.0 112.024 -176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.27 -55.91 5.49 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 168.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.0 m -59.26 -37.74 78.34 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.198 0.599 . . . . 0.0 110.777 -173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -55.48 -56.33 21.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.8 mt -61.17 -38.23 85.76 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 118.683 -0.675 . . . . 0.0 111.241 -175.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -67.1 0.42 Allowed 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 125.126 1.37 . . . . 0.0 107.385 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -57.06 -34.31 68.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -175.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -47.38 72.96 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 114.957 -2.449 . . . . 0.0 114.198 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -124.55 18.36 8.83 Favored 'General case' 0 C--N 1.348 0.531 0 CA-C-N 121.633 2.015 . . . . 0.0 110.069 -177.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 64.27 56.96 1.26 Allowed 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 127.013 2.125 . . . . 0.0 108.686 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . 0.26 0.0 OUTLIER -109.58 176.19 5.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 114.7 1.371 . . . . 0.0 114.7 -175.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -108.21 150.02 27.81 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.592 -1.185 . . . . 0.0 111.426 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.1 p -66.75 -48.33 69.45 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-O 122.309 1.052 . . . . 0.0 110.765 169.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.29 -9.47 58.58 Favored 'General case' 0 C--N 1.319 -0.722 0 O-C-N 120.772 -1.205 . . . . 0.0 112.326 -170.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -116.67 21.7 13.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 118.098 -0.953 . . . . 0.0 108.804 176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -113.01 136.08 53.08 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.989 0.813 . . . . 0.0 111.397 163.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -120.24 105.0 10.53 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.117 2.167 . . . . 0.0 111.003 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -78.4 148.64 33.57 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.299 1.04 . . . . 0.0 108.83 168.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.98 123.4 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 175.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -155.5 -5.53 0.09 OUTLIER Glycine 0 CA--C 1.53 1.008 0 N-CA-C 116.926 1.531 . . . . 0.0 116.926 -172.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 64.3 5.54 2.6 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.53 1.932 . . . . 0.0 115.953 163.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -115.94 10.04 15.09 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 -156.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t 52.6 5.41 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 129.805 3.242 . . . . 0.0 115.361 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.2 tt -112.27 -16.23 13.01 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 128.055 2.542 . . . . 0.0 110.099 -176.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.64 -52.29 64.95 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 129.167 2.987 . . . . 0.0 107.852 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.4 HG11 ' CB ' ' A' ' 185' ' ' SER . 7.7 p -52.65 -46.07 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 127.081 2.152 . . . . 0.0 112.267 171.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -62.02 -45.17 94.77 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -169.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.464 ' HB2' ' H ' ' A' ' 141' ' ' SER . 3.3 p90 -79.78 -32.88 40.91 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.025 -1.047 . . . . 0.0 112.346 175.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -52.28 -52.35 53.35 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.217 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -50.49 -51.59 45.93 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.272 1.829 . . . . 0.0 110.454 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -65.25 -28.15 69.15 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.29 -22.86 28.38 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.715 -1.241 . . . . 0.0 112.735 170.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 86.74 19.63 55.86 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.947 -0.918 . . . . 0.0 112.538 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 17.3 pt -97.54 167.06 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 124.132 0.973 . . . . 0.0 109.385 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -87.93 178.97 6.54 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.985 0.514 . . . . 0.0 109.955 -178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.17 151.9 19.99 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 120.69 -1.256 . . . . 0.0 111.645 173.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 35.8 mt -124.96 128.08 72.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 45.4 m-20 -144.15 139.62 28.91 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 124.192 0.997 . . . . 0.0 108.349 -167.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -68.25 -17.8 64.39 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 119.709 -0.796 . . . . 0.0 111.499 168.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.35 166.58 10.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.242 1.417 . . . . 0.0 111.235 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -72.73 169.16 17.26 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.82 175.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.4 ' CB ' HG11 ' A' ' 169' ' ' VAL . 45.5 t -156.49 171.85 19.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 157.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.1 p -73.1 4.65 4.13 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.347 2.259 . . . . 0.0 114.242 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -112.07 153.16 27.33 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.29 1.036 . . . . 0.0 110.569 -173.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.58 -45.58 68.33 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.72 1.208 . . . . 0.0 112.627 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.44 36.62 2.6 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 124.752 1.167 . . . . 0.0 110.311 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -111.35 93.13 4.32 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 174.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -86.06 108.46 18.27 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 14.3 mtp180 -62.08 149.33 41.5 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.34 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.7 pt -142.22 166.19 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 125.159 1.384 . . . . 0.0 110.675 173.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.422 HE21 ' CG ' ' A' ' 198' ' ' ASP . 2.1 pp0? -122.85 -2.68 8.74 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.129 1.772 . . . . 0.0 112.949 170.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.32 166.23 34.05 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 125.839 1.656 . . . . 0.0 108.788 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 63.6 mt -69.29 -41.92 76.15 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.34 -0.05 1.67 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.41 1.084 . . . . 0.0 113.892 172.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.422 ' CG ' HE21 ' A' ' 194' ' ' GLN . 17.3 t0 -81.78 -18.89 42.55 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.053 -1.654 . . . . 0.0 109.924 172.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 77.7 mt -58.47 -52.14 62.98 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 56.3 p -50.67 -43.48 57.48 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.26 0.482 . . . . 0.0 111.44 177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 63.8 mtt85 -62.86 -21.62 66.11 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.503 1.521 . . . . 0.0 113.296 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 75.0 mt -60.54 -47.98 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -84.61 -34.89 23.03 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.729 1.211 . . . . 0.0 111.336 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -82.97 22.32 0.95 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.904 1.282 . . . . 0.0 111.413 -169.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 25.2 m 56.63 78.44 0.21 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.958 1.703 . . . . 0.0 110.507 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.271 12.7 ptmt . . . . . 0 C--O 1.251 1.169 0 C-N-CA 131.133 3.773 . . . . 0.0 116.41 172.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.594 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 56.26 14.53 1.58 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.268 2.227 . . . . 0.0 116.195 175.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.8 mmm 48.69 73.2 0.23 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.846 1.307 . . . . 0.0 111.033 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -45.49 160.3 0.05 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 126.851 2.06 . . . . 0.0 111.292 166.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -44.24 97.57 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.347 1.859 . . . . 0.0 111.722 -172.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.2 m -125.82 155.81 40.54 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.23 150.55 50.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.484 0.714 . . . . 0.0 109.091 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -123.27 155.16 37.74 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.205 1.402 . . . . 0.0 108.333 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.4 mt -140.39 133.82 33.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -131.03 147.16 52.59 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.149 1.38 . . . . 0.0 111.737 -172.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -81.65 -22.3 37.62 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.655 1.582 . . . . 0.0 111.604 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.613 ' CD2' ' H ' ' A' ' 11' ' ' ASP . 0.4 OUTLIER 68.98 -179.71 0.23 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 127.416 2.286 . . . . 0.0 110.343 -169.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.613 ' H ' ' CD2' ' A' ' 10' ' ' LEU . 3.8 m-20 54.85 -80.39 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 129.688 3.195 . . . . 0.0 113.274 -178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.89 101.02 0.93 Allowed Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.452 -1.859 . . . . 0.0 108.452 -170.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.243 0.721 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 167.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.732 HD13 ' H ' ' A' ' 86' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.732 ' H ' HD13 ' A' ' 85' ' ' LEU . 52.0 ttm -116.55 85.33 16.36 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -62.33 118.87 5.77 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.456 2.771 . . . . 0.0 107.18 177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 119.7 -29.88 5.92 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.968 1.271 . . . . 0.0 110.865 -171.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.16 -34.23 29.19 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 118.531 1.165 . . . . 0.0 113.25 -174.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -39.06 70.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 119.149 0.886 . . . . 0.0 110.992 -166.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -58.28 -53.46 58.02 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.624 0.769 . . . . 0.0 110.699 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 96.9 t -61.33 -40.76 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 118.745 0.702 . . . . 0.0 110.266 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.74 -48.89 78.35 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 118.857 0.753 . . . . 0.0 109.519 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.29 -49.57 75.65 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 122.977 0.511 . . . . 0.0 111.669 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 22.4 t90 -57.19 -52.61 64.6 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.741 0.817 . . . . 0.0 110.263 178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.43 91.03 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.059 1.343 . . . . 0.0 111.874 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -68.13 -46.12 71.73 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 126.388 1.875 . . . . 0.0 111.399 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.63 -33.61 76.01 Favored 'General case' 0 N--CA 1.467 0.375 0 O-C-N 121.744 -0.597 . . . . 0.0 110.865 170.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.3 m -71.9 -2.82 19.34 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.495 1.118 . . . . 0.0 112.861 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.89 17.06 62.55 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.971 1.272 . . . . 0.0 112.283 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -67.6 116.25 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -67.87 97.02 0.62 Allowed 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -81.76 137.79 35.28 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.784 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -131.28 172.77 11.76 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.451 1.5 . . . . 0.0 110.366 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 71.3 mt -138.06 156.31 30.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 125.438 1.495 . . . . 0.0 108.358 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -138.08 126.61 23.44 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 167.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.1 t -142.49 169.86 16.79 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.909 0.861 . . . . 0.0 110.242 177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -105.07 -5.5 20.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.159 1.784 . . . . 0.0 111.85 169.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 ptpp? -68.33 -5.04 16.58 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.323 1.971 . . . . 0.0 116.323 -167.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.52 -179.72 38.95 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -64.38 -17.85 64.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -172.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -57.89 -14.14 5.66 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 174.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.41 -44.53 68.81 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.391 0.996 . . . . 0.0 111.728 169.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -62.3 -46.68 87.65 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.198 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -56.04 -46.02 78.99 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 123.698 0.799 . . . . 0.0 109.95 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.7 mt -60.69 -49.02 86.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.5 mt -67.32 -38.9 85.67 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.525 -0.734 . . . . 0.0 111.175 -175.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -62.56 -47.35 84.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -62.79 -32.35 73.5 Favored 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 124.077 0.951 . . . . 0.0 112.854 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 69.3 mt -90.17 1.54 56.32 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.379 1.472 . . . . 0.0 112.344 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 61.51 36.22 92.26 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.279 0.942 . . . . 0.0 112.842 174.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 15.4 m -130.84 20.57 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.748 1.219 . . . . 0.0 110.648 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -73.53 -36.47 65.69 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 120.6 -1.312 . . . . 0.0 113.188 -177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -28.79 69.93 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 119.039 -0.505 . . . . 0.0 111.065 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -67.32 -2.84 6.66 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 118.026 -0.988 . . . . 0.0 113.292 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -138.23 81.83 1.88 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.719 1.6 . . . . 0.0 108.577 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.7 m -44.9 -44.89 10.01 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 127.685 2.394 . . . . 0.0 114.514 -171.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -154.58 91.29 1.38 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-N 120.234 1.379 . . . . 0.0 112.1 -175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.8 mp -72.69 122.78 26.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.021 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.62 154.66 26.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 121.64 -0.663 . . . . 0.0 110.366 165.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.4 p -138.29 -174.67 3.87 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.296 1.839 . . . . 0.0 108.424 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 46.9 m -60.77 -13.79 17.36 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.903 -1.123 . . . . 0.0 112.802 164.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.93 -22.34 64.15 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 120.889 1.677 . . . . 0.0 109.739 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.5 p -53.63 -47.79 69.94 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 123.757 0.66 . . . . 0.0 110.354 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 94.86 -12.21 68.82 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 117.603 -1.665 . . . . 0.0 111.938 -171.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -52.66 148.54 7.09 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.004 1.402 . . . . 0.0 111.397 -177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.522 HG23 ' HB3' ' A' ' 141' ' ' SER . 22.9 m -66.1 169.16 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-O 122.322 1.058 . . . . 0.0 113.059 -163.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -60.45 143.22 53.88 Favored 'General case' 0 C--N 1.335 -0.056 0 O-C-N 121.308 -0.87 . . . . 0.0 109.697 174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -59.09 150.46 61.87 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 117.588 -1.196 . . . . 0.0 110.604 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -61.18 120.25 1.21 Allowed 'Cis proline' 0 CA--C 1.538 0.701 0 CA-C-N 120.618 1.256 . . . . 0.0 110.685 -17.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 137' ' ' VAL . 6.1 p -126.68 81.8 68.13 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.712 1.605 . . . . 0.0 112.546 -172.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -71.28 -10.76 27.73 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.968 2.446 . . . . 0.0 112.415 -170.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -44.91 -50.26 10.55 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.597 2.359 . . . . 0.0 110.918 177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -67.04 -15.61 63.83 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.06 -51.89 6.04 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.511 0.725 . . . . 0.0 109.521 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.7 m -50.59 -43.84 56.72 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.315 1.446 . . . . 0.0 109.853 175.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -57.7 -60.07 4.24 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 123.336 0.655 . . . . 0.0 109.604 177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 33.4 mt -61.57 -25.38 67.28 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -171.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.41 -71.66 0.14 Allowed 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 172.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -28.34 69.55 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.609 1.164 . . . . 0.0 113.011 -171.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.42 -31.24 65.67 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.168 1.387 . . . . 0.0 112.142 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -140.8 11.61 2.25 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 44.99 73.55 0.15 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 127.912 2.485 . . . . 0.0 111.565 -163.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.5 mp -103.08 154.92 18.78 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 166.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -93.42 136.96 33.19 Favored 'General case' 0 CA--C 1.51 -0.565 0 C-N-CA 126.108 1.763 . . . . 0.0 107.969 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.92 -41.89 97.05 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.095 0.474 . . . . 0.0 111.938 174.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -74.23 -19.27 60.57 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 120.997 -1.064 . . . . 0.0 112.396 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -101.87 16.07 27.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -110.1 133.95 52.68 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 120.272 1.396 . . . . 0.0 108.228 169.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -125.64 117.48 23.62 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.721 1.208 . . . . 0.0 108.327 -174.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -97.84 132.11 43.74 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.011 0.924 . . . . 0.0 109.172 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 7.2 mt -114.91 78.93 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -160.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -95.49 -177.94 37.01 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 125.494 1.521 . . . . 0.0 113.549 -170.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -134.82 1.88 3.08 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.665 1.186 . . . . 0.0 113.396 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.05 178.08 6.96 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 122.619 1.199 . . . . 0.0 111.344 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.12 -37.45 61.43 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.536 -177.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.78 -33.46 64.38 Favored 'General case' 0 C--O 1.226 -0.148 0 C-N-CA 125.665 1.586 . . . . 0.0 111.865 178.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -57.43 -33.29 67.75 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 124.097 0.959 . . . . 0.0 111.481 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.401 HG21 ' CB ' ' A' ' 185' ' ' SER . 8.2 t -92.31 -18.24 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.456 -176.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -61.3 -31.51 71.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 119.311 0.96 . . . . 0.0 108.502 168.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -64.34 -56.27 15.57 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 172.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -55.59 -44.73 77.2 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.836 0.854 . . . . 0.0 111.578 -177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -55.44 -44.97 76.81 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.575 1.55 . . . . 0.0 111.503 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -69.25 -52.49 27.09 Favored 'General case' 0 N--CA 1.463 0.211 0 O-C-N 121.756 -0.59 . . . . 0.0 110.793 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.1 m -66.96 -19.55 65.74 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.147 1.379 . . . . 0.0 112.48 -176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 67.15 49.77 50.67 Favored Glycine 0 N--CA 1.435 -1.395 0 C-N-CA 126.233 1.873 . . . . 0.0 110.799 -173.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.7 pt -117.9 -164.69 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.149 1.379 . . . . 0.0 109.224 176.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -117.94 163.96 15.79 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.512 0.725 . . . . 0.0 110.265 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 7.1 m -133.29 153.47 51.54 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.649 1.58 . . . . 0.0 110.005 -175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 55.1 mt -139.46 90.55 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -119.62 153.93 34.74 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.597 0.713 . . . . 0.0 109.399 -172.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -66.47 -17.13 64.62 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.5 pp -123.27 157.67 32.65 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 126.055 1.742 . . . . 0.0 110.339 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -70.41 139.72 51.9 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.401 ' CB ' HG21 ' A' ' 169' ' ' VAL . 16.5 m -126.67 -178.39 4.36 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -177.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p -72.48 4.97 3.3 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -169.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -142.79 133.01 24.61 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.27 1.428 . . . . 0.0 107.172 -160.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -69.84 -28.96 66.12 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.503 1.521 . . . . 0.0 110.967 -170.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -72.88 10.67 5.23 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.686 1.612 . . . . 0.0 113.865 175.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -98.12 105.06 17.15 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.206 1.503 . . . . 0.0 108.364 167.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -79.1 126.67 31.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -69.62 152.65 44.49 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.405 1.002 . . . . 0.0 111.961 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.6 pt -134.42 163.07 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.326 1.451 . . . . 0.0 111.085 168.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -118.45 -14.9 9.69 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.746 1.218 . . . . 0.0 113.105 170.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.72 168.29 21.71 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 175.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.43 -42.26 79.14 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.75 -27.24 68.58 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -59.92 -21.12 60.69 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.336 1.854 . . . . 0.0 111.319 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 87.7 mt -57.09 -54.79 25.62 Favored 'Isoleucine or valine' 0 C--N 1.342 0.243 0 C-N-CA 125.557 1.543 . . . . 0.0 108.75 170.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 92.2 p -52.66 -42.24 64.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 119.481 1.037 . . . . 0.0 110.46 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -17.66 64.35 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.567 1.147 . . . . 0.0 112.995 -174.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.5 mt -66.25 -55.59 18.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -78.07 -34.47 50.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.51 1.124 . . . . 0.0 111.685 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -83.97 2.61 38.03 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.648 1.179 . . . . 0.0 112.175 -171.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.33 4.6 t 47.37 84.95 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 130.437 3.495 . . . . 0.0 107.607 -173.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt . . . . . 0 C--O 1.249 1.055 0 C-N-CA 127.307 2.243 . . . . 0.0 110.464 168.87 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.124 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 60.52 40.26 17.16 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.059 2.143 . . . . 0.0 113.358 -174.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.2 mmm -98.29 76.14 2.3 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.734 1.255 . . . . 0.0 107.666 -177.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.58 171.51 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.381 159.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.7 mmmt -44.43 100.4 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 126.334 1.854 . . . . 0.0 110.348 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 55.1 m -127.63 149.82 50.01 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.64 147.26 49.94 Favored 'General case' 0 CA--C 1.521 -0.171 0 O-C-N 121.552 -0.717 . . . . 0.0 109.948 177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -126.85 149.93 49.48 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.899 1.28 . . . . 0.0 109.399 -174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' O ' HD12 ' A' ' 162' ' ' ILE . 32.1 mt -149.54 121.29 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -173.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . 0.588 ' CD2' HD13 ' A' ' 162' ' ' ILE . 76.1 m95 -112.12 -174.56 2.49 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 125.014 1.326 . . . . 0.0 110.493 -175.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -130.94 -173.41 3.08 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.96 1.304 . . . . 0.0 108.873 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.33 14.11 1.43 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 126.654 1.981 . . . . 0.0 110.101 175.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . 0.398 0.0 OUTLIER -113.65 4.89 16.26 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 177.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -142.09 -75.83 0.04 OUTLIER Glycine 0 CA--C 1.527 0.814 0 O-C-N 121.05 -1.031 . . . . 0.0 112.007 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.4 t . . . . . 0 C--O 1.25 1.103 0 C-N-CA 125.135 1.374 . . . . 0.0 110.065 178.799 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.3 tp . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 57.1 tpp 41.78 79.08 0.34 Allowed Pre-proline 0 N--CA 1.468 0.448 0 C-N-CA 124.893 1.277 . . . . 0.0 113.052 141.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.39 98.04 0.72 Allowed 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 123.112 2.541 . . . . 0.0 110.557 -174.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.86 -9.61 3.93 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.788 1.185 . . . . 0.0 114.234 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.53 -45.98 16.55 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 119.557 1.679 . . . . 0.0 109.008 -174.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.711 ' HA ' HD12 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -52.01 -31.42 29.55 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.111 1.364 . . . . 0.0 113.733 -174.018 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.33 -45.81 80.17 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.502 0.721 . . . . 0.0 110.963 174.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.421 HG11 ' CH2' ' A' ' 8' ' ' TRP . 0.8 OUTLIER -71.0 -41.07 76.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 -177.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.711 HD12 ' HA ' ' A' ' 90' ' ' ARG . 60.4 mt -62.37 -43.56 98.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -174.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -64.55 -52.45 57.6 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 125.917 1.687 . . . . 0.0 109.649 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.8 t90 -54.43 -45.39 73.01 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.134 0.573 . . . . 0.0 112.155 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.84 64.48 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.908 0.883 . . . . 0.0 112.124 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -56.97 -48.72 77.72 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.463 1.905 . . . . 0.0 109.926 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -70.3 -2.61 13.95 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.577 2.351 . . . . 0.0 113.407 174.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 29.5 m -120.54 7.63 10.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.809 1.644 . . . . 0.0 113.175 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.4 11.09 61.35 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 121.441 -0.787 . . . . 0.0 114.385 171.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.8 mt -60.18 121.27 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -69.58 106.53 3.05 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 167.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -91.17 151.18 21.06 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.414 ' CD1' HD22 ' A' ' 148' ' ' LEU . 80.6 m-85 -145.25 177.43 8.81 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 125.344 1.458 . . . . 0.0 109.609 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.586 ' HB ' HG23 ' A' ' 129' ' ' ILE . 18.8 mt -141.55 145.7 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 C-N-CA 124.404 1.082 . . . . 0.0 108.559 172.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -132.3 141.63 49.05 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.769 1.228 . . . . 0.0 107.81 163.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.628 HG23 ' H ' ' A' ' 109' ' ' LYS . 5.7 t -167.05 -175.46 3.01 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 175.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -104.98 8.13 34.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.376 1.47 . . . . 0.0 112.61 172.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.628 ' H ' HG23 ' A' ' 107' ' ' THR . 6.9 tttm -57.58 153.12 13.68 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 121.116 -0.99 . . . . 0.0 109.866 171.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.56 175.91 43.02 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.505 1.05 . . . . 0.0 111.341 174.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -60.69 -17.0 45.29 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.534 -0.98 . . . . 0.0 112.433 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.31 -26.76 8.01 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.7 1.2 . . . . 0.0 112.284 169.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.36 -53.06 18.93 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 124.761 1.224 . . . . 0.0 111.24 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -53.42 -42.89 67.51 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.382 1.073 . . . . 0.0 110.027 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 23.9 m -63.07 -49.34 74.89 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.189 0.595 . . . . 0.0 110.425 178.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.5 mt -59.14 -46.58 91.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 118.719 0.69 . . . . 0.0 109.769 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 mt -66.96 -35.89 80.98 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 122.075 -0.391 . . . . 0.0 110.559 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -60.24 -45.18 94.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.232 1.013 . . . . 0.0 109.124 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.7 -61.29 2.62 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.123 1.769 . . . . 0.0 111.654 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 60.2 mt -73.99 -32.97 63.64 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.212 -165.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 125.89 47.11 0.21 Allowed Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 148.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.772 HG23 ' CD2' ' A' ' 125' ' ' TYR . 3.6 p -159.4 44.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 CA-C-O 123.796 1.76 . . . . 0.0 107.425 -169.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.79 -25.02 26.59 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 118.731 -2.481 . . . . 0.0 112.357 173.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.05 -20.29 17.46 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 124.553 1.158 . . . . 0.0 111.37 -165.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.772 ' CD2' HG23 ' A' ' 122' ' ' VAL . 35.6 m-85 -62.5 1.94 0.32 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 128.578 2.751 . . . . 0.0 114.245 165.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.518 ' CE2' HG22 ' A' ' 122' ' ' VAL . 8.3 m-85 -141.37 109.02 5.62 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 104.43 -2.433 . . . . 0.0 104.43 174.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -53.44 -38.92 64.0 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.809 1.644 . . . . 0.0 111.153 -170.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -150.73 148.48 28.6 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.586 HG23 ' HB ' ' A' ' 105' ' ' ILE . 4.9 mp -126.84 126.48 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 70.9 mt -84.33 160.93 20.59 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 167.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 29.1 p -138.51 -177.59 4.92 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.428 1.091 . . . . 0.0 109.177 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.58 -30.1 19.71 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.485 -0.759 . . . . 0.0 111.159 161.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -72.23 -9.31 58.29 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.208 -0.933 . . . . 0.0 112.79 -169.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.8 m -56.73 -60.38 3.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.167 1.387 . . . . 0.0 110.758 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.75 -21.43 23.25 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 117.499 -1.723 . . . . 0.0 112.66 -171.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -51.22 154.53 1.62 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-N 119.802 1.801 . . . . 0.0 111.336 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 141' ' ' SER . 1.2 m -45.05 156.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.362 1.465 . . . . 0.0 112.257 170.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.0 ptt180 -70.66 166.99 19.6 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.603 176.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -43.69 142.36 1.92 Allowed Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 123.138 0.575 . . . . 0.0 110.669 170.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.98 -26.98 8.51 Favored 'Cis proline' 0 CA--C 1.55 1.282 0 CA-C-N 119.619 0.9 . . . . 0.0 114.154 2.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.495 ' HB2' HG23 ' A' ' 137' ' ' VAL 0.298 2.7 t 53.77 86.47 0.16 Allowed Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 126.227 1.811 . . . . 0.0 115.606 172.107 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.15 -19.3 29.85 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.397 2.065 . . . . 0.0 111.843 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -61.98 -43.57 98.56 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.175 0.898 . . . . 0.0 110.155 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.59 -23.79 67.53 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.31 -55.17 5.46 Favored 'General case' 0 C--N 1.34 0.169 0 O-C-N 121.224 -0.923 . . . . 0.0 109.464 174.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 98.7 m -52.47 -39.84 61.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.302 1.041 . . . . 0.0 110.548 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -50.29 -64.89 0.67 Allowed 'General case' 0 C--O 1.219 -0.532 0 C-N-CA 125.312 1.445 . . . . 0.0 109.735 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.414 HD22 ' CD1' ' A' ' 104' ' ' PHE . 52.2 mt -55.76 -39.71 71.58 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.547 0.612 . . . . 0.0 112.495 -173.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 75.5 mt -65.1 -50.82 64.62 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 125.329 1.452 . . . . 0.0 108.506 -176.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -58.6 -41.35 85.62 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.387 0.613 . . . . 0.0 111.217 172.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -56.91 -46.37 82.0 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 120.788 -1.195 . . . . 0.0 112.787 -172.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -121.72 21.36 10.81 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.055 0.843 . . . . 0.0 112.479 -179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 54.96 67.51 1.01 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.571 1.148 . . . . 0.0 108.973 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.517 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 14.7 mt -109.84 -179.74 3.89 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.09 1.356 . . . . 0.0 108.226 -176.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -121.28 140.04 52.59 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.337 0.655 . . . . 0.0 110.077 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.9 m -51.03 -46.82 61.73 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.508 1.523 . . . . 0.0 111.84 175.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.28 -30.62 62.18 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 121.082 -1.011 . . . . 0.0 112.068 -178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.89 13.67 12.16 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -175.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.1 t -108.74 154.6 21.81 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 175.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -133.97 143.08 47.95 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 174.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -114.2 159.8 19.71 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.617 1.167 . . . . 0.0 110.825 173.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.588 HD13 ' CD2' ' A' ' 8' ' ' TRP . 2.7 mp -132.42 125.86 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 119.946 1.248 . . . . 0.0 109.685 177.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -146.63 -170.36 15.04 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 170.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.18 15.8 2.61 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -166.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.73 -165.0 1.74 Allowed 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 124.357 1.063 . . . . 0.0 109.848 -164.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.7 t -87.74 -25.06 23.62 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.302 0.641 . . . . 0.0 111.418 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.3 -23.45 51.07 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.969 0.508 . . . . 0.0 111.03 -172.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.64 -30.55 61.17 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.249 1.419 . . . . 0.0 113.141 -172.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -111.49 -8.6 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 124.055 0.942 . . . . 0.0 110.666 -170.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -64.9 -38.63 91.6 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 120.757 -1.214 . . . . 0.0 110.041 176.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -73.94 -32.24 63.41 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.052 -1.03 . . . . 0.0 110.761 174.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -54.62 -37.39 65.56 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 118.576 0.625 . . . . 0.0 110.418 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -61.3 -54.09 48.38 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.596 1.159 . . . . 0.0 113.285 174.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -63.21 -48.61 77.58 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.682 1.128 . . . . 0.0 111.628 -167.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 67.6 m -64.48 -38.06 89.71 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 123.211 0.604 . . . . 0.0 110.955 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.88 71.23 1.26 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.551 -1.819 . . . . 0.0 108.551 -169.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 41.3 pt -126.78 -172.84 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 127.477 2.311 . . . . 0.0 107.032 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -95.17 -176.21 3.74 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.994 1.318 . . . . 0.0 109.875 173.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.72 162.92 40.46 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.563 -1.336 . . . . 0.0 109.799 168.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 53.1 mt -132.47 129.14 58.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 169.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -149.86 160.06 43.88 Favored 'General case' 0 CA--C 1.509 -0.612 0 O-C-N 120.992 -1.067 . . . . 0.0 110.291 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -74.62 -15.81 60.81 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 121.37 -0.831 . . . . 0.0 112.002 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 5.7 mt -116.04 156.83 25.64 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.08 1.752 . . . . 0.0 109.86 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -76.01 153.55 36.42 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 167.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.56 -167.83 2.51 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.39 1.076 . . . . 0.0 109.383 165.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.8 p -82.35 -10.97 58.87 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -81.43 177.59 8.87 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.167 0.987 . . . . 0.0 109.596 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.412 ' C ' ' H ' ' A' ' 190' ' ' ASN . 14.3 pt-20 -125.74 -36.32 2.42 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.885 1.068 . . . . 0.0 113.885 -172.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -75.22 28.37 1.18 Allowed Glycine 0 C--N 1.338 0.678 0 CA-C-N 119.375 0.989 . . . . 0.0 111.621 172.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -100.73 140.49 34.94 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 127.962 2.505 . . . . 0.0 106.397 177.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -121.16 109.32 14.85 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -64.52 129.38 39.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.637 HD12 ' O ' ' A' ' 195' ' ' ALA . 36.0 pt -131.05 176.32 9.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 124.301 1.04 . . . . 0.0 110.167 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -134.72 -16.39 2.02 Favored 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 124.971 1.308 . . . . 0.0 111.888 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.637 ' O ' HD12 ' A' ' 193' ' ' ILE . . . -128.74 -154.59 0.65 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.041 0.837 . . . . 0.0 111.115 173.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -98.9 -27.46 13.89 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.388 0.54 . . . . 0.0 110.409 163.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.02 -25.66 62.77 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 121.156 -0.965 . . . . 0.0 111.997 -167.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -31.6 65.78 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 129.313 3.045 . . . . 0.0 109.58 174.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 38.6 mt -57.34 -54.22 33.67 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-N 119.289 0.95 . . . . 0.0 109.388 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.6 m -55.69 -37.68 68.66 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -60.39 -32.26 71.15 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.177 1.391 . . . . 0.0 112.028 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 93.9 mt -53.56 -43.64 54.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 119.378 0.99 . . . . 0.0 109.556 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -85.09 -41.33 15.83 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 125.57 1.548 . . . . 0.0 109.426 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -85.4 36.8 0.65 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.899 1.68 . . . . 0.0 111.027 -171.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 93.3 m 44.85 84.94 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.248 2.219 . . . . 0.0 111.399 -176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-N 112.97 -1.923 . . . . 0.0 109.832 161.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.756 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -138.63 76.45 1.57 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 126.295 1.838 . . . . 0.0 107.412 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.8 mmm -126.33 76.79 1.64 Allowed 'General case' 0 C--O 1.234 0.272 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.68 173.39 0.57 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.029 1.332 . . . . 0.0 109.689 168.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -45.06 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.483 1.913 . . . . 0.0 112.294 -177.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.4 m -117.49 141.68 48.06 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.645 -1.242 . . . . 0.0 107.645 -176.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -127.7 144.94 51.05 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 121.313 0.577 . . . . 0.0 109.942 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.59 ' CD2' HD11 ' A' ' 162' ' ' ILE . 2.0 m-85 -131.39 145.47 51.83 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.872 1.669 . . . . 0.0 108.07 -172.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 56.2 mt -145.22 89.74 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.211 -0.952 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -171.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -78.36 -171.63 2.51 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 119.769 1.168 . . . . 0.0 110.383 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -131.28 164.42 25.65 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.516 1.526 . . . . 0.0 111.788 172.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.84 -30.41 45.17 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.327 2.251 . . . . 0.0 112.824 176.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -134.08 13.53 3.92 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.785 1.175 . . . . 0.0 113.905 -173.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -113.32 135.79 12.89 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.109 -1.996 . . . . 0.0 108.109 163.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.366 6.5 t . . . . . 0 C--O 1.253 1.242 0 C-N-CA 129.346 3.058 . . . . 0.0 114.948 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.458 ' HG ' ' H ' ' A' ' 86' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.458 ' H ' ' HG ' ' A' ' 85' ' ' LEU . 2.0 mpp? -103.83 87.13 1.4 Allowed Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 127.824 2.45 . . . . 0.0 105.775 176.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -56.66 117.82 4.56 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.504 2.803 . . . . 0.0 109.821 -171.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 127.73 -19.51 5.86 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.488 1.518 . . . . 0.0 111.57 -177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.413 ' HA ' HD23 ' A' ' 196' ' ' LEU . . . -88.19 -35.68 17.23 Favored 'General case' 0 C--N 1.344 0.334 0 CA-C-N 118.772 1.286 . . . . 0.0 112.766 -174.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.2 ttt-85 -59.91 -28.37 67.53 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 118.835 0.743 . . . . 0.0 112.177 -171.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -58.47 -60.66 3.45 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 125.832 1.653 . . . . 0.0 110.63 174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.4 t -60.56 -47.63 91.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 117.843 -1.075 . . . . 0.0 108.952 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.54 ' HA ' HE22 ' A' ' 103' ' ' GLN . 4.6 mp -44.37 -54.23 6.05 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 120.857 1.662 . . . . 0.0 113.521 171.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -63.82 -38.43 91.08 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.874 0.469 . . . . 0.0 112.085 -175.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 27.2 t90 -64.73 -54.23 34.8 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.084 0.954 . . . . 0.0 109.173 174.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.75 94.28 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.537 1.935 . . . . 0.0 112.957 -172.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.78 -55.01 34.68 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.663 1.585 . . . . 0.0 110.774 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.19 -36.72 80.02 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.537 0.684 . . . . 0.0 111.429 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 61.6 m -65.65 -2.39 3.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.545 1.138 . . . . 0.0 113.272 168.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.81 19.62 73.55 Favored Glycine 0 CA--C 1.525 0.706 0 O-C-N 119.874 -1.766 . . . . 0.0 112.161 174.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 25.3 mt -75.08 115.53 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 173.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -71.0 133.99 46.78 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 169.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.54 HE22 ' HA ' ' A' ' 93' ' ' LEU . 8.1 mt-30 -112.83 151.0 30.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 175.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -144.32 175.87 9.78 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 126.763 2.025 . . . . 0.0 106.838 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.3 mt -139.88 148.47 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 171.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -132.78 100.5 4.95 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.908 0.777 . . . . 0.0 110.323 168.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.2 t -103.44 170.84 7.7 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 122.428 1.109 . . . . 0.0 108.322 169.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -96.16 -9.24 31.09 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.042 1.337 . . . . 0.0 111.396 168.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 178.62 5.85 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 120.184 1.356 . . . . 0.0 112.152 -172.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.62 176.03 36.33 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.13 1.347 . . . . 0.0 112.579 -178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -57.57 -16.57 10.55 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.543 2.337 . . . . 0.0 111.792 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -44.56 -30.56 0.92 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.236 1.814 . . . . 0.0 111.3 164.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -44.96 -62.79 1.1 Allowed 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 126.106 1.763 . . . . 0.0 110.81 173.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.444 ' CE1' ' HB ' ' A' ' 129' ' ' ILE . 63.4 m-85 -57.07 -38.35 73.15 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.529 0.732 . . . . 0.0 111.226 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 7.7 m -63.43 -39.95 95.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.876 0.87 . . . . 0.0 110.701 177.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 72.6 mt -57.83 -57.18 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 119.493 1.042 . . . . 0.0 109.731 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.61 -37.52 84.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 119.569 1.077 . . . . 0.0 111.31 -173.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 15.8 mtmt -64.69 -45.81 85.06 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.527 0.731 . . . . 0.0 110.582 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -54.46 -53.64 51.52 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.794 0.838 . . . . 0.0 109.437 174.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.0 -14.81 63.26 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.249 1.02 . . . . 0.0 112.894 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 75.93 32.84 52.24 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.786 -1.008 . . . . 0.0 112.693 171.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.413 HG11 HD11 ' A' ' 85' ' ' LEU . 3.4 m -132.9 14.5 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.407 1.483 . . . . 0.0 111.672 177.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.45 -44.61 55.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 m -61.6 -26.28 67.87 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -171.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CD2' HD23 ' A' ' 93' ' ' LEU . 49.3 m-85 -60.55 -34.12 73.68 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 122.004 -0.435 . . . . 0.0 111.112 173.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -99.99 94.51 6.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.524 1.53 . . . . 0.0 107.259 -174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 39.0 m -52.96 -43.46 66.39 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.819 1.648 . . . . 0.0 111.13 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.28 156.81 44.82 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.824 1.65 . . . . 0.0 107.262 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.444 ' HB ' ' CE1' ' A' ' 114' ' ' PHE . 5.0 mp -137.93 157.03 32.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 177.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.5 mt -131.18 156.02 46.04 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.259 1.824 . . . . 0.0 108.699 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.3 p -158.89 -174.87 4.97 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.47 1.508 . . . . 0.0 110.367 -151.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.8 p -59.49 -30.87 68.86 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.975 -1.078 . . . . 0.0 112.255 162.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -63.38 -31.3 72.42 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.254 0.934 . . . . 0.0 111.044 -177.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.4 m -63.45 -37.24 86.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.006 1.323 . . . . 0.0 111.289 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 73.97 5.47 70.38 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.458 170.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -58.26 168.46 1.06 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 119.214 1.507 . . . . 0.0 111.793 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.3 m -53.27 161.79 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.599 1.16 . . . . 0.0 113.407 172.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.1 mmt180 -78.1 160.73 27.89 Favored 'General case' 0 CA--C 1.521 -0.144 0 C-N-CA 124.865 1.266 . . . . 0.0 110.526 169.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -58.53 137.9 85.83 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-O 117.616 -1.183 . . . . 0.0 109.303 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.9 121.72 5.16 Favored 'Cis proline' 0 CA--C 1.536 0.586 0 CA-C-N 120.405 1.181 . . . . 0.0 110.845 -8.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 p -122.08 68.2 26.24 Favored Pre-proline 0 C--O 1.238 0.469 0 C-N-CA 125.604 1.562 . . . . 0.0 110.98 -165.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.74 -24.29 47.49 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 CA-C-N 120.127 1.081 . . . . 0.0 112.198 -163.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -44.5 -44.11 8.38 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 130.08 3.352 . . . . 0.0 111.117 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.31 -19.94 64.71 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -174.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.55 -60.25 2.32 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 168.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 m -56.87 -33.59 67.0 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.332 1.053 . . . . 0.0 111.495 -167.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -54.27 -49.37 69.73 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.595 0.758 . . . . 0.0 111.197 173.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 95.2 mt -72.44 -31.64 65.64 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 124.914 1.286 . . . . 0.0 111.794 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 81.9 mt -61.49 -59.86 4.58 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -174.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -70.54 -17.24 62.93 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 119.888 -0.725 . . . . 0.0 112.19 -177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -54.34 -49.1 70.54 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.353 0.979 . . . . 0.0 109.962 172.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.92 23.57 5.33 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.487 0.66 . . . . 0.0 112.561 -171.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.0 mp0 45.17 46.69 9.87 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.867 2.067 . . . . 0.0 110.648 -171.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 29.0 mt -77.0 164.68 25.53 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 172.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.438 ' CG ' ' H ' ' A' ' 158' ' ' ASN . 26.1 p-10 -104.24 153.53 20.87 Favored 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 128.572 2.749 . . . . 0.0 108.533 176.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 48.2 m -62.15 -27.36 68.89 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.645 0.736 . . . . 0.0 109.715 165.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -84.74 -29.37 25.56 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 120.724 -1.235 . . . . 0.0 111.966 -156.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.438 ' H ' ' CG ' ' A' ' 155' ' ' ASN . 3.3 m-80 -102.05 20.64 16.21 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.458 -0.776 . . . . 0.0 109.732 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.8 m -100.4 122.84 43.8 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 178' ' ' GLN . 97.7 m-85 -125.15 148.13 48.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.736 1.614 . . . . 0.0 110.077 -174.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -115.53 -20.22 10.29 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -168.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.59 HD11 ' CD2' ' A' ' 6' ' ' PHE . 1.6 mp 44.68 74.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 126.944 2.098 . . . . 0.0 112.797 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.56 173.17 17.54 Favored Glycine 0 CA--C 1.52 0.351 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 177.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 53.8 p30 -125.19 25.6 7.15 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.521 -0.988 . . . . 0.0 112.573 -153.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -145.96 176.59 9.58 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -169.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.3 t -70.97 -29.46 65.47 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.82 1.248 . . . . 0.0 111.038 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.67 11.64 14.69 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.035 0.934 . . . . 0.0 110.481 -177.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -75.75 -54.47 6.9 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 76.7 t -71.33 -17.1 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.836 0 O-C-N 121.382 -0.824 . . . . 0.0 111.762 -173.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -59.94 -61.16 2.82 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.026 1.73 . . . . 0.0 111.355 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -68.95 -31.76 70.87 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 120.391 -1.443 . . . . 0.0 109.959 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.16 -50.62 72.89 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 117.921 -1.038 . . . . 0.0 109.171 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.5 -52.58 16.85 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.195 1.398 . . . . 0.0 110.618 174.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -73.1 -21.41 60.75 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.766 -171.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.0 m -81.66 -33.47 31.31 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.446 -0.784 . . . . 0.0 111.072 169.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.11 19.81 54.61 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.278 1.418 . . . . 0.0 112.521 -166.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.7 pt -102.14 174.01 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.331 0 CA-C-N 118.982 1.391 . . . . 0.0 111.51 -178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 160' ' ' TYR . 23.8 mm-40 -87.74 176.45 7.39 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 124.766 1.226 . . . . 0.0 110.338 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 5.5 m -153.09 139.48 18.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.86 1.264 . . . . 0.0 109.768 175.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.437 HG21 HG12 ' A' ' 199' ' ' ILE . 61.2 mt -123.0 84.25 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -114.63 149.84 36.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.925 0.869 . . . . 0.0 109.972 -172.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -64.42 -14.79 58.68 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.608 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 17.0 mt -100.74 166.94 10.62 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 125.254 1.422 . . . . 0.0 110.183 -178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -95.07 163.55 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.563 172.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 8.0 t -151.14 -175.04 5.0 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.239 1.816 . . . . 0.0 107.352 168.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.6 p -115.57 71.8 0.78 Allowed 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 170.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -142.28 137.11 30.4 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.99 91.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.412 1.885 . . . . 0.0 108.695 167.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 133.98 -3.51 4.52 Favored Glycine 0 CA--C 1.521 0.426 0 CA-C-O 117.941 -1.477 . . . . 0.0 113.255 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.46 131.28 34.41 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 120.525 2.163 . . . . 0.0 106.422 171.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 70.6 m-70 -126.61 118.76 25.47 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.782 1.233 . . . . 0.0 108.804 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -67.23 147.63 52.79 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 118.471 0.578 . . . . 0.0 112.039 176.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.5 pt -141.59 164.88 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.876 1.67 . . . . 0.0 111.505 168.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -121.09 -15.37 8.23 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 125.833 1.653 . . . . 0.0 112.468 171.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.72 164.99 33.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.009 1.724 . . . . 0.0 107.192 171.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 89' ' ' ALA . 1.4 mp -61.14 -30.69 70.53 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.114 0.966 . . . . 0.0 109.787 174.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -56.18 -33.07 64.92 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 176.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -64.77 -22.64 67.03 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.943 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.437 HG12 HG21 ' A' ' 180' ' ' ILE . 96.7 mt -55.27 -57.36 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 83.5 p -50.09 -39.4 42.44 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.444 0.64 . . . . 0.0 112.237 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -67.7 -29.4 68.65 Favored 'General case' 0 N--CA 1.458 -0.037 0 C-N-CA 125.499 1.52 . . . . 0.0 111.515 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.9 mt -52.37 -48.03 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -86.72 -0.88 57.15 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.263 1.425 . . . . 0.0 112.226 -173.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -119.88 14.04 12.38 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.276 1.43 . . . . 0.0 111.543 -175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 58.6 m 57.06 87.3 0.06 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 125.791 1.636 . . . . 0.0 111.143 -167.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt . . . . . 0 N--CA 1.426 -1.649 0 C-N-CA 127.246 2.219 . . . . 0.0 113.616 147.547 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.693 0 CA-C-O 119.644 -0.531 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 52.18 4.57 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 128.569 2.748 . . . . 0.0 118.294 167.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.1 mmm 55.63 62.23 2.51 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 123.306 1.527 . . . . 0.0 110.039 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -80.77 122.05 26.68 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 169.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.3 mtpp 43.08 58.94 3.1 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 161.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.3 m -103.69 149.56 24.85 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.43 146.14 51.32 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 121.7 -0.625 . . . . 0.0 109.962 173.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.14 149.93 51.63 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 125.29 1.436 . . . . 0.0 108.373 -173.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 53.7 mt -140.56 131.94 30.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -120.82 148.49 43.95 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.524 1.53 . . . . 0.0 110.371 -173.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -89.48 -37.73 14.56 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.277 -0.889 . . . . 0.0 112.315 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 65.16 -20.45 0.08 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 129.374 3.07 . . . . 0.0 114.157 178.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -86.78 25.09 1.33 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 120.701 1.591 . . . . 0.0 110.372 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 149.07 1.24 0.41 Allowed Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.233 -1.315 . . . . 0.0 115.471 176.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.37 0 CA-C-O 115.919 -1.991 . . . . 0.0 106.17 161.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.509 HD13 ' H ' ' A' ' 86' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.67 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.509 ' H ' HD13 ' A' ' 85' ' ' LEU . 1.8 mmt -118.04 87.27 28.04 Favored Pre-proline 0 C--O 1.237 0.412 0 C-N-CA 126.771 2.028 . . . . 0.0 109.487 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -66.1 94.74 0.3 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 124.555 3.503 . . . . 0.0 109.843 -175.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.08 -27.53 2.65 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 113.801 -1.545 . . . . 0.0 112.162 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.78 -34.81 26.93 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 119.295 1.547 . . . . 0.0 111.173 -170.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -51.73 -35.44 43.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.325 1.05 . . . . 0.0 111.969 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -45.09 -56.93 4.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.819 2.448 . . . . 0.0 111.079 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.99 -39.83 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.985 1.714 . . . . 0.0 110.052 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 59.2 mt -51.52 -46.65 63.36 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.939 1.245 . . . . 0.0 110.078 177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.66 -56.03 26.17 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 123.694 0.797 . . . . 0.0 111.257 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.46 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 15.4 t90 -52.57 -46.75 67.0 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.925 1.29 . . . . 0.0 111.198 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.02 -38.62 82.78 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.159 0.984 . . . . 0.0 111.75 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -70.94 -42.65 69.57 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.664 0.786 . . . . 0.0 111.017 -177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -60.4 -34.14 73.49 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.54 1.136 . . . . 0.0 110.701 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.4 m -78.09 -4.52 47.75 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.587 1.155 . . . . 0.0 113.549 172.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 57.71 27.26 58.73 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 119.768 1.167 . . . . 0.0 112.969 -177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.7 mt -60.81 124.67 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 163.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -74.04 103.32 4.47 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -91.29 137.87 32.03 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.235 0.47 . . . . 0.0 110.21 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -138.44 173.15 11.91 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.036 1.735 . . . . 0.0 110.51 -176.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.417 ' HB ' HG23 ' A' ' 129' ' ' ILE . 17.6 mt -146.62 150.83 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.229 1.412 . . . . 0.0 108.777 -172.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -158.44 124.94 4.72 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.329 1.452 . . . . 0.0 111.935 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.4 t -155.8 171.39 20.11 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.642 1.177 . . . . 0.0 111.579 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 42.4 p-80 -65.05 -26.36 68.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 126.263 1.825 . . . . 0.0 111.917 165.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -61.91 136.38 57.95 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -174.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.43 -161.95 28.29 Favored Glycine 0 N--CA 1.467 0.709 0 C-N-CA 124.146 0.879 . . . . 0.0 112.705 -170.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.406 ' ND2' ' HG3' ' A' ' 133' ' ' GLN . 32.0 m120 -47.24 -30.8 3.24 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.982 2.113 . . . . 0.0 111.999 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -58.45 -24.91 61.52 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.926 -1.109 . . . . 0.0 113.374 177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.64 -35.31 77.55 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.333 0.97 . . . . 0.0 111.636 -177.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -62.06 -40.77 96.91 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 119.312 0.96 . . . . 0.0 109.699 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.2 m -63.44 -41.9 98.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.975 1.31 . . . . 0.0 109.533 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 93.0 mt -57.56 -52.39 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.262 176.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.26 -41.17 96.46 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 120.834 1.652 . . . . 0.0 111.828 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt -66.44 -27.81 68.11 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.786 0.721 . . . . 0.0 112.429 178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -65.19 -49.1 71.07 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 122.534 1.159 . . . . 0.0 109.134 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 53.5 mt -73.89 -11.94 60.51 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.428 1.891 . . . . 0.0 112.123 -175.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 76.15 19.37 78.59 Favored Glycine 0 CA--C 1.526 0.747 0 CA-C-O 118.878 -0.957 . . . . 0.0 113.253 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.9 m -116.6 18.17 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 119.072 1.436 . . . . 0.0 111.143 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -53.85 -49.78 67.7 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.866 -0.521 . . . . 0.0 111.021 175.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 5.0 t -67.5 -22.44 65.45 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.724 0.64 . . . . 0.0 112.422 -168.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -59.7 -32.35 70.43 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 119.024 0.829 . . . . 0.0 111.644 176.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -103.12 122.68 45.19 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -173.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.8 m -61.48 -45.12 95.57 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -157.69 145.24 18.54 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -169.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.417 HG23 ' HB ' ' A' ' 105' ' ' ILE . 4.3 mp -135.14 131.54 52.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.406 0.622 . . . . 0.0 109.879 -170.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -89.23 162.92 15.63 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 122.034 0.921 . . . . 0.0 110.265 170.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 41.7 p -155.46 -179.06 7.73 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 125.555 1.542 . . . . 0.0 107.556 -171.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.35 -22.12 1.7 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.644 1.349 . . . . 0.0 114.644 168.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.406 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 91.5 mm-40 -67.39 -58.8 4.12 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.004 0.82 . . . . 0.0 110.357 173.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 61.6 m -99.95 55.36 0.93 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 104.07 -2.567 . . . . 0.0 104.07 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.91 -20.74 75.62 Favored Glycine 0 C--N 1.338 0.672 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.12 -171.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 45.0 -167.56 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 126.407 1.883 . . . . 0.0 112.863 -165.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.488 HG23 ' CB ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -54.68 172.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 C-N-CA 127.281 2.232 . . . . 0.0 112.252 173.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -59.54 152.71 21.33 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.743 169.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -48.23 138.14 11.0 Favored Pre-proline 0 C--O 1.236 0.359 0 CA-C-O 117.666 -1.159 . . . . 0.0 108.968 162.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.87 -43.97 0.42 Allowed 'Cis proline' 0 CA--C 1.533 0.458 0 CA-C-N 120.453 1.198 . . . . 0.0 113.822 6.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.488 ' CB ' HG23 ' A' ' 137' ' ' VAL . 3.6 t 55.17 81.45 0.26 Allowed Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 124.672 1.189 . . . . 0.0 111.679 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -66.3 -16.62 52.2 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.487 2.125 . . . . 0.0 111.462 166.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -55.4 -48.53 74.22 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 120.261 1.391 . . . . 0.0 110.824 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.99 -18.83 64.68 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.76 -52.9 5.72 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 118.194 -0.907 . . . . 0.0 108.982 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.5 m -54.44 -38.33 66.18 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.455 0.702 . . . . 0.0 110.157 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 21.2 t80 -54.52 -58.53 7.1 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.612 1.165 . . . . 0.0 110.403 171.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 22.2 mt -65.59 -27.72 68.62 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 119.561 1.073 . . . . 0.0 112.093 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 75.8 mt -65.9 -59.75 3.54 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 173.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.52 -30.72 69.92 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.314 1.046 . . . . 0.0 113.131 -177.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.544 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 5.6 mmpt? -57.42 -35.31 69.91 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.09 -1.006 . . . . 0.0 112.092 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -140.99 24.23 2.18 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -177.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.4 mp0 49.94 47.73 22.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.195 1.798 . . . . 0.0 110.235 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 59.3 mt -83.6 165.55 18.94 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.441 1.096 . . . . 0.0 109.395 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -106.34 134.43 49.48 Favored 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 124.144 0.977 . . . . 0.0 108.829 -171.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 m -60.47 -42.2 95.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.492 0.663 . . . . 0.0 109.74 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -74.02 -24.82 59.62 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 120.793 -1.192 . . . . 0.0 112.58 -176.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -92.95 5.59 50.86 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.917 -1.039 . . . . 0.0 109.429 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -107.32 146.97 30.89 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -132.04 167.45 19.68 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.873 1.669 . . . . 0.0 107.612 -176.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -143.37 151.38 40.37 Favored 'General case' 0 CA--C 1.522 -0.131 0 C-N-CA 123.593 0.757 . . . . 0.0 109.968 173.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.6 mt -138.45 118.82 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.49 -6.55 0.03 OUTLIER Glycine 0 CA--C 1.525 0.708 0 CA-C-O 119.056 -0.858 . . . . 0.0 113.904 -175.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.456 ' HB2' ' CD1' ' A' ' 182' ' ' PHE . 40.5 t0 56.16 67.69 0.97 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.132 2.573 . . . . 0.0 112.356 169.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -153.94 167.96 27.99 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 120.879 -1.138 . . . . 0.0 110.936 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.0 t -61.25 -44.53 97.09 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.293 0.568 . . . . 0.0 109.989 167.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -5.21 14.28 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.755 1.622 . . . . 0.0 112.3 -171.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -54.52 38.5 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.526 1.13 . . . . 0.0 109.786 171.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 185' ' ' SER . 25.7 m -70.76 -30.45 42.09 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 C-N-CA 118.248 -1.381 . . . . 0.0 111.688 -170.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -61.5 -48.69 79.94 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 123.825 0.85 . . . . 0.0 109.827 -172.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -80.02 -39.95 28.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.601 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.0 78.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.622 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -61.2 -53.77 52.71 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.833 0.853 . . . . 0.0 110.833 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -64.81 -34.96 79.6 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 119.574 -0.25 . . . . 0.0 110.975 -172.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.4 m -69.96 -34.98 74.1 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.096 0.862 . . . . 0.0 112.826 168.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.07 44.93 6.11 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 124.865 1.222 . . . . 0.0 111.785 -174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 10.9 pt -116.09 -179.14 1.29 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 125.565 1.546 . . . . 0.0 108.806 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -103.52 165.75 10.84 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.371 0.605 . . . . 0.0 109.745 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.93 143.27 38.55 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 123.987 0.915 . . . . 0.0 108.804 -163.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 62.7 mt -133.92 100.18 3.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.454 ' HB2' HD12 ' A' ' 183' ' ' LEU . 18.6 p30 -123.78 158.12 32.46 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 124.634 1.174 . . . . 0.0 109.947 -176.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 164' ' ' ASP . 64.3 m-85 -86.33 -3.16 58.94 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 120.229 -1.544 . . . . 0.0 111.218 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 181' ' ' ASN . 0.3 OUTLIER -129.34 155.8 45.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.427 1.891 . . . . 0.0 110.432 -174.324 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -74.79 142.24 44.27 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.451 ' HB3' HG21 ' A' ' 169' ' ' VAL . 0.6 OUTLIER -144.73 177.68 8.53 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.412 1.485 . . . . 0.0 107.996 173.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 32.8 p -93.15 59.65 3.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.126 1.37 . . . . 0.0 110.774 -160.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -142.93 175.06 10.12 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.972 0.509 . . . . 0.0 112.238 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -115.84 -3.37 12.2 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.203 1.401 . . . . 0.0 113.588 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -118.94 9.1 12.43 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.434 1.492 . . . . 0.0 112.417 175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.12 138.02 33.24 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 119.15 1.475 . . . . 0.0 107.462 173.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -112.64 107.08 15.64 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -59.69 142.64 52.65 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.438 168.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 11.6 pt -131.64 165.59 31.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 125.635 1.574 . . . . 0.0 110.126 170.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 3.4 pm0 -117.83 -16.3 9.97 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.011 0.924 . . . . 0.0 113.401 169.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -149.35 165.18 32.78 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.584 1.154 . . . . 0.0 109.021 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 30.6 mt -63.44 -44.55 94.2 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.232 1.813 . . . . 0.0 107.63 178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.42 -15.01 63.4 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -60.88 -22.89 64.74 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 120.337 1.426 . . . . 0.0 110.407 175.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 19.8 mt -55.83 -53.43 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.049 1.34 . . . . 0.0 109.55 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.46 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 8.6 m -60.06 -32.89 71.36 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 119.93 1.241 . . . . 0.0 111.898 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -65.02 -26.65 68.37 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 118.3 -0.857 . . . . 0.0 112.227 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.6 mt -53.55 -55.97 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.0 10.45 18.95 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.019 1.328 . . . . 0.0 113.62 -169.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -119.99 -1.29 10.44 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 124.552 1.141 . . . . 0.0 112.458 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.1 m -131.28 24.81 4.86 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.431 0.693 . . . . 0.0 111.878 -172.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 51.6 mttm . . . . . 0 C--O 1.247 0.963 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 170.598 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.243 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 56.3 m-70 -144.55 117.12 8.61 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 117.664 0.732 . . . . 0.0 110.135 -177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 mmm -134.9 45.32 2.55 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.07 1.748 . . . . 0.0 110.043 -172.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 55.49 -171.46 0.07 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.938 1.295 . . . . 0.0 113.117 175.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -78.8 79.4 5.21 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 152.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 m -101.99 146.59 27.67 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.97 149.41 51.71 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 121.501 -0.749 . . . . 0.0 109.242 176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -123.13 156.73 34.42 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.903 1.281 . . . . 0.0 108.03 176.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.2 mt -140.74 135.84 34.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 70.8 m95 -120.54 161.66 20.92 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.011 0.924 . . . . 0.0 111.068 -179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -102.91 -4.18 25.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.549 1.54 . . . . 0.0 111.941 -178.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 51.2 tp 46.95 73.3 0.19 Allowed 'General case' 0 C--O 1.235 0.314 0 C-N-CA 128.837 2.855 . . . . 0.0 111.347 -175.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -146.22 -159.37 1.01 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 175.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.25 1.36 49.95 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 118.064 -1.409 . . . . 0.0 114.309 175.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 87.2 m . . . . . 0 C--O 1.257 1.465 0 C-N-CA 126.493 1.917 . . . . 0.0 107.426 166.129 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.456 HD21 HG11 ' A' ' 122' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.502 -0.872 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 23.6 tpp -103.37 88.07 1.57 Allowed Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -175.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -53.6 121.12 8.94 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.346 2.031 . . . . 0.0 108.189 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.16 -41.8 1.72 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -168.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.24 -32.39 49.72 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 121.644 -0.915 . . . . 0.0 111.038 -169.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.9 -32.16 67.45 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 119.109 -0.472 . . . . 0.0 111.637 -176.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.32 -49.1 77.18 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.425 1.09 . . . . 0.0 111.563 173.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 83.9 t -77.55 -43.82 29.87 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 CA-C-O 117.552 -1.214 . . . . 0.0 109.678 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 mp -44.0 -56.18 4.15 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 125.649 1.58 . . . . 0.0 111.153 170.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.55 -54.92 41.38 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.74 0.416 . . . . 0.0 110.874 -177.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -56.71 -43.25 80.4 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.106 1.363 . . . . 0.0 112.502 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -77.5 -38.36 49.14 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 124.368 1.067 . . . . 0.0 112.049 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -69.89 -41.47 74.69 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 123.676 0.79 . . . . 0.0 110.845 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -61.03 -15.53 33.16 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.76 -0.587 . . . . 0.0 111.4 170.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.0 m -108.24 5.96 26.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.182 1.793 . . . . 0.0 113.468 -177.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.06 8.72 55.05 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.671 1.129 . . . . 0.0 113.695 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.4 mt -55.5 120.5 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 mm100 -71.05 92.68 0.97 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 172.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -71.95 151.56 43.17 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 168.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -141.78 172.59 12.48 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.008 2.123 . . . . 0.0 107.383 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.535 ' HB ' HG23 ' A' ' 129' ' ' ILE . 16.9 mt -136.4 155.07 33.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 171.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -136.46 115.38 12.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 164.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.3 t -121.88 157.04 32.02 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 122.206 1.003 . . . . 0.0 108.971 173.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 37.8 p-80 -63.57 -30.2 71.35 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.542 -0.753 . . . . 0.0 111.014 165.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -61.58 142.2 57.27 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 126.198 1.799 . . . . 0.0 109.898 -166.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.5 -170.02 39.09 Favored Glycine 0 CA--C 1.531 1.079 0 O-C-N 121.351 -0.843 . . . . 0.0 112.348 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -52.05 -24.94 7.51 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 128.387 2.675 . . . . 0.0 116.015 -163.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -69.91 -11.46 60.89 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 118.982 0.81 . . . . 0.0 112.154 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.37 80.3 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.23 1.012 . . . . 0.0 110.953 177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -48.4 -46.39 37.25 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 125.038 1.335 . . . . 0.0 110.454 170.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.2 m -70.88 -37.92 73.05 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.383 1.073 . . . . 0.0 111.382 -171.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.4 mt -60.77 -45.95 96.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 125.13 1.372 . . . . 0.0 108.9 171.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.2 mt -69.33 -35.5 75.98 Favored 'General case' 0 C--O 1.236 0.36 0 O-C-N 121.012 -1.055 . . . . 0.0 111.582 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -50.17 73.44 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.289 0.635 . . . . 0.0 109.692 170.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -48.96 -48.13 43.37 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.962 0.905 . . . . 0.0 111.544 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.7 mt -75.35 -10.36 59.39 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.097 1.359 . . . . 0.0 113.281 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 71.01 23.48 78.07 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.78 0.705 . . . . 0.0 114.27 173.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.456 HG11 HD21 ' A' ' 85' ' ' LEU . 13.3 m -124.23 13.46 4.86 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 C-N-CA 125.027 1.331 . . . . 0.0 110.471 176.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.36 -43.06 99.51 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.885 1.22 . . . . 0.0 110.617 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.1 m -74.21 3.0 7.83 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.458 1.503 . . . . 0.0 112.68 -175.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -80.12 -0.28 35.17 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 117.964 -1.017 . . . . 0.0 111.605 164.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -144.58 133.02 21.95 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.532 1.515 . . . . 0.0 108.728 -173.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 86.2 m -60.75 -68.86 0.26 Allowed 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 127.979 2.512 . . . . 0.0 112.072 -174.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -138.81 123.61 18.73 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.155 1.382 . . . . 0.0 107.726 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.535 HG23 ' HB ' ' A' ' 105' ' ' ILE . 5.1 mp -105.54 98.16 6.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 -172.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.73 HD12 ' CB ' ' A' ' 134' ' ' SER . 4.2 mm? -70.55 147.41 49.32 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.1 p -127.63 -168.78 1.94 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.506 2.322 . . . . 0.0 110.696 -172.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.9 t -56.96 -23.12 43.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.072 1.349 . . . . 0.0 113.426 166.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -64.98 -22.51 67.01 Favored 'General case' 0 C--O 1.228 -0.079 0 C-N-CA 124.014 0.926 . . . . 0.0 111.073 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.73 ' CB ' HD12 ' A' ' 130' ' ' LEU . 1.0 OUTLIER -110.07 72.52 0.8 Allowed 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 128.719 2.807 . . . . 0.0 105.597 177.251 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.36 48.68 3.67 Favored Glycine 0 N--CA 1.458 0.13 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -61.49 117.57 5.88 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 116.823 0.312 . . . . 0.0 110.723 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 138' ' ' ARG . 18.1 t 54.75 -165.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 124.906 1.283 . . . . 0.0 109.982 167.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.695 ' H ' HG12 ' A' ' 137' ' ' VAL . 82.6 mtt180 -128.12 0.4 5.84 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 120.036 -1.665 . . . . 0.0 114.521 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt 98.23 112.73 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.486 0 C-N-CA 129.003 2.921 . . . . 0.0 107.532 166.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -61.17 154.63 56.4 Favored 'Cis proline' 0 C--N 1.349 0.59 0 CA-C-N 120.729 1.296 . . . . 0.0 111.79 6.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.406 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 3.0 p -142.17 82.2 13.46 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 124.726 1.211 . . . . 0.0 111.57 -171.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.42 -20.24 24.22 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.08 2.52 . . . . 0.0 113.965 -177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -69.57 -27.16 64.89 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 121.209 -0.932 . . . . 0.0 112.034 -170.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.65 94.99 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.58 -44.79 85.6 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.34 -0.85 . . . . 0.0 110.144 173.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 73.9 m -53.85 -40.38 66.44 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.155 1.343 . . . . 0.0 111.158 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -61.76 -48.97 78.27 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.7 mp -62.59 -37.98 88.36 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.809 1.244 . . . . 0.0 111.496 -172.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.526 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 86.7 mt -64.51 -54.13 37.11 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.12 -35.94 76.38 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 176.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -56.92 -29.01 62.7 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 120.714 -1.241 . . . . 0.0 112.856 -175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -138.07 19.52 2.8 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.2 mm-40 48.59 70.19 0.48 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.862 1.665 . . . . 0.0 110.654 -173.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 76.0 mt -109.33 -176.2 2.96 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.184 1.394 . . . . 0.0 109.99 -172.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -122.08 129.1 52.08 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.465 1.106 . . . . 0.0 109.905 -172.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.37 -17.47 20.42 Favored 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 125.165 1.386 . . . . 0.0 112.007 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.413 ' HA ' HE22 ' A' ' 178' ' ' GLN . 0.3 OUTLIER -118.49 19.36 13.35 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 121.498 -0.751 . . . . 0.0 109.839 -174.024 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -128.3 8.61 6.05 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.87 1.668 . . . . 0.0 110.917 170.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.425 HG22 ' H ' ' A' ' 159' ' ' THR . 1.8 t -91.23 158.95 16.3 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.897 1.679 . . . . 0.0 109.783 176.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -147.84 105.47 3.69 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.015 -1.053 . . . . 0.0 109.64 177.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -85.6 133.07 34.07 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.093 0.957 . . . . 0.0 111.571 176.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.78 105.53 18.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 124.681 1.192 . . . . 0.0 109.056 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -126.37 -164.45 11.76 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.879 1.704 . . . . 0.0 110.859 177.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -136.91 -9.67 1.8 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.9 158.07 32.78 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 120.904 1.683 . . . . 0.0 110.912 -170.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 14.9 t -54.82 -32.3 60.22 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.618 -0.676 . . . . 0.0 112.489 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.6 -28.55 69.43 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.894 0.878 . . . . 0.0 110.507 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -69.9 -0.99 8.27 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.908 1.683 . . . . 0.0 112.024 176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 10.2 t -120.48 -17.21 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 125.284 1.434 . . . . 0.0 109.61 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -65.93 -58.5 5.41 Favored 'General case' 0 C--N 1.338 0.101 0 O-C-N 120.916 -1.115 . . . . 0.0 108.734 168.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -63.75 -33.86 76.61 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.202 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.58 97.58 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.451 -0.785 . . . . 0.0 109.913 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -62.54 -43.59 98.43 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.338 0.972 . . . . 0.0 111.08 171.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -64.61 -37.9 89.17 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 117.705 -1.141 . . . . 0.0 112.464 -172.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.4 p -79.14 -36.8 39.92 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 120.834 1.652 . . . . 0.0 110.778 168.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.26 65.61 1.26 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.533 -1.827 . . . . 0.0 108.533 -172.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.39 174.61 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 127.295 2.238 . . . . 0.0 108.587 174.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.413 HE22 ' HA ' ' A' ' 157' ' ' ASP . 14.0 mp0 -96.16 170.08 9.51 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.81 1.644 . . . . 0.0 111.96 -176.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 4.6 m -143.36 156.92 44.81 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.842 1.657 . . . . 0.0 111.729 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.2 mt -136.47 104.28 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -126.32 161.65 27.33 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.677 1.591 . . . . 0.0 107.43 -173.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -75.48 -13.19 60.36 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 120.685 -1.259 . . . . 0.0 112.903 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.3 pp -129.9 166.13 20.64 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 126.44 1.896 . . . . 0.0 110.16 -175.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -96.29 159.04 15.16 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.123 0.487 . . . . 0.0 111.268 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 38.6 m -151.65 27.91 0.63 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.821 1.649 . . . . 0.0 111.081 -168.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 63.4 p 56.5 10.44 0.68 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 128.917 2.887 . . . . 0.0 116.037 173.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -106.07 153.26 22.31 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.616 1.567 . . . . 0.0 110.465 -168.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.502 ' HG3' ' H ' ' A' ' 189' ' ' GLY . 0.3 OUTLIER -56.5 -77.48 0.03 OUTLIER 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.756 2.022 . . . . 0.0 112.215 -175.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.502 ' H ' ' HG3' ' A' ' 188' ' ' GLU . . . -75.93 18.33 3.26 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 126.448 1.975 . . . . 0.0 112.978 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -90.91 112.27 24.05 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 119.586 1.693 . . . . 0.0 107.28 170.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -101.84 127.87 48.46 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 25.0 mtm105 -68.57 148.12 50.97 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.283 0.492 . . . . 0.0 110.384 166.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.3 pt -135.36 170.19 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.325 1.85 . . . . 0.0 110.243 167.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -126.59 -10.75 6.21 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 124.554 1.142 . . . . 0.0 113.043 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -160.27 171.54 18.97 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 126.11 1.764 . . . . 0.0 108.117 172.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 80.9 mt -66.53 -42.42 87.27 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.334 1.054 . . . . 0.0 109.703 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.1 -27.43 69.39 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.94 -22.78 62.9 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.238 1.815 . . . . 0.0 111.07 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 94.1 mt -57.4 -56.9 12.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.333 0 C-N-CA 125.341 1.456 . . . . 0.0 108.863 171.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 80.3 p -53.06 -43.61 66.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.96 0.8 . . . . 0.0 111.483 -172.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -63.1 -21.99 66.56 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.912 1.685 . . . . 0.0 112.973 -177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.87 -42.96 98.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 118.838 0.744 . . . . 0.0 109.581 174.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -89.66 -32.57 16.99 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 123.62 0.768 . . . . 0.0 110.897 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -75.77 1.36 15.0 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.443 1.097 . . . . 0.0 112.878 -173.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.328 13.4 t 46.57 53.88 9.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.998 2.119 . . . . 0.0 111.468 -168.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.257 1.469 0 C-N-CA 126.242 1.817 . . . . 0.0 112.034 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.924 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 -77.52 -13.46 59.91 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -175.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.8 mmm 51.12 78.93 0.1 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.837 1.655 . . . . 0.0 111.635 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.5 167.04 0.07 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.419 1.888 . . . . 0.0 110.106 164.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.49 73.78 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 127.812 2.445 . . . . 0.0 114.365 -171.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.7 m -86.63 160.84 18.77 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 119.46 -2.025 . . . . 0.0 107.875 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.8 151.02 48.7 Favored 'General case' 0 C--O 1.233 0.202 0 O-C-N 120.738 -1.226 . . . . 0.0 109.338 165.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -122.74 154.01 38.7 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.214 1.406 . . . . 0.0 108.857 -178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 mt -141.46 135.3 30.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.1 m95 -120.52 143.47 48.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.346 1.858 . . . . 0.0 109.046 -176.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.36 -32.81 66.78 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 119.446 1.021 . . . . 0.0 111.341 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 tm? 60.94 120.2 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 128.81 2.844 . . . . 0.0 112.723 -178.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.9 t0 62.77 34.82 14.29 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.738 1.215 . . . . 0.0 108.845 175.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -176.92 36.35 0.09 OUTLIER Glycine 0 CA--C 1.528 0.865 0 C-N-CA 129.222 3.296 . . . . 0.0 109.066 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.244 0.779 0 N-CA-C 101.604 -3.48 . . . . 0.0 101.604 174.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.65 ' HG ' ' H ' ' A' ' 86' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.65 ' H ' ' HG ' ' A' ' 85' ' ' LEU . 0.3 OUTLIER -104.32 87.56 1.72 Allowed Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 129.91 3.284 . . . . 0.0 106.271 177.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -59.66 107.16 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.633 2.889 . . . . 0.0 109.048 -176.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.68 -9.58 3.14 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-O 116.725 -2.153 . . . . 0.0 112.933 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.63 -16.78 13.17 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 120.411 2.106 . . . . 0.0 114.845 -170.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -61.9 -37.86 86.18 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 120.473 -1.392 . . . . 0.0 112.823 -171.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -52.28 -54.6 29.26 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.533 1.933 . . . . 0.0 112.203 168.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.04 -33.54 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 119.634 1.107 . . . . 0.0 110.732 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 80.2 mt -57.1 -55.26 36.97 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 169.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.97 -13.69 62.35 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.636 1.175 . . . . 0.0 113.542 -174.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -79.74 -55.49 4.96 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 120.486 -1.384 . . . . 0.0 108.426 170.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -61.99 -37.81 86.23 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.236 1.414 . . . . 0.0 111.779 -176.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.36 -51.34 66.32 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 125.789 1.636 . . . . 0.0 111.12 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -65.1 -17.5 64.51 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.163 1.385 . . . . 0.0 110.743 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 33.7 m -94.61 -1.58 52.98 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.292 1.437 . . . . 0.0 112.799 176.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 74.54 5.11 72.2 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 125.036 1.303 . . . . 0.0 113.571 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.1 mt -56.51 112.29 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 168.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -64.81 101.82 0.52 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 171.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -83.58 150.18 26.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 119.325 0.966 . . . . 0.0 108.413 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -146.5 171.84 14.46 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.413 1.885 . . . . 0.0 108.834 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.536 ' HB ' HG23 ' A' ' 129' ' ' ILE . 18.6 mt -136.12 156.88 37.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 124.692 1.197 . . . . 0.0 109.222 171.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -139.76 125.45 19.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.131 0.973 . . . . 0.0 109.112 164.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 14.7 t -154.09 178.3 10.12 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.552 2.341 . . . . 0.0 108.26 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.6 p-80 -137.27 15.53 3.0 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.883 -1.136 . . . . 0.0 113.805 176.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -11.08 3.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.846 1.424 . . . . 0.0 114.846 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 121.73 167.23 13.09 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 128.043 2.735 . . . . 0.0 110.118 -177.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -52.02 -31.68 30.77 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.961 1.704 . . . . 0.0 111.367 170.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -53.0 -17.37 1.41 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.436 1.494 . . . . 0.0 114.026 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -51.19 -47.22 62.27 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.488 1.115 . . . . 0.0 111.028 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -56.78 -48.61 77.49 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 125.854 1.661 . . . . 0.0 109.93 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.6 m -55.43 -49.78 71.53 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.275 0.489 . . . . 0.0 109.795 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.8 mt -59.33 -47.91 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -175.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mp -66.79 -37.36 84.41 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.837 -1.165 . . . . 0.0 112.045 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.424 ' HE2' ' OE2' ' A' ' 123' ' ' GLU . 19.5 mtmt -59.71 -48.03 83.31 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.138 -0.934 . . . . 0.0 109.668 175.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.87 -43.62 95.53 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.532 1.133 . . . . 0.0 111.303 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.87 -4.1 35.93 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.194 0.998 . . . . 0.0 112.531 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 77.17 -3.22 58.8 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 126.192 1.853 . . . . 0.0 114.993 173.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 85' ' ' LEU . 10.5 m -92.53 3.33 7.98 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 118.921 1.36 . . . . 0.0 110.064 -170.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.424 ' OE2' ' HE2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -63.51 -27.34 69.2 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.433 1.015 . . . . 0.0 111.052 171.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 59.3 m -58.86 -15.26 11.75 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.465 -0.778 . . . . 0.0 112.684 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -96.9 3.05 52.33 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 117.043 -1.456 . . . . 0.0 114.295 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.449 ' HB2' HD11 ' A' ' 129' ' ' ILE . 52.3 m-85 -133.7 111.71 10.8 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 122.06 2.209 . . . . 0.0 109.471 -176.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 85.2 m -58.14 -39.91 79.97 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.92 1.688 . . . . 0.0 110.466 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -145.5 158.82 43.78 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 124.673 1.189 . . . . 0.0 108.007 167.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.536 HG23 ' HB ' ' A' ' 105' ' ' ILE . 5.3 mp -130.99 117.6 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 167.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.439 HD21 ' CE1' ' A' ' 147' ' ' TYR . 12.2 mt -71.63 165.98 22.83 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.719 0.771 . . . . 0.0 110.218 174.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.8 p -151.06 176.95 10.66 Favored 'General case' 0 C--O 1.231 0.088 0 O-C-N 121.466 -0.771 . . . . 0.0 110.498 -170.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.0 t -48.7 -33.84 10.86 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.037 0.935 . . . . 0.0 111.978 163.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -71.82 -6.67 43.3 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.204 1.402 . . . . 0.0 112.21 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 67.0 m -147.94 49.12 1.06 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 128.121 2.569 . . . . 0.0 105.229 -176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.05 -29.67 72.27 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.894 -166.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 45.23 -164.65 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.314 1.846 . . . . 0.0 112.595 -163.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 m -59.43 162.1 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.631 1.172 . . . . 0.0 112.224 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 37.1 mtt-85 -65.77 146.02 55.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 123.13 0.572 . . . . 0.0 110.374 168.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.41 133.52 13.11 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 116.872 -1.537 . . . . 0.0 110.194 166.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.29 126.07 9.55 Favored 'Cis proline' 0 C--N 1.348 0.552 0 CA-C-N 120.487 1.21 . . . . 0.0 111.498 -5.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 p -130.29 78.63 74.11 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 124.779 1.232 . . . . 0.0 112.035 -158.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -65.89 -30.41 48.93 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 121.916 1.744 . . . . 0.0 113.323 -174.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -53.41 -44.81 69.04 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.713 -1.242 . . . . 0.0 113.333 -176.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.74 -18.72 63.05 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 118.86 -0.59 . . . . 0.0 112.527 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.08 -53.41 7.04 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 119.115 0.87 . . . . 0.0 109.523 172.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.9 m -56.73 -41.46 77.52 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 125.371 1.469 . . . . 0.0 110.503 -174.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.439 ' CE1' HD21 ' A' ' 130' ' ' LEU . 4.0 t80 -56.86 -43.25 81.0 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.422 175.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 9.4 mt -78.35 -27.56 47.03 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.461 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 78.8 mt -59.37 -61.78 2.37 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 168.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -66.12 -17.84 64.97 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -64.78 -29.52 70.49 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.43 -1.419 . . . . 0.0 112.789 173.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -147.07 29.7 0.97 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 120.092 1.314 . . . . 0.0 112.468 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 54.82 45.12 27.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.608 1.563 . . . . 0.0 111.321 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 68.1 mt -95.34 170.87 9.07 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.422 -0.799 . . . . 0.0 110.0 -170.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -112.07 141.55 45.61 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.244 -0.91 . . . . 0.0 113.111 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.5 m -57.23 -49.87 74.66 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.817 0.847 . . . . 0.0 110.252 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.99 -16.83 60.61 Favored 'General case' 0 C--O 1.224 -0.239 0 CA-C-O 121.532 0.682 . . . . 0.0 112.356 -174.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -92.4 -3.09 55.8 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.701 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.4 t -101.36 135.61 42.58 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.62 1.1 . . . . 0.0 109.664 176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -125.91 112.9 16.5 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -77.69 159.04 29.39 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.792 0.437 . . . . 0.0 110.525 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 49.4 mt -131.09 92.82 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 C-N-CA 127.917 2.487 . . . . 0.0 104.511 -177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -124.41 169.31 16.46 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.786 1.184 . . . . 0.0 110.388 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -135.21 3.15 3.1 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.915 1.286 . . . . 0.0 113.225 -166.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.28 144.41 25.54 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 119.182 0.901 . . . . 0.0 111.231 -177.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 88.68 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.01 2.124 . . . . 0.0 111.822 -170.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 174.05 -29.62 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 128.691 2.796 . . . . 0.0 107.664 -176.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.9 p30 -52.55 -43.64 65.34 Favored 'General case' 0 N--CA 1.437 -1.102 0 C-N-CA 126.368 1.867 . . . . 0.0 111.436 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 79.7 t -77.8 -26.19 14.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 125.184 1.394 . . . . 0.0 111.821 177.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.32 -38.42 91.08 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.526 -0.734 . . . . 0.0 111.614 -165.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -82.52 -30.77 29.58 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 119.098 -0.477 . . . . 0.0 111.686 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.77 -45.34 89.99 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 123.838 0.855 . . . . 0.0 109.183 -176.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -54.24 -49.67 68.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.655 1.582 . . . . 0.0 111.08 173.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -63.84 -44.24 93.75 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.83 -0.544 . . . . 0.0 110.811 -177.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.0 m -75.0 -21.04 59.38 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 177.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.26 44.03 77.06 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.314 0.959 . . . . 0.0 112.171 -169.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 1.3 pt -110.6 168.73 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 118.094 0.947 . . . . 0.0 108.737 169.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -105.22 171.05 7.53 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-O 121.625 0.726 . . . . 0.0 110.626 -170.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.74 135.06 18.2 Favored 'General case' 0 C--O 1.224 -0.268 0 O-C-N 121.672 -0.643 . . . . 0.0 110.224 -157.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 42.9 mt -130.54 105.08 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 176.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -136.98 157.59 46.39 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 125.233 1.413 . . . . 0.0 111.148 -168.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -77.36 -12.43 59.95 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 121.32 -0.863 . . . . 0.0 112.371 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.14 156.61 38.08 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.984 0.914 . . . . 0.0 109.99 -178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.644 ' HA ' HD21 ' A' ' 190' ' ' ASN . 8.7 pt-20 -93.03 163.36 13.68 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.313 0.578 . . . . 0.0 110.835 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 44.8 t -145.6 179.8 7.18 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.13 1.772 . . . . 0.0 108.521 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . 0.303 0.2 OUTLIER -78.06 -22.36 49.19 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.701 -1.249 . . . . 0.0 111.333 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -71.19 121.8 19.03 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.1 1.36 . . . . 0.0 109.909 -174.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -64.79 -17.51 64.27 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.25 8.5 60.86 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.778 -1.012 . . . . 0.0 113.028 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.644 HD21 ' HA ' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -104.51 105.37 15.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 120.11 1.955 . . . . 0.0 110.043 -177.279 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -94.99 111.75 23.52 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.023 0.929 . . . . 0.0 109.613 -174.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.99 144.28 56.85 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 118.539 -0.743 . . . . 0.0 112.526 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.6 pt -137.42 171.36 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 126.922 2.089 . . . . 0.0 112.556 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -122.36 -21.29 5.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.475 1.51 . . . . 0.0 113.227 167.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -151.23 167.49 27.64 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 118.71 0.686 . . . . 0.0 109.244 -174.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 62.3 mt -74.32 -26.46 60.17 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 119.158 0.89 . . . . 0.0 110.277 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.45 -13.54 62.41 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.234 0.925 . . . . 0.0 112.514 174.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.413 ' HA ' ' HG2' ' A' ' 201' ' ' ARG . 31.5 t0 -79.06 -13.53 59.71 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 120.667 -1.27 . . . . 0.0 108.864 174.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.76 -57.07 11.47 Favored 'Isoleucine or valine' 0 C--N 1.343 0.312 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 167.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 3.6 p -59.96 -36.05 76.29 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 119.021 0.828 . . . . 0.0 111.499 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . 0.413 ' HG2' ' HA ' ' A' ' 198' ' ' ASP . 18.0 ptt180 -64.78 -34.78 79.14 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 119.101 0.864 . . . . 0.0 111.477 -172.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.8 mt -50.07 -57.63 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 126.144 1.777 . . . . 0.0 108.812 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -72.14 -0.67 12.5 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.821 0.849 . . . . 0.0 113.276 -174.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -121.09 4.43 10.39 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.083 1.353 . . . . 0.0 110.892 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.4 m -132.35 47.0 2.56 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.918 1.287 . . . . 0.0 110.561 -177.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt . . . . . 0 C--O 1.251 1.151 0 C-N-CA 128.486 2.714 . . . . 0.0 114.557 171.389 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.111 0 CA-C-O 118.808 -0.996 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . 0.273 6.8 p80 43.53 78.54 0.05 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.694 1.997 . . . . 0.0 115.898 162.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.6 mmm -135.17 89.56 2.53 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 126.413 1.885 . . . . 0.0 105.949 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -55.53 179.64 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.045 164.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 20.2 mmmt -44.36 106.49 0.07 Allowed 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.499 1.12 . . . . 0.0 108.797 169.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.3 m -129.83 151.34 50.52 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 170.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.35 156.9 48.18 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.43 0.692 . . . . 0.0 109.44 170.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 199' ' ' ILE . 1.4 m-85 -132.36 147.93 52.41 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 125.396 1.479 . . . . 0.0 109.213 -173.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 mp -132.1 129.46 60.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -103.49 164.75 11.46 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.301 1.04 . . . . 0.0 109.009 178.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.79 176.33 6.67 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.807 0.843 . . . . 0.0 109.891 171.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.6 mt -138.54 1.73 2.17 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.771 1.228 . . . . 0.0 111.147 -171.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -86.8 41.73 0.98 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.039 1.335 . . . . 0.0 111.086 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.6 -106.04 1.06 Allowed Glycine 0 C--N 1.331 0.277 0 N-CA-C 107.355 -2.298 . . . . 0.0 107.355 -173.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.02 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -161.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.469 ' HG ' ' H ' ' A' ' 86' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.469 ' H ' ' HG ' ' A' ' 85' ' ' LEU . 1.6 mpp? -104.82 86.27 1.43 Allowed Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.623 1.969 . . . . 0.0 107.583 166.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.99 99.84 0.49 Allowed 'Trans proline' 0 C--N 1.349 0.564 1 C-N-CA 125.599 4.199 . . . . 0.0 112.736 -164.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 148.62 -29.91 1.29 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 125.482 1.515 . . . . 0.0 109.742 -168.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.32 -34.09 23.77 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 118.186 0.993 . . . . 0.0 110.915 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -54.11 -36.37 63.16 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 119.109 0.868 . . . . 0.0 111.725 177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -61.81 -35.97 79.75 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.724 1.21 . . . . 0.0 112.882 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.2 t -83.3 -48.95 17.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 118.293 -0.86 . . . . 0.0 108.949 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.448 ' HA ' HE22 ' A' ' 103' ' ' GLN . 2.4 mp -44.3 -52.39 7.61 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-N 120.636 1.562 . . . . 0.0 113.287 170.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.61 -44.82 96.29 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.41 0.684 . . . . 0.0 111.22 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.461 ' CZ2' ' HA ' ' A' ' 200' ' ' SER . 20.6 t90 -57.95 -49.44 76.78 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.551 1.141 . . . . 0.0 110.812 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.19 -38.7 78.78 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.929 1.291 . . . . 0.0 113.24 -174.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.95 -44.42 85.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 122.941 0.496 . . . . 0.0 110.374 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -51.15 -49.8 60.16 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.194 1.397 . . . . 0.0 110.154 168.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.2 m -68.94 -12.81 61.99 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 115.759 1.763 . . . . 0.0 115.759 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.03 16.06 77.59 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 120.014 1.279 . . . . 0.0 113.605 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 43.1 mt -68.44 133.16 32.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.025 1.33 . . . . 0.0 108.32 170.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -83.14 118.67 23.74 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.448 HE22 ' HA ' ' A' ' 93' ' ' LEU . 12.4 mt-30 -99.07 154.24 18.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -147.84 166.33 27.92 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.909 1.684 . . . . 0.0 108.565 -177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 42.6 mt -137.43 158.94 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.754 1.622 . . . . 0.0 107.14 166.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.522 ' O ' HG22 ' A' ' 107' ' ' THR . 4.3 t80 -131.77 -85.9 0.48 Allowed 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 124.779 1.231 . . . . 0.0 108.034 166.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 106' ' ' TYR 0.255 15.3 t 65.04 164.98 0.16 Allowed 'General case' 0 C--N 1.315 -0.894 1 C-N-CA 136.816 6.047 . . . . 0.0 113.958 177.772 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -80.41 4.04 19.37 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.395 1.078 . . . . 0.0 111.346 166.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.0 ttmm -57.87 156.05 9.57 Favored 'General case' 0 C--O 1.237 0.412 0 O-C-N 120.201 -1.562 . . . . 0.0 108.221 167.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -81.07 171.36 53.58 Favored Glycine 0 N--CA 1.441 -0.976 0 CA-C-O 122.19 0.884 . . . . 0.0 111.107 173.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -44.87 -28.15 0.61 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 130.025 3.33 . . . . 0.0 114.944 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -63.89 -12.79 39.86 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 120.279 1.399 . . . . 0.0 112.311 176.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -48.52 -47.88 38.75 Favored 'General case' 0 C--N 1.341 0.208 0 CA-C-N 119.88 1.218 . . . . 0.0 111.573 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -56.8 -49.59 74.89 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.606 0.639 . . . . 0.0 110.238 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.7 m -59.39 -42.62 92.15 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.793 0.837 . . . . 0.0 111.129 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 52.3 mt -61.73 -48.8 87.03 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 119.319 0.963 . . . . 0.0 108.716 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -63.28 -44.24 95.62 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 121.878 -0.514 . . . . 0.0 110.457 -175.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -59.26 -51.3 70.54 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.403 1.081 . . . . 0.0 110.836 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -51.13 -56.52 12.3 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.26 1.424 . . . . 0.0 110.583 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.49 -9.73 37.43 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.046 1.338 . . . . 0.0 113.613 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 74.61 25.81 69.08 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 123.983 0.801 . . . . 0.0 112.525 173.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 85' ' ' LEU . 11.3 m -135.53 57.1 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.43 -46.94 10.43 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.901 160.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.9 m -73.62 -14.59 61.2 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -164.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -63.44 -33.83 76.43 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 120.393 1.451 . . . . 0.0 110.507 170.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -90.82 115.48 27.91 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.5 m -44.74 -65.95 0.46 Allowed 'General case' 0 N--CA 1.457 -0.118 0 C-N-CA 127.016 2.126 . . . . 0.0 108.669 174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.07 140.07 43.5 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.5 mt -110.36 148.69 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 171.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.402 ' HB2' ' HA ' ' A' ' 106' ' ' TYR . 45.9 mt -119.13 -166.89 1.31 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -173.26 -178.96 1.83 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.607 1.963 . . . . 0.0 107.888 167.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.0 m -44.53 -45.27 9.25 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.119 0.872 . . . . 0.0 110.458 167.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -70.2 -9.38 55.59 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.096 1.758 . . . . 0.0 112.96 -172.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 50.7 m -59.35 -24.04 63.03 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.839 1.256 . . . . 0.0 110.973 163.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 92.12 -8.18 77.96 Favored Glycine 0 C--N 1.335 0.492 0 CA-C-O 118.019 -1.434 . . . . 0.0 114.018 170.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -56.56 165.99 1.01 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 118.783 1.292 . . . . 0.0 111.161 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 m -44.73 155.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.158 1.783 . . . . 0.0 111.786 170.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -69.84 -76.77 0.09 Allowed 'General case' 0 C--O 1.222 -0.35 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -165.47 159.59 13.84 Favored Pre-proline 0 C--O 1.234 0.257 0 C-N-CA 124.33 1.052 . . . . 0.0 109.804 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -64.16 136.97 26.24 Favored 'Cis proline' 0 N--CA 1.458 -0.601 0 N-CA-C 108.703 -1.307 . . . . 0.0 108.703 -17.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 36.0 p -124.99 68.78 56.82 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 123.621 0.768 . . . . 0.0 111.917 -157.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -61.95 -29.45 82.06 Favored 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.388 2.059 . . . . 0.0 111.98 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -48.41 -41.08 28.04 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 126.624 1.97 . . . . 0.0 112.39 177.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.61 2.47 16.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.518 1.527 . . . . 0.0 112.623 -175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.84 -39.42 2.73 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.868 1.667 . . . . 0.0 108.727 173.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.8 m -49.99 -38.78 38.66 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 120.086 1.312 . . . . 0.0 110.456 174.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.653 ' HD1' HD12 ' A' ' 148' ' ' LEU . 53.7 t80 -52.01 -57.94 7.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.099 1.36 . . . . 0.0 110.76 171.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.653 HD12 ' HD1' ' A' ' 147' ' ' TYR . 9.0 mp -58.58 -37.96 76.88 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.896 1.678 . . . . 0.0 112.755 -177.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 87.0 mt -59.83 -57.96 10.65 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -175.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -75.18 -32.98 61.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.754 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 4.0 mmpt? -50.76 -53.32 32.63 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.801 -1.187 . . . . 0.0 111.8 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -115.23 8.86 15.62 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -173.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 54.26 66.71 1.16 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 123.064 1.411 . . . . 0.0 109.235 -172.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.17 162.17 13.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.899 1.68 . . . . 0.0 107.784 169.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -106.39 -4.82 19.51 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 125.235 2.445 . . . . 0.0 117.458 -161.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.0 m 76.27 -55.95 0.58 Allowed 'General case' 0 N--CA 1.411 -2.381 0 CA-C-N 110.647 -2.978 . . . . 0.0 109.07 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.84 -2.13 38.26 Favored 'General case' 0 N--CA 1.434 -1.228 0 O-C-N 120.881 -1.137 . . . . 0.0 112.941 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -98.35 -5.34 33.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 116.916 -1.516 . . . . 0.0 111.186 168.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -103.45 137.37 41.64 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.669 1.577 . . . . 0.0 108.099 -174.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -128.42 111.17 13.02 Favored 'General case' 0 C--N 1.34 0.157 0 C-N-CA 125.963 1.705 . . . . 0.0 109.263 -172.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -85.89 153.38 22.26 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.406 HD11 ' CD2' ' A' ' 6' ' ' PHE . 3.5 mt -133.01 119.55 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.85 -161.68 9.64 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 107.915 -2.074 . . . . 0.0 107.915 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.6 p30 -139.53 12.88 2.54 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -176.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.456 ' HB3' ' H ' ' A' ' 167' ' ' LEU . 3.0 mmt-85 -115.68 162.67 16.92 Favored 'General case' 0 N--CA 1.457 -0.107 0 CA-C-O 122.839 1.304 . . . . 0.0 111.489 -172.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 t -62.46 -26.95 68.79 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.297 -0.877 . . . . 0.0 109.538 163.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.456 ' H ' ' HB3' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -60.27 -29.82 69.05 Favored 'General case' 0 C--N 1.342 0.244 0 C-N-CA 125.487 1.515 . . . . 0.0 111.529 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -45.7 -44.93 13.97 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.104 1.762 . . . . 0.0 110.852 -176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.628 HG21 ' HB2' ' A' ' 185' ' ' SER . 28.4 m -90.69 -15.5 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -68.55 -50.79 49.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 121.081 -1.012 . . . . 0.0 108.69 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -79.3 -33.4 43.3 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 118.536 -0.745 . . . . 0.0 111.343 -177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.92 -42.64 90.17 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.041 -0.98 . . . . 0.0 110.378 172.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -61.16 -49.77 75.86 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 119.866 1.212 . . . . 0.0 111.151 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 62.9 m-20 -58.32 -25.37 61.82 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -174.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 74.9 m -86.03 -50.86 6.73 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.795 1.18 . . . . 0.0 110.615 165.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 96.09 63.17 0.95 Allowed Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 107.547 -2.221 . . . . 0.0 107.547 -164.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 37.9 pt -131.11 173.14 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 126.577 1.951 . . . . 0.0 106.286 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -99.65 165.83 11.42 Favored 'General case' 0 C--O 1.235 0.318 0 O-C-N 121.348 -0.845 . . . . 0.0 109.619 -171.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 39.4 m -136.26 155.36 50.22 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.637 1.175 . . . . 0.0 110.57 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 34.3 mt -140.66 74.81 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 39.3 p30 -96.14 169.64 9.81 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.842 0.829 . . . . 0.0 110.157 -177.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -88.25 2.14 52.98 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 120.532 -1.355 . . . . 0.0 111.951 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.06 132.78 19.96 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-O 124.72 2.2 . . . . 0.0 115.414 -175.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -63.24 138.65 58.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.568 -2.105 . . . . 0.0 109.4 -167.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.628 ' HB2' HG21 ' A' ' 169' ' ' VAL . 74.9 p -137.91 163.4 31.57 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.093 0.557 . . . . 0.0 110.704 -162.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 24.4 p -75.68 45.16 0.31 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.527 1.931 . . . . 0.0 111.55 173.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -131.34 175.67 8.93 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 120.95 -1.094 . . . . 0.0 109.717 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -98.26 -67.84 0.83 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 123.768 0.827 . . . . 0.0 109.202 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -73.15 51.49 1.68 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 126.984 2.231 . . . . 0.0 113.319 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -121.26 119.6 32.73 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.376 1.07 . . . . 0.0 108.766 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -106.67 106.56 17.15 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.815 0.846 . . . . 0.0 109.94 -172.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.66 139.85 58.81 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -177.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.8 pt -129.98 167.66 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.142 1.377 . . . . 0.0 113.084 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -120.26 -17.59 8.22 Favored 'General case' 0 C--N 1.343 0.298 0 C-N-CA 124.972 1.309 . . . . 0.0 113.52 168.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -156.63 168.69 26.62 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 18.4 mt -70.37 -38.58 74.79 Favored 'General case' 0 C--O 1.225 -0.197 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -171.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.12 -18.07 63.02 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 121.82 -0.55 . . . . 0.0 112.329 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -64.94 -21.34 66.81 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.223 -0.923 . . . . 0.0 110.686 176.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.436 HG21 ' CE2' ' A' ' 6' ' ' PHE . 72.7 mt -61.46 -50.52 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 118.161 -0.924 . . . . 0.0 109.132 176.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . 0.461 ' HA ' ' CZ2' ' A' ' 95' ' ' TRP . 94.4 p -58.04 -41.09 82.54 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 119.32 0.964 . . . . 0.0 110.364 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . 0.542 ' O ' HG22 ' A' ' 205' ' ' THR . 8.5 mtp-105 -58.98 -39.59 82.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 117.498 -1.239 . . . . 0.0 110.329 -176.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 40.6 mt -52.62 -51.96 30.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 118.983 0.81 . . . . 0.0 109.988 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -73.78 -35.76 64.98 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -74.9 -5.35 43.21 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 201' ' ' ARG . 5.3 t -130.98 23.88 4.94 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.88 0.848 . . . . 0.0 110.328 -176.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 2.8 mmtp . . . . . 0 C--O 1.256 1.396 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 158.335 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -115.94 23.91 11.87 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.156 0.982 . . . . 0.0 112.11 -168.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.4 mmm -98.63 82.92 2.9 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.808 -1.552 . . . . 0.0 106.808 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -167.13 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 129.402 3.081 . . . . 0.0 111.272 161.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -57.28 109.94 0.76 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 119.543 -1.973 . . . . 0.0 107.72 168.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.5 m -130.37 152.59 49.61 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 166.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -138.57 150.3 46.19 Favored 'General case' 0 CA--C 1.527 0.09 0 O-C-N 121.262 -0.899 . . . . 0.0 109.652 169.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -124.9 160.9 27.77 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 125.588 1.555 . . . . 0.0 110.211 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.7 mt -138.19 149.53 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -134.95 168.15 19.62 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 127.635 2.374 . . . . 0.0 109.598 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -123.46 24.67 8.55 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.721 2.008 . . . . 0.0 111.666 -171.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 tt 60.4 96.42 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.438 2.695 . . . . 0.0 112.791 172.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.2 t70 71.24 20.06 5.19 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.977 1.711 . . . . 0.0 112.979 169.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -116.73 12.31 15.35 Favored Glycine 0 CA--C 1.534 1.262 0 N-CA-C 117.377 1.711 . . . . 0.0 117.377 -164.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 55.3 p . . . . . 0 C--O 1.255 1.348 0 CA-C-N 120.131 1.965 . . . . 0.0 110.208 -168.702 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.506 HD13 ' H ' ' A' ' 86' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.506 ' H ' HD13 ' A' ' 85' ' ' LEU . 2.1 mmm -118.4 86.98 29.3 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 128.087 2.555 . . . . 0.0 110.121 178.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -64.85 94.34 0.22 Allowed 'Trans proline' 0 N--CA 1.451 -1.006 1 C-N-CA 125.438 4.092 . . . . 0.0 110.37 -173.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 149.71 -37.38 0.96 Allowed Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 126.608 2.052 . . . . 0.0 110.503 -176.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.25 -25.88 22.61 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -171.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.464 ' HA ' HD22 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -68.11 -24.13 64.99 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 118.974 -2.329 . . . . 0.0 111.97 -176.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -61.01 -45.72 93.67 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 123.952 0.901 . . . . 0.0 109.745 174.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.75 -44.39 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 123.88 0.872 . . . . 0.0 109.486 -170.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.61 HD23 ' CD2' ' A' ' 125' ' ' TYR . 4.4 mp -44.3 -44.73 8.28 Favored 'General case' 0 N--CA 1.418 -2.068 0 C-N-CA 126.125 1.77 . . . . 0.0 111.519 169.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -72.57 -33.57 66.85 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 120.03 -0.668 . . . . 0.0 112.593 -174.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 24.3 t90 -65.09 -55.3 19.58 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.853 1.261 . . . . 0.0 109.827 170.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.28 -36.42 77.8 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.752 1.621 . . . . 0.0 112.527 -174.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -63.19 -57.96 8.79 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.744 1.218 . . . . 0.0 111.687 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -60.82 -24.39 65.82 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.617 0.723 . . . . 0.0 112.363 175.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.1 m -78.28 -6.02 53.77 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.33 -0.856 . . . . 0.0 112.634 175.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 78.39 15.34 81.08 Favored Glycine 0 C--N 1.335 0.525 0 C-N-CA 124.228 0.918 . . . . 0.0 112.653 176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 20.5 mt -70.5 120.7 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 118.834 1.317 . . . . 0.0 107.726 174.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -75.13 105.28 6.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 167.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.452 HE22 ' HA ' ' A' ' 93' ' ' LEU . 19.4 mt-30 -88.65 150.56 22.96 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 178.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -142.28 169.16 18.11 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.432 1.093 . . . . 0.0 108.94 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 11.3 mt -131.63 149.67 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -121.7 141.87 50.73 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 157.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.4 t -163.25 -176.0 4.57 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 127.196 2.199 . . . . 0.0 105.719 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -134.11 9.22 3.79 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.844 0.858 . . . . 0.0 112.755 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -1.55 8.11 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.47 174.31 34.01 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 125.821 1.677 . . . . 0.0 111.019 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -52.61 -27.5 17.25 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 124.084 0.954 . . . . 0.0 112.293 -178.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -54.7 -17.87 3.94 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 177.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.57 -46.99 49.61 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.8 1.182 . . . . 0.0 112.223 171.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -60.32 -47.38 86.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.435 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.6 m -56.15 -49.83 72.86 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.732 0.696 . . . . 0.0 109.45 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.2 mt -58.89 -48.49 86.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -176.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mp -63.01 -38.42 91.13 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 121.326 -0.859 . . . . 0.0 112.235 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -48.85 80.05 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.54 -36.01 82.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 118.505 0.593 . . . . 0.0 111.354 -174.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 81.7 mt -77.83 -8.22 57.74 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.476 1.11 . . . . 0.0 112.05 174.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 57.12 33.49 64.69 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 125.44 1.495 . . . . 0.0 113.248 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -116.79 14.1 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 118.512 1.156 . . . . 0.0 110.36 171.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -41.37 97.53 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.186 0.994 . . . . 0.0 111.176 -177.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 t -65.52 -31.02 71.85 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.688 -169.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.61 ' CD2' HD23 ' A' ' 93' ' ' LEU . 37.8 m-85 -56.01 -43.91 78.19 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 118.553 0.615 . . . . 0.0 111.461 174.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -97.19 95.58 7.84 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -166.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 35.4 m -44.66 -49.83 10.18 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.566 1.546 . . . . 0.0 109.682 -175.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -143.44 147.44 34.57 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 -178.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.8 mp -129.96 119.31 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 -175.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.713 HD12 ' HB3' ' A' ' 134' ' ' SER . 4.3 mm? -82.0 163.94 21.79 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.582 0.705 . . . . 0.0 109.63 176.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.8 p -148.11 -174.2 4.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 122.239 1.019 . . . . 0.0 112.687 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.6 t -55.25 -15.51 2.47 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 162.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -73.32 -38.8 65.68 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 120.018 1.281 . . . . 0.0 110.499 173.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.713 ' HB3' HD12 ' A' ' 130' ' ' LEU . 2.6 p -77.71 77.6 4.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.25 45.76 1.21 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 125.058 1.313 . . . . 0.0 111.224 173.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -62.8 166.9 5.05 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.244 0.545 . . . . 0.0 111.227 168.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.9 m -53.35 161.43 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 127.149 2.18 . . . . 0.0 112.852 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.418 ' NE ' ' H ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -83.35 156.07 23.2 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.398 -0.814 . . . . 0.0 110.659 170.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt -51.02 139.49 23.09 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 125.631 1.572 . . . . 0.0 110.442 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.71 123.58 5.74 Favored 'Cis proline' 0 CA--C 1.537 0.644 0 CA-C-N 120.416 1.184 . . . . 0.0 110.099 -9.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.72 ' H ' ' HB3' ' A' ' 171' ' ' PHE . 2.8 p -128.84 81.26 71.16 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 126.398 1.879 . . . . 0.0 110.954 -162.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.62 -9.12 16.0 Favored 'Trans proline' 0 CA--C 1.551 1.334 0 C-N-CA 123.556 2.838 . . . . 0.0 114.635 -173.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.13 -44.73 94.69 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 120.022 1.283 . . . . 0.0 111.875 -177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -51.58 -45.47 63.13 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 124.064 0.946 . . . . 0.0 110.669 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.13 -34.77 75.54 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.769 -0.582 . . . . 0.0 112.139 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 21.1 m -68.51 -32.21 72.01 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.636 0.774 . . . . 0.0 110.364 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -65.19 -49.73 68.65 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.5 mp -59.47 -38.48 80.91 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.062 0.945 . . . . 0.0 111.332 -176.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.503 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -58.05 -68.12 0.28 Allowed 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 173.787 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -53.43 -46.56 69.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 123.852 0.72 . . . . 0.0 112.012 -171.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 11.6 tptp -51.72 -36.0 45.19 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -173.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -121.69 12.45 10.66 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.76 0.709 . . . . 0.0 111.539 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.8 mm-40 47.16 50.35 14.3 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 127.84 2.456 . . . . 0.0 110.283 -168.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 66.1 mt -76.85 -172.59 2.34 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.685 1.994 . . . . 0.0 110.105 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -129.34 134.42 47.89 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.79 1.236 . . . . 0.0 107.778 -170.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 2.8 p -59.35 -40.17 85.55 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 119.522 1.056 . . . . 0.0 111.198 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -75.12 -22.78 57.97 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 121.529 -0.732 . . . . 0.0 111.943 -172.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -95.82 2.53 53.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 121.462 -0.773 . . . . 0.0 109.43 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.6 m -96.57 126.56 41.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.702 1.201 . . . . 0.0 108.052 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -112.18 155.75 23.44 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -120.98 163.61 18.0 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.964 1.706 . . . . 0.0 106.694 161.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.4 mt -126.59 107.63 17.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 173.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -119.69 177.23 16.34 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.49 166.18 18.45 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 104.051 -2.574 . . . . 0.0 104.051 156.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 75.43 156.62 0.18 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 126.689 1.996 . . . . 0.0 111.389 -176.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 t -69.83 -30.1 67.52 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.83 -177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.17 -25.06 45.29 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.437 1.095 . . . . 0.0 112.631 -177.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -79.68 13.04 2.24 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.479 1.912 . . . . 0.0 111.558 -177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 1.2 p -109.12 -16.32 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 124.277 1.031 . . . . 0.0 110.553 163.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -73.9 -52.62 12.36 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-N 120.121 1.328 . . . . 0.0 110.805 -168.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.72 ' HB3' ' H ' ' A' ' 141' ' ' SER . 1.4 p90 -63.28 -29.39 70.72 Favored 'General case' 0 C--N 1.342 0.273 0 O-C-N 120.971 -1.081 . . . . 0.0 111.916 172.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.47 -52.55 64.73 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 118.761 -0.637 . . . . 0.0 109.302 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -49.11 -60.88 2.41 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 125.127 1.371 . . . . 0.0 110.708 170.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -68.33 -14.51 63.05 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -170.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.5 p -95.62 -23.4 17.05 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 120.73 1.604 . . . . 0.0 112.229 165.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 89.1 22.42 38.36 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.145 1.355 . . . . 0.0 112.515 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 2.2 pp -99.16 175.2 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.855 1.327 . . . . 0.0 109.982 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -117.65 162.07 18.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.619 1.168 . . . . 0.0 110.29 -173.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 12.4 m -139.33 143.98 38.06 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.76 1.224 . . . . 0.0 110.348 -165.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 73.6 mt -119.95 92.11 2.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -111.5 158.98 18.54 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-O 121.819 0.819 . . . . 0.0 108.956 -172.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -74.18 -6.5 48.15 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.517 -1.365 . . . . 0.0 112.835 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.99 158.81 41.75 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 126.83 2.052 . . . . 0.0 109.159 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.84 160.86 28.04 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 19.0 t -147.22 174.83 11.25 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.6 169.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.4 p -83.95 63.98 7.88 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 128.023 2.529 . . . . 0.0 108.434 -173.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -144.6 178.86 7.67 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.771 2.028 . . . . 0.0 108.355 -175.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -113.38 -35.95 5.13 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 120.431 1.469 . . . . 0.0 110.459 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -86.19 15.48 49.14 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 127.368 2.413 . . . . 0.0 112.77 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -84.75 152.87 23.39 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 120.621 2.211 . . . . 0.0 107.372 159.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -131.04 148.86 52.8 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 169.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.4 146.56 25.59 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.273 0.629 . . . . 0.0 110.85 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 18.6 pt -140.03 162.68 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.219 1.008 . . . . 0.0 112.0 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -108.86 -27.02 9.96 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 169.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -168.08 145.59 4.25 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 -163.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . 0.425 HD12 ' HA ' ' A' ' 196' ' ' LEU . 2.9 tp -61.74 -30.91 71.09 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 127.186 2.194 . . . . 0.0 111.497 -158.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.92 -11.87 50.43 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -77.16 -13.14 59.99 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.816 0.846 . . . . 0.0 109.6 176.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 39.7 mt -56.34 -59.37 2.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 83.1 p -53.89 -37.9 64.22 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -175.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 2.2 mtt85 -61.35 -34.64 75.63 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.77 0.828 . . . . 0.0 112.141 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 76.0 mt -58.22 -34.69 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.985 0.914 . . . . 0.0 110.729 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -91.48 -4.91 55.03 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 120.974 -1.079 . . . . 0.0 112.291 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -120.55 4.54 10.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.828 1.651 . . . . 0.0 111.036 -171.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -139.13 33.93 2.12 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.844 1.258 . . . . 0.0 112.819 -173.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.284 27.1 pttt . . . . . 0 C--O 1.249 1.027 0 C-N-CA 126.969 2.107 . . . . 0.0 113.1 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.826 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -158.98 73.3 0.6 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.469 1.108 . . . . 0.0 111.169 -178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.3 mmm -119.1 34.24 5.31 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.278 -0.889 . . . . 0.0 112.549 -166.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 52.73 -169.04 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.508 1.523 . . . . 0.0 111.965 171.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tppt? -80.32 48.64 1.04 Allowed 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 119.857 -1.777 . . . . 0.0 108.23 165.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 97.9 m -69.3 143.75 53.75 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 169.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.28 149.47 50.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 -125.53 152.91 44.39 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 124.484 1.114 . . . . 0.0 108.972 -172.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.5 mt -134.49 146.04 31.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 169.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -123.78 171.64 9.47 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.809 2.044 . . . . 0.0 107.82 172.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.18 164.33 15.75 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 165.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.7 tt -121.56 141.85 50.67 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 119.03 0.832 . . . . 0.0 109.185 -168.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 61.58 4.47 1.03 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.008 1.723 . . . . 0.0 112.687 -168.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -103.43 -88.67 2.07 Favored Glycine 0 C--N 1.335 0.501 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.296 2.9 t . . . . . 0 C--O 1.252 1.212 0 N-CA-C 105.723 -1.954 . . . . 0.0 105.723 172.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 119.858 -0.115 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . 0.263 3.7 tpt 40.52 76.48 0.5 Allowed Pre-proline 0 C--O 1.239 0.546 0 C-N-CA 124.688 1.195 . . . . 0.0 114.127 135.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -64.6 103.76 0.49 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 123.032 2.488 . . . . 0.0 108.246 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 124.68 -13.12 7.75 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.055 1.312 . . . . 0.0 113.71 -177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.18 70.85 Favored 'General case' 0 C--N 1.344 0.338 0 CA-C-N 121.009 2.404 . . . . 0.0 107.928 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.89 -24.08 67.6 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 118.402 -0.809 . . . . 0.0 112.697 -172.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -60.26 -58.46 8.41 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 175.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.64 -44.44 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 117.018 -1.468 . . . . 0.0 112.228 177.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.614 HD23 ' CG ' ' A' ' 125' ' ' TYR . 3.7 mp -52.68 -48.35 66.59 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 122.13 2.241 . . . . 0.0 112.368 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.89 -49.08 79.12 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 124.804 1.315 . . . . 0.0 109.552 -177.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -53.57 -48.08 69.51 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 118.632 -0.699 . . . . 0.0 111.191 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.39 -34.64 74.83 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.895 0.77 . . . . 0.0 111.752 -175.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -73.45 -40.89 63.83 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.286 1.834 . . . . 0.0 110.711 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -67.25 -1.28 4.3 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.227 1.811 . . . . 0.0 111.309 168.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 58.3 m -118.88 -6.6 10.53 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.423 1.489 . . . . 0.0 114.273 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.38 9.14 77.1 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.101 -1.624 . . . . 0.0 115.654 172.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 93.5 mt -45.63 147.18 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 149.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -98.65 115.4 28.59 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 167.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.471 HE22 ' HA ' ' A' ' 93' ' ' LEU . 5.3 mt-30 -88.67 150.75 22.85 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -140.0 164.95 28.64 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 125.12 1.368 . . . . 0.0 107.967 171.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.6 mt -124.51 149.86 29.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 161.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -129.16 143.84 51.0 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 152.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.4 t -151.6 163.5 38.93 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.863 1.265 . . . . 0.0 109.585 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -92.64 -0.39 57.31 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.983 -0.448 . . . . 0.0 111.962 165.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -59.19 153.0 19.28 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 119.477 1.035 . . . . 0.0 108.571 166.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -80.93 -175.21 49.6 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -55.72 -18.18 7.6 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.501 1.521 . . . . 0.0 114.038 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -58.63 -18.1 27.68 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 119.617 1.099 . . . . 0.0 112.119 172.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.69 -44.36 69.69 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.078 0.951 . . . . 0.0 110.366 175.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -57.15 -48.86 77.66 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.25 -48.03 83.14 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.829 2.052 . . . . 0.0 111.252 -174.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 59.9 mt -58.13 -50.61 77.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 124.481 1.112 . . . . 0.0 108.165 -178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.89 -37.28 87.11 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 122.16 -0.337 . . . . 0.0 111.162 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.72 -49.1 77.67 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.517 1.127 . . . . 0.0 109.608 174.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -50.46 73.59 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 124.016 0.926 . . . . 0.0 110.679 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.54 -40.2 77.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.544 -174.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 107.41 50.82 0.79 Allowed Glycine 0 C--N 1.339 0.697 0 CA-C-O 121.563 0.535 . . . . 0.0 111.825 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . 0.317 1.3 p -147.61 8.26 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 C-N-CA 129.912 3.285 . . . . 0.0 109.384 -170.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -34.25 77.93 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 120.768 -1.208 . . . . 0.0 113.028 174.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -15.91 53.71 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 123.576 0.547 . . . . 0.0 111.774 -168.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.614 ' CG ' HD23 ' A' ' 93' ' ' LEU . 13.1 m-85 -66.23 -30.77 71.29 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -174.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.523 ' CZ ' HD21 ' A' ' 93' ' ' LEU . 5.8 m-85 -110.8 129.4 55.86 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 105.95 -1.871 . . . . 0.0 105.95 -167.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.7 m -55.31 -30.87 61.06 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.819 -0.61 . . . . 0.0 110.383 174.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -154.28 151.83 29.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.229 1.012 . . . . 0.0 109.093 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 4.9 mp -130.85 77.63 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 174.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.4 mt -66.2 147.19 53.7 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -176.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 57.8 p -122.96 177.96 5.27 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.061 0.944 . . . . 0.0 110.14 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 t -45.91 -37.61 6.56 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.993 0.917 . . . . 0.0 110.604 165.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -62.32 -18.37 61.2 Favored 'General case' 0 C--N 1.343 0.299 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 -177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.3 p -48.37 -48.89 36.33 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.169 0.895 . . . . 0.0 112.277 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 100.96 -5.81 56.53 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 117.688 -1.618 . . . . 0.0 112.852 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -60.65 163.12 5.76 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 119.617 1.708 . . . . 0.0 110.904 172.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 6.2 m -52.73 156.29 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 126.973 2.109 . . . . 0.0 112.555 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.5 mmt85 -81.19 154.58 26.6 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.666 0.786 . . . . 0.0 108.924 173.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -54.66 144.29 45.52 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.282 1.033 . . . . 0.0 113.148 -173.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.58 135.53 35.98 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 N-CA-C 108.261 -1.477 . . . . 0.0 108.261 -8.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.6 p -128.43 61.28 53.24 Favored Pre-proline 0 CA--C 1.536 0.427 0 C-N-CA 123.223 0.609 . . . . 0.0 111.84 -157.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -60.56 -24.22 77.65 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.164 2.576 . . . . 0.0 113.155 -167.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -51.33 -38.56 53.69 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 120.897 -1.127 . . . . 0.0 112.366 173.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.671 ' O ' HD13 ' A' ' 148' ' ' LEU . . . -74.3 4.86 5.15 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.236 1.014 . . . . 0.0 112.702 -178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.71 -40.67 5.67 Favored 'General case' 0 C--O 1.221 -0.438 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.686 163.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.2 m -55.21 -35.45 64.91 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.415 1.007 . . . . 0.0 110.65 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.694 ' HD1' HD12 ' A' ' 148' ' ' LEU . 47.8 t80 -66.07 -49.37 67.86 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.574 0.75 . . . . 0.0 110.922 171.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.694 HD12 ' HD1' ' A' ' 147' ' ' TYR . 8.1 mp -67.43 -14.11 62.63 Favored 'General case' 0 C--O 1.223 -0.304 0 C-N-CA 125.441 1.496 . . . . 0.0 113.171 -177.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 92.1 mt -84.22 -53.48 5.47 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 126.877 2.071 . . . . 0.0 107.826 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.28 -37.55 85.95 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -174.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -54.87 -20.0 7.81 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.478 1.911 . . . . 0.0 115.125 -174.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -158.38 22.52 0.24 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 127.843 2.457 . . . . 0.0 112.71 -177.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.9 mm-40 49.25 46.8 22.76 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.004 1.721 . . . . 0.0 113.462 -178.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 30.0 mt -78.45 169.18 18.66 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.251 1.02 . . . . 0.0 109.899 -177.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -108.37 130.94 55.2 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 123.229 0.611 . . . . 0.0 109.958 -174.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.4 m -60.14 -43.96 95.31 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 123.944 0.898 . . . . 0.0 110.16 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.83 -23.68 59.68 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.633 -1.292 . . . . 0.0 113.449 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -93.2 3.86 54.97 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.067 176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.2 t -102.16 126.06 49.03 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -106.46 163.75 12.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -139.67 127.54 22.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 173.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 7.4 mt -98.91 116.92 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 125.884 1.674 . . . . 0.0 107.003 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -139.95 -164.97 10.1 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.466 1.508 . . . . 0.0 110.071 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -138.23 -1.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.984 1.476 . . . . 0.0 114.984 -172.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.09 169.14 13.71 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 122.404 1.097 . . . . 0.0 111.505 -160.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 12.1 t -59.63 -32.24 70.25 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.571 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.75 -17.25 64.0 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 120.566 -1.334 . . . . 0.0 111.864 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -83.95 1.7 42.31 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.076 -1.015 . . . . 0.0 111.933 -165.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.8 p -91.87 -28.44 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 O-C-N 121.401 -0.812 . . . . 0.0 112.148 158.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -67.23 -58.26 5.17 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 120.087 1.312 . . . . 0.0 111.399 -161.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -55.9 -45.12 78.75 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 124.645 1.178 . . . . 0.0 111.915 170.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.97 -48.91 79.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 122.63 0.372 . . . . 0.0 111.409 -176.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -59.12 -46.11 89.18 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.396 1.878 . . . . 0.0 109.822 175.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -59.71 -45.02 93.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.657 -178.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 74.6 m -81.22 -22.14 39.01 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.87 61.75 2.99 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.474 1.035 . . . . 0.0 110.693 -173.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 14.2 pt -129.0 -173.22 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.749 2.02 . . . . 0.0 109.058 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 37.4 mm-40 -111.81 166.01 11.56 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.992 0.917 . . . . 0.0 110.146 -176.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 32.7 m -145.19 151.57 38.63 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.355 1.062 . . . . 0.0 112.387 -170.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 10.5 mt -138.0 101.95 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -135.06 160.88 36.92 Favored 'General case' 0 CA--C 1.513 -0.477 0 O-C-N 120.867 -1.145 . . . . 0.0 109.209 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -73.52 0.42 12.54 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.297 -0.877 . . . . 0.0 111.362 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 22.8 mt -114.01 154.7 27.2 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 125.728 1.611 . . . . 0.0 109.54 177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -79.94 154.13 28.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 164.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.8 m -136.67 163.85 29.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 125.876 1.671 . . . . 0.0 107.218 173.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 62.0 p -93.38 64.56 3.71 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -169.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -146.52 162.19 38.87 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.687 1.195 . . . . 0.0 109.8 -170.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.8 -54.86 6.55 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.893 0.877 . . . . 0.0 110.774 -179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.15 24.48 6.15 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 125.074 1.321 . . . . 0.0 113.774 -175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -85.45 111.27 19.81 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 125.407 1.483 . . . . 0.0 108.31 171.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -99.23 125.0 44.73 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 168.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.2 148.47 30.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 118.737 -0.649 . . . . 0.0 109.394 169.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 13.6 pt -133.96 156.94 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 123.982 0.913 . . . . 0.0 112.457 172.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 -97.06 -29.63 13.52 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.446 1.098 . . . . 0.0 111.913 164.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -146.72 162.15 39.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.64 1.576 . . . . 0.0 108.496 -167.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 78.9 mt -65.49 -43.92 88.7 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -60.59 -19.63 58.23 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.79 0.723 . . . . 0.0 112.7 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.42 -21.53 66.67 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.038 0.835 . . . . 0.0 112.031 175.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 67.1 mt -50.91 -60.2 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 4.6 m -61.89 -32.27 72.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 119.164 0.893 . . . . 0.0 112.008 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 31.7 mtp180 -62.18 -35.33 78.5 Favored 'General case' 0 CA--C 1.518 -0.269 0 O-C-N 121.204 -0.935 . . . . 0.0 111.231 -178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 36.1 mt -54.87 -55.08 17.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 C-N-CA 124.767 1.227 . . . . 0.0 109.273 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -67.58 -5.65 16.4 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.285 0.634 . . . . 0.0 112.054 -177.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -121.14 8.5 10.36 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.659 2.383 . . . . 0.0 109.953 -173.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 26.3 m -151.33 62.0 0.89 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 127.067 2.147 . . . . 0.0 106.347 170.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? . . . . . 0 C--O 1.25 1.1 0 C-N-CA 129.317 3.047 . . . . 0.0 112.399 176.375 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.855 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 44.81 62.82 1.93 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.235 1.814 . . . . 0.0 113.572 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' CE ' HD11 ' A' ' 101' ' ' ILE . 61.2 mmm -123.75 85.02 2.35 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 122.814 1.292 . . . . 0.0 107.552 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.01 175.24 0.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.413 162.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.66 101.14 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.72 1.208 . . . . 0.0 109.747 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 86.9 m -122.88 152.7 40.51 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 -175.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.69 152.62 44.05 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.426 0.631 . . . . 0.0 110.154 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.428 ' CD2' HD11 ' A' ' 162' ' ' ILE . 1.6 m-85 -134.74 142.85 46.86 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 125.071 1.349 . . . . 0.0 108.854 -168.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.1 mt -145.98 77.83 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.712 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -165.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -69.08 172.19 7.13 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 118.196 0.453 . . . . 0.0 110.505 -173.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.426 ' CG ' ' H ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -127.08 -167.89 1.8 Allowed 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.578 -1.326 . . . . 0.0 108.559 170.071 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.426 ' H ' ' CG ' ' A' ' 9' ' ' ASP . 0.5 OUTLIER -142.66 66.56 1.32 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 127.921 2.489 . . . . 0.0 106.303 -159.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -162.65 -64.46 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 123.18 0.592 . . . . 0.0 109.547 -170.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -121.62 -1.54 10.84 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.859 1.218 . . . . 0.0 113.841 -173.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 C--O 1.26 1.628 0 C-N-CA 124.616 1.167 . . . . 0.0 108.859 168.055 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.625 HD13 ' N ' ' A' ' 86' ' ' MET . 3.1 tm? . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.625 ' N ' HD13 ' A' ' 85' ' ' LEU . 30.6 ttm -103.53 87.35 1.38 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 127.267 2.227 . . . . 0.0 108.793 -166.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -61.9 113.23 1.76 Allowed 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 124.341 3.361 . . . . 0.0 109.595 -174.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.53 -50.25 0.9 Allowed Glycine 0 CA--C 1.523 0.561 0 N-CA-C 108.548 -1.821 . . . . 0.0 108.548 -166.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.77 -44.9 88.54 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 123.988 0.915 . . . . 0.0 109.946 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.51 ' HA ' HD22 ' A' ' 93' ' ' LEU . 15.9 ttt180 -63.42 -25.43 68.28 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -164.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -55.68 -66.45 0.42 Allowed 'General case' 0 C--N 1.329 -0.326 0 O-C-N 124.57 1.169 . . . . 0.0 109.211 165.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.36 -46.51 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 116.653 -1.642 . . . . 0.0 113.259 -172.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.51 HD22 ' HA ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -45.44 -53.39 8.82 Favored 'General case' 0 N--CA 1.423 -1.796 0 CA-C-N 120.365 1.438 . . . . 0.0 112.286 171.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -69.37 -41.47 76.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.856 0.723 . . . . 0.0 110.611 -170.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 38.8 t90 -61.88 -50.15 73.36 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.322 1.049 . . . . 0.0 109.812 175.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.87 -33.43 74.73 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.809 1.643 . . . . 0.0 111.666 -175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -59.38 -60.57 3.65 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.631 0.772 . . . . 0.0 109.343 174.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -58.55 -13.92 6.84 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.2 -6.66 37.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 175.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 68.06 16.22 68.36 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.312 0.958 . . . . 0.0 111.927 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.413 HD11 ' CE ' ' A' ' 1' ' ' MET . 54.0 mt -66.65 99.69 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 C-N-CA 125.424 1.49 . . . . 0.0 107.013 171.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -62.36 108.36 1.09 Allowed 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -175.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -87.34 155.89 19.85 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -150.07 173.76 13.5 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 128.459 2.704 . . . . 0.0 107.325 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.473 HD12 HD11 ' A' ' 117' ' ' LEU . 13.7 mt -136.51 156.79 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.669 0.788 . . . . 0.0 109.438 171.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -135.37 140.44 45.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.11 0.964 . . . . 0.0 111.583 165.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.9 t -154.31 167.73 28.96 Favored 'General case' 0 C--O 1.234 0.266 0 O-C-N 121.33 -0.856 . . . . 0.0 110.455 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 30.3 m80 -94.66 -1.39 53.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.199 1.8 . . . . 0.0 111.803 168.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HE2' ' CD1' ' A' ' 116' ' ' ILE . 0.0 OUTLIER -78.43 171.02 15.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 121.365 1.893 . . . . 0.0 110.571 178.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.446 ' HA2' HE22 ' A' ' 133' ' ' GLN . . . -69.68 -178.16 20.6 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.738 1.161 . . . . 0.0 112.924 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -53.61 -18.98 3.36 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.556 1.542 . . . . 0.0 112.539 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.14 -27.34 0.95 Allowed 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 125.6 1.56 . . . . 0.0 113.379 172.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -49.83 -52.87 29.15 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.197 0.999 . . . . 0.0 111.506 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -56.7 -43.5 80.59 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.401 0.68 . . . . 0.0 110.311 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.6 m -59.89 -48.59 81.07 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.655 1.182 . . . . 0.0 110.898 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.401 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 62.0 mt -56.66 -46.84 82.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.825 0.85 . . . . 0.0 109.613 -177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 105' ' ' ILE . 94.1 mt -63.97 -44.6 92.26 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.78 0.832 . . . . 0.0 110.794 -174.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.96 -60.65 2.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 124.284 0.99 . . . . 0.0 108.943 169.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.61 -58.04 9.08 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.917 0.887 . . . . 0.0 112.185 -174.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.1 -32.17 73.47 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.68 -170.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.82 44.23 0.55 Allowed Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 157.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.722 HG23 ' HD2' ' A' ' 125' ' ' TYR . 2.0 p -166.22 52.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.428 -1.531 0 N-CA-C 102.986 -2.968 . . . . 0.0 102.986 -166.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -41.04 29.89 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 118.783 -2.448 . . . . 0.0 108.878 153.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 32.3 t -72.12 -8.29 53.85 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.349 1.46 . . . . 0.0 113.058 -158.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.722 ' HD2' HG23 ' A' ' 122' ' ' VAL . 75.7 m-85 -80.89 -31.8 35.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 123.005 0.522 . . . . 0.0 109.857 172.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.557 ' CE2' HG22 ' A' ' 122' ' ' VAL . 14.9 m-85 -105.58 101.97 11.46 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 120.624 -1.297 . . . . 0.0 108.229 -168.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.8 m -46.19 -51.28 14.51 Favored 'General case' 0 C--O 1.255 1.367 0 C-N-CA 126.117 1.767 . . . . 0.0 111.113 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -142.7 144.4 32.69 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.262 0.625 . . . . 0.0 109.553 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.3 mt -132.26 97.81 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 104.413 -2.439 . . . . 0.0 104.413 -166.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.41 162.13 29.89 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 38.9 p -144.48 -177.38 5.46 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.358 1.463 . . . . 0.0 108.559 -177.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 96.8 p -51.1 -32.62 23.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 119.093 0.86 . . . . 0.0 111.856 172.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.446 HE22 ' HA2' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -60.95 -21.87 63.88 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 126.499 1.92 . . . . 0.0 111.348 -178.032 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 65.0 p -57.51 -23.37 49.81 Favored 'General case' 0 C--O 1.225 -0.218 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 89.05 -14.95 59.24 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.225 0.916 . . . . 0.0 111.936 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -66.05 167.74 9.41 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 123.968 1.842 . . . . 0.0 113.23 -173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 46.7 t -58.04 154.14 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 C-N-CA 129.676 3.191 . . . . 0.0 109.91 177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.13 43.71 1.05 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.752 0.787 . . . . 0.0 110.808 -172.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 88.0 mttt 70.29 147.65 0.12 Allowed Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 128.394 2.678 . . . . 0.0 110.633 -168.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -62.8 124.34 3.2 Favored 'Cis proline' 0 N--CA 1.45 -1.051 0 N-CA-C 107.619 -1.724 . . . . 0.0 107.619 -22.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 13.1 t -116.32 85.26 15.6 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 -178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.49 -22.5 28.67 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.295 1.997 . . . . 0.0 111.405 172.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -56.31 -38.11 70.82 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.647 1.579 . . . . 0.0 110.397 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.596 ' O ' HD13 ' A' ' 148' ' ' LEU . . . -65.45 -20.55 66.41 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.551 -169.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.66 -41.27 10.82 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 116.338 -1.791 . . . . 0.0 109.553 171.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.453 ' HA ' HD12 ' A' ' 149' ' ' LEU . 23.5 m -56.58 -36.05 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 120.95 1.705 . . . . 0.0 110.586 -177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.721 ' HD1' HD12 ' A' ' 148' ' ' LEU . 22.8 t80 -56.99 -52.62 64.55 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.826 0.85 . . . . 0.0 109.756 171.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.721 HD12 ' HD1' ' A' ' 147' ' ' TYR . 8.8 mp -60.34 -39.74 88.22 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.726 1.61 . . . . 0.0 111.343 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.509 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 71.4 mt -57.82 -61.07 2.79 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.83 -31.31 72.45 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.707 0.803 . . . . 0.0 111.56 -171.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.19 -43.08 78.12 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 120.91 -1.119 . . . . 0.0 113.276 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -137.26 26.56 2.9 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -174.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 23.7 mp0 45.93 50.92 11.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.409 2.283 . . . . 0.0 110.441 -176.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' A' ' 149' ' ' LEU . 65.8 mt -81.68 167.86 18.72 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.231 -1.35 . . . . 0.0 109.698 -178.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -104.07 130.41 51.76 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 124.92 1.288 . . . . 0.0 108.407 -172.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -52.7 62.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 122.433 1.111 . . . . 0.0 109.038 176.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.91 -10.74 59.73 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 120.998 -1.064 . . . . 0.0 112.834 -170.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -112.15 17.54 19.45 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.945 0.898 . . . . 0.0 109.322 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 1.3 t -104.38 145.69 29.9 Favored 'General case' 0 C--N 1.351 0.632 0 CA-C-N 118.745 0.702 . . . . 0.0 109.501 169.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.474 ' CD1' ' HB2' ' A' ' 178' ' ' GLN . 95.8 m-85 -125.02 159.06 32.19 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 126.036 1.734 . . . . 0.0 109.856 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -116.03 -39.27 3.47 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 -177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.428 HD11 ' CD2' ' A' ' 6' ' ' PHE . 1.3 mp 57.09 75.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 125.604 1.562 . . . . 0.0 112.44 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -128.1 -175.97 14.28 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.367 0.984 . . . . 0.0 110.867 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -130.59 26.7 5.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.54 1.536 . . . . 0.0 114.106 -156.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.442 ' HD3' ' HB2' ' A' ' 167' ' ' LEU . 1.9 ptp85 -160.62 159.85 30.95 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.725 2.01 . . . . 0.0 107.899 -178.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 21.6 p -51.8 -37.56 52.09 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.761 0.791 . . . . 0.0 111.86 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.442 ' HB2' ' HD3' ' A' ' 165' ' ' ARG . 0.2 OUTLIER -62.1 -13.31 25.38 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -179.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.44 -35.15 78.66 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 119.988 1.267 . . . . 0.0 110.546 172.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 3.5 p -104.36 -24.27 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 124.3 1.04 . . . . 0.0 110.783 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -61.73 -38.26 87.27 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 120.474 -1.392 . . . . 0.0 110.949 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -75.27 -38.12 60.59 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 118.36 -0.829 . . . . 0.0 110.287 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.34 -45.26 69.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 124.978 1.311 . . . . 0.0 110.271 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -50.63 -43.09 56.91 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 124.946 1.299 . . . . 0.0 111.978 175.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -72.27 -22.12 61.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 118.419 -0.801 . . . . 0.0 113.057 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 t -96.1 -20.84 18.34 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 118.669 0.668 . . . . 0.0 110.314 173.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.9 49.8 6.25 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.374 -1.091 . . . . 0.0 110.374 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 6.6 pt -128.15 178.0 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 126.038 1.735 . . . . 0.0 109.239 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.474 ' HB2' ' CD1' ' A' ' 160' ' ' TYR . 7.2 mm-40 -109.04 168.61 9.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 122.661 1.22 . . . . 0.0 111.815 -174.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.56 141.39 25.76 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.868 2.067 . . . . 0.0 108.785 -174.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 57.3 mt -121.01 86.5 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 104.981 -2.229 . . . . 0.0 104.981 -177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 192' ' ' ARG . 0.1 OUTLIER -95.43 176.58 6.14 Favored 'General case' 0 C--O 1.212 -0.878 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.835 -167.054 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -109.64 -6.42 15.35 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 119.654 -1.904 . . . . 0.0 111.469 173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.494 ' H ' HD13 ' A' ' 183' ' ' LEU . 0.0 OUTLIER -118.96 146.2 45.18 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.644 1.978 . . . . 0.0 108.574 176.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.84 144.97 56.49 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 11.7 t -122.23 171.91 8.67 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 112.854 -1.976 . . . . 0.0 107.01 177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 9.9 p -114.4 27.7 9.28 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 126.26 1.824 . . . . 0.0 109.666 -175.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -123.24 140.81 52.64 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.418 1.487 . . . . 0.0 110.014 -175.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -77.54 96.61 4.8 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.28 1.832 . . . . 0.0 109.415 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 133.76 -1.89 4.38 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-O 119.101 -0.833 . . . . 0.0 112.427 -176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.8 153.51 34.85 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 119.394 1.597 . . . . 0.0 108.407 168.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -138.12 99.95 4.01 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 181' ' ' ASN 0.292 0.2 OUTLIER -75.0 151.44 38.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 115.682 -2.407 . . . . 0.0 109.4 175.403 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 10.0 pt -126.27 -176.5 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 C-N-CA 130.032 3.333 . . . . 0.0 107.982 179.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -126.83 -14.63 5.59 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 125.247 1.419 . . . . 0.0 111.75 167.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -157.93 165.0 36.29 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.52 0.6 . . . . 0.0 109.455 177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 1.1 tp -70.39 -25.89 63.45 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 121.146 -0.971 . . . . 0.0 110.474 -174.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -66.34 -32.12 73.32 Favored 'General case' 0 CA--C 1.532 0.288 0 O-C-N 121.06 -1.025 . . . . 0.0 111.115 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.65 -22.17 63.55 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.036 2.534 . . . . 0.0 110.728 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 63.2 mt -57.28 -56.7 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 C-N-CA 124.409 1.084 . . . . 0.0 109.009 171.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 96.3 p -52.45 -40.39 62.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.539 0.609 . . . . 0.0 111.384 -176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 34.0 mtt85 -64.03 -32.8 74.49 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 117.447 -1.263 . . . . 0.0 112.541 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 58.9 mt -53.23 -45.57 55.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 120.088 1.313 . . . . 0.0 109.192 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -78.69 -5.45 53.12 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -117.1 5.94 12.83 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.823 1.249 . . . . 0.0 113.205 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . 0.271 86.0 m -143.64 28.43 1.45 Allowed 'General case' 0 CA--C 1.546 0.819 0 O-C-N 120.893 -1.129 . . . . 0.0 110.816 -169.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.314 29.8 pttt . . . . . 0 N--CA 1.476 0.853 1 C-N-CA 132.07 4.148 . . . . 0.0 114.811 175.908 . . . . . . . . 2 1 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.813 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -123.49 15.39 9.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.049 0.925 . . . . 0.0 112.35 -174.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.9 mmm 50.19 74.11 0.23 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 124.735 1.214 . . . . 0.0 110.181 -172.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -62.63 173.51 1.25 Allowed 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 114.13 -1.396 . . . . 0.0 109.095 173.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 mmmm -44.17 83.74 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 127.029 2.132 . . . . 0.0 114.535 -175.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.8 m -110.76 159.83 17.27 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.821 1.248 . . . . 0.0 107.651 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.514 ' HB2' HD22 ' A' ' 154' ' ' LEU . . . -136.92 158.5 44.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.411 0.624 . . . . 0.0 110.937 162.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -114.3 174.85 5.74 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.61 1.164 . . . . 0.0 108.38 169.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 27.1 mt -139.84 137.2 39.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 163.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -119.07 178.2 4.59 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.485 1.914 . . . . 0.0 109.442 174.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.24 -179.8 6.47 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.246 1.819 . . . . 0.0 107.641 -170.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.57 -1.36 10.1 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 120.762 -1.211 . . . . 0.0 114.238 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.05 -42.05 27.37 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 120.743 -1.223 . . . . 0.0 111.6 -172.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -153.49 -155.89 7.37 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -170.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . 0.41 1.3 t . . . . . 0 C--O 1.255 1.378 0 C-N-CA 127.828 2.451 . . . . 0.0 111.139 170.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.616 HD11 ' HG2' ' A' ' 90' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.472 0.653 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.532 ' H ' HD13 ' A' ' 85' ' ' LEU . 41.3 tpp -115.34 86.3 14.41 Favored Pre-proline 0 N--CA 1.448 -0.574 0 C-N-CA 125.849 1.659 . . . . 0.0 108.322 -175.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -64.94 100.92 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.474 3.45 . . . . 0.0 110.255 -172.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 132.83 -40.46 1.61 Allowed Glycine 0 C--O 1.227 -0.31 0 C-N-CA 124.66 1.124 . . . . 0.0 110.571 -175.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.86 -20.11 60.53 Favored 'General case' 0 C--O 1.224 -0.28 0 O-C-N 121.126 -1.22 . . . . 0.0 109.319 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.616 ' HG2' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -92.74 -9.8 39.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.952 1.701 . . . . 0.0 112.393 176.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -65.82 -38.98 90.4 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.425 1.09 . . . . 0.0 110.796 165.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.7 -39.72 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.351 -0.843 . . . . 0.0 110.772 -173.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.922 HD23 ' CD2' ' A' ' 125' ' ' TYR . 6.9 mp -44.35 -41.0 5.75 Favored 'General case' 0 N--CA 1.426 -1.643 0 C-N-CA 127.797 2.439 . . . . 0.0 111.549 166.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -66.17 -50.8 62.66 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 124.903 1.377 . . . . 0.0 109.581 -177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 19.2 t90 -56.71 -45.45 81.85 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.766 0.827 . . . . 0.0 110.475 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.31 -38.81 71.73 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.362 1.065 . . . . 0.0 113.138 -174.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -64.58 -52.11 59.26 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.613 1.165 . . . . 0.0 109.635 -177.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -60.72 -38.12 84.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.336 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.0 m -71.86 -1.26 13.62 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.5 16.14 60.37 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.46 1.505 . . . . 0.0 113.259 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.9 mt -76.05 101.11 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -57.42 109.95 0.78 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.07 1.348 . . . . 0.0 108.913 -174.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -84.6 147.13 27.14 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 172.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -137.39 168.25 20.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 168.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mt -124.53 149.75 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 123.529 0.731 . . . . 0.0 109.132 171.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -134.04 128.11 33.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 157.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 t -145.97 -173.95 4.3 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 162.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -126.04 12.77 7.8 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.36 1.864 . . . . 0.0 112.229 -175.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.491 ' HE2' ' CD1' ' A' ' 116' ' ' ILE . 0.5 OUTLIER -73.28 -10.43 59.75 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -165.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 126.91 174.62 13.85 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 126.399 1.952 . . . . 0.0 109.764 -170.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.63 -29.08 70.37 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 117.491 0.645 . . . . 0.0 110.421 172.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -51.64 -14.81 0.37 Allowed 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 127.435 2.294 . . . . 0.0 114.544 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -53.68 -44.53 69.81 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.528 1.058 . . . . 0.0 111.061 169.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -63.22 -7.82 6.84 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.317 1.847 . . . . 0.0 114.122 174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 19.0 m -101.92 -49.3 4.0 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 120.521 -1.362 . . . . 0.0 108.501 179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.491 ' CD1' ' HE2' ' A' ' 109' ' ' LYS . 52.4 mt -52.64 -48.92 47.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.396 0 C-N-CA 123.799 0.84 . . . . 0.0 109.367 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.9 mt -64.01 -35.99 82.52 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.0 -1.062 . . . . 0.0 111.366 -172.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.12 -50.45 73.65 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.064 1.345 . . . . 0.0 109.359 172.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -57.01 -48.11 79.26 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 125.56 1.544 . . . . 0.0 111.312 -177.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 99.5 mt -58.81 -50.44 73.95 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.476 1.11 . . . . 0.0 108.391 174.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 104.9 36.16 3.04 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 125.065 1.317 . . . . 0.0 112.271 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.94 22.61 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.855 1.662 . . . . 0.0 110.314 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.25 -54.33 46.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.51 1.524 . . . . 0.0 112.657 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 43.7 m -76.56 -12.62 60.05 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -164.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.922 ' CD2' HD23 ' A' ' 93' ' ' LEU . 26.0 m-85 -54.82 -32.64 60.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.938 0.79 . . . . 0.0 110.943 164.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -98.37 106.18 18.42 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -172.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.4 m -45.08 -54.11 7.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.559 1.944 . . . . 0.0 110.752 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -142.93 150.24 39.49 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 mt -131.77 88.56 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 -168.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -71.94 145.2 48.6 Favored 'General case' 0 CA--C 1.514 -0.438 0 O-C-N 121.317 -0.864 . . . . 0.0 109.196 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 37.7 p -121.77 -173.31 2.62 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.766 0.826 . . . . 0.0 110.553 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.4 p -56.44 -20.0 17.81 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 121.001 -1.062 . . . . 0.0 113.31 167.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -77.21 -3.98 42.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.48 1.512 . . . . 0.0 111.918 174.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 88.3 p -58.76 -25.64 63.23 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -172.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.82 20.19 31.93 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.204 0.906 . . . . 0.0 114.824 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -78.16 -86.89 0.06 Allowed 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.559 1.679 . . . . 0.0 107.667 168.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.0 t -150.87 168.42 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 126.177 1.791 . . . . 0.0 107.743 -170.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.604 ' H ' ' HD3' ' A' ' 138' ' ' ARG 0.255 0.0 OUTLIER -74.06 -85.16 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 117.817 -1.087 . . . . 0.0 109.583 166.798 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -160.15 139.23 7.94 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 121.32 1.873 . . . . 0.0 109.42 -172.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.86 -28.56 4.55 Favored 'Cis proline' 0 C--N 1.35 0.629 0 CA-C-N 121.035 1.405 . . . . 0.0 115.12 7.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.9 t 59.98 62.3 3.55 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.667 1.187 . . . . 0.0 113.211 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -61.94 -24.42 76.93 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.549 2.166 . . . . 0.0 112.584 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -56.17 -28.77 59.35 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.939 1.296 . . . . 0.0 112.463 -171.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.08 -42.9 77.42 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.056 0.943 . . . . 0.0 110.055 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.56 -40.26 92.62 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.693 -0.63 . . . . 0.0 111.288 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.6 m -55.37 -40.32 71.18 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.268 0.627 . . . . 0.0 110.514 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -66.64 -51.24 58.47 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 5.9 mp -56.06 -38.67 70.94 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.458 1.103 . . . . 0.0 111.749 -174.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.479 ' HA ' ' HB2' ' A' ' 154' ' ' LEU . 0.0 OUTLIER -60.45 -61.85 2.29 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 126.823 2.049 . . . . 0.0 107.473 177.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -57.35 -36.89 71.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.53 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? -48.65 -45.4 38.62 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.378 1.071 . . . . 0.0 112.545 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.75 21.71 10.69 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 119.411 1.005 . . . . 0.0 112.863 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 50.78 69.5 0.63 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.921 1.689 . . . . 0.0 110.112 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 5' ' ' ALA . 1.1 mt -122.41 178.87 4.78 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 125.544 1.537 . . . . 0.0 108.506 -173.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -120.0 151.49 38.91 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 126.689 1.996 . . . . 0.0 111.361 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 53.5 m -55.91 -33.71 64.92 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 121.355 0.598 . . . . 0.0 110.084 174.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.93 -35.11 64.55 Favored 'General case' 0 N--CA 1.429 -1.518 0 O-C-N 120.559 -1.338 . . . . 0.0 109.866 -176.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -77.83 1.15 21.24 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.977 -1.487 . . . . 0.0 113.639 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.709 HG23 ' HB ' ' A' ' 177' ' ' ILE . 4.6 t -97.78 140.03 32.77 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 120.322 1.419 . . . . 0.0 110.43 -176.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -127.7 109.05 11.28 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.423 1.489 . . . . 0.0 110.559 177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -91.83 131.31 37.27 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 122.838 0.455 . . . . 0.0 111.079 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 8.2 mt -117.18 119.35 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 126.348 1.859 . . . . 0.0 109.011 -174.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -145.52 -21.49 0.14 Allowed Glycine 0 CA--C 1.535 1.299 0 N-CA-C 116.498 1.359 . . . . 0.0 116.498 -175.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.404 ' HB2' ' CD1' ' A' ' 182' ' ' PHE . 19.2 t70 59.29 58.13 3.15 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.538 1.935 . . . . 0.0 112.886 -174.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -163.35 164.28 24.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.498 -1.376 . . . . 0.0 112.128 172.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.3 t -51.72 -53.07 43.35 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.906 1.282 . . . . 0.0 111.366 167.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.76 -20.59 66.45 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 125.602 1.561 . . . . 0.0 110.882 -165.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -67.18 -34.78 78.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.677 -0.64 . . . . 0.0 110.267 -178.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.402 ' HA ' ' HB3' ' A' ' 172' ' ' ALA . 2.7 t -82.13 -11.98 12.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 123.5 0.72 . . . . 0.0 111.353 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.06 -55.89 18.91 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 169.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -54.05 -42.01 68.74 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.261 1.025 . . . . 0.0 111.479 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . . . -60.77 -26.48 67.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.767 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -90.14 -42.09 11.26 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 119.921 1.237 . . . . 0.0 109.225 -169.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.61 -29.23 69.22 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 176.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.419 ' HB3' HG23 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -80.04 -41.23 26.12 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.23 0.923 . . . . 0.0 110.377 169.028 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 80.4 56.32 3.22 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.354 -1.898 . . . . 0.0 108.354 -170.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.709 ' HB ' HG23 ' A' ' 159' ' ' THR . 41.7 pt -129.88 165.03 31.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 127.643 2.377 . . . . 0.0 106.146 -174.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -85.27 163.07 18.85 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 121.168 -0.958 . . . . 0.0 109.96 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.39 162.52 34.83 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.823 0.82 . . . . 0.0 109.834 172.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 36.0 mt -138.57 120.56 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -139.56 164.64 29.36 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' PHE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 164' ' ' ASP . 86.2 m-85 -74.69 9.02 2.0 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 177.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.5 151.81 36.99 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.009 1.324 . . . . 0.0 109.18 -166.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -70.55 147.55 49.18 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.15 26.19 2.03 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.522 1.129 . . . . 0.0 111.183 167.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 17.3 p 50.67 45.82 26.49 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.466 1.507 . . . . 0.0 111.734 164.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -136.28 157.06 47.71 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.983 2.113 . . . . 0.0 106.365 177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -75.4 -45.63 37.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.619 0.645 . . . . 0.0 111.665 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -68.86 -9.02 58.69 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 119.063 -0.854 . . . . 0.0 112.878 -176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -95.09 100.92 12.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 120.041 1.92 . . . . 0.0 109.181 -173.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -79.74 134.07 36.37 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.28 0.632 . . . . 0.0 109.343 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . 0.41 ' HB3' HH11 ' A' ' 192' ' ' ARG . 0.0 OUTLIER -77.72 151.56 34.1 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 166.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.83 166.68 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.409 1.883 . . . . 0.0 109.955 171.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -129.54 0.73 5.0 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.385 1.474 . . . . 0.0 112.799 168.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -152.05 165.56 34.32 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.289 1.436 . . . . 0.0 108.307 171.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 69.3 mt -73.62 -33.66 64.67 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 118.578 0.626 . . . . 0.0 110.154 176.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.51 -22.27 66.15 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -62.75 -21.72 66.04 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.367 -0.833 . . . . 0.0 110.799 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.49 -55.97 19.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 125.138 1.375 . . . . 0.0 109.087 174.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' SER . . . . . . . . . . . . . 95.0 p -60.02 -33.19 71.67 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 120.055 1.298 . . . . 0.0 110.877 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -63.24 -33.69 76.05 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.044 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.1 mt -50.31 -58.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -67.26 -12.76 60.94 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.584 1.153 . . . . 0.0 112.952 -174.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -106.23 5.73 30.11 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.184 1.394 . . . . 0.0 112.853 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.4 m -128.87 25.17 5.63 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.28 1.032 . . . . 0.0 112.236 -175.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . 0.271 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 C-N-CA 128.923 2.889 . . . . 0.0 111.19 -168.297 . . . . . . . . 2 2 . 1 stop_ save_